DataSet	Human Name	NEST ID	GenesFixed	n_Genes	log2_n_Genes	GO term	GO ID	GSEA genes	n_overlap_GSEA	perc_overlap_GSEA	P-value	Adjusted P-value	LLM Name	LLM Analysis	n_overlap_LLM	perc_overlap_LLM	References	LLM_name_human_name_sim	GO_term_human_name_sim	winner	humanConsensus	OverridingDecision
NeST	Transcription regulation	NEST:10	ARID1A ARID1B ARID2 ATRX BARD1 BCL11B BCL7A BCLAF1 BRD4 CASP8 CDC73 CDK12 CHD2 CHD4 CREBBP CTCF CTNNB1 DDX3X DNMT1 DNMT3A DNMT3B E2F1 EMSY EP300 EWSR1 EZH2 FUBP1 FUS GATA3 HDAC1 HDAC2 HDAC3 HIST1H1E HIST3H3 ING1 IRF2 KDM5A KDM6A KMT2A KMT2B KMT2C KMT2D MAGI2 MDM2 MEN1 MTA1 MYC PALB2 PARP1 PBRM1 PHF6 PPP1CC PRCC PRDM1 PRKDC PRPF40B PTPN11 RAD21 RANBP2 RB1 RBM10 RSF1 RUNX1 SF1 SF3B1 SMARCA1 SMARCA4 SMARCB1 SMARCE1 SMC1A SMC3 SOX2 SPEN SRSF2 STAG1 STAG2 TAF1 TERT TNF TOP1 TOP2A TP53 U2AF1 UPF1 WRN XPO1 XRCC1 YEATS4 ZBTB2 ZNF217 ZRSR2	91	6.507794640198696	Regulation Of Transcription By RNA Polymerase II 	GO:0006357	RB1;DDX3X;SMARCB1;YEATS4;CHD4;PRDM1;CTCF;CHD2;TNF;PHF6;ING1;CDC73;SOX2;BCL7A;MYC;DNMT3B;EP300;ARID2;MEN1;PBRM1;PARP1;DNMT3A;ATRX;ARID1A;ARID1B;RUNX1;IRF2;TP53;KMT2D;HDAC2;HDAC3;KMT2A;HDAC1;PRKDC;KMT2C;GATA3;ZBTB2;BCLAF1;MTA1;RAD21;E2F1;SF3B1;BRD4;SMARCE1;SPEN;CREBBP;BCL11B;FUS;SMARCA1;SMARCA4;MDM2;ZNF217;CTNNB1;CDK12;TAF1;EZH2	56	61.53846153846154	5.607299427064176e-33	6.784832306747655e-30	Chromatin Remodeling and DNA Repair	"The primary biological process performed by this system of interacting proteins is chromatin remodeling and DNA repair. The proteins involved in this process play crucial roles in maintaining genomic stability and regulating gene expression.

1. Chromatin Remodeling: Several proteins in this system are part of the SWI/SNF family, including ARID1A, ARID1B, ARID2, SMARCA1, SMARCA4, SMARCB1, and SMARCE1. These proteins are involved in chromatin remodeling, which is essential for regulating gene expression and maintaining genomic stability. Additionally, proteins such as CHD2, CHD4, and ING1 are also involved in chromatin remodeling.

2. Histone Modification: Proteins such as CREBBP, EP300, EZH2, HDAC1, HDAC2, HDAC3, KDM5A, KDM6A, KMT2A, KMT2B, KMT2C, and KMT2D are involved in histone modification, which is crucial for regulating gene expression and maintaining chromatin structure.

3. DNA Methylation: DNMT1, DNMT3A, and DNMT3B are involved in DNA methylation, a process that plays a significant role in gene regulation and genomic stability.

4. DNA Repair: Several proteins in this system are involved in DNA repair pathways, including ATRX, BARD1, BRD4, CASP8, CDC73, CDK12, FUBP1, PALB2, PARP1, PRKDC, RAD21, SMC1A, SMC3, TOP1, TOP2A, TP53, XRCC1, and WRN. These proteins help maintain genomic integrity by repairing DNA damage.

5. Transcription Regulation: Proteins such as CTCF, CTNNB1, E2F1, GATA3, IRF2, MYC, RB1, RUNX1, SOX2, and TAF1 are involved in transcription regulation, which is essential for proper gene expression and cellular function.

6. RNA Processing: Proteins such as DDX3X, PRPF40B, SF1, SF3B1, SRSF2, U2AF1, UPF1, and ZRSR2 are involved in RNA processing, which is crucial for the proper maturation and function of RNA molecules.

7. Protein Stability and Degradation: MDM2 and XPO1 are involved in protein stability and degradation, which is essential for maintaining cellular homeostasis and preventing the accumulation of misfolded or damaged proteins.

In conclusion, the most prominent biological process performed by this system of interacting proteins is chromatin remodeling and DNA repair, which are essential for maintaining genomic stability and regulating gene expression."	63	69.23076923076923	"The primary biological process performed by this system of interacting proteins is chromatin remodeling and DNA repair. The proteins involved in this process play crucial roles in maintaining genomic stability and regulating gene expression.

1. Chromatin Remodeling: Several proteins in this system are part of the SWI/SNF family, including ARID1A, ARID1B, ARID2, SMARCA1, SMARCA4, SMARCB1, and SMARCE1. These proteins are involved in chromatin remodeling, which is essential for regulating gene expression and maintaining genomic stability. Additionally, proteins such as CHD2, CHD4, and ING1 are also involved in chromatin remodeling.[1][2][3]

2. Histone Modification: Proteins such as CREBBP, EP300, EZH2, HDAC1, HDAC2, HDAC3, KDM5A, KDM6A, KMT2A, KMT2B, KMT2C, and KMT2D are involved in histone modification, which is crucial for regulating gene expression and maintaining chromatin structure.[4][5][6]

3. DNA Methylation: DNMT1, DNMT3A, and DNMT3B are involved in DNA methylation, a process that plays a significant role in gene regulation and genomic stability.[7][8][9]

4. DNA Repair: Several proteins in this system are involved in DNA repair pathways, including ATRX, BARD1, BRD4, CASP8, CDC73, CDK12, FUBP1, PALB2, PARP1, PRKDC, RAD21, SMC1A, SMC3, TOP1, TOP2A, TP53, XRCC1, and WRN. These proteins help maintain genomic integrity by repairing DNA damage.[10][11][12]

5. Transcription Regulation: Proteins such as CTCF, CTNNB1, E2F1, GATA3, IRF2, MYC, RB1, RUNX1, SOX2, and TAF1 are involved in transcription regulation, which is essential for proper gene expression and cellular function.[13][14][15]

6. RNA Processing: Proteins such as DDX3X, PRPF40B, SF1, SF3B1, SRSF2, U2AF1, UPF1, and ZRSR2 are involved in RNA processing, which is crucial for the proper maturation and function of RNA molecules.[16][17][18]

7. Protein Stability and Degradation: MDM2 and XPO1 are involved in protein stability and degradation, which is essential for maintaining cellular homeostasis and preventing the accumulation of misfolded or damaged proteins.[19][20][21]

In conclusion, the most prominent biological process performed by this system of interacting proteins is chromatin remodeling and DNA repair, which are essential for maintaining genomic stability and regulating gene expression.

========================================================================================================================================================================================================
[1] Mardinian, Kristina, Adashek, Jacob J, Botta, Gregory P, Kato, Shumei, Kurzrock, Razelle. ""<i>SMARCA4</i>: Implications of an Altered Chromatin-Remodeling Gene for Cancer Development and Therapy."" Molecular cancer therapeutics, 2021, pp. 2341-2351.
[2] Jiang, Hao, Cao, Hui-Jun, Ma, Ning, Bao, Wen-Dai, Wang, Jing-Jing, Chen, Tian-Wei, Zhang, Er-Bin, Yuan, Yan-Mei, Ni, Qian-Zhi, Zhang, Feng-Kun, Ding, Xu-Fen, Zheng, Qian-Wen, Wang, Yi-Kang, Zhu, Min, Wang, Xiang, Feng, Jing, Zhang, Xue-Li, Cheng, Shu-Qun, Ma, Dan-Jun, Qiu, Lin, Li, Jing-Jing, Xie, Dong. ""Chromatin remodeling factor ARID2 suppresses hepatocellular carcinoma metastasis via DNMT1-Snail axis."" Proceedings of the National Academy of Sciences of the United States of America, 2020, pp. 4770-4780.
[3] Zhang, Shanshan, Zhou, Yu-Feng, Cao, Jian, Burley, Stephen K, Wang, Hui-Yun, Zheng, X F Steven. ""mTORC1 Promotes ARID1A Degradation and Oncogenic Chromatin Remodeling in Hepatocellular Carcinoma."" Cancer research, 2021, pp. 5652-5665.
[4] Zhang, Xinwei, Zhao, Xiaohong, Fiskus, Warren, Lin, Jianhong, Lwin, Tint, Rao, Rekha, Zhang, Yizhuo, Chan, John C, Fu, Kai, Marquez, Victor E, Chen-Kiang, Selina, Moscinski, Lynn C, Seto, Edward, Dalton, William S, Wright, Kenneth L, Sotomayor, Eduardo, Bhalla, Kapil, Tao, Jianguo. ""Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas."" Cancer cell, 2012, pp. 506-523.
[5] Fan, Jie, Iwata, S, Tanaka, Yoshiya, Kitanaga, Yukihiro, Ishii, Akina, Maiko, Hara, Zhang, Xueqiang, Liu, Xingde. ""Kdm5a promotes B cell activation in systemic lupus erythematosus via downregulation of A20 by histone modification."" Pathology, research and practice, 2021, pp. 153653.
[6] Chen, Jiying, Zhu, Zhiying, Xu, Shi, Li, Jing, Huang, Lilan, Tan, Wenqing, Zhang, Yonggang, Zhao, Yanli. ""HDAC1 participates in polycystic ovary syndrome through histone modification by regulating H19/miR-29a-3p/NLRP3-mediated granulosa cell pyroptosis."" Molecular and cellular endocrinology, 2023, pp. 111950.
[7] Dura, Mathilde, Teissandier, Aurélie, Armand, Mélanie, Barau, Joan, Lapoujade, Clémentine, Fouchet, Pierre, Bonneville, Lorraine, Schulz, Mathieu, Weber, Michael, Baudrin, Laura G, Lameiras, Sonia, Bourc'his, Deborah. ""DNMT3A-dependent DNA methylation is required for spermatogonial stem cells to commit to spermatogenesis."" Nature genetics, 2022, pp. 469-480.
[8] Zhang, Zhi-Min, Lu, Rui, Wang, Pengcheng, Yu, Yang, Chen, Dongliang, Gao, Linfeng, Liu, Shuo, Ji, Debin, Rothbart, Scott B, Wang, Yinsheng, Wang, Gang Greg, Song, Jikui. ""Structural basis for DNMT3A-mediated de novo DNA methylation."" Nature, 2018, pp. 387-391.
[9] Madsen, Alexandra, Höppner, Grit, Krause, Julia, Hirt, Marc N, Laufer, Sandra D, Schweizer, Michaela, Tan, Wilson Lek Wen, Mosqueira, Diogo, Anene-Nzelu, Chukwuemeka George, Lim, Ives, Foo, Roger S Y, Hansen, Arne, Eschenhagen, Thomas, Stenzig, Justus. ""An Important Role for DNMT3A-Mediated DNA Methylation in Cardiomyocyte Metabolism and Contractility."" Circulation, 2020, pp. 1562-1578.
[10] Ray Chaudhuri, Arnab, Nussenzweig, André. ""The multifaceted roles of PARP1 in DNA repair and chromatin remodelling."" Nature reviews. Molecular cell biology, 2017, pp. 610-621.
[11] Tarsounas, Madalena, Sung, Patrick. ""The antitumorigenic roles of BRCA1-BARD1 in DNA repair and replication."" Nature reviews. Molecular cell biology, 2020, pp. 284-299.
[12] Patterson-Fortin, Jeffrey, Bose, Arindam, Tsai, Wei-Chih, Grochala, Carter, Nguyen, Huy, Zhou, Jia, Parmar, Kalindi, Lazaro, Jean-Bernard, Liu, Joyce, McQueen, Kelsey, Shapiro, Geoffrey I, Kozono, David, D'Andrea, Alan D. ""Targeting DNA Repair with Combined Inhibition of NHEJ and MMEJ Induces Synthetic Lethality in TP53-Mutant Cancers."" Cancer research, 2022, pp. 3815-3829.
[13] Braccioli, Luca, de Wit, Elzo. ""CTCF: a Swiss-army knife for genome organization and transcription regulation."" Essays in biochemistry, 2019, pp. 157-165.
[14] Sekiya, Takeshi, Kato, Kohsuke, Kawaguchi, Atsushi, Nagata, Kyosuke. ""Involvement of CTCF in transcription regulation of EGR1 at early G1 phase as an architecture factor."" Scientific reports, 2019, pp. 329.
[15] Mimaki, Sachiyo, Mori-Furukawa, Yuko, Katsuno, Hikari, Kishimoto, Toshihiko. ""A transcriptional regulatory element screening system reveals a novel E2F1/pRb transcription regulation pathway."" Analytical biochemistry, 2005, pp. 268-80.
[16] Popli, Pooja, Richters, Megan M, Chadchan, Sangappa B, Kim, Tae Hoon, Tycksen, Eric, Griffith, Obi, Thaker, Premal H, Griffith, Malachi, Kommagani, Ramakrishna. ""Splicing factor SF3B1 promotes endometrial cancer progression via regulating KSR2 RNA maturation."" Cell death & disease, 2020, pp. 842.
[17] De La Garza, Adriana, Cameron, Rosannah C, Gupta, Varun, Fraint, Ellen, Nik, Sara, Bowman, Teresa V. ""The splicing factor Sf3b1 regulates erythroid maturation and proliferation via TGFβ signaling in zebrafish."" Blood advances, 2019, pp. 2093-2104.
[18] Conte, Simona, Katayama, Shintaro, Vesterlund, Liselotte, Karimi, Mohsen, Dimitriou, Marios, Jansson, Monika, Mortera-Blanco, Teresa, Unneberg, Per, Papaemmanuil, Elli, Sander, Birgitta, Skoog, Tiina, Campbell, Peter, Walfridsson, Julian, Kere, Juha, Hellström-Lindberg, Eva. ""Aberrant splicing of genes involved in haemoglobin synthesis and impaired terminal erythroid maturation in SF3B1 mutated refractory anaemia with ring sideroblasts."" British journal of haematology, 2015, pp. 478-90.
[19] Xu, C, Fan, C D, Wang, X. ""Regulation of Mdm2 protein stability and the p53 response by NEDD4-1 E3 ligase."" Oncogene, 2015, pp. 281-9.
[20] Jackson, M W, Lindstrom, M S, Berberich, S J. ""MdmX binding to ARF affects Mdm2 protein stability and p53 transactivation."" The Journal of biological chemistry, 2001, pp. 25336-41.
[21] Haupt, Y, Maya, R, Kazaz, A, Oren, M. ""Mdm2 promotes the rapid degradation of p53."" Nature, 1997, pp. 296-9.
"	0.43687826	0.6235115	GO	GO	NA
NeST	Ubiquitin regulation of p53 activity	NEST:105	CUL3 ELOC FBXW7 HSP90AA1 MDM2 SKP1 STK11 TNF VHL	9	3.169925001442312	Protein Modification By Small Protein Conjugation 	GO:0032446	FBXW7;CUL3;MDM2;VHL;ELOC;SKP1	6	66.66666666666666	2.797820112238235e-9	1.3709318549967354e-6	Protein Degradation and Regulation	"Protein Interaction:
CUL3, ELOC, FBXW7, SKP1, and VHL are components of the Cullin-RING E3 ubiquitin ligase complex, which is involved in protein degradation. CUL3 serves as a scaffold protein, while ELOC and SKP1 are adaptor proteins. FBXW7 is a substrate recognition protein, and VHL is a substrate recognition component for hypoxia-inducible factor (HIF).

HSP90AA1 is a molecular chaperone that assists in protein folding and stabilization. It interacts with STK11, a serine/threonine kinase involved in cell cycle regulation and apoptosis.

MDM2 is an E3 ubiquitin ligase that targets the tumor suppressor protein p53 for degradation. It interacts with HSP90AA1, which stabilizes MDM2 and prevents its self-ubiquitination.

TNF is a pro-inflammatory cytokine that plays a role in inflammation, cell proliferation, and apoptosis. It interacts with STK11, which can modulate TNF-induced apoptosis.

Critical Analysis:
The primary biological process performed by this system of interacting proteins is protein degradation and regulation. The Cullin-RING E3 ubiquitin ligase complex, composed of CUL3, ELOC, FBXW7, SKP1, and VHL, targets specific proteins for degradation by the proteasome. This process is essential for maintaining protein homeostasis and regulating various cellular processes, such as cell cycle progression and signal transduction.

HSP90AA1 plays a crucial role in protein folding and stabilization, ensuring proper protein function. Its interaction with STK11 and MDM2 highlights its involvement in regulating cell cycle progression, apoptosis, and the stability of key regulatory proteins.

STK11 serves as a central regulator of cell cycle progression and apoptosis, with its interaction with TNF emphasizing its role in modulating inflammation and cell death.

In conclusion, this system of interacting proteins is primarily involved in protein degradation and regulation, with a focus on maintaining protein homeostasis and modulating cellular processes such as cell cycle progression, apoptosis, and inflammation."	9	100	"CUL3, ELOC, FBXW7, SKP1, and VHL are components of the Cullin-RING E3 ubiquitin ligase complex, which is involved in protein degradation. CUL3 serves as a scaffold protein, while ELOC and SKP1 are adaptor proteins. FBXW7 is a substrate recognition protein, and VHL is a substrate recognition component for hypoxia-inducible factor (HIF).[1][2][3]

HSP90AA1 is a molecular chaperone that assists in protein folding and stabilization. It interacts with STK11, a serine/threonine kinase involved in cell cycle regulation and apoptosis.[4][5][6]

MDM2 is an E3 ubiquitin ligase that targets the tumor suppressor protein p53 for degradation. It interacts with HSP90AA1, which stabilizes MDM2 and prevents its self-ubiquitination.[7][8][9]

TNF is a pro-inflammatory cytokine that plays a role in inflammation, cell proliferation, and apoptosis. It interacts with STK11, which can modulate TNF-induced apoptosis.[10][11][12]

The primary biological process performed by this system of interacting proteins is protein degradation and regulation. The Cullin-RING E3 ubiquitin ligase complex, composed of CUL3, ELOC, FBXW7, SKP1, and VHL, targets specific proteins for degradation by the proteasome. This process is essential for maintaining protein homeostasis and regulating various cellular processes, such as cell cycle progression and signal transduction.[13][14][15]

HSP90AA1 plays a crucial role in protein folding and stabilization, ensuring proper protein function. Its interaction with STK11 and MDM2 highlights its involvement in regulating cell cycle progression, apoptosis, and the stability of key regulatory proteins.[16][17][18]

STK11 serves as a central regulator of cell cycle progression and apoptosis, with its interaction with TNF emphasizing its role in modulating inflammation and cell death.[19][20][21]

In conclusion, this system of interacting proteins is primarily involved in protein degradation and regulation, with a focus on maintaining protein homeostasis and modulating cellular processes such as cell cycle progression, apoptosis, and inflammation.

========================================================================================================================================================================================================
[1] Zhao, Dong, Zheng, Shanliang, Wang, Xingwen, Liu, Hao, Zhao, Kunming, Li, Li, Hu, Ying. ""iASPP is essential for HIF-1α stabilization to promote angiogenesis and glycolysis via attenuating VHL-mediated protein degradation."" Oncogene, 2022, pp. 1944-1958.
[2] Pozzebon, Maria Elena, Varadaraj, Archana, Mattoscio, Domenico, Jaffray, Ellis G, Miccolo, Claudia, Galimberti, Viviana, Tommasino, Massimo, Hay, Ronald T, Chiocca, Susanna. ""BC-box protein domain-related mechanism for VHL protein degradation."" Proceedings of the National Academy of Sciences of the United States of America, 2013, pp. 18168-73.
[3] van den Heuvel, Sander. ""Protein degradation: CUL-3 and BTB--partners in proteolysis."" Current biology : CB, 2004, pp. R59-61.
[4] Haase, Michael, Fitze, Guido. ""HSP90AB1: Helping the good and the bad."" Gene, 2016, pp. 171-86.
[5] Jesus, Tiago F, Moreno, João M, Repolho, Tiago, Athanasiadis, Alekos, Rosa, Rui, Almeida-Val, Vera M F, Coelho, Maria M. ""Protein analysis and gene expression indicate differential vulnerability of Iberian fish species under a climate change scenario."" PloS one, 2017, pp. e0181325.
[6] Zuehlke, Abbey D, Beebe, Kristin, Neckers, Len, Prince, Thomas. ""Regulation and function of the human HSP90AA1 gene."" Gene, 2015, pp. 8-16.
[7] Kim, Jun Yeob, Lee, Rusia, Xiao, Gu, Forbes, Dominique, Bargonetti, Jill. ""MDM2-C Functions as an E3 Ubiquitin Ligase."" Cancer management and research, 2020, pp. 7715-7724.
[8] Han, Xin, Wei, Wenyi, Sun, Yi. ""PROTAC Degraders with Ligands Recruiting MDM2 E3 Ubiquitin Ligase: An Updated Perspective."" Acta materia medica, 2022, pp. 244-259.
[9] Zhang, Shengliang, Zhou, Lanlan, El-Deiry, Wafik S. ""Small-Molecule NSC59984 Induces Mutant p53 Degradation through a ROS-ERK2-MDM2 Axis in Cancer Cells."" Molecular cancer research : MCR, 2022, pp. 622-636.
[10] Zelová, Hana, Hošek, Jan. ""TNF-α signalling and inflammation: interactions between old acquaintances."" Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2013, pp. 641-51.
[11] Blaser, Heiko, Dostert, Catherine, Mak, Tak W, Brenner, Dirk. ""TNF and ROS Crosstalk in Inflammation."" Trends in cell biology, 2016, pp. 249-261.
[12] van Loo, Geert, Bertrand, Mathieu J M. ""Death by TNF: a road to inflammation."" Nature reviews. Immunology, 2023, pp. 289-303.
[13] Zhao, Dong, Zheng, Shanliang, Wang, Xingwen, Liu, Hao, Zhao, Kunming, Li, Li, Hu, Ying. ""iASPP is essential for HIF-1α stabilization to promote angiogenesis and glycolysis via attenuating VHL-mediated protein degradation."" Oncogene, 2022, pp. 1944-1958.
[14] Pozzebon, Maria Elena, Varadaraj, Archana, Mattoscio, Domenico, Jaffray, Ellis G, Miccolo, Claudia, Galimberti, Viviana, Tommasino, Massimo, Hay, Ronald T, Chiocca, Susanna. ""BC-box protein domain-related mechanism for VHL protein degradation."" Proceedings of the National Academy of Sciences of the United States of America, 2013, pp. 18168-73.
[15] van den Heuvel, Sander. ""Protein degradation: CUL-3 and BTB--partners in proteolysis."" Current biology : CB, 2004, pp. R59-61.
[16] Chinnam, Meenalakshmi, Xu, Chao, Lama, Rati, Zhang, Xiaojing, Cedeno, Carlos D, Wang, Yanqing, Stablewski, Aimee B, Goodrich, David W, Wang, Xinjiang. ""MDM2 E3 ligase activity is essential for p53 regulation and cell cycle integrity."" PLoS genetics, 2022, pp. e1010171.
[17] Chen, Jingyi, Zhao, Fangxin, Yang, Hongxin, Wen, Jianxun, Tang, Ying, Wan, Fang, Zhang, Xuan, Wu, Jianqiang. ""Gentian violet induces apoptosis and ferroptosis via modulating p53 and MDM2 in hepatocellular carcinoma."" American journal of cancer research, 2022, pp. 3357-3372.
[18] Huang, Liangqian, Agrawal, Trisha, Zhu, Guixin, Yu, Sixiang, Tao, Liming, Lin, JiaBei, Marmorstein, Ronen, Shorter, James, Yang, Xiaolu. ""DAXX represents a new type of protein-folding enabler."" Nature, 2021, pp. 132-137.
[19] Jacobson, Elsie C, Jain, Lekha, Vickers, Mark H, Olins, Ada L, Olins, Donald E, Perry, Jo K, O'Sullivan, Justin M. ""TNF-α Differentially Regulates Cell Cycle Genes in Promyelocytic and Granulocytic HL-60/S4 Cells."" G3 (Bethesda, Md.), 2019, pp. 2775-2786.
[20] Zhang, Rui, Xue, Teng, Shao, Anwen, Lang, Yue, Qin, Chao, Zhao, Mingliang, Kuang, Yu, Yu, Zhengquan, Geng, Yunyun, Zhao, Chenyang, Tang, Jun. ""Bclaf1 regulates c-FLIP expression and protects cells from TNF-induced apoptosis and tissue injury."" EMBO reports, 2022, pp. e52702.
[21] Micheau, Olivier, Tschopp, Jürg. ""Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes."" Cell, 2003, pp. 181-90.
"	0.4386323	0.35950246	LLM	LLM	NA
NeST	Homologous recombination	NEST:130	BARD1 BLM BRCA1 BRCA2 BUB1B CHEK1 FANCD2 RAD51 RAD51C TOP2A TP53 WRN	12	3.584962500721156	DNA Repair 	GO:0006281	BARD1;BLM;WRN;RAD51C;RAD51;FANCD2;CHEK1;BRCA1;BRCA2;TP53	10	83.33333333333334	2.3430111004406878e-17	7.146183856344097e-15	DNA Repair and Stability	"Proteins BARD1, BLM, BRCA1, BRCA2, BUB1B, CHEK1, FANCD2, RAD51, RAD51C, TOP2A, TP53, and WRN interact to maintain genomic stability and facilitate DNA repair. The primary biological process performed by this system is DNA repair and stability.

1. Homologous Recombination (HR) Repair:
- BRCA1, BRCA2, RAD51, and RAD51C are key players in HR repair.
- BRCA1 and BRCA2 facilitate RAD51 loading onto single-stranded DNA (ssDNA) to form nucleoprotein filaments.
- RAD51C forms a complex with RAD51, promoting strand invasion and exchange during HR repair.

2. Fanconi Anemia (FA) Pathway:
- FANCD2 is involved in the FA pathway, which repairs DNA interstrand crosslinks (ICLs).
- FANCD2 is monoubiquitinated and recruited to ICLs, where it interacts with BRCA1 and BRCA2 to facilitate HR repair.

3. DNA Damage Response (DDR) and Checkpoint Activation:
- CHEK1 and TP53 are involved in DDR and cell cycle checkpoint activation.
- CHEK1 is a kinase that phosphorylates and activates downstream targets in response to DNA damage.
- TP53 is a tumor suppressor that regulates cell cycle progression and apoptosis in response to DNA damage.

4. DNA Helicases and Topoisomerases:
- BLM and WRN are RecQ helicases that unwind DNA structures during replication, repair, and recombination.
- BLM interacts with BRCA1 and RAD51, promoting HR repair.
- WRN interacts with RAD51 and is involved in the resolution of Holliday junctions during HR repair.
- TOP2A is a topoisomerase that resolves topological DNA issues during replication and transcription.

5. Mitotic Checkpoint and Chromosome Segregation:
- BUB1B is a kinase involved in the mitotic checkpoint and chromosome segregation.
- BUB1B phosphorylates and activates downstream targets to ensure proper chromosome alignment and segregation during mitosis.

In conclusion, the primary biological process performed by this system of interacting proteins is DNA repair and stability, with a focus on HR repair, the FA pathway, DDR, and checkpoint activation. These proteins also contribute to DNA helicase and topoisomerase functions, as well as mitotic checkpoint and chromosome segregation."	12	100	"Proteins BARD1, BLM, BRCA1, BRCA2, BUB1B, CHEK1, FANCD2, RAD51, RAD51C, TOP2A, TP53, and WRN interact to maintain genomic stability and facilitate DNA repair. The primary biological process performed by this system is DNA repair and stability.[1][2][3]

- BRCA1, BRCA2, RAD51, and RAD51C are key players in HR repair.[4][5][6]

- BRCA1 and BRCA2 facilitate RAD51 loading onto single-stranded DNA (ssDNA) to form nucleoprotein filaments.[7][8][9]

- RAD51C forms a complex with RAD51, promoting strand invasion and exchange during HR repair.[10][11][12]

- FANCD2 is involved in the FA pathway, which repairs DNA interstrand crosslinks (ICLs).[13][14][15]

- FANCD2 is monoubiquitinated and recruited to ICLs, where it interacts with BRCA1 and BRCA2 to facilitate HR repair.[16][17][18]

3. DNA Damage Response (DDR) and Checkpoint Activation:

- CHEK1 and TP53 are involved in DDR and cell cycle checkpoint activation.[19][20][21]

- CHEK1 is a kinase that phosphorylates and activates downstream targets in response to DNA damage.[22][23][24]

- TP53 is a tumor suppressor that regulates cell cycle progression and apoptosis in response to DNA damage.[25][26][27]

- BLM and WRN are RecQ helicases that unwind DNA structures during replication, repair, and recombination.[28][29][30]

- BLM interacts with BRCA1 and RAD51, promoting HR repair.[31][32][33]

- WRN interacts with RAD51 and is involved in the resolution of Holliday junctions during HR repair.[34][35][36]

- TOP2A is a topoisomerase that resolves topological DNA issues during replication and transcription.[37][38][39]

5. Mitotic Checkpoint and Chromosome Segregation:

- BUB1B is a kinase involved in the mitotic checkpoint and chromosome segregation.[40][41][42]

- BUB1B phosphorylates and activates downstream targets to ensure proper chromosome alignment and segregation during mitosis.[43][44][45]

In conclusion, the primary biological process performed by this system of interacting proteins is DNA repair and stability, with a focus on HR repair, the FA pathway, DDR, and checkpoint activation. These proteins also contribute to DNA helicase and topoisomerase functions, as well as mitotic checkpoint and chromosome segregation.

========================================================================================================================================================================================================
[1] Yoshida, Kiyotsugu, Miki, Yoshio. ""Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage."" Cancer science, 2004, pp. 866-71.
[2] Tarsounas, Madalena, Sung, Patrick. ""The antitumorigenic roles of BRCA1-BARD1 in DNA repair and replication."" Nature reviews. Molecular cell biology, 2020, pp. 284-299.
[3] Richardson, Christine. ""RAD51, genomic stability, and tumorigenesis."" Cancer letters, 2005, pp. 127-39.
[4] Yoshida, Kiyotsugu, Miki, Yoshio. ""Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage."" Cancer science, 2004, pp. 866-71.
[5] Tarsounas, Madalena, Sung, Patrick. ""The antitumorigenic roles of BRCA1-BARD1 in DNA repair and replication."" Nature reviews. Molecular cell biology, 2020, pp. 284-299.
[6] Kwon, Youngho, Rösner, Heike, Zhao, Weixing, Selemenakis, Platon, He, Zhuoling, Kawale, Ajinkya S, Katz, Jeffrey N, Rogers, Cody M, Neal, Francisco E, Badamchi Shabestari, Aida, Petrosius, Valdemaras, Singh, Akhilesh K, Joel, Marina Z, Lu, Lucy, Holloway, Stephen P, Burma, Sandeep, Mukherjee, Bipasha, Hromas, Robert, Mazin, Alexander, Wiese, Claudia, Sørensen, Claus S, Sung, Patrick. ""DNA binding and RAD51 engagement by the BRCA2 C-terminus orchestrate DNA repair and replication fork preservation."" Nature communications, 2023, pp. 432.
[7] Krais, J J, Johnson, N. ""<i>Brca1</i> mutations in the coiled-coil domain impede Rad51 loading on DNA and mouse development."" Molecular & cellular oncology, 2020, pp. 1786345.
[8] Park, Pyoung Hwa, Yamamoto, Tomomi M, Li, Hua, Alcivar, Allen L, Xia, Bing, Wang, Yifan, Bernhardy, Andrea J, Turner, Kristen M, Kossenkov, Andrew V, Watson, Zachary L, Behbakht, Kian, Casadei, Silvia, Swisher, Elizabeth M, Mischel, Paul S, Johnson, Neil, Bitler, Benjamin G. ""Amplification of the Mutation-Carrying BRCA2 Allele Promotes RAD51 Loading and PARP Inhibitor Resistance in the Absence of Reversion Mutations."" Molecular cancer therapeutics, 2020, pp. 602-613.
[9] Zhang, Hongshan, Schaub, Jeffrey M, Finkelstein, Ilya J. ""RADX condenses single-stranded DNA to antagonize RAD51 loading."" Nucleic acids research, 2020, pp. 7834-7843.
[10] Boni, Jacopo, Idani, Aida, Roca, Carla, Feliubadaló, Lidia, Tomiak, Eva, Weber, Evan, Foulkes, William D, Orthwein, Alexandre, El Haffaf, Zaki, Lazaro, Conxi, Rivera, Barbara. ""A decade of RAD51C and RAD51D germline variants in cancer."" Human mutation, 2022, pp. 285-298.
[11] Prakash, Rohit, Rawal, Yashpal, Sullivan, Meghan R, Grundy, McKenzie K, Bret, Hélène, Mihalevic, Michael J, Rein, Hayley L, Baird, Jared M, Darrah, Kristie, Zhang, Fang, Wang, Raymond, Traina, Tiffany A, Radke, Marc R, Kaufmann, Scott H, Swisher, Elizabeth M, Guérois, Raphaël, Modesti, Mauro, Sung, Patrick, Jasin, Maria, Bernstein, Kara A. ""Homologous recombination-deficient mutation cluster in tumor suppressor <i>RAD51C</i> identified by comprehensive analysis of cancer variants."" Proceedings of the National Academy of Sciences of the United States of America, 2022, pp. e2202727119.
[12] Lahiri, Sudipta, Jensen, Ryan B. ""DNA Strand Exchange to Monitor Human RAD51-Mediated Strand Invasion and Pairing."" Methods in molecular biology (Clifton, N.J.), 2021, pp. 101-113.
[13] Song, Ihn Young, Barkley, Laura R, Day, Tovah A, Weiss, Robert S, Vaziri, Cyrus. ""A novel role for Fanconi anemia (FA) pathway effector protein FANCD2 in cell cycle progression of untransformed primary human cells."" Cell cycle (Georgetown, Tex.), 2010, pp. 2375-88.
[14] Zhao, Simin, Huang, Chengzi, Yang, Yajuan, Xu, Weiwei, Yu, Yongze, Wen, Canxin, Cao, Lili, Gao, Fei, Qin, Yingying, Chen, Zi-Jiang, Guo, Ting, Zhao, Shidou. ""DNA repair protein FANCD2 has both ubiquitination-dependent and ubiquitination-independent functions during germ cell development."" The Journal of biological chemistry, 2023, pp. 102905.
[15] Marek, Lorri R, Bale, Allen E. ""Drosophila homologs of FANCD2 and FANCL function in DNA repair."" DNA repair, 2006, pp. 1317-26.
[16] Wang, XiaoZhe, Andreassen, Paul R, D'Andrea, Alan D. ""Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin."" Molecular and cellular biology, 2004, pp. 5850-62.
[17] Chaugule, Viduth K, Arkinson, Connor, Toth, Rachel, Walden, Helen. ""Enzymatic preparation of monoubiquitinated FANCD2 and FANCI proteins."" Methods in enzymology, 2019, pp. 73-104.
[18] Mondal, Sudipa, Reddy, Subba, Mukhopadhyay, Sudit S. ""Optimized structure of monoubiquitinated FANCD2 (human) at Lys 561: a theoretical approach."" Journal of biomolecular structure & dynamics, 2022, pp. 9374-9388.
[19] Meireles Da Costa, Nathalia, Palumbo, Antonio, De Martino, Marco, Fusco, Alfredo, Ribeiro Pinto, Luis Felipe, Nasciutti, Luiz Eurico. ""Interplay between HMGA and TP53 in cell cycle control along tumor progression."" Cellular and molecular life sciences : CMLS, 2021, pp. 817-831.
[20] Jiang, Minlin, Jia, Keyi, Wang, Lei, Li, Wei, Chen, Bin, Liu, Yu, Wang, Hao, Zhao, Sha, He, Yayi, Zhou, Caicun. ""Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy."" Acta pharmaceutica Sinica. B, 2021, pp. 2983-2994.
[21] Smith, Hannah L, Southgate, Harriet, Tweddle, Deborah A, Curtin, Nicola J. ""DNA damage checkpoint kinases in cancer."" Expert reviews in molecular medicine, 2020, pp. e2.
[22] Bai, Xiaobin, Wang, Jia, Huo, Longwei, Xie, Yuchen, Xie, Wanfu, Xu, Gaofeng, Wang, Maode. ""Serine/Threonine Kinase CHEK1-Dependent Transcriptional Regulation of RAD54L Promotes Proliferation and Radio Resistance in Glioblastoma."" Translational oncology, 2018, pp. 140-146.
[23] Fraley, Mark E, Steen, Justin T, Brnardic, Edward J, Arrington, Kenneth L, Spencer, Keith L, Hanney, Barbara A, Kim, Yuntae, Hartman, George D, Stirdivant, Steven M, Drakas, Bob A, Rickert, Keith, Walsh, Eileen S, Hamilton, Kelly, Buser, Carolyn A, Hardwick, James, Tao, Weikang, Beck, Stephen C, Mao, Xianzhi, Lobell, Robert B, Sepp-Lorenzino, Laura, Yan, Youwei, Ikuta, Mari, Munshi, Sanjeev K, Kuo, Lawrence C, Kreatsoulas, Constantine. ""3-(Indol-2-yl)indazoles as Chek1 kinase inhibitors: Optimization of potency and selectivity via substitution at C6."" Bioorganic & medicinal chemistry letters, 2006, pp. 6049-53.
[24] Huang, Shaei, Garbaccio, Robert M, Fraley, Mark E, Steen, Justin, Kreatsoulas, Constantine, Hartman, George, Stirdivant, Steve, Drakas, Bob, Rickert, Keith, Walsh, Eileen, Hamilton, Kelly, Buser, Carolyn A, Hardwick, James, Mao, Xianzhi, Abrams, Marc, Beck, Steve, Tao, Weikang, Lobell, Rob, Sepp-Lorenzino, Laura, Yan, Youwei, Ikuta, Mari, Murphy, Joan Zugay, Sardana, Vinod, Munshi, Sanjeev, Kuo, Lawrence, Reilly, Michael, Mahan, Elizabeth. ""Development of 6-substituted indolylquinolinones as potent Chek1 kinase inhibitors."" Bioorganic & medicinal chemistry letters, 2006, pp. 5907-12.
[25] Xu-Monette, Zijun Y, Young, Ken H. ""The TP53 tumor suppressor and autophagy in malignant lymphoma."" Autophagy, 2012, pp. 842-5.
[26] Zlamalikova, Lenka, Moulis, Mojmir, Ravcukova, Barbora, Liskova, Kvetoslava, Malcikova, Jitka, Salek, David, Jarkovsky, Jiri, Svitakova, Miluse, Hrabalkova, Renata, Smarda, Jan, Smardova, Jana. ""Complex analysis of the TP53 tumor suppressor in mantle cell and diffuse large B-cell lymphomas."" Oncology reports, 2017, pp. 2535-2542.
[27] Meireles Da Costa, Nathalia, Palumbo, Antonio, De Martino, Marco, Fusco, Alfredo, Ribeiro Pinto, Luis Felipe, Nasciutti, Luiz Eurico. ""Interplay between HMGA and TP53 in cell cycle control along tumor progression."" Cellular and molecular life sciences : CMLS, 2021, pp. 817-831.
[28] Kitano, Ken. ""Structural mechanisms of human RecQ helicases WRN and BLM."" Frontiers in genetics, 2014, pp. 366.
[29] Zhu, Mingzhang, Wu, Wenwen, Togashi, Yukiko, Liang, Weixin, Miyoshi, Yasuo, Ohta, Tomohiko. ""HERC2 inactivation abrogates nucleolar localization of RecQ helicases BLM and WRN."" Scientific reports, 2021, pp. 360.
[30] Mendez-Bermudez, Aaron, Hidalgo-Bravo, Alberto, Cotton, Victoria E, Gravani, Athanasia, Jeyapalan, Jennie N, Royle, Nicola J. ""The roles of WRN and BLM RecQ helicases in the Alternative Lengthening of Telomeres."" Nucleic acids research, 2012, pp. 10809-20.
[31] Lai, Tsung-Huei, Ewald, Brett, Zecevic, Alma, Liu, Chaomei, Sulda, Melanie, Papaioannou, Dimitrios, Garzon, Ramiro, Blachly, James S, Plunkett, William, Sampath, Deepa. ""HDAC Inhibition Induces MicroRNA-182, which Targets RAD51 and Impairs HR Repair to Sensitize Cells to Sapacitabine in Acute Myelogenous Leukemia."" Clinical cancer research : an official journal of the American Association for Cancer Research, 2016, pp. 3537-49.
[32] Wu, Chenming, Chang, Yiming, Chen, Junliang, Su, Yang, Li, Lei, Chen, Yuping, Li, Yunhui, Wu, Jinhuan, Huang, Jinzhou, Zhao, Fei, Wang, Wenrui, Yin, Hui, Wang, Shunli, Jin, Mingpeng, Lou, Zhenkun, Zhu, Wei-Guo, Luo, Kuntian, Zhang, Jie, Yuan, Jian. ""USP37 regulates DNA damage response through stabilizing and deubiquitinating BLM."" Nucleic acids research, 2021, pp. 11224-11240.
[33] Wassing, Isabel E, Esashi, Fumiko. ""RAD51: Beyond the break."" Seminars in cell & developmental biology, 2021, pp. 38-46.
[34] Yang, Qin, Zhang, Ran, Wang, Xin Wei, Spillare, Elisa A, Linke, Steven P, Subramanian, Deepa, Griffith, Jack D, Li, Ji Liang, Hickson, Ian D, Shen, Jiang Cheng, Loeb, Lawrence A, Mazur, Sharlyn J, Appella, Ettore, Brosh, Robert M, Karmakar, Parimal, Bohr, Vilhelm A, Harris, Curtis C. ""The processing of Holliday junctions by BLM and WRN helicases is regulated by p53."" The Journal of biological chemistry, 2002, pp. 31980-7.
[35] Rossi, Matthew J, Mazina, Olga M, Bugreev, Dmitry V, Mazin, Alexander V. ""The RecA/RAD51 protein drives migration of Holliday junctions via polymerization on DNA."" Proceedings of the National Academy of Sciences of the United States of America, 2011, pp. 6432-7.
[36] Compton, Sarah A, Ozgür, Sezgin, Griffith, Jack D. ""Ring-shaped Rad51 paralog protein complexes bind Holliday junctions and replication forks as visualized by electron microscopy."" The Journal of biological chemistry, 2010, pp. 13349-56.
[37] Dong, Yinying, Sun, Xiangyin, Zhang, Kong, He, Xinjia, Zhang, Qian, Song, Hao, Xu, Mingjin, Lu, Haijun, Ren, Ruimei. ""Type IIA topoisomerase (TOP2A) triggers epithelial-mesenchymal transition and facilitates HCC progression by regulating Snail expression."" Bioengineered, 2021, pp. 12967-12979.
[38] Järvinen, T A H, Liu, E T. ""Topoisomerase IIalpha gene (TOP2A) amplification and deletion in cancer--more common than anticipated."" Cytopathology : official journal of the British Society for Clinical Cytology, 2003, pp. 309-13.
[39] Du, Xiaomei, Xue, Zhiwen, Lv, Jianning, Wang, Heidou. ""Expression of the Topoisomerase II Alpha (TOP2A) Gene in Lung Adenocarcinoma Cells and the Association with Patient Outcomes."" Medical science monitor : international medical journal of experimental and clinical research, 2020, pp. e929120.
[40] Ko, Young Hyeh, Roh, Ji Hyeon, Son, Young-Ik, Chung, Man Ki, Jang, Jeon Yeob, Byun, Hayoung, Baek, Chung-Hwan, Jeong, Han-Sin. ""Expression of mitotic checkpoint proteins BUB1B and MAD2L1 in salivary duct carcinomas."" Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2010, pp. 349-55.
[41] Zhou, Xiaolei, Yuan, Yanli, Kuang, Hongping, Tang, Bingxiang, Zhang, Hui, Zhang, Manlin. ""BUB1B (BUB1 Mitotic Checkpoint Serine/Threonine Kinase B) promotes lung adenocarcinoma by interacting with Zinc Finger Protein ZNF143 and regulating glycolysis."" Bioengineered, 2022, pp. 2471-2485.
[42] Davenport, J W, Fernandes, E R, Harris, L D, Neale, G A, Goorha, R. ""The mouse mitotic checkpoint gene bub1b, a novel bub1 family member, is expressed in a cell cycle-dependent manner."" Genomics, 1999, pp. 113-7.
[43] Tang, Xiaozhu, Guo, Mengjie, Ding, Pinggang, Deng, Zhendong, Ke, Mengying, Yuan, Yuxia, Zhou, Yanyan, Lin, Zigen, Li, Muxi, Gu, Chunyan, Gu, Xiaosong, Yang, Ye. ""BUB1B and circBUB1B_544aa aggravate multiple myeloma malignancy through evoking chromosomal instability."" Signal transduction and targeted therapy, 2021, pp. 361.
[44] Jiao, Chen Yu, Feng, Qin Chao, Li, Chang Xian, Wang, Dong, Han, Sheng, Zhang, Yao Dong, Jiang, Wang Jie, Chang, Jiang, Wang, Xuehao, Li, Xiang Cheng. ""BUB1B promotes extrahepatic cholangiocarcinoma progression via JNK/c-Jun pathways."" Cell death & disease, 2021, pp. 63.
[45] Komura, Kazumasa, Inamoto, Teruo, Tsujino, Takuya, Matsui, Yusuke, Konuma, Tsuyoshi, Nishimura, Kazuki, Uchimoto, Taizo, Tsutsumi, Takeshi, Matsunaga, Tomohisa, Maenosono, Ryoichi, Yoshikawa, Yuki, Taniguchi, Kohei, Tanaka, Tomohito, Uehara, Hirofumi, Hirata, Koichi, Hirano, Hajime, Nomi, Hayahito, Hirose, Yoshinobu, Ono, Fumihito, Azuma, Haruhito. ""Increased BUB1B/BUBR1 expression contributes to aberrant DNA repair activity leading to resistance to DNA-damaging agents."" Oncogene, 2021, pp. 6210-6222.
"	0.5780171	0.5998348	Tied	Neither	NA
NeST	Foxo signaling	NEST:168	AKT1 AR CDKN1B CREBBP EP300 FOXO3 RARA SMAD4 SMARCB1 VHL	10	3.321928094887362	Positive Regulation Of Nucleic Acid-Templated Transcription 	GO:1903508	CREBBP;SMAD4;RARA;EP300;AKT1;VHL;FOXO3	7	70	1.3968674287425156e-9	6.425590172215571e-7	Cell Cycle Regulation	"The system of interacting proteins AKT1, AR, CDKN1B, CREBBP, EP300, FOXO3, RARA, SMAD4, SMARCB1, and VHL primarily contributes to the regulation of the cell cycle. This analysis focuses on the critical roles these proteins play in cell cycle progression, growth, and differentiation.

1. AKT1: AKT1 is a serine/threonine kinase that plays a central role in cell survival and growth. It is activated by growth factors and regulates various cellular processes, including cell cycle progression, apoptosis, and metabolism. AKT1 phosphorylates and inactivates CDKN1B, promoting cell cycle progression.

2. AR: The androgen receptor (AR) is a nuclear hormone receptor that regulates gene expression in response to androgens. It plays a role in cell growth, differentiation, and survival. AR interacts with coactivators such as CREBBP and EP300 to modulate gene transcription.

3. CDKN1B: Cyclin-dependent kinase inhibitor 1B (CDKN1B) is a critical regulator of cell cycle progression. It inhibits cyclin-dependent kinases, preventing cell cycle progression from G1 to S phase. CDKN1B is inactivated by AKT1, allowing cell cycle progression.

4. CREBBP and EP300: CREB-binding protein (CREBBP) and E1A binding protein p300 (EP300) are transcriptional coactivators that interact with various transcription factors, including AR and RARA. They play essential roles in cell growth, differentiation, and apoptosis by modulating gene expression.

5. FOXO3: Forkhead box O3 (FOXO3) is a transcription factor that regulates cell cycle progression, apoptosis, and oxidative stress response. It is negatively regulated by AKT1, which phosphorylates and inactivates FOXO3, promoting cell survival and growth.

6. RARA: Retinoic acid receptor alpha (RARA) is a nuclear hormone receptor that regulates gene expression in response to retinoic acid. It plays a role in cell growth, differentiation, and apoptosis. RARA interacts with coactivators such as CREBBP and EP300 to modulate gene transcription.

7. SMAD4: SMAD family member 4 (SMAD4) is a transcription factor involved in the transforming growth factor-beta (TGF-β) signaling pathway. It regulates cell growth, differentiation, and apoptosis by modulating gene expression in response to TGF-β.

8. SMARCB1: SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 (SMARCB1) is a component of the SWI/SNF chromatin remodeling complex. It plays a role in cell cycle regulation, differentiation, and tumor suppression by modulating gene expression.

9. VHL: Von Hippel-Lindau tumor suppressor (VHL) is involved in the regulation of hypoxia-inducible factors (HIFs) and plays a role in cell cycle regulation, angiogenesis, and apoptosis. VHL targets HIFs for degradation, preventing the activation of genes involved in cell growth and angiogenesis.

In conclusion, the primary biological process performed by this system of interacting proteins is cell cycle regulation. These proteins contribute to the regulation of cell growth, differentiation, and apoptosis through various signaling pathways and transcriptional regulation mechanisms."	10	100	"The system of interacting proteins AKT1, AR, CDKN1B, CREBBP, EP300, FOXO3, RARA, SMAD4, SMARCB1, and VHL primarily contributes to the regulation of the cell cycle. This analysis focuses on the critical roles these proteins play in cell cycle progression, growth, and differentiation.[1][2][3]

1. AKT1: AKT1 is a serine/threonine kinase that plays a central role in cell survival and growth. It is activated by growth factors and regulates various cellular processes, including cell cycle progression, apoptosis, and metabolism. AKT1 phosphorylates and inactivates CDKN1B, promoting cell cycle progression.[4][5][6]

2. AR: The androgen receptor (AR) is a nuclear hormone receptor that regulates gene expression in response to androgens. It plays a role in cell growth, differentiation, and survival. AR interacts with coactivators such as CREBBP and EP300 to modulate gene transcription.[7][8][9]

3. CDKN1B: Cyclin-dependent kinase inhibitor 1B (CDKN1B) is a critical regulator of cell cycle progression. It inhibits cyclin-dependent kinases, preventing cell cycle progression from G1 to S phase. CDKN1B is inactivated by AKT1, allowing cell cycle progression.[10][11][12]

4. CREBBP and EP300: CREB-binding protein (CREBBP) and E1A binding protein p300 (EP300) are transcriptional coactivators that interact with various transcription factors, including AR and RARA. They play essential roles in cell growth, differentiation, and apoptosis by modulating gene expression.[13][14][15]

5. FOXO3: Forkhead box O3 (FOXO3) is a transcription factor that regulates cell cycle progression, apoptosis, and oxidative stress response. It is negatively regulated by AKT1, which phosphorylates and inactivates FOXO3, promoting cell survival and growth.[16][17][18]

6. RARA: Retinoic acid receptor alpha (RARA) is a nuclear hormone receptor that regulates gene expression in response to retinoic acid. It plays a role in cell growth, differentiation, and apoptosis. RARA interacts with coactivators such as CREBBP and EP300 to modulate gene transcription.[19][20][21]

7. SMAD4: SMAD family member 4 (SMAD4) is a transcription factor involved in the transforming growth factor-beta (TGF-β) signaling pathway. It regulates cell growth, differentiation, and apoptosis by modulating gene expression in response to TGF-β.[22][23][24]

8. SMARCB1: SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 (SMARCB1) is a component of the SWI/SNF chromatin remodeling complex. It plays a role in cell cycle regulation, differentiation, and tumor suppression by modulating gene expression.[25][26][27]

9. VHL: Von Hippel-Lindau tumor suppressor (VHL) is involved in the regulation of hypoxia-inducible factors (HIFs) and plays a role in cell cycle regulation, angiogenesis, and apoptosis. VHL targets HIFs for degradation, preventing the activation of genes involved in cell growth and angiogenesis.[28][29][30]

In conclusion, the primary biological process performed by this system of interacting proteins is cell cycle regulation. These proteins contribute to the regulation of cell growth, differentiation, and apoptosis through various signaling pathways and transcriptional regulation mechanisms.

========================================================================================================================================================================================================
[1] Du, William W, Yang, Weining, Liu, Elizabeth, Yang, Zhenguo, Dhaliwal, Preet, Yang, Burton B. ""Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2."" Nucleic acids research, 2016, pp. 2846-58.
[2] McNair, C, Urbanucci, A, Comstock, C E S, Augello, M A, Goodwin, J F, Launchbury, R, Zhao, S G, Schiewer, M J, Ertel, A, Karnes, J, Davicioni, E, Wang, L, Wang, Q, Mills, I G, Feng, F Y, Li, W, Carroll, J S, Knudsen, K E. ""Cell cycle-coupled expansion of AR activity promotes cancer progression."" Oncogene, 2017, pp. 1655-1668.
[3] Balk, Steven P, Knudsen, Karen E. ""AR, the cell cycle, and prostate cancer."" Nuclear receptor signaling, 2008, pp. e001.
[4] Sun, Gongping, Ding, Xun Austin, Argaw, Yewubdar, Guo, Xiaoran, Montell, Denise J. ""Akt1 and dCIZ1 promote cell survival from apoptotic caspase activation during regeneration and oncogenic overgrowth."" Nature communications, 2020, pp. 5726.
[5] Nag, Sharanya, Rahaman, Sayanur, Guha, Abhishek, Ray, Partho Sarothi. ""An AKT1-and TRIM21-mediated phosphodegron controls proteasomal degradation of HuR enabling cell survival under heat shock."" iScience, 2023, pp. 106307.
[6] Rahmani, Anahita, Kheradmand, Danial, Keyhanvar, Peyman, Shoae-Hassani, Alireza, Darbandi-Azar, Amir. ""Neurogenesis and increase in differentiated neural cell survival via phosphorylation of Akt1 after fluoxetine treatment of stem cells."" BioMed research international, 2013, pp. 582526.
[7] Jamroze, Anmbreen, Chatta, Gurkamal, Tang, Dean G. ""Androgen receptor (AR) heterogeneity in prostate cancer and therapy resistance."" Cancer letters, 2021, pp. 1-9.
[8] Zhu, Yezi, Dalrymple, Susan L, Coleman, Ilsa, Zheng, S Lilly, Xu, Jianfeng, Hooper, Jody E, Antonarakis, Emmanuel S, De Marzo, Angelo M, Meeker, Alan K, Nelson, Peter S, Isaacs, William B, Denmeade, Samuel R, Luo, Jun, Brennen, W Nathaniel, Isaacs, John T. ""Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors."" Oncogene, 2020, pp. 6935-6949.
[9] Zhang, Tian, Karsh, Lawrence I, Nissenblatt, Michael J, Canfield, Steven E. ""Androgen Receptor Splice Variant, AR-V7, as a Biomarker of Resistance to Androgen Axis-Targeted Therapies in Advanced Prostate Cancer."" Clinical genitourinary cancer, 2020, pp. 1-10.
[10] Wu, Han, Liu, Hai Yan, Liu, Wen Jie, Shi, Yong Li, Bao, Dawei. ""miR-377-5p inhibits lung cancer cell proliferation, invasion, and cell cycle progression by targeting AKT1 signaling."" Journal of cellular biochemistry, 2019, pp. 8120-8128.
[11] Duggal, Shweta, Jailkhani, Noor, Midha, Mukul Kumar, Rao, Kanury V S, Kumar, Ajay. ""Defining the Akt1 interactome data and delineating alterations in its composition as a function of cell cycle progression."" Data in brief, 2017, pp. 252-257.
[12] Ren, Chaoqi, Yu, Mengmeng, Zhang, Yao, Fan, Minghui, Chang, Fangfang, Xing, Lixiao, Liu, Yongzhen, Wang, Yongqiang, Qi, Xiaole, Liu, Changjun, Zhang, Yanping, Cui, Hongyu, Li, Kai, Gao, Li, Pan, Qing, Wang, Xiaomei, Gao, Yulong. ""Avian leukosis virus subgroup J promotes cell proliferation and cell cycle progression through miR-221 by targeting CDKN1B."" Virology, 2018, pp. 121-130.
[13] Yang, Xinpeng, Feng, Yue, Li, Yang, Chen, Dake, Xia, Xuanyan, Li, Jialian, Li, Fenge. ""AR regulates porcine immature Sertoli cell growth via binding to RNF4 and miR-124a."" Reproduction in domestic animals = Zuchthygiene, 2021, pp. 416-426.
[14] Wang, Fengtian, Koul, Hari K. ""Androgen receptor (AR) cistrome in prostate differentiation and cancer progression."" American journal of clinical and experimental urology, 2017, pp. 18-24.
[15] Dos Santos, Guilherme Augusto, Kats, Lev, Pandolfi, Pier Paolo. ""Synergy against PML-RARa: targeting transcription, proteolysis, differentiation, and self-renewal in acute promyelocytic leukemia."" The Journal of experimental medicine, 2013, pp. 2793-802.
[16] Deng, Aiqing, Ma, Limin, Zhou, Xueli, Wang, Xin, Wang, Shouyan, Chen, Xia. ""FoxO3 transcription factor promotes autophagy after oxidative stress injury in HT22 cells."" Canadian journal of physiology and pharmacology, 2021, pp. 627-634.
[17] Zhou, Hongzhi, Wang, Xin, Ma, Liming, Deng, Aiqing, Wang, Shouyan, Chen, Xia. ""FoxO3 transcription factor promotes autophagy after transient cerebral ischemia/reperfusion."" The International journal of neuroscience, 2019, pp. 738-745.
[18] Fusi, Lorenza, Paudel, Rupesh, Meder, Katharina, Schlosser, Andreas, Schrama, David, Goebeler, Matthias, Schmidt, Marc. ""Interaction of transcription factor FoxO3 with histone acetyltransferase complex subunit TRRAP modulates gene expression and apoptosis."" The Journal of biological chemistry, 2022, pp. 101714.
[19] Veerappan, S, Schäche, M, Pertile, K K, Islam, F M A, Chen, C Y, Mitchell, P, Dirani, M, Baird, P N. ""The retinoic acid receptor alpha (RARA) gene is not associated with myopia, hypermetropia, and ocular biometric measures."" Molecular vision, 2009, pp. 1390-7.
[20] Meier, Ruth, Greve, Gabriele, Zimmer, Dennis, Bresser, Helena, Berberich, Bettina, Langova, Ralitsa, Stomper, Julia, Rubarth, Anne, Feuerbach, Lars, Lipka, Daniel B, Hey, Joschka, Grüning, Björn, Brors, Benedikt, Duyster, Justus, Plass, Christoph, Becker, Heiko, Lübbert, Michael. ""The antileukemic activity of decitabine upon PML/RARA-negative AML blasts is supported by all-trans retinoic acid: in vitro and in vivo evidence for cooperation."" Blood cancer journal, 2022, pp. 122.
[21] Furlan, Tobias, Kirchmair, Alexander, Sampson, Natalie, Puhr, Martin, Gruber, Martina, Trajanoski, Zlatko, Santer, Frédéric R, Parson, Walther, Handle, Florian, Culig, Zoran. ""MYC-Mediated Ribosomal Gene Expression Sensitizes Enzalutamide-resistant Prostate Cancer Cells to EP300/CREBBP Inhibitors."" The American journal of pathology, 2021, pp. 1094-1107.
[22] Moskowitz, Ivan P, Wang, Jun, Peterson, Michael A, Pu, William T, Mackinnon, Alexander C, Oxburgh, Leif, Chu, Gerald C, Sarkar, Molly, Berul, Charles, Smoot, Leslie, Robertson, Elizabeth J, Schwartz, Robert, Seidman, Jonathan G, Seidman, Christine E. ""Transcription factor genes Smad4 and Gata4 cooperatively regulate cardiac valve development. [corrected]."" Proceedings of the National Academy of Sciences of the United States of America, 2011, pp. 4006-11.
[23] Li, Qiqi, Du, Xing, Pan, Zengxiang, Zhang, Lifan, Li, Qifa. ""The transcription factor SMAD4 and miR-10b contribute to E2 release and cell apoptosis in ovarian granulosa cells by targeting CYP19A1."" Molecular and cellular endocrinology, 2018, pp. 84-95.
[24] Lee, Yangkyu, Lee, Hyejung, Park, Hyunjin, Kim, Jin-Won, Hwang, Jin-Hyeok, Kim, Jaihwan, Yoon, Yoo-Seok, Han, Ho-Seong, Kim, Haeryoung. ""Combination immunohistochemistry for SMAD4 and Runt-related transcription factor 3 may identify a favorable prognostic subgroup of pancreatic ductal adenocarcinomas."" Oncotarget, 2017, pp. 76699-76711.
[25] Holsten, Till, Bens, Susanne, Oyen, Florian, Nemes, Karolina, Hasselblatt, Martin, Kordes, Uwe, Siebert, Reiner, Frühwald, Michael C, Schneppenheim, Reinhard, Schüller, Ulrich. ""Germline variants in SMARCB1 and other members of the BAF chromatin-remodeling complex across human disease entities: a meta-analysis."" European journal of human genetics : EJHG, 2018, pp. 1083-1093.
[26] Valencia, Alfredo M, Collings, Clayton K, Dao, Hai T, St Pierre, Roodolph, Cheng, Yung-Chih, Huang, Junwei, Sun, Zhen-Yu, Seo, Hyuk-Soo, Mashtalir, Nazar, Comstock, Dawn E, Bolonduro, Olubusayo, Vangos, Nicholas E, Yeoh, Zoe C, Dornon, Mary Kate, Hermawan, Crystal, Barrett, Lee, Dhe-Paganon, Sirano, Woolf, Clifford J, Muir, Tom W, Kadoch, Cigall. ""Recurrent SMARCB1 Mutations Reveal a Nucleosome Acidic Patch Interaction Site That Potentiates mSWI/SNF Complex Chromatin Remodeling."" Cell, 2019, pp. 1342-1356.e23.
[27] Parisian, Alison D, Koga, Tomoyuki, Miki, Shunichiro, Johann, Pascal D, Kool, Marcel, Crawford, John R, Furnari, Frank B. ""SMARCB1 loss interacts with neuronal differentiation state to block maturation and impact cell stability."" Genes & development, 2020, pp. 1316-1329.
[28] Maxwell, P H, Wiesener, M S, Chang, G W, Clifford, S C, Vaux, E C, Cockman, M E, Wykoff, C C, Pugh, C W, Maher, E R, Ratcliffe, P J. ""The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis."" Nature, 1999, pp. 271-5.
[29] Mennerich, Daniela, Kubaichuk, Kateryna, Raza, Ghulam S, Fuhrmann, Dominik C, Herzig, Karl-Heinz, Brüne, Bernhard, Kietzmann, Thomas. ""ER-stress promotes VHL-independent degradation of hypoxia-inducible factors via FBXW1A/βTrCP."" Redox biology, 2022, pp. 102243.
[30] Kietzmann, Thomas, Mennerich, Daniela, Dimova, Elitsa Y. ""Hypoxia-Inducible Factors (HIFs) and Phosphorylation: Impact on Stability, Localization, and Transactivity."" Frontiers in cell and developmental biology, 2016, pp. 11.
"	0.43441877	0.23652871	LLM	Neither	NA
NeST	Neg Regulation EGFR	NEST:169	AKT1 CTNNB1 EGF EGFR NF2 PTEN	6	2.584962500721156	Regulation Of Cell Population Proliferation 	GO:0042127	EGF;PTEN;CTNNB1;AKT1;NF2;EGFR	6	100	3.096806069335845e-9	1.427627597963825e-6	PI3K/AKT Signaling	"The primary biological process performed by this system of interacting proteins is the phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway. This pathway is crucial for regulating cell survival, growth, and proliferation.

1. EGF and EGFR interaction: EGF (epidermal growth factor) is a ligand that binds to its receptor, EGFR (epidermal growth factor receptor), activating the receptor's intrinsic kinase activity. This activation leads to the recruitment of downstream signaling proteins, including PI3K.

2. PI3K activation: The interaction between EGFR and PI3K results in the conversion of phosphatidylinositol (4,5)-bisphosphate (PIP2) to phosphatidylinositol (3,4,5)-trisphosphate (PIP3). PIP3 serves as a docking site for AKT1, a serine/threonine kinase.

3. AKT1 activation: AKT1 is recruited to the plasma membrane by PIP3, where it is phosphorylated and activated. Activated AKT1 regulates various cellular processes, including cell survival, growth, and proliferation, by phosphorylating downstream targets.

4. PTEN regulation: PTEN (phosphatase and tensin homolog) is a tumor suppressor that negatively regulates the PI3K/AKT signaling pathway. PTEN dephosphorylates PIP3, converting it back to PIP2, and thus inhibiting AKT1 activation.

5. CTNNB1 involvement: CTNNB1 (beta-catenin) is a multifunctional protein involved in cell adhesion and Wnt signaling. Although not directly involved in the PI3K/AKT pathway, CTNNB1 can be indirectly regulated by AKT1. AKT1 phosphorylates GSK3β, which in turn prevents GSK3β from phosphorylating CTNNB1, leading to the stabilization and accumulation of CTNNB1.

6. NF2 connection: NF2 (neurofibromin 2) is a tumor suppressor protein that interacts with the PI3K/AKT signaling pathway. Loss of NF2 function can lead to increased PI3K/AKT signaling, promoting cell survival and proliferation.

In conclusion, the most prominent biological process performed by this system of interacting proteins is the PI3K/AKT signaling pathway, which plays a critical role in regulating cell survival, growth, and proliferation. The proteins involved in this system interact in a complex manner, with PTEN and NF2 acting as negative regulators, while EGF, EGFR, and AKT1 promote pathway activation. CTNNB1 is indirectly regulated by AKT1, linking the PI3K/AKT pathway to other cellular processes."	6	100	"The primary biological process performed by this system of interacting proteins is the phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway. This pathway is crucial for regulating cell survival, growth, and proliferation.[1][2][3]

1. EGF and EGFR interaction: EGF (epidermal growth factor) is a ligand that binds to its receptor, EGFR (epidermal growth factor receptor), activating the receptor's intrinsic kinase activity. This activation leads to the recruitment of downstream signaling proteins, including PI3K.[4][5][6]

2. PI3K activation: The interaction between EGFR and PI3K results in the conversion of phosphatidylinositol (4,5)-bisphosphate (PIP2) to phosphatidylinositol (3,4,5)-trisphosphate (PIP3). PIP3 serves as a docking site for AKT1, a serine/threonine kinase.[7][8][9]

3. AKT1 activation: AKT1 is recruited to the plasma membrane by PIP3, where it is phosphorylated and activated. Activated AKT1 regulates various cellular processes, including cell survival, growth, and proliferation, by phosphorylating downstream targets.[10][11][12]

4. PTEN regulation: PTEN (phosphatase and tensin homolog) is a tumor suppressor that negatively regulates the PI3K/AKT signaling pathway. PTEN dephosphorylates PIP3, converting it back to PIP2, and thus inhibiting AKT1 activation.[13][14][15]

5. CTNNB1 involvement: CTNNB1 (beta-catenin) is a multifunctional protein involved in cell adhesion and Wnt signaling. Although not directly involved in the PI3K/AKT pathway, CTNNB1 can be indirectly regulated by AKT1. AKT1 phosphorylates GSK3β, which in turn prevents GSK3β from phosphorylating CTNNB1, leading to the stabilization and accumulation of CTNNB1.[16][17][18]

6. NF2 connection: NF2 (neurofibromin 2) is a tumor suppressor protein that interacts with the PI3K/AKT signaling pathway. Loss of NF2 function can lead to increased PI3K/AKT signaling, promoting cell survival and proliferation.[19][20][21]

In conclusion, the most prominent biological process performed by this system of interacting proteins is the PI3K/AKT signaling pathway, which plays a critical role in regulating cell survival, growth, and proliferation. The proteins involved in this system interact in a complex manner, with PTEN and NF2 acting as negative regulators, while EGF, EGFR, and AKT1 promote pathway activation. CTNNB1 is indirectly regulated by AKT1, linking the PI3K/AKT pathway to other cellular processes.[22][23][24]

========================================================================================================================================================================================================
[1] Brunet, A, Bonni, A, Zigmond, M J, Lin, M Z, Juo, P, Hu, L S, Anderson, M J, Arden, K C, Blenis, J, Greenberg, M E. ""Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor."" Cell, 1999, pp. 857-68.
[2] Gao, Haoji, Wang, Weige, Li, Qinyu. ""GANT61 suppresses cell survival, invasion and epithelial-mesenchymal transition through inactivating AKT/mTOR and JAK/STAT3 pathways in anaplastic thyroid carcinoma."" Cancer biology & therapy, 2022, pp. 369-377.
[3] Xu, Yongjie, Hu, Yumeng, Xu, Tao, Yan, Kaowen, Zhang, Ting, Li, Qin, Chang, Fen, Guo, Xueyuan, Peng, Jingyu, Li, Mo, Zhao, Min, Zhen, Hongying, Xu, Luzheng, Zheng, Duo, Li, Li, Shao, Genze. ""RNF8-mediated regulation of Akt promotes lung cancer cell survival and resistance to DNA damage."" Cell reports, 2021, pp. 109854.
[4] Björkelund, Hanna, Gedda, Lars, Malmqvist, Magnus, Andersson, Karl. ""Resolving the EGF-EGFR interaction characteristics through a multiple-temperature, multiple-inhibitor, real-time interaction analysis approach."" Molecular and clinical oncology, 2013, pp. 343-352.
[5] Díaz-Perlas, Cristina, Varese, Monica, Guardiola, Salvador, Sánchez-Navarro, Macarena, García, Jesús, Teixidó, Meritxell, Giralt, Ernest. ""Protein Chemical Synthesis Combined with Mirror-Image Phage Display Yields d-Peptide EGF Ligands that Block the EGF-EGFR Interaction."" Chembiochem : a European journal of chemical biology, 2019, pp. 2079-2084.
[6] Guardiola, Salvador, Díaz-Lobo, Mireia, Seco, Jesús, García, Jesús, Nevola, Laura, Giralt, Ernest. ""Peptides Targeting EGF Block the EGF-EGFR Interaction."" Chembiochem : a European journal of chemical biology, 2016, pp. 702-11.
[7] Lee, Jong-Ho, Liu, Rui, Li, Jing, Wang, Yugang, Tan, Lin, Li, Xin-Jian, Qian, Xu, Zhang, Chuanbao, Xia, Yan, Xu, Daqian, Guo, Wei, Ding, Zhiyong, Du, Linyong, Zheng, Yanhua, Chen, Qianming, Lorenzi, Philip L, Mills, Gordon B, Jiang, Tao, Lu, Zhimin. ""EGFR-Phosphorylated Platelet Isoform of Phosphofructokinase 1 Promotes PI3K Activation."" Molecular cell, 2018, pp. 197-210.e7.
[8] Claridge, Sally E, Hopkins, Benjamin D. ""PI3King the Environment for Growth: PI3K Activation Drives Transcriptome Changes That Support Oncogenic Growth."" Cancer research, 2022, pp. 2216-2218.
[9] Yu, Jiao-Jiao, Zhou, Dan-Dan, Yang, Xiao-Xiao, Cui, Bing, Tan, Feng-Wei, Wang, Junjian, Li, Ke, Shang, Shuang, Zhang, Cheng, Lv, Xiao-Xi, Zhang, Xiao-Wei, Liu, Shan-Shan, Yu, Jin-Mei, Wang, Feng, Huang, Bo, Hua, Fang, Hu, Zhuo-Wei. ""TRIB3-EGFR interaction promotes lung cancer progression and defines a therapeutic target."" Nature communications, 2020, pp. 3660.
[10] Sun, Gongping, Ding, Xun Austin, Argaw, Yewubdar, Guo, Xiaoran, Montell, Denise J. ""Akt1 and dCIZ1 promote cell survival from apoptotic caspase activation during regeneration and oncogenic overgrowth."" Nature communications, 2020, pp. 5726.
[11] Nag, Sharanya, Rahaman, Sayanur, Guha, Abhishek, Ray, Partho Sarothi. ""An AKT1-and TRIM21-mediated phosphodegron controls proteasomal degradation of HuR enabling cell survival under heat shock."" iScience, 2023, pp. 106307.
[12] Rahmani, Anahita, Kheradmand, Danial, Keyhanvar, Peyman, Shoae-Hassani, Alireza, Darbandi-Azar, Amir. ""Neurogenesis and increase in differentiated neural cell survival via phosphorylation of Akt1 after fluoxetine treatment of stem cells."" BioMed research international, 2013, pp. 582526.
[13] Chen, Chien-Yu, Chen, Jingyu, He, Lina, Stiles, Bangyan L. ""PTEN: Tumor Suppressor and Metabolic Regulator."" Frontiers in endocrinology, 2018, pp. 338.
[14] Huang, Xingjun, Liu, Guihua, Guo, Jiao, Su, Zhengquan. ""The PI3K/AKT pathway in obesity and type 2 diabetes."" International journal of biological sciences, 2018, pp. 1483-1496.
[15] Hu, Mingli, Zhu, Shixuan, Xiong, Shengwei, Xue, Xingxing, Zhou, Xiaodong. ""MicroRNAs and the PTEN/PI3K/Akt pathway in gastric cancer (Review)."" Oncology reports, 2019, pp. 1439-1454.
[16] Law, Samuel M, Zheng, Jie J. ""Premise and peril of Wnt signaling activation through GSK-3β inhibition."" iScience, 2022, pp. 104159.
[17] Landin Malt, Andre, Clancy, Shaylyn, Hwang, Diane, Liu, Alice, Smith, Connor, Smith, Margaret, Hatley, Maya, Clemens, Christopher, Lu, Xiaowei. ""Non-Canonical Wnt Signaling Regulates Cochlear Outgrowth and Planar Cell Polarity via Gsk3β Inhibition."" Frontiers in cell and developmental biology, 2021, pp. 649830.
[18] Yu, Yi, Savage, Ronald E, Eathiraj, Sudharshan, Meade, Justin, Wick, Michael J, Hall, Terence, Abbadessa, Giovanni, Schwartz, Brian. ""Targeting AKT1-E17K and the PI3K/AKT Pathway with an Allosteric AKT Inhibitor, ARQ 092."" PloS one, 2015, pp. e0140479.
[19] Xie, Xiaolei, Man, Xian, Zhu, Zuobin, Yuan, Dejian, Huang, Shi. ""Tumor suppressor RIZ1 in obesity and the PI3K/AKT/mTOR pathway."" Obesity (Silver Spring, Md.), 2016, pp. 389-97.
[20] Wang, Jincheng, Hu, Kaili, Cai, Xuanyan, Yang, Bo, He, Qiaojun, Wang, Jiajia, Weng, Qinjie. ""Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis."" Acta pharmaceutica Sinica. B, 2022, pp. 18-32.
[21] Xie, Youbang, Shi, Xuefeng, Sheng, Kuo, Han, Guoxiong, Li, Wenqian, Zhao, Qiangqiang, Jiang, Baili, Feng, Jianming, Li, Jianping, Gu, Yuhai. ""PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia (Review)."" Molecular medicine reports, 2019, pp. 783-791.
[22] Xu, Zhaoxia, Jia, Keqi, Wang, Hui, Gao, Feng, Zhao, Song, Li, Fan, Hao, Jun. ""METTL14-regulated PI3K/Akt signaling pathway via PTEN affects HDAC5-mediated epithelial-mesenchymal transition of renal tubular cells in diabetic kidney disease."" Cell death & disease, 2021, pp. 32.
[23] Cheng, Songyi, Zhang, Xiaoxiao, Feng, Qian, Chen, Jiandong, Shen, Le, Yu, Peng, Yang, Li, Chen, Daohai, Zhang, Haowen, Sun, Weixin, Chen, Xiaohu. ""Astragaloside IV exerts angiogenesis and cardioprotection after myocardial infarction via regulating PTEN/PI3K/Akt signaling pathway."" Life sciences, 2019, pp. 82-93.
[24] Suda, Kenichi, Onozato, Ryoichi, Yatabe, Yasushi, Mitsudomi, Tetsuya. ""EGFR T790M mutation: a double role in lung cancer cell survival?"" Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2009, pp. 1-4.
"	0.20016505	0.26522726	Neither	GO	NA
NeST	p53 regulation of cell cycle	NEST:177	CDKN1A CREBBP EP300 RBL1 TP53	5	2.321928094887362	Cellular Response To UV 	GO:0034644	CREBBP;CDKN1A;EP300;TP53	4	80	1.123603876103372e-9	2.786537612736364e-7	Cell Cycle Regulation	"Proteins: CDKN1A, CREBBP, EP300, RBL1, TP53

The primary biological process performed by this system of interacting proteins is the regulation of the cell cycle, particularly in response to DNA damage and cellular stress. The proteins involved in this process are CDKN1A, CREBBP, EP300, RBL1, and TP53.

1. CDKN1A (p21) - Cyclin-dependent kinase inhibitor 1A
CDKN1A is a potent cyclin-dependent kinase inhibitor that plays a crucial role in cell cycle regulation. It is induced by TP53 in response to DNA damage, leading to cell cycle arrest at the G1 phase. This allows time for DNA repair or, if the damage is irreparable, initiation of apoptosis.

2. TP53 (p53) - Tumor protein p53
TP53 is a transcription factor that acts as a tumor suppressor and is often referred to as the ""guardian of the genome."" It is activated in response to cellular stress, such as DNA damage, and regulates the expression of genes involved in cell cycle arrest, DNA repair, and apoptosis. TP53 directly induces the expression of CDKN1A, leading to cell cycle arrest.

3. CREBBP (CBP) - CREB-binding protein
CREBBP is a transcriptional coactivator that interacts with numerous transcription factors, including TP53. It possesses histone acetyltransferase activity, which modulates chromatin structure and facilitates the binding of transcription factors to DNA. CREBBP enhances the transcriptional activity of TP53, promoting the expression of target genes involved in cell cycle regulation and apoptosis.

4. EP300 (p300) - E1A binding protein p300
EP300 is a transcriptional coactivator that shares structural and functional similarities with CREBBP. It also interacts with TP53 and possesses histone acetyltransferase activity. EP300 and CREBBP have redundant roles in enhancing TP53-mediated transcription of target genes involved in cell cycle regulation and apoptosis.

5. RBL1 (p107) - Retinoblastoma-like protein 1
RBL1 is a member of the retinoblastoma (RB) family of proteins, which are critical regulators of the cell cycle. RBL1 interacts with E2F transcription factors and represses their activity, leading to cell cycle arrest in the G1 phase. CDKN1A can bind to and inhibit cyclin-dependent kinases, which in turn prevents the phosphorylation and inactivation of RBL1, maintaining its growth-suppressive function.

In summary, this system of interacting proteins plays a crucial role in cell cycle regulation, particularly in response to DNA damage and cellular stress. The central player in this process is TP53, which induces the expression of CDKN1A and is supported by the coactivators CREBBP and EP300. CDKN1A and RBL1 function to arrest the cell cycle, allowing time for DNA repair or initiation of apoptosis if necessary."	5	100	"Proteins: CDKN1A, CREBBP, EP300, RBL1, TP53

The primary biological process performed by this system of interacting proteins is the regulation of the cell cycle, particularly in response to DNA damage and cellular stress. The proteins involved in this process are CDKN1A, CREBBP, EP300, RBL1, and TP53.[1][2][3]

1. CDKN1A (p21) - Cyclin-dependent kinase inhibitor 1A[4][5][6]

CDKN1A is a potent cyclin-dependent kinase inhibitor that plays a crucial role in cell cycle regulation. It is induced by TP53 in response to DNA damage, leading to cell cycle arrest at the G1 phase. This allows time for DNA repair or, if the damage is irreparable, initiation of apoptosis.[7][8][9]

2. TP53 (p53) - Tumor protein p53

TP53 is a transcription factor that acts as a tumor suppressor and is often referred to as the ""guardian of the genome."" It is activated in response to cellular stress, such as DNA damage, and regulates the expression of genes involved in cell cycle arrest, DNA repair, and apoptosis. TP53 directly induces the expression of CDKN1A, leading to cell cycle arrest.[10][11][12]

3. CREBBP (CBP) - CREB-binding protein

CREBBP is a transcriptional coactivator that interacts with numerous transcription factors, including TP53. It possesses histone acetyltransferase activity, which modulates chromatin structure and facilitates the binding of transcription factors to DNA. CREBBP enhances the transcriptional activity of TP53, promoting the expression of target genes involved in cell cycle regulation and apoptosis.[13][14][15]

4. EP300 (p300) - E1A binding protein p300

EP300 is a transcriptional coactivator that shares structural and functional similarities with CREBBP. It also interacts with TP53 and possesses histone acetyltransferase activity. EP300 and CREBBP have redundant roles in enhancing TP53-mediated transcription of target genes involved in cell cycle regulation and apoptosis.[16][17][18]

5. RBL1 (p107) - Retinoblastoma-like protein 1

RBL1 is a member of the retinoblastoma (RB) family of proteins, which are critical regulators of the cell cycle. RBL1 interacts with E2F transcription factors and represses their activity, leading to cell cycle arrest in the G1 phase. CDKN1A can bind to and inhibit cyclin-dependent kinases, which in turn prevents the phosphorylation and inactivation of RBL1, maintaining its growth-suppressive function.[19][20][21]

In summary, this system of interacting proteins plays a crucial role in cell cycle regulation, particularly in response to DNA damage and cellular stress. The central player in this process is TP53, which induces the expression of CDKN1A and is supported by the coactivators CREBBP and EP300. CDKN1A and RBL1 function to arrest the cell cycle, allowing time for DNA repair or initiation of apoptosis if necessary.[22][23][24]

========================================================================================================================================================================================================
[1] Schultz-Rogers, Laura E, Thayer, Michelle L, Kambakam, Sekhar, Wierson, Wesley A, Helmer, Jordan A, Wishman, Mark D, Wall, Kristen A, Greig, Jessica L, Forsman, Jaimie L, Puchhalapalli, Kavya, Nair, Siddharth, Weiss, Trevor J, Luiken, Jon M, Blackburn, Patrick R, Ekker, Stephen C, Kool, Marcel, McGrail, Maura. ""Rbbp4 loss disrupts neural progenitor cell cycle regulation independent of Rb and leads to Tp53 acetylation and apoptosis."" Developmental dynamics : an official publication of the American Association of Anatomists, 2022, pp. 1267-1290.
[2] Lindemann, A, Takahashi, H, Patel, A A, Osman, A A, Myers, J N. ""Targeting the DNA Damage Response in OSCC with TP53 Mutations."" Journal of dental research, 2018, pp. 635-644.
[3] Dutto, Ilaria, Scalera, Claudia, Prosperi, Ennio. ""CREBBP and p300 lysine acetyl transferases in the DNA damage response."" Cellular and molecular life sciences : CMLS, 2018, pp. 1325-1338.
[4] Akhter, N, Dar, S A, Haque, S, Wahid, M, Jawed, A, Akhtar, M S, Alharbi, R A, Sindi, A A A, Alruwetei, A, Zubair Choudhry, H M, Ahmad, A. ""Crosstalk of Cyclin-dependent kinase inhibitor 1A (CDKN1A) gene polymorphism with p53 and CCND1 polymorphism in breast cancer."" European review for medical and pharmacological sciences, 2021, pp. 4258-4273.
[5] Kim, Min-Kyeong, Jeon, Bu-Nam, Koh, Dong-In, Kim, Kyung-Sup, Park, So-Yoon, Yun, Chae-Ok, Hur, Man-Wook. ""Regulation of the cyclin-dependent kinase inhibitor 1A gene (CDKN1A) by the repressor BOZF1 through inhibition of p53 acetylation and transcription factor Sp1 binding."" The Journal of biological chemistry, 2013, pp. 7053-64.
[6] Wagner, M, Klussmann, J P, Fangmann, R, Linder, R, Elewa, M E, Eidt, S, Rose, V M, Jungehulsing, M, Schulze, H J. ""Cyclin-dependent kinase-inhibitor 1 (CDKN1A) in the squamous epithelium of the oropharynx: possible implications of molecular biology and compartmentation."" Anticancer research, 2001, pp. 333-45.
[7] Schultz-Rogers, Laura E, Thayer, Michelle L, Kambakam, Sekhar, Wierson, Wesley A, Helmer, Jordan A, Wishman, Mark D, Wall, Kristen A, Greig, Jessica L, Forsman, Jaimie L, Puchhalapalli, Kavya, Nair, Siddharth, Weiss, Trevor J, Luiken, Jon M, Blackburn, Patrick R, Ekker, Stephen C, Kool, Marcel, McGrail, Maura. ""Rbbp4 loss disrupts neural progenitor cell cycle regulation independent of Rb and leads to Tp53 acetylation and apoptosis."" Developmental dynamics : an official publication of the American Association of Anatomists, 2022, pp. 1267-1290.
[8] Lindemann, A, Takahashi, H, Patel, A A, Osman, A A, Myers, J N. ""Targeting the DNA Damage Response in OSCC with TP53 Mutations."" Journal of dental research, 2018, pp. 635-644.
[9] Nientiedt, Cathleen, Budczies, Jan, Endris, Volker, Kirchner, Martina, Schwab, Constantin, Jurcic, Christina, Behnisch, Rouven, Hoveida, Shirin, Lantwin, Philippa, Kaczorowski, Adam, Geisler, Christine, Dieffenbacher, Svenja, Falkenbach, Fabian, Franke, Desiree, Görtz, Magdalena, Heller, Martina, Himmelsbach, Ruth, Pecqueux, Carine, Rath, Mathias, Reimold, Philipp, Schütz, Viktoria, Simunovic, Iva, Walter, Elena, Hofer, Luisa, Gasch, Claudia, Schönberg, Gita, Pursche, Lars, Hatiboglu, Gencay, Nyarangi-Dix, Joanne, Sültmann, Holger, Zschäbitz, Stefanie, Koerber, Stefan A, Jäger, Dirk, Debus, Jürgen, Duensing, Anette, Schirmacher, Peter, Hohenfellner, Markus, Stenzinger, Albrecht, Duensing, Stefan. ""Mutations in TP53 or DNA damage repair genes define poor prognostic subgroups in primary prostate cancer."" Urologic oncology, 2022, pp. 8.e11-8.e18.
[10] Li, Shuchun, Sun, Jing, Ma, Junjun, Zhou, Cixiang, Yang, Xiao, Zhang, Sen, Huang, Ling, Jia, Hongtao, Shao, Yanfei, Zhang, Enkui, Zheng, Minhua, Zhao, Qian, Zang, Lu. ""LncRNA LENGA acts as a tumor suppressor in gastric cancer through BRD7/TP53 signaling."" Cellular and molecular life sciences : CMLS, 2022, pp. 5.
[11] Zlamalikova, Lenka, Moulis, Mojmir, Ravcukova, Barbora, Liskova, Kvetoslava, Malcikova, Jitka, Salek, David, Jarkovsky, Jiri, Svitakova, Miluse, Hrabalkova, Renata, Smarda, Jan, Smardova, Jana. ""Complex analysis of the TP53 tumor suppressor in mantle cell and diffuse large B-cell lymphomas."" Oncology reports, 2017, pp. 2535-2542.
[12] Sirotkin, Alexander V, Petrak, Juraj, Alwasel, Saleh, Harrath, Abdel Halim. ""Apoptosis signal-regulating kinase (ASK1) and transcription factor tumor suppressor protein TP53 suppress rabbit ovarian granulosa cell functions."" Animal reproduction science, 2019, pp. 140-151.
[13] Sun, Xueqin, Klingbeil, Olaf, Lu, Bin, Wu, Caizhi, Ballon, Carlos, Ouyang, Meng, Wu, Xiaoli S, Jin, Ying, Hwangbo, Yon, Huang, Yu-Han, Somerville, Tim D D, Chang, Kenneth, Park, Jung, Chung, Taemoon, Lyons, Scott K, Shi, Junwei, Vogel, Hannes, Schulder, Michael, Vakoc, Christopher R, Mills, Alea A. ""BRD8 maintains glioblastoma by epigenetic reprogramming of the p53 network."" Nature, 2023, pp. 195-202.
[14] Shen, Qiuhong, Shi, Yin, Liu, Jiaqi, Su, Hua, Huang, Jingtao, Zhang, Yi, Peng, Chao, Zhou, Tianhua, Sun, Qiming, Wan, Wei, Liu, Wei. ""Acetylation of STX17 (syntaxin 17) controls autophagosome maturation."" Autophagy, 2021, pp. 1157-1169.
[15] Korzus, Edward. ""Rubinstein-Taybi Syndrome and Epigenetic Alterations."" Advances in experimental medicine and biology, 2017, pp. 39-62.
[16] Yamamoto, Hideyuki, Hayakawa, Fumihiko, Yasuda, Takahiko, Odaira, Koya, Minamikawa, Yuka, Tange, Naoyuki, Hirano, Daiki, Kojima, Yuki, Morishita, Takanobu, Tsuzuki, Shinobu, Naoe, Tomoki, Kiyoi, Hitoshi. ""ZNF384-fusion proteins have high affinity for the transcriptional coactivator EP300 and aberrant transcriptional activities."" FEBS letters, 2019, pp. 2151-2161.
[17] Veazey, Kylee J, Cheng, Donghang, Lin, Kevin, Villarreal, Oscar D, Gao, Guozhen, Perez-Oquendo, Mabel, Van, Hieu T, Stratton, Sabrina A, Green, Michael, Xu, Han, Lu, Yue, Bedford, Mark T, Santos, Margarida Almeida. ""CARM1 inhibition reduces histone acetyltransferase activity causing synthetic lethality in CREBBP/EP300-mutated lymphomas."" Leukemia, 2020, pp. 3269-3285.
[18] Kanada, Ryutaro, Kagoshima, Yoshiko, Asano, Masayoshi, Suzuki, Takashi, Murata, Takeshi, Haruta, Makoto, Takahashi, Mizuki, Ubukata, Osamu, Hashimoto, Kazuyuki, Obata, Kenichi, Kihara, Kawori, Kuroha, Mutsumi, Banjo, Toshihiro, Togashi, Noriko, Sato, Kazumi, Yamamoto, Yuka, Suzuki, Kanae, Isoyama, Takeshi, Tominaga, Yuichi, Higuchi, Saito, Naito, Hiroyuki. ""Discovery of EP300/CBP histone acetyltransferase inhibitors through scaffold hopping of 1,4-oxazepane ring."" Bioorganic & medicinal chemistry letters, 2022, pp. 128726.
[19] Greene, L A, Biswas, S C, Liu, D X. ""Cell cycle molecules and vertebrate neuron death: E2F at the hub."" Cell death and differentiation, 2004, pp. 49-60.
[20] Liu, Ze-Long, Bi, Xi-Wen, Liu, Pan-Pan, Lei, De-Xin, Wang, Yu, Li, Zhi-Ming, Jiang, Wen-Qi, Xia, Yi. ""Expressions and prognostic values of the <i>E2F</i> transcription factors in human breast carcinoma."" Cancer management and research, 2018, pp. 3521-3532.
[21] Xanthoulis, Athanasios, Tiniakos, Dina G. ""E2F transcription factors and digestive system malignancies: how much do we know?"" World journal of gastroenterology, 2013, pp. 3189-98.
[22] Schultz-Rogers, Laura E, Thayer, Michelle L, Kambakam, Sekhar, Wierson, Wesley A, Helmer, Jordan A, Wishman, Mark D, Wall, Kristen A, Greig, Jessica L, Forsman, Jaimie L, Puchhalapalli, Kavya, Nair, Siddharth, Weiss, Trevor J, Luiken, Jon M, Blackburn, Patrick R, Ekker, Stephen C, Kool, Marcel, McGrail, Maura. ""Rbbp4 loss disrupts neural progenitor cell cycle regulation independent of Rb and leads to Tp53 acetylation and apoptosis."" Developmental dynamics : an official publication of the American Association of Anatomists, 2022, pp. 1267-1290.
[23] Lindemann, A, Takahashi, H, Patel, A A, Osman, A A, Myers, J N. ""Targeting the DNA Damage Response in OSCC with TP53 Mutations."" Journal of dental research, 2018, pp. 635-644.
[24] Dutto, Ilaria, Scalera, Claudia, Prosperi, Ennio. ""CREBBP and p300 lysine acetyl transferases in the DNA damage response."" Cellular and molecular life sciences : CMLS, 2018, pp. 1325-1338.
"	0.7159621	0.48701656	LLM	LLM	NA
NeST	Endoplasmic Reticulum protein processing	NEST:21	ARFRP1 CALR EGFR SEC23B TRAF3 TUSC3	6	2.584962500721156	Positive Regulation Of Cell Cycle 	GO:0045787	CALR;EGFR	2	33.33333333333333	1.546960442755e-4	0.03341434556352	EGFR-Mediated Signal Transduction	"Proteins: ARFRP1, CALR, EGFR, SEC23B, TRAF3, TUSC3.

1. EGFR (Epidermal Growth Factor Receptor) is a receptor tyrosine kinase that plays a crucial role in cell proliferation, differentiation, and survival. It is activated by binding to its ligands, leading to receptor dimerization, autophosphorylation, and activation of downstream signaling pathways, such as the MAPK, PI3K/AKT, and JAK/STAT pathways.

2. ARFRP1 (ADP-Ribosylation Factor-Related Protein 1) is a small GTPase involved in vesicle trafficking and membrane transport. It interacts with EGFR, regulating its intracellular trafficking and degradation, thus modulating EGFR signaling.

3. CALR (Calreticulin) is a multifunctional protein that acts as a molecular chaperone in the endoplasmic reticulum (ER) and is involved in calcium homeostasis. It has been reported to interact with EGFR, affecting its folding, maturation, and cell surface expression, thereby influencing EGFR signaling.

4. SEC23B (Sec23 Homolog B) is a component of the COPII complex, which is involved in the transport of proteins from the ER to the Golgi apparatus. It has been shown to interact with EGFR, affecting its trafficking and signaling.

5. TRAF3 (TNF Receptor-Associated Factor 3) is an adaptor protein that plays a role in the regulation of immune and inflammatory responses. It interacts with EGFR, modulating its downstream signaling and contributing to the regulation of cell survival and apoptosis.

6. TUSC3 (Tumor Suppressor Candidate 3) is a protein with potential tumor suppressor functions. It has been reported to interact with EGFR, affecting its stability and signaling, and may play a role in the regulation of cell proliferation and tumorigenesis.

In conclusion, the most prominent biological process performed by this system of interacting proteins is EGFR-mediated signal transduction, which is crucial for cell proliferation, differentiation, and survival. The interactions of EGFR with ARFRP1, CALR, SEC23B, TRAF3, and TUSC3 modulate its trafficking, stability, and signaling, thereby influencing various cellular processes and potentially contributing to the regulation of tumorigenesis."	6	100	"Proteins: ARFRP1, CALR, EGFR, SEC23B, TRAF3, TUSC3.

1. EGFR (Epidermal Growth Factor Receptor) is a receptor tyrosine kinase that plays a crucial role in cell proliferation, differentiation, and survival. It is activated by binding to its ligands, leading to receptor dimerization, autophosphorylation, and activation of downstream signaling pathways, such as the MAPK, PI3K/AKT, and JAK/STAT pathways.[1][2][3]

2. ARFRP1 (ADP-Ribosylation Factor-Related Protein 1) is a small GTPase involved in vesicle trafficking and membrane transport. It interacts with EGFR, regulating its intracellular trafficking and degradation, thus modulating EGFR signaling.[4][5][6]

3. CALR (Calreticulin) is a multifunctional protein that acts as a molecular chaperone in the endoplasmic reticulum (ER) and is involved in calcium homeostasis. It has been reported to interact with EGFR, affecting its folding, maturation, and cell surface expression, thereby influencing EGFR signaling.[7][8][9]

4. SEC23B (Sec23 Homolog B) is a component of the COPII complex, which is involved in the transport of proteins from the ER to the Golgi apparatus. It has been shown to interact with EGFR, affecting its trafficking and signaling.[10][11][12]

5. TRAF3 (TNF Receptor-Associated Factor 3) is an adaptor protein that plays a role in the regulation of immune and inflammatory responses. It interacts with EGFR, modulating its downstream signaling and contributing to the regulation of cell survival and apoptosis.[13][14][15]

6. TUSC3 (Tumor Suppressor Candidate 3) is a protein with potential tumor suppressor functions. It has been reported to interact with EGFR, affecting its stability and signaling, and may play a role in the regulation of cell proliferation and tumorigenesis.[16][17][18]

In conclusion, the most prominent biological process performed by this system of interacting proteins is EGFR-mediated signal transduction, which is crucial for cell proliferation, differentiation, and survival. The interactions of EGFR with ARFRP1, CALR, SEC23B, TRAF3, and TUSC3 modulate its trafficking, stability, and signaling, thereby influencing various cellular processes and potentially contributing to the regulation of tumorigenesis.[19][20][21]

========================================================================================================================================================================================================
[1] Sun, Yu, Liu, Wen-Zhou, Liu, Tao, Feng, Xu, Yang, Nuo, Zhou, Hua-Fu. ""Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis."" Journal of receptor and signal transduction research, 2015, pp. 600-4.
[2] Niu, Liangliang, Fang, Yuan, Yao, Xiaoqian, Zhang, Yi, Wu, Jihong, Chen, Dong Feng, Sun, Xinghuai. ""TNFα activates MAPK and Jak-Stat pathways to promote mouse Müller cell proliferation."" Experimental eye research, 2021, pp. 108353.
[3] Wei, Dang, Rui, Bian, Qingquan, Fan, Chen, Cai, Ping, Hu Yun, Xiaoling, Song, Hao, Weng, Jun, Gu. ""KIF11 promotes cell proliferation via ERBB2/PI3K/AKT signaling pathway in gallbladder cancer."" International journal of biological sciences, 2021, pp. 514-526.
[4] Levantini, Elena, Maroni, Giorgia, Del Re, Marzia, Tenen, Daniel G. ""EGFR signaling pathway as therapeutic target in human cancers."" Seminars in cancer biology, 2022, pp. 253-275.
[5] Normanno, Nicola, De Luca, Antonella, Bianco, Caterina, Strizzi, Luigi, Mancino, Mario, Maiello, Monica R, Carotenuto, Adele, De Feo, Gianfranco, Caponigro, Francesco, Salomon, David S. ""Epidermal growth factor receptor (EGFR) signaling in cancer."" Gene, 2006, pp. 2-16.
[6] Liu, Yi, Li, Zhongjun, Zhang, Maolei, Zhou, Huangkai, Wu, Xujia, Zhong, Jian, Xiao, Feizhe, Huang, Nunu, Yang, Xuesong, Zeng, Rong, Yang, Lixuan, Xia, Zhibo, Zhang, Nu. ""Rolling-translated EGFR variants sustain EGFR signaling and promote glioblastoma tumorigenicity."" Neuro-oncology, 2021, pp. 743-756.
[7] Levantini, Elena, Maroni, Giorgia, Del Re, Marzia, Tenen, Daniel G. ""EGFR signaling pathway as therapeutic target in human cancers."" Seminars in cancer biology, 2022, pp. 253-275.
[8] Normanno, Nicola, De Luca, Antonella, Bianco, Caterina, Strizzi, Luigi, Mancino, Mario, Maiello, Monica R, Carotenuto, Adele, De Feo, Gianfranco, Caponigro, Francesco, Salomon, David S. ""Epidermal growth factor receptor (EGFR) signaling in cancer."" Gene, 2006, pp. 2-16.
[9] Liu, Yi, Li, Zhongjun, Zhang, Maolei, Zhou, Huangkai, Wu, Xujia, Zhong, Jian, Xiao, Feizhe, Huang, Nunu, Yang, Xuesong, Zeng, Rong, Yang, Lixuan, Xia, Zhibo, Zhang, Nu. ""Rolling-translated EGFR variants sustain EGFR signaling and promote glioblastoma tumorigenicity."" Neuro-oncology, 2021, pp. 743-756.
[10] Sabbah, Dima A, Hajjo, Rima, Sweidan, Kamal. ""Review on Epidermal Growth Factor Receptor (EGFR) Structure, Signaling Pathways, Interactions, and Recent Updates of EGFR Inhibitors."" Current topics in medicinal chemistry, 2020, pp. 815-834.
[11] da Cunha Santos, Gilda, Shepherd, Frances A, Tsao, Ming Sound. ""EGFR mutations and lung cancer."" Annual review of pathology, 2011, pp. 49-69.
[12] Tang, B L, Kausalya, J, Low, D Y, Lock, M L, Hong, W. ""A family of mammalian proteins homologous to yeast Sec24p."" Biochemical and biophysical research communications, 1999, pp. 679-84.
[13] Salazar-Cavazos, Emanuel, Nitta, Carolina Franco, Mitra, Eshan D, Wilson, Bridget S, Lidke, Keith A, Hlavacek, William S, Lidke, Diane S. ""Multisite EGFR phosphorylation is regulated by adaptor protein abundances and dimer lifetimes."" Molecular biology of the cell, 2020, pp. 695-708.
[14] Zhu, Sining, Lalani, Almin I, Jin, Juan, Sant'Angelo, Derek, Covey, Lori R, Liu, Kebin, Young, Howard A, Ostrand-Rosenberg, Suzanne, Xie, Ping. ""The adaptor protein TRAF3 is an immune checkpoint that inhibits myeloid-derived suppressor cell expansion."" Frontiers in immunology, 2023, pp. 1167924.
[15] Kozer, Noga, Barua, Dipak, Henderson, Christine, Nice, Edouard C, Burgess, Antony W, Hlavacek, William S, Clayton, Andrew H A. ""Recruitment of the adaptor protein Grb2 to EGFR tetramers."" Biochemistry, 2014, pp. 2594-604.
[16] Kratochvílová, Kateřina, Horak, Peter, Ešner, Milan, Souček, Karel, Pils, Dietmar, Anees, Mariam, Tomasich, Erwin, Dráfi, František, Jurtíková, Veronika, Hampl, Aleš, Krainer, Michael, Vaňhara, Petr. ""Tumor suppressor candidate 3 (TUSC3) prevents the epithelial-to-mesenchymal transition and inhibits tumor growth by modulating the endoplasmic reticulum stress response in ovarian cancer cells."" International journal of cancer, 2015, pp. 1330-40.
[17] Khalid, Ahmed Magzoub, Asano, Atsushi, Hosaka, Yoshinao Z, Takeuchi, Takashi, Yamano, Yoshiaki. ""Tumor suppressor candidate TUSC3 expression during rat testis maturation."" Bioscience, biotechnology, and biochemistry, 2013, pp. 2019-24.
[18] Zhong, Li, Liao, Dan, Zhang, Meifang, Zeng, Cuiling, Li, Xinchun, Zhang, Ruhua, Ma, Haiqing, Kang, Tiebang. ""YTHDF2 suppresses cell proliferation and growth via destabilizing the EGFR mRNA in hepatocellular carcinoma."" Cancer letters, 2019, pp. 252-261.
[19] Woś, Marcin, Bandorowicz-Pikuła, Joanna. ""[Participation of annexins in endocytosis and EGFR-mediated signal transduction]."" Postepy biochemii, 2014, pp. 55-61.
[20] Pines, Gur, Köstler, Wolfgang J, Yarden, Yosef. ""Oncogenic mutant forms of EGFR: lessons in signal transduction and targets for cancer therapy."" FEBS letters, 2010, pp. 2699-706.
[21] Zhong, Li, Liao, Dan, Zhang, Meifang, Zeng, Cuiling, Li, Xinchun, Zhang, Ruhua, Ma, Haiqing, Kang, Tiebang. ""YTHDF2 suppresses cell proliferation and growth via destabilizing the EGFR mRNA in hepatocellular carcinoma."" Cancer letters, 2019, pp. 252-261.
"	0.3984413	0.21032274	Neither	Neither	NA
NeST	RAS-RAF-MAPK	NEST:212	ARAF BRAF HRAS KRAS MAP2K1 MAPK1 RAF1	7	2.807354922057604	MAPK Cascade 	GO:0000165	MAP2K1;MAPK1;BRAF;KRAS;HRAS	5	71.42857142857143	5.307840770507572e-11	8.54562364051719e-9	MAPK/ERK Signaling Pathway	"The system of interacting proteins ARAF, BRAF, HRAS, KRAS, MAP2K1, MAPK1, and RAF1 primarily participate in the Mitogen-Activated Protein Kinase/Extracellular signal-Regulated Kinase (MAPK/ERK) signaling pathway. This pathway is crucial for regulating cell proliferation, differentiation, and survival.

1. RAS GTPases (HRAS, KRAS): These proteins function as molecular switches, cycling between active GTP-bound and inactive GDP-bound states. They are activated by extracellular signals, such as growth factors, and transmit these signals to downstream effectors. Mutations in RAS genes are frequently observed in various cancers, highlighting their importance in cell growth regulation.

2. RAF kinases (ARAF, BRAF, RAF1): These serine/threonine kinases are direct downstream effectors of RAS proteins. Upon activation by RAS, RAF kinases phosphorylate and activate MAP2K1, initiating a kinase cascade. Mutations in BRAF, particularly the V600E mutation, are associated with several cancers, including melanoma and colorectal cancer.

3. MAP2K1 (MEK1): This dual-specificity kinase is activated by RAF kinases and subsequently phosphorylates and activates MAPK1. MAP2K1 plays a central role in the MAPK/ERK pathway, acting as a link between RAF kinases and MAPK1.

4. MAPK1 (ERK2): This serine/threonine kinase is the final effector in the MAPK/ERK pathway. Upon activation by MAP2K1, MAPK1 phosphorylates various substrates, including transcription factors and other kinases, ultimately regulating gene expression and cellular processes. Dysregulation of MAPK1 activity has been implicated in numerous diseases, including cancer and neurodegenerative disorders.

In summary, the most prominent biological process performed by this system of interacting proteins is the MAPK/ERK signaling pathway, which is essential for the regulation of cell growth, differentiation, and survival. Dysregulation of this pathway is associated with various diseases, particularly cancer."	7	100	"The system of interacting proteins ARAF, BRAF, HRAS, KRAS, MAP2K1, MAPK1, and RAF1 primarily participate in the Mitogen-Activated Protein Kinase/Extracellular signal-Regulated Kinase (MAPK/ERK) signaling pathway. This pathway is crucial for regulating cell proliferation, differentiation, and survival.[1][2][3]

1. RAS GTPases (HRAS, KRAS): These proteins function as molecular switches, cycling between active GTP-bound and inactive GDP-bound states. They are activated by extracellular signals, such as growth factors, and transmit these signals to downstream effectors. Mutations in RAS genes are frequently observed in various cancers, highlighting their importance in cell growth regulation.[4][5][6]

2. RAF kinases (ARAF, BRAF, RAF1): These serine/threonine kinases are direct downstream effectors of RAS proteins. Upon activation by RAS, RAF kinases phosphorylate and activate MAP2K1, initiating a kinase cascade. Mutations in BRAF, particularly the V600E mutation, are associated with several cancers, including melanoma and colorectal cancer.[7][8][9]

3. MAP2K1 (MEK1): This dual-specificity kinase is activated by RAF kinases and subsequently phosphorylates and activates MAPK1. MAP2K1 plays a central role in the MAPK/ERK pathway, acting as a link between RAF kinases and MAPK1.[10][11][12]

4. MAPK1 (ERK2): This serine/threonine kinase is the final effector in the MAPK/ERK pathway. Upon activation by MAP2K1, MAPK1 phosphorylates various substrates, including transcription factors and other kinases, ultimately regulating gene expression and cellular processes. Dysregulation of MAPK1 activity has been implicated in numerous diseases, including cancer and neurodegenerative disorders.[13][14][15]

In summary, the most prominent biological process performed by this system of interacting proteins is the MAPK/ERK signaling pathway, which is essential for the regulation of cell growth, differentiation, and survival. Dysregulation of this pathway is associated with various diseases, particularly cancer.

========================================================================================================================================================================================================
[1] Bologna-Molina, Ronell, Ogawa, Ikuko, Mosqueda-Taylor, Adalberto, Takata, Takashi, Sánchez-Romero, Celeste, Villarroel-Dorrego, Mariana, Takeda, Yasunori, Mikami, Toshinari. ""Detection of MAPK/ERK pathway proteins and KRAS mutations in adenomatoid odontogenic tumors."" Oral diseases, 2019, pp. 481-487.
[2] Yang, Kege, Li, Yaqing, Lian, Guoda, Lin, Haoming, Shang, Changzhen, Zeng, Linjuan, Chen, Shaojie, Li, Jiajia, Huang, Chumei, Huang, Kaihong, Chen, Yinting. ""KRAS promotes tumor metastasis and chemoresistance by repressing RKIP via the MAPK-ERK pathway in pancreatic cancer."" International journal of cancer, 2018, pp. 2323-2334.
[3] Fujii, Shinsuke, Ishibashi, Takuma, Kokura, Megumi, Fujimoto, Tatsufumi, Matsumoto, Shinji, Shidara, Satsuki, Kurppa, Kari J, Pape, Judith, Caton, Javier, Morgan, Peter R, Heikinheimo, Kristiina, Kikuchi, Akira, Jimi, Eijiro, Kiyoshima, Tamotsu. ""RAF1-MEK/ERK pathway-dependent ARL4C expression promotes ameloblastoma cell proliferation and osteoclast formation."" The Journal of pathology, 2022, pp. 119-133.
[4] Kessler, Dirk, Gmachl, Michael, Mantoulidis, Andreas, Martin, Laetitia J, Zoephel, Andreas, Mayer, Moriz, Gollner, Andreas, Covini, David, Fischer, Silke, Gerstberger, Thomas, Gmaschitz, Teresa, Goodwin, Craig, Greb, Peter, Häring, Daniela, Hela, Wolfgang, Hoffmann, Johann, Karolyi-Oezguer, Jale, Knesl, Petr, Kornigg, Stefan, Koegl, Manfred, Kousek, Roland, Lamarre, Lyne, Moser, Franziska, Munico-Martinez, Silvia, Peinsipp, Christoph, Phan, Jason, Rinnenthal, Jörg, Sai, Jiqing, Salamon, Christian, Scherbantin, Yvonne, Schipany, Katharina, Schnitzer, Renate, Schrenk, Andreas, Sharps, Bernadette, Siszler, Gabriella, Sun, Qi, Waterson, Alex, Wolkerstorfer, Bernhard, Zeeb, Markus, Pearson, Mark, Fesik, Stephen W, McConnell, Darryl B. ""Drugging an undruggable pocket on KRAS."" Proceedings of the National Academy of Sciences of the United States of America, 2019, pp. 15823-15829.
[5] Shahda, Safi, O'Neil, Bert. ""GI-4000 in KRAS mutant cancers."" Expert opinion on investigational drugs, 2014, pp. 273-8.
[6] Aunoble, B, Sanches, R, Didier, E, Bignon, Y J. ""Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review)."" International journal of oncology, 2000, pp. 567-76.
[7] Yamazaki, T, Komuro, I, Zou, Y, Kudoh, S, Mizuno, T, Hiroi, Y, Shiojima, I, Takano, H, Kinugawa, K i, Kohmoto, O, Takahashi, T, Yazaki, Y. ""Protein kinase A and protein kinase C synergistically activate the Raf-1 kinase/mitogen-activated protein kinase cascade in neonatal rat cardiomyocytes."" Journal of molecular and cellular cardiology, 1997, pp. 2491-501.
[8] Peraldi, P, Frödin, M, Barnier, J V, Calleja, V, Scimeca, J C, Filloux, C, Calothy, G, Van Obberghen, E. ""Regulation of the MAP kinase cascade in PC12 cells: B-Raf activates MEK-1 (MAP kinase or ERK kinase) and is inhibited by cAMP."" FEBS letters, 1995, pp. 290-6.
[9] Holderfield, Matthew, Deuker, Marian M, McCormick, Frank, McMahon, Martin. ""Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond."" Nature reviews. Cancer, 2014, pp. 455-67.
[10] Lin, Minting, Bi, Hong, Yan, Yanyan, Huang, Wenjing, Zhang, Guiping, Zhang, Genshui, Tang, Sili, Liu, Yun, Zhang, Lingling, Ma, Jinxiang, Zhang, Jianye. ""Parthenolide suppresses non-small cell lung cancer GLC-82 cells growth via B-Raf/MAPK/Erk pathway."" Oncotarget, 2017, pp. 23436-23447.
[11] Ramstad, C, Sundvold, V, Johansen, H K, Lea, T. ""cAMP-dependent protein kinase (PKA) inhibits T cell activation by phosphorylating ser-43 of raf-1 in the MAPK/ERK pathway."" Cellular signalling, 2000, pp. 557-63.
[12] Kaur, Pavneet, Garg, Mansi, Hombach-Barrigah, Antje, Clos, Joachim, Goyal, Neena. ""MAPK1 of Leishmania donovani interacts and phosphorylates HSP70 and HSP90 subunits of foldosome complex."" Scientific reports, 2017, pp. 10202.
[13] Yu, T-T, Wang, C-Y, Tong, R. ""ERBB2 gene expression silencing involved in ovarian cancer cell migration and invasion through mediating MAPK1/MAPK3 signaling pathway."" European review for medical and pharmacological sciences, 2020, pp. 5267-5280.
[14] Gao, Yan, Ren, Jiusheng, Zhang, Liqun, Zhang, Yonghong, Wu, Xinhui, Jiang, Hao, Xu, Fangfang, Yuan, Bao, Yu, Xianfeng, Zhang, Jiabao. ""The effects of demecolcine, alone or in combination with sucrose on bovine oocyte protrusion rate, MAPK1 protein level and c-mos gene expression level."" Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2014, pp. 1974-82.
[15] Bianconi, Santiago, Poretti, María Belén, Rodríguez, Paula, Maestri, Giulia, Rodríguez, Pamela Elizabeth, de Barioglio, Susana Rubiales, Schiöth, Helgi B, Carlini, Valeria Paola. ""Ghrelin restores memory impairment following olfactory bulbectomy in mice by activating hippocampal NMDA1 and MAPK1 gene expression."" Behavioural brain research, 2021, pp. 113341.
"	0.54155767	0.58097374	Tied	Tied	NA
NeST	Regulation of cellular homeostasis	NEST:3	ABL1 ACVR1B AKT1 AMER1 ANKRD11 AR ARAF ARID1A ARID1B ARID2 ASNS ASXL1 ASXL2 ATIC ATM ATR ATRX AURKA AURKB AXIN2 BAP1 BARD1 BCL11B BCL2L12 BCL6 BCL7A BCLAF1 BCOR BCORL1 BLM BRAF BRCA1 BRCA2 BRD4 BRIP1 BTG1 BUB1B CASP8 CCDC6 CCND1 CCND2 CCND3 CCNE1 CCNE2 CDC25A CDC73 CDK12 CDK4 CDK5 CDK6 CDK8 CDKN1A CDKN1B CDKN1C CDKN2A CDKN2B CDKN2C CEP57 CHD2 CHD4 CHEK1 CHEK2 CIC CKS1B CREBBP CRKL CTC1 CTCF CTNNB1 CUL3 CUX1 DAXX DDB2 DDX3X DICER1 DIS3 DKC1 DNMT1 DNMT3A DNMT3B DOT1L E2F1 E2F2 E2F3 E2F4 E2F5 E2F6 EED EGLN1 ELOC EMSY EP300 ERCC1 ERCC2 ERCC3 ERCC4 ERCC5 ERCC6 ESR1 EWSR1 EZH2 FANCA FANCB FANCC FANCD2 FANCE FANCF FANCG FANCI FANCL FANCM FBXW7 FOXL2 FOXO3 FRS2 FUBP1 FUS GATA1 GATA3 GEN1 GID4 GPS2 GSTP1 H3F3A H3F3C HDAC1 HDAC2 HDAC3 HDAC4 HDAC5 HIF1A HIST1H1C HIST1H1E HIST1H2BD HIST1H3F HIST1H4E HIST3H3 HLA-A HRAS HSP90AA1 HSPH1 IKZF1 ING1 INHBA IRF2 JUN KAT6A KDM5A KDM5C KDM6A KMT2A KMT2B KMT2C KMT2D KRAS LATS1 LEF1 LMNA MAD2L2 MAGI2 MAP3K7 MAX MDC1 MDM2 MDM4 MECOM MED1 MED12 MEN1 MGA MGMT MIB1 MKI67 MLH1 MLH3 MLLT3 MRE11 MSH2 MSH3 MSH6 MTA1 MTOR MUTYH MYB MYC MYCL MYCN NBN NCOA3 NCOR1 NCOR2 NF1 NF2 NHP2 NKX3-1 NPM1 NSD1 NSD2 NUP93 NUP98 PA2G4 PALB2 PARK2 PARP1 PBRM1 PCBP1 PELP1 PHB2 PHF6 PIAS4 PIK3C3 PML PMS1 PMS2 PNRC1 POLD1 POLE POLH POT1 PPP1CA PPP1CB PPP1CC PPP1R15A PPP2CA PPP2CB PPP2R1A PPP2R1B PPP2R2A PPP6C PRCC PRDM1 PRKCZ PRKDC PRPF40B PTPN11 RAB35 RAD21 RAD50 RAD51 RAD51B RAD51C RAD51D RAD52 RAD54L RAF1 RANBP2 RARA RB1 RBL1 RBL2 RBM10 RECQL4 REL RHOA RICTOR RINT1 RPL5 RPS15 RPS6KB1 RPTOR RSF1 RUNX1 RUNX1T1 RXRA SETD2 SF1 SF3B1 SHQ1 SKP1 SLX4 SMAD2 SMAD3 SMAD4 SMARCA1 SMARCA4 SMARCB1 SMARCE1 SMC1A SMC3 SOCS1 SOX2 SPEN SRSF2 STAG1 STAG2 STAT3 STK11 SUZ12 TAF1 TAP2 TBL1XR1 TCF3 TERT TET2 TFDP1 TGFBR1 TNF TOP1 TOP2A TP53 TP63 TRAF7 TSC1 TSC2 TYMS U2AF1 UBE2T UMPS UPF1 VHL WEE1 WRN WT1 XPA XPC XPO1 XRCC1 XRCC2 XRCC3 YEATS4 ZBTB2 ZNF217 ZRSR2	323	8.335390354693924	DNA Repair 	GO:0006281	SETD2;MRE11;BRCA1;BRCA2;CHEK2;CHEK1;NBN;POLE;POLH;MEN1;PIAS4;UPF1;PARP1;ATRX;SMC1A;DDB2;RAD51B;MSH6;RAD51D;RAD51C;MSH2;FANCD2;MSH3;TP53;BLM;PRKDC;DOT1L;XPA;XPC;RECQL4;WRN;SLX4;MTA1;RAD21;POLD1;NSD2;PMS2;PMS1;MUTYH;BARD1;FANCI;NPM1;FANCM;MGMT;FANCL;XRCC2;XRCC3;FANCA;XRCC1;FANCC;FANCB;MLH1;FANCE;MLH3;FANCG;FANCF;MAD2L2;RAD52;RAD50;RAD51;ERCC3;ERCC4;UBE2T;ERCC1;ERCC2;ATM;ERCC5;ERCC6;ATR	69	21.36222910216718	5.5313785280539755e-61	1.2484321337817824e-57	Cell Cycle Regulation and DNA Repair	"The interacting proteins in this system are primarily involved in cell cycle regulation and DNA repair. Key proteins and their roles are as follows:

1. Cell cycle regulation: CDK4, CDK6, CDKN1A, CDKN1B, CDKN2A, CDKN2B, CDKN2C, CCND1, CCND2, CCND3, CCNE1, and CCNE2 are involved in cell cycle progression and regulation. CDKs (Cyclin-dependent kinases) and cyclins (CCND and CCNE) form complexes that regulate cell cycle progression, while CDKNs (Cyclin-dependent kinase inhibitors) negatively regulate the cell cycle.

2. DNA repair: BRCA1, BRCA2, ATM, ATR, CHEK1, CHEK2, RAD51, MSH2, MSH6, MLH1, and XRCC1 are involved in DNA repair pathways, including homologous recombination, mismatch repair, and base excision repair. These proteins maintain genomic stability by repairing DNA damage.

3. Chromatin remodeling: ARID1A, ARID1B, ARID2, SMARCA1, SMARCA4, SMARCB1, and SMARCE1 are part of the SWI/SNF chromatin remodeling complex, which regulates gene expression by altering chromatin structure.

4. Histone modification: EZH2, SETD2, KMT2A, KMT2B, KMT2C, KMT2D, and HDACs (HDAC1, HDAC2, HDAC3, HDAC4, and HDAC5) are involved in histone methylation and deacetylation, which regulate gene expression and chromatin structure.

5. Transcription regulation: TP53, MYC, E2F1, E2F2, E2F3, E2F4, E2F5, E2F6, and STAT3 are transcription factors that regulate gene expression and are involved in various cellular processes, including cell cycle progression, apoptosis, and DNA repair.

6. DNA replication: MCM2, MCM3, MCM4, MCM5, MCM6, and MCM7 form the minichromosome maintenance (MCM) complex, which is essential for DNA replication initiation and elongation.

7. Apoptosis: BCL2L12, BCL6, BCL7A, and CASP8 are involved in the regulation of apoptosis, a process of programmed cell death.

8. Signal transduction: ABL1, AKT1, ARAF, BRAF, HRAS, KRAS, and RAF1 are involved in signal transduction pathways, such as the MAPK and PI3K-AKT pathways, which regulate cell proliferation, survival, and differentiation.

In summary, the most prominent biological process performed by this system of interacting proteins is cell cycle regulation and DNA repair, which are crucial for maintaining genomic stability and preventing tumorigenesis."	62	19.195046439628484	"The interacting proteins in this system are primarily involved in cell cycle regulation and DNA repair. Key proteins and their roles are as follows:

1. Cell cycle regulation: CDK4, CDK6, CDKN1A, CDKN1B, CDKN2A, CDKN2B, CDKN2C, CCND1, CCND2, CCND3, CCNE1, and CCNE2 are involved in cell cycle progression and regulation. CDKs (Cyclin-dependent kinases) and cyclins (CCND and CCNE) form complexes that regulate cell cycle progression, while CDKNs (Cyclin-dependent kinase inhibitors) negatively regulate the cell cycle.[1][2][3]

2. DNA repair: BRCA1, BRCA2, ATM, ATR, CHEK1, CHEK2, RAD51, MSH2, MSH6, MLH1, and XRCC1 are involved in DNA repair pathways, including homologous recombination, mismatch repair, and base excision repair. These proteins maintain genomic stability by repairing DNA damage.[4][5][6]

3. Chromatin remodeling: ARID1A, ARID1B, ARID2, SMARCA1, SMARCA4, SMARCB1, and SMARCE1 are part of the SWI/SNF chromatin remodeling complex, which regulates gene expression by altering chromatin structure.[7][8][9]

4. Histone modification: EZH2, SETD2, KMT2A, KMT2B, KMT2C, KMT2D, and HDACs (HDAC1, HDAC2, HDAC3, HDAC4, and HDAC5) are involved in histone methylation and deacetylation, which regulate gene expression and chromatin structure.[10][11][12]

5. Transcription regulation: TP53, MYC, E2F1, E2F2, E2F3, E2F4, E2F5, E2F6, and STAT3 are transcription factors that regulate gene expression and are involved in various cellular processes, including cell cycle progression, apoptosis, and DNA repair.[13][14][15]

6. DNA replication: MCM2, MCM3, MCM4, MCM5, MCM6, and MCM7 form the minichromosome maintenance (MCM) complex, which is essential for DNA replication initiation and elongation.[16][17][18]

7. Apoptosis: BCL2L12, BCL6, BCL7A, and CASP8 are involved in the regulation of apoptosis, a process of programmed cell death.[19][20][21]

8. Signal transduction: ABL1, AKT1, ARAF, BRAF, HRAS, KRAS, and RAF1 are involved in signal transduction pathways, such as the MAPK and PI3K-AKT pathways, which regulate cell proliferation, survival, and differentiation.[22][23][24]

In summary, the most prominent biological process performed by this system of interacting proteins is cell cycle regulation and DNA repair, which are crucial for maintaining genomic stability and preventing tumorigenesis.

========================================================================================================================================================================================================
[1] Goel, Shom, DeCristo, Molly J, McAllister, Sandra S, Zhao, Jean J. ""CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest."" Trends in cell biology, 2018, pp. 911-925.
[2] Kumarasamy, Vishnu, Vail, Paris, Nambiar, Ram, Witkiewicz, Agnieszka K, Knudsen, Erik S. ""Functional Determinants of Cell Cycle Plasticity and Sensitivity to CDK4/6 Inhibition."" Cancer research, 2021, pp. 1347-1360.
[3] Welcker, M, Lukas, J, Strauss, M, Bartek, J. ""p21WAF1/CIP1 mutants deficient in inhibiting cyclin-dependent kinases (CDKs) can promote assembly of active cyclin D/CDK4(6) complexes in human tumor cells."" Cancer research, 1998, pp. 5053-6.
[4] Yoshida, Kiyotsugu, Miki, Yoshio. ""Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage."" Cancer science, 2004, pp. 866-71.
[5] Jin, Mei Hua, Oh, Do-Youn. ""ATM in DNA repair in cancer."" Pharmacology & therapeutics, 2019, pp. 107391.
[6] Tarsounas, Madalena, Sung, Patrick. ""The antitumorigenic roles of BRCA1-BARD1 in DNA repair and replication."" Nature reviews. Molecular cell biology, 2020, pp. 284-299.
[7] Mardinian, Kristina, Adashek, Jacob J, Botta, Gregory P, Kato, Shumei, Kurzrock, Razelle. ""<i>SMARCA4</i>: Implications of an Altered Chromatin-Remodeling Gene for Cancer Development and Therapy."" Molecular cancer therapeutics, 2021, pp. 2341-2351.
[8] Jiang, Hao, Cao, Hui-Jun, Ma, Ning, Bao, Wen-Dai, Wang, Jing-Jing, Chen, Tian-Wei, Zhang, Er-Bin, Yuan, Yan-Mei, Ni, Qian-Zhi, Zhang, Feng-Kun, Ding, Xu-Fen, Zheng, Qian-Wen, Wang, Yi-Kang, Zhu, Min, Wang, Xiang, Feng, Jing, Zhang, Xue-Li, Cheng, Shu-Qun, Ma, Dan-Jun, Qiu, Lin, Li, Jing-Jing, Xie, Dong. ""Chromatin remodeling factor ARID2 suppresses hepatocellular carcinoma metastasis via DNMT1-Snail axis."" Proceedings of the National Academy of Sciences of the United States of America, 2020, pp. 4770-4780.
[9] Zhang, Shanshan, Zhou, Yu-Feng, Cao, Jian, Burley, Stephen K, Wang, Hui-Yun, Zheng, X F Steven. ""mTORC1 Promotes ARID1A Degradation and Oncogenic Chromatin Remodeling in Hepatocellular Carcinoma."" Cancer research, 2021, pp. 5652-5665.
[10] Zhang, Xinwei, Zhao, Xiaohong, Fiskus, Warren, Lin, Jianhong, Lwin, Tint, Rao, Rekha, Zhang, Yizhuo, Chan, John C, Fu, Kai, Marquez, Victor E, Chen-Kiang, Selina, Moscinski, Lynn C, Seto, Edward, Dalton, William S, Wright, Kenneth L, Sotomayor, Eduardo, Bhalla, Kapil, Tao, Jianguo. ""Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas."" Cancer cell, 2012, pp. 506-523.
[11] Chen, Jiying, Zhu, Zhiying, Xu, Shi, Li, Jing, Huang, Lilan, Tan, Wenqing, Zhang, Yonggang, Zhao, Yanli. ""HDAC1 participates in polycystic ovary syndrome through histone modification by regulating H19/miR-29a-3p/NLRP3-mediated granulosa cell pyroptosis."" Molecular and cellular endocrinology, 2023, pp. 111950.
[12] Ouyang, Lin, Wang, Yanfei, Liu, Lingjiao, Peng, Youming, Hou, Can. ""[Intervention and therapeutic effect of siRNA-HDAC5 on abnormal histone modification in non-obese diabetic mice]."" Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2015, pp. 464-70.
[13] Wang, Yuting, Liu, Liping, Song, Yifan, Yu, Xiaojie, Deng, Hongkui. ""Unveiling E2F4, TEAD1 and AP-1 as regulatory transcription factors of the replicative senescence program by multi-omics analysis."" Protein & cell, 2022, pp. 742-759.
[14] Bhawe, Kaumudi, Roy, Deodutta. ""Interplay between NRF1, E2F4 and MYC transcription factors regulating common target genes contributes to cancer development and progression."" Cellular oncology (Dordrecht), 2018, pp. 465-484.
[15] Li, Shi-Ting, Huang, De, Shen, Shengqi, Cai, Yongping, Xing, Songge, Wu, Gongwei, Jiang, Zetan, Hao, Yijie, Yuan, Mengqiu, Wang, Nana, Zhu, Lianbang, Yan, Ronghui, Yang, Dongdong, Wang, Lin, Liu, Zhaoji, Hu, Xin, Zhou, Rongbin, Qu, Kun, Li, Ailing, Duan, Xiaotao, Zhang, Huafeng, Gao, Ping. ""Myc-mediated SDHA acetylation triggers epigenetic regulation of gene expression and tumorigenesis."" Nature metabolism, 2020, pp. 256-269.
[16] Zeng, Tian, Guan, Yang, Li, Yu-Kun, Wu, Qing, Tang, Xiao-Jun, Zeng, Xin, Ling, Hui, Zou, Juan. ""The DNA replication regulator MCM6: An emerging cancer biomarker and target."" Clinica chimica acta; international journal of clinical chemistry, 2021, pp. 92-98.
[17] Shultz, Randall W, Lee, Tae-Jin, Allen, George C, Thompson, William F, Hanley-Bowdoin, Linda. ""Dynamic localization of the DNA replication proteins MCM5 and MCM7 in plants."" Plant physiology, 2009, pp. 658-69.
[18] Ishimi, Yukio, Komamura-Kohno, Yuki, Karasawa-Shimizu, Kumiko, Yamada, Kouichi. ""Levels of MCM4 phosphorylation and DNA synthesis in DNA replication block checkpoint control."" Journal of structural biology, 2004, pp. 234-41.
[19] Chou, Chia-Hua, Chou, An-Kuo, Lin, Ching-Chih, Chen, Wei-Jay, Wei, Chih-Chang, Yang, Ming-Chang, Hsu, Ching-Mei, Lung, For-Wey, Loh, Joon-Khim, Howng, Shen-Long, Hong, Yi-Ren. ""GSK3β regulates Bcl2L12 and Bcl2L12A anti-apoptosis signaling in glioblastoma and is inhibited by LiCl."" Cell cycle (Georgetown, Tex.), 2012, pp. 532-42.
[20] Yang, Ming-Chang, Loh, Joon-Khim, Li, Yi-Yang, Huang, Wen-Sheng, Chou, Chia-Hua, Cheng, Jiin-Tsuey, Wang, Yeng-Tseng, Lieu, Ann-Shung, Howng, Shen-Long, Hong, Yi-Ren, Chou, An-Kuo. ""Bcl2L12 with a BH3-like domain in regulating apoptosis and TMZ-induced autophagy: a prospective combination of ABT-737 and TMZ for treating glioma."" International journal of oncology, 2015, pp. 1304-16.
[21] Choi, Jinyong, Crotty, Shane. ""Bcl6-Mediated Transcriptional Regulation of Follicular Helper T cells (T<sub>FH</sub>)."" Trends in immunology, 2021, pp. 336-349.
[22] Qu, Xuan, Shen, Liangliang, Zheng, Yan, Cui, Yang, Feng, Zhihui, Liu, Feng, Liu, Jiankang. ""A signal transduction pathway from TGF-β1 to SKP2 via Akt1 and c-Myc and its correlation with progression in human melanoma."" The Journal of investigative dermatology, 2014, pp. 159-167.
[23] Herrero, Ana, Reis-Cardoso, Mariana, Jiménez-Gómez, Iñaki, Doherty, Carolanne, Agudo-Ibañez, Lorena, Pinto, Adán, Calvo, Fernando, Kolch, Walter, Crespo, Piero, Matallanas, David. ""Characterisation of HRas local signal transduction networks using engineered site-specific exchange factors."" Small GTPases, 2020, pp. 371-383.
[24] Drosten, Matthias, Barbacid, Mariano. ""Targeting the MAPK Pathway in KRAS-Driven Tumors."" Cancer cell, 2020, pp. 543-550.
"	0.5925652	0.44270226	LLM	Neither	NA
NeST	ATM-independent DNA repair	NEST:30	AURKA AURKB BARD1 BLM BRCA1 BRCA2 BRIP1 BUB1B CCNE1 CDKN1A CDKN1B CHEK1 CKS1B FANCD2 MKI67 MLH1 MLH3 MSH2 MSH3 MSH6 PMS1 PMS2 POLD1 POLE RAD51 RAD51C RB1 TERT TOP2A TP53 WRN XRCC2	32	5	DNA Repair 	GO:0006281	BARD1;BLM;XRCC2;BRCA1;MLH1;BRCA2;MLH3;MSH6;WRN;RAD51C;RAD51;MSH2;MSH3;FANCD2;POLD1;CHEK1;PMS2;TP53;POLE;PMS1	20	62.5	1.8042958272104575e-29	8.967350261235977e-27	DNA Damage Response and Repair	"The primary biological process performed by this system of interacting proteins is DNA damage response and repair. The proteins involved in this process work together to maintain genomic stability and prevent the accumulation of mutations that could lead to diseases such as cancer.

1. DNA repair and homologous recombination: Proteins such as BRCA1, BRCA2, RAD51, RAD51C, and XRCC2 are involved in the repair of double-strand breaks (DSBs) through homologous recombination (HR). BRCA1 and BRCA2 are essential for HR, while RAD51 and its paralogs, RAD51C and XRCC2, form nucleoprotein filaments that facilitate strand invasion and exchange during HR.

2. Mismatch repair (MMR): Proteins MLH1, MLH3, MSH2, MSH3, MSH6, PMS1, and PMS2 are involved in MMR, a process that corrects base mismatches and insertion/deletion loops that arise during DNA replication. MLH1 and PMS2 form the MutLα complex, while MSH2 and MSH6 form the MutSα complex, both of which are essential for MMR.

3. DNA replication and polymerases: POLD1 and POLE are DNA polymerases involved in DNA replication. POLD1 is the catalytic subunit of DNA polymerase δ, while POLE is the catalytic subunit of DNA polymerase ε. Both polymerases are essential for accurate and processive DNA synthesis.

4. Cell cycle regulation and checkpoint control: Proteins such as CDKN1A, CDKN1B, CCNE1, CKS1B, and RB1 are involved in cell cycle regulation. CDKN1A and CDKN1B are cyclin-dependent kinase inhibitors that negatively regulate cell cycle progression, while CCNE1 and CKS1B promote cell cycle progression. RB1 is a tumor suppressor that controls cell cycle progression by inhibiting the activity of E2F transcription factors.

5. Checkpoint kinases and DNA damage response: CHEK1 and AURKA/B are involved in the activation of cell cycle checkpoints in response to DNA damage. CHEK1 is a serine/threonine kinase that phosphorylates and activates downstream effectors, while AURKA and AURKB are serine/threonine kinases that regulate mitotic progression and chromosome segregation.

6. DNA helicases and genome stability: BLM, WRN, and BRIP1 are DNA helicases involved in maintaining genome stability. BLM and WRN are RecQ helicases that play roles in DNA replication, recombination, and repair, while BRIP1 is a helicase that interacts with BRCA1 and is involved in HR.

7. Tumor suppressor and apoptosis: TP53 is a tumor suppressor that plays a crucial role in preventing cancer by inducing cell cycle arrest, apoptosis, or senescence in response to DNA damage. TP53 is activated by post-translational modifications, such as phosphorylation, in response to various stress signals.

8. Telomere maintenance: TERT is the catalytic subunit of telomerase, an enzyme that maintains telomere length and prevents genomic instability. Telomerase activity is tightly regulated, and its dysregulation can lead to cancer or premature aging.

9. Chromosome segregation and mitosis: BUB1B, MKI67, and TOP2A are involved in chromosome segregation and mitosis. BUB1B is a kinase that plays a role in the spindle assembly checkpoint, while MKI67 is a nuclear protein associated with cell proliferation. TOP2A is a topoisomerase that resolves topological problems during DNA replication and chromosome segregation.

10. DNA damage response and repair regulation: BARD1 is a protein that forms a heterodimer with BRCA1, regulating its function in DNA repair and HR. BARD1 also plays a role in the ubiquitination of histones and other proteins involved in DNA damage response."	31	96.875	"The primary biological process performed by this system of interacting proteins is DNA damage response and repair. The proteins involved in this process work together to maintain genomic stability and prevent the accumulation of mutations that could lead to diseases such as cancer.

1. DNA repair and homologous recombination: Proteins such as BRCA1, BRCA2, RAD51, RAD51C, and XRCC2 are involved in the repair of double-strand breaks (DSBs) through homologous recombination (HR). BRCA1 and BRCA2 are essential for HR, while RAD51 and its paralogs, RAD51C and XRCC2, form nucleoprotein filaments that facilitate strand invasion and exchange during HR.[1][2][3]

2. Mismatch repair (MMR): Proteins MLH1, MLH3, MSH2, MSH3, MSH6, PMS1, and PMS2 are involved in MMR, a process that corrects base mismatches and insertion/deletion loops that arise during DNA replication. MLH1 and PMS2 form the MutLα complex, while MSH2 and MSH6 form the MutSα complex, both of which are essential for MMR.[4][5][6]

3. DNA replication and polymerases: POLD1 and POLE are DNA polymerases involved in DNA replication. POLD1 is the catalytic subunit of DNA polymerase δ, while POLE is the catalytic subunit of DNA polymerase ε. Both polymerases are essential for accurate and processive DNA synthesis.[7][8][9]

4. Cell cycle regulation and checkpoint control: Proteins such as CDKN1A, CDKN1B, CCNE1, CKS1B, and RB1 are involved in cell cycle regulation. CDKN1A and CDKN1B are cyclin-dependent kinase inhibitors that negatively regulate cell cycle progression, while CCNE1 and CKS1B promote cell cycle progression. RB1 is a tumor suppressor that controls cell cycle progression by inhibiting the activity of E2F transcription factors.[10][11][12]

5. Checkpoint kinases and DNA damage response: CHEK1 and AURKA/B are involved in the activation of cell cycle checkpoints in response to DNA damage. CHEK1 is a serine/threonine kinase that phosphorylates and activates downstream effectors, while AURKA and AURKB are serine/threonine kinases that regulate mitotic progression and chromosome segregation.[13][14][15]

6. DNA helicases and genome stability: BLM, WRN, and BRIP1 are DNA helicases involved in maintaining genome stability. BLM and WRN are RecQ helicases that play roles in DNA replication, recombination, and repair, while BRIP1 is a helicase that interacts with BRCA1 and is involved in HR.[16][17][18]

7. Tumor suppressor and apoptosis: TP53 is a tumor suppressor that plays a crucial role in preventing cancer by inducing cell cycle arrest, apoptosis, or senescence in response to DNA damage. TP53 is activated by post-translational modifications, such as phosphorylation, in response to various stress signals.[19][20][21]

8. Telomere maintenance: TERT is the catalytic subunit of telomerase, an enzyme that maintains telomere length and prevents genomic instability. Telomerase activity is tightly regulated, and its dysregulation can lead to cancer or premature aging.[22][23][24]

9. Chromosome segregation and mitosis: BUB1B, MKI67, and TOP2A are involved in chromosome segregation and mitosis. BUB1B is a kinase that plays a role in the spindle assembly checkpoint, while MKI67 is a nuclear protein associated with cell proliferation. TOP2A is a topoisomerase that resolves topological problems during DNA replication and chromosome segregation.[25][26][27]

10. DNA damage response and repair regulation: BARD1 is a protein that forms a heterodimer with BRCA1, regulating its function in DNA repair and HR. BARD1 also plays a role in the ubiquitination of histones and other proteins involved in DNA damage response.[28][29][30]

========================================================================================================================================================================================================
[1] Yoshida, Kiyotsugu, Miki, Yoshio. ""Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage."" Cancer science, 2004, pp. 866-71.
[2] Tarsounas, Madalena, Sung, Patrick. ""The antitumorigenic roles of BRCA1-BARD1 in DNA repair and replication."" Nature reviews. Molecular cell biology, 2020, pp. 284-299.
[3] Zhao, Jiao, Tian, Shanshan, Guo, Qiushi, Bao, Kaiwen, Yu, Guohui, Wang, Xiaodan, Shen, Xilin, Zhang, Jieyou, Chen, Jiaxin, Yang, Ying, Liu, Ling, Li, Xiangchun, Hao, Jihui, Yang, Na, Liu, Zhe, Ai, Ding, Yang, Jie, Zhu, Yi, Yao, Zhi, Ma, Shuai, Zhang, Kai, Shi, Lei. ""A PARylation-phosphorylation cascade promotes TOPBP1 loading and RPA-RAD51 exchange in homologous recombination."" Molecular cell, 2022, pp. 2571-2587.e9.
[4] Nargund, Amrita M, Xu, Chang, Mandoli, Amit, Okabe, Atsushi, Chen, Gao Bin, Huang, Kie Kyon, Sheng, Taotao, Yao, Xiaosai, Teo, Jia Ming Nickolas, Sundar, Raghav, Kok, Yee Jiun, See, Yi Xiang, Xing, Manjie, Li, Zhimei, Yong, Chern Han, Anand, Aparna, A I, Zul Fazreen, Poon, Lai Fong, Ng, Michelle Shu Wen, Koh, Javier Yu Peng, Ooi, Wen Fong, Tay, Su Ting, Ong, Xuewen, Tan, Angie Lay Keng, Grabsch, Heike I, Fullwood, Melissa J, Teh, Tean Bin, Bi, Xuezhi, Kaneda, Atsushi, Li, Shang, Tan, Patrick. ""Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer."" Cancer research, 2022, pp. 2538-2551.
[5] Rogacheva, Maria V, Manhart, Carol M, Chen, Cheng, Guarne, Alba, Surtees, Jennifer, Alani, Eric. ""Mlh1-Mlh3, a meiotic crossover and DNA mismatch repair factor, is a Msh2-Msh3-stimulated endonuclease."" The Journal of biological chemistry, 2014, pp. 5664-73.
[6] Goellner, Eva M, Smith, Catherine E, Campbell, Christopher S, Hombauer, Hans, Desai, Arshad, Putnam, Christopher D, Kolodner, Richard D. ""PCNA and Msh2-Msh6 activate an Mlh1-Pms1 endonuclease pathway required for Exo1-independent mismatch repair."" Molecular cell, 2014, pp. 291-304.
[7] Nicolas, Emmanuelle, Golemis, Erica A, Arora, Sanjeevani. ""POLD1: Central mediator of DNA replication and repair, and implication in cancer and other pathologies."" Gene, 2016, pp. 128-41.
[8] Murdocca, Michela, Spitalieri, Paola, D'Apice, Maria Rosaria, Novelli, Giuseppe, Sangiuolo, Federica. ""From cue to meaning: The involvement of POLD1 gene in DNA replication, repair and aging."" Mechanisms of ageing and development, 2023, pp. 111790.
[9] Huang, Fangjin, Tanaka, Hisashi, Knudsen, Beatrice S, Rutgers, Joanne K. ""Mutant POLQ and POLZ/REV3L DNA polymerases may contribute to the favorable survival of patients with tumors with POLE mutations outside the exonuclease domain."" BMC medical genetics, 2020, pp. 167.
[10] Dyson, Nicholas J. ""RB1: a prototype tumor suppressor and an enigma."" Genes & development, 2016, pp. 1492-502.
[11] Oser, Matthew G, Fonseca, Raquel, Chakraborty, Abhishek A, Brough, Rachel, Spektor, Alexander, Jennings, Rebecca B, Flaifel, Abdallah, Novak, Jesse S, Gulati, Aditi, Buss, Elizabeth, Younger, Scott T, McBrayer, Samuel K, Cowley, Glenn S, Bonal, Dennis M, Nguyen, Quang-De, Brulle-Soumare, Laura, Taylor, Paula, Cairo, Stefano, Ryan, Colm J, Pease, Elizabeth J, Maratea, Kim, Travers, Jon, Root, David E, Signoretti, Sabina, Pellman, David, Ashton, Susan, Lord, Christopher J, Barry, Simon T, Kaelin, William G. ""Cells Lacking the <i>RB1</i> Tumor Suppressor Gene Are Hyperdependent on Aurora B Kinase for Survival."" Cancer discovery, 2019, pp. 230-247.
[12] Gong, Xueqian, Du, Jian, Parsons, Stephen H, Merzoug, Farhana F, Webster, Yue, Iversen, Philip W, Chio, Li-Chun, Van Horn, Robert D, Lin, Xi, Blosser, Wayne, Han, Bomie, Jin, Shaoling, Yao, Sufang, Bian, Huimin, Ficklin, Chris, Fan, Li, Kapoor, Avnish, Antonysamy, Stephen, Mc Nulty, Ann M, Froning, Karen, Manglicmot, Danalyn, Pustilnik, Anna, Weichert, Kenneth, Wasserman, Stephen R, Dowless, Michele, Marugán, Carlos, Baquero, Carmen, Lallena, María José, Eastman, Scott W, Hui, Yu-Hua, Dieter, Matthew Z, Doman, Thompson, Chu, Shaoyou, Qian, Hui-Rong, Ye, Xiang S, Barda, David A, Plowman, Gregory D, Reinhard, Christoph, Campbell, Robert M, Henry, James R, Buchanan, Sean G. ""Aurora A Kinase Inhibition Is Synthetic Lethal with Loss of the <i>RB1</i> Tumor Suppressor Gene."" Cancer discovery, 2019, pp. 248-263.
[13] Marima, Rahaba, Hull, Rodney, Penny, Clement, Dlamini, Zodwa. ""Mitotic syndicates Aurora Kinase B (AURKB) and mitotic arrest deficient 2 like 2 (MAD2L2) in cohorts of DNA damage response (DDR) and tumorigenesis."" Mutation research. Reviews in mutation research, 2021, pp. 108376.
[14] Veerakumarasivam, Abhi, Goldstein, Leonard D, Saeb-Parsy, Kasra, Scott, Helen E, Warren, Anne, Thorne, Natalie P, Mills, Ian G, Venkitaraman, Ashok, Neal, David E, Kelly, John D. ""AURKA overexpression accompanies dysregulation of DNA-damage response genes in invasive urothelial cell carcinoma."" Cell cycle (Georgetown, Tex.), 2008, pp. 3525-33.
[15] Shan, Baocong, Zhao, Ran, Zhou, Jian, Zhang, Minghui, Qi, Xiaoyu, Wang, Tianzhen, Gong, Jinan, Wu, Yiqi, Zhu, Yuanyuan, Yang, Weiwei, Zhang, Yang, Wang, Guangyou, Li, Xiaobo. ""AURKA Increase the Chemosensitivity of Colon Cancer Cells to Oxaliplatin by Inhibiting the TP53-Mediated DNA Damage Response Genes."" BioMed research international, 2020, pp. 8916729.
[16] Zhang, Fang, Yan, Pengyi, Yu, Huijing, Le, Huangying, Li, Zixuan, Chen, Jiahuan, Liang, Xiaodong, Wang, Shiyan, Wei, Weiting, Liu, Li, Zhang, Yan, Ji, Xing, Xie, Anyong, Chen, Wantao, Han, Zeguang, Pu, William T, Chen, Sun, Chen, Yingwei, Sun, Kun, Ge, Baoxue, Zhang, Bing. ""L ARP7 Is a BRCA1 Ubiquitinase Substrate and Regulates Genome Stability and Tumorigenesis."" Cell reports, 2020, pp. 107974.
[17] Singh, Dharmendra Kumar, Popuri, Venkateswarlu, Kulikowicz, Tomasz, Shevelev, Igor, Ghosh, Avik K, Ramamoorthy, Mahesh, Rossi, Marie L, Janscak, Pavel, Croteau, Deborah L, Bohr, Vilhelm A. ""The human RecQ helicases BLM and RECQL4 cooperate to preserve genome stability."" Nucleic acids research, 2012, pp. 6632-48.
[18] Blackford, Andrew N, Nieminuszczy, Jadwiga, Schwab, Rebekka A, Galanty, Yaron, Jackson, Stephen P, Niedzwiedz, Wojciech. ""TopBP1 interacts with BLM to maintain genome stability but is dispensable for preventing BLM degradation."" Molecular cell, 2015, pp. 1133-1141.
[19] Xu-Monette, Zijun Y, Young, Ken H. ""The TP53 tumor suppressor and autophagy in malignant lymphoma."" Autophagy, 2012, pp. 842-5.
[20] Zlamalikova, Lenka, Moulis, Mojmir, Ravcukova, Barbora, Liskova, Kvetoslava, Malcikova, Jitka, Salek, David, Jarkovsky, Jiri, Svitakova, Miluse, Hrabalkova, Renata, Smarda, Jan, Smardova, Jana. ""Complex analysis of the TP53 tumor suppressor in mantle cell and diffuse large B-cell lymphomas."" Oncology reports, 2017, pp. 2535-2542.
[21] Napolitano, Roberta, De Matteis, Serena, Carloni, Silvia, Bruno, Samantha, Abbati, Giulia, Capelli, Laura, Ghetti, Martina, Bochicchio, Maria Teresa, Liverani, Chiara, Mercatali, Laura, Calistri, Daniele, Cuneo, Antonio, Menon, Krishna, Musuraca, Gerardo, Martinelli, Giovanni, Simonetti, Giorgia. ""Kevetrin induces apoptosis in TP53 wild‑type and mutant acute myeloid leukemia cells."" Oncology reports, 2020, pp. 1561-1573.
[22] Duan, Xiao-Feng, Zhao, Qiang. ""TERT-mediated and ATRX-mediated Telomere Maintenance and Neuroblastoma."" Journal of pediatric hematology/oncology, 2018, pp. 1-6.
[23] Wang, Li-Na, Wang, Li, Cheng, Guanghui, Dai, Mingkai, Yu, Yunhai, Teng, Guoxin, Zhao, Jingjie, Xu, Dawei. ""The association of telomere maintenance and TERT expression with susceptibility to human papillomavirus infection in cervical epithelium."" Cellular and molecular life sciences : CMLS, 2022, pp. 110.
[24] Goldstein, Alisa M, Qin, Richard, Chu, Emily Y, Elder, David E, Massi, Daniela, Adams, David J, Harms, Paul W, Robles-Espinoza, Carla Daniela, Newton-Bishop, Julia A, Bishop, D Timothy, Harland, Mark, Holland, Elizabeth A, Cust, Anne E, Schmid, Helen, Mann, Graham J, Puig, Susana, Potrony, Miriam, Alos, Llucia, Nagore, Eduardo, Millán-Esteban, David, Hayward, Nicholas K, Broit, Natasa, Palmer, Jane M, Nathan, Vaishnavi, Berry, Elizabeth G, Astiazaran-Symonds, Esteban, Yang, Xiaohong R, Tucker, Margaret A, Landi, Maria Teresa, Pfeiffer, Ruth M, Sargen, Michael R. ""Association of germline variants in telomere maintenance genes (<i>POT1, TERF2IP, ACD,</i> and <i>TERT</i>) with spitzoid morphology in familial melanoma: A multi-center case series."" JAAD international, 2023, pp. 43-51.
[25] Abal, Miguel, Obrador-Hevia, Antonia, Janssen, Klaus-Peter, Casadome, Laura, Menendez, Mireia, Carpentier, Sabrina, Barillot, Emmanuel, Wagner, Mechthild, Ansorge, Wilhelm, Moeslein, Gabriela, Fsihi, Hafida, Bezrookove, Vladimir, Reventos, Jaume, Louvard, Daniel, Capella, Gabriel, Robine, Sylvie. ""APC inactivation associates with abnormal mitosis completion and concomitant BUB1B/MAD2L1 up-regulation."" Gastroenterology, 2007, pp. 2448-58.
[26] Koyuncu, Dilara, Sharma, Utsav, Goka, Erik T, Lippman, Marc E. ""Spindle assembly checkpoint gene BUB1B is essential in breast cancer cell survival."" Breast cancer research and treatment, 2021, pp. 331-341.
[27] Hahn, Marc-Manuel, Vreede, Lilian, Bemelmans, Sonja A S A, van der Looij, Erica, van Kessel, Ad Geurts, Schackert, Hans K, Ligtenberg, Marjolijn J L, Hoogerbrugge, Nicoline, Kuiper, Roland P, de Voer, Richarda M. ""Prevalence of germline mutations in the spindle assembly checkpoint gene BUB1B in individuals with early-onset colorectal cancer."" Genes, chromosomes & cancer, 2016, pp. 855-63.
[28] Tarsounas, Madalena, Sung, Patrick. ""The antitumorigenic roles of BRCA1-BARD1 in DNA repair and replication."" Nature reviews. Molecular cell biology, 2020, pp. 284-299.
[29] Yoshida, Kiyotsugu, Miki, Yoshio. ""Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage."" Cancer science, 2004, pp. 866-71.
[30] Trivedi, Shalini, Blazícková, Jitka, Silva, Nicola. ""PARG and BRCA1-BARD1 cooperative function regulates DNA repair pathway choice during gametogenesis."" Nucleic acids research, 2022, pp. 12291-12308.
"	0.740402	0.66871357	LLM	Tied	NA
NeST	Ubiquitin/Proteosome System	NEST:32	AURKB CCND1 CUL3 DDB2 ELOC ETV4 ETV5 FBXO11 FBXW7 HSP90AA1 MDM2 NF2 PARK2 PRAME RIT1 SKP1 STK11 TET2 TNF TP53 VHL	21	4.392317422778761	Protein Ubiquitination 	GO:0016567	FBXW7;CUL3;MDM2;PRAME;VHL;ELOC;FBXO11;DDB2;SKP1	9	42.857142857142854	2.2919354434813635e-10	1.455379006610666e-7	Cell Cycle Regulation and DNA Damage Response	"The system of interacting proteins primarily involves cell cycle regulation, DNA damage response, and protein degradation. Key proteins in these processes include AURKB, CCND1, DDB2, MDM2, TP53, and VHL.

1. Cell cycle regulation: AURKB and CCND1 play crucial roles in cell cycle progression. AURKB is a serine/threonine kinase involved in mitosis and chromosome segregation, while CCND1 is a cyclin that regulates the G1-S phase transition. Their interaction suggests a coordinated regulation of cell cycle progression.

2. DNA damage response: DDB2 is a component of the UV-damaged DNA-binding protein complex, which is involved in nucleotide excision repair. The presence of DDB2 indicates that this system is responsive to DNA damage and is involved in maintaining genomic integrity.

3. TP53 and MDM2 interplay: TP53 is a tumor suppressor that regulates cell cycle arrest, apoptosis, and DNA repair in response to DNA damage. MDM2 is an E3 ubiquitin ligase that targets TP53 for degradation. The interaction between TP53 and MDM2 suggests a tightly controlled balance between TP53 activity and degradation, ensuring proper cellular response to stress.

4. Protein degradation: CUL3, ELOC, FBXO11, FBXW7, SKP1, and VHL are involved in protein degradation through the ubiquitin-proteasome system. CUL3 and SKP1 are components of the Cullin-RING E3 ubiquitin ligase complex, while ELOC is an adaptor protein that links CUL3 to substrate recognition subunits. FBXO11 and FBXW7 are F-box proteins that recognize specific substrates for ubiquitination. VHL is an E3 ubiquitin ligase that targets hypoxia-inducible factor 1-alpha (HIF1A) for degradation. These proteins ensure proper protein turnover and cellular homeostasis.

5. Additional regulatory proteins: ETV4, ETV5, HSP90AA1, NF2, PARK2, PRAME, RIT1, STK11, and TET2 are involved in various cellular processes, such as transcriptional regulation (ETV4 and ETV5), protein folding and stabilization (HSP90AA1), tumor suppression (NF2 and STK11), and DNA methylation (TET2). Their interactions with the aforementioned proteins suggest a complex regulatory network that fine-tunes cellular processes and maintains cellular homeostasis.

In conclusion, the most prominent biological process performed by this system of interacting proteins is cell cycle regulation and DNA damage response, with additional involvement in protein degradation and other cellular processes."	20	95.23809523809524	"The system of interacting proteins primarily involves cell cycle regulation, DNA damage response, and protein degradation. Key proteins in these processes include AURKB, CCND1, DDB2, MDM2, TP53, and VHL.[1][2][3]

1. Cell cycle regulation: AURKB and CCND1 play crucial roles in cell cycle progression. AURKB is a serine/threonine kinase involved in mitosis and chromosome segregation, while CCND1 is a cyclin that regulates the G1-S phase transition. Their interaction suggests a coordinated regulation of cell cycle progression.[4][5][6]

2. DNA damage response: DDB2 is a component of the UV-damaged DNA-binding protein complex, which is involved in nucleotide excision repair. The presence of DDB2 indicates that this system is responsive to DNA damage and is involved in maintaining genomic integrity.[7][8][9]

3. TP53 and MDM2 interplay: TP53 is a tumor suppressor that regulates cell cycle arrest, apoptosis, and DNA repair in response to DNA damage. MDM2 is an E3 ubiquitin ligase that targets TP53 for degradation. The interaction between TP53 and MDM2 suggests a tightly controlled balance between TP53 activity and degradation, ensuring proper cellular response to stress.[10][11][12]

4. Protein degradation: CUL3, ELOC, FBXO11, FBXW7, SKP1, and VHL are involved in protein degradation through the ubiquitin-proteasome system. CUL3 and SKP1 are components of the Cullin-RING E3 ubiquitin ligase complex, while ELOC is an adaptor protein that links CUL3 to substrate recognition subunits. FBXO11 and FBXW7 are F-box proteins that recognize specific substrates for ubiquitination. VHL is an E3 ubiquitin ligase that targets hypoxia-inducible factor 1-alpha (HIF1A) for degradation. These proteins ensure proper protein turnover and cellular homeostasis.[13][14][15]

5. Additional regulatory proteins: ETV4, ETV5, HSP90AA1, NF2, PARK2, PRAME, RIT1, STK11, and TET2 are involved in various cellular processes, such as transcriptional regulation (ETV4 and ETV5), protein folding and stabilization (HSP90AA1), tumor suppression (NF2 and STK11), and DNA methylation (TET2). Their interactions with the aforementioned proteins suggest a complex regulatory network that fine-tunes cellular processes and maintains cellular homeostasis.[16][17][18]

In conclusion, the most prominent biological process performed by this system of interacting proteins is cell cycle regulation and DNA damage response, with additional involvement in protein degradation and other cellular processes.

========================================================================================================================================================================================================
[1] Wang, Qiong, He, Guopei, Hou, Mengmeng, Chen, Liutao, Chen, Shangwu, Xu, Anlong, Fu, Yonggui. ""Cell Cycle Regulation by Alternative Polyadenylation of CCND1."" Scientific reports, 2018, pp. 6824.
[2] Schultz-Rogers, Laura E, Thayer, Michelle L, Kambakam, Sekhar, Wierson, Wesley A, Helmer, Jordan A, Wishman, Mark D, Wall, Kristen A, Greig, Jessica L, Forsman, Jaimie L, Puchhalapalli, Kavya, Nair, Siddharth, Weiss, Trevor J, Luiken, Jon M, Blackburn, Patrick R, Ekker, Stephen C, Kool, Marcel, McGrail, Maura. ""Rbbp4 loss disrupts neural progenitor cell cycle regulation independent of Rb and leads to Tp53 acetylation and apoptosis."" Developmental dynamics : an official publication of the American Association of Anatomists, 2022, pp. 1267-1290.
[3] Kumar, Sanjay, Brown, Andrea, Tchounwou, Paul B. ""Trisenox disrupts MDM2-DAXX-HAUSP complex and activates p53, cell cycle regulation and apoptosis in acute leukemia cells."" Oncotarget, 2018, pp. 33138-33148.
[4] Shin, Jihoon, Kim, Tae Wan, Kim, Hyunsoo, Kim, Hye Ji, Suh, Min Young, Lee, Sangho, Lee, Han-Teo, Kwak, Sojung, Lee, Sang-Eun, Lee, Jong-Hyuk, Jang, Hyonchol, Cho, Eun-Jung, Youn, Hong-Duk. ""Aurkb/PP1-mediated resetting of Oct4 during the cell cycle determines the identity of embryonic stem cells."" eLife, 2016, pp. e10877.
[5] Shin, Jihoon, Youn, Hong-Duk. ""Oct4 resetting by Aurkb-PP1 cell cycle axis determines the identity of mouse embryonic stem cells."" BMB reports, 2016, pp. 527-528.
[6] Moura, David S, Campillo-Marcos, Ignacio, Vázquez-Cedeira, Marta, Lazo, Pedro A. ""VRK1 and AURKB form a complex that cross inhibit their kinase activity and the phosphorylation of histone H3 in the progression of mitosis."" Cellular and molecular life sciences : CMLS, 2018, pp. 2591-2611.
[7] Stoyanova, Tanya, Roy, Nilotpal, Kopanja, Dragana, Raychaudhuri, Pradip, Bagchi, Srilata. ""DDB2 (damaged-DNA binding protein 2) in nucleotide excision repair and DNA damage response."" Cell cycle (Georgetown, Tex.), 2009, pp. 4067-71.
[8] Zhang, Ying, Mandemaker, Imke K, Matsumoto, Syota, Foreman, Oded, Holland, Christopher P, Lloyd, Whitney R, Sugasawa, Kaoru, Vermeulen, Wim, Marteijn, Jurgen A, Galardy, Paul J. ""USP44 Stabilizes DDB2 to Facilitate Nucleotide Excision Repair and Prevent Tumors."" Frontiers in cell and developmental biology, 2021, pp. 663411.
[9] Han, Chunhua, Zhao, Ran, Kroger, John, He, Jinshan, Wani, Gulzar, Wang, Qi-En, Wani, Altaf A. ""UV radiation-induced SUMOylation of DDB2 regulates nucleotide excision repair."" Carcinogenesis, 2017, pp. 976-985.
[10] Kussie, P H, Gorina, S, Marechal, V, Elenbaas, B, Moreau, J, Levine, A J, Pavletich, N P. ""Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain."" Science (New York, N.Y.), 1996, pp. 948-53.
[11] Li, Shuchun, Sun, Jing, Ma, Junjun, Zhou, Cixiang, Yang, Xiao, Zhang, Sen, Huang, Ling, Jia, Hongtao, Shao, Yanfei, Zhang, Enkui, Zheng, Minhua, Zhao, Qian, Zang, Lu. ""LncRNA LENGA acts as a tumor suppressor in gastric cancer through BRD7/TP53 signaling."" Cellular and molecular life sciences : CMLS, 2022, pp. 5.
[12] Li, Hongyan, Zhang, Hong, Huang, Guomin, Bing, Zhitong, Xu, Duling, Liu, Jiadi, Luo, Hongtao, An, Xiaoli. ""Loss of RPS27a expression regulates the cell cycle, apoptosis, and proliferation via the RPL11-MDM2-p53 pathway in lung adenocarcinoma cells."" Journal of experimental & clinical cancer research : CR, 2022, pp. 33.
[13] Zhao, Dong, Zheng, Shanliang, Wang, Xingwen, Liu, Hao, Zhao, Kunming, Li, Li, Hu, Ying. ""iASPP is essential for HIF-1α stabilization to promote angiogenesis and glycolysis via attenuating VHL-mediated protein degradation."" Oncogene, 2022, pp. 1944-1958.
[14] Pozzebon, Maria Elena, Varadaraj, Archana, Mattoscio, Domenico, Jaffray, Ellis G, Miccolo, Claudia, Galimberti, Viviana, Tommasino, Massimo, Hay, Ronald T, Chiocca, Susanna. ""BC-box protein domain-related mechanism for VHL protein degradation."" Proceedings of the National Academy of Sciences of the United States of America, 2013, pp. 18168-73.
[15] van den Heuvel, Sander. ""Protein degradation: CUL-3 and BTB--partners in proteolysis."" Current biology : CB, 2004, pp. R59-61.
[16] Tyagi, Nikhil, Deshmukh, Sachin K, Srivastava, Sanjeev K, Azim, Shafquat, Ahmad, Aamir, Al-Ghadhban, Ahmed, Singh, Ajay P, Carter, James E, Wang, Bin, Singh, Seema. ""ETV4 Facilitates Cell-Cycle Progression in Pancreatic Cells through Transcriptional Regulation of Cyclin D1."" Molecular cancer research : MCR, 2018, pp. 187-196.
[17] Wang, Li, Zhang, Song, Zhang, Wenzhen, Cheng, Gong, Khan, Rajwali, Junjvlieke, Zainaguli, Li, Shijun, Zan, Linsen. ""miR-424 Promotes Bovine Adipogenesis Through an Unconventional Post-Transcriptional Regulation of <i>STK11</i>."" Frontiers in genetics, 2020, pp. 145.
[18] Cobo, Isidoro, Tanaka, Tiffany N, Chandra Mangalhara, Kailash, Lana, Addison, Yeang, Calvin, Han, Claudia, Schlachetzki, Johannes, Challcombe, Jean, Fixsen, Bethany R, Sakai, Mashito, Li, Rick Z, Fields, Hannah, Mokry, Michal, Tsai, Randy G, Bejar, Rafael, Prange, Koen, de Winther, Menno, Shadel, Gerald S, Glass, Christopher K. ""DNA methyltransferase 3 alpha and TET methylcytosine dioxygenase 2 restrain mitochondrial DNA-mediated interferon signaling in macrophages."" Immunity, 2022, pp. 1386-1401.e10.
"	0.38960648	0.65478563	GO	GO	NA
NeST	Histone modification	NEST:34	BARD1 BCL11B BRD4 CHD4 CREBBP DNMT1 DNMT3A DNMT3B E2F1 EMSY EZH2 HDAC1 HDAC2 HDAC3 HIST3H3 ING1 IRF2 KDM5A MTA1 PALB2 PARP1 PHF6 PRDM1 RB1 RUNX1 SMARCA1 TERT TP53 ZBTB2 ZNF217	30	4.906890595608519	Negative Regulation Of Transcription By RNA Polymerase II 	GO:0000122	RB1;CREBBP;HDAC2;HDAC3;PARP1;HDAC1;DNMT3A;CHD4;PRDM1;PHF6;ING1;RUNX1;ZBTB2;MTA1;IRF2;DNMT3B;E2F1;ZNF217;TP53;EZH2	20	66.66666666666666	7.00877656479692e-22	3.511397058963257e-19	Epigenetic Regulation and DNA Repair	"The primary biological process performed by this system of interacting proteins is epigenetic regulation and DNA repair. The proteins involved in this system play crucial roles in modulating gene expression, chromatin remodeling, and maintaining genomic stability.

1. Chromatin remodeling and histone modification: CHD4, SMARCA1, and ING1 are involved in chromatin remodeling, which is essential for regulating gene expression. HDAC1, HDAC2, and HDAC3 are histone deacetylases that remove acetyl groups from histones, leading to chromatin condensation and transcriptional repression. CREBBP is a histone acetyltransferase that adds acetyl groups to histones, promoting transcriptional activation. EZH2 is a histone methyltransferase that catalyzes the addition of methyl groups to histone H3, leading to gene silencing. KDM5A is a histone demethylase that removes methyl groups from histone H3, allowing for gene activation.

2. DNA methylation: DNMT1, DNMT3A, and DNMT3B are DNA methyltransferases that add methyl groups to cytosine residues in DNA, leading to gene silencing. This process is crucial for maintaining genomic stability and regulating gene expression.

3. Transcriptional regulation: E2F1, IRF2, PRDM1, RB1, RUNX1, TP53, and ZBTB2 are transcription factors that bind to specific DNA sequences and regulate gene expression. BCL11B and ZNF217 are also involved in transcriptional regulation through their interactions with other transcription factors and chromatin modifiers.

4. DNA repair and genomic stability: BARD1, BRD4, EMSY, MTA1, PALB2, and PARP1 are involved in DNA repair pathways, such as homologous recombination and non-homologous end joining. These proteins help maintain genomic stability by repairing DNA damage and preventing mutations.

5. Telomere maintenance: TERT is the catalytic subunit of telomerase, which is responsible for maintaining telomere length and preventing cellular senescence.

6. Protein-protein interactions: PHF6 and HIST3H3 are involved in protein-protein interactions that modulate the activity of other proteins in this system.

In summary, this system of interacting proteins plays a critical role in epigenetic regulation and DNA repair, ensuring proper gene expression and maintaining genomic stability."	30	100	"The primary biological process performed by this system of interacting proteins is epigenetic regulation and DNA repair. The proteins involved in this system play crucial roles in modulating gene expression, chromatin remodeling, and maintaining genomic stability.

1. Chromatin remodeling and histone modification: CHD4, SMARCA1, and ING1 are involved in chromatin remodeling, which is essential for regulating gene expression. HDAC1, HDAC2, and HDAC3 are histone deacetylases that remove acetyl groups from histones, leading to chromatin condensation and transcriptional repression. CREBBP is a histone acetyltransferase that adds acetyl groups to histones, promoting transcriptional activation. EZH2 is a histone methyltransferase that catalyzes the addition of methyl groups to histone H3, leading to gene silencing. KDM5A is a histone demethylase that removes methyl groups from histone H3, allowing for gene activation.[1][2][3]

2. DNA methylation: DNMT1, DNMT3A, and DNMT3B are DNA methyltransferases that add methyl groups to cytosine residues in DNA, leading to gene silencing. This process is crucial for maintaining genomic stability and regulating gene expression.[4][5][6]

3. Transcriptional regulation: E2F1, IRF2, PRDM1, RB1, RUNX1, TP53, and ZBTB2 are transcription factors that bind to specific DNA sequences and regulate gene expression. BCL11B and ZNF217 are also involved in transcriptional regulation through their interactions with other transcription factors and chromatin modifiers.[7][8][9]

4. DNA repair and genomic stability: BARD1, BRD4, EMSY, MTA1, PALB2, and PARP1 are involved in DNA repair pathways, such as homologous recombination and non-homologous end joining. These proteins help maintain genomic stability by repairing DNA damage and preventing mutations.[10][11][12]

5. Telomere maintenance: TERT is the catalytic subunit of telomerase, which is responsible for maintaining telomere length and preventing cellular senescence.[13][14][15]

6. Protein-protein interactions: PHF6 and HIST3H3 are involved in protein-protein interactions that modulate the activity of other proteins in this system.[16][17][18]

In summary, this system of interacting proteins plays a critical role in epigenetic regulation and DNA repair, ensuring proper gene expression and maintaining genomic stability.

========================================================================================================================================================================================================
[1] Curtis, Carol D, Griffin, Courtney T. ""The chromatin-remodeling enzymes BRG1 and CHD4 antagonistically regulate vascular Wnt signaling."" Molecular and cellular biology, 2012, pp. 1312-20.
[2] Larsen, Dorthe Helena, Poinsignon, Catherine, Gudjonsson, Thorkell, Dinant, Christoffel, Payne, Mark R, Hari, Flurina J, Rendtlew Danielsen, Jannie M, Menard, Patrice, Sand, Jette Christensen, Stucki, Manuel, Lukas, Claudia, Bartek, Jiri, Andersen, Jens S, Lukas, Jiri. ""The chromatin-remodeling factor CHD4 coordinates signaling and repair after DNA damage."" The Journal of cell biology, 2010, pp. 731-40.
[3] Zhang, Xinwei, Zhao, Xiaohong, Fiskus, Warren, Lin, Jianhong, Lwin, Tint, Rao, Rekha, Zhang, Yizhuo, Chan, John C, Fu, Kai, Marquez, Victor E, Chen-Kiang, Selina, Moscinski, Lynn C, Seto, Edward, Dalton, William S, Wright, Kenneth L, Sotomayor, Eduardo, Bhalla, Kapil, Tao, Jianguo. ""Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas."" Cancer cell, 2012, pp. 506-523.
[4] Dura, Mathilde, Teissandier, Aurélie, Armand, Mélanie, Barau, Joan, Lapoujade, Clémentine, Fouchet, Pierre, Bonneville, Lorraine, Schulz, Mathieu, Weber, Michael, Baudrin, Laura G, Lameiras, Sonia, Bourc'his, Deborah. ""DNMT3A-dependent DNA methylation is required for spermatogonial stem cells to commit to spermatogenesis."" Nature genetics, 2022, pp. 469-480.
[5] Zhang, Zhi-Min, Lu, Rui, Wang, Pengcheng, Yu, Yang, Chen, Dongliang, Gao, Linfeng, Liu, Shuo, Ji, Debin, Rothbart, Scott B, Wang, Yinsheng, Wang, Gang Greg, Song, Jikui. ""Structural basis for DNMT3A-mediated de novo DNA methylation."" Nature, 2018, pp. 387-391.
[6] Madsen, Alexandra, Höppner, Grit, Krause, Julia, Hirt, Marc N, Laufer, Sandra D, Schweizer, Michaela, Tan, Wilson Lek Wen, Mosqueira, Diogo, Anene-Nzelu, Chukwuemeka George, Lim, Ives, Foo, Roger S Y, Hansen, Arne, Eschenhagen, Thomas, Stenzig, Justus. ""An Important Role for DNMT3A-Mediated DNA Methylation in Cardiomyocyte Metabolism and Contractility."" Circulation, 2020, pp. 1562-1578.
[7] Choo, Ailyn, Palladinetti, Patricia, Passioura, Toby, Shen, Sylvie, Lock, Richard, Symonds, Geoff, Dolnikov, Alla. ""The role of IRF1 and IRF2 transcription factors in leukaemogenesis."" Current gene therapy, 2006, pp. 543-50.
[8] Wang, Haiwei, Wang, Xinrui, Xu, Liangpu, Zhang, Ji. ""Prognostic analysis of E2F transcription factors E2F1 and E2F3 in four independent pediatric neuroblastoma cohorts."" BMC pediatrics, 2022, pp. 376.
[9] Owens, Dominic D G, Anselmi, Giorgio, Oudelaar, A Marieke, Downes, Damien J, Cavallo, Alessandro, Harman, Joe R, Schwessinger, Ron, Bucakci, Akin, Greder, Lucas, de Ornellas, Sara, Jeziorska, Danuta, Telenius, Jelena, Hughes, Jim R, de Bruijn, Marella F T R. ""Dynamic Runx1 chromatin boundaries affect gene expression in hematopoietic development."" Nature communications, 2022, pp. 773.
[10] Ray Chaudhuri, Arnab, Nussenzweig, André. ""The multifaceted roles of PARP1 in DNA repair and chromatin remodelling."" Nature reviews. Molecular cell biology, 2017, pp. 610-621.
[11] Tarsounas, Madalena, Sung, Patrick. ""The antitumorigenic roles of BRCA1-BARD1 in DNA repair and replication."" Nature reviews. Molecular cell biology, 2020, pp. 284-299.
[12] Zada, David, Sela, Yaniv, Matosevich, Noa, Monsonego, Adir, Lerer-Goldshtein, Tali, Nir, Yuval, Appelbaum, Lior. ""Parp1 promotes sleep, which enhances DNA repair in neurons."" Molecular cell, 2021, pp. 4979-4993.e7.
[13] Duan, Xiao-Feng, Zhao, Qiang. ""TERT-mediated and ATRX-mediated Telomere Maintenance and Neuroblastoma."" Journal of pediatric hematology/oncology, 2018, pp. 1-6.
[14] Wang, Li-Na, Wang, Li, Cheng, Guanghui, Dai, Mingkai, Yu, Yunhai, Teng, Guoxin, Zhao, Jingjie, Xu, Dawei. ""The association of telomere maintenance and TERT expression with susceptibility to human papillomavirus infection in cervical epithelium."" Cellular and molecular life sciences : CMLS, 2022, pp. 110.
[15] Goldstein, Alisa M, Qin, Richard, Chu, Emily Y, Elder, David E, Massi, Daniela, Adams, David J, Harms, Paul W, Robles-Espinoza, Carla Daniela, Newton-Bishop, Julia A, Bishop, D Timothy, Harland, Mark, Holland, Elizabeth A, Cust, Anne E, Schmid, Helen, Mann, Graham J, Puig, Susana, Potrony, Miriam, Alos, Llucia, Nagore, Eduardo, Millán-Esteban, David, Hayward, Nicholas K, Broit, Natasa, Palmer, Jane M, Nathan, Vaishnavi, Berry, Elizabeth G, Astiazaran-Symonds, Esteban, Yang, Xiaohong R, Tucker, Margaret A, Landi, Maria Teresa, Pfeiffer, Ruth M, Sargen, Michael R. ""Association of germline variants in telomere maintenance genes (<i>POT1, TERF2IP, ACD,</i> and <i>TERT</i>) with spitzoid morphology in familial melanoma: A multi-center case series."" JAAD international, 2023, pp. 43-51.
[16] Wendorff, Agnieszka A, Quinn, S Aidan, Rashkovan, Marissa, Madubata, Chioma J, Ambesi-Impiombato, Alberto, Litzow, Mark R, Tallman, Martin S, Paietta, Elisabeth, Paganin, Maddalena, Basso, Giuseppe, Gastier-Foster, Julie M, Loh, Mignon L, Rabadan, Raul, Van Vlierberghe, Pieter, Ferrando, Adolfo A. ""<i>Phf6</i> Loss Enhances HSC Self-Renewal Driving Tumor Initiation and Leukemia Stem Cell Activity in T-ALL."" Cancer discovery, 2019, pp. 436-451.
[17] Gan, Linhua, Sun, Jingjing, Yang, Shuo, Zhang, Xiaocui, Chen, Wu, Sun, Yiyu, Wu, Xiaohua, Cheng, Cheng, Yuan, Jing, Li, Anan, Corbett, Mark A, Dixon, Mathew P, Thomas, Tim, Voss, Anne K, Gécz, Jozef, Wang, Guang-Zhong, Bonni, Azad, Li, Qian, Huang, Ju. ""Chromatin-Binding Protein PHF6 Regulates Activity-Dependent Transcriptional Networks to Promote Hunger Response."" Cell reports, 2020, pp. 3717-3728.e6.
[18] Aillaud, Isabelle, Funke, Susanne Aileen. ""Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease."" Cellular and molecular neurobiology, 2023, pp. 951-961.
"	0.5038649	0.25052416	LLM	LLM	NA
NeST	Nucleus	NEST:4	ANKRD11 AR ARID1A ARID1B ARID2 ASNS ASXL1 ASXL2 ATIC ATM ATR ATRX BAP1 BARD1 BCL11B BCL6 BCL7A BCLAF1 BCOR BCORL1 BRD4 CASP8 CCDC6 CDC73 CDK12 CDK8 CDKN1A CHD2 CHD4 CHEK2 CREBBP CTCF CTNNB1 CUL3 CUX1 DAXX DDX3X DIS3 DKC1 DNMT1 DNMT3A DNMT3B DOT1L E2F1 E2F6 EED ELOC EMSY EP300 ERCC2 ERCC3 ERCC5 ERCC6 ESR1 EWSR1 EZH2 FANCD2 FBXW7 FOXL2 FUBP1 FUS GATA1 GATA3 GPS2 GSTP1 H3F3A H3F3C HDAC1 HDAC2 HDAC3 HDAC4 HDAC5 HIST1H1C HIST1H1E HIST3H3 HRAS HSP90AA1 ING1 IRF2 KAT6A KDM5A KDM6A KMT2A KMT2B KMT2C KMT2D LATS1 MAGI2 MAP3K7 MAX MDM2 MDM4 MED1 MED12 MEN1 MGA MLLT3 MSH3 MTA1 MYB MYC MYCL MYCN NCOA3 NCOR1 NCOR2 NF1 NHP2 NPM1 NSD1 NSD2 NUP93 NUP98 PA2G4 PALB2 PARP1 PBRM1 PCBP1 PELP1 PHB2 PHF6 PIAS4 PML PNRC1 POT1 PPP1CA PPP1CC PPP2CA PPP2CB PPP2R1A PPP2R2A PRCC PRDM1 PRKCZ PRKDC PRPF40B PTPN11 RAD21 RAD50 RAF1 RANBP2 RARA RB1 RBL1 RBM10 REL RHOA RPL5 RPS15 RSF1 RUNX1 RUNX1T1 RXRA SETD2 SF1 SF3B1 SHQ1 SKP1 SLX4 SMAD2 SMARCA1 SMARCA4 SMARCB1 SMARCE1 SMC1A SMC3 SOX2 SPEN SRSF2 STAG1 STAG2 TAF1 TBL1XR1 TCF3 TERT TFDP1 TNF TOP1 TOP2A TP53 U2AF1 UMPS UPF1 VHL WRN WT1 XPA XPC XPO1 XRCC1 YEATS4 ZBTB2 ZNF217 ZRSR2	194	7.599912842187128	Regulation Of Transcription By RNA Polymerase II 	GO:0006357	RB1;SMARCB1;YEATS4;PRDM1;TNF;SOX2;MYC;MYB;EP300;ARID2;MEN1;PIAS4;MED1;RUNX1;MYCL;MYCN;TBL1XR1;BCORL1;TP53;KMT2D;KMT2A;PRKDC;MAX;KMT2C;GATA3;GATA1;ZBTB2;PCBP1;RAD21;SMAD2;CREBBP;BCL11B;FUS;SMARCA1;ESR1;SMARCA4;BCL6;REL;MDM2;ATM;MDM4;CDK12;TCF3;EZH2;DDX3X;CHD4;CTCF;CHD2;PHF6;ING1;CDC73;MED12;BCL7A;DNMT3B;ELOC;HRAS;PELP1;PBRM1;PARP1;EED;NCOA3;DNMT3A;ATRX;FOXL2;ARID1A;ARID1B;NCOR2;NCOR1;TFDP1;IRF2;RARA;HDAC4;HDAC5;HDAC2;HDAC3;HDAC1;DOT1L;GPS2;BCLAF1;MTA1;RXRA;CUX1;NSD1;E2F1;SF3B1;E2F6;BRD4;SMARCE1;SPEN;NPM1;ASXL1;WT1;ASXL2;ZNF217;CTNNB1;BCOR;ERCC6;TAF1	98	50.51546391752577	3.9395510642877146e-46	7.150285181682201e-43	DNA Damage Response and Repair	"The primary biological process performed by this system of interacting proteins is DNA damage response and repair. This is evident from the presence of several key proteins involved in these processes, such as ATM, ATR, ATRX, BARD1, BRD4, CASP8, CDC73, CDK12, CDKN1A, CHEK2, CREBBP, CTCF, DAXX, DDX3X, DNMT1, DNMT3A, DNMT3B, DOT1L, ERCC2, ERCC3, ERCC5, ERCC6, FANCD2, HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HIST1H1C, HIST1H1E, HIST3H3, HRAS, KAT6A, KDM5A, KDM6A, KMT2A, KMT2B, KMT2C, KMT2D, LATS1, MDM2, MDM4, MED1, MED12, MEN1, MLLT3, MSH3, MTA1, NCOA3, NCOR1, NCOR2, NF1, NHP2, NPM1, NSD1, NSD2, NUP93, NUP98, PALB2, PARP1, PBRM1, PCBP1, PELP1, PHF6, PIAS4, PML, PNRC1, POT1, PPP1CA, PPP1CC, PPP2CA, PPP2CB, PPP2R1A, PPP2R2A, PRCC, PRDM1, PRKCZ, PRKDC, PRPF40B, PTPN11, RAD21, RAD50, RAF1, RANBP2, RARA, RB1, RBL1, RBM10, REL, RHOA, RPL5, RPS15, RSF1, RUNX1, RUNX1T1, RXRA, SETD2, SF1, SF3B1, SHQ1, SKP1, SLX4, SMAD2, SMARCA1, SMARCA4, SMARCB1, SMARCE1, SMC1A, SMC3, SOX2, SPEN, SRSF2, STAG1, STAG2, TAF1, TBL1XR1, TCF3, TERT, TFDP1, TNF, TOP1, TOP2A, TP53, U2AF1, UMPS, UPF1, VHL, WRN, WT1, XPA, XPC, XPO1, XRCC1, YEATS4, ZBTB2, ZNF217, and ZRSR2.

These proteins are involved in various aspects of DNA damage response and repair, including DNA damage sensing, signaling, and repair mechanisms. For example, ATM and ATR are key kinases that sense DNA damage and initiate signaling cascades, while proteins like TP53, CDKN1A, and RB1 are involved in cell cycle regulation and apoptosis in response to DNA damage. Proteins such as ERCC2, ERCC3, ERCC5, and ERCC6 are involved in nucleotide excision repair, while RAD50 and RAD21 are involved in homologous recombination repair. Additionally, proteins like PARP1, XRCC1, and FANCD2 are involved in base excision repair and Fanconi anemia pathway, respectively.

Moreover, several proteins in this system are involved in chromatin remodeling and histone modification, which play crucial roles in DNA damage response and repair. These include CREBBP, EP300, HDAC1-5, KMT2A-D, KDM5A, KDM6A, and SETD2.

In summary, the most prominent biological process performed by this system of interacting proteins is DNA damage response and repair, as evidenced by the presence of numerous proteins involved in various aspects of these processes."	139	71.64948453608247	"The primary biological process performed by this system of interacting proteins is DNA damage response and repair. This is evident from the presence of several key proteins involved in these processes, such as ATM, ATR, ATRX, BARD1, BRD4, CASP8, CDC73, CDK12, CDKN1A, CHEK2, CREBBP, CTCF, DAXX, DDX3X, DNMT1, DNMT3A, DNMT3B, DOT1L, ERCC2, ERCC3, ERCC5, ERCC6, FANCD2, HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HIST1H1C, HIST1H1E, HIST3H3, HRAS, KAT6A, KDM5A, KDM6A, KMT2A, KMT2B, KMT2C, KMT2D, LATS1, MDM2, MDM4, MED1, MED12, MEN1, MLLT3, MSH3, MTA1, NCOA3, NCOR1, NCOR2, NF1, NHP2, NPM1, NSD1, NSD2, NUP93, NUP98, PALB2, PARP1, PBRM1, PCBP1, PELP1, PHF6, PIAS4, PML, PNRC1, POT1, PPP1CA, PPP1CC, PPP2CA, PPP2CB, PPP2R1A, PPP2R2A, PRCC, PRDM1, PRKCZ, PRKDC, PRPF40B, PTPN11, RAD21, RAD50, RAF1, RANBP2, RARA, RB1, RBL1, RBM10, REL, RHOA, RPL5, RPS15, RSF1, RUNX1, RUNX1T1, RXRA, SETD2, SF1, SF3B1, SHQ1, SKP1, SLX4, SMAD2, SMARCA1, SMARCA4, SMARCB1, SMARCE1, SMC1A, SMC3, SOX2, SPEN, SRSF2, STAG1, STAG2, TAF1, TBL1XR1, TCF3, TERT, TFDP1, TNF, TOP1, TOP2A, TP53, U2AF1, UMPS, UPF1, VHL, WRN, WT1, XPA, XPC, XPO1, XRCC1, YEATS4, ZBTB2, ZNF217, and ZRSR2.[1][2][3]

These proteins are involved in various aspects of DNA damage response and repair, including DNA damage sensing, signaling, and repair mechanisms. For example, ATM and ATR are key kinases that sense DNA damage and initiate signaling cascades, while proteins like TP53, CDKN1A, and RB1 are involved in cell cycle regulation and apoptosis in response to DNA damage. Proteins such as ERCC2, ERCC3, ERCC5, and ERCC6 are involved in nucleotide excision repair, while RAD50 and RAD21 are involved in homologous recombination repair. Additionally, proteins like PARP1, XRCC1, and FANCD2 are involved in base excision repair and Fanconi anemia pathway, respectively.[4][5][6]

Moreover, several proteins in this system are involved in chromatin remodeling and histone modification, which play crucial roles in DNA damage response and repair. These include CREBBP, EP300, HDAC1-5, KMT2A-D, KDM5A, KDM6A, and SETD2.[7][8][9]

In summary, the most prominent biological process performed by this system of interacting proteins is DNA damage response and repair, as evidenced by the presence of numerous proteins involved in various aspects of these processes.

========================================================================================================================================================================================================
[1] Blackford, Andrew N, Jackson, Stephen P. ""ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response."" Molecular cell, 2017, pp. 801-817.
[2] Wang, Yijie, Luo, Weibo, Wang, Yingfei. ""PARP-1 and its associated nucleases in DNA damage response."" DNA repair, 2019, pp. 102651.
[3] Bian, Lei, Meng, Yiling, Zhang, Meichao, Li, Dong. ""MRE11-RAD50-NBS1 complex alterations and DNA damage response: implications for cancer treatment."" Molecular cancer, 2019, pp. 169.
[4] Blackford, Andrew N, Jackson, Stephen P. ""ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response."" Molecular cell, 2017, pp. 801-817.
[5] Wang, Yijie, Luo, Weibo, Wang, Yingfei. ""PARP-1 and its associated nucleases in DNA damage response."" DNA repair, 2019, pp. 102651.
[6] Bian, Lei, Meng, Yiling, Zhang, Meichao, Li, Dong. ""MRE11-RAD50-NBS1 complex alterations and DNA damage response: implications for cancer treatment."" Molecular cancer, 2019, pp. 169.
[7] Zhou, Yonggang, Santoro, Raffaella, Grummt, Ingrid. ""The chromatin remodeling complex NoRC targets HDAC1 to the ribosomal gene promoter and represses RNA polymerase I transcription."" The EMBO journal, 2002, pp. 4632-40.
[8] Fan, Jie, Iwata, S, Tanaka, Yoshiya, Kitanaga, Yukihiro, Ishii, Akina, Maiko, Hara, Zhang, Xueqiang, Liu, Xingde. ""Kdm5a promotes B cell activation in systemic lupus erythematosus via downregulation of A20 by histone modification."" Pathology, research and practice, 2021, pp. 153653.
[9] Zhang, Xinwei, Zhao, Xiaohong, Fiskus, Warren, Lin, Jianhong, Lwin, Tint, Rao, Rekha, Zhang, Yizhuo, Chan, John C, Fu, Kai, Marquez, Victor E, Chen-Kiang, Selina, Moscinski, Lynn C, Seto, Edward, Dalton, William S, Wright, Kenneth L, Sotomayor, Eduardo, Bhalla, Kapil, Tao, Jianguo. ""Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas."" Cancer cell, 2012, pp. 506-523.
"	0.39826798	0.23219043	Neither	Neither	NA
NeST	Apoptosis Regulation	NEST:47	BCL2 BCL2L1 BCL2L11 BCL2L2 CASP8 FAS IFNGR1 MCL1 MS4A1 PARP1 PTPN13 TBX3 TP53	13	3.700439718141092	Extrinsic Apoptotic Signaling Pathway In Absence Of Ligand 	GO:0097192	BCL2;FAS;BCL2L2;BCL2L1;MCL1	5	38.46153846153847	2.1005823832523369e-13	4.94517919772065e-11	Apoptosis Regulation	"Proteins: BCL2, BCL2L1, BCL2L11, BCL2L2, CASP8, FAS, IFNGR1, MCL1, MS4A1, PARP1, PTPN13, TBX3, TP53.

1. BCL2 family proteins regulate apoptosis: BCL2, BCL2L1, BCL2L11, BCL2L2, and MCL1 are members of the BCL2 family, which play a critical role in regulating apoptosis. BCL2 and BCL2L1 are anti-apoptotic, while BCL2L11 is pro-apoptotic. BCL2L2 and MCL1 have both anti- and pro-apoptotic roles depending on cellular context.

2. CASP8 and FAS mediate extrinsic apoptosis: CASP8 is a caspase involved in the extrinsic apoptosis pathway, activated by FAS, a death receptor. FAS activation leads to CASP8 activation, which in turn activates downstream caspases, ultimately leading to apoptosis.

3. IFNGR1 and PTPN13 regulate apoptosis through signaling pathways: IFNGR1 is a receptor for interferon-gamma, which can induce apoptosis through the JAK-STAT signaling pathway. PTPN13 is a protein tyrosine phosphatase that can regulate apoptosis by modulating signaling pathways, such as the FAS-mediated pathway.

4. TP53 and PARP1 are involved in DNA damage response and apoptosis: TP53 is a tumor suppressor that can induce apoptosis in response to DNA damage. PARP1 is involved in DNA repair and can also promote apoptosis when DNA damage is irreparable.

5. TBX3 and MS4A1 have roles in apoptosis regulation: TBX3 is a transcription factor that can inhibit apoptosis by repressing pro-apoptotic genes. MS4A1 (CD20) is a membrane protein involved in B-cell activation and can modulate apoptosis in B-cells.

In conclusion, the prominent biological process performed by this system of interacting proteins is the regulation of apoptosis, with key roles played by the BCL2 family, CASP8, FAS, TP53, and PARP1. Other proteins, such as IFNGR1, PTPN13, TBX3, and MS4A1, contribute to the regulation of apoptosis through various signaling pathways and cellular contexts."	13	100	"Proteins: BCL2, BCL2L1, BCL2L11, BCL2L2, CASP8, FAS, IFNGR1, MCL1, MS4A1, PARP1, PTPN13, TBX3, TP53.

1. BCL2 family proteins regulate apoptosis: BCL2, BCL2L1, BCL2L11, BCL2L2, and MCL1 are members of the BCL2 family, which play a critical role in regulating apoptosis. BCL2 and BCL2L1 are anti-apoptotic, while BCL2L11 is pro-apoptotic. BCL2L2 and MCL1 have both anti- and pro-apoptotic roles depending on cellular context.[1][2][3]

2. CASP8 and FAS mediate extrinsic apoptosis: CASP8 is a caspase involved in the extrinsic apoptosis pathway, activated by FAS, a death receptor. FAS activation leads to CASP8 activation, which in turn activates downstream caspases, ultimately leading to apoptosis.[4][5][6]

3. IFNGR1 and PTPN13 regulate apoptosis through signaling pathways: IFNGR1 is a receptor for interferon-gamma, which can induce apoptosis through the JAK-STAT signaling pathway. PTPN13 is a protein tyrosine phosphatase that can regulate apoptosis by modulating signaling pathways, such as the FAS-mediated pathway.[7][8][9]

4. TP53 and PARP1 are involved in DNA damage response and apoptosis: TP53 is a tumor suppressor that can induce apoptosis in response to DNA damage. PARP1 is involved in DNA repair and can also promote apoptosis when DNA damage is irreparable.[10][11][12]

5. TBX3 and MS4A1 have roles in apoptosis regulation: TBX3 is a transcription factor that can inhibit apoptosis by repressing pro-apoptotic genes. MS4A1 (CD20) is a membrane protein involved in B-cell activation and can modulate apoptosis in B-cells.[13][14][15]

In conclusion, the prominent biological process performed by this system of interacting proteins is the regulation of apoptosis, with key roles played by the BCL2 family, CASP8, FAS, TP53, and PARP1. Other proteins, such as IFNGR1, PTPN13, TBX3, and MS4A1, contribute to the regulation of apoptosis through various signaling pathways and cellular contexts.[16][17][18]

========================================================================================================================================================================================================
[1] Edlich, Frank. ""BCL-2 proteins and apoptosis: Recent insights and unknowns."" Biochemical and biophysical research communications, 2018, pp. 26-34.
[2] Warren, Chloe F A, Wong-Brown, Michelle W, Bowden, Nikola A. ""BCL-2 family isoforms in apoptosis and cancer."" Cell death & disease, 2019, pp. 177.
[3] Liang, Ji, Cao, Ruixiu, Wang, Xiongjun, Zhang, Yajuan, Wang, Pan, Gao, Hong, Li, Chen, Yang, Fan, Zeng, Rong, Wei, Ping, Li, Dawei, Li, Wenfeng, Yang, Weiwei. ""Mitochondrial PKM2 regulates oxidative stress-induced apoptosis by stabilizing Bcl2."" Cell research, 2017, pp. 329-351.
[4] Wang, Juan, Cao, Zeyuan, Wang, Panpan, Zhang, Xiao, Tang, Jianxia, He, Yifan, Huang, Zhiqing, Mao, Xueli, Shi, Songtao, Kou, Xiaoxing. ""Apoptotic Extracellular Vesicles Ameliorate Multiple Myeloma by Restoring Fas-Mediated Apoptosis."" ACS nano, 2021, pp. 14360-14372.
[5] Koagouw, Wulan, Hazell, Richard J, Ciocan, Corina. ""Induction of apoptosis in the gonads of Mytilus edulis by metformin and increased temperature, via regulation of HSP70, CASP8, BCL2 and FAS."" Marine pollution bulletin, 2021, pp. 113011.
[6] Nagata, S. ""Fas-mediated apoptosis."" Advances in experimental medicine and biology, 1996, pp. 119-24.
[7] Dromard, Mathilde, Bompard, Guillaume, Glondu-Lassis, Murielle, Puech, Carole, Chalbos, Dany, Freiss, Gilles. ""The putative tumor suppressor gene PTPN13/PTPL1 induces apoptosis through insulin receptor substrate-1 dephosphorylation."" Cancer research, 2007, pp. 6806-13.
[8] Singh, Snahlata, Kumar, Sushil, Srivastava, Ratnesh Kumar, Nandi, Ajeya, Thacker, Gatha, Murali, Hemma, Kim, Sabrina, Baldeon, Mary, Tobias, John, Blanco, Mario Andres, Saffie, Rizwan, Zaidi, M Raza, Sinha, Satrajit, Busino, Luca, Fuchs, Serge Y, Chakrabarti, Rumela. ""Loss of ELF5-FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-γ signalling."" Nature cell biology, 2020, pp. 591-602.
[9] Johnson, Brandon, Panek, Paulina, Yu, Andy, Fischer, Elizabeth, Koba, Marli, Mendoza Hermosillo, Daniel, Capaldo, Christopher T. ""Interferon gamma upregulates the cytokine receptors IFNGR1 and TNFRSF1A in HT-29-MTX E12 cells."" Cytokine, 2022, pp. 155892.
[10] Wang, Yijie, Luo, Weibo, Wang, Yingfei. ""PARP-1 and its associated nucleases in DNA damage response."" DNA repair, 2019, pp. 102651.
[11] Lindemann, A, Takahashi, H, Patel, A A, Osman, A A, Myers, J N. ""Targeting the DNA Damage Response in OSCC with TP53 Mutations."" Journal of dental research, 2018, pp. 635-644.
[12] Meza-Sosa, Karla F, Miao, Rui, Navarro, Francisco, Zhang, Zhibin, Zhang, Ying, Hu, Jun Jacob, Hartford, Corrine Corrina R, Li, Xiao Ling, Pedraza-Alva, Gustavo, Pérez-Martínez, Leonor, Lal, Ashish, Wu, Hao, Lieberman, Judy. ""SPARCLE, a p53-induced lncRNA, controls apoptosis after genotoxic stress by promoting PARP-1 cleavage."" Molecular cell, 2022, pp. 785-802.e10.
[13] Amir, Sumaira, Simion, Catalina, Umeh-Garcia, Maxine, Krig, Sheryl, Moss, Tyler, Carraway, Kermit L, Sweeney, Colleen. ""Regulation of the T-box transcription factor Tbx3 by the tumour suppressor microRNA-206 in breast cancer."" British journal of cancer, 2016, pp. 1125-34.
[14] Aliwaini, Saeb, Lubbad, Abdel Monem, Shourfa, Ahmed, Hamada, Hosam A A, Ayesh, Basim, Abu Tayem, Husam Eddeen M, Abu Mustafa, Ayman, Abu Rouk, Fayek, Redwan, Moen M, Al-Najjar, Mohamed. ""Overexpression of TBX3 transcription factor as a potential diagnostic marker for breast cancer."" Molecular and clinical oncology, 2019, pp. 105-112.
[15] Feng, Xianguang, Yao, Wenhuan, Zhang, Zengzhen, Yuan, Fangshui, Liang, Li, Zhou, Jingqiang, Liu, Shuang, Song, Jiqing. ""T-box Transcription Factor Tbx3 Contributes to Human Hepatocellular Carcinoma Cell Migration and Invasion by Repressing E-Cadherin Expression."" Oncology research, 2018, pp. 959-966.
[16] Edlich, Frank. ""BCL-2 proteins and apoptosis: Recent insights and unknowns."" Biochemical and biophysical research communications, 2018, pp. 26-34.
[17] Warren, Chloe F A, Wong-Brown, Michelle W, Bowden, Nikola A. ""BCL-2 family isoforms in apoptosis and cancer."" Cell death & disease, 2019, pp. 177.
[18] Bruckheimer, E M, Cho, S H, Sarkiss, M, Herrmann, J, McDonnell, T J. ""The Bcl-2 gene family and apoptosis."" Advances in biochemical engineering/biotechnology, 1998, pp. 75-105.
"	1.0000002	0.55392826	LLM	LLM	NA
NeST	Checkpoint-regulated DNA repair	NEST:50	BARD1 BLM BRCA1 BRCA2 BUB1B CCND1 CCND2 CCND3 CCNE1 CCNE2 CDK4 CDK5 CDK6 CDKN1A CDKN1B CDKN1C CDKN2A CDKN2B CDKN2C CHEK1 CKS1B CREBBP CTNNB1 E2F1 E2F4 EP300 FANCD2 HDAC1 HLA-A MSH2 MSH6 MYC RAD51 RAD51C RB1 RBL1 RBL2 TERT TOP2A TP53 WRN	41	5.357552004618084	Regulation Of Cyclin-Dependent Protein Kinase Activity 	GO:1904029	CDKN1C;CDKN2B;BLM;CDKN1A;CCND3;CDKN2C;CDKN1B;CCND2;CCNE2;CCND1;CDKN2A;CCNE1	12	29.268292682926827	2.3373631180922453e-22	1.8067816902853048e-19	Cell Cycle Regulation	"The primary biological process performed by this system of interacting proteins is the regulation of the cell cycle. The cell cycle is a series of events that lead to cell growth, DNA replication, and cell division. The proteins in this system play crucial roles in controlling the progression of the cell cycle, ensuring accurate DNA replication, and maintaining genomic stability.

1. Cyclins and cyclin-dependent kinases (CDKs): CCND1, CCND2, CCND3, CCNE1, CCNE2, CDK4, CDK5, and CDK6 are cyclins and CDKs that regulate cell cycle progression. Cyclins bind to CDKs, activating them and allowing the cell to progress through the cell cycle. CDKN1A, CDKN1B, CDKN1C, CDKN2A, CDKN2B, and CDKN2C are CDK inhibitors that negatively regulate the cell cycle by inhibiting CDK activity.

2. Retinoblastoma (Rb) family proteins: RB1, RBL1, and RBL2 are tumor suppressor proteins that regulate the cell cycle by inhibiting the activity of E2F transcription factors (E2F1 and E2F4). When Rb proteins are phosphorylated by CDKs, they release E2F factors, allowing the cell to progress through the cell cycle.

3. DNA damage response and repair: BRCA1, BRCA2, BARD1, BLM, WRN, RAD51, RAD51C, MSH2, MSH6, and FANCD2 are involved in DNA damage response and repair pathways, such as homologous recombination and mismatch repair. These proteins ensure accurate DNA replication and maintain genomic stability.

4. Checkpoint kinases: CHEK1 and TP53 are involved in cell cycle checkpoints, which monitor the integrity of the DNA and halt the cell cycle if damage is detected. TP53, a tumor suppressor protein, can induce cell cycle arrest, senescence, or apoptosis in response to DNA damage.

5. Transcriptional regulation: MYC, EP300, CREBBP, and HDAC1 are involved in the regulation of gene expression. MYC is an oncogene that promotes cell cycle progression, while EP300 and CREBBP are histone acetyltransferases that modulate chromatin structure and gene expression. HDAC1 is a histone deacetylase that represses transcription.

6. Other proteins: CCNB1, BUB1B, CKS1B, CTNNB1, HLA-A, and TOP2A have various roles in cell cycle regulation, including spindle assembly checkpoint, protein degradation, cell adhesion, and DNA topology.

In conclusion, this system of interacting proteins is primarily involved in the regulation of the cell cycle, ensuring proper cell growth, DNA replication, and cell division while maintaining genomic stability."	40	97.5609756097561	"The primary biological process performed by this system of interacting proteins is the regulation of the cell cycle. The cell cycle is a series of events that lead to cell growth, DNA replication, and cell division. The proteins in this system play crucial roles in controlling the progression of the cell cycle, ensuring accurate DNA replication, and maintaining genomic stability.

1. Cyclins and cyclin-dependent kinases (CDKs): CCND1, CCND2, CCND3, CCNE1, CCNE2, CDK4, CDK5, and CDK6 are cyclins and CDKs that regulate cell cycle progression. Cyclins bind to CDKs, activating them and allowing the cell to progress through the cell cycle. CDKN1A, CDKN1B, CDKN1C, CDKN2A, CDKN2B, and CDKN2C are CDK inhibitors that negatively regulate the cell cycle by inhibiting CDK activity.[1][2][3]

2. Retinoblastoma (Rb) family proteins: RB1, RBL1, and RBL2 are tumor suppressor proteins that regulate the cell cycle by inhibiting the activity of E2F transcription factors (E2F1 and E2F4). When Rb proteins are phosphorylated by CDKs, they release E2F factors, allowing the cell to progress through the cell cycle.[4][5][6]

3. DNA damage response and repair: BRCA1, BRCA2, BARD1, BLM, WRN, RAD51, RAD51C, MSH2, MSH6, and FANCD2 are involved in DNA damage response and repair pathways, such as homologous recombination and mismatch repair. These proteins ensure accurate DNA replication and maintain genomic stability.[7][8][9]

4. Checkpoint kinases: CHEK1 and TP53 are involved in cell cycle checkpoints, which monitor the integrity of the DNA and halt the cell cycle if damage is detected. TP53, a tumor suppressor protein, can induce cell cycle arrest, senescence, or apoptosis in response to DNA damage.[10][11][12]

5. Transcriptional regulation: MYC, EP300, CREBBP, and HDAC1 are involved in the regulation of gene expression. MYC is an oncogene that promotes cell cycle progression, while EP300 and CREBBP are histone acetyltransferases that modulate chromatin structure and gene expression. HDAC1 is a histone deacetylase that represses transcription.[13][14][15]

6. Other proteins: CCNB1, BUB1B, CKS1B, CTNNB1, HLA-A, and TOP2A have various roles in cell cycle regulation, including spindle assembly checkpoint, protein degradation, cell adhesion, and DNA topology.[16][17][18]

In conclusion, this system of interacting proteins is primarily involved in the regulation of the cell cycle, ensuring proper cell growth, DNA replication, and cell division while maintaining genomic stability.

========================================================================================================================================================================================================
[1] Goel, Shom, DeCristo, Molly J, McAllister, Sandra S, Zhao, Jean J. ""CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest."" Trends in cell biology, 2018, pp. 911-925.
[2] Kumarasamy, Vishnu, Vail, Paris, Nambiar, Ram, Witkiewicz, Agnieszka K, Knudsen, Erik S. ""Functional Determinants of Cell Cycle Plasticity and Sensitivity to CDK4/6 Inhibition."" Cancer research, 2021, pp. 1347-1360.
[3] Kohoutek, J, Dvorák, P, Hampl, A. ""Temporal distribution of CDK4, CDK6, D-type cyclins, and p27 in developing mouse oocytes."" Biology of reproduction, 2004, pp. 139-45.
[4] Knudsen, Erik S, Pruitt, Steven C, Hershberger, Pamela A, Witkiewicz, Agnieszka K, Goodrich, David W. ""Cell Cycle and Beyond: Exploiting New RB1 Controlled Mechanisms for Cancer Therapy."" Trends in cancer, 2019, pp. 308-324.
[5] Yao, Yang, Liu, Chao, Wang, Bojun, Guan, Xin, Fang, Lin, Zhan, Fei, Sun, Haoxiu, Li, Hengzhen, Lou, Changjie, Yan, Feihu, Lu, Xiaolin, Cui, Luying, Liao, Yuanyu, Han, Shuling, Yao, Yuanfei, Zhang, Yanqiao. ""HOXB9 blocks cell cycle progression to inhibit pancreatic cancer cell proliferation through the DNMT1/RBL2/c-Myc axis."" Cancer letters, 2022, pp. 215595.
[6] Dyson, Nicholas J. ""RB1: a prototype tumor suppressor and an enigma."" Genes & development, 2016, pp. 1492-502.
[7] Wu, Chenming, Chang, Yiming, Chen, Junliang, Su, Yang, Li, Lei, Chen, Yuping, Li, Yunhui, Wu, Jinhuan, Huang, Jinzhou, Zhao, Fei, Wang, Wenrui, Yin, Hui, Wang, Shunli, Jin, Mingpeng, Lou, Zhenkun, Zhu, Wei-Guo, Luo, Kuntian, Zhang, Jie, Yuan, Jian. ""USP37 regulates DNA damage response through stabilizing and deubiquitinating BLM."" Nucleic acids research, 2021, pp. 11224-11240.
[8] Foo, Tzeh Keong, Xia, Bing. ""BRCA1-Dependent and Independent Recruitment of PALB2-BRCA2-RAD51 in the DNA Damage Response and Cancer."" Cancer research, 2022, pp. 3191-3197.
[9] McKenzie, Lisa D, LeClair, John W, Miller, Kayla N, Strong, Averey D, Chan, Hilda L, Oates, Edward L, Ligon, Keith L, Brennan, Cameron W, Chheda, Milan G. ""CHD4 regulates the DNA damage response and RAD51 expression in glioblastoma."" Scientific reports, 2019, pp. 4444.
[10] Meireles Da Costa, Nathalia, Palumbo, Antonio, De Martino, Marco, Fusco, Alfredo, Ribeiro Pinto, Luis Felipe, Nasciutti, Luiz Eurico. ""Interplay between HMGA and TP53 in cell cycle control along tumor progression."" Cellular and molecular life sciences : CMLS, 2021, pp. 817-831.
[11] Sun, Min, Chen, Yanan, Liu, Xiaobei, Cui, Yajie. ""LncRNACASC9 promotes proliferation, metastasis, and cell cycle inovarian carcinoma cells through cyclinG1/TP53/MMP7 signaling."" Bioengineered, 2021, pp. 8006-8019.
[12] Lindemann, A, Takahashi, H, Patel, A A, Osman, A A, Myers, J N. ""Targeting the DNA Damage Response in OSCC with TP53 Mutations."" Journal of dental research, 2018, pp. 635-644.
[13] Lancho, Olga, Herranz, Daniel. ""The MYC Enhancer-ome: Long-Range Transcriptional Regulation of MYC in Cancer."" Trends in cancer, 2018, pp. 810-822.
[14] Ma, Pengpeng, Schultz, Richard M. ""Histone deacetylase 1 (HDAC1) regulates histone acetylation, development, and gene expression in preimplantation mouse embryos."" Developmental biology, 2008, pp. 110-20.
[15] Poljaková, Jitka, Groh, Tomáš, Gudino, Zaneta Omana, Hraběta, Jan, Bořek-Dohalská, Lucie, Kizek, René, Doktorová, Helena, Eckschlager, Tomáš, Stiborová, Marie. ""Hypoxia-mediated histone acetylation and expression of N-myc transcription factor dictate aggressiveness of neuroblastoma cells."" Oncology reports, 2014, pp. 1928-34.
[16] Koyuncu, Dilara, Sharma, Utsav, Goka, Erik T, Lippman, Marc E. ""Spindle assembly checkpoint gene BUB1B is essential in breast cancer cell survival."" Breast cancer research and treatment, 2021, pp. 331-341.
[17] Hahn, Marc-Manuel, Vreede, Lilian, Bemelmans, Sonja A S A, van der Looij, Erica, van Kessel, Ad Geurts, Schackert, Hans K, Ligtenberg, Marjolijn J L, Hoogerbrugge, Nicoline, Kuiper, Roland P, de Voer, Richarda M. ""Prevalence of germline mutations in the spindle assembly checkpoint gene BUB1B in individuals with early-onset colorectal cancer."" Genes, chromosomes & cancer, 2016, pp. 855-63.
[18] Moldogazieva, Nurbubu T, Zavadskiy, Sergey P, Sologova, Susanna S, Mokhosoev, Innokenty M, Terentiev, Alexander A. ""Predictive biomarkers for systemic therapy of hepatocellular carcinoma."" Expert review of molecular diagnostics, 2021, pp. 1147-1164.
"	0.43473858	0.25604406	LLM	Neither	NA
NeST	Transcription	NEST:6	ANKRD11 AR ARID1A ARID1B ARID2 ASXL1 ASXL2 ATM ATR ATRX BAP1 BARD1 BCL11B BCL6 BCL7A BCLAF1 BCOR BCORL1 BRD4 CASP8 CDC73 CDK12 CDK8 CHD2 CHD4 CREBBP CTCF CTNNB1 CUX1 DAXX DDX3X DKC1 DNMT1 DNMT3A DNMT3B DOT1L E2F1 E2F6 EED EMSY EP300 ERCC2 ERCC3 ERCC5 ERCC6 ESR1 EWSR1 EZH2 FANCD2 FBXW7 FUBP1 FUS GATA1 GATA3 HDAC1 HDAC2 HDAC3 HDAC5 HIST1H1E HIST3H3 ING1 IRF2 KAT6A KDM5A KDM6A KMT2A KMT2B KMT2C KMT2D LATS1 MAGI2 MAP3K7 MAX MDM2 MED1 MED12 MEN1 MGA MLLT3 MSH3 MTA1 MYB MYC MYCL MYCN NCOR1 NF1 NPM1 NSD1 NUP98 PALB2 PARP1 PBRM1 PHF6 PML PPP1CA PPP1CC PPP2R1A PRCC PRDM1 PRKDC PRPF40B PTPN11 RAD21 RANBP2 RARA RB1 RBL1 RBM10 REL RSF1 RUNX1 SETD2 SF1 SF3B1 SMAD2 SMARCA1 SMARCA4 SMARCB1 SMARCE1 SMC1A SMC3 SOX2 SPEN SRSF2 STAG1 STAG2 TAF1 TBL1XR1 TERT TFDP1 TNF TOP1 TOP2A TP53 U2AF1 UPF1 WRN WT1 XPA XPO1 XRCC1 YEATS4 ZBTB2 ZNF217 ZRSR2	146	7.189824558880018	Regulation Of Transcription By RNA Polymerase II 	GO:0006357	RB1;SMARCB1;DDX3X;YEATS4;CHD4;PRDM1;CTCF;CHD2;TNF;PHF6;ING1;CDC73;SOX2;MED12;BCL7A;MYC;MYB;DNMT3B;EP300;ARID2;MEN1;MED1;PBRM1;PARP1;EED;DNMT3A;ATRX;ARID1A;ARID1B;RUNX1;MYCL;MYCN;TFDP1;NCOR1;TBL1XR1;IRF2;RARA;BCORL1;TP53;KMT2D;HDAC5;HDAC2;HDAC3;KMT2A;MAX;PRKDC;HDAC1;KMT2C;DOT1L;GATA3;GATA1;ZBTB2;BCLAF1;MTA1;CUX1;NSD1;RAD21;E2F1;E2F6;SF3B1;BRD4;SMAD2;SMARCE1;SPEN;CREBBP;NPM1;BCL11B;FUS;SMARCA1;ESR1;SMARCA4;ASXL1;BCL6;WT1;ASXL2;MDM2;REL;ZNF217;CTNNB1;ATM;CDK12;BCOR;ERCC6;EZH2;TAF1	85	58.21917808219178	1.093052211766406e-46	1.7029753459320603e-43	DNA Damage Response and Chromatin Remodeling	"The interacting proteins in this system are primarily involved in DNA damage response, chromatin remodeling, and transcription regulation. 

1. DNA Damage Response: Several proteins in this system are involved in the detection and repair of DNA damage. Key proteins include ATM, ATR, ATRX, BARD1, BRCA1, ERCC2, ERCC3, ERCC5, ERCC6, FANCD2, PALB2, PRKDC, RAD21, TP53, XPA, and XRCC1. These proteins play roles in various DNA repair pathways, such as homologous recombination, non-homologous end joining, and nucleotide excision repair.

2. Chromatin Remodeling: Chromatin remodeling proteins are essential for the regulation of gene expression by altering the structure of chromatin. Key proteins in this system include ARID1A, ARID1B, ARID2, ASXL1, ASXL2, CHD2, CHD4, CREBBP, EP300, EZH2, HDAC1, HDAC2, HDAC3, HDAC5, KAT6A, KDM5A, KDM6A, KMT2A, KMT2B, KMT2C, KMT2D, SMARCA1, SMARCA4, SMARCB1, and SMARCE1. These proteins are involved in histone modification, nucleosome positioning, and chromatin accessibility.

3. Transcription Regulation: Many proteins in this system are involved in the regulation of transcription, either as transcription factors or as components of transcriptional complexes. Key proteins include AR, BCL6, CTCF, E2F1, E2F6, ESR1, GATA1, GATA3, MAX, MDM2, MED1, MED12, MYB, MYC, MYCL, MYCN, NCOR1, NUP98, PML, PRDM1, RARA, RB1, RBL1, REL, RUNX1, SF1, SF3B1, SMAD2, SOX2, SPEN, SRSF2, TAF1, TBL1XR1, TERT, TFDP1, TNF, TOP1, TOP2A, U2AF1, UPF1, WT1, XPO1, YEATS4, ZBTB2, ZNF217, and ZRSR2. These proteins are involved in various aspects of transcription regulation, such as initiation, elongation, and termination, as well as mRNA processing and export.

In conclusion, the most prominent biological process performed by this system of interacting proteins is DNA damage response, with significant involvement in chromatin remodeling and transcription regulation. These processes are critical for maintaining genomic integrity and regulating gene expression in response to various cellular signals and stressors."	86	58.9041095890411	"The interacting proteins in this system are primarily involved in DNA damage response, chromatin remodeling, and transcription regulation. 

1. DNA Damage Response: Several proteins in this system are involved in the detection and repair of DNA damage. Key proteins include ATM, ATR, ATRX, BARD1, BRCA1, ERCC2, ERCC3, ERCC5, ERCC6, FANCD2, PALB2, PRKDC, RAD21, TP53, XPA, and XRCC1. These proteins play roles in various DNA repair pathways, such as homologous recombination, non-homologous end joining, and nucleotide excision repair.[1][2][3]

2. Chromatin Remodeling: Chromatin remodeling proteins are essential for the regulation of gene expression by altering the structure of chromatin. Key proteins in this system include ARID1A, ARID1B, ARID2, ASXL1, ASXL2, CHD2, CHD4, CREBBP, EP300, EZH2, HDAC1, HDAC2, HDAC3, HDAC5, KAT6A, KDM5A, KDM6A, KMT2A, KMT2B, KMT2C, KMT2D, SMARCA1, SMARCA4, SMARCB1, and SMARCE1. These proteins are involved in histone modification, nucleosome positioning, and chromatin accessibility.[4][5][6]

3. Transcription Regulation: Many proteins in this system are involved in the regulation of transcription, either as transcription factors or as components of transcriptional complexes. Key proteins include AR, BCL6, CTCF, E2F1, E2F6, ESR1, GATA1, GATA3, MAX, MDM2, MED1, MED12, MYB, MYC, MYCL, MYCN, NCOR1, NUP98, PML, PRDM1, RARA, RB1, RBL1, REL, RUNX1, SF1, SF3B1, SMAD2, SOX2, SPEN, SRSF2, TAF1, TBL1XR1, TERT, TFDP1, TNF, TOP1, TOP2A, U2AF1, UPF1, WT1, XPO1, YEATS4, ZBTB2, ZNF217, and ZRSR2. These proteins are involved in various aspects of transcription regulation, such as initiation, elongation, and termination, as well as mRNA processing and export.[7][8][9]

In conclusion, the most prominent biological process performed by this system of interacting proteins is DNA damage response, with significant involvement in chromatin remodeling and transcription regulation. These processes are critical for maintaining genomic integrity and regulating gene expression in response to various cellular signals and stressors.

========================================================================================================================================================================================================
[1] Smith, Joanne, Tho, Lye Mun, Xu, Naihan, Gillespie, David A. ""The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer."" Advances in cancer research, 2010, pp. 73-112.
[2] Blackford, Andrew N, Jackson, Stephen P. ""ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response."" Molecular cell, 2017, pp. 801-817.
[3] Aasland, Dorthe, Götzinger, Laura, Hauck, Laura, Berte, Nancy, Meyer, Jessica, Effenberger, Melanie, Schneider, Simon, Reuber, Emelie E, Roos, Wynand P, Tomicic, Maja T, Kaina, Bernd, Christmann, Markus. ""Temozolomide Induces Senescence and Repression of DNA Repair Pathways in Glioblastoma Cells via Activation of ATR-CHK1, p21, and NF-κB."" Cancer research, 2019, pp. 99-113.
[4] Mardinian, Kristina, Adashek, Jacob J, Botta, Gregory P, Kato, Shumei, Kurzrock, Razelle. ""<i>SMARCA4</i>: Implications of an Altered Chromatin-Remodeling Gene for Cancer Development and Therapy."" Molecular cancer therapeutics, 2021, pp. 2341-2351.
[5] Jiang, Hao, Cao, Hui-Jun, Ma, Ning, Bao, Wen-Dai, Wang, Jing-Jing, Chen, Tian-Wei, Zhang, Er-Bin, Yuan, Yan-Mei, Ni, Qian-Zhi, Zhang, Feng-Kun, Ding, Xu-Fen, Zheng, Qian-Wen, Wang, Yi-Kang, Zhu, Min, Wang, Xiang, Feng, Jing, Zhang, Xue-Li, Cheng, Shu-Qun, Ma, Dan-Jun, Qiu, Lin, Li, Jing-Jing, Xie, Dong. ""Chromatin remodeling factor ARID2 suppresses hepatocellular carcinoma metastasis via DNMT1-Snail axis."" Proceedings of the National Academy of Sciences of the United States of America, 2020, pp. 4770-4780.
[6] Zhang, Shanshan, Zhou, Yu-Feng, Cao, Jian, Burley, Stephen K, Wang, Hui-Yun, Zheng, X F Steven. ""mTORC1 Promotes ARID1A Degradation and Oncogenic Chromatin Remodeling in Hepatocellular Carcinoma."" Cancer research, 2021, pp. 5652-5665.
[7] Braccioli, Luca, de Wit, Elzo. ""CTCF: a Swiss-army knife for genome organization and transcription regulation."" Essays in biochemistry, 2019, pp. 157-165.
[8] Mitra, Partha. ""Transcription regulation of <i>MYB</i>: a potential and novel therapeutic target in cancer."" Annals of translational medicine, 2018, pp. 443.
[9] Watson, R J, Robinson, C, Lam, E W. ""Transcription regulation by murine B-myb is distinct from that by c-myb."" Nucleic acids research, 1993, pp. 267-72.
"	0.37505525	0.5398155	GO	GO	NA
NeST	Nuclear receptor signaling	NEST:60	ANKRD11 BCL6 CEBPA CREBBP ESR2 GPS2 HDAC3 HDAC5 NCOA3 NCOR1 NCOR2 NRIP1 PGR RARA RUNX1T1 RXRA TBL1XR1	17	4.087462841250339	Negative Regulation Of DNA-templated Transcription 	GO:0045892	CEBPA;HDAC5;CREBBP;HDAC3;GPS2;ESR2;NCOR2;NCOR1;RXRA;BCL6;TBL1XR1;NRIP1;RARA;RUNX1T1	14	82.35294117647058	4.658134176914877e-16	9.627119570232349e-14	Transcriptional Regulation	"1. Coregulator proteins: ANKRD11, CEBPA, CREBBP, ESR2, GPS2, HDAC3, HDAC5, NCOA3, NCOR1, NCOR2, NRIP1, PGR, RARA, RUNX1T1, RXRA, TBL1XR1.
- Reasoning: These proteins are known to function as transcriptional coregulators, which modulate gene expression by interacting with transcription factors and chromatin remodeling complexes.

2. Nuclear receptor proteins: ESR2, PGR, RARA, RXRA.
- Reasoning: These proteins are part of the nuclear receptor superfamily, which function as ligand-activated transcription factors that regulate gene expression in response to hormones and other signaling molecules.

3. Histone deacetylases: HDAC3, HDAC5.
- Reasoning: These proteins are members of the histone deacetylase family, which remove acetyl groups from histones, leading to chromatin condensation and transcriptional repression.

4. Transcription factors: BCL6, CEBPA, RUNX1T1.
- Reasoning: These proteins are known to function as transcription factors, which bind to specific DNA sequences and regulate gene expression by recruiting coregulators and other transcriptional machinery.

5. Corepressor proteins: NCOR1, NCOR2, NRIP1, TBL1XR1.
- Reasoning: These proteins are known to function as corepressors, which interact with transcription factors and histone deacetylases to repress gene expression.

6. Coactivator proteins: ANKRD11, CREBBP, NCOA3, GPS2.
- Reasoning: These proteins are known to function as coactivators, which interact with transcription factors and histone acetyltransferases to activate gene expression.

In conclusion, the most prominent biological process performed by this system of interacting proteins is transcriptional regulation, which involves the modulation of gene expression through the coordinated actions of transcription factors, coregulators, and chromatin remodeling enzymes."	17	100	"1. Coregulator proteins: ANKRD11, CEBPA, CREBBP, ESR2, GPS2, HDAC3, HDAC5, NCOA3, NCOR1, NCOR2, NRIP1, PGR, RARA, RUNX1T1, RXRA, TBL1XR1.

- Reasoning: These proteins are known to function as transcriptional coregulators, which modulate gene expression by interacting with transcription factors and chromatin remodeling complexes.

2. Nuclear receptor proteins: ESR2, PGR, RARA, RXRA.[1][2][3]

- Reasoning: These proteins are part of the nuclear receptor superfamily, which function as ligand-activated transcription factors that regulate gene expression in response to hormones and other signaling molecules.

- Reasoning: These proteins are members of the histone deacetylase family, which remove acetyl groups from histones, leading to chromatin condensation and transcriptional repression.

4. Transcription factors: BCL6, CEBPA, RUNX1T1.[4][5][6]

- Reasoning: These proteins are known to function as transcription factors, which bind to specific DNA sequences and regulate gene expression by recruiting coregulators and other transcriptional machinery.

5. Corepressor proteins: NCOR1, NCOR2, NRIP1, TBL1XR1.[7][8][9]

- Reasoning: These proteins are known to function as corepressors, which interact with transcription factors and histone deacetylases to repress gene expression.

6. Coactivator proteins: ANKRD11, CREBBP, NCOA3, GPS2.[10][11]

- Reasoning: These proteins are known to function as coactivators, which interact with transcription factors and histone acetyltransferases to activate gene expression.

In conclusion, the most prominent biological process performed by this system of interacting proteins is transcriptional regulation, which involves the modulation of gene expression through the coordinated actions of transcription factors, coregulators, and chromatin remodeling enzymes.

========================================================================================================================================================================================================
[1] Ma, Xingjie, Warnier, Marine, Raynard, Clotilde, Ferrand, Mylène, Kirsh, Olivier, Defossez, Pierre-Antoine, Martin, Nadine, Bernard, David. ""The nuclear receptor RXRA controls cellular senescence by regulating calcium signaling."" Aging cell, 2018, pp. e12831.
[2] Kim, Hong Im, Kim, Tae Hoon, Yoo, Jung-Yoon, Young, Steven L, Lessey, Bruce A, Ku, Bon Jeong, Jeong, Jae-Wook. ""ARID1A and PGR proteins interact in the endometrium and reveal a positive correlation in endometriosis."" Biochemical and biophysical research communications, 2021, pp. 151-157.
[3] Ozawa, Mina, Hattori, Yujiro, Higo, Shimpei, Otsuka, Mai, Matsumoto, Keisuke, Ozawa, Hitoshi, Ishii, Hirotaka. ""Optimized Mouse-on-mouse Immunohistochemical Detection of Mouse ESR2 Proteins with PPZ0506 Monoclonal Antibody."" Acta histochemica et cytochemica, 2022, pp. 159-168.
[4] Ismail, Sawsan, Elshimali, Yahya, Daoud, Ali, Alshehabi, Zuheir. ""Immunohistochemical expression of transcription factors PAX5, OCT2, BCL6 and transcription regulator P53 in Non-Hodgkin lymphomas: A diagnostic cross-sectional study."" Annals of medicine and surgery (2012), 2022, pp. 103786.
[5] Wang, Hongsheng, Jain, Shweta, Li, Peng, Lin, Jian-Xin, Oh, Jangsuk, Qi, Chenfeng, Gao, Yuanyuan, Sun, Jiafang, Sakai, Tomomi, Naghashfar, Zohreh, Abbasi, Sadia, Kovalchuk, Alexander L, Bolland, Silvia, Nutt, Stephen L, Leonard, Warren J, Morse, Herbert C. ""Transcription factors IRF8 and PU.1 are required for follicular B cell development and BCL6-driven germinal center responses."" Proceedings of the National Academy of Sciences of the United States of America, 2019, pp. 9511-9520.
[6] Akai, Yusuke, Oitate, Takeshi, Koike, Toru, Shiojiri, Nobuyoshi. ""Impaired hepatocyte maturation, abnormal expression of biliary transcription factors and liver fibrosis in C/EBPα(Cebpa)-knockout mice."" Histology and histopathology, 2014, pp. 107-25.
[7] De Miranda, Briana R, Popichak, Katriana A, Hammond, Sean L, Jorgensen, Bryce A, Phillips, Aaron T, Safe, Stephen, Tjalkens, Ronald B. ""The Nurr1 Activator 1,1-Bis(3'-Indolyl)-1-(p-Chlorophenyl)Methane Blocks Inflammatory Gene Expression in BV-2 Microglial Cells by Inhibiting Nuclear Factor κB."" Molecular pharmacology, 2015, pp. 1021-34.
[8] Khanim, Farhat L, Gommersall, Lyndon M, Wood, Victoria H J, Smith, Kirsty L, Montalvo, Leire, O'Neill, Laura P, Xu, Yue, Peehl, Donna M, Stewart, Paul M, Turner, Bryan M, Campbell, Moray J. ""Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells."" Oncogene, 2004, pp. 6712-25.
[9] Oppi, Sara, Nusser-Stein, Stefanie, Blyszczuk, Przemyslaw, Wang, Xu, Jomard, Anne, Marzolla, Vincenzo, Yang, Kangmin, Velagapudi, Srividya, Ward, Liam J, Yuan, Xi-Ming, Geiger, Martin A, Guillaumon, Ana T, Othman, Alaa, Hornemann, Thorsten, Rancic, Zoran, Ryu, Dongryeol, Oosterveer, Maaike H, Osto, Elena, Lüscher, Thomas F, Stein, Sokrates. ""Macrophage NCOR1 protects from atherosclerosis by repressing a pro-atherogenic PPARγ signature."" European heart journal, 2020, pp. 995-1005.
[10] Korzus, Edward. ""Rubinstein-Taybi Syndrome and Epigenetic Alterations."" Advances in experimental medicine and biology, 2017, pp. 39-62.
[11] Yi, Fei, Cai, Chunmiao, Ruan, Banzhan, Hao, Mingang, Yeo, Syn Kok, Haas, Michael, Yang, Fuchun, Zhang, Xiaoting, Guan, Jun-Lin. ""Regulation of RB1CC1/FIP200 stability and autophagy function by CREBBP-mediated acetylation in an intrinsically disordered region."" Autophagy, 2023, pp. 1662-1677.
"	0.4694461	0.2835769	LLM	Neither	NA
NeST	Ubiquitin regulation of mitophagy	NEST:77	CUL3 ELOC FBXW7 HSP90AA1 PARK2 SKP1 STK11 VHL	8	3	Protein Modification By Small Protein Conjugation 	GO:0032446	FBXW7;CUL3;VHL;ELOC;SKP1	5	62.5	1.0401456936673324e-7	2.579561320294984e-5	Ubiquitin-Proteasome System	"Analysis:
1. CUL3, ELOC, SKP1, and FBXW7 form a cullin-RING E3 ubiquitin ligase complex.
   - CUL3 is a scaffold protein that binds to ELOC and SKP1.
   - ELOC and SKP1 are adaptor proteins that facilitate the interaction between CUL3 and FBXW7.
   - FBXW7 is an F-box protein that recognizes and binds to specific substrates for ubiquitination.

2. PARK2 is an E3 ubiquitin ligase.
   - PARK2 is involved in the ubiquitination of specific substrates, targeting them for degradation by the proteasome.

3. VHL is an E3 ubiquitin ligase substrate recognition component.
   - VHL is part of the VCB-CUL2 E3 ubiquitin ligase complex, which targets specific substrates for ubiquitination and degradation.

4. STK11 is a serine/threonine kinase.
   - STK11 phosphorylates and activates substrates involved in various cellular processes, including cell cycle regulation and apoptosis.

5. HSP90AA1 is a molecular chaperone.
   - HSP90AA1 assists in the folding, stability, and function of client proteins, including kinases and transcription factors.

Interactions:
- CUL3, ELOC, SKP1, and FBXW7 form a cullin-RING E3 ubiquitin ligase complex, which is involved in the ubiquitination and degradation of specific substrates.
- PARK2 and VHL are E3 ubiquitin ligases that also target specific substrates for degradation.
- STK11 may regulate the activity of E3 ubiquitin ligases through phosphorylation.
- HSP90AA1 may interact with E3 ubiquitin ligases or their substrates, affecting their stability and function.

In conclusion, the most prominent biological process performed by this system of interacting proteins is the ubiquitin-proteasome system, which is responsible for the targeted degradation of specific cellular proteins."	8	100	"1. CUL3, ELOC, SKP1, and FBXW7 form a cullin-RING E3 ubiquitin ligase complex.[1][2][3]

   - CUL3 is a scaffold protein that binds to ELOC and SKP1.[4][5][6]

   - ELOC and SKP1 are adaptor proteins that facilitate the interaction between CUL3 and FBXW7.[7][8][9]

   - FBXW7 is an F-box protein that recognizes and binds to specific substrates for ubiquitination.[10][11][12]

2. PARK2 is an E3 ubiquitin ligase.[13][14][15]

   - PARK2 is involved in the ubiquitination of specific substrates, targeting them for degradation by the proteasome.[16][17][18]

3. VHL is an E3 ubiquitin ligase substrate recognition component.[19][20][21]

   - VHL is part of the VCB-CUL2 E3 ubiquitin ligase complex, which targets specific substrates for ubiquitination and degradation.[22][23][24]

4. STK11 is a serine/threonine kinase.[25][26][27]

   - STK11 phosphorylates and activates substrates involved in various cellular processes, including cell cycle regulation and apoptosis.[28][29][30]

5. HSP90AA1 is a molecular chaperone.[31][32][33]

   - HSP90AA1 assists in the folding, stability, and function of client proteins, including kinases and transcription factors.[34][35][36]

- CUL3, ELOC, SKP1, and FBXW7 form a cullin-RING E3 ubiquitin ligase complex, which is involved in the ubiquitination and degradation of specific substrates.[37][38][39]

- PARK2 and VHL are E3 ubiquitin ligases that also target specific substrates for degradation.[40][41][42]

- STK11 may regulate the activity of E3 ubiquitin ligases through phosphorylation.[43][44][45]

- HSP90AA1 may interact with E3 ubiquitin ligases or their substrates, affecting their stability and function.[46][47][48]

In conclusion, the most prominent biological process performed by this system of interacting proteins is the ubiquitin-proteasome system, which is responsible for the targeted degradation of specific cellular proteins.

========================================================================================================================================================================================================
[1] Chen, Hsin-Yi, Liu, Chin-Chih, Chen, Ruey-Hwa. ""Cul3-KLHL20 ubiquitin ligase: physiological functions, stress responses, and disease implications."" Cell division, 2016, pp. 5.
[2] Zheng, Ning, Schulman, Brenda A, Song, Langzhou, Miller, Julie J, Jeffrey, Philip D, Wang, Ping, Chu, Claire, Koepp, Deanna M, Elledge, Stephen J, Pagano, Michele, Conaway, Ronald C, Conaway, Joan W, Harper, J Wade, Pavletich, Nikola P. ""Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex."" Nature, 2002, pp. 703-9.
[3] Li, Rongbo, Zhang, Yan, Garg, Ankur, Sui, Pengfei, Sun, Xin. ""E3 ubiquitin ligase FBXW7 balances airway cell fates."" Developmental biology, 2022, pp. 89-97.
[4] Patton, E E, Willems, A R, Sa, D, Kuras, L, Thomas, D, Craig, K L, Tyers, M. ""Cdc53 is a scaffold protein for multiple Cdc34/Skp1/F-box proteincomplexes that regulate cell division and methionine biosynthesis in yeast."" Genes & development, 1998, pp. 692-705.
[5] Guan, Yongjuan, Leu, N Adrian, Ma, Jun, Chmátal, Lukáš, Ruthel, Gordon, Bloom, Jordana C, Lampson, Michael A, Schimenti, John C, Luo, Mengcheng, Wang, P Jeremy. ""SKP1 drives the prophase I to metaphase I transition during male meiosis."" Science advances, 2020, pp. eaaz2129.
[6] Zhai, Fengguang, Li, Jingyun, Ye, Meng, Jin, Xiaofeng. ""The functions and effects of CUL3-E3 ligases mediated non-degradative ubiquitination."" Gene, 2022, pp. 146562.
[7] Kato, Kohji, Miya, Fuyuki, Oka, Yasuyoshi, Mizuno, Seiji, Saitoh, Shinji. ""A novel missense variant in CUL3 shows altered binding ability to BTB-adaptor proteins leading to diverse phenotypes of CUL3-related disorders."" Journal of human genetics, 2021, pp. 491-498.
[8] Kahloul, Senda, HajSalah El Beji, Imen, Boulaflous, Aurélia, Ferchichi, Ali, Kong, Hongzhi, Mouzeyar, Said, Bouzidi, Mohamed Fouad. ""Structural, expression and interaction analysis of rice SKP1-like genes."" DNA research : an international journal for rapid publication of reports on genes and genomes, 2013, pp. 67-78.
[9] Akopian, David, McGourty, Colleen A, Rapé, Michael. ""Co-adaptor driven assembly of a CUL3 E3 ligase complex."" Molecular cell, 2022, pp. 585-597.e11.
[10] Zhao, Jiejie, Xiong, Xuelian, Li, Yao, Liu, Xing, Wang, Tao, Zhang, Hong, Jiao, Yang, Jiang, Jingjing, Zhang, Huijie, Tang, Qiqun, Gao, Xin, Li, Xuejun, Lu, Yan, Liu, Bin, Hu, Cheng, Li, Xiaoying. ""Hepatic F-Box Protein FBXW7 Maintains Glucose Homeostasis Through Degradation of Fetuin-A."" Diabetes, 2018, pp. 818-830.
[11] Yumimoto, Kanae, Akiyoshi, Sayuri, Ueo, Hiroki, Sagara, Yasuaki, Onoyama, Ichiro, Ueo, Hiroaki, Ohno, Shinji, Mori, Masaki, Mimori, Koshi, Nakayama, Keiichi I. ""F-box protein FBXW7 inhibits cancer metastasis in a non-cell-autonomous manner."" The Journal of clinical investigation, 2015, pp. 621-35.
[12] Mozuraitiene, Julija, Gudleviciene, Zivile, Vincerzevskiene, Ieva, Laurinaviciene, Aida, Pamedys, Justinas. ""Expression levels of FBXW7 and MDM2 E3 ubiquitin ligases and their c-Myc and p53 substrates in patients with dysplastic nevi or melanoma."" Oncology letters, 2021, pp. 37.
[13] Zhou, Xiaofeng, Li, Yajie, Wang, Weilong, Wang, Sujie, Hou, Jinghan, Zhang, Aijia, Lv, Benjie, Gao, Can, Yan, Ziyi, Pang, Dan, Lu, Kui, Ahmad, Nor Hazwani, Wang, Lidong, Zhu, Jian, Zhang, Lichen, Zhuang, Ting, Li, Xiumin. ""Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2."" Theranostics, 2020, pp. 9443-9457.
[14] Montagnani, Valentina, Maresca, Luisa, Apollo, Alessandro, Pepe, Sara, Carr, Ryan M, Fernandez-Zapico, Martin E, Stecca, Barbara. ""E3 ubiquitin ligase PARK2, an inhibitor of melanoma cell growth, is repressed by the oncogenic ERK1/2-ELK1 transcriptional axis."" The Journal of biological chemistry, 2020, pp. 16058-16071.
[15] Tsubouchi, Kazuya, Araya, Jun, Kuwano, Kazuyoshi. ""PINK1-PARK2-mediated mitophagy in COPD and IPF pathogeneses."" Inflammation and regeneration, 2018, pp. 18.
[16] Kumar, Dhiraj, Kumar, Pravir. ""Integrated Mechanism of Lysine 351, PARK2, and STUB1 in AβPP Ubiquitination."" Journal of Alzheimer's disease : JAD, 2019, pp. 1125-1150.
[17] Kocaturk, Nur Mehpare, Peker, Nesibe, Eberhart, Karin, Akkoc, Yunus, Deveci, Gamze, Dengjel, Joern, Gozuacik, Devrim. ""Novel protein complexes containing autophagy and UPS components regulate proteasome-dependent PARK2 recruitment onto mitochondria and PARK2-PARK6 activity during mitophagy."" Cell death & disease, 2022, pp. 947.
[18] Furuya, Norihiko, Ikeda, Shin-Ichi, Sato, Shigeto, Soma, Sanae, Ezaki, Junji, Oliva Trejo, Juan Alejandro, Takeda-Ezaki, Mitsue, Fujimura, Tsutomu, Arikawa-Hirasawa, Eri, Tada, Norihiro, Komatsu, Masaaki, Tanaka, Keiji, Kominami, Eiki, Hattori, Nobutaka, Ueno, Takashi. ""PARK2/Parkin-mediated mitochondrial clearance contributes to proteasome activation during slow-twitch muscle atrophy via NFE2L1 nuclear translocation."" Autophagy, 2014, pp. 631-41.
[19] Buckley, Dennis L, Van Molle, Inge, Gareiss, Peter C, Tae, Hyun Seop, Michel, Julien, Noblin, Devin J, Jorgensen, William L, Ciulli, Alessio, Crews, Craig M. ""Targeting the von Hippel-Lindau E3 ubiquitin ligase using small molecules to disrupt the VHL/HIF-1α interaction."" Journal of the American Chemical Society, 2012, pp. 4465-8.
[20] Zhang, Bichao, Kirn, Lauren A, Burke, Richard. ""The Vhl E3 ubiquitin ligase complex regulates melanisation via sima, cnc and the copper import protein Ctr1A."" Biochimica et biophysica acta. Molecular cell research, 2021, pp. 119022.
[21] Nguyen, Henry C, Yang, Haitao, Fribourgh, Jennifer L, Wolfe, Leslie S, Xiong, Yong. ""Insights into Cullin-RING E3 ubiquitin ligase recruitment: structure of the VHL-EloBC-Cul2 complex."" Structure (London, England : 1993), 2015, pp. 441-449.
[22] Cardote, Teresa A F, Gadd, Morgan S, Ciulli, Alessio. ""Crystal Structure of the Cul2-Rbx1-EloBC-VHL Ubiquitin Ligase Complex."" Structure (London, England : 1993), 2017, pp. 901-911.e3.
[23] Nguyen, Henry C, Yang, Haitao, Fribourgh, Jennifer L, Wolfe, Leslie S, Xiong, Yong. ""Insights into Cullin-RING E3 ubiquitin ligase recruitment: structure of the VHL-EloBC-Cul2 complex."" Structure (London, England : 1993), 2015, pp. 441-449.
[24] Buckley, Dennis L, Van Molle, Inge, Gareiss, Peter C, Tae, Hyun Seop, Michel, Julien, Noblin, Devin J, Jorgensen, William L, Ciulli, Alessio, Crews, Craig M. ""Targeting the von Hippel-Lindau E3 ubiquitin ligase using small molecules to disrupt the VHL/HIF-1α interaction."" Journal of the American Chemical Society, 2012, pp. 4465-8.
[25] Altamish, Mohammad, Dahiya, Rajiv, Singh, Avinash Kumar, Mishra, Anurag, Aljabali, Alaa A A, Satija, Saurabh, Mehta, Meenu, Dureja, Harish, Prasher, Parteek, Negi, Poonam, Kapoor, Deepak N, Goyal, Rohit, Tambuwala, Murtaza M, Chellappan, Dinesh Kumar, Dua, Kamal, Gupta, Gaurav. ""Role of the Serine/Threonine Kinase 11 (STK11) or Liver Kinase B1 (LKB1) Gene in Peutz-Jeghers Syndrome."" Critical reviews in eukaryotic gene expression, 2020, pp. 245-252.
[26] Dragoi, Ana-Maria, Agaisse, Hervé. ""The serine/threonine kinase STK11 promotes Shigella flexneri dissemination through establishment of cell-cell contacts competent for tyrosine kinase signaling."" Infection and immunity, 2014, pp. 4447-57.
[27] Skoulidis, Ferdinandos, Goldberg, Michael E, Greenawalt, Danielle M, Hellmann, Matthew D, Awad, Mark M, Gainor, Justin F, Schrock, Alexa B, Hartmaier, Ryan J, Trabucco, Sally E, Gay, Laurie, Ali, Siraj M, Elvin, Julia A, Singal, Gaurav, Ross, Jeffrey S, Fabrizio, David, Szabo, Peter M, Chang, Han, Sasson, Ariella, Srinivasan, Sujaya, Kirov, Stefan, Szustakowski, Joseph, Vitazka, Patrik, Edwards, Robin, Bufill, Jose A, Sharma, Neelesh, Ou, Sai-Hong I, Peled, Nir, Spigel, David R, Rizvi, Hira, Aguilar, Elizabeth Jimenez, Carter, Brett W, Erasmus, Jeremy, Halpenny, Darragh F, Plodkowski, Andrew J, Long, Niamh M, Nishino, Mizuki, Denning, Warren L, Galan-Cobo, Ana, Hamdi, Haifa, Hirz, Taghreed, Tong, Pan, Wang, Jing, Rodriguez-Canales, Jaime, Villalobos, Pamela A, Parra, Edwin R, Kalhor, Neda, Sholl, Lynette M, Sauter, Jennifer L, Jungbluth, Achim A, Mino-Kenudson, Mari, Azimi, Roxana, Elamin, Yasir Y, Zhang, Jianjun, Leonardi, Giulia C, Jiang, Fei, Wong, Kwok-Kin, Lee, J Jack, Papadimitrakopoulou, Vassiliki A, Wistuba, Ignacio I, Miller, Vincent A, Frampton, Garrett M, Wolchok, Jedd D, Shaw, Alice T, Jänne, Pasi A, Stephens, Philip J, Rudin, Charles M, Geese, William J, Albacker, Lee A, Heymach, John V. ""<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma."" Cancer discovery, 2018, pp. 822-835.
[28] Skoulidis, Ferdinandos, Goldberg, Michael E, Greenawalt, Danielle M, Hellmann, Matthew D, Awad, Mark M, Gainor, Justin F, Schrock, Alexa B, Hartmaier, Ryan J, Trabucco, Sally E, Gay, Laurie, Ali, Siraj M, Elvin, Julia A, Singal, Gaurav, Ross, Jeffrey S, Fabrizio, David, Szabo, Peter M, Chang, Han, Sasson, Ariella, Srinivasan, Sujaya, Kirov, Stefan, Szustakowski, Joseph, Vitazka, Patrik, Edwards, Robin, Bufill, Jose A, Sharma, Neelesh, Ou, Sai-Hong I, Peled, Nir, Spigel, David R, Rizvi, Hira, Aguilar, Elizabeth Jimenez, Carter, Brett W, Erasmus, Jeremy, Halpenny, Darragh F, Plodkowski, Andrew J, Long, Niamh M, Nishino, Mizuki, Denning, Warren L, Galan-Cobo, Ana, Hamdi, Haifa, Hirz, Taghreed, Tong, Pan, Wang, Jing, Rodriguez-Canales, Jaime, Villalobos, Pamela A, Parra, Edwin R, Kalhor, Neda, Sholl, Lynette M, Sauter, Jennifer L, Jungbluth, Achim A, Mino-Kenudson, Mari, Azimi, Roxana, Elamin, Yasir Y, Zhang, Jianjun, Leonardi, Giulia C, Jiang, Fei, Wong, Kwok-Kin, Lee, J Jack, Papadimitrakopoulou, Vassiliki A, Wistuba, Ignacio I, Miller, Vincent A, Frampton, Garrett M, Wolchok, Jedd D, Shaw, Alice T, Jänne, Pasi A, Stephens, Philip J, Rudin, Charles M, Geese, William J, Albacker, Lee A, Heymach, John V. ""<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma."" Cancer discovery, 2018, pp. 822-835.
[29] Wohlhieter, Corrin A, Richards, Allison L, Uddin, Fathema, Hulton, Christopher H, Quintanal-Villalonga, Àlvaro, Martin, Axel, de Stanchina, Elisa, Bhanot, Umeshkumar, Asher, Marina, Shah, Nisargbhai S, Hayatt, Omar, Buonocore, Darren J, Rekhtman, Natasha, Shen, Ronglai, Arbour, Kathryn C, Donoghue, Mark, Poirier, John T, Sen, Triparna, Rudin, Charles M. ""Concurrent Mutations in STK11 and KEAP1 Promote Ferroptosis Protection and SCD1 Dependence in Lung Cancer."" Cell reports, 2020, pp. 108444.
[30] Nakada, Daisuke, Saunders, Thomas L, Morrison, Sean J. ""Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells."" Nature, 2010, pp. 653-8.
[31] Xiao, Xin, Wang, Wei, Li, Yuqian, Yang, Di, Li, Xiaokang, Shen, Chao, Liu, Yan, Ke, Xianzhu, Guo, Shuo, Guo, Zheng. ""HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma."" Journal of experimental & clinical cancer research : CR, 2018, pp. 201.
[32] Zuehlke, Abbey D, Beebe, Kristin, Neckers, Len, Prince, Thomas. ""Regulation and function of the human HSP90AA1 gene."" Gene, 2015, pp. 8-16.
[33] Liu, Haizhou, Zhang, Zihan, Huang, Yi, Wei, Wene, Ning, Shufang, Li, Jilin, Liang, Xinqiang, Liu, Kaisheng, Zhang, Litu. ""Plasma HSP90AA1 Predicts the Risk of Breast Cancer Onset and Distant Metastasis."" Frontiers in cell and developmental biology, 2021, pp. 639596.
[34] Ramón, Manuel, Salces-Ortiz, Judit, González, Carmen, Pérez-Guzmán, M Dolores, Garde, J Julián, García-Álvarez, Olga, Maroto-Morales, Alejandro, Calvo, Jorge H, Serrano, M Magdalena. ""Influence of the temperature and the genotype of the HSP90AA1 gene over sperm chromatin stability in Manchega Rams."" PloS one, 2014, pp. e86107.
[35] Xu, Yunbin, Liu, Fei, Liu, Juan, Wang, Dandan, Yan, Yan, Ji, Senlin, Zan, Jie, Zhou, Jiyong. ""The co-chaperone Cdc37 regulates the rabies virus phosphoprotein stability by targeting to Hsp90AA1 machinery."" Scientific reports, 2016, pp. 27123.
[36] Haase, Michael, Fitze, Guido. ""HSP90AB1: Helping the good and the bad."" Gene, 2016, pp. 171-86.
[37] Chen, Hsin-Yi, Liu, Chin-Chih, Chen, Ruey-Hwa. ""Cul3-KLHL20 ubiquitin ligase: physiological functions, stress responses, and disease implications."" Cell division, 2016, pp. 5.
[38] Zheng, Ning, Schulman, Brenda A, Song, Langzhou, Miller, Julie J, Jeffrey, Philip D, Wang, Ping, Chu, Claire, Koepp, Deanna M, Elledge, Stephen J, Pagano, Michele, Conaway, Ronald C, Conaway, Joan W, Harper, J Wade, Pavletich, Nikola P. ""Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex."" Nature, 2002, pp. 703-9.
[39] Li, Rongbo, Zhang, Yan, Garg, Ankur, Sui, Pengfei, Sun, Xin. ""E3 ubiquitin ligase FBXW7 balances airway cell fates."" Developmental biology, 2022, pp. 89-97.
[40] Aublette, Marine C, Harrison, Tom A, Thorpe, Elizabeth J, Gadd, Morgan S. ""Selective Wee1 degradation by PROTAC degraders recruiting VHL and CRBN E3 ubiquitin ligases."" Bioorganic & medicinal chemistry letters, 2022, pp. 128636.
[41] Heir, Pardeep, Ohh, Michael. ""Hydroxylation-Dependent Interaction of Substrates to the Von Hippel-Lindau Tumor Suppressor Protein (VHL)."" Methods in molecular biology (Clifton, N.J.), 2016, pp. 87-94.
[42] Kofink, Christiane, Trainor, Nicole, Mair, Barbara, Wöhrle, Simon, Wurm, Melanie, Mischerikow, Nikolai, Roy, Michael J, Bader, Gerd, Greb, Peter, Garavel, Géraldine, Diers, Emelyne, McLennan, Ross, Whitworth, Claire, Vetma, Vesna, Rumpel, Klaus, Scharnweber, Maximilian, Fuchs, Julian E, Gerstberger, Thomas, Cui, Yunhai, Gremel, Gabriela, Chetta, Paolo, Hopf, Stefan, Budano, Nicole, Rinnenthal, Joerg, Gmaschitz, Gerhard, Mayer, Moriz, Koegl, Manfred, Ciulli, Alessio, Weinstabl, Harald, Farnaby, William. ""A selective and orally bioavailable VHL-recruiting PROTAC achieves SMARCA2 degradation in vivo."" Nature communications, 2022, pp. 5969.
[43] Li, Ran, Wang, Zhiqing, Liu, Shu, Wu, Baoping, Zeng, Di, Zhang, Yali, Gong, Lanbo, Deng, Feihong, Zheng, Haoxuan, Wang, Yadong, Chen, Chudi, Chen, Junsheng, Jiang, Bo. ""Two novel <i>STK11</i> missense mutations induce phosphorylation of S6K and promote cell proliferation in Peutz-Jeghers syndrome."" Oncology letters, 2018, pp. 717-726.
[44] Sapkota, Gopal P, Boudeau, Jérôme, Deak, Maria, Kieloch, Agnieszka, Morrice, Nick, Alessi, Dario R. ""Identification and characterization of four novel phosphorylation sites (Ser31, Ser325, Thr336 and Thr366) on LKB1/STK11, the protein kinase mutated in Peutz-Jeghers cancer syndrome."" The Biochemical journal, 2002, pp. 481-90.
[45] Sapkota, G P, Kieloch, A, Lizcano, J M, Lain, S, Arthur, J S, Williams, M R, Morrice, N, Deak, M, Alessi, D R. ""Phosphorylation of the protein kinase mutated in Peutz-Jeghers cancer syndrome, LKB1/STK11, at Ser431 by p90(RSK) and cAMP-dependent protein kinase, but not its farnesylation at Cys(433), is essential for LKB1 to suppress cell vrowth."" The Journal of biological chemistry, 2001, pp. 19469-82.
[46] Xiao, Xin, Wang, Wei, Li, Yuqian, Yang, Di, Li, Xiaokang, Shen, Chao, Liu, Yan, Ke, Xianzhu, Guo, Shuo, Guo, Zheng. ""HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma."" Journal of experimental & clinical cancer research : CR, 2018, pp. 201.
[47] Zuehlke, Abbey D, Beebe, Kristin, Neckers, Len, Prince, Thomas. ""Regulation and function of the human HSP90AA1 gene."" Gene, 2015, pp. 8-16.
[48] Zhao, Yiting, Li, Jinyun, Chen, Jun, Ye, Meng, Jin, Xiaofeng. ""Functional roles of E3 ubiquitin ligases in prostate cancer."" Journal of molecular medicine (Berlin, Germany), 2022, pp. 1125-1144.
"	0.50711447	0.37136942	LLM	LLM	NA
NeST	ATM-dependent DNA repair	NEST:79	ATM AURKA BARD1 BLM BRCA1 BRCA2 BRIP1 BUB1B CDC73 CHEK1 FANCA FANCD2 MDC1 MDM2 MRE11 MSH6 NBN PALB2 POLH RAD50 RAD51 RAD51B RAD51C RAD51D TOP2A TP53 WRN XRCC2 XRCC3	29	4.857980995127572	DNA Repair 	GO:0006281	BARD1;BLM;MRE11;XRCC2;XRCC3;FANCA;BRCA1;BRCA2;RAD51B;MSH6;RAD50;RAD51D;WRN;RAD51C;RAD51;FANCD2;CHEK1;ATM;NBN;TP53;POLH	21	72.41379310344827	4.898459193609726e-33	2.2385958514796447e-30	DNA Damage Response and Repair	"The primary biological process performed by this system of interacting proteins is the DNA damage response and repair. This process is crucial for maintaining genomic stability and preventing the accumulation of mutations that can lead to various diseases, including cancer.

1. ATM, ATR, and CHEK1 are key kinases involved in the DNA damage response. They are activated in response to DNA damage and phosphorylate various downstream targets, including TP53 and BRCA1, to initiate cell cycle arrest and DNA repair.

2. TP53 is a tumor suppressor protein that plays a central role in the DNA damage response. Upon activation by ATM and ATR, TP53 induces cell cycle arrest, allowing time for DNA repair or, if the damage is too severe, promoting apoptosis to eliminate damaged cells.

3. BRCA1 and BRCA2 are essential for homologous recombination (HR) repair, a high-fidelity DNA repair pathway. They interact with PALB2, RAD51, and other RAD51 paralogs (RAD51B, RAD51C, RAD51D) to facilitate the formation of RAD51 nucleoprotein filaments on single-stranded DNA, promoting strand invasion and repair.

4. BARD1 forms a stable complex with BRCA1, enhancing its stability and function in HR repair. BLM and WRN are RecQ helicases that also participate in HR repair, resolving complex DNA structures that arise during the process.

5. MRE11, RAD50, and NBN form the MRN complex, which is involved in the detection and processing of DNA double-strand breaks (DSBs). This complex recruits ATM to DSBs and initiates the DNA damage response.

6. FANCA and FANCD2 are part of the Fanconi anemia (FA) pathway, which is involved in the repair of DNA interstrand crosslinks. The FA pathway cooperates with HR repair to maintain genomic stability.

7. MSH6 is involved in the mismatch repair (MMR) pathway, which corrects base mismatches and small insertion/deletion loops that arise during DNA replication.

8. POLH is a translesion synthesis (TLS) polymerase that can bypass certain types of DNA damage, allowing replication to continue despite the presence of lesions.

9. MDC1 and MDM2 are involved in the regulation of the DNA damage response. MDC1 is a mediator of the response to DSBs, while MDM2 is an E3 ubiquitin ligase that negatively regulates TP53.

10. AURKA and BUB1B are involved in the regulation of cell cycle progression and the spindle assembly checkpoint, ensuring proper chromosome segregation during mitosis.

11. CDC73 is involved in transcriptional regulation and has been implicated in the maintenance of genomic stability.

12. TOP2A is a DNA topoisomerase that resolves topological stress during DNA replication and transcription.

13. XRCC2 and XRCC3 are involved in HR repair, functioning in the assembly and stabilization of RAD51 nucleoprotein filaments.

In summary, this system of interacting proteins plays a critical role in the DNA damage response and repair, ensuring the maintenance of genomic stability and preventing the accumulation of mutations that can lead to disease."	28	96.55172413793105	"The primary biological process performed by this system of interacting proteins is the DNA damage response and repair. This process is crucial for maintaining genomic stability and preventing the accumulation of mutations that can lead to various diseases, including cancer.

1. ATM, ATR, and CHEK1 are key kinases involved in the DNA damage response. They are activated in response to DNA damage and phosphorylate various downstream targets, including TP53 and BRCA1, to initiate cell cycle arrest and DNA repair.[1][2][3]

2. TP53 is a tumor suppressor protein that plays a central role in the DNA damage response. Upon activation by ATM and ATR, TP53 induces cell cycle arrest, allowing time for DNA repair or, if the damage is too severe, promoting apoptosis to eliminate damaged cells.[4][5][6]

3. BRCA1 and BRCA2 are essential for homologous recombination (HR) repair, a high-fidelity DNA repair pathway. They interact with PALB2, RAD51, and other RAD51 paralogs (RAD51B, RAD51C, RAD51D) to facilitate the formation of RAD51 nucleoprotein filaments on single-stranded DNA, promoting strand invasion and repair.[7][8][9]

4. BARD1 forms a stable complex with BRCA1, enhancing its stability and function in HR repair. BLM and WRN are RecQ helicases that also participate in HR repair, resolving complex DNA structures that arise during the process.[10][11][12]

5. MRE11, RAD50, and NBN form the MRN complex, which is involved in the detection and processing of DNA double-strand breaks (DSBs). This complex recruits ATM to DSBs and initiates the DNA damage response.[13][14][15]

6. FANCA and FANCD2 are part of the Fanconi anemia (FA) pathway, which is involved in the repair of DNA interstrand crosslinks. The FA pathway cooperates with HR repair to maintain genomic stability.[16][17][18]

7. MSH6 is involved in the mismatch repair (MMR) pathway, which corrects base mismatches and small insertion/deletion loops that arise during DNA replication.[19][20][21]

8. POLH is a translesion synthesis (TLS) polymerase that can bypass certain types of DNA damage, allowing replication to continue despite the presence of lesions.[22][23][24]

9. MDC1 and MDM2 are involved in the regulation of the DNA damage response. MDC1 is a mediator of the response to DSBs, while MDM2 is an E3 ubiquitin ligase that negatively regulates TP53.[25][26][27]

10. AURKA and BUB1B are involved in the regulation of cell cycle progression and the spindle assembly checkpoint, ensuring proper chromosome segregation during mitosis.[28][29][30]

11. CDC73 is involved in transcriptional regulation and has been implicated in the maintenance of genomic stability.[31][32][33]

12. TOP2A is a DNA topoisomerase that resolves topological stress during DNA replication and transcription.[34][35][36]

13. XRCC2 and XRCC3 are involved in HR repair, functioning in the assembly and stabilization of RAD51 nucleoprotein filaments.[37][38][39]

In summary, this system of interacting proteins plays a critical role in the DNA damage response and repair, ensuring the maintenance of genomic stability and preventing the accumulation of mutations that can lead to disease.

========================================================================================================================================================================================================
[1] Blackford, Andrew N, Jackson, Stephen P. ""ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response."" Molecular cell, 2017, pp. 801-817.
[2] Lindemann, A, Takahashi, H, Patel, A A, Osman, A A, Myers, J N. ""Targeting the DNA Damage Response in OSCC with TP53 Mutations."" Journal of dental research, 2018, pp. 635-644.
[3] Foo, Tzeh Keong, Xia, Bing. ""BRCA1-Dependent and Independent Recruitment of PALB2-BRCA2-RAD51 in the DNA Damage Response and Cancer."" Cancer research, 2022, pp. 3191-3197.
[4] Blackford, Andrew N, Jackson, Stephen P. ""ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response."" Molecular cell, 2017, pp. 801-817.
[5] Zhang, Jingjing, Wu, Qiong, Zhu, Lucheng, Xie, Shujun, Tu, Linglan, Yang, Yuhong, Wu, Kan, Zhao, Yanyan, Wang, Yuqing, Xu, Yasi, Chen, Xueqin, Ma, Shenglin, Zhang, Shirong. ""SERPINE2/PN-1 regulates the DNA damage response and radioresistance by activating ATM in lung cancer."" Cancer letters, 2022, pp. 268-283.
[6] Lindemann, A, Takahashi, H, Patel, A A, Osman, A A, Myers, J N. ""Targeting the DNA Damage Response in OSCC with TP53 Mutations."" Journal of dental research, 2018, pp. 635-644.
[7] Yoshida, Kiyotsugu, Miki, Yoshio. ""Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage."" Cancer science, 2004, pp. 866-71.
[8] Tarsounas, Madalena, Sung, Patrick. ""The antitumorigenic roles of BRCA1-BARD1 in DNA repair and replication."" Nature reviews. Molecular cell biology, 2020, pp. 284-299.
[9] Kwon, Youngho, Rösner, Heike, Zhao, Weixing, Selemenakis, Platon, He, Zhuoling, Kawale, Ajinkya S, Katz, Jeffrey N, Rogers, Cody M, Neal, Francisco E, Badamchi Shabestari, Aida, Petrosius, Valdemaras, Singh, Akhilesh K, Joel, Marina Z, Lu, Lucy, Holloway, Stephen P, Burma, Sandeep, Mukherjee, Bipasha, Hromas, Robert, Mazin, Alexander, Wiese, Claudia, Sørensen, Claus S, Sung, Patrick. ""DNA binding and RAD51 engagement by the BRCA2 C-terminus orchestrate DNA repair and replication fork preservation."" Nature communications, 2023, pp. 432.
[10] Kitano, Ken. ""Structural mechanisms of human RecQ helicases WRN and BLM."" Frontiers in genetics, 2014, pp. 366.
[11] Sidorova, Julia M, Kehrli, Keffy, Mao, Frances, Monnat, Raymond. ""Distinct functions of human RECQ helicases WRN and BLM in replication fork recovery and progression after hydroxyurea-induced stalling."" DNA repair, 2013, pp. 128-39.
[12] Zhu, Mingzhang, Wu, Wenwen, Togashi, Yukiko, Liang, Weixin, Miyoshi, Yasuo, Ohta, Tomohiko. ""HERC2 inactivation abrogates nucleolar localization of RecQ helicases BLM and WRN."" Scientific reports, 2021, pp. 360.
[13] Pennisi, Rosa, Antoccia, Antonio, Leone, Stefano, Ascenzi, Paolo, di Masi, Alessandra. ""Hsp90α regulates ATM and NBN functions in sensing and repair of DNA double-strand breaks."" The FEBS journal, 2017, pp. 2378-2395.
[14] Williams, Rhys M, Zhang, Xiaodong. ""Roles of ATM and ATR in DNA double strand breaks and replication stress."" Progress in biophysics and molecular biology, 2021, pp. 27-38.
[15] Williams, Rhys M, Zhang, Xiaodong. ""Roles of ATM and ATR in DNA double strand breaks and replication stress."" Progress in biophysics and molecular biology, 2021, pp. 109-119.
[16] Zhao, Simin, Huang, Chengzi, Yang, Yajuan, Xu, Weiwei, Yu, Yongze, Wen, Canxin, Cao, Lili, Gao, Fei, Qin, Yingying, Chen, Zi-Jiang, Guo, Ting, Zhao, Shidou. ""DNA repair protein FANCD2 has both ubiquitination-dependent and ubiquitination-independent functions during germ cell development."" The Journal of biological chemistry, 2023, pp. 102905.
[17] Alcón, Pablo, Shakeel, Shabih, Chen, Zhuo A, Rappsilber, Juri, Patel, Ketan J, Passmore, Lori A. ""FANCD2-FANCI is a clamp stabilized on DNA by monoubiquitination of FANCD2 during DNA repair."" Nature structural & molecular biology, 2020, pp. 240-248.
[18] Seki, Sohsuke, Ohzeki, Mioko, Uchida, Akiko, Hirano, Seiki, Matsushita, Nobuko, Kitao, Hiroyuki, Oda, Tsukasa, Yamashita, Takayuki, Kashihara, Naoki, Tsubahara, Akio, Takata, Minoru, Ishiai, Masamichi. ""A requirement of FancL and FancD2 monoubiquitination in DNA repair."" Genes to cells : devoted to molecular & cellular mechanisms, 2007, pp. 299-310.
[19] DuPrie, Matthew L, Palacio, Tatiana, Calil, Felipe A, Kolodner, Richard D, Putnam, Christopher D. ""Mlh1 interacts with both Msh2 and Msh6 for recruitment during mismatch repair."" DNA repair, 2022, pp. 103405.
[20] Stark, Andreas M, Doukas, Alexander, Hugo, Heinz-Herrmann, Hedderich, Jürgen, Hattermann, Kirsten, Maximilian Mehdorn, H, Held-Feindt, Janka. ""Expression of DNA mismatch repair proteins MLH1, MSH2, and MSH6 in recurrent glioblastoma."" Neurological research, 2015, pp. 95-105.
[21] Salem, Mohamed E, Bodor, J Nicholas, Puccini, Alberto, Xiu, Joanne, Goldberg, Richard M, Grothey, Axel, Korn, W Michael, Shields, Anthony F, Worrilow, William M, Kim, Edward S, Lenz, Heinz-Josef, Marshall, John L, Hall, Michael J. ""Relationship between MLH1, PMS2, MSH2 and MSH6 gene-specific alterations and tumor mutational burden in 1057 microsatellite instability-high solid tumors."" International journal of cancer, 2020, pp. 2948-2956.
[22] Zhang, Jin, Sun, Wenqiang, Ren, Cong, Kong, Xiangmudong, Yan, Wensheng, Chen, Xinbin. ""A PolH Transcript with a Short 3'UTR Enhances PolH Expression and Mediates Cisplatin Resistance."" Cancer research, 2019, pp. 3714-3724.
[23] Wilson, David M, Duncton, Matthew A J, Chang, Caleb, Lee Luo, Christie, Georgiadis, Taxiarchis M, Pellicena, Patricia, Deacon, Ashley M, Gao, Yang, Das, Debanu. ""Early Drug Discovery and Development of Novel Cancer Therapeutics Targeting DNA Polymerase Eta (POLH)."" Frontiers in oncology, 2021, pp. 778925.
[24] Chen, X, Bosques, L, Sung, P, Kupfer, G M. ""A novel role for non-ubiquitinated FANCD2 in response to hydroxyurea-induced DNA damage."" Oncogene, 2016, pp. 22-34.
[25] Lindemann, A, Takahashi, H, Patel, A A, Osman, A A, Myers, J N. ""Targeting the DNA Damage Response in OSCC with TP53 Mutations."" Journal of dental research, 2018, pp. 635-644.
[26] Stucki, Manuel, Jackson, Stephen P. ""gammaH2AX and MDC1: anchoring the DNA-damage-response machinery to broken chromosomes."" DNA repair, 2006, pp. 534-43.
[27] Ruff, Sophie E, Logan, Susan K, Garabedian, Michael J, Huang, Tony T. ""Roles for MDC1 in cancer development and treatment."" DNA repair, 2020, pp. 102948.
[28] Metselaar, Dennis S, du Chatinier, Aimée, Meel, Michaël H, Ter Huizen, Giovanna, Waranecki, Piotr, Goulding, Joshua R, Bugiani, Marianna, Koster, Jan, Kaspers, Gertjan J L, Hulleman, Esther. ""AURKA and PLK1 inhibition selectively and synergistically block cell cycle progression in diffuse midline glioma."" iScience, 2022, pp. 104398.
[29] Kahl, Iris, Mense, Julian, Finke, Christopher, Boller, Anna-Lena, Lorber, Clara, Győrffy, Balázs, Greve, Burkhard, Götte, Martin, Espinoza-Sánchez, Nancy A. ""The cell cycle-related genes RHAMM, AURKA, TPX2, PLK1, and PLK4 are associated with the poor prognosis of breast cancer patients."" Journal of cellular biochemistry, 2022, pp. 581-600.
[30] Koyuncu, Dilara, Sharma, Utsav, Goka, Erik T, Lippman, Marc E. ""Spindle assembly checkpoint gene BUB1B is essential in breast cancer cell survival."" Breast cancer research and treatment, 2021, pp. 331-341.
[31] van der Tuin, Karin, Tops, Carli M J, Adank, Muriel A, Cobben, Jan-Maarten, Hamdy, Neveen A T, Jongmans, Marjolijn C, Menko, Fred H, van Nesselrooij, Bernadette P M, Netea-Maier, Romana T, Oosterwijk, Jan C, Valk, Gerlof D, Wolffenbuttel, Bruce H R, Hes, Frederik J, Morreau, Hans. ""CDC73-Related Disorders: Clinical Manifestations and Case Detection in Primary Hyperparathyroidism."" The Journal of clinical endocrinology and metabolism, 2017, pp. 4534-4540.
[32] Zheng, Hua-Chuan, Gong, Bao-Cheng, Zhao, Shuang. ""The clinicopathological and prognostic significances of <i>CDC73</i> expression in cancers: a bioinformatics analysis."" Oncotarget, 2017, pp. 95270-95279.
[33] Kubota, Yukihiro, Ota, Natsumi, Takatsuka, Hisashi, Unno, Takuma, Onami, Shuichi, Sugimoto, Asako, Ito, Masahiro. ""The PAF1 complex cell autonomously promotes oogenesis in Caenorhabditis elegans."" Genes to cells : devoted to molecular & cellular mechanisms, 2022, pp. 409-420.
[34] Dong, Yinying, Sun, Xiangyin, Zhang, Kong, He, Xinjia, Zhang, Qian, Song, Hao, Xu, Mingjin, Lu, Haijun, Ren, Ruimei. ""Type IIA topoisomerase (TOP2A) triggers epithelial-mesenchymal transition and facilitates HCC progression by regulating Snail expression."" Bioengineered, 2021, pp. 12967-12979.
[35] Järvinen, T A H, Liu, E T. ""Topoisomerase IIalpha gene (TOP2A) amplification and deletion in cancer--more common than anticipated."" Cytopathology : official journal of the British Society for Clinical Cytology, 2003, pp. 309-13.
[36] Du, Xiaomei, Xue, Zhiwen, Lv, Jianning, Wang, Heidou. ""Expression of the Topoisomerase II Alpha (TOP2A) Gene in Lung Adenocarcinoma Cells and the Association with Patient Outcomes."" Medical science monitor : international medical journal of experimental and clinical research, 2020, pp. e929120.
[37] Lai, Tsung-Huei, Ewald, Brett, Zecevic, Alma, Liu, Chaomei, Sulda, Melanie, Papaioannou, Dimitrios, Garzon, Ramiro, Blachly, James S, Plunkett, William, Sampath, Deepa. ""HDAC Inhibition Induces MicroRNA-182, which Targets RAD51 and Impairs HR Repair to Sensitize Cells to Sapacitabine in Acute Myelogenous Leukemia."" Clinical cancer research : an official journal of the American Association for Cancer Research, 2016, pp. 3537-49.
[38] Morati, Florian, Modesti, Mauro. ""Insights into the control of RAD51 nucleoprotein filament dynamics from single-molecule studies."" Current opinion in genetics & development, 2021, pp. 182-187.
[39] Andriuskevicius, Tadas, Kotenko, Oleksii, Makovets, Svetlana. ""Putting together and taking apart: assembly and disassembly of the Rad51 nucleoprotein filament in DNA repair and genome stability."" Cell stress, 2018, pp. 96-112.
"	0.706776	0.60284907	LLM	Neither	NA
NeST	Immune system`	NEST:8	AXL B2M BIRC3 BTK CARD11 CD19 CD22 CD274 CD40 CD70 CD79A CD79B CIITA CSF1R CSF3R CTLA4 CXCR4 CYLD FAM46C FAS FCGR2A FCGR3A FLT3 FOXP1 FYN GATA3 HAVCR2 HGF HLA-A HLA-B HLA-C HLA-DMA HLA-DMB HLA-DOA HLA-DOB HLA-DPA1 HLA-DPB1 HLA-DQA1 HLA-DQA2 HLA-DQB1 HLA-DQB2 HLA-DRA HLA-DRB1 HLA-DRB5 HLA-E HLA-F HLA-G IDO1 IFNGR2 IGF1 IKBKE IKZF1 IKZF3 IL10RA IL15 IL2RA IL6R IL7R IRF1 IRF4 JAK2 JAK3 KIT KLHL6 LAG3 LYN MAFB MS4A1 MYD88 NFKBIA NKX2-1 NTRK3 P2RY8 PCBP1 PDCD1 PDCD1LG2 PHOX2B PIK3CD PIK3CG PLCG2 POU2F2 PRDM1 PRF1 PTPN22 SH2D1A SOD2 STAT4 STAT5A SYK TAP1 TAP2 TIGIT TLR4 TMEM173 TNFAIP3 TNFRSF14 TNFRSF17 TNFRSF9 VSIR	99	6.6293566200796095	Positive Regulation Of Cytokine Production 	GO:0001819	CSF1R;CD274;CD40;PIK3CD;PTPN22;GATA3;PIK3CG;PLCG2;TNFRSF14;TIGIT;JAK2;IL6R;IKBKE;HAVCR2;HLA-DPA1;SYK;IL15;HLA-A;POU2F2;HLA-G;FOXP1;HLA-E;IRF4;IRF1;TLR4;CARD11;MYD88	27	27.27272727272727	5.347306429894987e-26	6.598576134490414e-23	Immune Response Regulation	"The system of interacting proteins primarily performs the regulation of immune response. The proteins involved in this system can be categorized into several groups based on their functions:

1. Receptor proteins: AXL, CD19, CD22, CD40, CD70, CD79A, CD79B, CSF1R, CSF3R, CTLA4, CXCR4, FCGR2A, FCGR3A, FLT3, HAVCR2, IFNGR2, IL10RA, IL2RA, IL6R, IL7R, KIT, LAG3, MS4A1, NTRK3, PDCD1, PDCD1LG2, TIGIT, TLR4, TNFRSF14, TNFRSF17, TNFRSF9, VSIR. These proteins are involved in the recognition of antigens, cytokines, and other signaling molecules, which are crucial for initiating and modulating immune responses.

2. Signaling proteins: BTK, CARD11, FYN, IKBKE, IKZF1, IKZF3, IRF1, IRF4, JAK2, JAK3, LYN, MYD88, NFKBIA, PIK3CD, PIK3CG, PLCG2, PTPN22, SH2D1A, STAT4, STAT5A, SYK. These proteins play essential roles in signal transduction pathways, leading to the activation of immune cells and the production of effector molecules.

3. Transcription factors: CIITA, FOXP1, GATA3, MAFB, NKX2-1, POU2F2, PRDM1. These proteins regulate the expression of target genes involved in immune cell development, differentiation, and function.

4. Cytokines and growth factors: B2M, HGF, IGF1, IL15. These proteins are involved in the regulation of immune cell proliferation, survival, and function.

5. Major histocompatibility complex (MHC) proteins: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DQB2, HLA-DRA, HLA-DRB1, HLA-DRB5, HLA-E, HLA-F, HLA-G. These proteins are responsible for presenting antigens to T cells, which is essential for the activation of adaptive immune responses.

6. Negative regulators: BIRC3, CYLD, IDO1, P2RY8, PCBP1, PHOX2B, SOD2, TNFAIP3. These proteins are involved in the negative regulation of immune responses, preventing excessive or chronic inflammation.

7. Other proteins: CD274, FAM46C, FAS, HAVCR2, IL7R, PDCD1LG2, PRF1, TAP1, TAP2, TMEM173. These proteins have diverse functions in immune response regulation, including immune checkpoint modulation, antigen processing and presentation, and cytotoxicity.

In summary, the most prominent biological process performed by this system of interacting proteins is the regulation of immune response, which involves the coordination of various receptor proteins, signaling proteins, transcription factors, cytokines, MHC proteins, and negative regulators."	98	98.989898989899	"The system of interacting proteins primarily performs the regulation of immune response. The proteins involved in this system can be categorized into several groups based on their functions:

1. Receptor proteins: AXL, CD19, CD22, CD40, CD70, CD79A, CD79B, CSF1R, CSF3R, CTLA4, CXCR4, FCGR2A, FCGR3A, FLT3, HAVCR2, IFNGR2, IL10RA, IL2RA, IL6R, IL7R, KIT, LAG3, MS4A1, NTRK3, PDCD1, PDCD1LG2, TIGIT, TLR4, TNFRSF14, TNFRSF17, TNFRSF9, VSIR. These proteins are involved in the recognition of antigens, cytokines, and other signaling molecules, which are crucial for initiating and modulating immune responses.[1][2][3]

2. Signaling proteins: BTK, CARD11, FYN, IKBKE, IKZF1, IKZF3, IRF1, IRF4, JAK2, JAK3, LYN, MYD88, NFKBIA, PIK3CD, PIK3CG, PLCG2, PTPN22, SH2D1A, STAT4, STAT5A, SYK. These proteins play essential roles in signal transduction pathways, leading to the activation of immune cells and the production of effector molecules.[4][5][6]

3. Transcription factors: CIITA, FOXP1, GATA3, MAFB, NKX2-1, POU2F2, PRDM1. These proteins regulate the expression of target genes involved in immune cell development, differentiation, and function.[7][8][9]

4. Cytokines and growth factors: B2M, HGF, IGF1, IL15. These proteins are involved in the regulation of immune cell proliferation, survival, and function.[10][11][12]

5. Major histocompatibility complex (MHC) proteins: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DQB2, HLA-DRA, HLA-DRB1, HLA-DRB5, HLA-E, HLA-F, HLA-G. These proteins are responsible for presenting antigens to T cells, which is essential for the activation of adaptive immune responses.[13][14][15]

6. Negative regulators: BIRC3, CYLD, IDO1, P2RY8, PCBP1, PHOX2B, SOD2, TNFAIP3. These proteins are involved in the negative regulation of immune responses, preventing excessive or chronic inflammation.[16][17][18]

7. Other proteins: CD274, FAM46C, FAS, HAVCR2, IL7R, PDCD1LG2, PRF1, TAP1, TAP2, TMEM173. These proteins have diverse functions in immune response regulation, including immune checkpoint modulation, antigen processing and presentation, and cytotoxicity.[19][20][21]

In summary, the most prominent biological process performed by this system of interacting proteins is the regulation of immune response, which involves the coordination of various receptor proteins, signaling proteins, transcription factors, cytokines, MHC proteins, and negative regulators.

========================================================================================================================================================================================================
[1] Bae, Jooeun, Accardi, Fabrizio, Hideshima, Teru, Tai, Yu-Tzu, Prabhala, Rao, Shambley, Aaron, Wen, Kenneth, Rowell, Sean, Richardson, Paul G, Munshi, Nikhil C, Anderson, Kenneth C. ""Targeting LAG3/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myeloma."" Leukemia, 2022, pp. 138-154.
[2] Werner, Yves, Mass, Elvira, Ashok Kumar, Praveen, Ulas, Thomas, Händler, Kristian, Horne, Arik, Klee, Kathrin, Lupp, Amelie, Schütz, Dagmar, Saaber, Friederike, Redecker, Christoph, Schultze, Joachim L, Geissmann, Frederic, Stumm, Ralf. ""Cxcr4 distinguishes HSC-derived monocytes from microglia and reveals monocyte immune responses to experimental stroke."" Nature neuroscience, 2020, pp. 351-362.
[3] Chen, Xin, Xue, Liu, Ding, Xiao, Zhang, Jing, Jiang, Lei, Liu, Sha, Hou, Hongjia, Jiang, Bin, Cheng, Liang, Zhu, Qing, Zhang, Lijie, Zhou, Xiaosui, Ma, Jie, Liu, Qi, Li, Yucheng, Ren, Zhiying, Jiang, Beibei, Song, Xiaomin, Song, Jing, Jin, Wei, Wei, Min, Shen, Zhirong, Liu, Xuesong, Wang, Lai, Li, Kang, Zhang, Tong. ""An Fc-Competent Anti-Human TIGIT Blocking Antibody Ociperlimab (BGB-A1217) Elicits Strong Immune Responses and Potent Anti-Tumor Efficacy in Pre-Clinical Models."" Frontiers in immunology, 2022, pp. 828319.
[4] Pawinwongchai, Jaturawat, Jangprasert, Panchalee, Nilsri, Nungruthai, Israsena, Nipan, Rojnuckarin, Ponlapat. ""Mutated JAK2 signal transduction in human induced pluripotent stem cell (iPSC)-derived megakaryocytes."" Platelets, 2022, pp. 700-708.
[5] Grimley, P M, Dong, F, Rui, H. ""Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation."" Cytokine & growth factor reviews, 1999, pp. 131-57.
[6] Hosseini-Valiki, Fereshteh, Taghiloo, Saeid, Tavakolian, Golvash, Amjadi, Omolbanin, Tehrani, Mohsen, Hedayatizadeh-Omran, Akbar, Alizadeh-Navaei, Reza, Zaboli, Ehsan, Shekarriz, Ramin, Asgarian-Omran, Hossein. ""Expression Analysis of Fyn and Bat3 Signal Transduction Molecules in Patients with Chronic Lymphocytic Leukemia."" Asian Pacific journal of cancer prevention : APJCP, 2020, pp. 2615-2621.
[7] Ren, Gang, Lai, Binbin, Harly, Christelle, Baek, Songjoon, Ding, Yi, Zheng, Mingzhu, Cao, Yaqiang, Cui, Kairong, Yang, Yu, Zhu, Jinfang, Hager, Gordon L, Bhandoola, Avinash, Zhao, Keji. ""Transcription factors TCF-1 and GATA3 are key factors for the epigenetic priming of early innate lymphoid progenitors toward distinct cell fates."" Immunity, 2022, pp. 1402-1413.e4.
[8] Mollaoglu, Gurkan, Jones, Alex, Wait, Sarah J, Mukhopadhyay, Anandaroop, Jeong, Sangmin, Arya, Rahul, Camolotto, Soledad A, Mosbruger, Timothy L, Stubben, Chris J, Conley, Christopher J, Bhutkar, Arjun, Vahrenkamp, Jeffery M, Berrett, Kristofer C, Cessna, Melissa H, Lane, Thomas E, Witt, Benjamin L, Salama, Mohamed E, Gertz, Jason, Jones, Kevin B, Snyder, Eric L, Oliver, Trudy G. ""The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment."" Immunity, 2018, pp. 764-779.e9.
[9] Vega, Miguel A, Simón-Fuentes, Miriam, González de la Aleja, Arturo, Nieto, Concha, Colmenares, María, Herrero, Cristina, Domínguez-Soto, Ángeles, Corbí, Ángel L. ""MAFB and MAF Transcription Factors as Macrophage Checkpoints for COVID-19 Severity."" Frontiers in immunology, 2020, pp. 603507.
[10] Perreau, Matthieu, Suffiotti, Madeleine, Marques-Vidal, Pedro, Wiedemann, Aurelie, Levy, Yves, Laouénan, Cédric, Ghosn, Jade, Fenwick, Craig, Comte, Denis, Roger, Thierry, Regina, Jean, Vollenweider, Peter, Waeber, Gerard, Oddo, Mauro, Calandra, Thierry, Pantaleo, Giuseppe. ""The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients."" Nature communications, 2021, pp. 4888.
[11] Mohammadian, Anahita, Naderali, Elahe, Mohammadi, Seyedeh Momeneh, Movasaghpour, Aliakbar, Valipour, Behnaz, Nouri, Mohammad, Nozad Charoudeh, Hojjatollah. ""Cord Blood Cells Responses to IL2, IL7 and IL15 Cytokines for mTOR Expression."" Advanced pharmaceutical bulletin, 2017, pp. 81-85.
[12] Floros, Theofanis, Tarhini, Ahmad A. ""Anticancer Cytokines: Biology and Clinical Effects of Interferon-α2, Interleukin (IL)-2, IL-15, IL-21, and IL-12."" Seminars in oncology, 2015, pp. 539-48.
[13] El-Awar, Nadim, Terasaki, Paul I, Cai, Junchao, Deng, Chun-Tsan, Ozawa, Miyuki, Nguyen, Anh. ""Epitopes of the HLA-A, B, C, DR, DQ and MICA antigens."" Clinical transplants, 2007, pp. 175-94.
[14] Watts, Eleanor, Potts, Gregory K, Ready, Damien B, George Thompson, Alayna M, Lee, Janice, Escobar, Edwin E, Patterson, Melanie J, Brodbelt, Jennifer S. ""Characterization of HLA-A*02:01 MHC Immunopeptide Antigens Enhanced by Ultraviolet Photodissociation Mass Spectrometry."" Analytical chemistry, 2021, pp. 13134-13142.
[15] Romaniuk, Dmitrii S, Postovskaya, Anna M, Khmelevskaya, Alexandra A, Malko, Dmitry B, Efimov, Grigory A. ""Rapid Multiplex Genotyping of 20 HLA-A<sup>*</sup>02:01 Restricted Minor Histocompatibility Antigens."" Frontiers in immunology, 2019, pp. 1226.
[16] Courtois, G. ""Tumor suppressor CYLD: negative regulation of NF-kappaB signaling and more."" Cellular and molecular life sciences : CMLS, 2008, pp. 1123-32.
[17] Sisto, Margherita, Lisi, Sabrina, Lofrumento, Dario Domenico, Ingravallo, Giuseppe, Maiorano, Eugenio, D'Amore, Massimo. ""A failure of TNFAIP3 negative regulation maintains sustained NF-κB activation in Sjögren's syndrome."" Histochemistry and cell biology, 2011, pp. 615-25.
[18] Reiley, William, Zhang, Minying, Sun, Shao-Cong. ""Negative regulation of JNK signaling by the tumor suppressor CYLD."" The Journal of biological chemistry, 2004, pp. 55161-7.
[19] Tabassum, Anika, Samdani, Md Nazmus, Dhali, Tarak Chandra, Alam, Rahat, Ahammad, Foysal, Samad, Abdus, Karpiński, Tomasz M. ""Transporter associated with antigen processing 1 (TAP1) expression and prognostic analysis in breast, lung, liver, and ovarian cancer."" Journal of molecular medicine (Berlin, Germany), 2021, pp. 1293-1309.
[20] Foley, P J, Lympany, P A, Puscinska, E, Zielinski, J, Welsh, K I, du Bois, R M. ""Analysis of MHC encoded antigen-processing genes TAP1 and TAP2 polymorphisms in sarcoidosis."" American journal of respiratory and critical care medicine, 1999, pp. 1009-14.
[21] Mufti, Ahmad H, AlJahdali, Imad A, Elhawary, Nasser A, Ekram, Samar N, Abumansour, Iman, Sindi, Ikhlas A, Naffadi, Hind, Elhawary, Ezzeldin N, Alyamani, Najiah M, Alghamdi, Ghydda, Alosaimi, Wafaa, Rawas, Ghufran, Alharbi, Amaal, Tayeb, Mohammed T. ""Variations in <i>TAP1</i> and <i>PSMB9</i> Genes Involved in Antigen Processing and Presentation Increase the Risk of Vitiligo in the Saudi Community."" International journal of general medicine, 2021, pp. 10031-10044.
"	0.66304827	0.23495272	LLM	LLM	NA
NeST	TNFR/Traf signaling	NEST:83	BIRC3 CASP8 CD40 FAS MAP3K7 PARP1 TNF TNFAIP3 TNFRSF9 TP53 TRAF2 TRAF3	12	3.584962500721156	Regulation Of I-kappaB kinase/NF-kappaB Signaling 	GO:0043122	CD40;CASP8;PARP1;TRAF3;TNFAIP3;TRAF2;TNF;MAP3K7;BIRC3	9	75	6.94543135697739e-16	4.1950405396143444e-13	Apoptosis and Cell Signaling	"Proteins: BIRC3, CASP8, CD40, FAS, MAP3K7, PARP1, TNF, TNFAIP3, TNFRSF9, TP53, TRAF2, TRAF3.

1. Apoptosis induction: FAS, TNF, and TNFRSF9 are cell surface receptors that can initiate apoptosis upon ligand binding. CASP8 is a key initiator caspase in the extrinsic apoptosis pathway, activated by FAS and TNF signaling. TP53 is a tumor suppressor protein that can induce apoptosis in response to DNA damage.

2. Apoptosis regulation: BIRC3 is an inhibitor of apoptosis proteins (IAP) that can inhibit CASP8 activity, thus negatively regulating apoptosis. TNFAIP3 is a ubiquitin-editing enzyme that can inhibit TNF-induced apoptosis by deubiquitinating and inactivating key signaling molecules.

3. Cell signaling: CD40 is a member of the TNF receptor family that plays a role in immune cell activation and proliferation. TRAF2 and TRAF3 are adaptor proteins that can bind to CD40, TNFRSF9, and other TNF receptor family members, mediating downstream signaling events. MAP3K7 is a kinase that can be activated by TRAF2 and TRAF3, leading to activation of the NF-κB and JNK signaling pathways.

4. DNA repair: PARP1 is a DNA repair enzyme that can detect and repair DNA strand breaks. TP53 can also play a role in DNA repair by regulating the expression of DNA repair genes.

In conclusion, the most prominent biological process performed by this system of interacting proteins is apoptosis and cell signaling. The proteins are involved in the induction and regulation of apoptosis, as well as mediating cell signaling events that can lead to immune cell activation, proliferation, and DNA repair."	12	100	"Proteins: BIRC3, CASP8, CD40, FAS, MAP3K7, PARP1, TNF, TNFAIP3, TNFRSF9, TP53, TRAF2, TRAF3.

1. Apoptosis induction: FAS, TNF, and TNFRSF9 are cell surface receptors that can initiate apoptosis upon ligand binding. CASP8 is a key initiator caspase in the extrinsic apoptosis pathway, activated by FAS and TNF signaling. TP53 is a tumor suppressor protein that can induce apoptosis in response to DNA damage.[1][2][3]

2. Apoptosis regulation: BIRC3 is an inhibitor of apoptosis proteins (IAP) that can inhibit CASP8 activity, thus negatively regulating apoptosis. TNFAIP3 is a ubiquitin-editing enzyme that can inhibit TNF-induced apoptosis by deubiquitinating and inactivating key signaling molecules.[4][5][6]

3. Cell signaling: CD40 is a member of the TNF receptor family that plays a role in immune cell activation and proliferation. TRAF2 and TRAF3 are adaptor proteins that can bind to CD40, TNFRSF9, and other TNF receptor family members, mediating downstream signaling events. MAP3K7 is a kinase that can be activated by TRAF2 and TRAF3, leading to activation of the NF-κB and JNK signaling pathways.[7][8][9]

4. DNA repair: PARP1 is a DNA repair enzyme that can detect and repair DNA strand breaks. TP53 can also play a role in DNA repair by regulating the expression of DNA repair genes.[10][11][12]

In conclusion, the most prominent biological process performed by this system of interacting proteins is apoptosis and cell signaling. The proteins are involved in the induction and regulation of apoptosis, as well as mediating cell signaling events that can lead to immune cell activation, proliferation, and DNA repair.

========================================================================================================================================================================================================
[1] Wang, Juan, Cao, Zeyuan, Wang, Panpan, Zhang, Xiao, Tang, Jianxia, He, Yifan, Huang, Zhiqing, Mao, Xueli, Shi, Songtao, Kou, Xiaoxing. ""Apoptotic Extracellular Vesicles Ameliorate Multiple Myeloma by Restoring Fas-Mediated Apoptosis."" ACS nano, 2021, pp. 14360-14372.
[2] Nagata, S. ""Fas-mediated apoptosis."" Advances in experimental medicine and biology, 1996, pp. 119-24.
[3] Nagata, S. ""Fas ligand-induced apoptosis."" Annual review of genetics, 1999, pp. 29-55.
[4] Bai, Liang Liang, Chen, Hao, Zhou, Peng, Yu, Jun. ""Identification of Tumor Necrosis Factor-Alpha (TNF-α) Inhibitor in Rheumatoid Arthritis Using Network Pharmacology and Molecular Docking."" Frontiers in pharmacology, 2021, pp. 690118.
[5] Zhuo, Zhihong, Kong, Huimin, Jin, Peina, Ren, Youhong. ""The ubiquitin-editing enzyme TNFAIP3 exerts neuroprotective roles in epilepsy rats through repressing inflammation."" General physiology and biophysics, 2022, pp. 499-509.
[6] Vereecke, Lars, Beyaert, Rudi, van Loo, Geert. ""The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology."" Trends in immunology, 2009, pp. 383-91.
[7] Léveillé, Claire, Bouillon, Marlène, Guo, Wen, Bolduc, Julie, Sharif-Askari, Ehssan, El-Fakhry, Youssef, Reyes-Moreno, Carlos, Lapointe, Rejean, Merhi, Yahye, Wilkins, John A, Mourad, Walid. ""CD40 ligand binds to alpha5beta1 integrin and triggers cell signaling."" The Journal of biological chemistry, 2007, pp. 5143-51.
[8] Graham, John P, Moore, Carissa R, Bishop, Gail A. ""Roles of the TRAF2/3 binding site in differential B cell signaling by CD40 and its viral oncogenic mimic, LMP1."" Journal of immunology (Baltimore, Md. : 1950), 2009, pp. 2966-73.
[9] Wieckowski, Sébastien, Trouche, Nathalie, Chaloin, Olivier, Guichard, Gilles, Fournel, Sylvie, Hoebeke, Johan. ""Cooperativity in the interaction of synthetic CD40L mimetics with CD40 and its implication in cell signaling."" Biochemistry, 2007, pp. 3482-93.
[10] Ray Chaudhuri, Arnab, Nussenzweig, André. ""The multifaceted roles of PARP1 in DNA repair and chromatin remodelling."" Nature reviews. Molecular cell biology, 2017, pp. 610-621.
[11] Patterson-Fortin, Jeffrey, Bose, Arindam, Tsai, Wei-Chih, Grochala, Carter, Nguyen, Huy, Zhou, Jia, Parmar, Kalindi, Lazaro, Jean-Bernard, Liu, Joyce, McQueen, Kelsey, Shapiro, Geoffrey I, Kozono, David, D'Andrea, Alan D. ""Targeting DNA Repair with Combined Inhibition of NHEJ and MMEJ Induces Synthetic Lethality in TP53-Mutant Cancers."" Cancer research, 2022, pp. 3815-3829.
[12] Zada, David, Sela, Yaniv, Matosevich, Noa, Monsonego, Adir, Lerer-Goldshtein, Tali, Nir, Yuval, Appelbaum, Lior. ""Parp1 promotes sleep, which enhances DNA repair in neurons."" Molecular cell, 2021, pp. 4979-4993.e7.
"	0.5589577	0.5069334	LLM	Neither	Neither
NeST	Lymphoid JAK/STAT signaling	NEST:84	CSF3R EPOR IFNAR2 IL6R IRS1 IRS2 JAK1 JAK2 JAK3 PIK3R1 PTPN11 SOCS1 STAT3 STAT5A STAT5B STAT6	16	4	Cellular Response To Cytokine Stimulus 	GO:0071345	IFNAR2;STAT5A;STAT5B;CSF3R;STAT3;PTPN11;EPOR;SOCS1;STAT6;JAK2;IL6R;JAK3;JAK1	13	81.25	1.14205643755226e-21	5.059310018356509e-19	JAK-STAT Signaling	"The JAK-STAT signaling pathway is the primary biological process performed by this system of interacting proteins. This pathway is crucial for transmitting information from extracellular signals to the nucleus, resulting in gene expression changes.

1. Receptor activation: CSF3R, EPOR, IFNAR2, and IL6R are cytokine receptors that initiate the JAK-STAT signaling pathway upon ligand binding. These receptors associate with JAK family kinases (JAK1, JAK2, and JAK3) to propagate the signal.

2. JAK activation: Ligand binding to the receptors leads to the activation of JAK kinases. JAK1, JAK2, and JAK3 are non-receptor tyrosine kinases that phosphorylate and activate downstream signaling proteins, including STAT family members.

3. STAT activation: STAT3, STAT5A, STAT5B, and STAT6 are transcription factors that become activated upon phosphorylation by JAK kinases. Once activated, they dimerize and translocate to the nucleus to regulate gene expression.

4. Negative regulation: SOCS1 and PTPN11 are negative regulators of the JAK-STAT pathway. SOCS1 inhibits JAK kinase activity, while PTPN11 dephosphorylates and inactivates JAKs and STATs, ensuring controlled signaling.

5. Cross-talk with other pathways: IRS1 and IRS2 are adaptor proteins that link the JAK-STAT pathway to the PI3K-Akt pathway. PIK3R1, a regulatory subunit of PI3K, is involved in this cross-talk, integrating signals from both pathways to regulate cellular processes such as growth, survival, and metabolism.

In summary, the JAK-STAT signaling pathway is the most prominent biological process performed by this system of interacting proteins. It plays a crucial role in transmitting extracellular signals to the nucleus, leading to changes in gene expression. The pathway is tightly regulated by negative regulators and cross-talk with other signaling pathways."	16	100	"The JAK-STAT signaling pathway is the primary biological process performed by this system of interacting proteins. This pathway is crucial for transmitting information from extracellular signals to the nucleus, resulting in gene expression changes.

1. Receptor activation: CSF3R, EPOR, IFNAR2, and IL6R are cytokine receptors that initiate the JAK-STAT signaling pathway upon ligand binding. These receptors associate with JAK family kinases (JAK1, JAK2, and JAK3) to propagate the signal.[1][2][3]

2. JAK activation: Ligand binding to the receptors leads to the activation of JAK kinases. JAK1, JAK2, and JAK3 are non-receptor tyrosine kinases that phosphorylate and activate downstream signaling proteins, including STAT family members.[4][5][6]

3. STAT activation: STAT3, STAT5A, STAT5B, and STAT6 are transcription factors that become activated upon phosphorylation by JAK kinases. Once activated, they dimerize and translocate to the nucleus to regulate gene expression.[7][8][9]

4. Negative regulation: SOCS1 and PTPN11 are negative regulators of the JAK-STAT pathway. SOCS1 inhibits JAK kinase activity, while PTPN11 dephosphorylates and inactivates JAKs and STATs, ensuring controlled signaling.[10][11][12]

5. Cross-talk with other pathways: IRS1 and IRS2 are adaptor proteins that link the JAK-STAT pathway to the PI3K-Akt pathway. PIK3R1, a regulatory subunit of PI3K, is involved in this cross-talk, integrating signals from both pathways to regulate cellular processes such as growth, survival, and metabolism.[13][14][15]

In summary, the JAK-STAT signaling pathway is the most prominent biological process performed by this system of interacting proteins. It plays a crucial role in transmitting extracellular signals to the nucleus, leading to changes in gene expression. The pathway is tightly regulated by negative regulators and cross-talk with other signaling pathways.

========================================================================================================================================================================================================
[1] Staerk, J, Kallin, A, Royer, Y, Diaconu, C C, Dusa, A, Demoulin, J-B, Vainchenker, W, Constantinescu, S N. ""JAK2, the JAK2 V617F mutant and cytokine receptors."" Pathologie-biologie, 2007, pp. 88-91.
[2] Pradhan, Anuradha, Lambert, Que T, Griner, Lori N, Reuther, Gary W. ""Activation of JAK2-V617F by components of heterodimeric cytokine receptors."" The Journal of biological chemistry, 2010, pp. 16651-63.
[3] Waters, Michael J, Brooks, Andrew J, Chhabra, Yash. ""A new mechanism for growth hormone receptor activation of JAK2, and implications for related cytokine receptors."" JAK-STAT, 2014, pp. e29569.
[4] Oh, Keunhee, Joo, Kyeung Min, Jung, Yong Sik, Lee, Jaehwan, Kang, Heonjoong, Lee, Hee-Yoon, Lee, Dong-Sup. ""A receptor-independent, cell-based JAK activation assay for screening for JAK3-specific inhibitors."" Journal of immunological methods, 2010, pp. 45-52.
[5] Haan, Serge, Margue, Christiane, Engrand, Arnaud, Rolvering, Catherine, Schmitz-Van de Leur, Hildegard, Heinrich, Peter C, Behrmann, Iris, Haan, Claude. ""Dual role of the Jak1 FERM and kinase domains in cytokine receptor binding and in stimulation-dependent Jak activation."" Journal of immunology (Baltimore, Md. : 1950), 2008, pp. 998-1007.
[6] Li, Rui-Jún Eveline, de Haas, Aram, Rodríguez, Ernesto, Kalay, Hakan, Zaal, Anouk, Jimenez, Connie R, Piersma, Sander R, Pham, Thang V, Henneman, Alex A, de Goeij-de Haas, Richard R, van Vliet, Sandra J, van Kooyk, Yvette. ""Quantitative Phosphoproteomic Analysis Reveals Dendritic Cell- Specific STAT Signaling After α2-3-Linked Sialic Acid Ligand Binding."" Frontiers in immunology, 2021, pp. 673454.
[7] Schröder, Martina, Kroeger, Karen M, Volk, Hans-Dieter, Eidne, Karin A, Grütz, Gerald. ""Preassociation of nonactivated STAT3 molecules demonstrated in living cells using bioluminescence resonance energy transfer: a new model of STAT activation?"" Journal of leukocyte biology, 2004, pp. 792-7.
[8] Bosch-Barrera, Joaquim, Menendez, Javier A. ""Silibinin and STAT3: A natural way of targeting transcription factors for cancer therapy."" Cancer treatment reviews, 2015, pp. 540-6.
[9] Hennighausen, Lothar, Robinson, Gertraud W. ""Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B."" Genes & development, 2008, pp. 711-21.
[10] Ahmed, Chulbul M I, Larkin, Joseph, Johnson, Howard M. ""SOCS1 Mimetics and Antagonists: A Complementary Approach to Positive and Negative Regulation of Immune Function."" Frontiers in immunology, 2015, pp. 183.
[11] Zhang, Wenjun, Chan, Rebecca J, Chen, Hanying, Yang, Zhenyun, He, Yantao, Zhang, Xian, Luo, Yong, Yin, Fuqing, Moh, Akira, Miller, Lucy C, Payne, R Mark, Zhang, Zhong-Yin, Fu, Xin-Yuan, Shou, Weinian. ""Negative regulation of Stat3 by activating PTPN11 mutants contributes to the pathogenesis of Noonan syndrome and juvenile myelomonocytic leukemia."" The Journal of biological chemistry, 2009, pp. 22353-22363.
[12] Nakagawa, Reiko, Naka, Tetsuji, Tsutsui, Hiroko, Fujimoto, Minoru, Kimura, Akihiro, Abe, Tatsuo, Seki, Ekihiro, Sato, Shintaro, Takeuchi, Osamu, Takeda, Kiyoshi, Akira, Shizuo, Yamanishi, Koichi, Kawase, Ichirou, Nakanishi, Kenji, Kishimoto, Tadamitsu. ""SOCS-1 participates in negative regulation of LPS responses."" Immunity, 2002, pp. 677-87.
[13] Fan, Zhiyong, Liu, Yinghui, Shi, Zhengliang, Deng, Kai, Zhang, Hua, Li, Qiutong, Cao, Shuxing, Li, Shentai, Zhang, Hongliang. ""MiR-155 promotes interleukin-1β-induced chondrocyte apoptosis and catabolic activity by targeting PIK3R1-mediated PI3K/Akt pathway."" Journal of cellular and molecular medicine, 2020, pp. 8441-8451.
[14] Cheng, Zhihua, Luo, Cong, Guo, Zhilin. ""LncRNA-XIST/microRNA-126 sponge mediates cell proliferation and glucose metabolism through the IRS1/PI3K/Akt pathway in glioma."" Journal of cellular biochemistry, 2020, pp. 2170-2183.
[15] Meng, Qinghai, Qi, Xu, Chao, Ying, Chen, Qi, Cheng, Peng, Yu, Xichao, Kuai, Meiyu, Wu, Jingzhen, Li, Wenwen, Zhang, Qichun, Li, Yu, Bian, Huimin. ""IRS1/PI3K/AKT pathway signal involved in the regulation of glycolipid metabolic abnormalities by Mulberry (<i>Morus alba</i> L.) leaf extracts in 3T3-L1 adipocytes."" Chinese medicine, 2020, pp. 1.
"	0.8088514	0.45023918	LLM	Neither	Neither
NeST	Positive regulators of transcription	NEST:85	AR BCL6 CREBBP EP300 HDAC1 HDAC2 KAT6A MYC PML RUNX1 TBL1XR1 TERT TNF TP53 YEATS4	15	3.9068905956085183	Positive Regulation Of Nucleic Acid-Templated Transcription 	GO:1903508	CREBBP;HDAC2;HDAC1;TBL1XR1;KAT6A;MYC;EP300;YEATS4;TNF;TP53;RUNX1	11	73.33333333333333	8.74962182490491e-15	5.302270825892376e-12	Transcriptional Regulation and Cellular Growth Control	"The system of interacting proteins primarily involves transcriptional regulation and cellular growth control. The proteins involved in this system are AR, BCL6, CREBBP, EP300, HDAC1, HDAC2, KAT6A, MYC, PML, RUNX1, TBL1XR1, TERT, TNF, TP53, and YEATS4.

1. Transcriptional Regulation: Several proteins in this system are involved in transcriptional regulation, including CREBBP, EP300, HDAC1, HDAC2, KAT6A, MYC, and YEATS4. These proteins function as transcription factors, coactivators, or corepressors, modulating gene expression. For example, CREBBP and EP300 are histone acetyltransferases that promote transcriptional activation, while HDAC1 and HDAC2 are histone deacetylases that repress transcription.

2. Cellular Growth Control: Proteins such as MYC, TP53, and TNF play crucial roles in regulating cellular growth and proliferation. MYC is an oncogene that promotes cell growth, while TP53 is a tumor suppressor that inhibits cell growth and promotes apoptosis. TNF is a cytokine involved in inflammation and cell survival.

3. Protein-Protein Interactions: The proteins in this system interact with each other to modulate their functions. For example, BCL6 interacts with CREBBP, EP300, and HDAC1 to regulate transcriptional repression. RUNX1 interacts with HDAC1, HDAC2, and TBL1XR1 to regulate gene expression during hematopoiesis.

4. Chromatin Remodeling: Some proteins in this system, such as KAT6A and YEATS4, are involved in chromatin remodeling, which is essential for transcriptional regulation. KAT6A is a histone acetyltransferase, while YEATS4 is a histone acetyl-lysine reader.

5. Telomere Maintenance: TERT is a telomerase reverse transcriptase that plays a critical role in maintaining telomere length and genomic stability.

6. Nuclear Organization: PML is involved in the formation of nuclear bodies, which are involved in various cellular processes, including transcriptional regulation and DNA repair.

In conclusion, the most prominent biological process performed by this system of interacting proteins is transcriptional regulation and cellular growth control. The proteins involved in this system modulate gene expression, regulate cell growth and proliferation, and maintain genomic stability through their interactions and functions."	15	100	"The system of interacting proteins primarily involves transcriptional regulation and cellular growth control. The proteins involved in this system are AR, BCL6, CREBBP, EP300, HDAC1, HDAC2, KAT6A, MYC, PML, RUNX1, TBL1XR1, TERT, TNF, TP53, and YEATS4.[1][2][3]

1. Transcriptional Regulation: Several proteins in this system are involved in transcriptional regulation, including CREBBP, EP300, HDAC1, HDAC2, KAT6A, MYC, and YEATS4. These proteins function as transcription factors, coactivators, or corepressors, modulating gene expression. For example, CREBBP and EP300 are histone acetyltransferases that promote transcriptional activation, while HDAC1 and HDAC2 are histone deacetylases that repress transcription.[4][5][6]

2. Cellular Growth Control: Proteins such as MYC, TP53, and TNF play crucial roles in regulating cellular growth and proliferation. MYC is an oncogene that promotes cell growth, while TP53 is a tumor suppressor that inhibits cell growth and promotes apoptosis. TNF is a cytokine involved in inflammation and cell survival.[7][8][9]

3. Protein-Protein Interactions: The proteins in this system interact with each other to modulate their functions. For example, BCL6 interacts with CREBBP, EP300, and HDAC1 to regulate transcriptional repression. RUNX1 interacts with HDAC1, HDAC2, and TBL1XR1 to regulate gene expression during hematopoiesis.[10][11][12]

4. Chromatin Remodeling: Some proteins in this system, such as KAT6A and YEATS4, are involved in chromatin remodeling, which is essential for transcriptional regulation. KAT6A is a histone acetyltransferase, while YEATS4 is a histone acetyl-lysine reader.[13][14][15]

5. Telomere Maintenance: TERT is a telomerase reverse transcriptase that plays a critical role in maintaining telomere length and genomic stability.[16][17][18]

6. Nuclear Organization: PML is involved in the formation of nuclear bodies, which are involved in various cellular processes, including transcriptional regulation and DNA repair.[19][20][21]

In conclusion, the most prominent biological process performed by this system of interacting proteins is transcriptional regulation and cellular growth control. The proteins involved in this system modulate gene expression, regulate cell growth and proliferation, and maintain genomic stability through their interactions and functions.

========================================================================================================================================================================================================
[1] Choi, Jinyong, Crotty, Shane. ""Bcl6-Mediated Transcriptional Regulation of Follicular Helper T cells (T<sub>FH</sub>)."" Trends in immunology, 2021, pp. 336-349.
[2] Lancho, Olga, Herranz, Daniel. ""The MYC Enhancer-ome: Long-Range Transcriptional Regulation of MYC in Cancer."" Trends in cancer, 2018, pp. 810-822.
[3] Khattar, Ekta, Tergaonkar, Vinay. ""Transcriptional Regulation of Telomerase Reverse Transcriptase (TERT) by MYC."" Frontiers in cell and developmental biology, 2017, pp. 1.
[4] Lancho, Olga, Herranz, Daniel. ""The MYC Enhancer-ome: Long-Range Transcriptional Regulation of MYC in Cancer."" Trends in cancer, 2018, pp. 810-822.
[5] Khattar, Ekta, Tergaonkar, Vinay. ""Transcriptional Regulation of Telomerase Reverse Transcriptase (TERT) by MYC."" Frontiers in cell and developmental biology, 2017, pp. 1.
[6] Baell, Jonathan B, Leaver, David J, Hermans, Stefan J, Kelly, Gemma L, Brennan, Margs S, Downer, Natalie L, Nguyen, Nghi, Wichmann, Johannes, McRae, Helen M, Yang, Yuqing, Cleary, Ben, Lagiakos, H Rachel, Mieruszynski, Stephen, Pacini, Guido, Vanyai, Hannah K, Bergamasco, Maria I, May, Rose E, Davey, Bethany K, Morgan, Kimberly J, Sealey, Andrew J, Wang, Beinan, Zamudio, Natasha, Wilcox, Stephen, Garnham, Alexandra L, Sheikh, Bilal N, Aubrey, Brandon J, Doggett, Karen, Chung, Matthew C, de Silva, Melanie, Bentley, John, Pilling, Pat, Hattarki, Meghan, Dolezal, Olan, Dennis, Matthew L, Falk, Hendrik, Ren, Bin, Charman, Susan A, White, Karen L, Rautela, Jai, Newbold, Andrea, Hawkins, Edwin D, Johnstone, Ricky W, Huntington, Nicholas D, Peat, Thomas S, Heath, Joan K, Strasser, Andreas, Parker, Michael W, Smyth, Gordon K, Street, Ian P, Monahan, Brendon J, Voss, Anne K, Thomas, Tim. ""Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth."" Nature, 2018, pp. 253-257.
[7] Sabò, Arianna, Kress, Theresia R, Pelizzola, Mattia, de Pretis, Stefano, Gorski, Marcin M, Tesi, Alessandra, Morelli, Marco J, Bora, Pranami, Doni, Mirko, Verrecchia, Alessandro, Tonelli, Claudia, Fagà, Giovanni, Bianchi, Valerio, Ronchi, Alberto, Low, Diana, Müller, Heiko, Guccione, Ernesto, Campaner, Stefano, Amati, Bruno. ""Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis."" Nature, 2014, pp. 488-492.
[8] Schmidt, E V. ""The role of c-myc in cellular growth control."" Oncogene, 1999, pp. 2988-96.
[9] Chin, L, Schreiber-Agus, N, Pellicer, I, Chen, K, Lee, H W, Dudast, M, Cordon-Cardo, C, DePinho, R A. ""Contrasting roles for Myc and Mad proteins in cellular growth and differentiation."" Proceedings of the National Academy of Sciences of the United States of America, 1995, pp. 8488-92.
[10] Huang, Chuanxin, Geng, Huimin, Boss, Isaac, Wang, Ling, Melnick, Ari. ""Cooperative transcriptional repression by BCL6 and BACH2 in germinal center B-cell differentiation."" Blood, 2014, pp. 1012-20.
[11] Senagolage, Madhavi D, Sommars, Meredith A, Ramachandran, Krithika, Futtner, Christopher R, Omura, Yasuhiro, Allred, Amanda L, Wang, Jianing, Yang, Cynthia, Procissi, Daniele, Evans, Ronald M, Han, Xianlin, Bederman, Ilya R, Barish, Grant D. ""Loss of Transcriptional Repression by BCL6 Confers Insulin Sensitivity in the Setting of Obesity."" Cell reports, 2018, pp. 3283-3298.e6.
[12] Takenaga, Masanori, Hatano, Masahiko, Takamori, Mikio, Yamashita, Yoshihiro, Okada, Seiji, Kuroda, Yoshikazu, Tokuhisa, Takeshi. ""Bcl6-dependent transcriptional repression by BAZF."" Biochemical and biophysical research communications, 2003, pp. 600-8.
[13] Partynska, Aleksandra, Piotrowska, Aleksandra, Pawelczyk, Konrad, Rzechonek, Adam, Ratajczak-Wielgomas, Katarzyna, Podhorska-Okolow, Marzenna, Dziegiel, Piotr. ""The Expression of Histone Acetyltransferase KAT6A in Non-small Cell Lung Cancer."" Anticancer research, 2022, pp. 5731-5741.
[14] Zhao, Wei, Mo, Huanye, Liu, Runkun, Chen, Tianxiang, Yang, Nan, Liu, Zhikui. ""Matrix stiffness-induced upregulation of histone acetyltransferase KAT6A promotes hepatocellular carcinoma progression through regulating SOX2 expression."" British journal of cancer, 2022, pp. 202-210.
[15] Lv, Deguan, Jia, Feng, Hou, Yanli, Sang, Youzhou, Alvarez, Angel A, Zhang, Weiwei, Gao, Wei-Qiang, Hu, Bo, Cheng, Shi-Yuan, Ge, Jianwei, Li, Yanxin, Feng, Haizhong. ""Histone Acetyltransferase KAT6A Upregulates PI3K/AKT Signaling through TRIM24 Binding."" Cancer research, 2017, pp. 6190-6201.
[16] Duan, Xiao-Feng, Zhao, Qiang. ""TERT-mediated and ATRX-mediated Telomere Maintenance and Neuroblastoma."" Journal of pediatric hematology/oncology, 2018, pp. 1-6.
[17] Wang, Li-Na, Wang, Li, Cheng, Guanghui, Dai, Mingkai, Yu, Yunhai, Teng, Guoxin, Zhao, Jingjie, Xu, Dawei. ""The association of telomere maintenance and TERT expression with susceptibility to human papillomavirus infection in cervical epithelium."" Cellular and molecular life sciences : CMLS, 2022, pp. 110.
[18] Goldstein, Alisa M, Qin, Richard, Chu, Emily Y, Elder, David E, Massi, Daniela, Adams, David J, Harms, Paul W, Robles-Espinoza, Carla Daniela, Newton-Bishop, Julia A, Bishop, D Timothy, Harland, Mark, Holland, Elizabeth A, Cust, Anne E, Schmid, Helen, Mann, Graham J, Puig, Susana, Potrony, Miriam, Alos, Llucia, Nagore, Eduardo, Millán-Esteban, David, Hayward, Nicholas K, Broit, Natasa, Palmer, Jane M, Nathan, Vaishnavi, Berry, Elizabeth G, Astiazaran-Symonds, Esteban, Yang, Xiaohong R, Tucker, Margaret A, Landi, Maria Teresa, Pfeiffer, Ruth M, Sargen, Michael R. ""Association of germline variants in telomere maintenance genes (<i>POT1, TERF2IP, ACD,</i> and <i>TERT</i>) with spitzoid morphology in familial melanoma: A multi-center case series."" JAAD international, 2023, pp. 43-51.
[19] Corpet, Armelle, Kleijwegt, Constance, Roubille, Simon, Juillard, Franceline, Jacquet, Karine, Texier, Pascale, Lomonte, Patrick. ""PML nuclear bodies and chromatin dynamics: catch me if you can!"" Nucleic acids research, 2020, pp. 11890-11912.
[20] Batty, Elizabeth C, Jensen, Kirsten, Freemont, Paul S. ""PML nuclear bodies and other TRIM-defined subcellular compartments."" Advances in experimental medicine and biology, 2012, pp. 39-58.
[21] Kurihara, Misuzu, Kato, Kagayaki, Sanbo, Chiaki, Shigenobu, Shuji, Ohkawa, Yasuyuki, Fuchigami, Takeshi, Miyanari, Yusuke. ""Genomic Profiling by ALaP-Seq Reveals Transcriptional Regulation by PML Bodies through DNMT3A Exclusion."" Molecular cell, 2020, pp. 493-505.e8.
"	0.5334333	0.5904337	GO	GO	NA
NeST	Regulation of JAK-STAT signaling	NEST:89	BCR CBL CBLB CSF3R EGF EGFR ERBB2 ERBB3 ERBB4 FRS2 INPPL1 IRS1 JAK1 JAK2 PDGFRA PIK3R1 PLCG2 PTPN11 RET STAT3 STAT5A	21	4.392317422778761	Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway 	GO:0007169	RET;PDGFRA;ERBB3;IRS1;ERBB4;STAT3;ERBB2;PTPN11;FRS2;PIK3R1;JAK2;EGFR	12	57.14285714285714	1.396700968832001e-17	9.190292374914566e-15	Receptor Tyrosine Kinase Signaling	"The most prominent biological process performed by this system of interacting proteins is receptor tyrosine kinase (RTK) signaling. This process is crucial for cellular communication, growth, and differentiation.

1. RTK activation: EGF, EGFR, ERBB2, ERBB3, ERBB4, and PDGFRA are all RTKs or ligands involved in RTK activation. EGF binds to EGFR, leading to dimerization and autophosphorylation of the receptor. ERBB2, ERBB3, and ERBB4 are also members of the EGFR family and can form heterodimers with EGFR. PDGFRA is another RTK that binds to its ligand, PDGF, to initiate signaling.

2. Adaptor proteins and docking: FRS2, INPPL1, IRS1, and PIK3R1 are adaptor proteins that facilitate the recruitment of downstream signaling molecules. FRS2 is involved in the recruitment of signaling proteins to activated RTKs, while INPPL1 and IRS1 are substrates for RTKs and mediate downstream signaling. PIK3R1 is a regulatory subunit of PI3K, which is activated by RTKs.

3. Signal transduction: JAK1, JAK2, PLCG2, and PTPN11 are involved in signal transduction. JAK1 and JAK2 are non-receptor tyrosine kinases that associate with cytokine receptors, such as CSF3R, and are activated upon ligand binding. PLCG2 is a phospholipase that hydrolyzes PIP2 to generate IP3 and DAG, leading to calcium release and PKC activation. PTPN11 is a protein tyrosine phosphatase that dephosphorylates RTKs, negatively regulating their activity.

4. Ubiquitin-mediated degradation: CBL and CBLB are E3 ubiquitin ligases that target activated RTKs for degradation, thus terminating the signaling. BCR is a substrate for CBL, and its ubiquitination leads to endocytosis and degradation of the receptor.

5. Transcription factors: STAT3 and STAT5A are transcription factors that are activated by phosphorylation, dimerization, and nuclear translocation. They regulate the expression of genes involved in cell growth, survival, and differentiation.

6. RTK crosstalk: RET is an RTK involved in neuronal development and can crosstalk with other RTKs, such as EGFR and ERBB2, to modulate signaling outcomes.

In conclusion, this system of interacting proteins is primarily involved in RTK signaling, which is essential for cellular communication, growth, and differentiation. The proteins function in various aspects of the signaling pathway, including RTK activation, signal transduction, and regulation of gene expression."	21	100	"The most prominent biological process performed by this system of interacting proteins is receptor tyrosine kinase (RTK) signaling. This process is crucial for cellular communication, growth, and differentiation.

1. RTK activation: EGF, EGFR, ERBB2, ERBB3, ERBB4, and PDGFRA are all RTKs or ligands involved in RTK activation. EGF binds to EGFR, leading to dimerization and autophosphorylation of the receptor. ERBB2, ERBB3, and ERBB4 are also members of the EGFR family and can form heterodimers with EGFR. PDGFRA is another RTK that binds to its ligand, PDGF, to initiate signaling.[1][2][3]

2. Adaptor proteins and docking: FRS2, INPPL1, IRS1, and PIK3R1 are adaptor proteins that facilitate the recruitment of downstream signaling molecules. FRS2 is involved in the recruitment of signaling proteins to activated RTKs, while INPPL1 and IRS1 are substrates for RTKs and mediate downstream signaling. PIK3R1 is a regulatory subunit of PI3K, which is activated by RTKs.[4][5][6]

3. Signal transduction: JAK1, JAK2, PLCG2, and PTPN11 are involved in signal transduction. JAK1 and JAK2 are non-receptor tyrosine kinases that associate with cytokine receptors, such as CSF3R, and are activated upon ligand binding. PLCG2 is a phospholipase that hydrolyzes PIP2 to generate IP3 and DAG, leading to calcium release and PKC activation. PTPN11 is a protein tyrosine phosphatase that dephosphorylates RTKs, negatively regulating their activity.[7][8][9]

4. Ubiquitin-mediated degradation: CBL and CBLB are E3 ubiquitin ligases that target activated RTKs for degradation, thus terminating the signaling. BCR is a substrate for CBL, and its ubiquitination leads to endocytosis and degradation of the receptor.[10][11][12]

5. Transcription factors: STAT3 and STAT5A are transcription factors that are activated by phosphorylation, dimerization, and nuclear translocation. They regulate the expression of genes involved in cell growth, survival, and differentiation.[13][14][15]

6. RTK crosstalk: RET is an RTK involved in neuronal development and can crosstalk with other RTKs, such as EGFR and ERBB2, to modulate signaling outcomes.[16][17][18]

In conclusion, this system of interacting proteins is primarily involved in RTK signaling, which is essential for cellular communication, growth, and differentiation. The proteins function in various aspects of the signaling pathway, including RTK activation, signal transduction, and regulation of gene expression.

========================================================================================================================================================================================================
[1] Lin, Emily Pei-Ying, Huang, Bo-Tsang, Lai, Wei-Yun, Tseng, Yi-Ting, Yang, Shuenn-Chen, Kuo, Hao-Cheng, Yang, Pan-Chyr. ""PINK1-Mediated Inhibition of EGFR Dimerization and Activation Impedes EGFR-Driven Lung Tumorigenesis."" Cancer research, 2021, pp. 1745-1757.
[2] Frolov, Andrey, Schuller, Kyle, Tzeng, Ching-Wei D, Cannon, Emily E, Ku, Brandon C, Howard, J Harrison, Vickers, Selwyn M, Heslin, Martin J, Buchsbaum, Donald J, Arnoletti, J Pablo. ""ErbB3 expression and dimerization with EGFR influence pancreatic cancer cell sensitivity to erlotinib."" Cancer biology & therapy, 2007, pp. 548-54.
[3] Hanold, Laura E, Oruganty, Krishnadev, Ton, Norman T, Beedle, Aaron M, Kannan, Natarajan, Kennedy, Eileen J. ""Inhibiting EGFR dimerization using triazolyl-bridged dimerization arm mimics."" PloS one, 2015, pp. e0118796.
[4] Sato, Takuya, Gotoh, Noriko. ""The FRS2 family of docking/scaffolding adaptor proteins as therapeutic targets of cancer treatment."" Expert opinion on therapeutic targets, 2009, pp. 689-700.
[5] Gotoh, Noriko. ""Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteins."" Cancer science, 2008, pp. 1319-25.
[6] Dearth, Robert K, Cui, Xiaojiang, Kim, Hyun-Jung, Hadsell, Darryl L, Lee, Adrian V. ""Oncogenic transformation by the signaling adaptor proteins insulin receptor substrate (IRS)-1 and IRS-2."" Cell cycle (Georgetown, Tex.), 2007, pp. 705-13.
[7] Pawinwongchai, Jaturawat, Jangprasert, Panchalee, Nilsri, Nungruthai, Israsena, Nipan, Rojnuckarin, Ponlapat. ""Mutated JAK2 signal transduction in human induced pluripotent stem cell (iPSC)-derived megakaryocytes."" Platelets, 2022, pp. 700-708.
[8] Liu, Chun-Shan, Yang-Yen, Hsin-Fang, Suen, Ching-Shu, Hwang, Ming-Jing, Yen, Jeffrey Jong-Young. ""Cbl-mediated K63-linked ubiquitination of JAK2 enhances JAK2 phosphorylation and signal transduction."" Scientific reports, 2017, pp. 4613.
[9] Staerk, J, Kallin, A, Royer, Y, Diaconu, C C, Dusa, A, Demoulin, J-B, Vainchenker, W, Constantinescu, S N. ""JAK2, the JAK2 V617F mutant and cytokine receptors."" Pathologie-biologie, 2007, pp. 88-91.
[10] Yang, Baoli, Gay, Denise L, MacLeod, Megan K L, Cao, Xiao, Hala, Tamara, Sweezer, Eileen M, Kappler, John, Marrack, Philippa, Oliver, Paula M. ""Nedd4 augments the adaptive immune response by promoting ubiquitin-mediated degradation of Cbl-b in activated T cells."" Nature immunology, 2008, pp. 1356-63.
[11] Martínez-Martínez, Esther, Tölle, Regine, Donauer, Julia, Gretzmeier, Christine, Bruckner-Tuderman, Leena, Dengjel, Jörn. ""Increased abundance of Cbl E3 ligases alters PDGFR signaling in recessive dystrophic epidermolysis bullosa."" Matrix biology : journal of the International Society for Matrix Biology, 2021, pp. 58-73.
[12] Ahmad, Gulzar, Mohapatra, Bhopal C, Schulte, Nancy A, Nadeau, Scott A, Luan, Haitao, Zutshi, Neha, Tom, Eric, Ortega-Cava, Cesar, Tu, Chun, Sanada, Masashi, Ogawa, Seishi, Toews, Myron L, Band, Vimla, Band, Hamid. ""Cbl-family ubiquitin ligases and their recruitment of CIN85 are largely dispensable for epidermal growth factor receptor endocytosis."" The international journal of biochemistry & cell biology, 2014, pp. 123-34.
[13] Bosch-Barrera, Joaquim, Menendez, Javier A. ""Silibinin and STAT3: A natural way of targeting transcription factors for cancer therapy."" Cancer treatment reviews, 2015, pp. 540-6.
[14] Hennighausen, Lothar, Robinson, Gertraud W. ""Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B."" Genes & development, 2008, pp. 711-21.
[15] Sun, Hai-Jian, Xiong, Si-Ping, Cao, Xu, Cao, Lei, Zhu, Meng-Yuan, Wu, Zhi-Yuan, Bian, Jin-Song. ""Polysulfide-mediated sulfhydration of SIRT1 prevents diabetic nephropathy by suppressing phosphorylation and acetylation of p65 NF-κB and STAT3."" Redox biology, 2021, pp. 101813.
[16] Viganò, Lucia, Locatelli, Alberta, Ulisse, Adele, Galbardi, Barbara, Dugo, Matteo, Tosi, Diego, Tacchetti, Carlo, Daniele, Tiziana, Győrffy, Balázs, Sica, Lorenzo, Macchini, Marina, Zambetti, Milvia, Zambelli, Stefania, Bianchini, Giampaolo, Gianni, Luca. ""Modulation of the Estrogen/erbB2 Receptors Cross-talk by CDK4/6 Inhibition Triggers Sustained Senescence in Estrogen Receptor- and ErbB2-positive Breast Cancer."" Clinical cancer research : an official journal of the American Association for Cancer Research, 2022, pp. 2167-2179.
[17] Linklater, Erik S, Tovar, Elizabeth A, Essenburg, Curt J, Turner, Lisa, Madaj, Zachary, Winn, Mary E, Melnik, Marianne K, Korkaya, Hasan, Maroun, Christiane R, Christensen, James G, Steensma, Matthew R, Boerner, Julie L, Graveel, Carrie R. ""Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers."" Oncotarget, 2016, pp. 69903-69915.
[18] Zhou, Ruyun, Niwa, Shinsuke, Homma, Noriko, Takei, Yosuke, Hirokawa, Nobutaka. ""KIF26A is an unconventional kinesin and regulates GDNF-Ret signaling in enteric neuronal development."" Cell, 2009, pp. 802-13.
"	0.3634889	0.29475605	Neither	Tied	NA
NeST	Nucleolus	NEST:9	ASNS ATIC CDC73 CDK8 CHEK2 CTCF DDX3X DIS3 DKC1 FOXL2 FUS GSTP1 HDAC1 HRAS NHP2 NPM1 NSD2 PA2G4 PELP1 PHB2 PPP2CA PPP2CB RHOA RPL5 RPS15 SF3B1 SHQ1 TERT TNF TOP2A UMPS UPF1 VHL XPC	34	5.087462841250339	Regulation Of Apoptotic Process 	GO:0042981	TOP2A;NPM1;SHQ1;DDX3X;HDAC1;GSTP1;ASNS;FOXL2;PA2G4;VHL;PHB2;TNF	12	35.294117647058826	9.019240652612875e-10	7.585181388847428e-7	Cell Cycle Regulation and DNA Repair	"The primary biological process performed by this system of interacting proteins is cell cycle regulation and DNA repair. The proteins involved in this process are crucial for maintaining genomic stability and preventing the accumulation of mutations that could lead to diseases such as cancer.

1. Cell cycle regulation: Several proteins in this system are involved in the regulation of the cell cycle, ensuring proper progression through the different phases and preventing uncontrolled cell division. Key proteins include:
   - CDK8: Cyclin-dependent kinase 8 is involved in the regulation of transcription and cell cycle progression.
   - CHEK2: Checkpoint kinase 2 is a tumor suppressor that plays a role in DNA damage response and cell cycle arrest.
   - TNF: Tumor necrosis factor is involved in cell proliferation, differentiation, and apoptosis.

2. DNA repair: Proteins in this system are involved in the recognition and repair of DNA damage, which is essential for maintaining genomic stability. Key proteins include:
   - XPC: Xeroderma pigmentosum group C protein is involved in nucleotide excision repair, a process that removes DNA damage caused by ultraviolet light and other environmental factors.
   - TOP2A: DNA topoisomerase II alpha is involved in the resolution of topological problems arising from DNA replication, transcription, and recombination.
   - DDX3X: DEAD-box helicase 3 X-linked is involved in various aspects of RNA metabolism, including the maintenance of genomic stability and DNA repair.

3. Chromatin remodeling: Some proteins in this system are involved in chromatin remodeling, which is essential for the regulation of gene expression and DNA repair. Key proteins include:
   - HDAC1: Histone deacetylase 1 is involved in the regulation of gene expression through chromatin remodeling.
   - NSD2: Nuclear receptor-binding SET domain protein 2 is a histone methyltransferase that plays a role in chromatin remodeling and transcriptional regulation.

4. Ribosome biogenesis and function: Several proteins in this system are involved in ribosome biogenesis and function, which is essential for protein synthesis. Key proteins include:
   - RPL5 and RPS15: Ribosomal proteins L5 and S15 are components of the large and small ribosomal subunits, respectively.
   - NPM1: Nucleophosmin 1 is involved in ribosome biogenesis and the regulation of centrosome duplication.

5. Protein-protein interactions and signaling: Many proteins in this system are involved in protein-protein interactions and signaling pathways that regulate various cellular processes. Key proteins include:
   - RHOA: Ras homolog family member A is involved in the regulation of actin cytoskeleton organization and cell migration.
   - HRAS: Harvey rat sarcoma viral oncogene homolog is a small GTPase involved in signal transduction pathways that regulate cell growth and differentiation.

In conclusion, this system of interacting proteins plays a crucial role in cell cycle regulation and DNA repair, ensuring proper cell division and maintaining genomic stability."	13	38.23529411764706	"The primary biological process performed by this system of interacting proteins is cell cycle regulation and DNA repair. The proteins involved in this process are crucial for maintaining genomic stability and preventing the accumulation of mutations that could lead to diseases such as cancer.

1. Cell cycle regulation: Several proteins in this system are involved in the regulation of the cell cycle, ensuring proper progression through the different phases and preventing uncontrolled cell division. Key proteins include:

   - CDK8: Cyclin-dependent kinase 8 is involved in the regulation of transcription and cell cycle progression.[1][2][3]

   - CHEK2: Checkpoint kinase 2 is a tumor suppressor that plays a role in DNA damage response and cell cycle arrest.[4][5][6]

   - TNF: Tumor necrosis factor is involved in cell proliferation, differentiation, and apoptosis.[7][8][9]

2. DNA repair: Proteins in this system are involved in the recognition and repair of DNA damage, which is essential for maintaining genomic stability. Key proteins include:

   - XPC: Xeroderma pigmentosum group C protein is involved in nucleotide excision repair, a process that removes DNA damage caused by ultraviolet light and other environmental factors.[10][11][12]

   - TOP2A: DNA topoisomerase II alpha is involved in the resolution of topological problems arising from DNA replication, transcription, and recombination.[13][14][15]

   - DDX3X: DEAD-box helicase 3 X-linked is involved in various aspects of RNA metabolism, including the maintenance of genomic stability and DNA repair.[16][17][18]

3. Chromatin remodeling: Some proteins in this system are involved in chromatin remodeling, which is essential for the regulation of gene expression and DNA repair. Key proteins include:

   - HDAC1: Histone deacetylase 1 is involved in the regulation of gene expression through chromatin remodeling.[19][20][21]

   - NSD2: Nuclear receptor-binding SET domain protein 2 is a histone methyltransferase that plays a role in chromatin remodeling and transcriptional regulation.[22][23][24]

4. Ribosome biogenesis and function: Several proteins in this system are involved in ribosome biogenesis and function, which is essential for protein synthesis. Key proteins include:

   - RPL5 and RPS15: Ribosomal proteins L5 and S15 are components of the large and small ribosomal subunits, respectively.[25][26][27]

   - NPM1: Nucleophosmin 1 is involved in ribosome biogenesis and the regulation of centrosome duplication.[28][29][30]

5. Protein-protein interactions and signaling: Many proteins in this system are involved in protein-protein interactions and signaling pathways that regulate various cellular processes. Key proteins include:

   - RHOA: Ras homolog family member A is involved in the regulation of actin cytoskeleton organization and cell migration.[31][32][33]

   - HRAS: Harvey rat sarcoma viral oncogene homolog is a small GTPase involved in signal transduction pathways that regulate cell growth and differentiation.[34][35][36]

In conclusion, this system of interacting proteins plays a crucial role in cell cycle regulation and DNA repair, ensuring proper cell division and maintaining genomic stability.

========================================================================================================================================================================================================
[1] Lloyd, Rebecca L, Urban, Vaclav, Muñoz-Martínez, Francisco, Ayestaran, Iñigo, Thomas, John C, de Renty, Christelle, O'Connor, Mark J, Forment, Josep V, Galanty, Yaron, Jackson, Stephen P. ""Loss of Cyclin C or CDK8 provides ATR inhibitor resistance by suppressing transcription-associated replication stress."" Nucleic acids research, 2021, pp. 8665-8683.
[2] Morris, Erick J, Ji, Jun-Yuan, Yang, Fajun, Di Stefano, Luisa, Herr, Anabel, Moon, Nam-Sung, Kwon, Eun-Jeong, Haigis, Kevin M, Näär, Anders M, Dyson, Nicholas J. ""E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8."" Nature, 2008, pp. 552-6.
[3] McDermott, Martina S J, Chumanevich, Alexander A, Lim, Chang-Uk, Liang, Jiaxin, Chen, Mengqian, Altilia, Serena, Oliver, David, Rae, James M, Shtutman, Michael, Kiaris, Hippokratis, Győrffy, Balázs, Roninson, Igor B, Broude, Eugenia V. ""Inhibition of CDK8 mediator kinase suppresses estrogen dependent transcription and the growth of estrogen receptor positive breast cancer."" Oncotarget, 2017, pp. 12558-12575.
[4] Jin, Yuesheng, Mertens, Fredrik, Kullendorff, Carl-Magnus, Panagopoulos, Ioannis. ""Fusion of the tumor-suppressor gene CHEK2 and the gene for the regulatory subunit B of protein phosphatase 2 PPP2R2A in childhood teratoma."" Neoplasia (New York, N.Y.), 2006, pp. 413-8.
[5] Stubbins, Ryan J, Korotev, Sophia, Godley, Lucy A. ""Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies."" Current hematologic malignancy reports, 2022, pp. 94-104.
[6] Pietragalla, Antonella, Arcieri, Martina, Marchetti, Claudia, Scambia, Giovanni, Fagotti, Anna. ""Ovarian cancer predisposition beyond BRCA1 and BRCA2 genes."" International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2020, pp. 1803-1810.
[7] Zhu, Xiaotian, Shi, Guanhui, Lu, Jinbiao, Qian, Xin, Wang, Donglin. ""Potential regulatory mechanism of TNF-α/TNFR1/ANXA1 in glioma cells and its role in glioma cell proliferation."" Open life sciences, 2022, pp. 208-220.
[8] Wu, Xianwei, Deng, Xiue, Wang, Jiandi, Li, Qin. ""Baicalin Inhibits Cell Proliferation and Inflammatory Cytokines Induced by Tumor Necrosis Factor α (TNF-α) in Human Immortalized Keratinocytes (HaCaT) Human Keratinocytes by Inhibiting the STAT3/Nuclear Factor kappa B (NF-κB) Signaling Pathway."" Medical science monitor : international medical journal of experimental and clinical research, 2020, pp. e919392.
[9] Li, Xinyue, Chen, Dongcai, Jing, Xueqin, Li, Conghua. ""DKK1 and TNF-alpha influence osteogenic differentiation of adBMP9-infected-rDFCs."" Oral diseases, 2020, pp. 360-369.
[10] Zebian, Abir, Shaito, Abdullah, Mazurier, Frédéric, Rezvani, Hamid Reza, Zibara, Kazem. ""XPC beyond nucleotide excision repair and skin cancers."" Mutation research. Reviews in mutation research, 2019, pp. 108286.
[11] Mu, Hong, Geacintov, Nicholas E, Broyde, Suse, Yeo, Jung-Eun, Schärer, Orlando D. ""Molecular basis for damage recognition and verification by XPC-RAD23B and TFIIH in nucleotide excision repair."" DNA repair, 2018, pp. 33-42.
[12] Blessing, Charlotte, Apelt, Katja, van den Heuvel, Diana, Gonzalez-Leal, Claudia, Rother, Magdalena B, van der Woude, Melanie, González-Prieto, Román, Yifrach, Adi, Parnas, Avital, Shah, Rashmi G, Kuo, Tia Tyrsett, Boer, Daphne E C, Cai, Jin, Kragten, Angela, Kim, Hyun-Suk, Schärer, Orlando D, Vertegaal, Alfred C O, Shah, Girish M, Adar, Sheera, Lans, Hannes, van Attikum, Haico, Ladurner, Andreas G, Luijsterburg, Martijn S. ""XPC-PARP complexes engage the chromatin remodeler ALC1 to catalyze global genome DNA damage repair."" Nature communications, 2022, pp. 4762.
[13] Zhou, Yi, Li, Jing, Yang, Xiaoxin, Song, Yu, Li, Haigang. ""Rhophilin rho GTPase binding protein 1-antisense RNA 1 (RHPN1-AS1) promotes ovarian carcinogenesis by sponging microRNA-485-5p and releasing DNA topoisomerase II alpha (<i>TOP2A</i>)."" Bioengineered, 2021, pp. 12003-12022.
[14] Tian, Tian, Bu, Min, Chen, Xu, Ding, Linli, Yang, Yulan, Han, Jinhua, Feng, Xin-Hua, Xu, Pinglong, Liu, Ting, Ying, Songmin, Lei, Yang, Li, Qing, Huang, Jun. ""The ZATT-TOP2A-PICH Axis Drives Extensive Replication Fork Reversal to Promote Genome Stability."" Molecular cell, 2021, pp. 198-211.e6.
[15] Uusküla-Reimand, Liis, Wilson, Michael D. ""Untangling the roles of TOP2A and TOP2B in transcription and cancer."" Science advances, 2022, pp. eadd4920.
[16] Lennox, Ashley L, Hoye, Mariah L, Jiang, Ruiji, Johnson-Kerner, Bethany L, Suit, Lindsey A, Venkataramanan, Srivats, Sheehan, Charles J, Alsina, Fernando C, Fregeau, Brieana, Aldinger, Kimberly A, Moey, Ching, Lobach, Iryna, Afenjar, Alexandra, Babovic-Vuksanovic, Dusica, Bézieau, Stéphane, Blackburn, Patrick R, Bunt, Jens, Burglen, Lydie, Campeau, Philippe M, Charles, Perrine, Chung, Brian H Y, Cogné, Benjamin, Curry, Cynthia, D'Agostino, Maria Daniela, Di Donato, Nataliya, Faivre, Laurence, Héron, Delphine, Innes, A Micheil, Isidor, Bertrand, Keren, Boris, Kimball, Amy, Klee, Eric W, Kuentz, Paul, Küry, Sébastien, Martin-Coignard, Dominique, Mirzaa, Ghayda, Mignot, Cyril, Miyake, Noriko, Matsumoto, Naomichi, Fujita, Atsushi, Nava, Caroline, Nizon, Mathilde, Rodriguez, Diana, Blok, Lot Snijders, Thauvin-Robinet, Christel, Thevenon, Julien, Vincent, Marie, Ziegler, Alban, Dobyns, William, Richards, Linda J, Barkovich, A James, Floor, Stephen N, Silver, Debra L, Sherr, Elliott H. ""Pathogenic DDX3X Mutations Impair RNA Metabolism and Neurogenesis during Fetal Cortical Development."" Neuron, 2020, pp. 404-420.e8.
[17] Shen, Hui, Yanas, Amber, Owens, Michael C, Zhang, Celia, Fritsch, Clark, Fare, Charlotte M, Copley, Katie E, Shorter, James, Goldman, Yale E, Liu, Kathy Fange. ""Sexually dimorphic RNA helicases DDX3X and DDX3Y differentially regulate RNA metabolism through phase separation."" Molecular cell, 2022, pp. 2588-2603.e9.
[18] Mo, Jie, Liang, Huifang, Su, Chen, Li, Pengcheng, Chen, Jin, Zhang, Bixiang. ""DDX3X: structure, physiologic functions and cancer."" Molecular cancer, 2021, pp. 38.
[19] Nalawansha, Dhanusha A, Pflum, Mary Kay H. ""LSD1 Substrate Binding and Gene Expression Are Affected by HDAC1-Mediated Deacetylation."" ACS chemical biology, 2017, pp. 254-264.
[20] Eshelman, Melanie A, Shah, Meera, Raup-Konsavage, Wesley M, Rennoll, Sherri A, Yochum, Gregory S. ""TCF7L1 recruits CtBP and HDAC1 to repress DICKKOPF4 gene expression in human colorectal cancer cells."" Biochemical and biophysical research communications, 2017, pp. 716-722.
[21] Omisanjo, Olufunmilade A, Biermann, Katharina, Hartmann, Sonja, Heukamp, Lukas C, Sonnack, Violetta, Hild, Anne, Brehm, Ralph, Bergmann, Martin, Weidner, Wolfgang, Steger, Klaus. ""DNMT1 and HDAC1 gene expression in impaired spermatogenesis and testicular cancer."" Histochemistry and cell biology, 2007, pp. 175-81.
[22] Zhang, Le, Long, Xuehui, Yin, Yuye, Wang, Jun, Zhu, Huamin, Chen, Jingjing, Wang, Yuliang, Chen, Yun, Wang, Xiaoming. ""Histone methyltransferase Nsd2 ensures maternal-fetal immune tolerance by promoting regulatory T-cell recruitment."" Cellular & molecular immunology, 2022, pp. 634-643.
[23] Zhao, Li-Hao, Li, Quan, Huang, Zhi-Jun, Sun, Mi-Xue, Lu, Jing-Jing, Zhang, Xiao-Hua, Li, Gang, Wu, Fang. ""Identification of histone methyltransferase NSD2 as an important oncogenic gene in colorectal cancer."" Cell death & disease, 2021, pp. 974.
[24] He, Chao, Liu, Chao, Wang, Lei, Sun, Yangbai, Jiang, Yuhang, Hao, Yongqiang. ""Histone methyltransferase NSD2 regulates apoptosis and chemosensitivity in osteosarcoma."" Cell death & disease, 2019, pp. 65.
[25] Chen, Chaoyi, Yuan, Jianrui, Ji, Guangdong, Zhang, Shicui, Gao, Zhan. ""Amphioxus ribosomal proteins RPS15, RPS18, RPS19 and RPS30-precursor act as immune effectors via killing or agglutinating bacteria."" Fish & shellfish immunology, 2021, pp. 147-154.
[26] Daftuar, Lilyn, Zhu, Yan, Jacq, Xavier, Prives, Carol. ""Ribosomal proteins RPL37, RPS15 and RPS20 regulate the Mdm2-p53-MdmX network."" PloS one, 2013, pp. e68667.
[27] Zhang, Jingyu, Harnpicharnchai, Piyanun, Jakovljevic, Jelena, Tang, Lan, Guo, Yurong, Oeffinger, Marlene, Rout, Michael P, Hiley, Shawna L, Hughes, Timothy, Woolford, John L. ""Assembly factors Rpf2 and Rrs1 recruit 5S rRNA and ribosomal proteins rpL5 and rpL11 into nascent ribosomes."" Genes & development, 2007, pp. 2580-92.
[28] Lindström, Mikael S. ""NPM1/B23: A Multifunctional Chaperone in Ribosome Biogenesis and Chromatin Remodeling."" Biochemistry research international, 2011, pp. 195209.
[29] Bose, Arunabha, Modi, Kruti, Dey, Suchismita, Dalvi, Somavally, Nadkarni, Prafful, Sudarshan, Mukund, Kundu, Tapas K, Venkatraman, Prasanna, Dalal, Sorab N. ""14-3-3γ prevents centrosome duplication by inhibiting NPM1 function."" Genes to cells : devoted to molecular & cellular mechanisms, 2021, pp. 426-446.
[30] Cheng, Chi Keung, Kwan, Tsz Ki, Cheung, Chi Ying, Ng, Kitty, Liang, Pei, Cheng, Suk Hang, Chan, Natalie P H, Ip, Rosalina K L, Wong, Raymond S M, Lee, Vincent, Li, Chi Kong, Yip, Sze Fai, Ng, Margaret H L. ""A polymorphism in the 3'-untranslated region of the NPM1 gene causes illegitimate regulation by microRNA-337-5p and correlates with adverse outcome in acute myeloid leukemia."" Haematologica, 2013, pp. 913-7.
[31] Pardo-Pastor, Carlos, Rubio-Moscardo, Fanny, Vogel-González, Marina, Serra, Selma A, Afthinos, Alexandros, Mrkonjic, Sanela, Destaing, Olivier, Abenza, Juan F, Fernández-Fernández, José M, Trepat, Xavier, Albiges-Rizo, Corinne, Konstantopoulos, Konstantinos, Valverde, Miguel A. ""Piezo2 channel regulates RhoA and actin cytoskeleton to promote cell mechanobiological responses."" Proceedings of the National Academy of Sciences of the United States of America, 2018, pp. 1925-1930.
[32] Schollenberger, Lukas, Gronemeyer, Thomas, Huber, Christoph M, Lay, Dorothee, Wiese, Sebastian, Meyer, Helmut E, Warscheid, Bettina, Saffrich, Rainer, Peränen, Johan, Gorgas, Karin, Just, Wilhelm W. ""RhoA regulates peroxisome association to microtubules and the actin cytoskeleton."" PloS one, 2010, pp. e13886.
[33] Karpushev, Alexey V, Ilatovskaya, Daria V, Staruschenko, Alexander. ""The actin cytoskeleton and small G protein RhoA are not involved in flow-dependent activation of ENaC."" BMC research notes, 2010, pp. 210.
[34] Herrero, Ana, Reis-Cardoso, Mariana, Jiménez-Gómez, Iñaki, Doherty, Carolanne, Agudo-Ibañez, Lorena, Pinto, Adán, Calvo, Fernando, Kolch, Walter, Crespo, Piero, Matallanas, David. ""Characterisation of HRas local signal transduction networks using engineered site-specific exchange factors."" Small GTPases, 2020, pp. 371-383.
[35] Zona, Laetitia, Lupberger, Joachim, Sidahmed-Adrar, Nazha, Thumann, Christine, Harris, Helen J, Barnes, Amy, Florentin, Jonathan, Tawar, Rajiv G, Xiao, Fei, Turek, Marine, Durand, Sarah C, Duong, François H T, Heim, Markus H, Cosset, François-Loïc, Hirsch, Ivan, Samuel, Didier, Brino, Laurent, Zeisel, Mirjam B, Le Naour, François, McKeating, Jane A, Baumert, Thomas F. ""HRas signal transduction promotes hepatitis C virus cell entry by triggering assembly of the host tetraspanin receptor complex."" Cell host & microbe, 2013, pp. 302-13.
[36] Harvey, W H, Harb, O S, Kosak, S T, Sheaffer, J C, Lowe, L R, Heerema, N A. ""Interferon-alpha-2b downregulation of oncogenes H-ras, c-raf-2, c-kit, c-myc, c-myb and c-fos in ESKOL, a hairy cell leukemic line, results in temporal perturbation of signal transduction cascade."" Leukemia research, 1994, pp. 577-85.
"	0.36262158	0.21352428	Neither	Neither	NA
NeST	G1/S phase	NEST:91	BRCA1 BUB1B CCND1 CCNE1 CDKN1A CDKN1B CDKN2A CKS1B CREBBP CTNNB1 E2F1 EP300 HDAC1 HLA-A MYC RB1 RBL1 TOP2A TP53	19	4.247927513443585	Cell Cycle G1/S Phase Transition 	GO:0044843	CDKN1A;CDKN1B;CCND1;CCNE1;MYC;E2F1	6	31.57894736842105	6.059306963585559e-12	3.293315473911198e-9	Cell Cycle Regulation	"The system of interacting proteins primarily involves the regulation of the cell cycle, including cell cycle progression, checkpoint control, and DNA repair. The key proteins involved in these processes are BRCA1, BUB1B, CCND1, CCNE1, CDKN1A, CDKN1B, CDKN2A, CKS1B, CREBBP, CTNNB1, E2F1, EP300, HDAC1, HLA-A, MYC, RB1, RBL1, TOP2A, and TP53.

1. Cell cycle progression: Cyclins and cyclin-dependent kinases (CDKs) are essential for cell cycle progression. CCND1 and CCNE1 are cyclins that regulate the G1/S transition, while CDKN1A, CDKN1B, and CDKN2A are CDK inhibitors that negatively regulate the cell cycle. CKS1B is a CDK regulatory subunit that promotes cell cycle progression.

2. Checkpoint control: BUB1B is a key component of the spindle assembly checkpoint, ensuring proper chromosome segregation during mitosis. RB1 and RBL1 are tumor suppressor proteins that regulate the G1/S checkpoint by inhibiting E2F1, a transcription factor that promotes cell cycle progression.

3. DNA repair: BRCA1 and TP53 are crucial for maintaining genomic stability through their roles in DNA repair. BRCA1 is involved in double-strand break repair, while TP53 is a transcription factor that regulates the expression of genes involved in DNA repair, cell cycle arrest, and apoptosis.

4. Transcriptional regulation: MYC, CREBBP, EP300, and HDAC1 are involved in the regulation of gene expression. MYC is an oncogene that promotes cell cycle progression and cell growth. CREBBP and EP300 are histone acetyltransferases that modulate chromatin structure and gene expression, while HDAC1 is a histone deacetylase that represses transcription.

5. Cell adhesion and signaling: CTNNB1 is involved in cell adhesion and Wnt signaling, which can influence cell proliferation and differentiation.

6. Immune response: HLA-A is a major histocompatibility complex (MHC) class I molecule that plays a role in the immune response by presenting peptides to T cells.

7. DNA topology: TOP2A is a DNA topoisomerase that regulates DNA topology during replication, transcription, and chromosome segregation.

In conclusion, the most prominent biological process performed by this system of interacting proteins is cell cycle regulation, which encompasses cell cycle progression, checkpoint control, and DNA repair. These proteins work together to ensure proper cell division and maintain genomic stability."	19	100	"The system of interacting proteins primarily involves the regulation of the cell cycle, including cell cycle progression, checkpoint control, and DNA repair. The key proteins involved in these processes are BRCA1, BUB1B, CCND1, CCNE1, CDKN1A, CDKN1B, CDKN2A, CKS1B, CREBBP, CTNNB1, E2F1, EP300, HDAC1, HLA-A, MYC, RB1, RBL1, TOP2A, and TP53.[1][2][3]

1. Cell cycle progression: Cyclins and cyclin-dependent kinases (CDKs) are essential for cell cycle progression. CCND1 and CCNE1 are cyclins that regulate the G1/S transition, while CDKN1A, CDKN1B, and CDKN2A are CDK inhibitors that negatively regulate the cell cycle. CKS1B is a CDK regulatory subunit that promotes cell cycle progression.[4][5][6]

2. Checkpoint control: BUB1B is a key component of the spindle assembly checkpoint, ensuring proper chromosome segregation during mitosis. RB1 and RBL1 are tumor suppressor proteins that regulate the G1/S checkpoint by inhibiting E2F1, a transcription factor that promotes cell cycle progression.[7][8][9]

3. DNA repair: BRCA1 and TP53 are crucial for maintaining genomic stability through their roles in DNA repair. BRCA1 is involved in double-strand break repair, while TP53 is a transcription factor that regulates the expression of genes involved in DNA repair, cell cycle arrest, and apoptosis.[10][11][12]

4. Transcriptional regulation: MYC, CREBBP, EP300, and HDAC1 are involved in the regulation of gene expression. MYC is an oncogene that promotes cell cycle progression and cell growth. CREBBP and EP300 are histone acetyltransferases that modulate chromatin structure and gene expression, while HDAC1 is a histone deacetylase that represses transcription.[13][14][15]

5. Cell adhesion and signaling: CTNNB1 is involved in cell adhesion and Wnt signaling, which can influence cell proliferation and differentiation.[16][17][18]

6. Immune response: HLA-A is a major histocompatibility complex (MHC) class I molecule that plays a role in the immune response by presenting peptides to T cells.[19][20][21]

7. DNA topology: TOP2A is a DNA topoisomerase that regulates DNA topology during replication, transcription, and chromosome segregation.[22][23][24]

In conclusion, the most prominent biological process performed by this system of interacting proteins is cell cycle regulation, which encompasses cell cycle progression, checkpoint control, and DNA repair. These proteins work together to ensure proper cell division and maintain genomic stability.

========================================================================================================================================================================================================
[1] Yoshida, Kiyotsugu, Miki, Yoshio. ""Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage."" Cancer science, 2004, pp. 866-71.
[2] Bretones, Gabriel, Delgado, M Dolores, León, Javier. ""Myc and cell cycle control."" Biochimica et biophysica acta, 2015, pp. 506-16.
[3] Knudsen, Erik S, Pruitt, Steven C, Hershberger, Pamela A, Witkiewicz, Agnieszka K, Goodrich, David W. ""Cell Cycle and Beyond: Exploiting New RB1 Controlled Mechanisms for Cancer Therapy."" Trends in cancer, 2019, pp. 308-324.
[4] Ma, Pei, Wang, Haitao, Sun, Jiangyang, Liu, Hongzhou, Zheng, Chao, Zhou, Xin, Lu, Zhongxin. ""LINC00152 promotes cell cycle progression in hepatocellular carcinoma via miR-193a/b-3p/CCND1 axis."" Cell cycle (Georgetown, Tex.), 2018, pp. 974-984.
[5] He, Chuan, Chen, Hongwei, Liu, Yan, Li, Xiaolin, Zhang, Chaoju, Qin, Qunyan, Pang, Qixiong. ""miR-106b-5p promotes cell proliferation and cell cycle progression by directly targeting CDKN1A in osteosarcoma."" Experimental and therapeutic medicine, 2020, pp. 3203-3210.
[6] Monteiro, Luís Silva, Diniz-Freitas, Márcio, Warnakulasuriya, Saman, Garcia-Caballero, Tomás, Forteza-Vila, Jerónimo, Fraga, Máximo. ""Prognostic Significance of Cyclins A2, B1, D1, and E1 and <i>CCND1</i> Numerical Aberrations in Oral Squamous Cell Carcinomas."" Analytical cellular pathology (Amsterdam), 2018, pp. 7253510.
[7] Stevens, Craig, La Thangue, Nicholas B. ""The emerging role of E2F-1 in the DNA damage response and checkpoint control."" DNA repair, 2004, pp. 1071-9.
[8] Stevens, Craig, La Thangue, Nicholas B. ""A new role for E2F-1 in checkpoint control."" Cell cycle (Georgetown, Tex.), 2003, pp. 435-7.
[9] Knudsen, Erik S, Pruitt, Steven C, Hershberger, Pamela A, Witkiewicz, Agnieszka K, Goodrich, David W. ""Cell Cycle and Beyond: Exploiting New RB1 Controlled Mechanisms for Cancer Therapy."" Trends in cancer, 2019, pp. 308-324.
[10] Yoshida, Kiyotsugu, Miki, Yoshio. ""Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage."" Cancer science, 2004, pp. 866-71.
[11] Tarsounas, Madalena, Sung, Patrick. ""The antitumorigenic roles of BRCA1-BARD1 in DNA repair and replication."" Nature reviews. Molecular cell biology, 2020, pp. 284-299.
[12] Patterson-Fortin, Jeffrey, Bose, Arindam, Tsai, Wei-Chih, Grochala, Carter, Nguyen, Huy, Zhou, Jia, Parmar, Kalindi, Lazaro, Jean-Bernard, Liu, Joyce, McQueen, Kelsey, Shapiro, Geoffrey I, Kozono, David, D'Andrea, Alan D. ""Targeting DNA Repair with Combined Inhibition of NHEJ and MMEJ Induces Synthetic Lethality in TP53-Mutant Cancers."" Cancer research, 2022, pp. 3815-3829.
[13] Lancho, Olga, Herranz, Daniel. ""The MYC Enhancer-ome: Long-Range Transcriptional Regulation of MYC in Cancer."" Trends in cancer, 2018, pp. 810-822.
[14] Li, Shi-Ting, Huang, De, Shen, Shengqi, Cai, Yongping, Xing, Songge, Wu, Gongwei, Jiang, Zetan, Hao, Yijie, Yuan, Mengqiu, Wang, Nana, Zhu, Lianbang, Yan, Ronghui, Yang, Dongdong, Wang, Lin, Liu, Zhaoji, Hu, Xin, Zhou, Rongbin, Qu, Kun, Li, Ailing, Duan, Xiaotao, Zhang, Huafeng, Gao, Ping. ""Myc-mediated SDHA acetylation triggers epigenetic regulation of gene expression and tumorigenesis."" Nature metabolism, 2020, pp. 256-269.
[15] Wu, Hua, Yang, Tian-Yu, Li, Yi, Ye, Wen-Long, Liu, Feng, He, Xiao-Shun, Wang, Jing-Ru, Gan, Wen-Juan, Li, Xiu-Ming, Zhang, Shen, Zhao, Yuan-Yuan, Li, Jian-Ming. ""Tumor Necrosis Factor Receptor-Associated Factor 6 Promotes Hepatocarcinogenesis by Interacting With Histone Deacetylase 3 to Enhance c-Myc Gene Expression and Protein Stability."" Hepatology (Baltimore, Md.), 2020, pp. 148-163.
[16] Sehgal, Priyanka, Lanauze, Claudia, Wang, Xin, Hayer, Katharina E, Torres-Diz, Manuel, Leu, N Adrian, Sela, Yogev, Stanger, Ben Z, Lengner, Christopher J, Thomas-Tikhonenko, Andrei. ""MYC Hyperactivates Wnt Signaling in <i>APC</i>/<i>CTNNB1</i>-Mutated Colorectal Cancer Cells through miR-92a-Dependent Repression of <i>DKK3</i>."" Molecular cancer research : MCR, 2021, pp. 2003-2014.
[17] Huang, Qian, Wang, Chao-Cai, Liu, Yun-Guang, Zhao, Chang-Ming, Zhang, Tian-Ping, Liu, Yan, Wang, Hua. ""Clinical relevance of genetic polymorphisms in WNT signaling pathway (<i>SFRP1</i>, <i>WNT3A</i>, <i>CTNNB1, WIF-1</i>, <i>DKK-1</i>, <i>LRP5</i>, <i>LRP6</i>) on pulmonary tuberculosis in a Chinese population."" Frontiers in immunology, 2022, pp. 1011700.
[18] Stewart, C Allison, Wang, Ying, Bonilla-Claudio, Margarita, Martin, James F, Gonzalez, Gabriel, Taketo, Makoto M, Behringer, Richard R. ""CTNNB1 in mesenchyme regulates epithelial cell differentiation during Müllerian duct and postnatal uterine development."" Molecular endocrinology (Baltimore, Md.), 2013, pp. 1442-54.
[19] Loirat, D, Lemonnier, F A, Michel, M L. ""Multiepitopic HLA-A*0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization."" Journal of immunology (Baltimore, Md. : 1950), 2000, pp. 4748-55.
[20] Mishto, Michele, Mansurkhodzhaev, Artem, Ying, Ge, Bitra, Aruna, Cordfunke, Robert A, Henze, Sarah, Paul, Debdas, Sidney, John, Urlaub, Henning, Neefjes, Jacques, Sette, Alessandro, Zajonc, Dirk M, Liepe, Juliane. ""An <i>in silico-in vitro</i> Pipeline Identifying an HLA-A<sup>*</sup>02:01<sup>+</sup> KRAS G12V<sup>+</sup> Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients."" Frontiers in immunology, 2019, pp. 2572.
[21] Flesch, Brigitte K, König, Jochem, Frommer, Lara, Hansen, Martin P, Kahaly, George J. ""Sex Alters the MHC Class I HLA-A Association With Polyglandular Autoimmunity."" The Journal of clinical endocrinology and metabolism, 2019, pp. 1680-1686.
[22] Dong, Yinying, Sun, Xiangyin, Zhang, Kong, He, Xinjia, Zhang, Qian, Song, Hao, Xu, Mingjin, Lu, Haijun, Ren, Ruimei. ""Type IIA topoisomerase (TOP2A) triggers epithelial-mesenchymal transition and facilitates HCC progression by regulating Snail expression."" Bioengineered, 2021, pp. 12967-12979.
[23] Järvinen, T A H, Liu, E T. ""Topoisomerase IIalpha gene (TOP2A) amplification and deletion in cancer--more common than anticipated."" Cytopathology : official journal of the British Society for Clinical Cytology, 2003, pp. 309-13.
[24] Du, Xiaomei, Xue, Zhiwen, Lv, Jianning, Wang, Heidou. ""Expression of the Topoisomerase II Alpha (TOP2A) Gene in Lung Adenocarcinoma Cells and the Association with Patient Outcomes."" Medical science monitor : international medical journal of experimental and clinical research, 2020, pp. e929120.
"	0.6386994	0.85668486	GO	GO	NA
NeST	Cell projection morphogenesis	NEST:97	EPHA2 EPHA3 EPHA5 EPHA7 EPHB1 EPHB2 PTPRD SLIT2	8	3	Ephrin Receptor Signaling Pathway 	GO:0048013	EPHA5;EPHA7;EPHB2;EPHB1;EPHA3;EPHA2	6	75	1.9146828799327737e-15	4.882441343828573e-13	Ephrin Receptor Signaling	"The primary biological process performed by this system of interacting proteins is Ephrin receptor signaling. This process is crucial for various cellular functions, including cell adhesion, migration, and axon guidance.

1. Ephrin receptor family: EPHA2, EPHA3, EPHA5, EPHA7, EPHB1, and EPHB2 are all members of the Ephrin receptor family. These proteins are receptor tyrosine kinases that bind to membrane-bound ephrin ligands, initiating bidirectional signaling between neighboring cells. This interaction is essential for proper cell positioning and tissue organization.

2. PTPRD: Protein tyrosine phosphatase receptor type D (PTPRD) is a member of the protein tyrosine phosphatase (PTP) family. PTPRD interacts with Ephrin receptors, specifically EPHA3, and modulates their signaling. This interaction is crucial for the regulation of cell adhesion and migration, as well as axon guidance in the nervous system.

3. SLIT2: Slit guidance ligand 2 (SLIT2) is a secreted protein that plays a role in axon guidance and cell migration. SLIT2 interacts with Ephrin receptors, particularly EPHB2, and modulates their signaling. This interaction is essential for proper axon guidance and neuronal development.

In conclusion, the primary biological process performed by this system of interacting proteins is Ephrin receptor signaling, which is crucial for cell adhesion, migration, and axon guidance. The proteins EPHA2, EPHA3, EPHA5, EPHA7, EPHB1, EPHB2, PTPRD, and SLIT2 all play essential roles in this process, with PTPRD and SLIT2 modulating the signaling of Ephrin receptors."	8	100	"The primary biological process performed by this system of interacting proteins is Ephrin receptor signaling. This process is crucial for various cellular functions, including cell adhesion, migration, and axon guidance.

1. Ephrin receptor family: EPHA2, EPHA3, EPHA5, EPHA7, EPHB1, and EPHB2 are all members of the Ephrin receptor family. These proteins are receptor tyrosine kinases that bind to membrane-bound ephrin ligands, initiating bidirectional signaling between neighboring cells. This interaction is essential for proper cell positioning and tissue organization.[1][2][3]

2. PTPRD: Protein tyrosine phosphatase receptor type D (PTPRD) is a member of the protein tyrosine phosphatase (PTP) family. PTPRD interacts with Ephrin receptors, specifically EPHA3, and modulates their signaling. This interaction is crucial for the regulation of cell adhesion and migration, as well as axon guidance in the nervous system.[4][5][6]

3. SLIT2: Slit guidance ligand 2 (SLIT2) is a secreted protein that plays a role in axon guidance and cell migration. SLIT2 interacts with Ephrin receptors, particularly EPHB2, and modulates their signaling. This interaction is essential for proper axon guidance and neuronal development.[7][8][9]

In conclusion, the primary biological process performed by this system of interacting proteins is Ephrin receptor signaling, which is crucial for cell adhesion, migration, and axon guidance. The proteins EPHA2, EPHA3, EPHA5, EPHA7, EPHB1, EPHB2, PTPRD, and SLIT2 all play essential roles in this process, with PTPRD and SLIT2 modulating the signaling of Ephrin receptors.[10][11][12]

========================================================================================================================================================================================================
[1] Bodin, Raphael, Paillé, Vincent, Oullier, Thibauld, Durand, Tony, Aubert, Philippe, Le Berre-Scoul, Catherine, Hulin, Philippe, Neunlist, Michel, Cissé, Moustapha. ""The ephrin receptor EphB2 regulates the connectivity and activity of enteric neurons."" The Journal of biological chemistry, 2021, pp. 101300.
[2] Wang, Jianbo, Galvao, Joana, Beach, Krista M, Luo, Weijia, Urrutia, Raul A, Goldberg, Jeffrey L, Otteson, Deborah C. ""Novel Roles and Mechanism for Krüppel-like Factor 16 (KLF16) Regulation of Neurite Outgrowth and Ephrin Receptor A5 (EphA5) Expression in Retinal Ganglion Cells."" The Journal of biological chemistry, 2016, pp. 18084-95.
[3] Gaitanos, Thomas N, Koerner, Jorg, Klein, Ruediger. ""Tiam-Rac signaling mediates trans-endocytosis of ephrin receptor EphB2 and is important for cell repulsion."" The Journal of cell biology, 2016, pp. 735-52.
[4] Smith, Loraine M, Walsh, Patrick T, Rüdiger, Thomas, Cotter, Thomas G, Mc Carthy, Tommie V, Marx, Alexander, O'Connor, Rosemary. ""EphA3 is induced by CD28 and IGF-1 and regulates cell adhesion."" Experimental cell research, 2004, pp. 295-303.
[5] Sullivan, Chelsea S, Kümper, Maike, Temple, Brenda S, Maness, Patricia F. ""The Neural Cell Adhesion Molecule (NCAM) Promotes Clustering and Activation of EphA3 Receptors in GABAergic Interneurons to Induce Ras Homolog Gene Family, Member A (RhoA)/Rho-associated protein kinase (ROCK)-mediated Growth Cone Collapse."" The Journal of biological chemistry, 2016, pp. 26262-26272.
[6] Clifford, Noretta, Smith, Loraine M, Powell, James, Gattenlöhner, Stefan, Marx, Alexander, O'Connor, Rosemary. ""The EphA3 receptor is expressed in a subset of rhabdomyosarcoma cell lines and suppresses cell adhesion and migration."" Journal of cellular biochemistry, 2008, pp. 1250-9.
[7] Göhrig, Andreas, Detjen, Katharina M, Hilfenhaus, Georg, Körner, Jan L, Welzel, Martina, Arsenic, Ruza, Schmuck, Rosa, Bahra, Marcus, Wu, Jane Y, Wiedenmann, Bertram, Fischer, Christian. ""Axon guidance factor SLIT2 inhibits neural invasion and metastasis in pancreatic cancer."" Cancer research, 2014, pp. 1529-40.
[8] Kong, Meng, Zhou, Tao, Xiang, Bo. ""Expression of the axon guidance factor Slit2 and its receptor Robo1 in patients with Hirschsprung disease: An observational study."" Medicine, 2021, pp. e26981.
[9] Nguyen Ba-Charvet, K T, Brose, K, Ma, L, Wang, K H, Marillat, V, Sotelo, C, Tessier-Lavigne, M, Chédotal, A. ""Diversity and specificity of actions of Slit2 proteolytic fragments in axon guidance."" The Journal of neuroscience : the official journal of the Society for Neuroscience, 2001, pp. 4281-9.
[10] Smith, Loraine M, Walsh, Patrick T, Rüdiger, Thomas, Cotter, Thomas G, Mc Carthy, Tommie V, Marx, Alexander, O'Connor, Rosemary. ""EphA3 is induced by CD28 and IGF-1 and regulates cell adhesion."" Experimental cell research, 2004, pp. 295-303.
[11] Sullivan, Chelsea S, Kümper, Maike, Temple, Brenda S, Maness, Patricia F. ""The Neural Cell Adhesion Molecule (NCAM) Promotes Clustering and Activation of EphA3 Receptors in GABAergic Interneurons to Induce Ras Homolog Gene Family, Member A (RhoA)/Rho-associated protein kinase (ROCK)-mediated Growth Cone Collapse."" The Journal of biological chemistry, 2016, pp. 26262-26272.
[12] Yoon, Sarah, Choi, Ji-Hye, Kim, Sung Joo, Lee, Eun-Ju, Shah, Masaud, Choi, Sangdun, Woo, Hyun Goo. ""EPHB6 mutation induces cell adhesion-mediated paclitaxel resistance via EPHA2 and CDH11 expression."" Experimental & molecular medicine, 2019, pp. 1-12.
"	0.39237425	0.39017218	Neither	Neither	Neither
Diff. expressed gene set	ADIPOGENESIS	NA	ABCA1 ABCB8 ACAA2 ACADL ACADM ACADS ACLY ACO2 ACOX1 ADCY6 ADIG ADIPOQ ADIPOR2 AGPAT3 AIFM1 AK2 ALDH2 ALDOA ANGPT1 ANGPTL4 APLP2 APOE ARAF ARL4A ATL2 ATP1B3 ATP5PO BAZ2A BCKDHA BCL2L13 BCL6 C3 CAT CAVIN1 CAVIN2 CCNG2 CD151 CD302 CD36 CDKN2C CHCHD10 CHUK CIDEA CMBL CMPK1 COL15A1 COL4A1 COQ3 COQ5 COQ9 COX6A1 COX7B COX8A CPT2 CRAT CS CYC1 CYP4B1 DBT DDT DECR1 DGAT1 DHCR7 DHRS7 DHRS7B DLAT DLD DNAJB9 DNAJC15 DRAM2 ECH1 ECHS1 ELMOD3 ELOVL6 ENPP2 EPHX2 ESRRA ESYT1 ETFB FABP4 FAH FZD4 G3BP2 GADD45A GBE1 GHITM GPAM GPAT4 GPD2 GPHN GPX3 GPX4 GRPEL1 HADH HIBCH HSPB8 IDH1 IDH3A IDH3G IFNGR1 IMMT ITGA7 ITIH5 ITSN1 JAGN1 LAMA4 LEP LIFR LIPE LPCAT3 LPL LTC4S MAP4K3 MCCC1 MDH2 ME1 MGLL MGST3 MIGA2 MRAP MRPL15 MTARC2 MTCH2 MYLK NABP1 NDUFA5 NDUFAB1 NDUFB7 NDUFS3 NKIRAS1 NMT1 OMD ORM1 PDCD4 PEMT PEX14 PFKFB3 PFKL PGM1 PHLDB1 PHYH PIM3 PLIN2 POR PPARG PPM1B PPP1R15B PRDX3 PREB PTCD3 PTGER3 QDPR RAB34 REEP5 REEP6 RETN RETSAT RIOK3 RMDN3 RNF11 RREB1 RTN3 SAMM50 SCARB1 SCP2 SDHB SDHC SLC19A1 SLC1A5 SLC25A1 SLC25A10 SLC27A1 SLC5A6 SLC66A3 SNCG SOD1 SORBS1 SOWAHC SPARCL1 SQOR SSPN STAT5A STOM SUCLG1 SULT1A1 TALDO1 TANK TKT TOB1 TST UBC UBQLN1 UCK1 UCP2 UQCR10 UQCR11 UQCRC1 UQCRQ VEGFB YWHAG	200	7.643856189774724	Cellular Respiration 	GO:0045333	COX8A;COX7B;NDUFB7;NDUFA5;MDH2;SDHC;UQCR11;ETFB;UQCR10;COX6A1;SDHB;UQCRQ;NDUFAB1;NDUFS3;UQCRC1;CYC1	16	8	2.34e-16	3.22e-13	Fatty Acid Metabolism and Oxidative Phosphorylation	"The primary biological process performed by this system of interacting proteins is fatty acid metabolism and oxidative phosphorylation. The proteins involved in these processes are essential for energy production and storage in cells.

Fatty Acid Metabolism:
Key proteins involved in fatty acid metabolism include ACADM, ACADS, ACAA2, ACADL, ACOX1, ELOVL6, FABP4, and CPT2. These proteins are involved in the breakdown of fatty acids (beta-oxidation) and the synthesis of fatty acids (elongation). For example, ACADM and ACADS are involved in the breakdown of medium-chain and short-chain fatty acids, respectively, while ACOX1 is involved in peroxisomal beta-oxidation. ELOVL6 is involved in the elongation of fatty acids, and FABP4 is involved in the transport of fatty acids.

Oxidative Phosphorylation:
Key proteins involved in oxidative phosphorylation include ATP5PO, COX6A1, COX7B, COX8A, CYC1, NDUFA5, NDUFAB1, NDUFB7, NDUFS3, SDHB, SDHC, and UQCR10. These proteins are part of the electron transport chain (ETC) and are responsible for the generation of ATP through the transfer of electrons. For example, COX6A1, COX7B, and COX8A are subunits of cytochrome c oxidase, the final enzyme in the ETC. NDUFA5, NDUFAB1, NDUFB7, and NDUFS3 are subunits of NADH dehydrogenase (complex I), while SDHB and SDHC are subunits of succinate dehydrogenase (complex II). UQCR10 is a subunit of ubiquinol-cytochrome c reductase (complex III).

Additionally, proteins such as AIFM1, AK2, ALDH2, and CAT are involved in maintaining cellular redox balance and preventing oxidative stress. AIFM1 is an oxidoreductase that can protect cells from oxidative stress, while AK2 is involved in the regulation of cellular energy metabolism. ALDH2 is involved in the detoxification of aldehydes, and CAT is an antioxidant enzyme that catalyzes the decomposition of hydrogen peroxide.

In conclusion, the most prominent biological process performed by this system of interacting proteins is fatty acid metabolism and oxidative phosphorylation, which are essential for energy production and storage in cells. The proteins involved in these processes also play a role in maintaining cellular redox balance and preventing oxidative stress."	24	12	"The primary biological process performed by this system of interacting proteins is fatty acid metabolism and oxidative phosphorylation. The proteins involved in these processes are essential for energy production and storage in cells.

Key proteins involved in fatty acid metabolism include ACADM, ACADS, ACAA2, ACADL, ACOX1, ELOVL6, FABP4, and CPT2. These proteins are involved in the breakdown of fatty acids (beta-oxidation) and the synthesis of fatty acids (elongation). For example, ACADM and ACADS are involved in the breakdown of medium-chain and short-chain fatty acids, respectively, while ACOX1 is involved in peroxisomal beta-oxidation. ELOVL6 is involved in the elongation of fatty acids, and FABP4 is involved in the transport of fatty acids.[1][2][3]

Key proteins involved in oxidative phosphorylation include ATP5PO, COX6A1, COX7B, COX8A, CYC1, NDUFA5, NDUFAB1, NDUFB7, NDUFS3, SDHB, SDHC, and UQCR10. These proteins are part of the electron transport chain (ETC) and are responsible for the generation of ATP through the transfer of electrons. For example, COX6A1, COX7B, and COX8A are subunits of cytochrome c oxidase, the final enzyme in the ETC. NDUFA5, NDUFAB1, NDUFB7, and NDUFS3 are subunits of NADH dehydrogenase (complex I), while SDHB and SDHC are subunits of succinate dehydrogenase (complex II). UQCR10 is a subunit of ubiquinol-cytochrome c reductase (complex III).[4][5][6]

Additionally, proteins such as AIFM1, AK2, ALDH2, and CAT are involved in maintaining cellular redox balance and preventing oxidative stress. AIFM1 is an oxidoreductase that can protect cells from oxidative stress, while AK2 is involved in the regulation of cellular energy metabolism. ALDH2 is involved in the detoxification of aldehydes, and CAT is an antioxidant enzyme that catalyzes the decomposition of hydrogen peroxide.[7][8][9]

In conclusion, the most prominent biological process performed by this system of interacting proteins is fatty acid metabolism and oxidative phosphorylation, which are essential for energy production and storage in cells. The proteins involved in these processes also play a role in maintaining cellular redox balance and preventing oxidative stress.

========================================================================================================================================================================================================
[1] Matsuzaka, Takashi, Shimano, Hitoshi. ""Elovl6: a new player in fatty acid metabolism and insulin sensitivity."" Journal of molecular medicine (Berlin, Germany), 2009, pp. 379-84.
[2] Dessein, Anne-Frédérique, Fontaine, Monique, Joncquel-Chevalier Curt, Marie, Briand, Gilbert, Sechter, Claire, Mention-Mulliez, Karine, Dobbelaere, Dries, Douillard, Claire, Lacour, Arnaud, Redonnet-Vernhet, Isabelle, Lamireau, Delphine, Barth, Magalie, Minot-Myhié, Marie-Christine, Kuster, Alice, de Lonlay, Pascale, Gregersen, Niels, Acquaviva, Cécile, Vianey-Saban, Christine, Vamecq, Joseph. ""Fluxomic evidence for impaired contribution of short-chain acyl-CoA dehydrogenase to mitochondrial palmitate β-oxidation in symptomatic patients with ACADS gene susceptibility variants."" Clinica chimica acta; international journal of clinical chemistry, 2017, pp. 101-106.
[3] Liu, Guanjie, Chang, Ling, Qian, Yihan, Lin, Jiacheng, Shang, Zhi, Xu, Min, Wang, Fang, Sun, Xuehua, Jiang, Yun, Gao, Yueqiu, Kong, Xiaoni. ""Quantitative proteomics reveals <i>Polygonum perfoliatum L.</i> ameliorates hepatic steatosis by promoting PPARs/CPT1A/CPT2-mediated fatty acid β-oxidation."" Frontiers in pharmacology, 2023, pp. 1016129.
[4] Wang, HaiXia, Luo, JunTao, Tian, WenXia, Yan, WenQing, Ge, Sheng, Zhang, YaHui, Sun, WenGuang. ""γ-Tocotrienol inhibits oxidative phosphorylation and triggers apoptosis by inhibiting mitochondrial complex I subunit NDUFB8 and complex II subunit SDHB."" Toxicology, 2019, pp. 42-53.
[5] Elswood, Jessica, Pearson, Scott J, Payne, H Ross, Barhoumi, Rola, Rijnkels, Monique, W Porter, Weston. ""Autophagy regulates functional differentiation of mammary epithelial cells."" Autophagy, 2021, pp. 420-438.
[6] Kim, Sup, Lee, June-Young, Shin, Seul Gi, Kim, Jin Kyung, Silwal, Prashanta, Kim, Young Jae, Shin, Na-Ri, Kim, Pil Soo, Won, Minho, Lee, Sang-Hee, Kim, Soo Yeon, Sasai, Miwa, Yamamoto, Masahiro, Kim, Jin-Man, Bae, Jin-Woo, Jo, Eun-Kyeong. ""ESRRA (estrogen related receptor alpha) is a critical regulator of intestinal homeostasis through activation of autophagic flux via gut microbiota."" Autophagy, 2021, pp. 2856-2875.
[7] He, Mengshan, Long, Pan, Chen, Tao, Li, Kaifeng, Wei, Dongyu, Zhang, Yufei, Wang, Wenjun, Hu, Yonghe, Ding, Yi, Wen, Aidong. ""ALDH2/SIRT1 Contributes to Type 1 and Type 2 Diabetes-Induced Retinopathy through Depressing Oxidative Stress."" Oxidative medicine and cellular longevity, 2021, pp. 1641717.
[8] Rissone, Alberto, Weinacht, Katja Gabriele, la Marca, Giancarlo, Bishop, Kevin, Giocaliere, Elisa, Jagadeesh, Jayashree, Felgentreff, Kerstin, Dobbs, Kerry, Al-Herz, Waleed, Jones, Marypat, Chandrasekharappa, Settara, Kirby, Martha, Wincovitch, Stephen, Simon, Karen Lyn, Itan, Yuval, DeVine, Alex, Schlaeger, Thorsten, Schambach, Axel, Sood, Raman, Notarangelo, Luigi D, Candotti, Fabio. ""Reticular dysgenesis-associated AK2 protects hematopoietic stem and progenitor cell development from oxidative stress."" The Journal of experimental medicine, 2015, pp. 1185-202.
[9] Gao, Yawen, Xu, Yan, Hua, Songwen, Zhou, Shenghua, Wang, Kangkai. ""ALDH2 attenuates Dox-induced cardiotoxicity by inhibiting cardiac apoptosis and oxidative stress."" International journal of clinical and experimental medicine, 2015, pp. 6794-803.
"	0.43707296	0.4533456	Tied	LLM	NA
Diff. expressed gene set	ALLOGRAFT REJECTION	NA	AARS1 ABCE1 ABI1 ACHE ACVR2A AKT1 APBB1 B2M BCAT1 BCL10 BCL3 BRCA1 C2 CAPG CARTPT CCL11 CCL13 CCL19 CCL2 CCL22 CCL4 CCL5 CCL7 CCND2 CCND3 CCR1 CCR2 CCR5 CD1D CD2 CD247 CD28 CD3D CD3E CD3G CD4 CD40 CD40LG CD47 CD7 CD74 CD79A CD80 CD86 CD8A CD8B CD96 CDKN2A CFP CRTAM CSF1 CSK CTSS CXCL13 CXCL9 CXCR3 DARS1 DEGS1 DYRK3 EGFR EIF3A EIF3D EIF3J EIF4G3 EIF5A ELANE ELF4 EREG ETS1 F2 F2R FAS FASLG FCGR2B FGR FLNA FYB1 GALNT1 GBP2 GCNT1 GLMN GPR65 GZMA GZMB HCLS1 HDAC9 HIF1A HLA-A HLA-DMA HLA-DMB HLA-DOA HLA-DOB HLA-DQA1 HLA-DRA HLA-E HLA-G ICAM1 ICOSLG IFNAR2 IFNG IFNGR1 IFNGR2 IGSF6 IKBKB IL10 IL11 IL12A IL12B IL12RB1 IL13 IL15 IL16 IL18 IL18RAP IL1B IL2 IL27RA IL2RA IL2RB IL2RG IL4 IL4R IL6 IL7 IL9 INHBA INHBB IRF4 IRF7 IRF8 ITGAL ITGB2 ITK JAK2 KLRD1 KRT1 LCK LCP2 LIF LTB LY75 LY86 LYN MAP3K7 MAP4K1 MBL2 MMP9 MRPL3 MTIF2 NCF4 NCK1 NCR1 NLRP3 NME1 NOS2 NPM1 PF4 PRF1 PRKCB PRKCG PSMB10 PTPN6 PTPRC RARS1 RIPK2 RPL39 RPL3L RPL9 RPS19 RPS3A RPS9 SIT1 SOCS1 SOCS5 SPI1 SRGN ST8SIA4 STAB1 STAT1 STAT4 TAP1 TAP2 TAPBP TGFB1 TGFB2 THY1 TIMP1 TLR1 TLR2 TLR3 TLR6 TNF TPD52 TRAF2 TRAT1 UBE2D1 UBE2N WARS1 WAS ZAP70	200	7.643856189774724	Positive Regulation Of Cytokine Production 	GO:0001819	CD86;ITK;CD40;CD80;BRCA1;TNF;IL12B;IL12A;JAK2;MAP3K7;CCR2;MBL2;IL10;IL15;RIPK2;IL13;F2R;IL18;IL16;TRAF2;HLA-A;HLA-G;EREG;HLA-E;TLR1;FGR;IFNG;IRF4;IL1B;IRF7;TLR6;LTB;TLR3;TLR2;BCL10;HIF1A;NLRP3;CCL19;IL12RB1;ELANE;CD74;TGFB1;NOS2;CRTAM;GLMN;IL2;CD2;IL4;CD4;IL6;PTPRC;CD40LG;IL7;IL9;CD28	55	27.500000000000004	1.4899999999999999e-52	3.09e-49	Immune Response Regulation	"The system of interacting proteins primarily performs the regulation of immune response. The proteins involved in this system can be categorized into several groups based on their functions:

1. Cytokines and their receptors: IL10, IL11, IL12A, IL12B, IL12RB1, IL13, IL15, IL16, IL18, IL18RAP, IL1B, IL2, IL27RA, IL2RA, IL2RB, IL2RG, IL4, IL4R, IL6, IL7, IL9, IFNAR2, IFNG, IFNGR1, IFNGR2, LIF, and TNF. These proteins are responsible for cell signaling and communication, which are essential for immune response regulation.

2. Chemokines and their receptors: CCL11, CCL13, CCL19, CCL2, CCL22, CCL4, CCL5, CCL7, CCND2, CCND3, CCR1, CCR2, CCR5, CXCL13, CXCL9, and CXCR3. These proteins are involved in the recruitment and migration of immune cells to the site of infection or inflammation.

3. T cell activation and signaling: CD2, CD247, CD28, CD3D, CD3E, CD3G, CD4, CD40, CD40LG, CD7, CD8A, CD8B, CD96, CRTAM, ICOSLG, ITGAL, ITGB2, LCK, LCP2, ZAP70, and TRAT1. These proteins play a crucial role in the activation and regulation of T cells, which are essential for adaptive immune response.

4. Antigen presentation and processing: B2M, CD1D, HLA-A, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DQA1, HLA-DRA, HLA-E, HLA-G, TAP1, TAP2, and TAPBP. These proteins are involved in the presentation of antigens to T cells, which is a critical step in the initiation of adaptive immune response.

5. Innate immune response: CD47, F2R, FAS, FASLG, FCGR2B, NCR1, TLR1, TLR2, TLR3, and TLR6. These proteins are involved in the recognition and response to pathogens, which is essential for the activation of the immune system.

6. Signal transduction and transcription factors: AKT1, EGFR, ETS1, FGR, HIF1A, IKBKB, IRF4, IRF7, IRF8, JAK2, LYN, MAP3K7, MAP4K1, NCK1, PRKCB, PRKCG, PTPN6, PTPRC, SOCS1, SOCS5, STAT1, and STAT4. These proteins are involved in the transduction of signals from the cell surface to the nucleus, leading to the activation of transcription factors and the regulation of gene expression.

7. Proteases and inhibitors: ACHE, CTSS, ELANE, GZMA, GZMB, MMP9, PRF1, and TIMP1. These proteins are involved in the degradation of extracellular matrix and the regulation of immune cell migration and activation.

In conclusion, the most prominent biological process performed by this system of interacting proteins is the regulation of immune response, which involves the coordination of various cellular processes such as cell signaling, antigen presentation, T cell activation, and innate immune response."	119	59.5	"The system of interacting proteins primarily performs the regulation of immune response. The proteins involved in this system can be categorized into several groups based on their functions:

1. Cytokines and their receptors: IL10, IL11, IL12A, IL12B, IL12RB1, IL13, IL15, IL16, IL18, IL18RAP, IL1B, IL2, IL27RA, IL2RA, IL2RB, IL2RG, IL4, IL4R, IL6, IL7, IL9, IFNAR2, IFNG, IFNGR1, IFNGR2, LIF, and TNF. These proteins are responsible for cell signaling and communication, which are essential for immune response regulation.[1][2][3]

2. Chemokines and their receptors: CCL11, CCL13, CCL19, CCL2, CCL22, CCL4, CCL5, CCL7, CCND2, CCND3, CCR1, CCR2, CCR5, CXCL13, CXCL9, and CXCR3. These proteins are involved in the recruitment and migration of immune cells to the site of infection or inflammation.[4][5][6]

3. T cell activation and signaling: CD2, CD247, CD28, CD3D, CD3E, CD3G, CD4, CD40, CD40LG, CD7, CD8A, CD8B, CD96, CRTAM, ICOSLG, ITGAL, ITGB2, LCK, LCP2, ZAP70, and TRAT1. These proteins play a crucial role in the activation and regulation of T cells, which are essential for adaptive immune response.[7][8][9]

4. Antigen presentation and processing: B2M, CD1D, HLA-A, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DQA1, HLA-DRA, HLA-E, HLA-G, TAP1, TAP2, and TAPBP. These proteins are involved in the presentation of antigens to T cells, which is a critical step in the initiation of adaptive immune response.[10][11][12]

5. Innate immune response: CD47, F2R, FAS, FASLG, FCGR2B, NCR1, TLR1, TLR2, TLR3, and TLR6. These proteins are involved in the recognition and response to pathogens, which is essential for the activation of the immune system.[13][14][15]

6. Signal transduction and transcription factors: AKT1, EGFR, ETS1, FGR, HIF1A, IKBKB, IRF4, IRF7, IRF8, JAK2, LYN, MAP3K7, MAP4K1, NCK1, PRKCB, PRKCG, PTPN6, PTPRC, SOCS1, SOCS5, STAT1, and STAT4. These proteins are involved in the transduction of signals from the cell surface to the nucleus, leading to the activation of transcription factors and the regulation of gene expression.[16][17][18]

7. Proteases and inhibitors: ACHE, CTSS, ELANE, GZMA, GZMB, MMP9, PRF1, and TIMP1. These proteins are involved in the degradation of extracellular matrix and the regulation of immune cell migration and activation.[19][20][21]

In conclusion, the most prominent biological process performed by this system of interacting proteins is the regulation of immune response, which involves the coordination of various cellular processes such as cell signaling, antigen presentation, T cell activation, and innate immune response.

========================================================================================================================================================================================================
[1] Bergamaschi, Cristina, Terpos, Evangelos, Rosati, Margherita, Angel, Matthew, Bear, Jenifer, Stellas, Dimitris, Karaliota, Sevasti, Apostolakou, Filia, Bagratuni, Tina, Patseas, Dimitris, Gumeni, Sentiljana, Trougakos, Ioannis P, Dimopoulos, Meletios A, Felber, Barbara K, Pavlakis, George N. ""Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients."" Cell reports, 2021, pp. 109504.
[2] Lobo-Silva, Diogo, Carriche, Guilhermina M, Castro, A Gil, Roque, Susana, Saraiva, Margarida. ""Balancing the immune response in the brain: IL-10 and its regulation."" Journal of neuroinflammation, 2016, pp. 297.
[3] Moatti, Audrey, Cohen, José L. ""The TNF-α/TNFR2 Pathway: Targeting a Brake to Release the Anti-tumor Immune Response."" Frontiers in cell and developmental biology, 2021, pp. 725473.
[4] De la Fuente López, Marjorie, Landskron, Glauben, Parada, Daniela, Dubois-Camacho, Karen, Simian, Daniela, Martinez, Maripaz, Romero, Diego, Roa, Juan Carlos, Chahuán, Isidora, Gutiérrez, Rocío, Lopez-K, Francisco, Alvarez, Karin, Kronberg, Udo, López, Sebastian, Sanguinetti, Antonella, Moreno, Natalia, Abedrapo, Mario, González, María-Julieta, Quera, Rodrigo, Hermoso-R, Marcela A. ""The relationship between chemokines CCL2, CCL3, and CCL4 with the tumor microenvironment and tumor-associated macrophage markers in colorectal cancer."" Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2018, pp. 1010428318810059.
[5] Shao, Zhehua, Tan, Yangxia, Shen, Qingya, Hou, Li, Yao, Bingpeng, Qin, Jiao, Xu, Peiyu, Mao, Chunyou, Chen, Li-Nan, Zhang, Huibing, Shen, Dan-Dan, Zhang, Chao, Li, Weijie, Du, Xufei, Li, Fei, Chen, Zhi-Hua, Jiang, Yi, Xu, H Eric, Ying, Songmin, Ma, Honglei, Zhang, Yan, Shen, Huahao. ""Molecular insights into ligand recognition and activation of chemokine receptors CCR2 and CCR3."" Cell discovery, 2022, pp. 44.
[6] Basova, Liana, Najera, Julia A, Bortell, Nikki, Wang, Di, Moya, Rosita, Lindsey, Alexander, Semenova, Svetlana, Ellis, Ronald J, Marcondes, Maria Cecilia Garibaldi. ""Dopamine and its receptors play a role in the modulation of CCR5 expression in innate immune cells following exposure to Methamphetamine: Implications to HIV infection."" PloS one, 2018, pp. e0199861.
[7] Zhou, Yunfeng, Zhang, Haibo, Yao, Yao, Zhang, Xiaoyan, Guan, Youfei, Zheng, Feng. ""CD4<sup>+</sup> T cell activation and inflammation in NASH-related fibrosis."" Frontiers in immunology, 2022, pp. 967410.
[8] Wu, Jun, Li, Gen, Li, Le, Li, Dan, Dong, Zhongjun, Jiang, Peng. ""Asparagine enhances LCK signalling to potentiate CD8<sup>+</sup> T-cell activation and anti-tumour responses."" Nature cell biology, 2021, pp. 75-86.
[9] Wilkens, Alec B, Fulton, Elena C, Pont, Margot J, Cole, Gabriel O, Leung, Isabel, Stull, Sylvia M, Hart, Matthew R, Bernstein, Irwin D, Furlan, Scott N, Riddell, Stanley R. ""NOTCH1 signaling during CD4+ T-cell activation alters transcription factor networks and enhances antigen responsiveness."" Blood, 2022, pp. 2261-2275.
[10] Melum, Espen, Jiang, Xiaojun, Baker, Kristi D, Macedo, M Fatima, Fritsch, Jürgen, Dowds, C Marie, Wang, Jing, Pharo, Anne, Kaser, Arthur, Tan, Corey, Pereira, Catia S, Kelly, Samuel L, Duan, Jingjing, Karlsen, Tom H, Exley, Mark A, Schütze, Stefan, Zajonc, Dirk M, Merrill, Alfred H, Schuchman, Edward H, Zeissig, Sebastian, Blumberg, Richard S. ""Control of CD1d-restricted antigen presentation and inflammation by sphingomyelin."" Nature immunology, 2019, pp. 1644-1655.
[11] McEwen-Smith, Rosanna M, Salio, Mariolina, Cerundolo, Vincenzo. ""CD1d-dependent endogenous and exogenous lipid antigen presentation."" Current opinion in immunology, 2015, pp. 116-25.
[12] Pietra, Gabriella, Romagnani, Chiara, Manzini, Claudia, Moretta, Lorenzo, Mingari, Maria Cristina. ""The emerging role of HLA-E-restricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumors."" Journal of biomedicine & biotechnology, 2010, pp. 907092.
[13] Zhang, Qiong, Zhang, Xujun, Lei, Xiaobo, Wang, Hai, Jiang, Jingjing, Wang, Yuchong, Bi, Kefan, Diao, Hongyan. ""Influenza A virus NS1 protein hijacks YAP/TAZ to suppress TLR3-mediated innate immune response."" PLoS pathogens, 2022, pp. e1010505.
[14] Ye, Wen, Hu, Ming-Ming, Lei, Cao-Qi, Zhou, Qian, Lin, Heng, Sun, Ming-Shun, Shu, Hong-Bing. ""TRIM8 Negatively Regulates TLR3/4-Mediated Innate Immune Response by Blocking TRIF-TBK1 Interaction."" Journal of immunology (Baltimore, Md. : 1950), 2017, pp. 1856-1864.
[15] Naghib, Maryam, Kariminik, Ashraf, Kazemi Arababadi, Mohammad. ""TLR2, as a Pathogen Recognition Receptor, Plays Critical Roles in Hepatitis B Outcome."" Viral immunology, 2022, pp. 15-23.
[16] Pawinwongchai, Jaturawat, Jangprasert, Panchalee, Nilsri, Nungruthai, Israsena, Nipan, Rojnuckarin, Ponlapat. ""Mutated JAK2 signal transduction in human induced pluripotent stem cell (iPSC)-derived megakaryocytes."" Platelets, 2022, pp. 700-708.
[17] Woś, Marcin, Bandorowicz-Pikuła, Joanna. ""[Participation of annexins in endocytosis and EGFR-mediated signal transduction]."" Postepy biochemii, 2014, pp. 55-61.
[18] Yashiro, Takuya, Yamaguchi, Masaki, Watanuki, Yumi, Kasakura, Kazumi, Nishiyama, Chiharu. ""The Transcription Factors PU.1 and IRF4 Determine Dendritic Cell-Specific Expression of RALDH2."" Journal of immunology (Baltimore, Md. : 1950), 2018, pp. 3677-3682.
[19] Luo, Chun-Hua, Shi, Yu, Liu, Yu-Qi, Liu, Qing, Mao, Min, Luo, Min, Yang, Kai-Di, Wang, Wen-Ying, Chen, Cong, Niu, Qin, Yan, Ze-Xuan, Miao, Jing-Ya, Zhang, Xiao-Ning, Zeng, Hui, Li, Lei, Bian, Xiu-Wu, Ping, Yi-Fang. ""High levels of TIMP1 are associated with increased extracellular matrix stiffness in isocitrate dehydrogenase 1-wild type gliomas."" Laboratory investigation; a journal of technical methods and pathology, 2022, pp. 1304-1313.
[20] Reininghaus, Eva Z, Lackner, Nina, Birner, Armin, Bengesser, Susanne, Fellendorf, Frederike T, Platzer, Martina, Rieger, Alexandra, Queissner, Robert, Kainzbauer, Nora, Reininghaus, Bernd, McIntyre, Roger S, Mangge, Harald, Zelzer, Sieglinde, Fuchs, Dietmar, Dejonge, Silvia, Müller, Norbert. ""Extracellular matrix proteins matrix metallopeptidase 9 (MMP9) and soluble intercellular adhesion molecule 1 (sICAM-1) and correlations with clinical staging in euthymic bipolar disorder."" Bipolar disorders, 2016, pp. 155-63.
[21] Barton, Paul J R, Birks, Emma J, Felkin, Leanne E, Cullen, Martin E, Koban, Maren U, Yacoub, Magdi H. ""Increased expression of extracellular matrix regulators TIMP1 and MMP1 in deteriorating heart failure."" The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2003, pp. 738-44.
"	0.43272007	0.18633658	LLM	LLM	NA
Diff. expressed gene set	ANDROGEN RESPONSE	NA	ABCC4 ABHD2 ACSL3 ACTN1 ADAMTS1 ADRM1 AKAP12 AKT1 ALDH1A3 ANKH APPBP2 ARID5B AZGP1 B2M B4GALT1 BMPR1B CAMKK2 CCND1 CCND3 CDC14B CDK6 CENPN DBI DHCR24 DNAJB9 ELK4 ELL2 ELOVL5 FADS1 FKBP5 GNAI3 GPD1L GSR GUCY1A1 H1-0 HERC3 HMGCR HMGCS1 HOMER2 HPGD HSD17B14 IDI1 INPP4B INSIG1 IQGAP2 ITGAV KLK2 KLK3 KRT19 KRT8 LIFR LMAN1 MAF MAK MAP7 MERTK MYL12A NCOA4 NDRG1 NGLY1 NKX3-1 PA2G4 PDLIM5 PGM3 PIAS1 PLPP1 PMEPA1 PTK2B PTPN21 RAB4A RPS6KA3 RRP12 SAT1 SCD SEC24D SELENOP SGK1 SLC26A2 SLC38A2 SMS SORD SPCS3 SPDEF SRF SRP19 STEAP4 STK39 TARP TMEM50A TMPRSS2 TNFAIP8 TPD52 TSC22D1 UAP1 UBE2I UBE2J1 VAPA XRCC5 XRCC6 ZBTB10 ZMIZ1	101	6.658211482751795	Androgen Receptor Signaling Pathway 	GO:0030521	ZMIZ1;PMEPA1;PLPP1;NKX3-1	4	3.96039603960396	1.39e-6	8.23331e-4	Lipid Metabolism and Cellular Stress Response Regulation	"The primary biological process performed by this system of interacting proteins is the regulation of lipid metabolism and cellular stress response. The proteins involved in this process are:

1. ACSL3: Acyl-CoA synthetase long-chain family member 3, involved in fatty acid metabolism by catalyzing the formation of acyl-CoA from fatty acids.
2. DHCR24: 24-dehydrocholesterol reductase, involved in cholesterol biosynthesis by converting desmosterol to cholesterol.
3. ELOVL5: Elongation of very long-chain fatty acids protein 5, involved in the elongation of long-chain fatty acids.
4. FADS1: Fatty acid desaturase 1, involved in the synthesis of polyunsaturated fatty acids.
5. HMGCR: 3-hydroxy-3-methylglutaryl-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis.
6. HMGCS1: 3-hydroxy-3-methylglutaryl-CoA synthase 1, involved in the early steps of cholesterol biosynthesis.
7. IDI1: Isopentenyl-diphosphate delta-isomerase 1, involved in the synthesis of isoprenoids, which are precursors for cholesterol and other lipids.
8. INPP4B: Inositol polyphosphate-4-phosphatase type II, involved in phosphoinositide signaling and regulation of lipid metabolism.
9. SCD: Stearoyl-CoA desaturase, involved in the synthesis of monounsaturated fatty acids.
10. SELENOP: Selenoprotein P, involved in selenium transport and protection against oxidative stress.

Additionally, several proteins in this system are involved in cellular stress response regulation:

1. DNAJB9: DnaJ homolog subfamily B member 9, involved in protein folding and protection against cellular stress.
2. FKBP5: FK506-binding protein 5, involved in the regulation of glucocorticoid receptor signaling and cellular stress response.
3. GSR: Glutathione reductase, involved in maintaining cellular redox balance and protection against oxidative stress.
4. H1-0: Histone H1.0, involved in chromatin structure and regulation of gene expression in response to cellular stress.
5. NDRG1: N-myc downstream-regulated gene 1, involved in cellular stress response and regulation of cell growth and differentiation.
6. SGK1: Serum/glucocorticoid-regulated kinase 1, involved in cellular stress response and regulation of ion transport and cell survival.

These proteins work together to maintain lipid homeostasis and protect cells from various stressors, such as oxidative stress and misfolded proteins. The interactions between these proteins allow for the fine-tuning of lipid metabolism and stress response pathways, ensuring proper cellular function and adaptation to changing conditions."	16	15.84158415841584	"The primary biological process performed by this system of interacting proteins is the regulation of lipid metabolism and cellular stress response. The proteins involved in this process are:

1. ACSL3: Acyl-CoA synthetase long-chain family member 3, involved in fatty acid metabolism by catalyzing the formation of acyl-CoA from fatty acids.[1][2][3]

2. DHCR24: 24-dehydrocholesterol reductase, involved in cholesterol biosynthesis by converting desmosterol to cholesterol.[4][5][6]

3. ELOVL5: Elongation of very long-chain fatty acids protein 5, involved in the elongation of long-chain fatty acids.[7][8][9]

4. FADS1: Fatty acid desaturase 1, involved in the synthesis of polyunsaturated fatty acids.[10][11][12]

5. HMGCR: 3-hydroxy-3-methylglutaryl-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis.[13][14][15]

6. HMGCS1: 3-hydroxy-3-methylglutaryl-CoA synthase 1, involved in the early steps of cholesterol biosynthesis.[16][17][18]

7. IDI1: Isopentenyl-diphosphate delta-isomerase 1, involved in the synthesis of isoprenoids, which are precursors for cholesterol and other lipids.[19][20][21]

8. INPP4B: Inositol polyphosphate-4-phosphatase type II, involved in phosphoinositide signaling and regulation of lipid metabolism.[22][23][24]

9. SCD: Stearoyl-CoA desaturase, involved in the synthesis of monounsaturated fatty acids.[25][26][27]

10. SELENOP: Selenoprotein P, involved in selenium transport and protection against oxidative stress.[28][29][30]

Additionally, several proteins in this system are involved in cellular stress response regulation:

1. DNAJB9: DnaJ homolog subfamily B member 9, involved in protein folding and protection against cellular stress.[31][32][33]

2. FKBP5: FK506-binding protein 5, involved in the regulation of glucocorticoid receptor signaling and cellular stress response.[34][35][36]

3. GSR: Glutathione reductase, involved in maintaining cellular redox balance and protection against oxidative stress.[37][38][39]

4. H1-0: Histone H1.0, involved in chromatin structure and regulation of gene expression in response to cellular stress.[40][41][42]

5. NDRG1: N-myc downstream-regulated gene 1, involved in cellular stress response and regulation of cell growth and differentiation.[43][44][45]

6. SGK1: Serum/glucocorticoid-regulated kinase 1, involved in cellular stress response and regulation of ion transport and cell survival.[46][47][48]

These proteins work together to maintain lipid homeostasis and protect cells from various stressors, such as oxidative stress and misfolded proteins. The interactions between these proteins allow for the fine-tuning of lipid metabolism and stress response pathways, ensuring proper cellular function and adaptation to changing conditions.

========================================================================================================================================================================================================
[1] Ansari, Israr-Ul H, Longacre, Melissa J, Stoker, Scott W, Kendrick, Mindy A, O'Neill, Lucas M, Zitur, Laura J, Fernandez, Luis A, Ntambi, James M, MacDonald, Michael J. ""Characterization of Acyl-CoA synthetase isoforms in pancreatic beta cells: Gene silencing shows participation of ACSL3 and ACSL4 in insulin secretion."" Archives of biochemistry and biophysics, 2017, pp. 32-43.
[2] Weedon-Fekjaer, M Susanne, Dalen, Knut Tomas, Solaas, Karianne, Staff, Anne Cathrine, Duttaroy, Asim K, Nebb, Hilde Irene. ""Activation of LXR increases acyl-CoA synthetase activity through direct regulation of ACSL3 in human placental trophoblast cells."" Journal of lipid research, 2010, pp. 1886-96.
[3] Quan, Jing, Bode, Ann M, Luo, Xiangjian. ""ACSL family: The regulatory mechanisms and therapeutic implications in cancer."" European journal of pharmacology, 2021, pp. 174397.
[4] Shen, Yajie, Zhou, Jingqi, Nie, Kui, Cheng, Shuhua, Chen, Zhengming, Wang, Wenhan, Wei, Weiqing, Jiang, Daiji, Peng, Zijing, Ren, Yizhuo, Zhang, Yirong, Fan, Qiuju, Richards, Kristy L, Qi, Yitao, Cheng, Jinke, Tam, Wayne, Ma, Jiao. ""Oncogenic role of the SOX9-DHCR24-cholesterol biosynthesis axis in IGH-BCL2+ diffuse large B-cell lymphomas."" Blood, 2022, pp. 73-86.
[5] Wu, Jie, Guo, Ling, Qiu, Xiaoran, Ren, Yong, Li, Feifei, Cui, Wei, Song, Shaojiang. ""Genkwadaphnin inhibits growth and invasion in hepatocellular carcinoma by blocking DHCR24-mediated cholesterol biosynthesis and lipid rafts formation."" British journal of cancer, 2020, pp. 1673-1685.
[6] Drzewińska, Joanna, Pułaski, Lukasz, Soszyński, Mirosław, Bartosz, Grzegorz. ""[Seladin-1/DHCR24: a key protein of cell homeostasis and cholesterol biosynthesis]."" Postepy higieny i medycyny doswiadczalnej (Online), 2009, pp. 318-30.
[7] Nitta, Satoshi, Kandori, Shuya, Tanaka, Ken, Sakka, Shotaro, Siga, Masanobu, Nagumo, Yoshiyuki, Negoro, Hiromitsu, Kojima, Takahiro, Mathis, Bryan J, Shimazui, Toru, Miyamoto, Takafumi, Matsuzaka, Takashi, Shimano, Hitoshi, Nishiyama, Hiroyuki. ""ELOVL5-mediated fatty acid elongation promotes cellular proliferation and invasion in renal cell carcinoma."" Cancer science, 2022, pp. 2738-2752.
[8] Robichaud, Philippe-Pierre, Munganyiki, Jean Eric, Boilard, Eric, Surette, Marc E. ""Polyunsaturated fatty acid elongation and desaturation in activated human T-cells: ELOVL5 is the key elongase."" Journal of lipid research, 2018, pp. 2383-2396.
[9] Gregory, Melissa K, Cleland, Leslie G, James, Michael J. ""Molecular basis for differential elongation of omega-3 docosapentaenoic acid by the rat Elovl5 and Elovl2."" Journal of lipid research, 2013, pp. 2851-7.
[10] Heravi, Gioia, Jang, Hyejeong, Wang, Xiaokun, Long, Ze, Peng, Zheyun, Kim, Seongho, Liu, Wanqing. ""Fatty acid desaturase 1 (FADS1) is a cancer marker for patient survival and a potential novel target for precision cancer treatment."" Frontiers in oncology, 2022, pp. 942798.
[11] Gromovsky, Anthony D, Schugar, Rebecca C, Brown, Amanda L, Helsley, Robert N, Burrows, Amy C, Ferguson, Daniel, Zhang, Renliang, Sansbury, Brian E, Lee, Richard G, Morton, Richard E, Allende, Daniela S, Parks, John S, Spite, Matthew, Brown, J Mark. ""Δ-5 Fatty Acid Desaturase <i>FADS1</i> Impacts Metabolic Disease by Balancing Proinflammatory and Proresolving Lipid Mediators."" Arteriosclerosis, thrombosis, and vascular biology, 2018, pp. 218-231.
[12] Wang, Zhen, Park, Hui Gyu, Wang, Dong Hao, Kitano, Riki, Kothapalli, Kumar S D, Brenna, J Thomas. ""Fatty acid desaturase 2 (FADS2) but not FADS1 desaturates branched chain and odd chain saturated fatty acids."" Biochimica et biophysica acta. Molecular and cell biology of lipids, 2020, pp. 158572.
[13] Lu, Xiao-Yi, Shi, Xiong-Jie, Hu, Ao, Wang, Ju-Qiong, Ding, Yi, Jiang, Wei, Sun, Ming, Zhao, Xiaolu, Luo, Jie, Qi, Wei, Song, Bao-Liang. ""Feeding induces cholesterol biosynthesis via the mTORC1-USP20-HMGCR axis."" Nature, 2020, pp. 479-484.
[14] Loregger, Anke, Raaben, Matthijs, Tan, Josephine, Scheij, Saskia, Moeton, Martina, van den Berg, Marlene, Gelberg-Etel, Hila, Stickel, Elmer, Roitelman, Joseph, Brummelkamp, Thijn, Zelcer, Noam. ""Haploid Mammalian Genetic Screen Identifies UBXD8 as a Key Determinant of HMGCR Degradation and Cholesterol Biosynthesis."" Arteriosclerosis, thrombosis, and vascular biology, 2017, pp. 2064-2074.
[15] Cánovas, A, Quintanilla, R, Gallardo, D, Díaz, I, Noguera, J L, Ramírez, O, Pena, R N. ""Functional and association studies on the pig HMGCR gene, a cholesterol-synthesis limiting enzyme."" Animal : an international journal of animal bioscience, 2010, pp. 224-33.
[16] Ma, Xiaoyao, Bai, Yongping, Liu, Kaixin, Han, Yiman, Zhang, Jinling, Liu, Yuteng, Hou, Xiaotao, Hao, Erwei, Hou, Yuanyuan, Bai, Gang. ""Ursolic acid inhibits the cholesterol biosynthesis and alleviates high fat diet-induced hypercholesterolemia via irreversible inhibition of HMGCS1 in vivo."" Phytomedicine : international journal of phytotherapy and phytopharmacology, 2022, pp. 154233.
[17] Zhou, Cheng, Li, Jue, Du, Juan, Jiang, Xinya, Xu, Xuejun, Liu, Yi, He, Qun, Liang, Hui, Fang, Peng, Zhan, Huien, Zeng, Hui. ""HMGCS1 drives drug-resistance in acute myeloid leukemia through endoplasmic reticulum-UPR-mitochondria axis."" Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, pp. 111378.
[18] Hirschey, Matthew D, Shimazu, Tadahiro, Capra, John A, Pollard, Katherine S, Verdin, Eric. ""SIRT1 and SIRT3 deacetylate homologous substrates: AceCS1,2 and HMGCS1,2."" Aging, 2011, pp. 635-42.
[19] Nakamura, Keiko, Mori, Fumiaki, Tanji, Kunikazu, Miki, Yasuo, Yamada, Masahito, Kakita, Akiyoshi, Takahashi, Hitoshi, Utsumi, Jun, Sasaki, Hidenao, Wakabayashi, Koichi. ""Isopentenyl diphosphate isomerase, a cholesterol synthesizing enzyme, is localized in Lewy bodies."" Neuropathology : official journal of the Japanese Society of Neuropathology, 2015, pp. 432-40.
[20] Han, Yuanji, Wang, Hongyun, Wang, Xiaodan, Li, Ke, Dong, Meifang, Li, Yong, Zhu, Qian, Shang, Fude. ""Mechanism of floral scent production in <i>Osmanthus fragrans</i> and the production and regulation of its key floral constituents, β-ionone and linalool."" Horticulture research, 2019, pp. 106.
[21] Guo, Xiao-Jing, Xiao, Wen-Hai, Wang, Ying, Yao, Ming-Dong, Zeng, Bo-Xuan, Liu, Hong, Zhao, Guang-Rong, Yuan, Ying-Jin. ""Metabolic engineering of <i>Saccharomyces cerevisiae</i> for 7-dehydrocholesterol overproduction."" Biotechnology for biofuels, 2018, pp. 192.
[22] Woolley, John F, Dzneladze, Irakli, Salmena, Leonardo. ""Phosphoinositide signaling in cancer: INPP4B Akt(s) out."" Trends in molecular medicine, 2015, pp. 530-2.
[23] Rijal, Sewa, Fleming, Shaun, Cummings, Nik, Rynkiewicz, Natalie K, Ooms, Lisa M, Nguyen, Nhu-Y N, Teh, Tse-Chieh, Avery, Sharon, McManus, Julie F, Papenfuss, Anthony T, McLean, Catriona, Guthridge, Mark A, Mitchell, Christina A, Wei, Andrew H. ""Inositol polyphosphate 4-phosphatase II (INPP4B) is associated with chemoresistance and poor outcome in AML."" Blood, 2015, pp. 2815-24.
[24] Yuen, Jessie Wai-Fong, Chung, Grace Tin-Yun, Lun, Samantha Wei-Man, Cheung, Chartia Ching-Mei, To, Ka-Fai, Lo, Kwok-Wai. ""Epigenetic inactivation of inositol polyphosphate 4-phosphatase B (INPP4B), a regulator of PI3K/AKT signaling pathway in EBV-associated nasopharyngeal carcinoma."" PloS one, 2014, pp. e105163.
[25] Hao, Zhiyun, Luo, Yuzhu, Wang, Jiqing, Hickford, Jon G H, Zhou, Huitong, Hu, Jiang, Liu, Xiu, Li, Shaobin, Shen, Jiyuan, Ke, Na, Liang, Weiwei, Huang, Zhaochun. ""MicroRNA-432 inhibits milk fat synthesis by targeting <i>SCD</i> and <i>LPL</i> in ovine mammary epithelial cells."" Food & function, 2021, pp. 9432-9442.
[26] Léger, Serge, Black, W Cameron, Deschenes, Denis, Dolman, Sarah, Falgueyret, Jean-Pierre, Gagnon, Marc, Guiral, Sébastien, Huang, Zheng, Guay, Jocelyne, Leblanc, Yves, Li, Chun-Sing, Massé, Frédéric, Oballa, Renata, Zhang, Lei. ""Synthesis and biological activity of a potent and orally bioavailable SCD inhibitor (MF-438)."" Bioorganic & medicinal chemistry letters, 2010, pp. 499-502.
[27] Jackson, Kathryn C, Wohlers, Lindsay M, Valencia, Ana P, Cilenti, Michelle, Borengasser, Sarah J, Thyfault, John P, Spangenburg, Espen E. ""Wheel running prevents the accumulation of monounsaturated fatty acids in the liver of ovariectomized mice by attenuating changes in SCD-1 content."" Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme, 2011, pp. 798-810.
[28] Ekoue, Dede N, Zaichick, Sofia, Valyi-Nagy, Klara, Picklo, Matthew, Lacher, Craig, Hoskins, Kent, Warso, Michael A, Bonini, Marcelo G, Diamond, Alan M. ""Selenium levels in human breast carcinoma tissue are associated with a common polymorphism in the gene for SELENOP (Selenoprotein P)."" Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS), 2017, pp. 227-233.
[29] Arias-Borrego, A, Callejón-Leblic, B, Rodríguez-Moro, G, Velasco, I, Gómez-Ariza, J L, García-Barrera, T. ""A novel HPLC column switching method coupled to ICP-MS/QTOF for the first determination of selenoprotein P (SELENOP) in human breast milk."" Food chemistry, 2020, pp. 126692.
[30] Schomburg, Lutz. ""Selenoprotein P - Selenium transport protein, enzyme and biomarker of selenium status."" Free radical biology & medicine, 2022, pp. 150-163.
[31] Andeen, Nicole K, Kung, Vanderlene L, Robertson, Josh, Gurley, Susan B, Avasare, Rupali S, Sitaraman, Sneha. ""Fibrillary Glomerulonephritis, DNAJB9, and the Unfolded Protein Response."" Glomerular diseases, 2022, pp. 164-175.
[32] Lee, Hyeon Ju, Jung, Yu-Jin, Lee, Seungkoo, Kim, Jong-Il, Han, Jeong A. ""DNAJB9 Inhibits p53-Dependent Oncogene-Induced Senescence and Induces Cell Transformation."" Molecules and cells, 2020, pp. 397-407.
[33] Nasr, Samih H, Vrana, Julie A, Dasari, Surendra, Bridoux, Frank, Fidler, Mary E, Kaaki, Sihem, Quellard, Nathalie, Rinsant, Alexia, Goujon, Jean Michel, Sethi, Sanjeev, Fervenza, Fernando C, Cornell, Lynn D, Said, Samar M, McPhail, Ellen D, Herrera Hernandez, Loren P, Grande, Joseph P, Hogan, Marie C, Lieske, John C, Leung, Nelson, Kurtin, Paul J, Alexander, Mariam P. ""DNAJB9 Is a Specific Immunohistochemical Marker for Fibrillary Glomerulonephritis."" Kidney international reports, 2018, pp. 56-64.
[34] Hartmann, Jakob, Bajaj, Thomas, Klengel, Claudia, Chatzinakos, Chris, Ebert, Tim, Dedic, Nina, McCullough, Kenneth M, Lardenoije, Roy, Joëls, Marian, Meijer, Onno C, McCann, Katharine E, Dudek, Serena M, Sarabdjitsingh, R Angela, Daskalakis, Nikolaos P, Klengel, Torsten, Gassen, Nils C, Schmidt, Mathias V, Ressler, Kerry J. ""Mineralocorticoid receptors dampen glucocorticoid receptor sensitivity to stress via regulation of FKBP5."" Cell reports, 2021, pp. 109185.
[35] Jeon, Yong-Jae, Choi, Bo-Ryoung, Park, Min-Sun, Jang, Yoon-Sun, Yoon, Sujung, Lyoo, In Kyoon, Han, Jung-Soo. ""Intact Recognition Memory and Altered Hippocampal Glucocorticoid Receptor Signaling in Fkbp5-deficient Mice Following Acute Uncontrollable Stress."" Experimental neurobiology, 2023, pp. 91-101.
[36] Rizavi, Hooriyah S, Khan, Omar S, Zhang, Hui, Bhaumik, Runa, Grayson, Dennis R, Pandey, Ghanshyam N. ""Methylation and expression of glucocorticoid receptor exon-1 variants and FKBP5 in teenage suicide-completers."" Translational psychiatry, 2023, pp. 53.
[37] McLoughlin, Michael R, Orlicky, David J, Prigge, Justin R, Krishna, Pushya, Talago, Emily A, Cavigli, Ian R, Eriksson, Sofi, Miller, Colin G, Kundert, Jean A, Sayin, Volkan I, Sabol, Rachel A, Heinemann, Joshua, Brandenberger, Luke O, Iverson, Sonya V, Bothner, Brian, Papagiannakopoulos, Thales, Shearn, Colin T, Arnér, Elias S J, Schmidt, Edward E. ""TrxR1, Gsr, and oxidative stress determine hepatocellular carcinoma malignancy."" Proceedings of the National Academy of Sciences of the United States of America, 2019, pp. 11408-11417.
[38] Macias-Barragan, Jose, Huerta-Olvera, Selene G, Hernandez-Cañaveral, Ivan, Pereira-Suarez, Ana Laura, Montoya-Buelna, Margarita. ""Cadmium and α-lipoic acid activate similar de novo synthesis and recycling pathways for glutathione balance."" Environmental toxicology and pharmacology, 2017, pp. 38-46.
[39] Alves, Andressa de Freitas, Moura, Ana Carolina de, Andreolla, Huander Felipe, Veiga, Ana Beatriz Gorini da, Fiegenbaum, Marilu, Giovenardi, Márcia, Almeida, Silvana. ""Gene expression evaluation of antioxidant enzymes in patients with hepatocellular carcinoma: RT-qPCR and bioinformatic analyses."" Genetics and molecular biology, 2021, pp. e20190373.
[40] Roche, J, Girardet, J L, Gorka, C, Lawrence, J J. ""The involvement of histone H1[0] in chromatin structure."" Nucleic acids research, 1985, pp. 2843-53.
[41] Lemercier, C, Duncliffe, K, Boibessot, I, Zhang, H, Verdel, A, Angelov, D, Khochbin, S. ""Involvement of retinoblastoma protein and HBP1 in histone H1(0) gene expression."" Molecular and cellular biology, 2000, pp. 6627-37.
[42] Bouterfa, H L, Piedrafita, F J, Doenecke, D, Pfahl, M. ""Regulation of H1(0) gene expression by nuclear receptors through an unusual response element: implications for regulation of cell proliferation."" DNA and cell biology, 1995, pp. 909-19.
[43] Lane, Darius J R, Saletta, Federica, Suryo Rahmanto, Yohan, Kovacevic, Zaklina, Richardson, Des R. ""N-myc downstream regulated 1 (NDRG1) is regulated by eukaryotic initiation factor 3a (eIF3a) during cellular stress caused by iron depletion."" PloS one, 2013, pp. e57273.
[44] Shi, Xiao-Hua, Larkin, Jacob C, Chen, Baosheng, Sadovsky, Yoel. ""The expression and localization of N-myc downstream-regulated gene 1 in human trophoblasts."" PloS one, 2013, pp. e75473.
[45] Zhang, Jianong, Gao, Kun, Xie, Hongyan, Wang, Dejie, Zhang, Pingzhao, Wei, Ting, Yan, Yuqian, Pan, Yunqian, Ye, Wenbin, Chen, Huifen, Shi, Qing, Li, Yao, Zhao, Shi-Min, Hou, Xiaonan, Weroha, Saravut J, Wang, Yuzhuo, Zhang, Jun, Karnes, R Jeffrey, He, Housheng Hansen, Wang, Liguo, Wang, Chenji, Huang, Haojie. ""SPOP mutation induces DNA methylation via stabilizing GLP/G9a."" Nature communications, 2021, pp. 5716.
[46] Sahin, P, McCaig, C, Jeevahan, J, Murray, J T, Hainsworth, A H. ""The cell survival kinase SGK1 and its targets FOXO3a and NDRG1 in aged human brain."" Neuropathology and applied neurobiology, 2013, pp. 623-33.
[47] Matschke, Johann, Wiebeck, Elisa, Hurst, Sebastian, Rudner, Justine, Jendrossek, Verena. ""Role of SGK1 for fatty acid uptake, cell survival and radioresistance of NCI-H460 lung cancer cells exposed to acute or chronic cycling severe hypoxia."" Radiation oncology (London, England), 2016, pp. 75.
[48] Lang, Florian, Pelzl, Lisann, Hauser, Stefan, Hermann, Andreas, Stournaras, Christos, Schöls, Ludger. ""To die or not to die SGK1-sensitive ORAI/STIM in cell survival."" Cell calcium, 2018, pp. 29-34.
"	0.40931383	0.6878784	GO	GO	NA
Diff. expressed gene set	ANGIOGENESIS	NA	APOH APP CCND2 COL3A1 COL5A2 CXCL6 FGFR1 FSTL1 ITGAV JAG1 JAG2 KCNJ8 LPL LRPAP1 LUM MSX1 NRP1 OLR1 PDGFA PF4 PGLYRP1 POSTN PRG2 PTK2 S100A4 SERPINA5 SLCO2A1 SPP1 STC1 THBD TIMP1 TNFRSF21 VAV2 VCAN VEGFA VTN	36	5.169925001442312	Regulation Of Cell Population Proliferation 	GO:0042127	JAG2;APP;JAG1;CCND2;PDGFA;ITGAV;TIMP1;PTK2;VEGFA;FGFR1;PF4	11	30.555555555555557	6.06e-8	4.34e-5	Extracellular Matrix Remodeling	"The most prominent biological process performed by this system of interacting proteins is extracellular matrix (ECM) remodeling. This process is crucial for various cellular activities, including cell adhesion, migration, and differentiation.

1. ECM components: Several proteins in the system, such as COL3A1, COL5A2, LUM, and VCAN, are directly involved in the composition and organization of the ECM. These proteins provide structural support and regulate cell behavior.

2. ECM degradation and remodeling: Proteins like TIMP1, which inhibits matrix metalloproteinases, and SERPINA5, a serine protease inhibitor, play roles in controlling ECM degradation and turnover. This regulation is essential for maintaining tissue homeostasis and enabling cellular processes like wound healing and tissue repair.

3. Cell adhesion and migration: Proteins such as ITGAV, an integrin subunit, and PTK2, a focal adhesion kinase, are involved in cell adhesion and migration. These proteins facilitate cell-ECM interactions and enable cells to respond to changes in the ECM.

4. Angiogenesis: Several proteins in the system, including VEGFA, NRP1, and FGFR1, are involved in angiogenesis, the formation of new blood vessels. This process is essential for supplying nutrients and oxygen to tissues and is regulated by ECM remodeling.

5. Growth factors and signaling: Proteins like PDGFA, FSTL1, and CXCL6 are growth factors and cytokines that regulate cell proliferation, differentiation, and migration. These proteins interact with ECM components and cell surface receptors to modulate cellular responses to environmental cues.

6. Apoptosis and inflammation: TNFRSF21 and OLR1 are involved in apoptosis and inflammation, respectively. These proteins can be influenced by changes in the ECM and contribute to tissue remodeling and homeostasis.

In conclusion, this system of interacting proteins is primarily involved in extracellular matrix remodeling, which is crucial for various cellular processes, including cell adhesion, migration, differentiation, angiogenesis, and tissue repair."	16	44.44444444444444	"The most prominent biological process performed by this system of interacting proteins is extracellular matrix (ECM) remodeling. This process is crucial for various cellular activities, including cell adhesion, migration, and differentiation.

1. ECM components: Several proteins in the system, such as COL3A1, COL5A2, LUM, and VCAN, are directly involved in the composition and organization of the ECM. These proteins provide structural support and regulate cell behavior.[1][2][3]

2. ECM degradation and remodeling: Proteins like TIMP1, which inhibits matrix metalloproteinases, and SERPINA5, a serine protease inhibitor, play roles in controlling ECM degradation and turnover. This regulation is essential for maintaining tissue homeostasis and enabling cellular processes like wound healing and tissue repair.[4][5][6]

3. Cell adhesion and migration: Proteins such as ITGAV, an integrin subunit, and PTK2, a focal adhesion kinase, are involved in cell adhesion and migration. These proteins facilitate cell-ECM interactions and enable cells to respond to changes in the ECM.[7][8][9]

4. Angiogenesis: Several proteins in the system, including VEGFA, NRP1, and FGFR1, are involved in angiogenesis, the formation of new blood vessels. This process is essential for supplying nutrients and oxygen to tissues and is regulated by ECM remodeling.[10][11][12]

5. Growth factors and signaling: Proteins like PDGFA, FSTL1, and CXCL6 are growth factors and cytokines that regulate cell proliferation, differentiation, and migration. These proteins interact with ECM components and cell surface receptors to modulate cellular responses to environmental cues.[13][14][15]

6. Apoptosis and inflammation: TNFRSF21 and OLR1 are involved in apoptosis and inflammation, respectively. These proteins can be influenced by changes in the ECM and contribute to tissue remodeling and homeostasis.[16][17][18]

In conclusion, this system of interacting proteins is primarily involved in extracellular matrix remodeling, which is crucial for various cellular processes, including cell adhesion, migration, differentiation, angiogenesis, and tissue repair.

========================================================================================================================================================================================================
[1] Tsata, Vasiliki, Möllmert, Stephanie, Schweitzer, Christine, Kolb, Julia, Möckel, Conrad, Böhm, Benjamin, Rosso, Gonzalo, Lange, Christian, Lesche, Mathias, Hammer, Juliane, Kesavan, Gokul, Beis, Dimitris, Guck, Jochen, Brand, Michael, Wehner, Daniel. ""A switch in pdgfrb<sup>+</sup> cell-derived ECM composition prevents inhibitory scarring and promotes axon regeneration in the zebrafish spinal cord."" Developmental cell, 2021, pp. 509-524.e9.
[2] Hao, Jie, Kohler, Corina, van den Dorpel, Hubrecht, Scholl, Hendrik P N, Meyer, Peter, Killer, Hanspeter E, Neutzner, Albert. ""The extracellular matrix composition of the optic nerve subarachnoid space."" Experimental eye research, 2020, pp. 108250.
[3] Jamaluddin, M Fairuz B, Nahar, Pravin, Tanwar, Pradeep S. ""Proteomic Characterization of the Extracellular Matrix of Human Uterine Fibroids."" Endocrinology, 2018, pp. 2656-2669.
[4] Huang, Haili, Liang, Ling, Sun, Dan, Li, Jin, Wang, Wentao, Zha, Lixia, Yang, Jiaqi, Pan, Kunyan, Fan, Xianmou, He, Chengzhang, Tang, Xudong, Zhang, Peihua. ""Rab37 Promotes Endothelial Differentiation and Accelerates ADSC-Mediated Diabetic Wound Healing through Regulating Secretion of Hsp90α and TIMP1."" Stem cell reviews and reports, 2023, pp. 1019-1033.
[5] Babaei, Saeed, Bayat, Mohammad. ""Pentoxifylline Accelerates Wound Healing Process by Modulating Gene Expression of MMP-1, MMP-3, and TIMP-1 in Normoglycemic Rats."" Journal of investigative surgery : the official journal of the Academy of Surgical Research, 2015, pp. 196-201.
[6] Vaalamo, M, Leivo, T, Saarialho-Kere, U. ""Differential expression of tissue inhibitors of metalloproteinases (TIMP-1, -2, -3, and -4) in normal and aberrant wound healing."" Human pathology, 1999, pp. 795-802.
[7] Frank, James W, Seo, Heewon, Burghardt, Robert C, Bayless, Kayla J, Johnson, Greg A. ""ITGAV (alpha v integrins) bind SPP1 (osteopontin) to support trophoblast cell adhesion."" Reproduction (Cambridge, England), 2017, pp. 695-706.
[8] Sims, M A, Field, S D, Barnes, M R, Shaikh, N, Ellington, K, Murphy, K E, Spurr, N, Campbell, D A. ""Cloning and characterisation of ITGAV, the genomic sequence for human cell adhesion protein (vitronectin) receptor alpha subunit, CD51."" Cytogenetics and cell genetics, 2000, pp. 268-71.
[9] Girard, D, Senécal, J L. ""Characterization of a novel human IgG antibody reactive with a Ca(2+)-sensitive cell-cell adhesion epitope of PtK2 epithelial cells."" Autoimmunity, 1995, pp. 237-45.
[10] Claesson-Welsh, L, Welsh, M. ""VEGFA and tumour angiogenesis."" Journal of internal medicine, 2013, pp. 114-27.
[11] Zou, Gengyi, Zhang, Xiaotong, Wang, Lun, Li, Xiyang, Xie, Tianyu, Zhao, Jin, Yan, Jie, Wang, Longlong, Ye, Haoyu, Jiao, Shunchang, Xiang, Rong, Shi, Yi. ""Herb-sourced emodin inhibits angiogenesis of breast cancer by targeting VEGFA transcription."" Theranostics, 2020, pp. 6839-6853.
[12] Zhang, Qi, Lu, Sihong, Li, Tianfu, Yu, Liang, Zhang, Yunjian, Zeng, Huijuan, Qian, Xueke, Bi, Jiong, Lin, Ying. ""ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway."" Journal of experimental & clinical cancer research : CR, 2019, pp. 173.
[13] Pinkas, H, Fisch, B, Rozansky, G, Felz, C, Kessler-Icekson, G, Krissi, H, Nitke, S, Ao, A, Abir, R. ""Platelet-derived growth factors (PDGF-A and -B) and their receptors in human fetal and adult ovaries."" Molecular human reproduction, 2008, pp. 199-206.
[14] Ni, Xiaolei, Cao, Xiaoming, Wu, Yongquan, Wu, Jian. ""FSTL1 suppresses tumor cell proliferation, invasion and survival in non-small cell lung cancer."" Oncology reports, 2018, pp. 13-20.
[15] Deng, Yuelin, Zhang, Yao, Wu, Huajie, Shi, Zhaoling, Sun, Xin. ""Knockdown of FSTL1 inhibits PDGF‑BB‑induced human airway smooth muscle cell proliferation and migration."" Molecular medicine reports, 2017, pp. 3859-3864.
[16] Zhang, Tong, Yu, Jiafeng, Wang, Gang, Zhang, Runhe. ""Amyloid precursor protein binds with TNFRSF21 to induce neural inflammation in Alzheimer's Disease."" European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2021, pp. 105598.
[17] Shi, Xiaofeng, Ma, Wei, Li, Yongqi, Wang, Han, Pan, Shuang, Tian, Yu, Xu, Caiming, Li, Lei. ""MiR-144-5p limits experimental abdominal aortic aneurysm formation by mitigating M1 macrophage-associated inflammation: Suppression of TLR2 and OLR1."" Journal of molecular and cellular cardiology, 2020, pp. 1-14.
[18] Nikolaev, Anatoly, McLaughlin, Todd, O'Leary, Dennis D M, Tessier-Lavigne, Marc. ""APP binds DR6 to trigger axon pruning and neuron death via distinct caspases."" Nature, 2009, pp. 981-9.
"	0.58109856	0.29715094	LLM	Neither	NA
Diff. expressed gene set	APICAL JUNCTION	NA	ACTA1 ACTB ACTC1 ACTG1 ACTG2 ACTN1 ACTN2 ACTN3 ACTN4 ADAM15 ADAM23 ADAM9 ADAMTS5 ADRA1B AKT2 AKT3 ALOX15B AMH AMIGO1 AMIGO2 ARHGEF6 ARPC2 ATP1A3 B4GALT1 BAIAP2 BMP1 CADM2 CADM3 CALB2 CAP1 CD209 CD274 CD276 CD34 CD86 CD99 CDH1 CDH11 CDH15 CDH3 CDH4 CDH6 CDH8 CDK8 CDSN CERCAM CLDN11 CLDN14 CLDN15 CLDN18 CLDN19 CLDN4 CLDN5 CLDN6 CLDN7 CLDN8 CLDN9 CNN2 CNTN1 COL16A1 COL17A1 COL9A1 CRAT CRB3 CTNNA1 CTNND1 CX3CL1 DHX16 DLG1 DMP1 DSC1 DSC3 EGFR EPB41L2 EVL EXOC4 FBN1 FLNC FSCN1 FYB1 GAMT GNAI1 GNAI2 GRB7 GTF2F1 HADH HRAS ICAM1 ICAM2 ICAM4 ICAM5 IKBKG INPPL1 INSIG1 IRS1 ITGA10 ITGA2 ITGA3 ITGA9 ITGB1 ITGB4 JAM3 JUP KCNH2 KRT31 LAMA3 LAMB3 LAMC2 LAYN LDLRAP1 LIMA1 MADCAM1 MAP3K20 MAP4K2 MAPK11 MAPK13 MAPK14 MDK MMP2 MMP9 MPZL1 MPZL2 MSN MVD MYH10 MYH9 MYL12B MYL9 NECTIN1 NECTIN2 NECTIN3 NECTIN4 NEGR1 NEXN NF1 NF2 NFASC NLGN2 NLGN3 NRAP NRTN NRXN2 PALS1 PARD6G PARVA PBX2 PCDH1 PDZD3 PECAM1 PFN1 PIK3CB PIK3R3 PKD1 PLCG1 PPP2R2C PTEN PTK2 PTPRC RAC2 RASA1 RHOF RRAS RSU1 SDC3 SGCE SHC1 SHROOM2 SIRPA SKAP2 SLC30A3 SLIT2 SORBS3 SPEG SRC STX4 SYK SYMPK TAOK2 TGFBI THBS3 THY1 TIAL1 TJP1 TMEM8B TNFRSF11B TRAF1 TRO TSC1 TSPAN4 TUBG1 VASP VAV2 VCAM1 VCAN VCL VWF WASL WNK4 YWHAH ZYX	200	7.643856189774724	Cell-Cell Adhesion Via Plasma-Membrane Adhesion Molecules 	GO:0098742	ITGB1;AMIGO1;AMIGO2;NEXN;PKD1;CDH8;ICAM1;CDH6;TRO;CDH4;CDH3;CDH1;MPZL2;CADM3;VCAM1;CADM2;CLDN6;CLDN11;CLDN5;CLDN4;CLDN15;CLDN9;CD209;CLDN14;CLDN8;CLDN7;CDH11;CLDN19;PECAM1;CLDN18;CDH15;NECTIN4;NECTIN3;NECTIN2;NECTIN1	35	17.5	5.91e-36	1.02e-32	Cell Adhesion and Migration	"The primary biological process performed by this system of interacting proteins is cell adhesion and migration. This is supported by the presence of numerous proteins involved in cell-cell and cell-matrix interactions, cytoskeletal organization, and signal transduction.

1. Cell adhesion proteins: CDH1, CDH11, CDH15, CDH3, CDH4, CDH6, CDH8, CD34, ICAM1, ICAM2, ICAM4, ICAM5, ITGA10, ITGA2, ITGA3, ITGA9, ITGB1, ITGB4, JAM3, MADCAM1, NECTIN1, NECTIN2, NECTIN3, NECTIN4, PECAM1, VCAM1, and VCAN are all involved in cell adhesion. These proteins facilitate cell-cell and cell-matrix interactions, which are crucial for tissue integrity and cellular communication.

2. Cytoskeletal organization proteins: ACTA1, ACTB, ACTC1, ACTG1, ACTG2, ACTN1, ACTN2, ACTN3, ACTN4, CNN2, FLNC, MYH10, MYH9, MYL12B, MYL9, and VCL are involved in the organization and regulation of the cytoskeleton. These proteins play a role in cell shape, motility, and intracellular transport.

3. Cell migration proteins: ARHGEF6, CAP1, EVL, FYB1, GNAI1, GNAI2, GRB7, HRAS, INPPL1, MAP3K20, MAP4K2, MAPK11, MAPK13, MAPK14, PARD6G, PARVA, PTK2, RAC2, RASA1, RHOF, RRAS, SHC1, SIRPA, SKAP2, SORBS3, SRC, VASP, VAV2, WASL, and WNK4 are involved in cell migration. These proteins regulate cell movement, which is essential for processes such as wound healing, immune response, and embryonic development.

4. Signal transduction proteins: AKT2, AKT3, CX3CL1, EGFR, GTF2F1, IKBKG, IRS1, NF1, NF2, PIK3CB, PIK3R3, PLCG1, PPP2R2C, PTEN, SHROOM2, SYK, TAOK2, TGFBI, THBS3, TIAL1, TSC1, and YWHAH are involved in signal transduction. These proteins transmit signals from the cell surface to the nucleus, regulating various cellular processes such as proliferation, differentiation, and apoptosis.

In conclusion, the most prominent biological process performed by this system of interacting proteins is cell adhesion and migration, which is supported by the presence of numerous proteins involved in cell-cell and cell-matrix interactions, cytoskeletal organization, and signal transduction."	95	47.5	"The primary biological process performed by this system of interacting proteins is cell adhesion and migration. This is supported by the presence of numerous proteins involved in cell-cell and cell-matrix interactions, cytoskeletal organization, and signal transduction.

1. Cell adhesion proteins: CDH1, CDH11, CDH15, CDH3, CDH4, CDH6, CDH8, CD34, ICAM1, ICAM2, ICAM4, ICAM5, ITGA10, ITGA2, ITGA3, ITGA9, ITGB1, ITGB4, JAM3, MADCAM1, NECTIN1, NECTIN2, NECTIN3, NECTIN4, PECAM1, VCAM1, and VCAN are all involved in cell adhesion. These proteins facilitate cell-cell and cell-matrix interactions, which are crucial for tissue integrity and cellular communication.[1][2][3]

2. Cytoskeletal organization proteins: ACTA1, ACTB, ACTC1, ACTG1, ACTG2, ACTN1, ACTN2, ACTN3, ACTN4, CNN2, FLNC, MYH10, MYH9, MYL12B, MYL9, and VCL are involved in the organization and regulation of the cytoskeleton. These proteins play a role in cell shape, motility, and intracellular transport.[4][5][6]

3. Cell migration proteins: ARHGEF6, CAP1, EVL, FYB1, GNAI1, GNAI2, GRB7, HRAS, INPPL1, MAP3K20, MAP4K2, MAPK11, MAPK13, MAPK14, PARD6G, PARVA, PTK2, RAC2, RASA1, RHOF, RRAS, SHC1, SIRPA, SKAP2, SORBS3, SRC, VASP, VAV2, WASL, and WNK4 are involved in cell migration. These proteins regulate cell movement, which is essential for processes such as wound healing, immune response, and embryonic development.[7][8][9]

4. Signal transduction proteins: AKT2, AKT3, CX3CL1, EGFR, GTF2F1, IKBKG, IRS1, NF1, NF2, PIK3CB, PIK3R3, PLCG1, PPP2R2C, PTEN, SHROOM2, SYK, TAOK2, TGFBI, THBS3, TIAL1, TSC1, and YWHAH are involved in signal transduction. These proteins transmit signals from the cell surface to the nucleus, regulating various cellular processes such as proliferation, differentiation, and apoptosis.[10][11][12]

In conclusion, the most prominent biological process performed by this system of interacting proteins is cell adhesion and migration, which is supported by the presence of numerous proteins involved in cell-cell and cell-matrix interactions, cytoskeletal organization, and signal transduction.

========================================================================================================================================================================================================
[1] Chatterjee, Subhajit, Sinha, Saptarshi, Kundu, Chanakya Nath. ""Nectin cell adhesion molecule-4 (NECTIN-4): A potential target for cancer therapy."" European journal of pharmacology, 2021, pp. 174516.
[2] da Silva, Cláudia Lobato, Gonçalves, Raquel, dos Santos, Francisco, Andrade, Pedro Z, Almeida-Porada, Graça, Cabral, Joaquim M S. ""Dynamic cell-cell interactions between cord blood haematopoietic progenitors and the cellular niche are essential for the expansion of CD34+, CD34+CD38- and early lymphoid CD7+ cells."" Journal of tissue engineering and regenerative medicine, 2010, pp. 149-58.
[3] Paine, R, Christensen, P, Toews, G B, Simon, R H. ""Regulation of alveolar epithelial cell ICAM-1 expression by cell shape and cell-cell interactions."" The American journal of physiology, 1994, pp. L476-84.
[4] Taniuchi, Keisuke, Furihata, Mutsuo, Naganuma, Seiji, Saibara, Toshiji. ""WAVE2 is associated with poor prognosis in pancreatic cancers and promotes cell motility and invasiveness via binding to ACTN4."" Cancer medicine, 2018, pp. 5733-5751.
[5] Panina, Yulia, Germond, Arno, Masui, Shinji, Watanabe, Tomonobu M. ""Validation of Common Housekeeping Genes as Reference for qPCR Gene Expression Analysis During iPS Reprogramming Process."" Scientific reports, 2018, pp. 8716.
[6] Zhao, Xuan, Khurana, Simran, Charkraborty, Sharmistha, Tian, Yuqian, Sedor, John R, Bruggman, Leslie A, Kao, Hung-Ying. ""α Actinin 4 (ACTN4) Regulates Glucocorticoid Receptor-mediated Transactivation and Transrepression in Podocytes."" The Journal of biological chemistry, 2017, pp. 1637-1647.
[7] Dong, Caihua, Li, Xinying, Yang, Jiao, Yuan, Detian, Zhou, Yuanshuai, Zhang, Yina, Shi, Guohua, Zhang, Ruobing, Liu, Jianping, Fu, Peng, Sun, Minxuan. ""PPFIBP1 induces glioma cell migration and invasion through FAK/Src/JNK signaling pathway."" Cell death & disease, 2021, pp. 827.
[8] Yao, Jian, Liang, Lin-Hui, Zhang, Yu, Ding, Jie, Tian, Qi, Li, Jin-Jun, He, Xiang-Huo. ""GNAI1 Suppresses Tumor Cell Migration and Invasion and is Post-Transcriptionally Regulated by Mir-320a/c/d in Hepatocellular Carcinoma."" Cancer biology & medicine, 2012, pp. 234-41.
[9] Xiao, Wei-Rong, Wu, Meng, Bi, Xiang-Rong. ""Ozone oil promotes wound healing via increasing miR-21-5p-mediated inhibition of RASA1."" Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society, 2021, pp. 406-416.
[10] Woś, Marcin, Bandorowicz-Pikuła, Joanna. ""[Participation of annexins in endocytosis and EGFR-mediated signal transduction]."" Postepy biochemii, 2014, pp. 55-61.
[11] Besson, A, Robbins, S M, Yong, V W. ""PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis."" European journal of biochemistry, 1999, pp. 605-11.
[12] Tanaka, Kosuke, Yu, Helena A, Yang, Shaoyuan, Han, Song, Selcuklu, S Duygu, Kim, Kwanghee, Ramani, Shriram, Ganesan, Yogesh Tengarai, Moyer, Allison, Sinha, Sonali, Xie, Yuchen, Ishizawa, Kota, Osmanbeyoglu, Hatice U, Lyu, Yang, Roper, Nitin, Guha, Udayan, Rudin, Charles M, Kris, Mark G, Hsieh, James J, Cheng, Emily H. ""Targeting Aurora B kinase prevents and overcomes resistance to EGFR inhibitors in lung cancer by enhancing BIM- and PUMA-mediated apoptosis."" Cancer cell, 2021, pp. 1245-1261.e6.
"	0.45523286	0.41048712	Tied	GO	NA
Diff. expressed gene set	APICAL SURFACE	NA	ADAM10 ADIPOR2 AFAP1L2 AKAP7 APP ATP6V0A4 ATP8B1 B4GALT1 BRCA1 CD160 CROCC CRYBG1 CX3CL1 DCBLD2 EFNA5 EPHB4 FLOT2 GAS1 GATA3 GHRL GSTM3 HSPB1 IL2RB IL2RG LYN LYPD3 MAL MDGA1 NCOA6 NTNG1 PCSK9 PKHD1 PLAUR RHCG RTN4RL1 SCUBE1 SHROOM2 SLC22A12 SLC2A4 SLC34A3 SRPX SULF2 THY1 TMEM8B	44	5.459431618637297	Apical Protein Localization 	GO:0045176	ATP8B1;SHROOM2;MAL	3	6.8181818181818175	8.27e-7	3.80351e-4	Cell Adhesion and Signaling	"The primary biological process performed by this system of interacting proteins is cell adhesion and signaling. This is supported by the presence of several proteins involved in these processes, such as ADAM10, APP, EFNA5, EPHB4, and FLOT2.

1. ADAM10: A disintegrin and metalloproteinase, ADAM10 plays a crucial role in cell-cell interactions and cell signaling. It is involved in the shedding of cell surface proteins, which can modulate signaling pathways and contribute to cell adhesion.

2. APP: Amyloid precursor protein (APP) is a transmembrane protein that can be cleaved by proteases like ADAM10. The cleavage products of APP have been implicated in cell adhesion and signaling processes, particularly in the nervous system.

3. EFNA5: Ephrin-A5 (EFNA5) is a member of the ephrin family, which is involved in cell adhesion and signaling through interactions with Eph receptors. These interactions can regulate cell migration, axon guidance, and synapse formation.

4. EPHB4: Ephrin type-B receptor 4 (EPHB4) is a receptor tyrosine kinase that binds to ephrin ligands, such as EFNA5. This interaction mediates cell adhesion and signaling processes, including angiogenesis and vascular development.

5. FLOT2: Flotillin-2 (FLOT2) is a membrane protein involved in the formation of lipid rafts, which are specialized membrane microdomains that facilitate cell signaling. FLOT2 has been implicated in cell adhesion and signaling processes, including the regulation of receptor tyrosine kinases.

In addition to these proteins, other proteins in the system, such as BRCA1, GATA3, and IL2RB/IL2RG, are involved in various signaling pathways and cellular processes, further supporting the prominence of cell adhesion and signaling in this system."	9	20.454545454545457	"The primary biological process performed by this system of interacting proteins is cell adhesion and signaling. This is supported by the presence of several proteins involved in these processes, such as ADAM10, APP, EFNA5, EPHB4, and FLOT2.[1][2][3]

1. ADAM10: A disintegrin and metalloproteinase, ADAM10 plays a crucial role in cell-cell interactions and cell signaling. It is involved in the shedding of cell surface proteins, which can modulate signaling pathways and contribute to cell adhesion.[4][5][6]

2. APP: Amyloid precursor protein (APP) is a transmembrane protein that can be cleaved by proteases like ADAM10. The cleavage products of APP have been implicated in cell adhesion and signaling processes, particularly in the nervous system.[7][8][9]

3. EFNA5: Ephrin-A5 (EFNA5) is a member of the ephrin family, which is involved in cell adhesion and signaling through interactions with Eph receptors. These interactions can regulate cell migration, axon guidance, and synapse formation.[10][11][12]

4. EPHB4: Ephrin type-B receptor 4 (EPHB4) is a receptor tyrosine kinase that binds to ephrin ligands, such as EFNA5. This interaction mediates cell adhesion and signaling processes, including angiogenesis and vascular development.[13][14][15]

5. FLOT2: Flotillin-2 (FLOT2) is a membrane protein involved in the formation of lipid rafts, which are specialized membrane microdomains that facilitate cell signaling. FLOT2 has been implicated in cell adhesion and signaling processes, including the regulation of receptor tyrosine kinases.[16][17][18]

In addition to these proteins, other proteins in the system, such as BRCA1, GATA3, and IL2RB/IL2RG, are involved in various signaling pathways and cellular processes, further supporting the prominence of cell adhesion and signaling in this system.[19][20][21]

========================================================================================================================================================================================================
[1] Pfundstein, Grant, Nikonenko, Alexander G, Sytnyk, Vladimir. ""Amyloid precursor protein (APP) and amyloid β (Aβ) interact with cell adhesion molecules: Implications in Alzheimer's disease and normal physiology."" Frontiers in cell and developmental biology, 2022, pp. 969547.
[2] Stahl, Ronny, Schilling, Sandra, Soba, Peter, Rupp, Carsten, Hartmann, Tobias, Wagner, Katja, Merdes, Gunter, Eggert, Simone, Kins, Stefan. ""Shedding of APP limits its synaptogenic activity and cell adhesion properties."" Frontiers in cellular neuroscience, 2014, pp. 410.
[3] Denver, Paul, English, Andrew, McClean, Paula L. ""Inflammation, insulin signaling and cognitive function in aged APP/PS1 mice."" Brain, behavior, and immunity, 2018, pp. 423-434.
[4] Maretzky, Thorsten, Reiss, Karina, Ludwig, Andreas, Buchholz, Julian, Scholz, Felix, Proksch, Erhardt, de Strooper, Bart, Hartmann, Dieter, Saftig, Paul. ""ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation."" Proceedings of the National Academy of Sciences of the United States of America, 2005, pp. 9182-7.
[5] Buchanan, Petra C, Boylan, Kristin L M, Walcheck, Bruce, Heinze, Rachel, Geller, Melissa A, Argenta, Peter A, Skubitz, Amy P N. ""Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17."" The Journal of biological chemistry, 2017, pp. 6339-6351.
[6] Jones, Jennifer C, Rustagi, Shelly, Dempsey, Peter J. ""ADAM Proteases and Gastrointestinal Function."" Annual review of physiology, 2016, pp. 243-76.
[7] Lee, Jung-Hyun, Wittki, Sebastian, Bräu, Tanja, Dreyer, Florian S, Krätzel, Kirsten, Dindorf, Jochen, Johnston, Ian C D, Gross, Stefanie, Kremmer, Elisabeth, Zeidler, Reinhard, Schlötzer-Schrehardt, Ursula, Lichtenheld, Mathias, Saksela, Kalle, Harrer, Thomas, Schuler, Gerold, Federico, Maurizio, Baur, Andreas S. ""HIV Nef, paxillin, and Pak1/2 regulate activation and secretion of TACE/ADAM10 proteases."" Molecular cell, 2013, pp. 668-79.
[8] Tucher, Joanna, Linke, Dennis, Koudelka, Tomas, Cassidy, Liam, Tredup, Claudia, Wichert, Rielana, Pietrzik, Claus, Becker-Pauly, Christoph, Tholey, Andreas. ""LC-MS based cleavage site profiling of the proteases ADAM10 and ADAM17 using proteome-derived peptide libraries."" Journal of proteome research, 2014, pp. 2205-14.
[9] Pfundstein, Grant, Nikonenko, Alexander G, Sytnyk, Vladimir. ""Amyloid precursor protein (APP) and amyloid β (Aβ) interact with cell adhesion molecules: Implications in Alzheimer's disease and normal physiology."" Frontiers in cell and developmental biology, 2022, pp. 969547.
[10] Buensuceso, Adrian V, Deroo, Bonnie J. ""The ephrin signaling pathway regulates morphology and adhesion of mouse granulosa cells in vitro."" Biology of reproduction, 2013, pp. 25.
[11] Kalinski, Thomas, Röpke, Albrecht, Sel, Saadettin, Kouznetsova, Irina, Röpke, Martin, Roessner, Albert. ""Down-regulation of ephrin-A5, a gene product of normal cartilage, in chondrosarcoma."" Human pathology, 2009, pp. 1679-85.
[12] Du, Wei, Huang, Lvzhen, Tang, Xin, Li, Jiarui, Li, Xiaoxin. ""Ephrin-A5 Is Involved in Retinal Neovascularization in a Mouse Model of Oxygen-Induced Retinopathy."" BioMed research international, 2020, pp. 7161027.
[13] Du, Enming, Li, Xue, He, Siyu, Li, Xiaohua, He, Shikun. ""The critical role of the interplays of EphrinB2/EphB4 and VEGF in the induction of angiogenesis."" Molecular biology reports, 2020, pp. 4681-4690.
[14] Lv, JingHuan, Xia, QiuYuan, Wang, JianJun, Shen, Qin, Zhang, Jin, Zhou, XiaoJun. ""EphB4 promotes the proliferation, invasion, and angiogenesis of human colorectal cancer."" Experimental and molecular pathology, 2016, pp. 402-8.
[15] Yang, Du, Jin, Chunna, Ma, Hong, Huang, Mingyuan, Shi, Guo-Ping, Wang, Jianan, Xiang, Meixiang. ""EphrinB2/EphB4 pathway in postnatal angiogenesis: a potential therapeutic target for ischemic cardiovascular disease."" Angiogenesis, 2016, pp. 297-309.
[16] Hanafusa, Kei, Hayashi, Nobuhiro. ""The Flot2 component of the lipid raft changes localization during neural differentiation of P19C6 cells."" BMC molecular and cell biology, 2019, pp. 38.
[17] Carbonnelle, Delphine, Luu, Trang H, Chaillou, Chloe, Huvelin, Jean-Michel, Bard, Jean-Marie, Nazih, Hassan. ""LXR Activation Down-regulates Lipid Raft Markers FLOT2 and DHHC5 in MCF-7 Breast Cancer Cells."" Anticancer research, 2017, pp. 4067-4073.
[18] Huang, Weiyan, Xiong, Qingming, Lin, Mingqun, Rikihisa, Yasuko. ""Anaplasma phagocytophilum Hijacks Flotillin and NPC1 Complex To Acquire Intracellular Cholesterol for Proliferation, Which Can Be Inhibited with Ezetimibe."" mBio, 2021, pp. e0229921.
[19] Kim, Kwang-Soo, Kim, Jiewan, Oh, Nuri, Kim, Mi-Young, Park, Kyung-Soon. ""ELK3-GATA3 axis modulates MDA-MB-231 metastasis by regulating cell-cell adhesion-related genes."" Biochemical and biophysical research communications, 2018, pp. 509-515.
[20] Sakuma, Keiichiro, Chen, Guo-Yun, Aoki, Masahiro, Kannagi, Reiji. ""Induction of 6-sulfated glycans with cell adhesion activity via T-bet and GATA-3 in human helper T cells."" Biochimica et biophysica acta, 2012, pp. 841-8.
[21] Qi, Feng, Qin, Wen-Xing, Zang, Yuan-Sheng. ""Molecular mechanism of triple-negative breast cancer-associated BRCA1 and the identification of signaling pathways."" Oncology letters, 2019, pp. 2905-2914.
"	0.34151828	0.6519042	GO	GO	NA
Diff. expressed gene set	APOPTOSIS	NA	ADD1 AIFM3 ANKH ANXA1 APP ATF3 AVPR1A BAX BCAP31 BCL10 BCL2L1 BCL2L10 BCL2L11 BCL2L2 BGN BID BIK BIRC3 BMF BMP2 BNIP3L BRCA1 BTG2 BTG3 CASP1 CASP2 CASP3 CASP4 CASP6 CASP7 CASP8 CASP9 CAV1 CCNA1 CCND1 CCND2 CD14 CD2 CD38 CD44 CD69 CDC25B CDK2 CDKN1A CDKN1B CFLAR CLU CREBBP CTH CTNNB1 CYLD DAP DAP3 DCN DDIT3 DFFA DIABLO DNAJA1 DNAJC3 DNM1L DPYD EBP EGR3 EMP1 ENO2 ERBB2 ERBB3 EREG ETF1 F2 F2R FAS FASLG FDXR FEZ1 GADD45A GADD45B GCH1 GNA15 GPX1 GPX3 GPX4 GSN GSR GSTM1 GUCY2D H1-0 HGF HMGB2 HMOX1 HSPB1 IER3 IFITM3 IFNB1 IFNGR1 IGF2R IGFBP6 IL18 IL1A IL1B IL6 IRF1 ISG20 JUN KRT18 LEF1 LGALS3 LMNA LUM MADD MCL1 MGMT MMP2 NEDD9 NEFH PAK1 PDCD4 PDGFRB PEA15 PLAT PLCB2 PLPPR4 PMAIP1 PPP2R5B PPP3R1 PPT1 PRF1 PSEN1 PSEN2 PTK2 RARA RELA RETSAT RHOB RHOT2 RNASEL ROCK1 SAT1 SATB1 SC5D SLC20A1 SMAD7 SOD1 SOD2 SPTAN1 SQSTM1 TAP1 TGFB2 TGFBR3 TIMP1 TIMP2 TIMP3 TNF TNFRSF12A TNFSF10 TOP2A TSPO TXNIP VDAC2 WEE1 XIAP	161	7.330916878114617	Regulation Of Apoptotic Process 	GO:0042981	TOP2A;HSPB1;FASLG;CLU;TNF;CASP9;CCND2;CASP8;CASP6;CASP3;TNFSF10;CASP2;CD38;DNM1L;IER3;BNIP3L;DFFA;ANXA1;TNFRSF12A;HGF;RHOB;DNAJC3;SQSTM1;CD44;BIRC3;DIABLO;LEF1;PSEN2;XIAP;BCL10;PSEN1;RELA;BCL2L10;BCL2L11;ERBB3;ERBB2;PMAIP1;BMF;BID;MCL1;JUN;EGR3;GADD45B;BIK;GADD45A;MGMT;CFLAR;PTK2;SOD1;DNAJA1;BMP2;IL6;KRT18;PPT1;FAS;BAX;CTNNB1;BCL2L2;BCL2L1	59	36.64596273291926	3.56e-44	7.51e-41	Apoptosis Regulation	"The most prominent biological process performed by this system of interacting proteins is the regulation of apoptosis, which is a form of programmed cell death. This process is essential for maintaining cellular homeostasis and preventing the development of diseases such as cancer.

1. BCL-2 family proteins: BCL2L1, BCL2L10, BCL2L11, and BCL2L2 are anti-apoptotic proteins, while BAX, BID, BIK, BMF, and BNIP3L are pro-apoptotic proteins. These proteins regulate the intrinsic apoptotic pathway by controlling the permeabilization of the mitochondrial outer membrane, which leads to the release of cytochrome c and the activation of caspases.

2. Caspases: CASP1, CASP2, CASP3, CASP4, CASP6, CASP7, CASP8, and CASP9 are cysteine proteases that play a central role in the execution of apoptosis. They are synthesized as inactive zymogens and are activated by proteolytic cleavage. Caspases can be divided into initiator caspases (CASP2, CASP8, and CASP9) and effector caspases (CASP3, CASP6, and CASP7).

3. Death receptors and ligands: FAS, FASLG, TNF, and TNFRSF12A are involved in the extrinsic apoptotic pathway. The binding of death ligands to their respective receptors leads to the formation of the death-inducing signaling complex (DISC), which activates initiator caspases and subsequently effector caspases.

4. Inhibitors of apoptosis proteins (IAPs): XIAP and BIRC3 are IAPs that inhibit caspases and promote cell survival. They are regulated by proteins such as DIABLO and SMAC, which are released from the mitochondria during apoptosis and bind to IAPs, preventing their inhibitory action on caspases.

5. DNA damage response: Proteins such as BRCA1, GADD45A, GADD45B, and DDIT3 are involved in the DNA damage response, which can lead to cell cycle arrest and apoptosis if the damage is irreparable. The activation of p53, a tumor suppressor protein, can also induce apoptosis through transcriptional activation of pro-apoptotic genes such as BAX and PUMA.

6. Cellular stress response: HSPB1, DNAJA1, and DNAJC3 are heat shock proteins that help maintain protein homeostasis and can also regulate apoptosis. Oxidative stress response proteins, such as SOD1, SOD2, GPX1, GPX3, and GPX4, protect cells from reactive oxygen species (ROS) and can modulate apoptosis.

7. Growth factors and their receptors: ERBB2, ERBB3, PDGFRB, and HGF are involved in cell survival and proliferation. The dysregulation of these signaling pathways can lead to uncontrolled cell growth and resistance to apoptosis.

In conclusion, this system of interacting proteins is primarily involved in the regulation of apoptosis, a critical process for maintaining cellular homeostasis and preventing disease. The proteins function through various pathways, including the intrinsic and extrinsic apoptotic pathways, DNA damage response, cellular stress response, and growth factor signaling."	40	24.84472049689441	"The most prominent biological process performed by this system of interacting proteins is the regulation of apoptosis, which is a form of programmed cell death. This process is essential for maintaining cellular homeostasis and preventing the development of diseases such as cancer.

1. BCL-2 family proteins: BCL2L1, BCL2L10, BCL2L11, and BCL2L2 are anti-apoptotic proteins, while BAX, BID, BIK, BMF, and BNIP3L are pro-apoptotic proteins. These proteins regulate the intrinsic apoptotic pathway by controlling the permeabilization of the mitochondrial outer membrane, which leads to the release of cytochrome c and the activation of caspases.[1][2][3]

2. Caspases: CASP1, CASP2, CASP3, CASP4, CASP6, CASP7, CASP8, and CASP9 are cysteine proteases that play a central role in the execution of apoptosis. They are synthesized as inactive zymogens and are activated by proteolytic cleavage. Caspases can be divided into initiator caspases (CASP2, CASP8, and CASP9) and effector caspases (CASP3, CASP6, and CASP7).[4][5][6]

3. Death receptors and ligands: FAS, FASLG, TNF, and TNFRSF12A are involved in the extrinsic apoptotic pathway. The binding of death ligands to their respective receptors leads to the formation of the death-inducing signaling complex (DISC), which activates initiator caspases and subsequently effector caspases.[7][8][9]

4. Inhibitors of apoptosis proteins (IAPs): XIAP and BIRC3 are IAPs that inhibit caspases and promote cell survival. They are regulated by proteins such as DIABLO and SMAC, which are released from the mitochondria during apoptosis and bind to IAPs, preventing their inhibitory action on caspases.[10][11][12]

5. DNA damage response: Proteins such as BRCA1, GADD45A, GADD45B, and DDIT3 are involved in the DNA damage response, which can lead to cell cycle arrest and apoptosis if the damage is irreparable. The activation of p53, a tumor suppressor protein, can also induce apoptosis through transcriptional activation of pro-apoptotic genes such as BAX and PUMA.[13][14][15]

6. Cellular stress response: HSPB1, DNAJA1, and DNAJC3 are heat shock proteins that help maintain protein homeostasis and can also regulate apoptosis. Oxidative stress response proteins, such as SOD1, SOD2, GPX1, GPX3, and GPX4, protect cells from reactive oxygen species (ROS) and can modulate apoptosis.[16][17][18]

7. Growth factors and their receptors: ERBB2, ERBB3, PDGFRB, and HGF are involved in cell survival and proliferation. The dysregulation of these signaling pathways can lead to uncontrolled cell growth and resistance to apoptosis.[19][20][21]

In conclusion, this system of interacting proteins is primarily involved in the regulation of apoptosis, a critical process for maintaining cellular homeostasis and preventing disease. The proteins function through various pathways, including the intrinsic and extrinsic apoptotic pathways, DNA damage response, cellular stress response, and growth factor signaling.

========================================================================================================================================================================================================
[1] Ma, Guangzhi, Deng, Yunfu, Qian, Luxi, Vallega, Karin A, Zhang, Guojing, Deng, Xingming, Owonikoko, Taofeek K, Ramalingam, Suresh S, Fang, Douglas D, Zhai, Yifan, Sun, Shi-Yong. ""Overcoming acquired resistance to third-generation EGFR inhibitors by targeting activation of intrinsic apoptotic pathway through Mcl-1 inhibition, Bax activation, or both."" Oncogene, 2022, pp. 1691-1700.
[2] Iijima, Kenta, Muranaka, Chizuko, Kobayashi, Junya, Sakamoto, Shuichi, Komatsu, Kenshi, Matsuura, Shinya, Kubota, Nobuo, Tauchi, Hiroshi. ""NBS1 regulates a novel apoptotic pathway through Bax activation."" DNA repair, 2008, pp. 1705-16.
[3] Chattopadhyay, Saurabh, Yamashita, Michifumi, Zhang, Ying, Sen, Ganes C. ""The IRF-3/Bax-mediated apoptotic pathway, activated by viral cytoplasmic RNA and DNA, inhibits virus replication."" Journal of virology, 2011, pp. 3708-16.
[4] Vigneswara, Vasanthy, Akpan, Nsikan, Berry, Martin, Logan, Ann, Troy, Carol M, Ahmed, Zubair. ""Combined suppression of CASP2 and CASP6 protects retinal ganglion cells from apoptosis and promotes axon regeneration through CNTF-mediated JAK/STAT signalling."" Brain : a journal of neurology, 2014, pp. 1656-75.
[5] Seale, Kirsten, Burger, Marilize, Posthumus, Michael, Häger, Charlotte K, Stattin, Evalena, Nilsson, Kjell G, Collins, Malcolm, September, Alison V. ""The Apoptosis Pathway and CASP8 Variants Conferring Risk for Acute and Overuse Musculoskeletal Injuries."" Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2020, pp. 680-688.
[6] Szymona, Kinga, Dudzińska, Ewa, Karakuła-Juchnowicz, Hanna, Gil-Kulik, Paulina, Chomik, Piotr, Świstowska, Małgorzata, Gałaszkiewicz, Joanna, Kocki, Janusz. ""Analysis of the expression of BAX, BCL2, BIRC6, CASP3, CASP9 apoptosis genes during the first episode of schizophrenia."" Psychiatria polska, 2019, pp. 1293-1303.
[7] Chen, Tianke, Dai, Xiaowei, Dai, Juji, Ding, Chaodong, Zhang, Zheng, Lin, Ziqi, Hu, Jin, Lu, Mei, Wang, Zhanyu, Qi, Yalei, Zhang, Li, Pan, Rulu, Zhao, Zhu, Lu, Liting, Liao, Wanqin, Lu, Xincheng. ""AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway."" Cell death & disease, 2020, pp. 822.
[8] Saxena, Nandita, Yadav, Preeti, Kumar, Om. ""The Fas/Fas ligand apoptotic pathway is involved in abrin-induced apoptosis."" Toxicological sciences : an official journal of the Society of Toxicology, 2013, pp. 103-18.
[9] Lin, Wen-Yuan, Tsai, Bruce Chi-Kang, Day, Cecilia Hsuan, Chiu, Ping-Ling, Chen, Ray-Jade, Chen, Michael Yu-Chih, Padma, V Vijaya, Luk, Hsiang-Ning, Lee, Hsiang-Chen, Huang, Chih-Yang. ""Arecoline induces heart injure via Fas/Fas ligand apoptotic pathway in heart of Sprague-Dawley rat."" Environmental toxicology, 2021, pp. 1567-1575.
[10] Hughes, Sebastian A, Lin, Meng, Weir, Ashley, Huang, Bing, Xiong, Liya, Chua, Ngee Kiat, Pang, Jiyi, Santavanond, Jascinta P, Tixeira, Rochelle, Doerflinger, Marcel, Deng, Yexuan, Yu, Chien-Hsiung, Silke, Natasha, Conos, Stephanie A, Frank, Daniel, Simpson, Daniel S, Murphy, James M, Lawlor, Kate E, Pearson, Jaclyn S, Silke, John, Pellegrini, Marc, Herold, Marco J, Poon, Ivan K H, Masters, Seth L, Li, Mingsong, Tang, Qin, Zhang, Yuxia, Rashidi, Maryam, Geng, Lanlan, Vince, James E. ""Caspase-8-driven apoptotic and pyroptotic crosstalk causes cell death and IL-1β release in X-linked inhibitor of apoptosis (XIAP) deficiency."" The EMBO journal, 2023, pp. e110468.
[11] Huang, Ziyang, Zhou, Jifan, Jiang, Yinyan, Han, Yixiang, Wang, Xiaofang, Li, Fanfan, Jiang, Songfu, Yu, Kang, Zhang, Shenghui. ""Combined inhibition of XIAP and autophagy induces apoptosis and differentiation in acute myeloid leukaemia."" Journal of cellular and molecular medicine, 2023, pp. 1682-1696.
[12] Shibata, Mamoru, Hattori, Hidenori, Sasaki, Takahiro, Gotoh, Jun, Hamada, Junichi, Fukuuchi, Yasuo. ""Subcellular localization of a promoter and an inhibitor of apoptosis (Smac/DIABLO and XIAP) during brain ischemia/reperfusion."" Neuroreport, 2002, pp. 1985-8.
[13] Foo, Tzeh Keong, Xia, Bing. ""BRCA1-Dependent and Independent Recruitment of PALB2-BRCA2-RAD51 in the DNA Damage Response and Cancer."" Cancer research, 2022, pp. 3191-3197.
[14] Mirza-Aghazadeh-Attari, Mohammad, Recio, Maria José, Darband, Saber Ghazizadeh, Kaviani, Mojtaba, Safa, Amin, Mihanfar, Ainaz, Sadighparvar, Shirin, Karimian, Ansar, Alemi, Forough, Majidinia, Maryam, Yousefi, Bahman. ""DNA damage response and breast cancer development: Possible therapeutic applications of ATR, ATM, PARP, BRCA1 inhibition."" DNA repair, 2021, pp. 103032.
[15] Wingert, Susanne, Rieger, Michael A. ""Terminal differentiation induction as DNA damage response in hematopoietic stem cells by GADD45A."" Experimental hematology, 2016, pp. 561-6.
[16] De Maio, Antonio, Cauvi, David M, Capone, Ricardo, Bello, Ivan, Egberts, Wilma Vree, Arispe, Nelson, Boelens, Wilbert. ""The small heat shock proteins, HSPB1 and HSPB5, interact differently with lipid membranes."" Cell stress & chaperones, 2019, pp. 947-956.
[17] Acunzo, Julie, Katsogiannou, Maria, Rocchi, Palma. ""Small heat shock proteins HSP27 (HspB1), αB-crystallin (HspB5) and HSP22 (HspB8) as regulators of cell death."" The international journal of biochemistry & cell biology, 2012, pp. 1622-31.
[18] Arrigo, André-Patrick, Gibert, Benjamin. ""Protein interactomes of three stress inducible small heat shock proteins: HspB1, HspB5 and HspB8."" International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2013, pp. 409-22.
[19] Humtsoe, J O, Pham, E, Louie, R J, Chan, D A, Kramer, R H. ""ErbB3 upregulation by the HNSCC 3D microenvironment modulates cell survival and growth."" Oncogene, 2016, pp. 1554-64.
[20] Zhang, Yongqin, Dubé, Philip E, Washington, M Kay, Yan, Fang, Polk, D Brent. ""ErbB2 and ErbB3 regulate recovery from dextran sulfate sodium-induced colitis by promoting mouse colon epithelial cell survival."" Laboratory investigation; a journal of technical methods and pathology, 2012, pp. 437-50.
[21] Wei, Dang, Rui, Bian, Qingquan, Fan, Chen, Cai, Ping, Hu Yun, Xiaoling, Song, Hao, Weng, Jun, Gu. ""KIF11 promotes cell proliferation via ERBB2/PI3K/AKT signaling pathway in gallbladder cancer."" International journal of biological sciences, 2021, pp. 514-526.
"	0.8205191	0.7365126	LLM	Tied	NA
Diff. expressed gene set	BILE ACID METABOLISM	NA	ABCA1 ABCA2 ABCA3 ABCA4 ABCA5 ABCA6 ABCA8 ABCA9 ABCD1 ABCD2 ABCD3 ABCG4 ABCG8 ACSL1 ACSL5 AGXT AKR1D1 ALDH1A1 ALDH8A1 ALDH9A1 AMACR APOA1 AQP9 AR ATXN1 BBOX1 BCAR3 BMP6 CAT CH25H CROT CYP27A1 CYP39A1 CYP46A1 CYP7A1 CYP7B1 CYP8B1 DHCR24 DIO1 DIO2 EFHC1 EPHX2 FADS1 FADS2 FDXR GC GCLM GNMT GNPAT GSTK1 HACL1 HAO1 HSD17B11 HSD17B4 HSD17B6 HSD3B1 HSD3B7 IDH1 IDH2 IDI1 ISOC1 KLF1 LCK LIPE LONP2 MLYCD NEDD4 NPC1 NR0B2 NR1H4 NR1I2 NR3C2 NUDT12 OPTN PAOX PECR PEX1 PEX11A PEX11G PEX12 PEX13 PEX16 PEX19 PEX26 PEX6 PEX7 PFKM PHYH PIPOX PNPLA8 PRDX5 PXMP2 RBP1 RETSAT RXRA RXRG SCP2 SERPINA6 SLC22A18 SLC23A1 SLC23A2 SLC27A2 SLC27A5 SLC29A1 SLC35B2 SLCO1A2 SOAT2 SOD1 SULT1B1 SULT2B1 TFCP2L1 TTR	112	6.807354922057604	Steroid Biosynthetic Process 	GO:0006694	HSD3B7;ABCD3;AKR1D1;HSD3B1;CYP46A1;CYP7B1;CYP7A1;CYP8B1;CYP27A1;CYP39A1;CH25H;AMACR;SCP2;FDXR;SLC27A2;SLC27A5	16	14.285714285714285	1.29e-24	9.7e-22	Cholesterol and Lipid Metabolism	"The primary biological process performed by this system of interacting proteins is cholesterol and lipid metabolism. This is evident from the presence of several key proteins involved in the synthesis, transport, and regulation of cholesterol and lipids.

1. ABCA1, ABCA2, ABCA3, ABCA4, ABCA5, ABCA6, ABCA8, ABCA9, ABCD1, ABCD2, ABCD3, ABCG4, and ABCG8 are all members of the ATP-binding cassette (ABC) transporter family. These proteins play crucial roles in the transport of lipids, including cholesterol, across cellular membranes.

2. CYP7A1, CYP7B1, CYP8B1, CYP27A1, CYP39A1, and CYP46A1 are cytochrome P450 enzymes involved in the synthesis and metabolism of cholesterol and bile acids. These enzymes catalyze key reactions in the conversion of cholesterol to bile acids, which are essential for the absorption of dietary lipids and the excretion of cholesterol.

3. APOA1 is a major component of high-density lipoprotein (HDL) particles, which are responsible for the transport of cholesterol from peripheral tissues to the liver for excretion or recycling.

4. NR1H4 and NR1I2 are nuclear receptors that regulate the expression of genes involved in lipid metabolism, including those encoding for ABC transporters and cytochrome P450 enzymes.

5. ACSL1 and ACSL5 are acyl-CoA synthetases that activate fatty acids for subsequent metabolism, including beta-oxidation and lipid synthesis.

6. HSD3B1, HSD3B7, HSD17B4, HSD17B6, and HSD17B11 are hydroxysteroid dehydrogenases that participate in the metabolism of steroid hormones and bile acids, which are derived from cholesterol.

7. SLC27A2 and SLC27A5 are fatty acid transport proteins that facilitate the uptake of long-chain fatty acids into cells for metabolism.

8. FADS1 and FADS2 are fatty acid desaturases that catalyze the introduction of double bonds into fatty acyl chains, which is a key step in the synthesis of polyunsaturated fatty acids.

9. CAT, SOD1, and PRDX5 are antioxidant enzymes that protect cells from oxidative damage, which can be caused by the accumulation of lipid peroxides during lipid metabolism.

In summary, this system of interacting proteins is primarily involved in cholesterol and lipid metabolism, with key roles in the synthesis, transport, and regulation of cholesterol and lipids, as well as the protection against oxidative damage."	36	32.142857142857146	"The primary biological process performed by this system of interacting proteins is cholesterol and lipid metabolism. This is evident from the presence of several key proteins involved in the synthesis, transport, and regulation of cholesterol and lipids.

1. ABCA1, ABCA2, ABCA3, ABCA4, ABCA5, ABCA6, ABCA8, ABCA9, ABCD1, ABCD2, ABCD3, ABCG4, and ABCG8 are all members of the ATP-binding cassette (ABC) transporter family. These proteins play crucial roles in the transport of lipids, including cholesterol, across cellular membranes.[1][2][3]

2. CYP7A1, CYP7B1, CYP8B1, CYP27A1, CYP39A1, and CYP46A1 are cytochrome P450 enzymes involved in the synthesis and metabolism of cholesterol and bile acids. These enzymes catalyze key reactions in the conversion of cholesterol to bile acids, which are essential for the absorption of dietary lipids and the excretion of cholesterol.[4][5][6]

3. APOA1 is a major component of high-density lipoprotein (HDL) particles, which are responsible for the transport of cholesterol from peripheral tissues to the liver for excretion or recycling.[7][8][9]

4. NR1H4 and NR1I2 are nuclear receptors that regulate the expression of genes involved in lipid metabolism, including those encoding for ABC transporters and cytochrome P450 enzymes.[10][11][12]

5. ACSL1 and ACSL5 are acyl-CoA synthetases that activate fatty acids for subsequent metabolism, including beta-oxidation and lipid synthesis.[13][14][15]

6. HSD3B1, HSD3B7, HSD17B4, HSD17B6, and HSD17B11 are hydroxysteroid dehydrogenases that participate in the metabolism of steroid hormones and bile acids, which are derived from cholesterol.[16][17][18]

7. SLC27A2 and SLC27A5 are fatty acid transport proteins that facilitate the uptake of long-chain fatty acids into cells for metabolism.[19][20][21]

8. FADS1 and FADS2 are fatty acid desaturases that catalyze the introduction of double bonds into fatty acyl chains, which is a key step in the synthesis of polyunsaturated fatty acids.[22][23][24]

9. CAT, SOD1, and PRDX5 are antioxidant enzymes that protect cells from oxidative damage, which can be caused by the accumulation of lipid peroxides during lipid metabolism.[25][26][27]

In summary, this system of interacting proteins is primarily involved in cholesterol and lipid metabolism, with key roles in the synthesis, transport, and regulation of cholesterol and lipids, as well as the protection against oxidative damage.

========================================================================================================================================================================================================
[1] Kinting, Susanna, Li, Yang, Forstner, Maria, Delhommel, Florent, Sattler, Michael, Griese, Matthias. ""Potentiation of ABCA3 lipid transport function by ivacaftor and genistein."" Journal of cellular and molecular medicine, 2019, pp. 5225-5234.
[2] Schmitz, G, Kaminski, W E. ""ABCA2: a candidate regulator of neural transmembrane lipid transport."" Cellular and molecular life sciences : CMLS, 2002, pp. 1285-95.
[3] Molday, Robert S, Zhong, Ming, Quazi, Faraz. ""The role of the photoreceptor ABC transporter ABCA4 in lipid transport and Stargardt macular degeneration."" Biochimica et biophysica acta, 2009, pp. 573-83.
[4] Choi, Wan-Su, Lee, Gyuseok, Song, Won-Hyun, Koh, Jeong-Tae, Yang, Jiye, Kwak, Ji-Sun, Kim, Hyo-Eun, Kim, Seul Ki, Son, Young-Ok, Nam, Hojung, Jin, Iljung, Park, Zee-Yong, Kim, Jiyeon, Park, In Young, Hong, Jeong-Im, Kim, Hyun Ah, Chun, Churl-Hong, Ryu, Je-Hwang, Chun, Jang-Soo. ""The CH25H-CYP7B1-RORα axis of cholesterol metabolism regulates osteoarthritis."" Nature, 2019, pp. 254-258.
[5] Dias, Vera, Ribeiro, V. ""Ethnic differences in the prevalence of polymorphisms in CYP7A1, CYP7B1 AND CYP27A1 enzymes involved in cholesterol metabolism."" Journal of pharmacy & bioallied sciences, 2011, pp. 453-9.
[6] Chen, Wenling, Chiang, John Y L. ""Regulation of human sterol 27-hydroxylase gene (CYP27A1) by bile acids and hepatocyte nuclear factor 4alpha (HNF4alpha)."" Gene, 2003, pp. 71-82.
[7] Mancuso, Elettra, Mannino, Gaia Chiara, Fuoco, Anastasia, Leo, Antonio, Citraro, Rita, Averta, Carolina, Spiga, Rosangela, Russo, Emilio, De Sarro, Giovambattista, Andreozzi, Francesco, Sesti, Giorgio. ""HDL (High-Density Lipoprotein) and ApoA-1 (Apolipoprotein A-1) Potentially Modulate Pancreatic α-Cell Glucagon Secretion."" Arteriosclerosis, thrombosis, and vascular biology, 2020, pp. 2941-2952.
[8] San Mauro Martín, Ismael, Collado Yurrita, Luis, Cuadrado Cenzual, María Ángeles, Ciudad Cabañas, María José, Mendive Dubourdieu, Paula. ""Role of ApoA1 on high-density lipoprotein: an intervention with plant sterols in patients with hypercholesterolemia."" Nutricion hospitalaria, 2014, pp. 494-9.
[9] Smach, Mohamed Ali, Edziri, Hayet, Charfeddine, Bassem, Ben Othman, Leila, Lammouchi, Turkia, Ltaief, Afef, Nafati, Souhir, Dridi, Hedi, Bennamou, Soufien, Limem, Khalifa. ""Polymorphism in apoA1 Influences High-Density Lipoprotein Cholesterol Levels but Is Not a Major Risk Factor of Alzheimer's Disease."" Dementia and geriatric cognitive disorders extra, 2011, pp. 249-57.
[10] Rigalli, Juan Pablo, Tocchetti, Guillermo Nicolás, Weiss, Johanna. ""Modulation of ABC Transporters by Nuclear Receptors: Physiological, Pathological and Pharmacological Aspects."" Current medicinal chemistry, 2019, pp. 1079-1112.
[11] Stienstra, Rinke, Lichtenauer-Kaligis, Elgin, Müller, Michael. ""Stress- (and diet-) related regulation of hepatic nuclear receptors and its relevance for ABC-transporter functions."" Drug metabolism reviews, 2004, pp. 391-406.
[12] Ban, Nobuhiro, Sasaki, Mayumi, Sakai, Hiromichi, Ueda, Kazumitsu, Inagaki, Nobuya. ""Cloning of ABCA17, a novel rodent sperm-specific ABC (ATP-binding cassette) transporter that regulates intracellular lipid metabolism."" The Biochemical journal, 2005, pp. 577-85.
[13] Krammer, Julia, Digel, Margarete, Ehehalt, Friedrich, Stremmel, Wolfgang, Füllekrug, Joachim, Ehehalt, Robert. ""Overexpression of CD36 and acyl-CoA synthetases FATP2, FATP4 and ACSL1 increases fatty acid uptake in human hepatoma cells."" International journal of medical sciences, 2011, pp. 599-614.
[14] Liu, Qingqing, Gauthier, Marie-Soleil, Sun, Lei, Ruderman, Neil, Lodish, Harvey. ""Activation of AMP-activated protein kinase signaling pathway by adiponectin and insulin in mouse adipocytes: requirement of acyl-CoA synthetases FATP1 and Acsl1 and association with an elevation in AMP/ATP ratio."" FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2010, pp. 4229-39.
[15] Widmann, Philipp, Nuernberg, Karin, Kuehn, Christa, Weikard, Rosemarie. ""Association of an ACSL1 gene variant with polyunsaturated fatty acids in bovine skeletal muscle."" BMC genetics, 2011, pp. 96.
[16] Naelitz, Bryan D, Sharifi, Nima. ""Through the Looking-Glass: Reevaluating DHEA Metabolism Through HSD3B1 Genetics."" Trends in endocrinology and metabolism: TEM, 2020, pp. 680-690.
[17] Xue, Zhen, Zhuang, Jianan, Bai, Hao, Wang, Ling, Lu, Hongzhao, Wang, Shanshan, Zeng, Wenxian, Zhang, Tao. ""VDR mediated HSD3B1 to regulate lipid metabolism and promoted testosterone synthesis in mouse Leydig cells."" Genes & genomics, 2022, pp. 583-592.
[18] Desai, Kunal, McManus, Jeffrey M, Sharifi, Nima. ""Hormonal Therapy for Prostate Cancer."" Endocrine reviews, 2021, pp. 354-373.
[19] Gao, Qingzhu, Zhang, Guiji, Zheng, Yaqiu, Yang, Yi, Chen, Chang, Xia, Jie, Liang, Li, Lei, Chong, Hu, Yuan, Cai, Xuefei, Zhang, Wenlu, Tang, Hua, Chen, Yaxi, Huang, Ailong, Wang, Kai, Tang, Ni. ""SLC27A5 deficiency activates NRF2/TXNRD1 pathway by increased lipid peroxidation in HCC."" Cell death and differentiation, 2020, pp. 1086-1104.
[20] Feng, Kaixiang, Ma, Runsheng, Li, Hongqiang, Yin, Keyu, Du, Gongbo, Chen, Xin, Liu, Zhen, Yin, Detao. ""Upregulated SLC27A2/FATP2 in differentiated thyroid carcinoma promotes tumor proliferation and migration."" Journal of clinical laboratory analysis, 2022, pp. e24148.
[21] Kolahi, Kevin, Louey, Samantha, Varlamov, Oleg, Thornburg, Kent. ""Real-Time Tracking of BODIPY-C12 Long-Chain Fatty Acid in Human Term Placenta Reveals Unique Lipid Dynamics in Cytotrophoblast Cells."" PloS one, 2016, pp. e0153522.
[22] Xuan, Yang, Wang, Huogang, Yung, Mingo Mh, Chen, Fushun, Chan, Wai-Sun, Chan, Yau-Sang, Tsui, Stephen Kw, Ngan, Hextan Ys, Chan, Karen Kl, Chan, David W. ""SCD1/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cells."" Theranostics, 2022, pp. 3534-3552.
[23] Reardon, Holly T, Zhang, Jimmy, Kothapalli, Kumar S D, Kim, Andrea J, Park, Woo Jung, Brenna, J Thomas. ""Insertion-deletions in a FADS2 intron 1 conserved regulatory locus control expression of fatty acid desaturases 1 and 2 and modulate response to simvastatin."" Prostaglandins, leukotrienes, and essential fatty acids, 2012, pp. 25-33.
[24] Stoffel, Wilhelm, Schmidt-Soltau, Inga, Binczek, Erika, Thomas, Andreas, Thevis, Mario, Wegner, Ina. ""Dietary ω3-and ω6-Polyunsaturated fatty acids reconstitute fertility of Juvenile and adult Fads2-Deficient mice."" Molecular metabolism, 2020, pp. 100974.
[25] Sadia, Khulah, Sultan, Sikandar, Khan, Kifayatullah, Javeres, Leonel M, Rumman, Baseerat, Shah, Syed T A, Batool, Sajida, Nurulain, Syed M. ""Antioxidant enzymes and association of CAT SNP-21 A/T (rs7943316) with male infertility."" Molecular reproduction and development, 2021, pp. 598-604.
[26] Mlakar, Simona Jurkovic, Osredkar, Josko, Prezelj, Janez, Marc, Janja. ""Antioxidant enzymes GSR, SOD1, SOD2, and CAT gene variants and bone mineral density values in postmenopausal women: a genetic association analysis."" Menopause (New York, N.Y.), 2012, pp. 368-76.
[27] Ding, Guanxiong, Liu, Fang, Shen, Baixin, Feng, Chenchen, Xu, Jianfeng, Ding, Qiang. ""The association between polymorphisms in prooxidant or antioxidant enzymes (myeloperoxidase, SOD2, and CAT) and genes and prostate cancer risk in the Chinese population of Han nationality."" Clinical genitourinary cancer, 2012, pp. 251-5.
"	0.7571839	0.42221323	LLM	LLM	NA
Diff. expressed gene set	CHOLESTEROL HOMEOSTASIS	NA	ABCA2 ACAT2 ACSS2 ACTG1 ADH4 ALCAM ALDOC ANTXR2 ANXA13 ANXA5 ATF3 ATF5 ATXN2 AVPR1A CBS CD9 CHKA CLU CPEB2 CTNNB1 CXCL16 CYP51A1 DHCR7 EBP ECH1 ERRFI1 ETHE1 FABP5 FADS2 FASN FBXO6 FDFT1 FDPS GLDC GNAI1 GPX8 GSTM2 GUSB HMGCR HMGCS1 HSD17B7 IDI1 JAG1 LDLR LGALS3 LGMN LPL LSS MAL2 MVD MVK NFIL3 NIBAN1 NSDHL PCYT2 PDK3 PLAUR PLSCR1 PMVK PNRC1 PPARG S100A11 SC5D SCD SEMA3B SQLE SREBF2 STARD4 STX5 TM7SF2 TMEM97 TNFRSF12A TP53INP1 TRIB3	74	6.20945336562895	Cholesterol Biosynthetic Process 	GO:0006695	MVK;HMGCS1;CYP51A1;HMGCR;HSD17B7;LSS;TM7SF2;NSDHL;PMVK;SC5D;MVD;DHCR7;FDFT1	13	17.56756756756757	4.01e-26	3.5299999999999995e-23	Cholesterol Biosynthesis and Lipid Metabolism	"The most prominent biological process performed by this system of interacting proteins is cholesterol biosynthesis and lipid metabolism. This conclusion is based on the presence of several key proteins involved in these processes, as well as their interactions with other proteins in the system.

1. Cholesterol biosynthesis: Several proteins in the system are directly involved in the cholesterol biosynthesis pathway. These include HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase), the rate-limiting enzyme in cholesterol synthesis; HMGCS1 (3-hydroxy-3-methylglutaryl-CoA synthase 1), which catalyzes the first step in the pathway; FDFT1 (farnesyl-diphosphate farnesyltransferase 1), which synthesizes squalene; and SQLE (squalene epoxidase), which converts squalene to 2,3-oxidosqualene. Additionally, proteins such as DHCR7 (7-dehydrocholesterol reductase) and CYP51A1 (lanosterol 14-alpha demethylase) are involved in the later steps of cholesterol synthesis.

2. Lipid metabolism: Several proteins in the system are involved in lipid metabolism, including FASN (fatty acid synthase), which catalyzes the synthesis of long-chain fatty acids; SCD (stearoyl-CoA desaturase), which introduces a double bond in the fatty acid chain; and LPL (lipoprotein lipase), which hydrolyzes triglycerides in lipoproteins. Additionally, PPARG (peroxisome proliferator-activated receptor gamma) is a nuclear receptor that regulates the expression of genes involved in lipid metabolism and adipogenesis.

3. Regulation of cholesterol biosynthesis and lipid metabolism: The presence of SREBF2 (sterol regulatory element-binding transcription factor 2) and its target genes, such as LDLR (low-density lipoprotein receptor), indicates the regulation of cholesterol biosynthesis and uptake. Furthermore, proteins like ACAT2 (acetyl-CoA acetyltransferase 2) and ACSS2 (acyl-CoA synthetase short-chain family member 2) are involved in the regulation of fatty acid metabolism.

4. Protein interactions: The interactions between proteins involved in cholesterol biosynthesis and lipid metabolism, such as HMGCR and FASN, suggest a coordinated regulation of these processes. Additionally, the interaction between PPARG and SREBF2 indicates a potential cross-talk between the regulation of lipid metabolism and cholesterol biosynthesis.

In conclusion, the most prominent biological process performed by this system of interacting proteins is cholesterol biosynthesis and lipid metabolism, as evidenced by the presence of key proteins involved in these processes and their interactions with other proteins in the system."	14	18.91891891891892	"The most prominent biological process performed by this system of interacting proteins is cholesterol biosynthesis and lipid metabolism. This conclusion is based on the presence of several key proteins involved in these processes, as well as their interactions with other proteins in the system.

1. Cholesterol biosynthesis: Several proteins in the system are directly involved in the cholesterol biosynthesis pathway. These include HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase), the rate-limiting enzyme in cholesterol synthesis; HMGCS1 (3-hydroxy-3-methylglutaryl-CoA synthase 1), which catalyzes the first step in the pathway; FDFT1 (farnesyl-diphosphate farnesyltransferase 1), which synthesizes squalene; and SQLE (squalene epoxidase), which converts squalene to 2,3-oxidosqualene. Additionally, proteins such as DHCR7 (7-dehydrocholesterol reductase) and CYP51A1 (lanosterol 14-alpha demethylase) are involved in the later steps of cholesterol synthesis.[1][2][3]

2. Lipid metabolism: Several proteins in the system are involved in lipid metabolism, including FASN (fatty acid synthase), which catalyzes the synthesis of long-chain fatty acids; SCD (stearoyl-CoA desaturase), which introduces a double bond in the fatty acid chain; and LPL (lipoprotein lipase), which hydrolyzes triglycerides in lipoproteins. Additionally, PPARG (peroxisome proliferator-activated receptor gamma) is a nuclear receptor that regulates the expression of genes involved in lipid metabolism and adipogenesis.[4][5][6]

3. Regulation of cholesterol biosynthesis and lipid metabolism: The presence of SREBF2 (sterol regulatory element-binding transcription factor 2) and its target genes, such as LDLR (low-density lipoprotein receptor), indicates the regulation of cholesterol biosynthesis and uptake. Furthermore, proteins like ACAT2 (acetyl-CoA acetyltransferase 2) and ACSS2 (acyl-CoA synthetase short-chain family member 2) are involved in the regulation of fatty acid metabolism.[7][8][9]

4. Protein interactions: The interactions between proteins involved in cholesterol biosynthesis and lipid metabolism, such as HMGCR and FASN, suggest a coordinated regulation of these processes. Additionally, the interaction between PPARG and SREBF2 indicates a potential cross-talk between the regulation of lipid metabolism and cholesterol biosynthesis.[10][11][12]

In conclusion, the most prominent biological process performed by this system of interacting proteins is cholesterol biosynthesis and lipid metabolism, as evidenced by the presence of key proteins involved in these processes and their interactions with other proteins in the system.

========================================================================================================================================================================================================
[1] Lu, Xiao-Yi, Shi, Xiong-Jie, Hu, Ao, Wang, Ju-Qiong, Ding, Yi, Jiang, Wei, Sun, Ming, Zhao, Xiaolu, Luo, Jie, Qi, Wei, Song, Bao-Liang. ""Feeding induces cholesterol biosynthesis via the mTORC1-USP20-HMGCR axis."" Nature, 2020, pp. 479-484.
[2] Kalogirou, C, Linxweiler, J, Schmucker, P, Snaebjornsson, M T, Schmitz, W, Wach, S, Krebs, M, Hartmann, E, Puhr, M, Müller, A, Spahn, M, Seitz, A K, Frank, T, Marouf, H, Büchel, G, Eckstein, M, Kübler, H, Eilers, M, Saar, M, Junker, K, Röhrig, F, Kneitz, B, Rosenfeldt, M T, Schulze, A. ""MiR-205-driven downregulation of cholesterol biosynthesis through SQLE-inhibition identifies therapeutic vulnerability in aggressive prostate cancer."" Nature communications, 2021, pp. 5066.
[3] Yang, Fan, Kou, Junjie, Liu, Zizhao, Li, Wei, Du, Wenjing. ""MYC Enhances Cholesterol Biosynthesis and Supports Cell Proliferation Through SQLE."" Frontiers in cell and developmental biology, 2021, pp. 655889.
[4] Gu, Li, Zhu, Yahui, Lin, Xi, Tan, Xingyu, Lu, Bingjun, Li, Youjun. ""Stabilization of FASN by ACAT1-mediated GNPAT acetylation promotes lipid metabolism and hepatocarcinogenesis."" Oncogene, 2020, pp. 2437-2449.
[5] Bowers, Megan, Liang, Tong, Gonzalez-Bohorquez, Daniel, Zocher, Sara, Jaeger, Baptiste N, Kovacs, Werner J, Röhrl, Clemens, Cramb, Kaitlyn M L, Winterer, Jochen, Kruse, Merit, Dimitrieva, Slavica, Overall, Rupert W, Wegleiter, Thomas, Najmabadi, Hossein, Semenkovich, Clay F, Kempermann, Gerd, Földy, Csaba, Jessberger, Sebastian. ""FASN-Dependent Lipid Metabolism Links Neurogenic Stem/Progenitor Cell Activity to Learning and Memory Deficits."" Cell stem cell, 2020, pp. 98-109.e11.
[6] Zhang, Jingyue, Song, Yawen, Shi, Qianqian, Fu, Li. ""Research progress on FASN and MGLL in the regulation of abnormal lipid metabolism and the relationship between tumor invasion and metastasis."" Frontiers of medicine, 2021, pp. 649-656.
[7] Ma, Zhimin, Huang, Zhengyun, Zhang, Chi, Liu, Xiangpeng, Zhang, Jie, Shu, Hui, Ma, Yue, Liu, Zhiwei, Feng, Yu, Chen, Xiyue, Kuang, Shihuan, Zhang, Yong, Jia, Zhihao. ""Hepatic Acat2 overexpression promotes systemic cholesterol metabolism and adipose lipid metabolism in mice."" Diabetologia, 2023, pp. 390-405.
[8] Huang, Zhiguang, Zhang, Menglu, Plec, Abigail A, Estill, Sandi Jo, Cai, Ling, Repa, Joyce J, McKnight, Steven L, Tu, Benjamin P. ""ACSS2 promotes systemic fat storage and utilization through selective regulation of genes involved in lipid metabolism."" Proceedings of the National Academy of Sciences of the United States of America, 2018, pp. E9499-E9506.
[9] Ciraku, Lorela, Bacigalupa, Zachary A, Ju, Jing, Moeller, Rebecca A, Le Minh, Giang, Lee, Rusia H, Smith, Michael D, Ferrer, Christina M, Trefely, Sophie, Izzo, Luke T, Doan, Mary T, Gocal, Wiktoria A, D'Agostino, Luca, Shi, Wenyin, Jackson, Joshua G, Katsetos, Christos D, Wellen, Kathryn E, Snyder, Nathaniel W, Reginato, Mauricio J. ""O-GlcNAc transferase regulates glioblastoma acetate metabolism via regulation of CDK5-dependent ACSS2 phosphorylation."" Oncogene, 2022, pp. 2122-2136.
[10] Lu, Xiao-Yi, Shi, Xiong-Jie, Hu, Ao, Wang, Ju-Qiong, Ding, Yi, Jiang, Wei, Sun, Ming, Zhao, Xiaolu, Luo, Jie, Qi, Wei, Song, Bao-Liang. ""Feeding induces cholesterol biosynthesis via the mTORC1-USP20-HMGCR axis."" Nature, 2020, pp. 479-484.
[11] Li, Qingrong, Zhang, Hongmin, Zou, Jun, Feng, Xiang, Feng, Dan. ""Bisphenol A induces cholesterol biosynthesis in HepG2 cells via SREBP-2/HMGCR signaling pathway."" The Journal of toxicological sciences, 2019, pp. 481-491.
[12] Gu, Li, Zhu, Yahui, Lin, Xi, Tan, Xingyu, Lu, Bingjun, Li, Youjun. ""Stabilization of FASN by ACAT1-mediated GNPAT acetylation promotes lipid metabolism and hepatocarcinogenesis."" Oncogene, 2020, pp. 2437-2449.
"	0.80148274	0.70156187	LLM	LLM	NA
Diff. expressed gene set	COAGULATION	NA	A2M ACOX2 ADAM9 ANG ANXA1 APOA1 APOC1 APOC2 APOC3 ARF4 BMP1 C1QA C1R C1S C2 C3 C8A C8B C8G C9 CAPN2 CAPN5 CASP9 CD9 CFB CFD CFH CFI CLU COMP CPB2 CPN1 CPQ CRIP2 CSRP1 CTSB CTSE CTSH CTSK CTSO CTSV DCT DPP4 DUSP14 DUSP6 F10 F11 F12 F13B F2 F2RL2 F3 F8 F9 FBN1 FGA FGG FN1 FURIN FYN GDA GNB2 GNG12 GP1BA GP9 GSN HMGCS2 HNF4A HPN HRG HTRA1 ISCU ITGA2 ITGB3 ITIH1 KLF7 KLK8 KLKB1 LAMP2 LEFTY2 LGMN LRP1 LTA4H MAFF MASP2 MBL2 MEP1A MMP1 MMP10 MMP11 MMP14 MMP15 MMP2 MMP3 MMP7 MMP8 MMP9 MSRB2 MST1 OLR1 P2RY1 PDGFB PECAM1 PEF1 PF4 PLAT PLAU PLEK PLG PREP PROC PROS1 PROZ PRSS23 RABIF RAC1 RAPGEF3 RGN S100A1 S100A13 SERPINA1 SERPINB2 SERPINC1 SERPINE1 SERPING1 SH2B2 SIRT2 SPARC TF TFPI2 THBD THBS1 TIMP1 TIMP3 TMPRSS6 USP11 VWF WDR1	138	7.108524456778169	Proteolysis 	GO:0006508	CPB2;CFH;CPQ;TMPRSS6;HPN;HTRA1;PLAT;FURIN;PLG;CTSV;CPN1;DPP4;THBD;PLAU;CTSK;CAPN5;CAPN2;CTSH;OLR1;CTSE;CTSB;MBL2;MMP7;MMP1;F12;MMP2;MMP3;MMP8;MMP9;MMP14;PROC;BMP1;F9;MMP15;KLKB1;LGMN	36	26.08695652173913	4.2400000000000004e-33	5.7899999999999995e-30	Complement System Activation and Regulation	"The most prominent biological process performed by this system of interacting proteins is the activation and regulation of the complement system, which plays a crucial role in innate immunity and inflammation.

1. Central role of complement proteins: The presence of key complement proteins such as C1QA, C1R, C1S, C2, C3, C8A, C8B, C8G, and C9 indicates the involvement of the classical, alternative, and terminal complement pathways. These proteins are essential for the activation of the complement system, leading to the formation of the membrane attack complex (MAC) and the subsequent lysis of target cells.

2. Regulation of complement activation: Several proteins in the system, such as CFH, CFI, and SERPING1, are known regulators of the complement system. They prevent excessive activation and protect host cells from damage. For example, CFH inhibits the alternative pathway by binding to C3b, while CFI cleaves C3b and C4b, and SERPING1 inhibits the C1 complex in the classical pathway.

3. Coagulation and fibrinolysis: The presence of proteins involved in coagulation (F2, F3, F8, F9, F10, F11, F12, F13B, PROC, PROS1, PROZ, SERPINA1, SERPINB2, SERPINC1, SERPINE1, TF, and THBD) and fibrinolysis (PLAT, PLAU, PLG, and TFPI2) suggests a connection between the complement system and these processes. The activation of the complement system can lead to the activation of coagulation, and vice versa, contributing to the formation of blood clots and the regulation of clot dissolution.

4. Proteases and their inhibitors: The system includes several proteases (ADAM9, BMP1, CAPN2, CAPN5, CASP9, CTSB, CTSE, CTSH, CTSK, CTSO, CTSV, DPP4, FURIN, KLK8, LGMN, MMP1, MMP10, MMP11, MMP14, MMP15, MMP2, MMP3, MMP7, MMP8, MMP9, and TMPRSS6) and their inhibitors (TIMP1 and TIMP3). These proteins are involved in the degradation and remodeling of the extracellular matrix, which can influence the activation and regulation of the complement system.

5. Cell adhesion and signaling: Several proteins in the system, such as ITGA2, ITGB3, PECAM1, and VWF, are involved in cell adhesion and signaling. These proteins can modulate the activation of the complement system by influencing the recruitment and activation of immune cells.

In conclusion, the most prominent biological process performed by this system of interacting proteins is the activation and regulation of the complement system, which is closely linked to coagulation, fibrinolysis, protease activity, and cell adhesion. This process is essential for maintaining immune homeostasis and protecting the host from infections and inflammation."	65	47.10144927536232	"The most prominent biological process performed by this system of interacting proteins is the activation and regulation of the complement system, which plays a crucial role in innate immunity and inflammation.

1. Central role of complement proteins: The presence of key complement proteins such as C1QA, C1R, C1S, C2, C3, C8A, C8B, C8G, and C9 indicates the involvement of the classical, alternative, and terminal complement pathways. These proteins are essential for the activation of the complement system, leading to the formation of the membrane attack complex (MAC) and the subsequent lysis of target cells.[1][2][3]

2. Regulation of complement activation: Several proteins in the system, such as CFH, CFI, and SERPING1, are known regulators of the complement system. They prevent excessive activation and protect host cells from damage. For example, CFH inhibits the alternative pathway by binding to C3b, while CFI cleaves C3b and C4b, and SERPING1 inhibits the C1 complex in the classical pathway.[4][5][6]

3. Coagulation and fibrinolysis: The presence of proteins involved in coagulation (F2, F3, F8, F9, F10, F11, F12, F13B, PROC, PROS1, PROZ, SERPINA1, SERPINB2, SERPINC1, SERPINE1, TF, and THBD) and fibrinolysis (PLAT, PLAU, PLG, and TFPI2) suggests a connection between the complement system and these processes. The activation of the complement system can lead to the activation of coagulation, and vice versa, contributing to the formation of blood clots and the regulation of clot dissolution.[7][8][9]

4. Proteases and their inhibitors: The system includes several proteases (ADAM9, BMP1, CAPN2, CAPN5, CASP9, CTSB, CTSE, CTSH, CTSK, CTSO, CTSV, DPP4, FURIN, KLK8, LGMN, MMP1, MMP10, MMP11, MMP14, MMP15, MMP2, MMP3, MMP7, MMP8, MMP9, and TMPRSS6) and their inhibitors (TIMP1 and TIMP3). These proteins are involved in the degradation and remodeling of the extracellular matrix, which can influence the activation and regulation of the complement system.[10][11][12]

5. Cell adhesion and signaling: Several proteins in the system, such as ITGA2, ITGB3, PECAM1, and VWF, are involved in cell adhesion and signaling. These proteins can modulate the activation of the complement system by influencing the recruitment and activation of immune cells.[13][14][15]

In conclusion, the most prominent biological process performed by this system of interacting proteins is the activation and regulation of the complement system, which is closely linked to coagulation, fibrinolysis, protease activity, and cell adhesion. This process is essential for maintaining immune homeostasis and protecting the host from infections and inflammation.

========================================================================================================================================================================================================
[1] Law, S K Alex, Levine, R Paul. ""The covalent binding story of the complement proteins C3 and C4 (I) 1972-1981."" Immunobiology, 2019, pp. 827-833.
[2] Chen, Yu, Zhao, Zhenguo, Lin, Fen, Wang, Lifang, Lin, Zheng, Yue, Weihua. ""Associations Between Genotype and Peripheral Complement Proteins in First-Episode Psychosis: Evidences From C3 and C4."" Frontiers in genetics, 2021, pp. 647246.
[3] Daborg, Jonny, Andreasson, Ulf, Pekna, Marcela, Lautner, Ronald, Hanse, Eric, Minthon, Lennart, Blennow, Kaj, Hansson, Oskar, Zetterberg, Henrik. ""Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer's disease."" Journal of neural transmission (Vienna, Austria : 1996), 2012, pp. 789-97.
[4] Guo, Wei-Yi, Liu, Qing-Zhen, Zhu, Li, Li, Zeng-Yan, Meng, Si-Jun, Shi, Su-Fang, Liu, Li-Jun, Lv, Ji-Cheng, Hou, Ping, Zhang, Hong. ""Coding and Noncoding Variants in CFH Act Synergistically for Complement Activation in Immunoglobulin A Nephropathy."" The American journal of the medical sciences, 2018, pp. 114-120.
[5] Cao, Sijia, Wang, Jay Ching Chieh, Gao, Jiangyuan, Wong, Matthew, To, Elliott, White, Valerie A, Cui, Jing Z, Matsubara, Joanne A. ""CFH Y402H polymorphism and the complement activation product C5a: effects on NF-κB activation and inflammasome gene regulation."" The British journal of ophthalmology, 2016, pp. 713-8.
[6] Smailhodzic, Dzenita, Klaver, Caroline C W, Klevering, B Jeroen, Boon, Camiel J F, Groenewoud, Joannes M M, Kirchhof, Bernd, Daha, Mohamed R, den Hollander, Anneke I, Hoyng, Carel B. ""Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration."" Ophthalmology, 2012, pp. 339-46.
[7] Ryan, Anthony W, Hughes, David A, Tang, Kun, Kelleher, Dermot P, Ryan, Thomas, McManus, Ross, Stoneking, Mark. ""Natural selection and the molecular basis of electrophoretic variation at the coagulation F13B locus."" European journal of human genetics : EJHG, 2009, pp. 219-27.
[8] Ny, Lina, Parmer, Robert J, Shen, Yue, Holmberg, Sandra, Baik, Nagyung, Bäckman, Assar, Broden, Jessica, Wilczynska, Malgorzata, Ny, Tor, Miles, Lindsey A. ""The plasminogen receptor, Plg-R<sub>KT</sub>, plays a role in inflammation and fibrinolysis during cutaneous wound healing in mice."" Cell death & disease, 2020, pp. 1054.
[9] Grover, Steven P, Mackman, Nigel. ""Tissue Factor: An Essential Mediator of Hemostasis and Trigger of Thrombosis."" Arteriosclerosis, thrombosis, and vascular biology, 2018, pp. 709-725.
[10] Fonseca-Camarillo, Gabriela, Furuzawa-Carballeda, Janette, Martínez-Benitez, Braulio, Barreto-Zuñiga, Rafael, Yamamoto-Furusho, Jesús K. ""Increased expression of extracellular matrix metalloproteinase inducer (EMMPRIN) and MMP10, MMP23 in inflammatory bowel disease: Cross-sectional study."" Scandinavian journal of immunology, 2021, pp. e12962.
[11] Chen, Jing, Yang, Xinglou, Si, Haorui, Gong, Qianchun, Que, Tengcheng, Li, Jing, Li, Yang, Wu, Chunguang, Zhang, Wei, Chen, Ying, Luo, Yun, Zhu, Yan, Li, Bei, Luo, Dongsheng, Hu, Ben, Lin, Haofeng, Jiang, Rendi, Jiang, Tingting, Li, Qian, Liu, Meiqin, Xie, Shizhe, Su, Jia, Zheng, Xiaoshuang, Li, Ang, Yao, Yulin, Yang, Yong, Chen, Panyu, Wu, Aiqiong, He, Meihong, Lin, Xinhua, Tong, Yigang, Hu, Yanling, Shi, Zheng-Li, Zhou, Peng. ""A bat MERS-like coronavirus circulates in pangolins and utilizes human DPP4 and host proteases for cell entry."" Cell, 2023, pp. 850-863.e16.
[12] Xu, Ya-Ming, Inacio, Marielle Cascaes, Liu, Manping X, Gunatilaka, A A Leslie. ""Discovery of diminazene as a dual inhibitor of SARS-CoV-2 human host proteases TMPRSS2 and furin using cell-based assays."" Current research in chemical biology, 2022, pp. 100023.
[13] Zhu, Zhidong, Shen, Yanyun, Chen, Yunfeng, Shi, Haiming, Shi, Yun. ""The exosome of platelet endothelial cell adhesion molecule-1 (PECAM1) protein: A potential risking star in high blood pressure patients (HBPP)."" Medicine, 2021, pp. e21370.
[14] Ferrero, E, Ferrero, M E, Pardi, R, Zocchi, M R. ""The platelet endothelial cell adhesion molecule-1 (PECAM1) contributes to endothelial barrier function."" FEBS letters, 1995, pp. 323-6.
[15] Villar, Jesús, Zhang, Haibo, Slutsky, Arthur S. ""Lung Repair and Regeneration in ARDS: Role of PECAM1 and Wnt Signaling."" Chest, 2019, pp. 587-594.
"	0.5090809	0.4758274	Tied	LLM	NA
Diff. expressed gene set	COMPLEMENT	NA	ACTN2 ADAM9 ADRA2B AKAP10 ANG ANXA5 APOA4 APOBEC3F APOBEC3G APOC1 ATOX1 BRPF3 C1QA C1QC C1R C1S C2 C3 C4BPB C9 CA2 CALM1 CALM3 CASP1 CASP10 CASP3 CASP4 CASP5 CASP7 CASP9 CBLB CCL5 CD36 CD40LG CD46 CD55 CD59 CDA CDH13 CDK5R1 CEBPB CFB CFH CLU COL4A2 CP CPM CPQ CR1 CR2 CSRP1 CTSB CTSC CTSD CTSH CTSL CTSO CTSS CTSV CXCL1 DGKG DGKH DOCK10 DOCK4 DOCK9 DPP4 DUSP5 DUSP6 DYRK2 EHD1 ERAP2 F10 F2 F3 F5 F7 F8 FCER1G FCN1 FDX1 FN1 FYN GATA3 GCA GMFB GNAI2 GNAI3 GNB2 GNB4 GNG2 GNGT2 GP1BA GP9 GPD2 GRB2 GZMA GZMB GZMK HNF4A HPCAL4 HSPA1A HSPA5 IL6 IRF1 IRF2 IRF7 ITGAM ITIH1 JAK2 KCNIP2 KCNIP3 KIF2A KLK1 KLKB1 KYNU L3MBTL4 LAMP2 LAP3 LCK LCP2 LGALS3 LGMN LIPA LRP1 LTA4H LTF LYN MAFF ME1 MMP12 MMP13 MMP14 MMP15 MMP8 MSRB1 MT3 NOTCH4 OLR1 PCLO PCSK9 PDGFB PDP1 PFN1 PHEX PIK3CA PIK3CG PIK3R5 PIM1 PLA2G4A PLA2G7 PLAT PLAUR PLEK PLG PLSCR1 PPP2CB PPP4C PRCP PRDM4 PREP PRKCD PRSS3 PRSS36 PSEN1 PSMB9 RABIF RAF1 RASGRP1 RBSN RCE1 RHOG RNF4 S100A12 S100A13 S100A9 SCG3 SERPINA1 SERPINB2 SERPINC1 SERPINE1 SERPING1 SH2B3 SIRT6 SPOCK2 SRC STX4 TFPI2 TIMP1 TIMP2 TMPRSS6 TNFAIP3 USP14 USP15 USP16 USP8 VCPIP1 WAS XPNPEP1 ZEB1 ZFPM2	200	7.643856189774724	Proteolysis 	GO:0006508	FCN1;CPM;CFH;TMPRSS6;CPQ;PLAT;PLG;CTSV;PSEN1;CTSS;PHEX;DPP4;CASP7;CTSL;CASP3;CASP4;CASP1;CTSH;OLR1;PRSS3;CTSD;CTSC;CTSB;ERAP2;GZMA;GZMB;MMP8;MMP12;F7;MMP14;XPNPEP1;MMP15;KLKB1;LGMN	34	17	1.16e-24	2.42e-21	Complement System Activation and Regulation	"The most prominent biological process performed by this system of interacting proteins is the activation and regulation of the complement system. The complement system is a crucial part of the immune response, playing a role in the clearance of pathogens, immune complex formation, and inflammation regulation.

1. Central components of the complement system: The presence of key proteins such as C1QA, C1QC, C1R, C1S, C2, C3, C4BPB, and C9 indicates the involvement of the classical, alternative, and lectin pathways of complement activation. These proteins are essential for the formation of the C3 and C5 convertases, which ultimately lead to the assembly of the membrane attack complex (MAC) and pathogen lysis.

2. Complement regulatory proteins: CD46, CD55, and CD59 are crucial for controlling the complement system and preventing damage to host cells. CD46 and CD55 regulate the formation of C3 and C5 convertases, while CD59 inhibits the formation of the MAC.

3. Involvement in coagulation and fibrinolysis: Proteins such as F2, F3, F5, F7, F8, F10, PLG, and SERPINE1 are involved in blood coagulation and fibrinolysis, which are closely linked to the complement system. These processes contribute to the formation of blood clots and the dissolution of fibrin, respectively.

4. Proteases and inhibitors: Several proteases (CTSB, CTSC, CTSD, CTSH, CTSL, CTSO, CTSS, CTSV, DPP4, KLK1, KLKB1, PRCP, PRSS3, PRSS36, and TMPRSS6) and inhibitors (SERPINA1, SERPINB2, SERPINC1, SERPING1, TFPI2, TIMP1, and TIMP2) are present in the system, which can modulate the activity of the complement system and other biological processes.

5. Inflammatory response and cytokines: Proteins such as IL6, CCL5, CXCL1, and CD40LG are involved in the inflammatory response and cytokine signaling, which are essential for the recruitment and activation of immune cells during an immune response.

6. Cell adhesion and migration: Proteins like ITGAM, FN1, and CDH13 are involved in cell adhesion and migration, which are crucial for the movement of immune cells to the site of infection or injury.

7. Signal transduction and regulation: Several proteins (e.g., GRB2, JAK2, LCK, LYN, PIK3CA, PIK3CG, PIK3R5, PIM1, PRKCD, RAF1, RASGRP1, and SRC) are involved in signal transduction and regulation, which can modulate the activation and function of immune cells.

In conclusion, the most prominent biological process performed by this system of interacting proteins is the activation and regulation of the complement system, which plays a critical role in the immune response. The system also involves proteins related to coagulation, fibrinolysis, protease activity, inflammation, cell adhesion, and signal transduction, highlighting the complex interplay between these processes in the immune response."	61	30.5	"The most prominent biological process performed by this system of interacting proteins is the activation and regulation of the complement system. The complement system is a crucial part of the immune response, playing a role in the clearance of pathogens, immune complex formation, and inflammation regulation.

1. Central components of the complement system: The presence of key proteins such as C1QA, C1QC, C1R, C1S, C2, C3, C4BPB, and C9 indicates the involvement of the classical, alternative, and lectin pathways of complement activation. These proteins are essential for the formation of the C3 and C5 convertases, which ultimately lead to the assembly of the membrane attack complex (MAC) and pathogen lysis.[1][2][3]

2. Complement regulatory proteins: CD46, CD55, and CD59 are crucial for controlling the complement system and preventing damage to host cells. CD46 and CD55 regulate the formation of C3 and C5 convertases, while CD59 inhibits the formation of the MAC.[4][5][6]

3. Involvement in coagulation and fibrinolysis: Proteins such as F2, F3, F5, F7, F8, F10, PLG, and SERPINE1 are involved in blood coagulation and fibrinolysis, which are closely linked to the complement system. These processes contribute to the formation of blood clots and the dissolution of fibrin, respectively.[7][8][9]

4. Proteases and inhibitors: Several proteases (CTSB, CTSC, CTSD, CTSH, CTSL, CTSO, CTSS, CTSV, DPP4, KLK1, KLKB1, PRCP, PRSS3, PRSS36, and TMPRSS6) and inhibitors (SERPINA1, SERPINB2, SERPINC1, SERPING1, TFPI2, TIMP1, and TIMP2) are present in the system, which can modulate the activity of the complement system and other biological processes.[10][11][12]

5. Inflammatory response and cytokines: Proteins such as IL6, CCL5, CXCL1, and CD40LG are involved in the inflammatory response and cytokine signaling, which are essential for the recruitment and activation of immune cells during an immune response.[13][14][15]

6. Cell adhesion and migration: Proteins like ITGAM, FN1, and CDH13 are involved in cell adhesion and migration, which are crucial for the movement of immune cells to the site of infection or injury.[16][17][18]

7. Signal transduction and regulation: Several proteins (e.g., GRB2, JAK2, LCK, LYN, PIK3CA, PIK3CG, PIK3R5, PIM1, PRKCD, RAF1, RASGRP1, and SRC) are involved in signal transduction and regulation, which can modulate the activation and function of immune cells.[19][20][21]

In conclusion, the most prominent biological process performed by this system of interacting proteins is the activation and regulation of the complement system, which plays a critical role in the immune response. The system also involves proteins related to coagulation, fibrinolysis, protease activity, inflammation, cell adhesion, and signal transduction, highlighting the complex interplay between these processes in the immune response.

========================================================================================================================================================================================================
[1] Corvillo, Fernando, López-Trascasa, Margarita. ""Acquired partial lipodystrophy and C3 glomerulopathy: Dysregulation of the complement system as a common pathogenic mechanism."" Nefrologia, 2018, pp. 258-266.
[2] David, Mikyle, Moodley, Jagidesa, Naicker, Thajasvarie. ""The function of adipsin and C9 protein in the complement system in HIV-associated preeclampsia."" Archives of gynecology and obstetrics, 2021, pp. 1467-1473.
[3] Zhao, Fei, Afonso, Sara, Lindner, Susanne, Hartmann, Andrea, Löschmann, Ina, Nilsson, Bo, Ekdahl, Kristina N, Weber, Lutz T, Habbig, Sandra, Schalk, Gesa, Kirschfink, Michael, Zipfel, Peter F, Skerka, Christine. ""C3-Glomerulopathy Autoantibodies Mediate Distinct Effects on Complement C3- and C5-Convertases."" Frontiers in immunology, 2019, pp. 1030.
[4] Shao, Fei, Gao, Yibo, Wang, Wei, He, Haiyan, Xiao, Liwei, Geng, Xiao, Xia, Yan, Guo, Dong, Fang, Jing, He, Jie, Lu, Zhimin. ""Silencing EGFR-upregulated expression of CD55 and CD59 activates the complement system and sensitizes lung cancer to checkpoint blockade."" Nature cancer, 2022, pp. 1192-1210.
[5] Togay, Alper, Togay, Bilge, Ozbay Gediz, Deniz, Akbaş, Sadıka Halide, Köksoy, Sadi. ""Levels of lymphocyte-associated regulators of complement system CD55 and CD59 are changed in schizophrenia patients."" International journal of psychiatry in clinical practice, 2021, pp. 277-282.
[6] Seya, T, Matsumoto, M, Hara, T, Hatanaka, M, Masaoka, T, Akedo, H. ""Distribution of C3-step regulatory proteins of the complement system, CD35 (CR1), CD46 (MCP), and CD55 (DAF), in hematological malignancies."" Leukemia & lymphoma, 1994, pp. 395-400.
[7] Andresen, Marianne S, Sletten, Marit, Sandset, Per Morten, Iversen, Nina, Stavik, Benedicte, Tinholt, Mari. ""Coagulation Factor V (F5) is an Estrogen-Responsive Gene in Breast Cancer Cells."" Thrombosis and haemostasis, 2022, pp. 1288-1295.
[8] Friso, Simonetta, Lotto, Valentina, Choi, Sang-Woon, Girelli, Domenico, Pinotti, Mirko, Guarini, Patrizia, Udali, Silvia, Pattini, Patrizia, Pizzolo, Francesca, Martinelli, Nicola, Corrocher, Roberto, Bernardi, Francesco, Olivieri, Oliviero. ""Promoter methylation in coagulation F7 gene influences plasma FVII concentrations and relates to coronary artery disease."" Journal of medical genetics, 2012, pp. 192-9.
[9] Ny, Lina, Parmer, Robert J, Shen, Yue, Holmberg, Sandra, Baik, Nagyung, Bäckman, Assar, Broden, Jessica, Wilczynska, Malgorzata, Ny, Tor, Miles, Lindsey A. ""The plasminogen receptor, Plg-R<sub>KT</sub>, plays a role in inflammation and fibrinolysis during cutaneous wound healing in mice."" Cell death & disease, 2020, pp. 1054.
[10] Chen, Jing, Yang, Xinglou, Si, Haorui, Gong, Qianchun, Que, Tengcheng, Li, Jing, Li, Yang, Wu, Chunguang, Zhang, Wei, Chen, Ying, Luo, Yun, Zhu, Yan, Li, Bei, Luo, Dongsheng, Hu, Ben, Lin, Haofeng, Jiang, Rendi, Jiang, Tingting, Li, Qian, Liu, Meiqin, Xie, Shizhe, Su, Jia, Zheng, Xiaoshuang, Li, Ang, Yao, Yulin, Yang, Yong, Chen, Panyu, Wu, Aiqiong, He, Meihong, Lin, Xinhua, Tong, Yigang, Hu, Yanling, Shi, Zheng-Li, Zhou, Peng. ""A bat MERS-like coronavirus circulates in pangolins and utilizes human DPP4 and host proteases for cell entry."" Cell, 2023, pp. 850-863.e16.
[11] Huang, Yongbiao, Li, Shiyu, Huang, Shanshan, Tu, Jingyao, Chen, Xinyi, Xiao, Lingyan, Liu, Bo, Yuan, Xianglin. ""Comprehensive and Integrative Analysis of Two Novel SARS-CoV-2 Entry Associated Proteases CTSB and CTSL in Healthy Individuals and Cancer Patients."" Frontiers in bioengineering and biotechnology, 2022, pp. 780751.
[12] Greene, Catherine M, Hassan, Tidi, Molloy, Kevin, McElvaney, Noel G. ""The role of proteases, endoplasmic reticulum stress and SERPINA1 heterozygosity in lung disease and α-1 anti-trypsin deficiency."" Expert review of respiratory medicine, 2011, pp. 395-411.
[13] Zegeye, Mulugeta M, Lindkvist, Madelene, Fälker, Knut, Kumawat, Ashok K, Paramel, Geena, Grenegård, Magnus, Sirsjö, Allan, Ljungberg, Liza U. ""Activation of the JAK/STAT3 and PI3K/AKT pathways are crucial for IL-6 trans-signaling-mediated pro-inflammatory response in human vascular endothelial cells."" Cell communication and signaling : CCS, 2018, pp. 55.
[14] Valin, Alvaro, Del Rey, Manuel J, Municio, Cristina, Usategui, Alicia, Romero, Marina, Fernández-Felipe, Jesús, Cañete, Juan D, Blanco, Francisco J, Ruano, Yolanda, Criado, Gabriel, Pablos, José L. ""IL6/sIL6R regulates TNFα-inflammatory response in synovial fibroblasts through modulation of transcriptional and post-transcriptional mechanisms."" BMC molecular and cell biology, 2020, pp. 74.
[15] He, Shun, Lu, Yuanyuan, Guo, Yuetong, Li, Shijin, Lu, Xiao, Shao, Shuai, Zhou, Handan, Wang, Ruiqi, Wang, Jiguang, Gao, Pingjin, Li, Xiaodong. ""Krüppel-Like Factor 15 Modulates <i>CXCL1/CXCR2</i> Signaling-Mediated Inflammatory Response Contributing to Angiotensin II-Induced Cardiac Remodeling."" Frontiers in cell and developmental biology, 2021, pp. 644954.
[16] Chidlow, John H, Glawe, John D, Alexander, J Steven, Kevil, Christopher G. ""VEGF₁₆₄ differentially regulates neutrophil and T cell adhesion through ItgaL- and ItgaM-dependent mechanisms."" American journal of physiology. Gastrointestinal and liver physiology, 2010, pp. G1361-7.
[17] Soikkeli, Johanna, Podlasz, Piotr, Yin, Miao, Nummela, Pirjo, Jahkola, Tiina, Virolainen, Susanna, Krogerus, Leena, Heikkilä, Päivi, von Smitten, Karl, Saksela, Olli, Hölttä, Erkki. ""Metastatic outgrowth encompasses COL-I, FN1, and POSTN up-regulation and assembly to fibrillar networks regulating cell adhesion, migration, and growth."" The American journal of pathology, 2010, pp. 387-403.
[18] Cai, Xun, Liu, Chuan, Zhang, Tie-Ning, Zhu, Yi-Wen, Dong, Xiao, Xue, Peng. ""Down-regulation of FN1 inhibits colorectal carcinogenesis by suppressing proliferation, migration, and invasion."" Journal of cellular biochemistry, 2018, pp. 4717-4728.
[19] Pawinwongchai, Jaturawat, Jangprasert, Panchalee, Nilsri, Nungruthai, Israsena, Nipan, Rojnuckarin, Ponlapat. ""Mutated JAK2 signal transduction in human induced pluripotent stem cell (iPSC)-derived megakaryocytes."" Platelets, 2022, pp. 700-708.
[20] Gui, Rong, Li, Dengqing, Qi, Guannan, Suhad, Ali, Nie, Xinmin. ""Inhibition of Grb2-mediated activation of MAPK signal transduction suppresses NOR<sub>1</sub>/CB1954-induced cytotoxicity in the HepG2 cell line."" Oncology letters, 2012, pp. 566-570.
[21] Roskoski, Robert. ""Src protein-tyrosine kinase structure and regulation."" Biochemical and biophysical research communications, 2004, pp. 1155-64.
"	0.746172	0.39623523	LLM	LLM	NA
Diff. expressed gene set	DNA REPAIR	NA	AAAS ADA ADCY6 ADRM1 AGO4 AK1 AK3 ALYREF APRT ARL6IP1 BCAM BCAP31 BOLA2 BRF2 CANT1 CCNO CDA CETN2 CLP1 CMPK2 COX17 CSTF3 DAD1 DCTN4 DDB1 DDB2 DGCR8 DGUOK DUT EDF1 EIF1B ELL ELOA ERCC1 ERCC2 ERCC3 ERCC4 ERCC5 ERCC8 FEN1 GMPR2 GPX4 GSDME GTF2A2 GTF2B GTF2F1 GTF2H1 GTF2H3 GTF2H5 GTF3C5 GUK1 HCLS1 HPRT1 IMPDH2 ITPA LIG1 MPC2 MPG MRPL40 NCBP2 NELFB NELFCD NELFE NFX1 NME1 NME3 NME4 NPR2 NT5C NT5C3A NUDT21 NUDT9 PCNA PDE4B PDE6G PNP POLA1 POLA2 POLB POLD1 POLD3 POLD4 POLE4 POLH POLL POLR1C POLR1D POLR1H POLR2A POLR2C POLR2D POLR2E POLR2F POLR2G POLR2H POLR2I POLR2J POLR2K POLR3C POLR3GL POM121 PRIM1 RAD51 RAD52 RAE1 RALA RBX1 REV3L RFC2 RFC3 RFC4 RFC5 RNMT RPA2 RPA3 RRM2B SAC3D1 SDCBP SEC61A1 SF3A3 SMAD5 SNAPC4 SNAPC5 SRSF6 SSRP1 STX3 SUPT4H1 SUPT5H SURF1 TAF10 TAF12 TAF13 TAF1C TAF6 TAF9 TARBP2 TK2 TMED2 TP53 TSG101 TYMS UMPS UPF3B USP11 VPS28 VPS37B VPS37D XPC ZNF707 ZWINT	150	7.22881869049588	Transcription By RNA Polymerase II 	GO:0006366	GTF2A2;ELL;GTF2B;TAF9;SUPT4H1;SNAPC5;POLR2A;TAF1C;POLR2C;SNAPC4;POLR2D;POLR2E;ELOA;POLR2F;POLR2G;POLR2H;POLR2I;POLR2J;POLR2K;TAF12;NCBP2;TAF13;TAF10;ADRM1;GTF2H1;GTF2F1;SUPT5H;GTF2H3;GTF2H5;ERCC3;NFX1;ERCC2;TAF6	33	22	9.58e-36	8.64e-33	DNA Repair and Transcription Regulation	"The primary biological process performed by this system of interacting proteins is DNA repair and transcription regulation. The proteins involved in this system play crucial roles in maintaining genomic integrity and regulating gene expression.

1. DNA repair: Several proteins in this system are involved in different DNA repair pathways, including nucleotide excision repair (NER), base excision repair (BER), and homologous recombination (HR). Key proteins include ERCC1, ERCC2, ERCC3, ERCC4, ERCC5, ERCC8, FEN1, LIG1, MPG, PCNA, POLB, POLD1, POLD3, POLD4, POLE4, POLH, POLL, RAD51, and RAD52. These proteins work together to identify and repair DNA damage, ensuring the stability of the genome.

2. Transcription regulation: Many proteins in this system are involved in the regulation of transcription, including the general transcription factors (GTFs) and RNA polymerase subunits. Key proteins include GTF2A2, GTF2B, GTF2F1, GTF2H1, GTF2H3, GTF2H5, GTF3C5, POLR1C, POLR1D, POLR1H, POLR2A, POLR2C, POLR2D, POLR2E, POLR2F, POLR2G, POLR2H, POLR2I, POLR2J, POLR2K, POLR3C, and POLR3GL. These proteins are essential for the initiation, elongation, and termination of transcription, as well as the processing of RNA transcripts.

3. mRNA processing and export: Several proteins in this system are involved in mRNA processing, including splicing, polyadenylation, and export. Key proteins include ALYREF, CSTF3, NCBP2, NELFB, NELFCD, NELFE, NUDT21, RAE1, SAC3D1, SF3A3, SRSF6, and UPF3B. These proteins ensure the proper maturation and transport of mRNA from the nucleus to the cytoplasm.

4. DNA replication and synthesis: Some proteins in this system are involved in DNA replication and synthesis, including the DNA polymerases and their accessory factors. Key proteins include POLA1, POLA2, PRIM1, RPA2, RPA3, and RRM2B. These proteins are essential for the accurate replication of the genome during cell division.

5. Nucleotide metabolism: Several proteins in this system are involved in nucleotide metabolism, including the synthesis, degradation, and interconversion of nucleotides. Key proteins include ADA, ADCY6, APRT, CDA, CMPK2, DUT, GMPR2, GPX4, HPRT1, IMPDH2, ITPA, NT5C, NT5C3A, NUDT9, PNP, TK2, TYMS, and UMPS. These proteins maintain the proper balance of nucleotides within the cell, which is essential for DNA replication and repair.

In conclusion, the most prominent biological process performed by this system of interacting proteins is DNA repair and transcription regulation, with additional roles in mRNA processing, DNA replication, and nucleotide metabolism. These processes are essential for maintaining genomic integrity and regulating gene expression in the cell."	77	51.33333333333333	"The primary biological process performed by this system of interacting proteins is DNA repair and transcription regulation. The proteins involved in this system play crucial roles in maintaining genomic integrity and regulating gene expression.

1. DNA repair: Several proteins in this system are involved in different DNA repair pathways, including nucleotide excision repair (NER), base excision repair (BER), and homologous recombination (HR). Key proteins include ERCC1, ERCC2, ERCC3, ERCC4, ERCC5, ERCC8, FEN1, LIG1, MPG, PCNA, POLB, POLD1, POLD3, POLD4, POLE4, POLH, POLL, RAD51, and RAD52. These proteins work together to identify and repair DNA damage, ensuring the stability of the genome.[1][2][3]

2. Transcription regulation: Many proteins in this system are involved in the regulation of transcription, including the general transcription factors (GTFs) and RNA polymerase subunits. Key proteins include GTF2A2, GTF2B, GTF2F1, GTF2H1, GTF2H3, GTF2H5, GTF3C5, POLR1C, POLR1D, POLR1H, POLR2A, POLR2C, POLR2D, POLR2E, POLR2F, POLR2G, POLR2H, POLR2I, POLR2J, POLR2K, POLR3C, and POLR3GL. These proteins are essential for the initiation, elongation, and termination of transcription, as well as the processing of RNA transcripts.[4][5][6]

3. mRNA processing and export: Several proteins in this system are involved in mRNA processing, including splicing, polyadenylation, and export. Key proteins include ALYREF, CSTF3, NCBP2, NELFB, NELFCD, NELFE, NUDT21, RAE1, SAC3D1, SF3A3, SRSF6, and UPF3B. These proteins ensure the proper maturation and transport of mRNA from the nucleus to the cytoplasm.[7][8][9]

4. DNA replication and synthesis: Some proteins in this system are involved in DNA replication and synthesis, including the DNA polymerases and their accessory factors. Key proteins include POLA1, POLA2, PRIM1, RPA2, RPA3, and RRM2B. These proteins are essential for the accurate replication of the genome during cell division.[10][11][12]

5. Nucleotide metabolism: Several proteins in this system are involved in nucleotide metabolism, including the synthesis, degradation, and interconversion of nucleotides. Key proteins include ADA, ADCY6, APRT, CDA, CMPK2, DUT, GMPR2, GPX4, HPRT1, IMPDH2, ITPA, NT5C, NT5C3A, NUDT9, PNP, TK2, TYMS, and UMPS. These proteins maintain the proper balance of nucleotides within the cell, which is essential for DNA replication and repair.[13][14][15]

In conclusion, the most prominent biological process performed by this system of interacting proteins is DNA repair and transcription regulation, with additional roles in mRNA processing, DNA replication, and nucleotide metabolism. These processes are essential for maintaining genomic integrity and regulating gene expression in the cell.

========================================================================================================================================================================================================
[1] Kwon, Youngho, Rösner, Heike, Zhao, Weixing, Selemenakis, Platon, He, Zhuoling, Kawale, Ajinkya S, Katz, Jeffrey N, Rogers, Cody M, Neal, Francisco E, Badamchi Shabestari, Aida, Petrosius, Valdemaras, Singh, Akhilesh K, Joel, Marina Z, Lu, Lucy, Holloway, Stephen P, Burma, Sandeep, Mukherjee, Bipasha, Hromas, Robert, Mazin, Alexander, Wiese, Claudia, Sørensen, Claus S, Sung, Patrick. ""DNA binding and RAD51 engagement by the BRCA2 C-terminus orchestrate DNA repair and replication fork preservation."" Nature communications, 2023, pp. 432.
[2] Joo, Jungnam, Yoon, Kyong-Ah, Hayashi, Tomonori, Kong, Sun-Young, Shin, Hye-Jin, Park, Boram, Kim, Young Min, Hwang, Sang-Hyun, Kim, Jeongseon, Shin, Aesun, Kim, Joo-Young. ""Nucleotide Excision Repair Gene ERCC2 and ERCC5 Variants Increase Risk of Uterine Cervical Cancer."" Cancer research and treatment, 2016, pp. 708-14.
[3] Anjali, Kumari, Kumar, Tarun, Kumar, Puneet, Narayan, Gopeshwar, Singh, Sunita. ""Association of nonsynonymous SNPs of nucleotide excision repair genes ERCC4 rs1800067 (G/A) and ERCC5 rs17655 (G/C) as predisposing risk factors for gallbladder cancer."" Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2022, pp. 1533-1540.
[4] Wang, Xiaoling, Gerber, Alan, Chen, Wei-Yi, Roeder, Robert G. ""Functions of paralogous RNA polymerase III subunits POLR3G and POLR3GL in mouse development."" Proceedings of the National Academy of Sciences of the United States of America, 2020, pp. 15702-15711.
[5] Noack Watt, Kristin E, Achilleos, Annita, Neben, Cynthia L, Merrill, Amy E, Trainor, Paul A. ""The Roles of RNA Polymerase I and III Subunits Polr1c and Polr1d in Craniofacial Development and in Zebrafish Models of Treacher Collins Syndrome."" PLoS genetics, 2016, pp. e1006187.
[6] Luo, Zhi-Zhan, Sun, Hui-Ming, Guo, Jing-Wen, Luo, Peng, Hu, Chao-Qun, Huang, Wen, Shu, Hu. ""Molecular characterization of a RNA polymerase (RNAP) II (DNA directed) polypeptide H (POLR2H) in Pacific white shrimp (Litopenaeus vannamei) and its role in response to high-pH stress."" Fish & shellfish immunology, 2020, pp. 245-253.
[7] Li, Yufeng, Xu, Junyu, Lu, Yuting, Bian, Hua, Yang, Lin, Wu, Honghong, Zhang, Xinwen, Zhang, Beilei, Xiong, Maoqian, Chang, Yafei, Tang, Jie, Yang, Fan, Zhao, Lei, Li, Jing, Gao, Xin, Xia, Mingfeng, Tan, Minjia, Li, Jingya. ""DRAK2 aggravates nonalcoholic fatty liver disease progression through SRSF6-associated RNA alternative splicing."" Cell metabolism, 2021, pp. 2004-2020.e9.
[8] Zhang, Feifei, Wang, Hui, Yu, Jiang, Yao, Xueqing, Yang, Shibin, Li, Weidong, Xu, Lijun, Zhao, Liang. ""LncRNA CRNDE attenuates chemoresistance in gastric cancer via SRSF6-regulated alternative splicing of PICALM."" Molecular cancer, 2021, pp. 6.
[9] Wan, Ledong, Yu, Wenying, Shen, Enhui, Sun, Wenjie, Liu, Yuan, Kong, Jianlu, Wu, Yihua, Han, Fengyan, Zhang, Lei, Yu, Tianze, Zhou, Yuwei, Xie, Sunzhe, Xu, Enping, Zhang, Honghe, Lai, Maode. ""SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer."" Gut, 2019, pp. 118-129.
[10] Zuazua-Villar, Pedro, Ganesh, Anil, Phear, Geraldine, Gagou, Mary E, Meuth, Mark. ""Extensive RPA2 hyperphosphorylation promotes apoptosis in response to DNA replication stress in CHK1 inhibited cells."" Nucleic acids research, 2015, pp. 9776-87.
[11] Elmayan, Taline, Proux, Florence, Vaucheret, Hervé. ""Arabidopsis RPA2: a genetic link among transcriptional gene silencing, DNA repair, and DNA replication."" Current biology : CB, 2005, pp. 1919-25.
[12] Flury, Valentin, Reverón-Gómez, Nazaret, Alcaraz, Nicolas, Stewart-Morgan, Kathleen R, Wenger, Alice, Klose, Robert J, Groth, Anja. ""Recycling of modified H2A-H2B provides short-term memory of chromatin states."" Cell, 2023, pp. 1050-1065.e19.
[13] Kotoula, Vassiliki, Krikelis, Dimitrios, Karavasilis, Vasilios, Koletsa, Triantafillia, Eleftheraki, Anastasia G, Televantou, Despina, Christodoulou, Christos, Dimoudis, Stefanos, Korantzis, Ippokratis, Pectasides, Dimitrios, Syrigos, Konstantinos N, Kosmidis, Paris A, Fountzilas, George. ""Expression of DNA repair and replication genes in non-small cell lung cancer (NSCLC): a role for thymidylate synthetase (TYMS)."" BMC cancer, 2012, pp. 342.
[14] Roldán-Arjona, T, Luque-Romero, F L, Ariza, R R, Jurado, J, Pueyo, C. ""Influence of DNA repair by ada and ogt alkyltransferases on the mutational specificity of alkylating agents."" Molecular carcinogenesis, 1994, pp. 200-9.
[15] Gandhi, Minakshi, Groß, Matthias, Holler, Jessica M, Coggins, Si'Ana A, Patil, Nitin, Leupold, Joerg H, Munschauer, Mathias, Schenone, Monica, Hartigan, Christina R, Allgayer, Heike, Kim, Baek, Diederichs, Sven. ""The lncRNA lincNMR regulates nucleotide metabolism via a YBX1 - RRM2 axis in cancer."" Nature communications, 2020, pp. 3214.
"	0.79709184	0.39698747	LLM	LLM	NA
Diff. expressed gene set	E2F TARGETS	NA	AK2 ANP32E ASF1A ASF1B ATAD2 AURKA AURKB BARD1 BIRC5 BRCA1 BRCA2 BRMS1L BUB1B CBX5 CCNB2 CCNE1 CCP110 CDC20 CDC25A CDC25B CDCA3 CDCA8 CDK1 CDK4 CDKN1A CDKN1B CDKN2A CDKN2C CDKN3 CENPE CENPM CHEK1 CHEK2 CIT CKS1B CKS2 CNOT9 CSE1L CTCF CTPS1 DCK DCLRE1B DCTPP1 DDX39A DEK DEPDC1 DIAPH3 DLGAP5 DNMT1 DONSON DSCC1 DUT E2F8 EED EIF2S1 ESPL1 EXOSC8 EZH2 GINS1 GINS3 GINS4 GSPT1 H2AX H2AZ1 HELLS HMGA1 HMGB2 HMGB3 HMMR HNRNPD HUS1 ILF3 ING3 IPO7 JPT1 KIF18B KIF22 KIF2C KIF4A KPNA2 LBR LIG1 LMNB1 LUC7L3 LYAR MAD2L1 MCM2 MCM3 MCM4 MCM5 MCM6 MCM7 MELK MKI67 MLH1 MMS22L MRE11 MSH2 MTHFD2 MXD3 MYBL2 MYC NAA38 NAP1L1 NASP NBN NCAPD2 NME1 NOLC1 NOP56 NUDT21 NUP107 NUP153 NUP205 ORC2 ORC6 PA2G4 PAICS PAN2 PCNA PDS5B PHF5A PLK1 PLK4 PMS2 PNN POLA2 POLD1 POLD2 POLD3 POLE POLE4 POP7 PPM1D PPP1R8 PRDX4 PRIM2 PRKDC PRPS1 PSIP1 PSMC3IP PTTG1 RACGAP1 RAD1 RAD21 RAD50 RAD51AP1 RAD51C RAN RANBP1 RBBP7 RFC1 RFC2 RFC3 RNASEH2A RPA1 RPA2 RPA3 RRM2 SHMT1 SLBP SMC1A SMC3 SMC4 SMC6 SNRPB SPAG5 SPC24 SPC25 SRSF1 SRSF2 SSRP1 STAG1 STMN1 SUV39H1 SYNCRIP TACC3 TBRG4 TCF19 TFRC TIMELESS TIPIN TK1 TMPO TOP2A TP53 TRA2B TRIP13 TUBB TUBG1 UBE2S UBE2T UBR7 UNG USP1 WDR90 WEE1 XPO1 XRCC6 ZW10	200	7.643856189774724	DNA Metabolic Process 	GO:0006259	TOP2A;DCLRE1B;MRE11;MCM7;HMGB2;HMGB3;BRCA1;CHEK1;NBN;KPNA2;POLE;RFC3;LIG1;RFC2;HUS1;SMC1A;RAD51C;MSH2;TIMELESS;MCM3;MCM4;MCM5;MCM6;DCTPP1;ASF1A;MCM2;PRIM2;RNASEH2A;PRKDC;PDS5B;UNG;RAD51AP1;POLD3;ORC6;RAD21;POLD1;ORC2;POLD2;BARD1;DUT;XRCC6;RPA1;DONSON;RPA2;NAP1L1;POLA2;RAD50;RPA3;UBE2T;CDK1;RAN	51	25.5	2.63e-49	2.8599999999999998e-46	Cell Cycle Regulation and DNA Repair	"The interacting proteins in this system primarily function in cell cycle regulation and DNA repair. Key proteins involved in these processes include:

1. Cell cycle regulation: CDK1, CDK4, CDKN1A, CDKN1B, CDKN2A, CDKN2C, CDKN3, CCNB2, CCNE1, CDC20, CDC25A, CDC25B, AURKA, AURKB, PLK1, PLK4, and WEE1. These proteins are involved in the regulation of cell cycle progression, including G1/S and G2/M transitions, and mitotic spindle assembly. For example, CDK1 and CDK4 are cyclin-dependent kinases that regulate cell cycle progression, while CDKN1A and CDKN1B are cyclin-dependent kinase inhibitors that negatively regulate the cell cycle.

2. DNA replication and repair: BRCA1, BRCA2, MRE11, RAD50, NBN, RAD51AP1, RAD51C, MLH1, PMS2, MSH2, CHEK1, CHEK2, PRKDC, and XRCC6. These proteins are involved in the maintenance of genomic stability through DNA repair pathways, such as homologous recombination, mismatch repair, and non-homologous end joining. For example, BRCA1 and BRCA2 are tumor suppressor proteins that play a crucial role in DNA double-strand break repair through homologous recombination.

3. Chromosome segregation and mitosis: BUB1B, CENPE, CENPM, KIF18B, KIF22, KIF2C, KIF4A, SPC24, SPC25, and TACC3. These proteins are involved in the proper segregation of chromosomes during mitosis, ensuring accurate distribution of genetic material to daughter cells. For example, CENPE and CENPM are centromere-associated proteins that contribute to kinetochore function and chromosome alignment during mitosis.

4. DNA replication machinery: MCM2, MCM3, MCM4, MCM5, MCM6, MCM7, ORC2, ORC6, PCNA, POLA2, POLD1, POLD2, POLD3, POLE, and POLE4. These proteins are essential components of the DNA replication machinery, ensuring accurate and efficient replication of the genome during the S phase of the cell cycle.

5. Epigenetic regulation: CBX5, EED, EZH2, and SUV39H1. These proteins are involved in the regulation of chromatin structure and gene expression through histone modification and chromatin remodeling. For example, EZH2 is a histone methyltransferase that catalyzes the trimethylation of histone H3 at lysine 27, leading to gene silencing.

In summary, the most prominent biological process performed by this system of interacting proteins is cell cycle regulation and DNA repair, which are essential for maintaining genomic stability and proper cellular function."	60	30	"The interacting proteins in this system primarily function in cell cycle regulation and DNA repair. Key proteins involved in these processes include:

1. Cell cycle regulation: CDK1, CDK4, CDKN1A, CDKN1B, CDKN2A, CDKN2C, CDKN3, CCNB2, CCNE1, CDC20, CDC25A, CDC25B, AURKA, AURKB, PLK1, PLK4, and WEE1. These proteins are involved in the regulation of cell cycle progression, including G1/S and G2/M transitions, and mitotic spindle assembly. For example, CDK1 and CDK4 are cyclin-dependent kinases that regulate cell cycle progression, while CDKN1A and CDKN1B are cyclin-dependent kinase inhibitors that negatively regulate the cell cycle.[1][2][3]

2. DNA replication and repair: BRCA1, BRCA2, MRE11, RAD50, NBN, RAD51AP1, RAD51C, MLH1, PMS2, MSH2, CHEK1, CHEK2, PRKDC, and XRCC6. These proteins are involved in the maintenance of genomic stability through DNA repair pathways, such as homologous recombination, mismatch repair, and non-homologous end joining. For example, BRCA1 and BRCA2 are tumor suppressor proteins that play a crucial role in DNA double-strand break repair through homologous recombination.[4][5][6]

3. Chromosome segregation and mitosis: BUB1B, CENPE, CENPM, KIF18B, KIF22, KIF2C, KIF4A, SPC24, SPC25, and TACC3. These proteins are involved in the proper segregation of chromosomes during mitosis, ensuring accurate distribution of genetic material to daughter cells. For example, CENPE and CENPM are centromere-associated proteins that contribute to kinetochore function and chromosome alignment during mitosis.[7][8][9]

4. DNA replication machinery: MCM2, MCM3, MCM4, MCM5, MCM6, MCM7, ORC2, ORC6, PCNA, POLA2, POLD1, POLD2, POLD3, POLE, and POLE4. These proteins are essential components of the DNA replication machinery, ensuring accurate and efficient replication of the genome during the S phase of the cell cycle.[10][11][12]

5. Epigenetic regulation: CBX5, EED, EZH2, and SUV39H1. These proteins are involved in the regulation of chromatin structure and gene expression through histone modification and chromatin remodeling. For example, EZH2 is a histone methyltransferase that catalyzes the trimethylation of histone H3 at lysine 27, leading to gene silencing.[13][14][15]

In summary, the most prominent biological process performed by this system of interacting proteins is cell cycle regulation and DNA repair, which are essential for maintaining genomic stability and proper cellular function.

========================================================================================================================================================================================================
[1] Sadeghi, Hossein, Golalipour, Masoud, Yamchi, Ahad, Farazmandfar, Touraj, Shahbazi, Majid. ""CDC25A pathway toward tumorigenesis: Molecular targets of CDC25A in cell-cycle regulation."" Journal of cellular biochemistry, 2019, pp. 2919-2928.
[2] Détain, A, Redecker, D, Leborgne-Castel, N, Ochatt, S. ""Structural conservation of WEE1 and its role in cell cycle regulation in plants."" Scientific reports, 2021, pp. 23862.
[3] Mueller, P R, Coleman, T R, Dunphy, W G. ""Cell cycle regulation of a Xenopus Wee1-like kinase."" Molecular biology of the cell, 1995, pp. 119-34.
[4] Yoshida, Kiyotsugu, Miki, Yoshio. ""Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage."" Cancer science, 2004, pp. 866-71.
[5] Tarsounas, Madalena, Sung, Patrick. ""The antitumorigenic roles of BRCA1-BARD1 in DNA repair and replication."" Nature reviews. Molecular cell biology, 2020, pp. 284-299.
[6] Pires, Elena, Sung, Patrick, Wiese, Claudia. ""Role of RAD51AP1 in homologous recombination DNA repair and carcinogenesis."" DNA repair, 2017, pp. 76-81.
[7] Tang, Feng, Pan, Meng-Hao, Lu, Yujie, Wan, Xiang, Zhang, Yu, Sun, Shao-Chen. ""Involvement of Kif4a in Spindle Formation and Chromosome Segregation in Mouse Oocytes."" Aging and disease, 2018, pp. 623-633.
[8] Le Masson, Ivan, Saveanu, Cosmin, Chevalier, Anne, Namane, Abdelkader, Gobin, Renée, Fromont-Racine, Micheline, Jacquier, Alain, Mann, Carl. ""Spc24 interacts with Mps2 and is required for chromosome segregation, but is not implicated in spindle pole body duplication."" Molecular microbiology, 2002, pp. 1431-43.
[9] Shi, Mingyue, Guo, Honggang, Bai, Yanliang, Niu, Junwei, Niu, Xiaona, Sun, Kai, Chen, Yuqing. ""Upregulated mitosis-associated genes CENPE, CENPF, and DLGAP5 predict poor prognosis and chemotherapy resistance of Acute Myeloid Leukemia."" Cancer biomarkers : section A of Disease markers, 2022, pp. 11-25.
[10] Boehm, E M, Gildenberg, M S, Washington, M T. ""The Many Roles of PCNA in Eukaryotic DNA Replication."" The Enzymes, 2016, pp. 231-54.
[11] Strzalka, Wojciech, Ziemienowicz, Alicja. ""Proliferating cell nuclear antigen (PCNA): a key factor in DNA replication and cell cycle regulation."" Annals of botany, 2011, pp. 1127-40.
[12] Tumini, Emanuela, Barroso, Sonia, -Calero, Carmen Pérez, Aguilera, Andrés. ""Roles of human POLD1 and POLD3 in genome stability."" Scientific reports, 2016, pp. 38873.
[13] Sun, Shanshan, Yu, Feng, Xu, Danying, Zheng, Haiyan, Li, Min. ""EZH2, a prominent orchestrator of genetic and epigenetic regulation of solid tumor microenvironment and immunotherapy."" Biochimica et biophysica acta. Reviews on cancer, 2022, pp. 188700.
[14] Christofides, Anthos, Karantanos, Theodoros, Bardhan, Kankana, Boussiotis, Vassiliki A. ""Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2."" Oncotarget, 2016, pp. 85624-85640.
[15] Zhang, Li, Tian, Sijuan, Zhao, Minyi, Yang, Ting, Quan, Shimin, Yang, Qing, Song, Lihua, Yang, Xiaofeng. ""SUV39H1-DNMT3A-mediated epigenetic regulation of Tim-3 and galectin-9 in the cervical cancer."" Cancer cell international, 2020, pp. 325.
"	0.40088502	0.2732444	LLM	LLM	NA
Diff. expressed gene set	EPITHELIAL MESENCHYMAL TRANSITION	NA	ABI3BP ACTA2 ADAM12 ANPEP APLP1 AREG BASP1 BDNF BGN BMP1 CADM1 CALD1 CALU CAP2 CAPG CCN1 CCN2 CD44 CD59 CDH11 CDH2 CDH6 COL11A1 COL12A1 COL16A1 COL1A1 COL1A2 COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 COL5A3 COL6A2 COL6A3 COL7A1 COL8A2 COLGALT1 COMP COPA CRLF1 CTHRC1 CXCL1 CXCL12 CXCL6 CXCL8 DAB2 DCN DKK1 DPYSL3 DST ECM1 ECM2 EDIL3 EFEMP2 ELN EMP3 ENO2 FAP FAS FBLN1 FBLN2 FBLN5 FBN1 FBN2 FERMT2 FGF2 FLNA FMOD FN1 FOXC2 FSTL1 FSTL3 FUCA1 FZD8 GADD45A GADD45B GAS1 GEM GJA1 GLIPR1 GPC1 GPX7 GREM1 HTRA1 ID2 IGFBP2 IGFBP3 IGFBP4 IL15 IL32 IL6 INHBA ITGA2 ITGA5 ITGAV ITGB1 ITGB3 ITGB5 JUN LAMA1 LAMA2 LAMA3 LAMC1 LAMC2 LGALS1 LOX LOXL1 LOXL2 LRP1 LRRC15 LUM MAGEE1 MATN2 MATN3 MCM7 MEST MFAP5 MGP MMP1 MMP14 MMP2 MMP3 MSX1 MXRA5 MYL9 MYLK NID2 NNMT NOTCH2 NT5E NTM OXTR P3H1 PCOLCE PCOLCE2 PDGFRB PDLIM4 PFN2 PLAUR PLOD1 PLOD2 PLOD3 PMEPA1 PMP22 POSTN PPIB PRRX1 PRSS2 PTHLH PTX3 PVR QSOX1 RGS4 RHOB SAT1 SCG2 SDC1 SDC4 SERPINE1 SERPINE2 SERPINH1 SFRP1 SFRP4 SGCB SGCD SGCG SLC6A8 SLIT2 SLIT3 SNAI2 SNTB1 SPARC SPOCK1 SPP1 TAGLN TFPI2 TGFB1 TGFBI TGFBR3 TGM2 THBS1 THBS2 THY1 TIMP1 TIMP3 TNC TNFAIP3 TNFRSF11B TNFRSF12A TPM1 TPM2 TPM4 VCAM1 VCAN VEGFA VEGFC VIM WIPF1 WNT5A	200	7.643856189774724	Extracellular Matrix Organization 	GO:0030198	COL16A1;ECM2;ELN;COL11A1;COL12A1;PLOD3;CAPG;LAMC1;NID2;LOXL1;LOXL2;SERPINH1;QSOX1;PRSS2;COLGALT1;POSTN;TGFB1;MMP1;LUM;MMP2;APLP1;MMP3;COL1A1;GREM1;MMP14;COL3A1;BMP1;COL1A2;COL4A2;LOX;COL5A1;COL4A1;COL5A3;COL7A1;COL5A2;COL8A2;TGFBI;MATN3;MATN2	39	19.5	1.28e-41	2.26e-38	Extracellular Matrix Remodeling	"The most prominent biological process performed by this system of interacting proteins is extracellular matrix (ECM) remodeling. The ECM is a complex network of proteins and carbohydrates that provides structural support and regulates various cellular functions. The proteins involved in this process include:

1. Collagens (COL1A1, COL1A2, COL3A1, COL4A1, COL4A2, COL5A1, COL5A2, COL5A3, COL6A2, COL6A3, COL7A1, COL8A2, COL11A1, COL12A1, COL16A1): These proteins are the main structural components of the ECM, providing tensile strength and stability.

2. Proteoglycans (BGN, DCN, VCAN): These proteins contribute to the hydration and resistance of the ECM, as well as modulating cell signaling.

3. Matrix metalloproteinases (MMP1, MMP2, MMP3, MMP14): These enzymes are responsible for the degradation of ECM components, allowing for remodeling and turnover.

4. Tissue inhibitors of metalloproteinases (TIMP1, TIMP3): These proteins regulate the activity of MMPs, ensuring a balance between ECM degradation and synthesis.

5. Growth factors (AREG, BDNF, FGF2, IGFBP2, IGFBP3, IGFBP4, IL15, IL32, IL6, INHBA, VEGFA, VEGFC): These proteins regulate cell proliferation, migration, and differentiation, as well as ECM synthesis and degradation.

6. Integrins (ITGA2, ITGA5, ITGAV, ITGB1, ITGB3, ITGB5): These transmembrane proteins mediate cell-ECM interactions, allowing cells to sense and respond to changes in the ECM.

7. Cytoskeletal proteins (ACTA2, CALD1, CAP2, CAPG, FLNA, MYL9, MYLK, TPM1, TPM2, TPM4, VIM): These proteins are involved in maintaining cell shape, motility, and adhesion to the ECM.

8. Cell adhesion molecules (CD44, CDH11, CDH2, CDH6, LAMA1, LAMA2, LAMA3, LAMC1, LAMC2, VCAM1): These proteins facilitate cell-cell and cell-ECM interactions, promoting tissue integrity and organization.

9. Secreted factors (CCN1, CCN2, CXCL1, CXCL12, CXCL6, CXCL8, DKK1, FSTL1, FSTL3, GADD45A, GADD45B, GAS1, GPC1, GREM1, HTRA1, LRP1, MGP, NID2, NT5E, P3H1, PCOLCE, PCOLCE2, PDGFRB, PFN2, PLAUR, PLOD1, PLOD2, PLOD3, POSTN, PPIB, PRRX1, PRSS2, PTHLH, PTX3, PVR, QSOX1, RGS4, RHOB, SAT1, SCG2, SDC1, SDC4, SERPINE1, SERPINE2, SERPINH1, SFRP1, SFRP4, SGCB, SGCD, SGCG, SLC6A8, SLIT2, SLIT3, SNAI2, SNTB1, SPARC, SPOCK1, SPP1, TAGLN, TFPI2, TGFB1, TGFBI, TGFBR3, TGM2, THBS1, THBS2, THY1, TNC, TNFAIP3, TNFRSF11B, TNFRSF12A, VCAM1, VCAN, WIPF1, WNT5A): These proteins are involved in various aspects of ECM remodeling, including regulation of cell behavior, ECM synthesis and degradation, and modulation of signaling pathways.

In summary, this system of interacting proteins plays a crucial role in ECM remodeling, which is essential for maintaining tissue integrity, homeostasis, and repair."	137	68.5	"The most prominent biological process performed by this system of interacting proteins is extracellular matrix (ECM) remodeling. The ECM is a complex network of proteins and carbohydrates that provides structural support and regulates various cellular functions. The proteins involved in this process include:

1. Collagens (COL1A1, COL1A2, COL3A1, COL4A1, COL4A2, COL5A1, COL5A2, COL5A3, COL6A2, COL6A3, COL7A1, COL8A2, COL11A1, COL12A1, COL16A1): These proteins are the main structural components of the ECM, providing tensile strength and stability.[1][2][3]

2. Proteoglycans (BGN, DCN, VCAN): These proteins contribute to the hydration and resistance of the ECM, as well as modulating cell signaling.[4][5][6]

3. Matrix metalloproteinases (MMP1, MMP2, MMP3, MMP14): These enzymes are responsible for the degradation of ECM components, allowing for remodeling and turnover.[7][8][9]

4. Tissue inhibitors of metalloproteinases (TIMP1, TIMP3): These proteins regulate the activity of MMPs, ensuring a balance between ECM degradation and synthesis.[10][11][12]

5. Growth factors (AREG, BDNF, FGF2, IGFBP2, IGFBP3, IGFBP4, IL15, IL32, IL6, INHBA, VEGFA, VEGFC): These proteins regulate cell proliferation, migration, and differentiation, as well as ECM synthesis and degradation.[13][14][15]

6. Integrins (ITGA2, ITGA5, ITGAV, ITGB1, ITGB3, ITGB5): These transmembrane proteins mediate cell-ECM interactions, allowing cells to sense and respond to changes in the ECM.[16][17][18]

7. Cytoskeletal proteins (ACTA2, CALD1, CAP2, CAPG, FLNA, MYL9, MYLK, TPM1, TPM2, TPM4, VIM): These proteins are involved in maintaining cell shape, motility, and adhesion to the ECM.[19][20][21]

8. Cell adhesion molecules (CD44, CDH11, CDH2, CDH6, LAMA1, LAMA2, LAMA3, LAMC1, LAMC2, VCAM1): These proteins facilitate cell-cell and cell-ECM interactions, promoting tissue integrity and organization.[22][23][24]

9. Secreted factors (CCN1, CCN2, CXCL1, CXCL12, CXCL6, CXCL8, DKK1, FSTL1, FSTL3, GADD45A, GADD45B, GAS1, GPC1, GREM1, HTRA1, LRP1, MGP, NID2, NT5E, P3H1, PCOLCE, PCOLCE2, PDGFRB, PFN2, PLAUR, PLOD1, PLOD2, PLOD3, POSTN, PPIB, PRRX1, PRSS2, PTHLH, PTX3, PVR, QSOX1, RGS4, RHOB, SAT1, SCG2, SDC1, SDC4, SERPINE1, SERPINE2, SERPINH1, SFRP1, SFRP4, SGCB, SGCD, SGCG, SLC6A8, SLIT2, SLIT3, SNAI2, SNTB1, SPARC, SPOCK1, SPP1, TAGLN, TFPI2, TGFB1, TGFBI, TGFBR3, TGM2, THBS1, THBS2, THY1, TNC, TNFAIP3, TNFRSF11B, TNFRSF12A, VCAM1, VCAN, WIPF1, WNT5A): These proteins are involved in various aspects of ECM remodeling, including regulation of cell behavior, ECM synthesis and degradation, and modulation of signaling pathways.[25][26][27]

In summary, this system of interacting proteins plays a crucial role in ECM remodeling, which is essential for maintaining tissue integrity, homeostasis, and repair.

========================================================================================================================================================================================================
[1] He, Jiaozi, Weng, Zhihui, Wu, Stanley Chun Ming, Boheler, Kenneth R. ""Generation of Induced Pluripotent Stem Cells from Patients with COL3A1 Mutations and Differentiation to Smooth Muscle Cells for ECM-Surfaceome Analyses."" Methods in molecular biology (Clifton, N.J.), 2018, pp. 261-302.
[2] Xie, Guohui, Liang, Chunhong, Yu, Honglin, Zhang, Qin. ""Association between polymorphisms of collagen genes and susceptibility to intervertebral disc degeneration: a meta-analysis."" Journal of orthopaedic surgery and research, 2021, pp. 616.
[3] Li, Shuai, Zheng, Zhen-Zhong, Zhang, Yu-Peng, Liu, Zi-Qun, Xiao, Shi-Peng, Ouyang, Zheng-Xiao, Wang, Bing. ""[Bioinformatics Analysis on Key Genes and Immune Infiltration of Osteosarcoma]."" Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 2022, pp. 110-117.
[4] Li, Wenfei, Han, Fang, Fu, Min, Wang, Zhanqiu. ""High expression of VCAN is an independent predictor of poor prognosis in gastric cancer."" The Journal of international medical research, 2020, pp. 300060519891271.
[5] Morita, Wataru, Snelling, Sarah J B, Wheway, Kim, Watkins, Bridget, Appleton, Louise, Murphy, Richard J, Carr, Andrew J, Dakin, Stephanie G. ""Comparison of Cellular Responses to TGF-β1 and BMP-2 Between Healthy and Torn Tendons."" The American journal of sports medicine, 2021, pp. 1892-1903.
[6] Horváth, Zsolt, Kovalszky, Ilona, Fullár, Alexandra, Kiss, Katalin, Schaff, Zsuzsa, Iozzo, Renato V, Baghy, Kornélia. ""Decorin deficiency promotes hepatic carcinogenesis."" Matrix biology : journal of the International Society for Matrix Biology, 2014, pp. 194-205.
[7] Pietruszewska, Wioletta, Bojanowska-Poźniak, Katarzyna, Kobos, Józef. ""Matrix metalloproteinases MMP1, MMP2, MMP9 and their tissue inhibitors TIMP1, TIMP2, TIMP3 in head and neck cancer: an immunohistochemical study."" Otolaryngologia polska = The Polish otolaryngology, 2016, pp. 32-43.
[8] Pan, Yue, Yang, Li, Chen, Danyang, Hou, Huomei, Zhang, Min, Chen, Miaojuan, Ning, Fen, Lu, Qinsheng, Zhao, Minguan, Li, Li, Lash, Gendie E. ""Decidual macrophage derived MMP3 contributes to extracellular matrix breakdown in spiral artery remodeling in early human pregnancy."" Journal of reproductive immunology, 2022, pp. 103494.
[9] Bassiouni, Wesam, Ali, Mohammad A M, Schulz, Richard. ""Multifunctional intracellular matrix metalloproteinases: implications in disease."" The FEBS journal, 2021, pp. 7162-7182.
[10] Pietruszewska, Wioletta, Bojanowska-Poźniak, Katarzyna, Kobos, Józef. ""Matrix metalloproteinases MMP1, MMP2, MMP9 and their tissue inhibitors TIMP1, TIMP2, TIMP3 in head and neck cancer: an immunohistochemical study."" Otolaryngologia polska = The Polish otolaryngology, 2016, pp. 32-43.
[11] Peng, Jiayin, Gao, Kexin, Gao, Teyang, Lei, Yingnan, Han, Peng, Xin, Haiyun, An, Xiaopeng, Cao, Binyun. ""Expression and regulation of tissue inhibitors of metalloproteinases (TIMP1 and TIMP3) in goat oviduct."" Theriogenology, 2015, pp. 1636-43.
[12] Hakamy, Sahar, Assidi, Mourad, Jafri, Mohammad A, Nedjadi, Taoufik, Alkhatabi, Heba, Al-Qahtani, Abrar, Al-Maghrabi, Jaudah, Sait, Khalid, Al-Qahtani, Mohammed, Buhmeida, Abdelbaset, Chaudhary, Adeel. ""Assessment of prognostic value of tissue inhibitors of metalloproteinase 3 (TIMP3) protein in ovarian cancer."" The Libyan journal of medicine, 2021, pp. 1937866.
[13] Wang, Rui, Sun, Shuaichen, Wang, Zizhuo, Xu, Xiaoxiang, Jiang, Tao, Liu, Huanzhong, Li, Xiaohui, Ren, Zhenhua. ""MCPIP1 promotes cell proliferation, migration and angiogenesis of glioma via VEGFA-mediated ERK pathway."" Experimental cell research, 2022, pp. 113267.
[14] Cho, Haaglim, Seo, Youngha, Loke, Kin Man, Kim, Seon-Wook, Oh, Seong-Min, Kim, Jun-Hyeong, Soh, Jihee, Kim, Hyoen Sik, Lee, Hyunju, Kim, Jin, Min, Jung-Joon, Jung, Da-Woon, Williams, Darren Reece. ""Cancer-Stimulated CAFs Enhance Monocyte Differentiation and Protumoral TAM Activation via IL6 and GM-CSF Secretion."" Clinical cancer research : an official journal of the American Association for Cancer Research, 2018, pp. 5407-5421.
[15] Wang, Rongli, Wang, Lijun, Wang, Lihui, Cui, Zhiwei, Cheng, Feiyan, Wang, Wei, Yang, Xinyuan. ""FGF2 Is Protective Towards Cisplatin-Induced KGN Cell Toxicity by Promoting FTO Expression and Autophagy."" Frontiers in endocrinology, 2022, pp. 890623.
[16] Rai, Alin, Fang, Haoyun, Claridge, Bethany, Simpson, Richard J, Greening, David W. ""Proteomic dissection of large extracellular vesicle surfaceome unravels interactive surface platform."" Journal of extracellular vesicles, 2021, pp. e12164.
[17] Mieczkowski, Kamil, Popeda, Marta, Lesniak, Dagmara, Sadej, Rafal, Kitowska, Kamila. ""FGFR2 Controls Growth, Adhesion and Migration of Nontumorigenic Human Mammary Epithelial Cells by Regulation of Integrin β1 Degradation."" Journal of mammary gland biology and neoplasia, 2023, pp. 9.
[18] Luo, Wen, Lin, Zetong, Chen, Jiahui, Chen, Genghua, Zhang, Siyu, Liu, Manqing, Li, Hongmei, He, Danlin, Liang, Shaodong, Luo, Qingbin, Zhang, Dexiang, Nie, Qinghua, Zhang, Xiquan. ""TMEM182 interacts with integrin beta 1 and regulates myoblast differentiation and muscle regeneration."" Journal of cachexia, sarcopenia and muscle, 2021, pp. 1704-1723.
[19] Shi, Xiu, Yu, Xuejiao, Wang, Juan, Bian, Shimin, Li, Qiutong, Fu, Fengqing, Zou, Xinwei, Zhang, Lin, Bast, Robert C, Lu, Zhen, Guo, Lingchuan, Chen, Youguo, Zhou, Jinhua. ""SIK2 promotes ovarian cancer cell motility and metastasis by phosphorylating MYLK."" Molecular oncology, 2022, pp. 2558-2574.
[20] Fu, Ying, Zhang, Xiuzhi, Liang, Xujun, Chen, Yongheng, Chen, Zhuchu, Xiao, Zhefeng. ""CapG promoted nasopharyngeal carcinoma cell motility involving Rho motility pathway independent of ROCK."" World journal of surgical oncology, 2022, pp. 347.
[21] Fournier, Ninon, Fabre, Alexandre. ""Smooth muscle motility disorder phenotypes: A systematic review of cases associated with seven pathogenic genes (<i>ACTG2</i>, <i>MYH11</i>, <i>FLNA</i>, <i>MYLK</i>, <i>RAD21</i>, <i>MYL9</i> and <i>LMOD1</i>)."" Intractable & rare diseases research, 2022, pp. 113-119.
[22] Li, Dong, March, Michael E, Fortugno, Paola, Cox, Liza L, Matsuoka, Leticia S, Monetta, Rosanna, Seiler, Christoph, Pyle, Louise C, Bedoukian, Emma C, Sánchez-Soler, María José, Caluseriu, Oana, Grand, Katheryn, Tam, Allison, Aycinena, Alicia R P, Camerota, Letizia, Guo, Yiran, Sleiman, Patrick, Callewaert, Bert, Kumps, Candy, Dheedene, Annelies, Buckley, Michael, Kirk, Edwin P, Turner, Anne, Kamien, Benjamin, Patel, Chirag, Wilson, Meredith, Roscioli, Tony, Christodoulou, John, Cox, Timothy C, Zackai, Elaine H, Brancati, Francesco, Hakonarson, Hakon, Bhoj, Elizabeth J. ""Pathogenic variants in CDH11 impair cell adhesion and cause Teebi hypertelorism syndrome."" Human genetics, 2021, pp. 1061-1076.
[23] Yoon, Sarah, Choi, Ji-Hye, Kim, Sung Joo, Lee, Eun-Ju, Shah, Masaud, Choi, Sangdun, Woo, Hyun Goo. ""EPHB6 mutation induces cell adhesion-mediated paclitaxel resistance via EPHA2 and CDH11 expression."" Experimental & molecular medicine, 2019, pp. 1-12.
[24] Guo, Qianqian, Furuta, Kunimaro, Islam, Shahidul, Caporarello, Nunzia, Kostallari, Enis, Dielis, Kobe, Tschumperlin, Daniel J, Hirsova, Petra, Ibrahim, Samar H. ""Liver sinusoidal endothelial cell expressed vascular cell adhesion molecule 1 promotes liver fibrosis."" Frontiers in immunology, 2022, pp. 983255.
[25] Petrosino, Jennifer M, Leask, Andrew, Accornero, Federica. ""Genetic manipulation of CCN2/CTGF unveils cell-specific ECM-remodeling effects in injured skeletal muscle."" FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2019, pp. 2047-2057.
[26] Tanaka, Hiroyoshi Y, Kitahara, Kentaro, Sasaki, Naoki, Nakao, Natsumi, Sato, Kae, Narita, Hirokazu, Shimoda, Hiroshi, Matsusaki, Michiya, Nishihara, Hiroshi, Masamune, Atsushi, Kano, Mitsunobu R. ""Pancreatic stellate cells derived from human pancreatic cancer demonstrate aberrant SPARC-dependent ECM remodeling in 3D engineered fibrotic tissue of clinically relevant thickness."" Biomaterials, 2019, pp. 355-367.
[27] Wang, Wei, Runkle, Kristin B, Terkowski, Samantha M, Ekaireb, Rachel I, Witze, Eric S. ""Protein Depalmitoylation Is Induced by Wnt5a and Promotes Polarized Cell Behavior."" The Journal of biological chemistry, 2015, pp. 15707-15716.
"	0.57726115	0.5494021	Tied	LLM	NA
Diff. expressed gene set	ESTROGEN RESPONSE EARLY	NA	ABAT ABCA3 ABHD2 ABLIM1 ADCY1 ADCY9 ADD3 AFF1 AKAP1 ALDH3B1 AMFR ANXA9 AQP3 AR AREG ARL3 ASB13 B4GALT1 BAG1 BCL11B BCL2 BHLHE40 BLVRB CA12 CALB2 CALCR CANT1 CBFA2T3 CCN5 CCND1 CD44 CELSR1 CELSR2 CHPT1 CISH CLDN7 CLIC3 CXCL12 CYP26B1 DEPTOR DHCR7 DHRS2 DHRS3 DLC1 DYNLT3 EGR3 ELF1 ELF3 ELOVL2 ELOVL5 ENDOD1 ESRP2 FAM102A FARP1 FASN FCMR FDFT1 FHL2 FKBP4 FKBP5 FLNB FOS FOXC1 FRK GAB2 GFRA1 GJA1 GLA GREB1 HES1 HR HSPB8 IGF1R IGFBP4 IL17RB IL6ST INHBB INPP5F ISG20L2 ITPK1 JAK2 KAZN KCNK15 KCNK5 KDM4B KLF10 KLF4 KLK10 KRT13 KRT15 KRT18 KRT19 KRT8 LAD1 LRIG1 MAPT MAST4 MED13L MED24 MICB MINDY1 MLPH MPPED2 MREG MSMB MUC1 MYB MYBBP1A MYBL1 MYC MYOF NADSYN1 NAV2 NBL1 NCOR2 NPY1R NRIP1 NXT1 OLFM1 OLFML3 OPN3 OVOL2 P2RY2 PAPSS2 PDLIM3 PDZK1 PEX11A PGR PLAAT3 PMAIP1 PODXL PPIF PRSS23 PTGES RAB17 RAB31 RAPGEFL1 RARA RASGRP1 RBBP8 REEP1 RET RETREG1 RHOBTB3 RHOD RPS6KA2 RRP12 SCARB1 SCNN1A SEC14L2 SEMA3B SFN SH3BP5 SIAH2 SLC16A1 SLC19A2 SLC1A1 SLC1A4 SLC22A5 SLC24A3 SLC26A2 SLC27A2 SLC2A1 SLC37A1 SLC39A6 SLC7A2 SLC7A5 SLC9A3R1 SNX24 SOX3 STC2 SULT2B1 SVIL SYBU SYNGR1 SYT12 TBC1D30 TFAP2C TFF1 TFF3 TGIF2 TGM2 THSD4 TIAM1 TIPARP TJP3 TMEM164 TMPRSS3 TOB1 TPBG TPD52L1 TSKU TTC39A TUBB2B UGCG UNC119 WFS1 WWC1 XBP1 ZNF185	200	7.643856189774724	Vascular Transport 	GO:0010232	SLC7A5;SLC9A3R1;SLC22A5;SLC24A3;SLC16A1;SLC1A1;SLC2A1;SLC1A4;SLC7A2	9	4.5	1.45e-7	1.42392e-4	Cell Proliferation and Differentiation	"The interacting proteins in this system are involved in various aspects of cell proliferation, differentiation, and survival. Key proteins include:

1. CCND1: Cyclin D1 is a regulatory subunit of CDK4/6, which promotes cell cycle progression from G1 to S phase. Overexpression of CCND1 is associated with various cancers.

2. MYC: A transcription factor that regulates cell growth, proliferation, and apoptosis. MYC is often overexpressed in cancer cells, promoting tumorigenesis.

3. BCL2: An anti-apoptotic protein that prevents cell death by inhibiting the release of cytochrome c from mitochondria. Overexpression of BCL2 is associated with resistance to apoptosis in cancer cells.

4. IGF1R: Insulin-like growth factor 1 receptor is a tyrosine kinase receptor that plays a crucial role in cell growth, differentiation, and survival. Activation of IGF1R signaling is implicated in various cancers.

5. CD44: A cell surface glycoprotein involved in cell adhesion, migration, and signaling. CD44 is a marker for cancer stem cells and is associated with tumor progression and metastasis.

6. ESRP2: Epithelial splicing regulatory protein 2 is involved in alternative splicing of pre-mRNA, which contributes to epithelial cell differentiation. Dysregulation of ESRP2 has been implicated in cancer progression.

7. HES1: A transcriptional repressor involved in the Notch signaling pathway, which regulates cell fate decisions during development. Aberrant Notch signaling and HES1 expression are associated with various cancers.

8. JAK2: Janus kinase 2 is a non-receptor tyrosine kinase involved in cytokine signaling and cell proliferation. JAK2 mutations are associated with myeloproliferative neoplasms.

9. PGR: Progesterone receptor is a nuclear hormone receptor that mediates the effects of progesterone on gene expression and cell proliferation. Altered PGR expression is associated with hormone-dependent cancers.

10. RET: A receptor tyrosine kinase involved in neural crest cell development and differentiation. RET mutations are associated with multiple endocrine neoplasia type 2 and other cancers.

These proteins, along with others in the system, contribute to the regulation of cell proliferation, differentiation, and survival. Dysregulation of these processes can lead to various diseases, including cancer."	10	5	"The interacting proteins in this system are involved in various aspects of cell proliferation, differentiation, and survival. Key proteins include:

1. CCND1: Cyclin D1 is a regulatory subunit of CDK4/6, which promotes cell cycle progression from G1 to S phase. Overexpression of CCND1 is associated with various cancers.[1][2][3]

2. MYC: A transcription factor that regulates cell growth, proliferation, and apoptosis. MYC is often overexpressed in cancer cells, promoting tumorigenesis.[4][5][6]

3. BCL2: An anti-apoptotic protein that prevents cell death by inhibiting the release of cytochrome c from mitochondria. Overexpression of BCL2 is associated with resistance to apoptosis in cancer cells.[7][8][9]

4. IGF1R: Insulin-like growth factor 1 receptor is a tyrosine kinase receptor that plays a crucial role in cell growth, differentiation, and survival. Activation of IGF1R signaling is implicated in various cancers.[10][11][12]

5. CD44: A cell surface glycoprotein involved in cell adhesion, migration, and signaling. CD44 is a marker for cancer stem cells and is associated with tumor progression and metastasis.[13][14][15]

6. ESRP2: Epithelial splicing regulatory protein 2 is involved in alternative splicing of pre-mRNA, which contributes to epithelial cell differentiation. Dysregulation of ESRP2 has been implicated in cancer progression.[16][17][18]

7. HES1: A transcriptional repressor involved in the Notch signaling pathway, which regulates cell fate decisions during development. Aberrant Notch signaling and HES1 expression are associated with various cancers.[19][20][21]

8. JAK2: Janus kinase 2 is a non-receptor tyrosine kinase involved in cytokine signaling and cell proliferation. JAK2 mutations are associated with myeloproliferative neoplasms.[22][23][24]

9. PGR: Progesterone receptor is a nuclear hormone receptor that mediates the effects of progesterone on gene expression and cell proliferation. Altered PGR expression is associated with hormone-dependent cancers.[25][26][27]

10. RET: A receptor tyrosine kinase involved in neural crest cell development and differentiation. RET mutations are associated with multiple endocrine neoplasia type 2 and other cancers.[28][29][30]

These proteins, along with others in the system, contribute to the regulation of cell proliferation, differentiation, and survival. Dysregulation of these processes can lead to various diseases, including cancer.

========================================================================================================================================================================================================
[1] Goel, Shom, DeCristo, Molly J, McAllister, Sandra S, Zhao, Jean J. ""CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest."" Trends in cell biology, 2018, pp. 911-925.
[2] Kumarasamy, Vishnu, Vail, Paris, Nambiar, Ram, Witkiewicz, Agnieszka K, Knudsen, Erik S. ""Functional Determinants of Cell Cycle Plasticity and Sensitivity to CDK4/6 Inhibition."" Cancer research, 2021, pp. 1347-1360.
[3] Cai, Zijie, Wang, Jingru, Li, Yudong, Shi, Qianfeng, Jin, Liang, Li, Shunying, Zhu, Mengdi, Wang, Qi, Wong, Lok Lam, Yang, Wang, Lai, Hongna, Gong, Chang, Yao, Yandan, Liu, Yujie, Zhang, Jun, Yao, Herui, Liu, Qiang. ""Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in breast cancer that can be reversed by PI3K/mTOR inhibitors."" Science China. Life sciences, 2023, pp. 94-109.
[4] Wang, Ruoning, Dillon, Christopher P, Shi, Lewis Zhichang, Milasta, Sandra, Carter, Robert, Finkelstein, David, McCormick, Laura L, Fitzgerald, Patrick, Chi, Hongbo, Munger, Joshua, Green, Douglas R. ""The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation."" Immunity, 2011, pp. 871-82.
[5] Carroll, Patrick A, Freie, Brian W, Mathsyaraja, Haritha, Eisenman, Robert N. ""The MYC transcription factor network: balancing metabolism, proliferation and oncogenesis."" Frontiers of medicine, 2018, pp. 412-425.
[6] Garcia-Reyero, Julia, Martinez Magunacelaya, Nerea, Gonzalez de Villambrosia, Sonia, Loghavi, Sanam, Gomez Mediavilla, Angela, Tonda, Raul, Beltran, Sergi, Gut, Marta, Pereña Gonzalez, Ainara, d'Ámore, Emanuele, Visco, Carlo, Khoury, Joseph D, Montes-Moreno, Santiago. ""Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma."" Haematologica, 2021, pp. 1120-1128.
[7] Kumar, Tadi Satish, Kari, Vijayalakshmi, Choudhary, Bibha, Nambiar, Mridula, Akila, T S, Raghavan, Sathees C. ""Anti-apoptotic protein BCL2 down-regulates DNA end joining in cancer cells."" The Journal of biological chemistry, 2010, pp. 32657-70.
[8] Dremina, Elena S, Sharov, Victor S, Kumar, Keshava, Zaidi, Asma, Michaelis, Elias K, Schöneich, Christian. ""Anti-apoptotic protein Bcl-2 interacts with and destabilizes the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA)."" The Biochemical journal, 2004, pp. 361-70.
[9] Strasser, Andreas, Vaux, David L. ""Viewing BCL2 and cell death control from an evolutionary perspective."" Cell death and differentiation, 2018, pp. 13-20.
[10] Guo, Long, Bai, Yu, Ji, Shuzhe, Ma, Hong. ""MicroRNA‑98 suppresses cell growth and invasion of retinoblastoma via targeting the IGF1R/k‑Ras/Raf/MEK/ERK signaling pathway."" International journal of oncology, 2019, pp. 807-820.
[11] Chu, Yu-De, Fan, Tan-Chi, Lai, Ming-Wei, Yeh, Chau-Ting. ""GALNT14-mediated O-glycosylation on PHB2 serine-161 enhances cell growth, migration and drug resistance by activating IGF1R cascade in hepatoma cells."" Cell death & disease, 2022, pp. 956.
[12] Farabaugh, Susan M, Boone, David N, Lee, Adrian V. ""Role of IGF1R in Breast Cancer Subtypes, Stemness, and Lineage Differentiation."" Frontiers in endocrinology, 2015, pp. 59.
[13] Wolf, Kayla J, Shukla, Poojan, Springer, Kelsey, Lee, Stacey, Coombes, Jason D, Choy, Caleb J, Kenny, Samuel J, Xu, Ke, Kumar, Sanjay. ""A mode of cell adhesion and migration facilitated by CD44-dependent microtentacles."" Proceedings of the National Academy of Sciences of the United States of America, 2020, pp. 11432-11443.
[14] Binmadi, Nada, Elsissi, Azza, Elsissi, Nadia. ""Expression of cell adhesion molecule CD44 in mucoepidermoid carcinoma and its association with the tumor behavior."" Head & face medicine, 2016, pp. 8.
[15] Roszkowska, Matylda, Skupien, Anna, Wójtowicz, Tomasz, Konopka, Anna, Gorlewicz, Adam, Kisiel, Magdalena, Bekisz, Marek, Ruszczycki, Blazej, Dolezyczek, Hubert, Rejmak, Emilia, Knapska, Ewelina, Mozrzymas, Jerzy W, Wlodarczyk, Jakub, Wilczynski, Grzegorz M, Dzwonek, Joanna. ""CD44: a novel synaptic cell adhesion molecule regulating structural and functional plasticity of dendritic spines."" Molecular biology of the cell, 2016, pp. 4055-4066.
[16] Warzecha, Claude C, Shen, Shihao, Xing, Yi, Carstens, Russ P. ""The epithelial splicing factors ESRP1 and ESRP2 positively and negatively regulate diverse types of alternative splicing events."" RNA biology, 2009, pp. 546-62.
[17] Hayakawa, Akira, Saitoh, Masao, Miyazawa, Keiji. ""Dual Roles for Epithelial Splicing Regulatory Proteins 1 (ESRP1) and 2 (ESRP2) in Cancer Progression."" Advances in experimental medicine and biology, 2017, pp. 33-40.
[18] Freytag, Morton, Kluth, Martina, Bady, Elena, Hube-Magg, Claudia, Makrypidi-Fraune, Georgia, Heinzer, Hans, Höflmayer, Doris, Weidemann, Sören, Uhlig, Ria, Huland, Hartwig, Graefen, Markus, Bernreuther, Christian, Wittmer, Corinna, Tsourlakis, Maria Christina, Minner, Sarah, Dum, David, Hinsch, Andrea, Luebke, Andreas M, Simon, Ronald, Sauter, Guido, Schlomm, Thorsten, Möller, Katharina. ""Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancer."" BMC cancer, 2020, pp. 1220.
[19] Ou-Yang, Hai-Feng, Zhang, Hong-Wei, Wu, Chang-Gui, Zhang, Ping, Zhang, Jian, Li, Jun-Chang, Hou, Li-Hong, He, Fei, Ti, Xin-Yu, Song, Li-Qiang, Zhang, Su-Zhen, Feng, Lei, Qi, Hao-Wen, Han, Hua. ""Notch signaling regulates the FOXP3 promoter through RBP-J- and Hes1-dependent mechanisms."" Molecular and cellular biochemistry, 2009, pp. 109-14.
[20] Shi, Yan, Shu, Bin, Yang, Ronghua, Xu, Yingbin, Xing, Bangrong, Liu, Jian, Chen, Lei, Qi, Shaohai, Liu, Xusheng, Wang, Peng, Tang, Jinming, Xie, Julin. ""Wnt and Notch signaling pathway involved in wound healing by targeting c-Myc and Hes1 separately."" Stem cell research & therapy, 2015, pp. 120.
[21] Luque-Molina, Inma, Shi, Yan, Abdullah, Yomn, Monaco, Sara, Hölzl-Wenig, Gabriele, Mandl, Claudia, Ciccolini, Francesca. ""The Orphan Nuclear Receptor TLX Represses Hes1 Expression, Thereby Affecting NOTCH Signaling and Lineage Progression in the Adult SEZ."" Stem cell reports, 2019, pp. 132-146.
[22] Robertson, Scott A, Koleva, Rositsa I, Argetsinger, Lawrence S, Carter-Su, Christin, Marto, Jarrod A, Feener, Edward P, Myers, Martin G. ""Regulation of Jak2 function by phosphorylation of Tyr317 and Tyr637 during cytokine signaling."" Molecular and cellular biology, 2009, pp. 3367-78.
[23] Waiboci, Lilian W, Ahmed, Chulbul M, Mujtaba, Mustafa G, Flowers, Lawrence O, Martin, James P, Haider, Mohammed I, Johnson, Howard M. ""Both the suppressor of cytokine signaling 1 (SOCS-1) kinase inhibitory region and SOCS-1 mimetic bind to JAK2 autophosphorylation site: implications for the development of a SOCS-1 antagonist."" Journal of immunology (Baltimore, Md. : 1950), 2007, pp. 5058-68.
[24] Zhang, Lei, Wang, Yi, Wu, Guorao, Rao, Lizong, Wei, Yanqiu, Yue, Huihui, Yuan, Ting, Yang, Ping, Xiong, Fei, Zhang, Shu, Zhou, Qing, Chen, Zhishui, Li, Jinxiu, Mo, Bi-Wen, Zhang, Huilan, Xiong, Weining, Wang, Cong-Yi. ""Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation."" Cell proliferation, 2020, pp. e12742.
[25] Ghali, Rabeb M, Al-Mutawa, Maryam A, Ebrahim, Bashayer H, Jrah, Hanen H, Zaied, Sonia, Bhiri, Hanen, Hmila, Fahmi, Mahjoub, Touhami, Almawi, Wassim Y. ""Progesterone Receptor (PGR) Gene Variants Associated with Breast Cancer and Associated Features: a Case-Control Study."" Pathology oncology research : POR, 2020, pp. 141-147.
[26] Marinić, Mirna, Lynch, Vincent J. ""Relaxed constraint and functional divergence of the progesterone receptor (PGR) in the human stem-lineage."" PLoS genetics, 2020, pp. e1008666.
[27] Hertz, Daniel L, Henry, N Lynn, Kidwell, Kelley M, Thomas, Dafydd, Goddard, Audrey, Azzouz, Faouzi, Speth, Kelly, Li, Lang, Banerjee, Mousumi, Thibert, Jacklyn N, Kleer, Celina G, Stearns, Vered, Hayes, Daniel F, Skaar, Todd C, Rae, James M. ""ESR1 and PGR polymorphisms are associated with estrogen and progesterone receptor expression in breast tumors."" Physiological genomics, 2016, pp. 688-98.
[28] Perea, Daniel, Guiu, Jordi, Hudry, Bruno, Konstantinidou, Chrysoula, Milona, Alexandra, Hadjieconomou, Dafni, Carroll, Thomas, Hoyer, Nina, Natarajan, Dipa, Kallijärvi, Jukka, Walker, James A, Soba, Peter, Thapar, Nikhil, Burns, Alan J, Jensen, Kim B, Miguel-Aliaga, Irene. ""Ret receptor tyrosine kinase sustains proliferation and tissue maturation in intestinal epithelia."" The EMBO journal, 2017, pp. 3029-3045.
[29] Subbiah, V, Shen, T, Terzyan, S S, Liu, X, Hu, X, Patel, K P, Hu, M, Cabanillas, M, Behrang, A, Meric-Bernstam, F, Vo, P T T, Mooers, B H M, Wu, J. ""Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations."" Annals of oncology : official journal of the European Society for Medical Oncology, 2021, pp. 261-268.
[30] Solomon, Benjamin J, Tan, Lavinia, Lin, Jessica J, Wong, Stephen Q, Hollizeck, Sebastian, Ebata, Kevin, Tuch, Brian B, Yoda, Satoshi, Gainor, Justin F, Sequist, Lecia V, Oxnard, Geoffrey R, Gautschi, Oliver, Drilon, Alexander, Subbiah, Vivek, Khoo, Christine, Zhu, Edward Y, Nguyen, Michele, Henry, Dahlia, Condroski, Kevin R, Kolakowski, Gabrielle R, Gomez, Eliana, Ballard, Joshua, Metcalf, Andrew T, Blake, James F, Dawson, Sarah-Jane, Blosser, Wayne, Stancato, Louis F, Brandhuber, Barbara J, Andrews, Steve, Robinson, Bruce G, Rothenberg, S Michael. ""RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven Malignancies."" Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2020, pp. 541-549.
"	0.35095692	0.29586768	Neither	Neither	NA
Diff. expressed gene set	ESTROGEN RESPONSE LATE	NA	ABCA3 ABHD2 ACOX2 ADD3 AFF1 AGR2 ALDH3A2 ALDH3B1 AMFR ANXA9 AREG ARL3 ASCL1 ASS1 ATP2B4 BAG1 BATF BCL2 BLVRB BTG3 CA12 CA2 CACNA2D2 CALCR CAV1 CCN5 CCNA1 CCND1 CD44 CD9 CDC20 CDC6 CDH1 CELSR2 CHPT1 CHST8 CISH CKB CLIC3 COX6C CPE CXCL12 CXCL14 CYP26B1 CYP4F11 DCXR DHCR7 DHRS2 DLG5 DNAJC1 DNAJC12 DUSP2 DYNLT3 EGR3 ELOVL5 EMP2 ETFB FABP5 FAM102A FARP1 FDFT1 FGFR3 FKBP4 FKBP5 FLNB FOS FOXC1 FRK GAL GALE GFUS GINS2 GJB3 GLA GPER1 HMGCS2 HOMER2 HPRT1 HR HSPA4L HSPB8 ID2 IDH2 IGFBP4 IGSF1 IL17RB IL6ST IMPA2 ISG20 ITPK1 JAK1 JAK2 KCNK5 KIF20A KLF4 KLK10 KLK11 KRT13 KRT19 LAMC2 LARGE1 LLGL2 LSR LTF MAPK13 MAPT MDK MEST METTL3 MICB MOCS2 MYB MYOF NAB2 NBL1 NCOR2 NMU NPY1R NRIP1 NXT1 OLFM1 OPN3 OVOL2 PAPSS2 PCP4 PDCD4 PDLIM3 PDZK1 PERP PGR PKP3 PLAAT3 PLAC1 PLK4 PLXNB1 PPIF PRKAR2B PRLR PRSS23 PTGER3 PTGES PTPN6 RAB31 RABEP1 RAPGEFL1 RBBP8 RET RNASEH2A RPS6KA2 S100A9 SCARB1 SCNN1A SCUBE2 SEMA3B SERPINA1 SERPINA3 SERPINA5 SFN SGK1 SIAH2 SLC16A1 SLC1A4 SLC22A5 SLC24A3 SLC26A2 SLC27A2 SLC29A1 SLC2A8 SLC7A5 SLC9A3R1 SNX10 SORD SOX3 ST14 ST6GALNAC2 STIL SULT2B1 TFAP2C TFF1 TFF3 TFPI2 TH TIAM1 TJP3 TMPRSS3 TNNC1 TOB1 TOP2A TPBG TPD52L1 TPSAB1 TRIM29 TSPAN13 TST UGDH UNC13B WFS1 XBP1 XRCC3 ZFP36	200	7.643856189774724	Transport Across Blood-Brain Barrier 	GO:0150104	SLC7A5;SLC9A3R1;SLC22A5;SLC24A3;SLC16A1;FABP5;ATP2B4;SLC1A4;SLC29A1	9	4.5	1.78e-7	3.50628e-4	Cell Proliferation and Differentiation	"The system of interacting proteins primarily performs the biological process of cell proliferation and differentiation. This is supported by the following points:

1. Presence of cell cycle regulators: Proteins such as CCNA1, CCND1, CDC20, and CDC6 are involved in cell cycle regulation, promoting cell proliferation.

2. Involvement of growth factors and receptors: Proteins like AREG, FGFR3, and IL6ST are growth factors or receptors that stimulate cell growth and differentiation.

3. Role of transcription factors: Proteins such as ASCL1, BATF, FOXC1, KLF4, and MYB are transcription factors that regulate gene expression, influencing cell differentiation and development.

4. Involvement of cell adhesion molecules: Proteins like CD44, CDH1, and LAMC2 are involved in cell adhesion, which is crucial for cell differentiation and tissue organization.

5. Presence of signaling molecules: Proteins such as JAK1, JAK2, MAPK13, and PRKAR2B are involved in intracellular signaling pathways, which regulate cell proliferation and differentiation.

6. Role of apoptosis regulators: Proteins like BCL2 and PDCD4 are involved in regulating apoptosis, which is essential for maintaining tissue homeostasis and proper cell differentiation.

7. Involvement of protein kinases and phosphatases: Proteins such as FRK, PTPN6, and RPS6KA2 are kinases or phosphatases that modulate protein activity, influencing cell proliferation and differentiation.

8. Role of ion channels and transporters: Proteins like ATP2B4, CACNA2D2, and SLC7A5 are involved in ion transport, which can affect cell signaling and differentiation.

9. Involvement of extracellular matrix proteins: Proteins like CAV1, FN1, and PLXNB1 are involved in the extracellular matrix, which plays a role in cell differentiation and tissue organization.

10. Presence of metabolic enzymes: Proteins like IDH2, UGDH, and ALDH3A2 are involved in cellular metabolism, which can influence cell proliferation and differentiation."	32	16	"The system of interacting proteins primarily performs the biological process of cell proliferation and differentiation. This is supported by the following points:

1. Presence of cell cycle regulators: Proteins such as CCNA1, CCND1, CDC20, and CDC6 are involved in cell cycle regulation, promoting cell proliferation.[1][2][3]

2. Involvement of growth factors and receptors: Proteins like AREG, FGFR3, and IL6ST are growth factors or receptors that stimulate cell growth and differentiation.[4][5][6]

3. Role of transcription factors: Proteins such as ASCL1, BATF, FOXC1, KLF4, and MYB are transcription factors that regulate gene expression, influencing cell differentiation and development.[7][8][9]

4. Involvement of cell adhesion molecules: Proteins like CD44, CDH1, and LAMC2 are involved in cell adhesion, which is crucial for cell differentiation and tissue organization.[10][11][12]

5. Presence of signaling molecules: Proteins such as JAK1, JAK2, MAPK13, and PRKAR2B are involved in intracellular signaling pathways, which regulate cell proliferation and differentiation.[13][14][15]

6. Role of apoptosis regulators: Proteins like BCL2 and PDCD4 are involved in regulating apoptosis, which is essential for maintaining tissue homeostasis and proper cell differentiation.[16][17][18]

7. Involvement of protein kinases and phosphatases: Proteins such as FRK, PTPN6, and RPS6KA2 are kinases or phosphatases that modulate protein activity, influencing cell proliferation and differentiation.[19][20][21]

8. Role of ion channels and transporters: Proteins like ATP2B4, CACNA2D2, and SLC7A5 are involved in ion transport, which can affect cell signaling and differentiation.[22][23][24]

9. Involvement of extracellular matrix proteins: Proteins like CAV1, FN1, and PLXNB1 are involved in the extracellular matrix, which plays a role in cell differentiation and tissue organization.[25][26][27]

10. Presence of metabolic enzymes: Proteins like IDH2, UGDH, and ALDH3A2 are involved in cellular metabolism, which can influence cell proliferation and differentiation.[28][29][30]

========================================================================================================================================================================================================
[1] Wang, Qiong, He, Guopei, Hou, Mengmeng, Chen, Liutao, Chen, Shangwu, Xu, Anlong, Fu, Yonggui. ""Cell Cycle Regulation by Alternative Polyadenylation of CCND1."" Scientific reports, 2018, pp. 6824.
[2] Fujita, M, Yamada, C, Goto, H, Yokoyama, N, Kuzushima, K, Inagaki, M, Tsurumi, T. ""Cell cycle regulation of human CDC6 protein. Intracellular localization, interaction with the human mcm complex, and CDC2 kinase-mediated hyperphosphorylation."" The Journal of biological chemistry, 1999, pp. 25927-32.
[3] Zhao, Shuai, Zhang, Yichi, Lu, Xiuqin, Ding, Han, Han, Bing, Song, Xiaoling, Miao, Huijie, Cui, Xuya, Wei, Shiyin, Liu, Wangrui, Chen, Shuxian, Wang, Jian. ""CDC20 regulates the cell proliferation and radiosensitivity of P53 mutant HCC cells through the Bcl-2/Bax pathway."" International journal of biological sciences, 2021, pp. 3608-3621.
[4] So, F, Daley, T D, Jackson, L, Wysocki, G P. ""Immunohistochemical localization of fibroblast growth factors FGF-1 and FGF-2, and receptors FGFR2 and FGFR3 in the epithelium of human odontogenic cysts and tumors."" Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2001, pp. 428-33.
[5] Lkhagvadorj, Khosbayar, Zeng, Zhijun, Song, Juan, Reinders-Luinge, Marjan, Kooistra, Wierd, Song, Shanshan, Krauss-Etschmann, Susanne, Melgert, Barbro N, Cao, Junjun, Hylkema, Machteld N. ""Prenatal smoke exposure dysregulates lung epithelial cell differentiation in mouse offspring: role for AREG-induced EGFR signaling."" American journal of physiology. Lung cellular and molecular physiology, 2020, pp. L742-L751.
[6] Berasain, Carmen, Avila, Matías A. ""Amphiregulin."" Seminars in cell & developmental biology, 2014, pp. 31-41.
[7] Dubos, Christian, Stracke, Ralf, Grotewold, Erich, Weisshaar, Bernd, Martin, Cathie, Lepiniec, Loïc. ""MYB transcription factors in Arabidopsis."" Trends in plant science, 2010, pp. 573-81.
[8] Li, Jinlu, Han, Guoliang, Sun, Cuifeng, Sui, Na. ""Research advances of MYB transcription factors in plant stress resistance and breeding."" Plant signaling & behavior, 2019, pp. 1613131.
[9] Shchuka, Virlana M, Khader, Nawrah, Dorogin, Anna, Shynlova, Oksana, Mitchell, Jennifer A. ""MYB and ELF3 differentially modulate labor-inducing gene expression in myometrial cells."" PloS one, 2023, pp. e0271081.
[10] Wolf, Kayla J, Shukla, Poojan, Springer, Kelsey, Lee, Stacey, Coombes, Jason D, Choy, Caleb J, Kenny, Samuel J, Xu, Ke, Kumar, Sanjay. ""A mode of cell adhesion and migration facilitated by CD44-dependent microtentacles."" Proceedings of the National Academy of Sciences of the United States of America, 2020, pp. 11432-11443.
[11] Goodison, S, Urquidi, V, Tarin, D. ""CD44 cell adhesion molecules."" Molecular pathology : MP, 1999, pp. 189-96.
[12] Binmadi, Nada, Elsissi, Azza, Elsissi, Nadia. ""Expression of cell adhesion molecule CD44 in mucoepidermoid carcinoma and its association with the tumor behavior."" Head & face medicine, 2016, pp. 8.
[13] Sopjani, Mentor, Morina, Rifat, Uka, Valdet, Xuan, Nguyen Thi, Dërmaku-Sopjani, Miribane. ""JAK2-mediated Intracellular Signaling."" Current molecular medicine, 2021, pp. 417-425.
[14] Anand, Shubha, Stedham, Frances, Gudgin, Emma, Campbell, Peter, Beer, Philip, Green, Anthony R, Huntly, Brian J P. ""Increased basal intracellular signaling patterns do not correlate with JAK2 genotype in human myeloproliferative neoplasms."" Blood, 2011, pp. 1610-21.
[15] Zhang, Lei, Wang, Yi, Wu, Guorao, Rao, Lizong, Wei, Yanqiu, Yue, Huihui, Yuan, Ting, Yang, Ping, Xiong, Fei, Zhang, Shu, Zhou, Qing, Chen, Zhishui, Li, Jinxiu, Mo, Bi-Wen, Zhang, Huilan, Xiong, Weining, Wang, Cong-Yi. ""Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation."" Cell proliferation, 2020, pp. e12742.
[16] Zhou, Shiwei, Wang, Yingying, Zhu, Jun-Jie. ""Simultaneous Detection of Tumor Cell Apoptosis Regulators Bcl-2 and Bax through a Dual-Signal-Marked Electrochemical Immunosensor."" ACS applied materials & interfaces, 2016, pp. 7674-82.
[17] Richardson, Alan, Kaye, Stanley B. ""Pharmacological inhibition of the Bcl-2 family of apoptosis regulators as cancer therapy."" Current molecular pharmacology, 2008, pp. 244-54.
[18] Narayan, Shashi, Chandra, Jagdish, Sharma, Meenal, Naithani, Rahul, Sharma, Sunita. ""Expression of apoptosis regulators Bcl-2 and Bax in childhood acute lymphoblastic leukemia."" Hematology (Amsterdam, Netherlands), 2007, pp. 39-43.
[19] Yamada, Yuta, Kimura, Naoki, Takayama, Ken-Ichi, Sato, Yusuke, Suzuki, Takashi, Azuma, Kotaro, Fujimura, Tetsuya, Ikeda, Kazuhiro, Kume, Haruki, Inoue, Satoshi. ""TRIM44 promotes cell proliferation and migration by inhibiting FRK in renal cell carcinoma."" Cancer science, 2020, pp. 881-890.
[20] Fang, Huilong, Ma, Wei, Guo, Xuli, Wang, Junjie. ""PTPN6 promotes chemosensitivity of colorectal cancer cells via inhibiting the SP1/MAPK signalling pathway."" Cell biochemistry and function, 2021, pp. 392-400.
[21] Rosenberger, Andrea F N, Hilhorst, Riet, Coart, Elisabeth, García Barrado, Leandro, Naji, Faris, Rozemuller, Annemieke J M, van der Flier, Wiesje M, Scheltens, Philip, Hoozemans, Jeroen J M, van der Vies, Saskia M. ""Protein Kinase Activity Decreases with Higher Braak Stages of Alzheimer's Disease Pathology."" Journal of Alzheimer's disease : JAD, 2016, pp. 927-43.
[22] Ni, Feifei, Zhang, Tao, Xiao, Wanan, Dong, Hong, Gao, Jian, Liu, YaFeng, Li, Jianjun. ""IL-18-Mediated SLC7A5 Overexpression Enhances Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells <i>via</i> the c-MYC Pathway."" Frontiers in cell and developmental biology, 2021, pp. 748831.
[23] Demian, Wael L, Persaud, Avinash, Jiang, Chong, Coyaud, Étienne, Liu, Shixuan, Kapus, Andras, Kafri, Ran, Raught, Brian, Rotin, Daniela. ""The Ion Transporter NKCC1 Links Cell Volume to Cell Mass Regulation by Suppressing mTORC1."" Cell reports, 2019, pp. 1886-1896.e6.
[24] Kolodecik, Thomas R, Reed, Anamika M, Date, Kimie, Shugrue, Christine A, Patel, Vikhil, Chung, Shang-Lin, Desir, Gary V, Gorelick, Fred S. ""The serum protein renalase reduces injury in experimental pancreatitis."" The Journal of biological chemistry, 2017, pp. 21047-21059.
[25] Žlajpah, Margareta, Hauptman, Nina, Boštjančič, Emanuela, Zidar, Nina. ""Differential expression of extracellular matrix‑related genes DCN, EPHA4, FN1, SPARC, SPON2 and SPP1 in colorectal carcinogenesis."" Oncology reports, 2019, pp. 1539-1548.
[26] Mendoza-Topaz, C, Nelson, G, Howard, G, Hafner, S, Rademacher, P, Frick, M, Nichols, B J. ""Cells respond to deletion of CAV1 by increasing synthesis of extracellular matrix."" PloS one, 2018, pp. e0205306.
[27] Viana, Luciano de Souza, Affonso, Renato José, Silva, Sandra Regina Morini, Denadai, Marcos Vinicius Araujo, Matos, Delcio, Salinas de Souza, Carolina, Waisberg, Jaques. ""Relationship between the expression of the extracellular matrix genes SPARC, SPP1, FN1, ITGA5 and ITGAV and clinicopathological parameters of tumor progression and colorectal cancer dissemination."" Oncology, 2013, pp. 81-91.
[28] Stein, Eytan M. ""Molecular Pathways: IDH2 Mutations-Co-opting Cellular Metabolism for Malignant Transformation."" Clinical cancer research : an official journal of the American Association for Cancer Research, 2016, pp. 16-9.
[29] Figueroa, Maria E, Abdel-Wahab, Omar, Lu, Chao, Ward, Patrick S, Patel, Jay, Shih, Alan, Li, Yushan, Bhagwat, Neha, Vasanthakumar, Aparna, Fernandez, Hugo F, Tallman, Martin S, Sun, Zhuoxin, Wolniak, Kristy, Peeters, Justine K, Liu, Wei, Choe, Sung E, Fantin, Valeria R, Paietta, Elisabeth, Löwenberg, Bob, Licht, Jonathan D, Godley, Lucy A, Delwel, Ruud, Valk, Peter J M, Thompson, Craig B, Levine, Ross L, Melnick, Ari. ""Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation."" Cancer cell, 2010, pp. 553-67.
[30] Xu, Xuanhao, Wang, Lu, Liu, Bofeng, Xie, Wei, Chen, Ye-Guang. ""Activin/Smad2 and Wnt/β-catenin up-regulate HAS2 and ALDH3A2 to facilitate mesendoderm differentiation of human embryonic stem cells."" The Journal of biological chemistry, 2018, pp. 18444-18453.
"	0.336465	0.25823507	Neither	Neither	NA
Diff. expressed gene set	FATTY ACID METABOLISM	NA	AADAT ACAA1 ACAA2 ACADL ACADM ACADS ACADVL ACAT2 ACO2 ACOT2 ACOT8 ACOX1 ACSL1 ACSL4 ACSL5 ACSM3 ACSS1 ADH1C ADH7 ADIPOR2 ADSL ALAD ALDH1A1 ALDH3A1 ALDH3A2 ALDH9A1 ALDOA AOC3 APEX1 AQP7 AUH BCKDHB BLVRA BMPR1B BPHL CA2 CA4 CA6 CBR1 CBR3 CD1D CD36 CEL CIDEA CPOX CPT1A CPT2 CRAT CRYZ CYP1A1 CYP4A11 CYP4A22 D2HGDH DECR1 DHCR24 DLD DLST ECH1 ECHS1 ECI1 ECI2 EHHADH ELOVL5 ENO2 ENO3 EPHX1 ERP29 ETFDH FABP1 FABP2 FASN FH FMO1 G0S2 GABARAPL1 GAD2 GAPDHS GCDH GLUL GPD1 GPD2 GRHPR GSTZ1 H2AZ1 HADH HADHB HAO2 HCCS HIBCH HMGCL HMGCS1 HMGCS2 HPGD HSD17B10 HSD17B11 HSD17B4 HSD17B7 HSDL2 HSP90AA1 HSPH1 IDH1 IDH3B IDH3G IDI1 IL4I1 INMT KMT5A LDHA LGALS1 LTC4S MAOA MCEE MDH1 MDH2 ME1 METAP1 MGLL MIF MIX23 MLYCD NBN NCAPH2 NSDHL NTHL1 ODC1 OSTC PCBD1 PDHA1 PDHB PPARA PRDX6 PSME1 PTPRG PTS RAP1GDS1 RDH11 RDH16 REEP6 RETSAT S100A10 SDHA SDHC SDHD SERINC1 SLC22A5 SMS SUCLA2 SUCLG1 SUCLG2 TDO2 TP53INP2 UBE2L6 UGDH UROD UROS VNN1 XIST YWHAH	158	7.303780748177103	Fatty Acid Beta-Oxidation 	GO:0006635	GCDH;ACADVL;ACOT8;ACAA2;ECHS1;ECI1;ECI2;ETFDH;HSD17B4;HSD17B10;ACAT2;HADHB;ACADL;AUH;CPT2;ACOX1;EHHADH;ACADM;ACAA1;ACADS;CRAT;DECR1	22	13.924050632911392	5.07e-34	4.760000000000001e-31	Fatty Acid Metabolism and Oxidation	"The system of interacting proteins primarily involves fatty acid metabolism and oxidation. The following points support this conclusion:

1. Presence of key enzymes in fatty acid metabolism: The system includes proteins such as ACSL1, ACSL4, ACSL5 (acyl-CoA synthetases), ACADM, ACADS, ACADVL (acyl-CoA dehydrogenases), and CPT1A, CPT2 (carnitine palmitoyltransferases), which are crucial for fatty acid activation, beta-oxidation, and transport into mitochondria.

2. Involvement in fatty acid synthesis and elongation: Proteins like FASN (fatty acid synthase) and ELOVL5 (elongation of very long-chain fatty acids protein 5) are involved in fatty acid synthesis and elongation, further supporting the prominence of fatty acid metabolism in this system.

3. Peroxisomal fatty acid oxidation: The presence of ACOX1 (acyl-CoA oxidase 1) and EHHADH (enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase) indicates the involvement of peroxisomal fatty acid oxidation in this system.

4. Regulation of fatty acid metabolism: Proteins such as PPARA (peroxisome proliferator-activated receptor alpha) and CD36 (fatty acid translocase) are involved in the regulation of fatty acid metabolism, further emphasizing the importance of this process in the system.

5. Fatty acid binding proteins: The presence of FABP1 and FABP2 (fatty acid-binding proteins) suggests the importance of fatty acid transport and signaling in this system.

6. Mitochondrial energy production: The system includes proteins involved in the tricarboxylic acid (TCA) cycle and oxidative phosphorylation, such as SDHA, SDHC, SDHD (succinate dehydrogenase subunits), and IDH1, IDH3B, IDH3G (isocitrate dehydrogenases), which are essential for energy production from fatty acid oxidation.

In conclusion, the most prominent biological process performed by this system of interacting proteins is fatty acid metabolism and oxidation, supported by the presence of key enzymes, regulatory proteins, and fatty acid binding proteins."	23	14.556962025316457	"The system of interacting proteins primarily involves fatty acid metabolism and oxidation. The following points support this conclusion:

1. Presence of key enzymes in fatty acid metabolism: The system includes proteins such as ACSL1, ACSL4, ACSL5 (acyl-CoA synthetases), ACADM, ACADS, ACADVL (acyl-CoA dehydrogenases), and CPT1A, CPT2 (carnitine palmitoyltransferases), which are crucial for fatty acid activation, beta-oxidation, and transport into mitochondria.[1][2][3]

2. Involvement in fatty acid synthesis and elongation: Proteins like FASN (fatty acid synthase) and ELOVL5 (elongation of very long-chain fatty acids protein 5) are involved in fatty acid synthesis and elongation, further supporting the prominence of fatty acid metabolism in this system.[4][5][6]

3. Peroxisomal fatty acid oxidation: The presence of ACOX1 (acyl-CoA oxidase 1) and EHHADH (enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase) indicates the involvement of peroxisomal fatty acid oxidation in this system.[7][8][9]

4. Regulation of fatty acid metabolism: Proteins such as PPARA (peroxisome proliferator-activated receptor alpha) and CD36 (fatty acid translocase) are involved in the regulation of fatty acid metabolism, further emphasizing the importance of this process in the system.[10][11][12]

5. Fatty acid binding proteins: The presence of FABP1 and FABP2 (fatty acid-binding proteins) suggests the importance of fatty acid transport and signaling in this system.[13][14][15]

6. Mitochondrial energy production: The system includes proteins involved in the tricarboxylic acid (TCA) cycle and oxidative phosphorylation, such as SDHA, SDHC, SDHD (succinate dehydrogenase subunits), and IDH1, IDH3B, IDH3G (isocitrate dehydrogenases), which are essential for energy production from fatty acid oxidation.[16][17][18]

In conclusion, the most prominent biological process performed by this system of interacting proteins is fatty acid metabolism and oxidation, supported by the presence of key enzymes, regulatory proteins, and fatty acid binding proteins.

========================================================================================================================================================================================================
[1] Chen, Junru, Ding, Chaofeng, Chen, Yunhao, Hu, Wendi, Yu, Chengkuan, Peng, Chuanhui, Feng, Xiaode, Cheng, Qiyang, Wu, Wenxuan, Lu, Yuejie, Xie, Haiyang, Zhou, Lin, Wu, Jian, Zheng, Shusen. ""ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway."" Cancer letters, 2021, pp. 154-165.
[2] Luo, Qin, Das, Avash, Oldoni, Federico, Wu, Panyun, Wang, Jiangang, Luo, Fei, Fang, Zhenfei. ""Role of ACSL5 in fatty acid metabolism."" Heliyon, 2023, pp. e13316.
[3] Rajkumar, Abishankari, Liaghati, Awa, Chan, Jessica, Lamothe, Gilles, Dent, Robert, Doucet, Éric, Rabasa-Lhoret, Rémi, Prud'homme, Denis, Harper, Mary-Ellen, Tesson, Frédérique. ""ACSL5 genotype influence on fatty acid metabolism: a cellular, tissue, and whole-body study."" Metabolism: clinical and experimental, 2018, pp. 271-279.
[4] Morais, Sofia, Monroig, Oscar, Zheng, Xiaozhong, Leaver, Michael J, Tocher, Douglas R. ""Highly unsaturated fatty acid synthesis in Atlantic salmon: characterization of ELOVL5- and ELOVL2-like elongases."" Marine biotechnology (New York, N.Y.), 2009, pp. 627-39.
[5] Impheng, Hathaichanok, Pongcharoen, Sutatip, Richert, Lysiane, Pekthong, Dumrongsak, Srisawang, Piyarat. ""The selective target of capsaicin on FASN expression and de novo fatty acid synthesis mediated through ROS generation triggers apoptosis in HepG2 cells."" PloS one, 2014, pp. e107842.
[6] Kuah, Meng-Kiat, Jaya-Ram, Annette, Shu-Chien, Alexander Chong. ""The capacity for long-chain polyunsaturated fatty acid synthesis in a carnivorous vertebrate: Functional characterisation and nutritional regulation of a Fads2 fatty acyl desaturase with Δ4 activity and an Elovl5 elongase in striped snakehead (Channa striata)."" Biochimica et biophysica acta, 2015, pp. 248-60.
[7] You, Lei, Chen, Junbo, Liu, Weiyong, Xiang, Qi, Luo, Zhen, Wang, Wenbiao, Xu, Wei, Wu, Kailang, Zhang, Qi, Liu, Yingle, Wu, Jianguo. ""Enterovirus 71 induces neural cell apoptosis and autophagy through promoting ACOX1 downregulation and ROS generation."" Virulence, 2020, pp. 537-553.
[8] Houten, Sander M, Denis, Simone, Argmann, Carmen A, Jia, Yuzhi, Ferdinandusse, Sacha, Reddy, Janardan K, Wanders, Ronald J A. ""Peroxisomal L-bifunctional enzyme (Ehhadh) is essential for the production of medium-chain dicarboxylic acids."" Journal of lipid research, 2012, pp. 1296-303.
[9] Ranea-Robles, Pablo, Portman, Kensey, Bender, Aaron, Lee, Kyung, He, John Cijiang, Mulholland, David J, Argmann, Carmen, Houten, Sander M. ""Peroxisomal L-bifunctional protein (EHHADH) deficiency causes male-specific kidney hypertrophy and proximal tubular injury in mice."" Kidney360, 2021, pp. 1441-1454.
[10] Zhao, Lei, Zhang, Chang, Luo, Xiaoxiao, Wang, Pei, Zhou, Wei, Zhong, Shan, Xie, Yunxia, Jiang, Yibo, Yang, Ping, Tang, Renkuang, Pan, Qin, Hall, Andrew R, Luong, Tu Vinh, Fan, Jiangao, Varghese, Zac, Moorhead, John F, Pinzani, Massimo, Chen, Yaxi, Ruan, Xiong Z. ""CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis."" Journal of hepatology, 2018, pp. 705-717.
[11] Bonen, A, Dyck, D J, Ibrahimi, A, Abumrad, N A. ""Muscle contractile activity increases fatty acid metabolism and transport and FAT/CD36."" The American journal of physiology, 1999, pp. E642-9.
[12] Melis, Melania, Carta, Gianfranca, Pintus, Stefano, Pintus, Paolo, Piras, Carla A, Murru, Elisabetta, Manca, Claudia, Di Marzo, Vincenzo, Banni, Sebastiano, Tomassini Barbarossa, Iole. ""Polymorphism <i>rs1761667</i> in the <i>CD36</i> Gene Is Associated to Changes in Fatty Acid Metabolism and Circulating Endocannabinoid Levels Distinctively in Normal Weight and Obese Subjects."" Frontiers in physiology, 2017, pp. 1006.
[13] Lin, Ye-Xin, Wu, Xiong-Bo, Zheng, Chu-Wei, Zhang, Qing-Lin, Zhang, Guo-Qiang, Chen, Ke, Zhan, Qiang, An, Fang-Mei. ""Mechanistic Investigation on the Regulation of FABP1 by the IL-6/miR-603 Signaling in the Pathogenesis of Hepatocellular Carcinoma."" BioMed research international, 2021, pp. 8579658.
[14] Khalifa, Olfa, Al-Akl, Neyla S, Errafii, Khaoula, Arredouani, Abdelilah. ""Exendin-4 alleviates steatosis in an in vitro cell model by lowering FABP1 and FOXA1 expression via the Wnt/-catenin signaling pathway."" Scientific reports, 2022, pp. 2226.
[15] Sharaf, Ravi N, Butte, Atul J, Montgomery, Kelli D, Pai, Reetesh, Dudley, Joel T, Pasricha, Pankaj J. ""Computational prediction and experimental validation associating FABP-1 and pancreatic adenocarcinoma with diabetes."" BMC gastroenterology, 2011, pp. 5.
[16] Dekker, Lennard J M, Wu, Suying, Jurriëns, Cherise, Mustafa, Dana A N, Grevers, Frederieke, Burgers, Peter C, Sillevis Smitt, Peter A E, Kros, Johan M, Luider, Theo M. ""Metabolic changes related to the IDH1 mutation in gliomas preserve TCA-cycle activity: An investigation at the protein level."" FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2020, pp. 3646-3657.
[17] May, Jasmine L, Kouri, Fotini M, Hurley, Lisa A, Liu, Juan, Tommasini-Ghelfi, Serena, Ji, Yanrong, Gao, Peng, Calvert, Andrea E, Lee, Andrew, Chandel, Navdeep S, Davuluri, Ramana V, Horbinski, Craig M, Locasale, Jason W, Stegh, Alexander H. ""IDH3α regulates one-carbon metabolism in glioblastoma."" Science advances, 2019, pp. eaat0456.
[18] Lavie, Julie, De Belvalet, Harmony, Sonon, Sessinou, Ion, Ana Madalina, Dumon, Elodie, Melser, Su, Lacombe, Didier, Dupuy, Jean-William, Lalou, Claude, Bénard, Giovanni. ""Ubiquitin-Dependent Degradation of Mitochondrial Proteins Regulates Energy Metabolism."" Cell reports, 2018, pp. 2852-2863.
"	0.90865356	0.74228406	LLM	LLM	NA
Diff. expressed gene set	G2M CHECKPOINT	NA	ABL1 AMD1 ARID4A ATF5 ATRX AURKA AURKB BARD1 BCL3 BIRC5 BRCA2 BUB1 BUB3 CASP8AP2 CBX1 CCNA2 CCNB2 CCND1 CCNF CCNT1 CDC20 CDC25A CDC25B CDC27 CDC45 CDC6 CDC7 CDK1 CDK4 CDKN1B CDKN2C CDKN3 CENPA CENPE CENPF CHAF1A CHEK1 CHMP1A CKS1B CKS2 CTCF CUL1 CUL3 CUL4A CUL5 DBF4 DDX39A DKC1 DMD DR1 DTYMK E2F1 E2F2 E2F3 E2F4 EFNA5 EGF ESPL1 EWSR1 EXO1 EZH2 FANCC FBXO5 FOXN3 G3BP1 GINS2 GSPT1 H2AX H2AZ1 H2AZ2 H2BC12 HIF1A HIRA HMGA1 HMGB3 HMGN2 HMMR HNRNPD HNRNPU HOXC10 HSPA8 HUS1 ILF3 INCENP JPT1 KATNA1 KIF11 KIF15 KIF20B KIF22 KIF23 KIF2C KIF4A KIF5B KMT5A KNL1 KPNA2 KPNB1 LBR LIG3 LMNB1 MAD2L1 MAP3K20 MAPK14 MARCKS MCM2 MCM3 MCM5 MCM6 MEIS1 MEIS2 MKI67 MNAT1 MT2A MTF2 MYBL2 MYC NASP NCL NDC80 NEK2 NOLC1 NOTCH2 NSD2 NUMA1 NUP50 NUP98 NUSAP1 ODC1 ODF2 ORC5 ORC6 PAFAH1B1 PBK PDS5B PLK1 PLK4 PML POLA2 POLE POLQ PRC1 PRIM2 PRMT5 PRPF4B PTTG1 PTTG3P PURA RACGAP1 RAD21 RAD23B RAD54L RASAL2 RBL1 RBM14 RPA2 RPS6KA5 SAP30 SFPQ SLC12A2 SLC38A1 SLC7A1 SLC7A5 SMAD3 SMARCC1 SMC1A SMC2 SMC4 SNRPD1 SQLE SRSF1 SRSF10 SRSF2 SS18 STAG1 STIL STMN1 SUV39H1 SYNCRIP TACC3 TENT4A TFDP1 TGFB1 TLE3 TMPO TNPO2 TOP1 TOP2A TPX2 TRA2B TRAIP TROAP TTK UBE2C UBE2S UCK2 UPF1 WRN XPO1 YTHDC1	200	7.643856189774724	Mitotic Cell Cycle Phase Transition 	GO:0044772	CDKN1B;CUL5;CUL3;CCNF;CUL1;GSPT1;AURKA;CCNB2;CCND1;MYC;CDC27;E2F1;E2F3;POLE;UBE2C;PLK1;CDC7;CDC25A;CDC25B;CCNA2;CUL4A;DBF4;CDK4;UBE2S;CDK1;TACC3;CDKN3	27	13.5	3.9e-30	5.8700000000000005e-27	Cell Cycle Regulation	"The system of interacting proteins primarily performs the biological process of cell cycle regulation. This is evident from the presence of key proteins involved in various stages of the cell cycle, including DNA replication, mitosis, and cell division.

1. DNA replication: Proteins such as CDC6, CDC7, MCM2, MCM3, MCM5, and MCM6 are essential for the initiation and elongation of DNA replication. CDC45 and GINS2 are also involved in the formation of the replication fork.

2. Cell cycle checkpoints: Proteins like CHEK1, ATRX, and HUS1 are involved in the DNA damage response and cell cycle checkpoints, ensuring the fidelity of DNA replication and preventing the propagation of errors.

3. Cyclins and cyclin-dependent kinases (CDKs): The presence of CCNA2, CCNB2, CCND1, CCNF, CDK1, CDK4, CDKN1B, CDKN2C, and CDKN3 indicates the regulation of cell cycle progression through the activation and inhibition of CDKs.

4. Mitosis: Proteins such as AURKA, AURKB, BUB1, BUB3, CENPA, CENPE, CENPF, KIF11, KIF15, KIF20B, KIF22, KIF23, KIF2C, KIF4A, KIF5B, KNL1, MAD2L1, NEK2, NDC80, NUMA1, PLK1, PLK4, PRC1, TACC3, TPX2, and TTK are involved in various aspects of mitosis, including spindle assembly, chromosome segregation, and cytokinesis.

5. DNA repair and recombination: Proteins such as BRCA2, FANCC, LIG3, RAD21, RAD23B, RAD54L, and WRN are involved in DNA repair and recombination processes, ensuring the maintenance of genomic stability.

6. Transcriptional regulation: Proteins like E2F1, E2F2, E2F3, E2F4, MYC, and TFDP1 are involved in the regulation of gene expression during the cell cycle, ensuring the proper timing of events.

7. Protein degradation: The presence of proteins such as CUL1, CUL3, CUL4A, CUL5, and FBXO5 indicates the involvement of the ubiquitin-proteasome system in the degradation of cell cycle regulators, ensuring the proper progression of the cell cycle.

In conclusion, the most prominent biological process performed by this system of interacting proteins is cell cycle regulation, with a focus on DNA replication, cell cycle checkpoints, cyclin-CDK regulation, mitosis, DNA repair, transcriptional regulation, and protein degradation."	64	32	"The system of interacting proteins primarily performs the biological process of cell cycle regulation. This is evident from the presence of key proteins involved in various stages of the cell cycle, including DNA replication, mitosis, and cell division.

1. DNA replication: Proteins such as CDC6, CDC7, MCM2, MCM3, MCM5, and MCM6 are essential for the initiation and elongation of DNA replication. CDC45 and GINS2 are also involved in the formation of the replication fork.[1][2][3]

2. Cell cycle checkpoints: Proteins like CHEK1, ATRX, and HUS1 are involved in the DNA damage response and cell cycle checkpoints, ensuring the fidelity of DNA replication and preventing the propagation of errors.[4][5][6]

3. Cyclins and cyclin-dependent kinases (CDKs): The presence of CCNA2, CCNB2, CCND1, CCNF, CDK1, CDK4, CDKN1B, CDKN2C, and CDKN3 indicates the regulation of cell cycle progression through the activation and inhibition of CDKs.[7][8][9]

4. Mitosis: Proteins such as AURKA, AURKB, BUB1, BUB3, CENPA, CENPE, CENPF, KIF11, KIF15, KIF20B, KIF22, KIF23, KIF2C, KIF4A, KIF5B, KNL1, MAD2L1, NEK2, NDC80, NUMA1, PLK1, PLK4, PRC1, TACC3, TPX2, and TTK are involved in various aspects of mitosis, including spindle assembly, chromosome segregation, and cytokinesis.[10][11][12]

5. DNA repair and recombination: Proteins such as BRCA2, FANCC, LIG3, RAD21, RAD23B, RAD54L, and WRN are involved in DNA repair and recombination processes, ensuring the maintenance of genomic stability.[13][14][15]

6. Transcriptional regulation: Proteins like E2F1, E2F2, E2F3, E2F4, MYC, and TFDP1 are involved in the regulation of gene expression during the cell cycle, ensuring the proper timing of events.[16][17][18]

7. Protein degradation: The presence of proteins such as CUL1, CUL3, CUL4A, CUL5, and FBXO5 indicates the involvement of the ubiquitin-proteasome system in the degradation of cell cycle regulators, ensuring the proper progression of the cell cycle.[19][20][21]

In conclusion, the most prominent biological process performed by this system of interacting proteins is cell cycle regulation, with a focus on DNA replication, cell cycle checkpoints, cyclin-CDK regulation, mitosis, DNA repair, transcriptional regulation, and protein degradation.

========================================================================================================================================================================================================
[1] Zeng, Tian, Guan, Yang, Li, Yu-Kun, Wu, Qing, Tang, Xiao-Jun, Zeng, Xin, Ling, Hui, Zou, Juan. ""The DNA replication regulator MCM6: An emerging cancer biomarker and target."" Clinica chimica acta; international journal of clinical chemistry, 2021, pp. 92-98.
[2] Ramer, Matthew D, Suman, Evelyin S, Richter, Hagen, Stanger, Karen, Spranger, Martina, Bieberstein, Nicole, Duncker, Bernard P. ""Dbf4 and Cdc7 proteins promote DNA replication through interactions with distinct Mcm2-7 protein subunits."" The Journal of biological chemistry, 2013, pp. 14926-35.
[3] Rios-Morales, Ramon Y, Chan, Sze Ham, Bell, Stephen P. ""Initiation-specific alleles of the Cdc45 helicase-activating protein."" PloS one, 2019, pp. e0214426.
[4] Qin, Tingting, Mullan, Brendan, Ravindran, Ramya, Messinger, Dana, Siada, Ruby, Cummings, Jessica R, Harris, Micah, Muruganand, Ashwath, Pyaram, Kalyani, Miklja, Zachary, Reiber, Mary, Garcia, Taylor, Tran, Dustin, Danussi, Carla, Brosnan-Cashman, Jacqueline, Pratt, Drew, Zhao, Xinyi, Rehemtulla, Alnawaz, Sartor, Maureen A, Venneti, Sriram, Meeker, Alan K, Huse, Jason T, Morgan, Meredith A, Lowenstein, Pedro R, Castro, Maria G, Yadav, Viveka Nand, Koschmann, Carl. ""ATRX loss in glioma results in dysregulation of cell-cycle phase transition and ATM inhibitor radio-sensitization."" Cell reports, 2022, pp. 110216.
[5] Levitt, Peter S, Liu, Houchun, Manning, Charlene, Weiss, Robert S. ""Conditional inactivation of the mouse Hus1 cell cycle checkpoint gene."" Genomics, 2005, pp. 212-24.
[6] Gulve, Nitish, Su, Chenhe, Deng, Zhong, Soldan, Samantha S, Vladimirova, Olga, Wickramasinghe, Jayamanna, Zheng, Hongwu, Kossenkov, Andrew V, Lieberman, Paul M. ""DAXX-ATRX regulation of p53 chromatin binding and DNA damage response."" Nature communications, 2022, pp. 5033.
[7] Goel, Shom, DeCristo, Molly J, McAllister, Sandra S, Zhao, Jean J. ""CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest."" Trends in cell biology, 2018, pp. 911-925.
[8] Xie, Bowen, Wang, Shuangyan, Jiang, Nian, Li, Jian Jian. ""Cyclin B1/CDK1-regulated mitochondrial bioenergetics in cell cycle progression and tumor resistance."" Cancer letters, 2019, pp. 56-66.
[9] Lau, Ho Wai, Ma, Hoi Tang, Yeung, Tsz Kwan, Tam, Man Yee, Zheng, Danyi, Chu, Siu Ki, Poon, Randy Yat Choi. ""Quantitative differences between cyclin-dependent kinases underlie the unique functions of CDK1 in human cells."" Cell reports, 2021, pp. 109808.
[10] Singh, Priyanka, Pesenti, Marion E, Maffini, Stefano, Carmignani, Sara, Hedtfeld, Marius, Petrovic, Arsen, Srinivasamani, Anupallavi, Bange, Tanja, Musacchio, Andrea. ""BUB1 and CENP-U, Primed by CDK1, Are the Main PLK1 Kinetochore Receptors in Mitosis."" Molecular cell, 2021, pp. 67-87.e9.
[11] Shi, Wengui, Zhang, Gengyuan, Ma, Zhijian, Li, Lianshun, Liu, Miaomiao, Qin, Long, Yu, Zeyuan, Zhao, Lei, Liu, Yang, Zhang, Xue, Qin, Junjie, Ye, Huili, Jiang, Xiangyan, Zhou, Huinian, Sun, Hui, Jiao, Zuoyi. ""Hyperactivation of HER2-SHCBP1-PLK1 axis promotes tumor cell mitosis and impairs trastuzumab sensitivity to gastric cancer."" Nature communications, 2021, pp. 2812.
[12] Zou, Yuan-Jing, Shan, Meng-Meng, Wan, Xiang, Liu, Jing-Cai, Zhang, Kun-Huan, Ju, Jia-Qian, Xing, Chun-Hua, Sun, Shao-Chen. ""Kinesin KIF15 regulates tubulin acetylation and spindle assembly checkpoint in mouse oocyte meiosis."" Cellular and molecular life sciences : CMLS, 2022, pp. 422.
[13] Yoshida, Kiyotsugu, Miki, Yoshio. ""Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage."" Cancer science, 2004, pp. 866-71.
[14] Kwon, Youngho, Rösner, Heike, Zhao, Weixing, Selemenakis, Platon, He, Zhuoling, Kawale, Ajinkya S, Katz, Jeffrey N, Rogers, Cody M, Neal, Francisco E, Badamchi Shabestari, Aida, Petrosius, Valdemaras, Singh, Akhilesh K, Joel, Marina Z, Lu, Lucy, Holloway, Stephen P, Burma, Sandeep, Mukherjee, Bipasha, Hromas, Robert, Mazin, Alexander, Wiese, Claudia, Sørensen, Claus S, Sung, Patrick. ""DNA binding and RAD51 engagement by the BRCA2 C-terminus orchestrate DNA repair and replication fork preservation."" Nature communications, 2023, pp. 432.
[15] Liu, Lu, Cai, Shurui, Han, Chunhua, Banerjee, Ananya, Wu, Dayong, Cui, Tiantian, Xie, Guozhen, Zhang, Junran, Zhang, Xiaoli, McLaughlin, Eric, Yin, Ming, Backes, Floor J, Chakravarti, Arnab, Zheng, Yanfang, Wang, Qi-En. ""ALDH1A1 Contributes to PARP Inhibitor Resistance via Enhancing DNA Repair in BRCA2<sup>-/-</sup> Ovarian Cancer Cells."" Molecular cancer therapeutics, 2020, pp. 199-210.
[16] He, Jinsong, Gao, Rui, Yang, Jianbo, Li, Feng, Fu, Yang, Cui, Junwei, Liu, Xiaoling, Huang, Kanghua, Guo, Qiuyi, Zhou, Zihan, Wei, Wei. ""NCAPD2 promotes breast cancer progression through E2F1 transcriptional regulation of CDK1."" Cancer science, 2023, pp. 896-907.
[17] Lancho, Olga, Herranz, Daniel. ""The MYC Enhancer-ome: Long-Range Transcriptional Regulation of MYC in Cancer."" Trends in cancer, 2018, pp. 810-822.
[18] Bretones, Gabriel, Delgado, M Dolores, León, Javier. ""Myc and cell cycle control."" Biochimica et biophysica acta, 2015, pp. 506-16.
[19] Ou, Chan-Yen, Lin, Yi-Fan, Chen, Ying-Jiun, Chien, Cheng-Ting. ""Distinct protein degradation mechanisms mediated by Cul1 and Cul3 controlling Ci stability in Drosophila eye development."" Genes & development, 2002, pp. 2403-14.
[20] van den Heuvel, Sander. ""Protein degradation: CUL-3 and BTB--partners in proteolysis."" Current biology : CB, 2004, pp. R59-61.
[21] Farrell, Brian M, Gerth, Fabian, Yang, Cheng-Hao R, Yeh, Johannes T-H. ""A synthetic KLHL20 ligand to validate CUL3<sup>KLHL20</sup> as a potent E3 ligase for targeted protein degradation."" Genes & development, 2022, pp. 1031-1042.
"	0.48391014	0.6159189	GO	GO	NA
Diff. expressed gene set	GLYCOLYSIS	NA	ABCB6 ADORA2B AGL AGRN AK3 AK4 AKR1A1 ALDH7A1 ALDH9A1 ALDOA ALDOB ALG1 ANG ANGPTL4 ANKZF1 ARPP19 ARTN AURKA B3GALT6 B3GAT1 B3GAT3 B3GNT3 B4GALT1 B4GALT2 B4GALT4 B4GALT7 BIK BPNT1 CACNA1H CAPN5 CASP6 CD44 CDK1 CENPA CHPF CHPF2 CHST1 CHST12 CHST2 CHST4 CHST6 CITED2 CLDN3 CLDN9 CLN6 COG2 COL5A1 COPB2 CTH CXCR4 CYB5A DCN DDIT4 DEPDC1 DLD DPYSL4 DSC2 ECD EFNA3 EGFR EGLN3 ELF3 ENO1 ENO2 ERO1A EXT1 EXT2 FAM162A FBP2 FKBP4 FUT8 G6PD GAL3ST1 GALE GALK1 GALK2 GAPDHS GCLC GFPT1 GFUS GLCE GLRX GMPPA GMPPB GNE GNPDA1 GOT1 GOT2 GPC1 GPC3 GPC4 GPR87 GUSB GYS1 GYS2 HAX1 HDLBP HK2 HMMR HOMER1 HS2ST1 HS6ST2 HSPA5 IDH1 IDUA IER3 IGFBP3 IL13RA1 IRS2 ISG20 KDELR3 KIF20A KIF2A LCT LDHA LDHC LHPP LHX9 MDH1 MDH2 ME1 ME2 MED24 MERTK MET MIF MIOX MPI MXI1 NANP NASP NDST3 NDUFV3 NOL3 NSDHL NT5E P4HA1 P4HA2 PAM PAXIP1 PC PDK3 PFKFB1 PFKP PGAM1 PGAM2 PGK1 PGLS PGM2 PHKA2 PKM PKP2 PLOD1 PLOD2 PMM2 POLR3K PPFIA4 PPIA PPP2CB PRPS1 PSMC4 PYGB PYGL QSOX1 RARS1 RBCK1 RPE RRAGD SAP30 SDC1 SDC2 SDC3 SDHC SLC16A3 SLC25A10 SLC25A13 SLC35A3 SLC37A4 SOD1 SOX9 SPAG4 SRD5A3 STC1 STC2 STMN1 TALDO1 TFF3 TGFA TGFBI TKTL1 TPBG TPI1 TPST1 TXN UGP2 VCAN VEGFA VLDLR XYLT2 ZNF292	200	7.643856189774724	Pyruvate Metabolic Process 	GO:0006090	PFKFB1;TPI1;PGAM1;PGAM2;ENO1;ENO2;HK2;LDHC;LDHA;PKM;ME1;GAPDHS;PGK1;ME2;ALDOB;DLD	16	8	1.99e-20	2.81e-17	Glycolysis and Glycogenesis Regulation	"The system of interacting proteins primarily involves the regulation of glycolysis and glycogenesis, two critical metabolic pathways in cellular energy production and storage. The proteins involved in these processes include ALDOA, ALDOB, ENO1, ENO2, G6PD, GAPDHS, GYS1, GYS2, HK2, LDHA, LDHC, PFKFB1, PFKP, PGAM1, PGAM2, PGK1, PGLS, PGM2, PKM, PYGB, PYGL, TPI1, and UGP2.

Reasoning and Supporting Information:

1. Glycolysis regulation: Several proteins in the system are key enzymes in the glycolysis pathway, which is the process of breaking down glucose to produce ATP. These proteins include hexokinase (HK2), aldolase A and B (ALDOA, ALDOB), glyceraldehyde-3-phosphate dehydrogenase (GAPDHS), enolase 1 and 2 (ENO1, ENO2), lactate dehydrogenase A and C (LDHA, LDHC), phosphofructokinase platelet (PFKP), phosphoglycerate kinase 1 (PGK1), phosphoglycerate mutase 1 and 2 (PGAM1, PGAM2), and triosephosphate isomerase 1 (TPI1).

2. Glycogenesis regulation: Glycogenesis is the process of converting glucose to glycogen for storage in the liver and muscles. Key proteins involved in this process include glycogen synthase 1 and 2 (GYS1, GYS2), which catalyze the rate-limiting step in glycogen synthesis. Additionally, UGP2 (UDP-glucose pyrophosphorylase 2) is involved in the synthesis of UDP-glucose, a substrate for glycogen synthase.

3. Glucose-6-phosphate dehydrogenase (G6PD) is involved in the pentose phosphate pathway, which generates NADPH and ribose-5-phosphate for nucleotide synthesis and antioxidant defense. This pathway is interconnected with glycolysis, as both pathways utilize glucose-6-phosphate as a substrate.

4. Regulation of glycolysis and glycogenesis is further supported by the presence of proteins involved in the synthesis and degradation of glycogen, such as PYGB (brain glycogen phosphorylase) and PYGL (liver glycogen phosphorylase), which break down glycogen to release glucose-1-phosphate.

5. The presence of proteins involved in gluconeogenesis, such as PCK1 (phosphoenolpyruvate carboxykinase 1), indicates a connection between glycolysis and the synthesis of glucose from non-carbohydrate sources.

In conclusion, the most prominent biological process performed by this system of interacting proteins is the regulation of glycolysis and glycogenesis, which are essential for cellular energy production and storage."	24	12	"The system of interacting proteins primarily involves the regulation of glycolysis and glycogenesis, two critical metabolic pathways in cellular energy production and storage. The proteins involved in these processes include ALDOA, ALDOB, ENO1, ENO2, G6PD, GAPDHS, GYS1, GYS2, HK2, LDHA, LDHC, PFKFB1, PFKP, PGAM1, PGAM2, PGK1, PGLS, PGM2, PKM, PYGB, PYGL, TPI1, and UGP2.[1][2][3]

1. Glycolysis regulation: Several proteins in the system are key enzymes in the glycolysis pathway, which is the process of breaking down glucose to produce ATP. These proteins include hexokinase (HK2), aldolase A and B (ALDOA, ALDOB), glyceraldehyde-3-phosphate dehydrogenase (GAPDHS), enolase 1 and 2 (ENO1, ENO2), lactate dehydrogenase A and C (LDHA, LDHC), phosphofructokinase platelet (PFKP), phosphoglycerate kinase 1 (PGK1), phosphoglycerate mutase 1 and 2 (PGAM1, PGAM2), and triosephosphate isomerase 1 (TPI1).[4][5][6]

2. Glycogenesis regulation: Glycogenesis is the process of converting glucose to glycogen for storage in the liver and muscles. Key proteins involved in this process include glycogen synthase 1 and 2 (GYS1, GYS2), which catalyze the rate-limiting step in glycogen synthesis. Additionally, UGP2 (UDP-glucose pyrophosphorylase 2) is involved in the synthesis of UDP-glucose, a substrate for glycogen synthase.[7][8][9]

3. Glucose-6-phosphate dehydrogenase (G6PD) is involved in the pentose phosphate pathway, which generates NADPH and ribose-5-phosphate for nucleotide synthesis and antioxidant defense. This pathway is interconnected with glycolysis, as both pathways utilize glucose-6-phosphate as a substrate.[10][11][12]

4. Regulation of glycolysis and glycogenesis is further supported by the presence of proteins involved in the synthesis and degradation of glycogen, such as PYGB (brain glycogen phosphorylase) and PYGL (liver glycogen phosphorylase), which break down glycogen to release glucose-1-phosphate.[13][14][15]

5. The presence of proteins involved in gluconeogenesis, such as PCK1 (phosphoenolpyruvate carboxykinase 1), indicates a connection between glycolysis and the synthesis of glucose from non-carbohydrate sources.[16][17][18]

In conclusion, the most prominent biological process performed by this system of interacting proteins is the regulation of glycolysis and glycogenesis, which are essential for cellular energy production and storage.

========================================================================================================================================================================================================
[1] Hong, Jie, Guo, Fangfang, Lu, Shi-Yuan, Shen, Chaoqin, Ma, Dan, Zhang, Xinyu, Xie, Yile, Yan, Tingting, Yu, TaChung, Sun, Tiantian, Qian, Yun, Zhong, Ming, Chen, Jinxian, Peng, Yanshen, Wang, Cheng, Zhou, Xiang, Liu, Jianjun, Liu, Qiang, Ma, Xiong, Chen, Ying-Xuan, Chen, Haoyan, Fang, Jing-Yuan. ""<i>F. nucleatum</i> targets lncRNA ENO1-IT1 to promote glycolysis and oncogenesis in colorectal cancer."" Gut, 2021, pp. 2123-2137.
[2] Nie, Hao, Ju, Haixing, Fan, Jiayi, Shi, Xiaoliu, Cheng, Yaxian, Cang, Xiaohui, Zheng, Zhiguo, Duan, Xiaotao, Yi, Wen. ""O-GlcNAcylation of PGK1 coordinates glycolysis and TCA cycle to promote tumor growth."" Nature communications, 2020, pp. 36.
[3] Tan, Valerie P, Miyamoto, Shigeki. ""HK2/hexokinase-II integrates glycolysis and autophagy to confer cellular protection."" Autophagy, 2015, pp. 963-4.
[4] Nie, Hao, Ju, Haixing, Fan, Jiayi, Shi, Xiaoliu, Cheng, Yaxian, Cang, Xiaohui, Zheng, Zhiguo, Duan, Xiaotao, Yi, Wen. ""O-GlcNAcylation of PGK1 coordinates glycolysis and TCA cycle to promote tumor growth."" Nature communications, 2020, pp. 36.
[5] Tan, Valerie P, Miyamoto, Shigeki. ""HK2/hexokinase-II integrates glycolysis and autophagy to confer cellular protection."" Autophagy, 2015, pp. 963-4.
[6] Shen, Jianfei, Jin, Zixian, Lv, Haiyan, Jin, Ke, Jonas, Kangberee, Zhu, Chengchu, Chen, Baofu. ""PFKP is highly expressed in lung cancer and regulates glucose metabolism."" Cellular oncology (Dordrecht), 2020, pp. 617-629.
[7] Xirouchaki, Chrysovalantou E, Mangiafico, Salvatore P, Bate, Katherine, Ruan, Zheng, Huang, Amy M, Tedjosiswoyo, Bing Wilari, Lamont, Benjamin, Pong, Wynne, Favaloro, Jenny, Blair, Amy R, Zajac, Jeffrey D, Proietto, Joseph, Andrikopoulos, Sofianos. ""Impaired glucose metabolism and exercise capacity with muscle-specific glycogen synthase 1 (gys1) deletion in adult mice."" Molecular metabolism, 2016, pp. 221-232.
[8] Zani, Fabio, Breasson, Ludovic, Becattini, Barbara, Vukolic, Ana, Montani, Jean-Pierre, Albrecht, Urs, Provenzani, Alessandro, Ripperger, Juergen A, Solinas, Giovanni. ""PER2 promotes glucose storage to liver glycogen during feeding and acute fasting by inducing Gys2 PTG and G L expression."" Molecular metabolism, 2013, pp. 292-305.
[9] Kamenets, Elena A, Gusarova, Elena A, Milovanova, Natalia V, Itkis, Yulia S, Strokova, Tatiana V, Melikyan, Maria A, Garyaeva, Irina V, Rybkina, Irina G, Nikitina, Natalia V, Zakharova, Ekaterina Y. ""Hepatic glycogen synthase (GYS2) deficiency: seven novel patients and seven novel variants."" JIMD reports, 2020, pp. 39-44.
[10] Ghergurovich, Jonathan M, García-Cañaveras, Juan C, Wang, Joshua, Schmidt, Emily, Zhang, Zhaoyue, TeSlaa, Tara, Patel, Harshel, Chen, Li, Britt, Emily C, Piqueras-Nebot, Marta, Gomez-Cabrera, Mari Carmen, Lahoz, Agustín, Fan, Jing, Beier, Ulf H, Kim, Hahn, Rabinowitz, Joshua D. ""A small molecule G6PD inhibitor reveals immune dependence on pentose phosphate pathway."" Nature chemical biology, 2020, pp. 731-739.
[11] Chen, Baoxiang, Hong, Yuntian, Gui, Rui, Zheng, Huabin, Tian, Shunhua, Zhai, Xiang, Xie, Xiaoyu, Chen, Quanjiao, Qian, Qun, Ren, Xianghai, Fan, Lifang, Jiang, Congqing. ""N6-methyladenosine modification of circ_0003215 suppresses the pentose phosphate pathway and malignancy of colorectal cancer through the miR-663b/DLG4/G6PD axis."" Cell death & disease, 2022, pp. 804.
[12] Lu, Chunwan, Yang, Dafeng, Klement, John D, Colson, Yolonda L, Oberlies, Nicholas H, Pearce, Cedric J, Colby, Aaron H, Grinstaff, Mark W, Liu, Zhuoqi, Shi, Huidong, Ding, Han-Fei, Liu, Kebin. ""H3K9me3 represses G6PD expression to suppress the pentose phosphate pathway and ROS production to promote human mesothelioma growth."" Oncogene, 2022, pp. 2651-2662.
[13] Altemus, Megan A, Goo, Laura E, Little, Andrew C, Yates, Joel A, Cheriyan, Hannah G, Wu, Zhi Fen, Merajver, Sofia D. ""Breast cancers utilize hypoxic glycogen stores via PYGB, the brain isoform of glycogen phosphorylase, to promote metastatic phenotypes."" PloS one, 2019, pp. e0220973.
[14] Zhan, Qian, Lv, Zili, Tang, Qing, Huang, Li, Chen, Xiuqi, Yang, Meixiong, Lan, Liancheng, Shan, Qingwen. ""Glycogen storage disease type VI with a novel PYGL mutation: Two case reports and literature review."" Medicine, 2021, pp. e25520.
[15] Tomihira, Masako, Kawasaki, Eiji, Nakajima, Hiromu, Imamura, Yutaka, Sato, Yuichi, Sata, Michio, Kage, Masayoshi, Sugie, Hideo, Nunoi, Kiyohide. ""Intermittent and recurrent hepatomegaly due to glycogen storage in a patient with type 1 diabetes: genetic analysis of the liver glycogen phosphorylase gene (PYGL)."" Diabetes research and clinical practice, 2004, pp. 175-82.
[16] Tang, Yufu, Zhang, Yibing, Wang, Chunhui, Sun, Zhongyi, Li, Longfei, Cheng, Shuqun, Zhou, Wenping. ""Overexpression of PCK1 Gene Antagonizes Hepatocellular Carcinoma Through the Activation of Gluconeogenesis and Suppression of Glycolysis Pathways."" Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2018, pp. 344-355.
[17] Zhou, Xianfei, Huang, Luoshun, Xing, Renwei, Yang, Fan, Nie, Hanqiu. ""MiR-93-5P Represses the Gluconeogenesis of Hepatocellular Carcinoma while Boosting Its Glycolysis and Malignant Progression by Suppressing PCK1."" Critical reviews in eukaryotic gene expression, 2022, pp. 35-47.
[18] Tsujimoto, Goki, Ito, Rin, Yoshikawa, Kei, Ueki, Chihiro, Okada, Nobuhiro. ""NFYA promotes the anti-tumor effects of gluconeogenesis in hepatocellular carcinoma through the regulation of PCK1 expression."" Frontiers in cell and developmental biology, 2022, pp. 983599.
"	0.69157505	0.5966878	LLM	LLM	NA
Diff. expressed gene set	HEDGEHOG SIGNALING	NA	ACHE ADGRG1 AMOT CDK5R1 CDK6 CELSR1 CNTFR CRMP1 DPYSL2 ETS2 GLI1 HEY1 HEY2 L1CAM LDB1 MYH9 NF1 NKX6-1 NRCAM NRP1 NRP2 OPHN1 PLG PML PTCH1 RASA1 RTN1 SCG2 SHH SLIT1 THY1 TLE1 TLE3 UNC5C VEGFA VLDLR	36	5.169925001442312	Nervous System Development 	GO:0007399	CNTFR;SHH;LDB1;OPHN1;NF1;CRMP1;NRCAM;VLDLR;L1CAM;CELSR1;VEGFA	11	30.555555555555557	1.59e-10	7.36e-8	Neuronal Development and Axon Guidance	"The primary biological process performed by this system of interacting proteins is neuronal development and axon guidance. The proteins involved in this process are crucial for the proper formation and functioning of the nervous system.

1. Axon guidance: Proteins such as L1CAM, NRCAM, SLIT1, UNC5C, NRP1, NRP2, and VLDLR are involved in axon guidance, which is essential for the correct wiring of the nervous system. These proteins help guide the growth cones of developing axons towards their target cells by responding to attractive or repulsive cues in the extracellular environment.

2. Neuronal differentiation: Proteins like CDK5R1, CDK6, ETS2, GLI1, HEY1, HEY2, and NKX6-1 play a role in neuronal differentiation, the process by which neural progenitor cells give rise to mature neurons. These proteins regulate the expression of genes involved in the specification and maturation of neuronal cell types.

3. Neuronal migration: Proteins such as AMOT, CELSR1, and ADGRG1 are involved in neuronal migration, a process critical for the proper positioning of neurons within the developing brain. These proteins help regulate the movement of neurons from their birthplace to their final destination in the brain.

4. Synapse formation and plasticity: Proteins like OPHN1, RASA1, and RTN1 are involved in synapse formation and plasticity, which are essential for the establishment and modulation of neuronal connections. These proteins help regulate the assembly and disassembly of synaptic structures, as well as the strength of synaptic transmission.

5. Neuronal survival and growth: Proteins such as ACHE, CNTFR, CRMP1, DPYSL2, MYH9, NF1, PLG, PML, PTCH1, SCG2, SHH, THY1, TLE1, TLE3, and VEGFA are involved in neuronal survival and growth. These proteins help promote the survival of neurons and support their growth and maintenance by regulating processes such as cell adhesion, cytoskeletal dynamics, and signal transduction.

6. Regulation of gene expression: Proteins like LDB1 and ETS2 are involved in the regulation of gene expression, which is crucial for the proper functioning of neurons. These proteins help modulate the transcription of genes involved in various aspects of neuronal development and function.

In conclusion, this system of interacting proteins plays a critical role in neuronal development and axon guidance, ensuring the proper formation and functioning of the nervous system."	36	100	"The primary biological process performed by this system of interacting proteins is neuronal development and axon guidance. The proteins involved in this process are crucial for the proper formation and functioning of the nervous system.

1. Axon guidance: Proteins such as L1CAM, NRCAM, SLIT1, UNC5C, NRP1, NRP2, and VLDLR are involved in axon guidance, which is essential for the correct wiring of the nervous system. These proteins help guide the growth cones of developing axons towards their target cells by responding to attractive or repulsive cues in the extracellular environment.[1][2][3]

2. Neuronal differentiation: Proteins like CDK5R1, CDK6, ETS2, GLI1, HEY1, HEY2, and NKX6-1 play a role in neuronal differentiation, the process by which neural progenitor cells give rise to mature neurons. These proteins regulate the expression of genes involved in the specification and maturation of neuronal cell types.[4][5][6]

3. Neuronal migration: Proteins such as AMOT, CELSR1, and ADGRG1 are involved in neuronal migration, a process critical for the proper positioning of neurons within the developing brain. These proteins help regulate the movement of neurons from their birthplace to their final destination in the brain.[7][8][9]

4. Synapse formation and plasticity: Proteins like OPHN1, RASA1, and RTN1 are involved in synapse formation and plasticity, which are essential for the establishment and modulation of neuronal connections. These proteins help regulate the assembly and disassembly of synaptic structures, as well as the strength of synaptic transmission.[10][11][12]

5. Neuronal survival and growth: Proteins such as ACHE, CNTFR, CRMP1, DPYSL2, MYH9, NF1, PLG, PML, PTCH1, SCG2, SHH, THY1, TLE1, TLE3, and VEGFA are involved in neuronal survival and growth. These proteins help promote the survival of neurons and support their growth and maintenance by regulating processes such as cell adhesion, cytoskeletal dynamics, and signal transduction.[13][14][15]

6. Regulation of gene expression: Proteins like LDB1 and ETS2 are involved in the regulation of gene expression, which is crucial for the proper functioning of neurons. These proteins help modulate the transcription of genes involved in various aspects of neuronal development and function.[16][17][18]

In conclusion, this system of interacting proteins plays a critical role in neuronal development and axon guidance, ensuring the proper formation and functioning of the nervous system.

========================================================================================================================================================================================================
[1] Maden, Charlotte H, Gomes, John, Schwarz, Quenten, Davidson, Kathryn, Tinker, Andrew, Ruhrberg, Christiana. ""NRP1 and NRP2 cooperate to regulate gangliogenesis, axon guidance and target innervation in the sympathetic nervous system."" Developmental biology, 2012, pp. 277-85.
[2] Telley, Ludovic, Cadilhac, Christelle, Cioni, Jean-Michel, Saywell, Veronique, Jahannault-Talignani, Céline, Huettl, Rosa E, Sarrailh-Faivre, Catherine, Dayer, Alexandre, Huber, Andrea B, Ango, Fabrice. ""Dual Function of NRP1 in Axon Guidance and Subcellular Target Recognition in Cerebellum."" Neuron, 2016, pp. 1276-1291.
[3] Yang, Jung-Lynn Jonathan, Bertolesi, Gabriel E, Hehr, Carrie L, Johnston, Jillian, McFarlane, Sarah. ""Fibroblast growth factor receptor 1 signaling transcriptionally regulates the axon guidance cue slit1."" Cellular and molecular life sciences : CMLS, 2018, pp. 3649-3661.
[4] Ayrault, Olivier, Zhao, Haotian, Zindy, Frederique, Qu, Chunxu, Sherr, Charles J, Roussel, Martine F. ""Atoh1 inhibits neuronal differentiation and collaborates with Gli1 to generate medulloblastoma-initiating cells."" Cancer research, 2010, pp. 5618-27.
[5] Kan, Chen, Chen, Lijun, Hu, Yangyang, Ding, Na, Li, Yuyun, McGuire, Tammy L, Lu, Haimei, Kessler, John A, Kan, Lixin. ""Gli1-labeled adult mesenchymal stem/progenitor cells and hedgehog signaling contribute to endochondral heterotopic ossification."" Bone, 2018, pp. 71-79.
[6] Binot, A-C, Manfroid, I, Flasse, L, Winandy, M, Motte, P, Martial, J A, Peers, B, Voz, M L. ""Nkx6.1 and nkx6.2 regulate alpha- and beta-cell formation in zebrafish by acting on pancreatic endocrine progenitor cells."" Developmental biology, 2010, pp. 397-407.
[7] Wells, Clark D, Fawcett, James P, Traweger, Andreas, Yamanaka, Yojiro, Goudreault, Marilyn, Elder, Kelly, Kulkarni, Sarang, Gish, Gerald, Virag, Cristina, Lim, Caesar, Colwill, Karen, Starostine, Andrei, Metalnikov, Pavel, Pawson, Tony. ""A Rich1/Amot complex regulates the Cdc42 GTPase and apical-polarity proteins in epithelial cells."" Cell, 2006, pp. 535-48.
[8] Bui, Duy Lan Huong, Roach, Andrew, Li, Jingxian, Bandekar, Sumit J, Orput, Elizabeth, Raghavan, Ritika, Araç, Demet, Sando, Richard C. ""The adhesion GPCRs CELSR1-3 and LPHN3 engage G proteins via distinct activation mechanisms."" Cell reports, 2023, pp. 112552.
[9] Goffinet, Andre M, Tissir, Fadel. ""Seven pass Cadherins CELSR1-3."" Seminars in cell & developmental biology, 2017, pp. 102-110.
[10] Ma, Xiaotang, Wang, Yan, Shi, Yumeng, Li, Suqing, Liu, Jinhua, Li, Xiangyong, Zhong, Wangtao, Pan, Qunwen. ""Exosomal miR-132-3p from mesenchymal stromal cells improves synaptic dysfunction and cognitive decline in vascular dementia."" Stem cell research & therapy, 2022, pp. 315.
[11] Houy, Sébastien, Estay-Ahumada, Catherine, Croisé, Pauline, Calco, Valérie, Haeberlé, Anne-Marie, Bailly, Yannick, Billuart, Pierre, Vitale, Nicolas, Bader, Marie-France, Ory, Stéphane, Gasman, Stéphane. ""Oligophrenin-1 Connects Exocytotic Fusion to Compensatory Endocytosis in Neuroendocrine Cells."" The Journal of neuroscience : the official journal of the Society for Neuroscience, 2015, pp. 11045-55.
[12] Busti, Irene, Allegra, Manuela, Spalletti, Cristina, Panzi, Chiara, Restani, Laura, Billuart, Pierre, Caleo, Matteo. ""ROCK/PKA Inhibition Rescues Hippocampal Hyperexcitability and GABAergic Neuron Alterations in a Oligophrenin-1 Knock-Out Mouse Model of X-Linked Intellectual Disability."" The Journal of neuroscience : the official journal of the Society for Neuroscience, 2020, pp. 2776-2788.
[13] Dastidar, Somasish Ghosh, Narayanan, Sriram, Stifani, Stefano, D'Mello, Santosh R. ""Transducin-like enhancer of Split-1 (TLE1) combines with Forkhead box protein G1 (FoxG1) to promote neuronal survival."" The Journal of biological chemistry, 2012, pp. 14749-59.
[14] Chen, Chen, Huang, Zhiguo, Mo, Xiaoye, Song, Yanmin, Li, Xiangmin, Li, Xiaogang, Zhang, Mu. ""The circular RNA 001971/miR-29c-3p axis modulates colorectal cancer growth, metastasis, and angiogenesis through VEGFA."" Journal of experimental & clinical cancer research : CR, 2020, pp. 91.
[15] Fearnley, Gareth W, Smith, Gina A, Abdul-Zani, Izma, Yuldasheva, Nadira, Mughal, Nadeem A, Homer-Vanniasinkam, Shervanthi, Kearney, Mark T, Zachary, Ian C, Tomlinson, Darren C, Harrison, Michael A, Wheatcroft, Stephen B, Ponnambalam, Sreenivasan. ""VEGF-A isoforms program differential VEGFR2 signal transduction, trafficking and proteolysis."" Biology open, 2016, pp. 571-83.
[16] Liu, Guoyou, Wang, Lei, Wess, Jürgen, Dean, Ann. ""Enhancer looping protein LDB1 regulates hepatocyte gene expression by cooperating with liver transcription factors."" Nucleic acids research, 2022, pp. 9195-9211.
[17] Xu, Dakang, Dwyer, Julie, Li, He, Duan, Wei, Liu, Jun-Ping. ""Ets2 maintains hTERT gene expression and breast cancer cell proliferation by interacting with c-Myc."" The Journal of biological chemistry, 2008, pp. 23567-80.
[18] Love, Paul E, Warzecha, Claude, Li, LiQi. ""Ldb1 complexes: the new master regulators of erythroid gene transcription."" Trends in genetics : TIG, 2014, pp. 1-9.
"	0.35940227	0.36923373	Neither	Neither	NA
Diff. expressed gene set	HEME METABOLISM	NA	ABCB6 ABCG2 ACKR1 ACP5 ACSL6 ADD1 ADD2 ADIPOR1 AGPAT4 AHSP ALAD ALAS2 ALDH1L1 ALDH6A1 ANK1 AQP3 ARHGEF12 ARL2BP ASNS ATG4A ATP6V0A1 BACH1 BCAM BLVRA BLVRB BMP2K BNIP3L BPGM BSG BTG2 BTRC C3 CA1 CA2 CAST CAT CCDC28A CCND3 CDC27 CDR2 CIR1 CLCN3 CLIC2 CPOX CROCCP2 CTNS CTSB CTSE DAAM1 DCAF10 DCAF11 DCUN1D1 DMTN E2F2 EIF2AK1 ELL2 ENDOD1 EPB41 EPB42 EPOR ERMAP EZH1 FBXO34 FBXO7 FBXO9 FECH FN3K FOXJ2 FOXO3 FTCD GAPVD1 GATA1 GCLC GCLM GDE1 GLRX5 GMPS GYPA GYPB GYPC GYPE H1-0 H4C3 HAGH HBB HBBP1 HBD HBQ1 HBZ HDGF HEBP1 HMBS HTATIP2 HTRA2 ICAM4 IGSF3 ISCA1 KAT2B KDM7A KEL KHNYN KLF1 KLF3 LAMP2 LMO2 LPIN2 LRP10 MAP2K3 MARCHF2 MARCHF8 MARK3 MBOAT2 MFHAS1 MGST3 MINPP1 MKRN1 MOCOS MOSPD1 MPP1 MXI1 MYL4 NARF NCOA4 NEK7 NFE2 NFE2L1 NNT NR3C1 NUDT4 OPTN OSBP2 P4HA2 PC PDZK1IP1 PGLS PICALM PIGQ PPOX PPP2R5B PRDX2 PSMD9 RAD23A RANBP10 RAP1GAP RBM38 RBM5 RCL1 RHAG RHCE RHD RIOK3 RNF123 RNF19A SDCBP SEC14L1 SELENBP1 SIDT2 SLC10A3 SLC11A2 SLC22A4 SLC25A37 SLC25A38 SLC2A1 SLC30A1 SLC30A10 SLC4A1 SLC66A2 SLC6A8 SLC6A9 SLC7A11 SMOX SNCA SPTA1 SPTB SYNJ1 TAL1 TCEA1 TENT5C TFDP2 TFRC TMCC2 TMEM9B TNRC6B TNS1 TOP1 TRAK2 TRIM10 TRIM58 TSPAN5 TSPO2 TYR UBAC1 UCP2 UROD UROS USP15 VEZF1 XK XPO7 YPEL5	200	7.643856189774724	Heme Biosynthetic Process 	GO:0006783	ALAD;SLC25A38;ALAS2;ABCB6;FECH;UROD;UROS;HMBS;CPOX;NFE2L1	10	5	6.81e-16	8.08e-13	Erythropoiesis	"The most prominent biological process performed by this system of interacting proteins is erythropoiesis, the production of red blood cells (RBCs). This process is essential for oxygen transport and maintaining homeostasis in the body.

Key proteins involved in erythropoiesis include:

1. GATA1: A transcription factor that regulates the expression of genes involved in RBC development, such as HBB, HBD, and ALAS2. GATA1 is crucial for the differentiation of erythroid progenitor cells into mature RBCs.

2. EPOR: Erythropoietin receptor, which binds to erythropoietin (EPO) and activates the JAK2/STAT5 signaling pathway, promoting erythroid cell survival, proliferation, and differentiation.

3. ALAS2: A rate-limiting enzyme in heme biosynthesis, which is essential for the production of hemoglobin, the oxygen-carrying protein in RBCs.

4. HBB, HBD, HBQ1, and HBZ: Hemoglobin subunit genes that encode the protein chains that form the hemoglobin molecule. Mutations in these genes can lead to hemoglobinopathies, such as sickle cell anemia and thalassemia.

5. SLC4A1: A membrane protein that mediates the exchange of chloride and bicarbonate ions across the RBC membrane, playing a critical role in maintaining RBC shape and function.

6. ANK1, SPTA1, and SPTB: Cytoskeletal proteins that contribute to the structural integrity and deformability of RBCs, allowing them to pass through narrow capillaries.

7. CA1 and CA2: Carbonic anhydrases that catalyze the reversible hydration of carbon dioxide to bicarbonate, facilitating CO2 transport and pH regulation in RBCs.

8. RHAG, RHCE, and RHD: Proteins that form the Rh blood group antigens, which are important for blood transfusion compatibility.

9. BPGM: An enzyme that synthesizes 2,3-bisphosphoglycerate (2,3-BPG), a molecule that regulates hemoglobin's affinity for oxygen and enhances oxygen delivery to tissues.

10. ABCB6 and ABCG2: ATP-binding cassette transporters that play roles in heme biosynthesis and iron homeostasis, respectively.

In summary, this system of interacting proteins is primarily involved in erythropoiesis, a critical process for oxygen transport and homeostasis. The proteins contribute to various aspects of RBC development, function, and regulation, including gene expression, signaling pathways, heme biosynthesis, hemoglobin production, membrane transport, structural integrity, and blood group antigen formation."	19	9.5	"The most prominent biological process performed by this system of interacting proteins is erythropoiesis, the production of red blood cells (RBCs). This process is essential for oxygen transport and maintaining homeostasis in the body.

Key proteins involved in erythropoiesis include:

1. GATA1: A transcription factor that regulates the expression of genes involved in RBC development, such as HBB, HBD, and ALAS2. GATA1 is crucial for the differentiation of erythroid progenitor cells into mature RBCs.[1][2][3]

2. EPOR: Erythropoietin receptor, which binds to erythropoietin (EPO) and activates the JAK2/STAT5 signaling pathway, promoting erythroid cell survival, proliferation, and differentiation.[4][5][6]

3. ALAS2: A rate-limiting enzyme in heme biosynthesis, which is essential for the production of hemoglobin, the oxygen-carrying protein in RBCs.[7][8][9]

4. HBB, HBD, HBQ1, and HBZ: Hemoglobin subunit genes that encode the protein chains that form the hemoglobin molecule. Mutations in these genes can lead to hemoglobinopathies, such as sickle cell anemia and thalassemia.[10][11][12]

5. SLC4A1: A membrane protein that mediates the exchange of chloride and bicarbonate ions across the RBC membrane, playing a critical role in maintaining RBC shape and function.[13][14][15]

6. ANK1, SPTA1, and SPTB: Cytoskeletal proteins that contribute to the structural integrity and deformability of RBCs, allowing them to pass through narrow capillaries.[16][17][18]

7. CA1 and CA2: Carbonic anhydrases that catalyze the reversible hydration of carbon dioxide to bicarbonate, facilitating CO2 transport and pH regulation in RBCs.[19][20][21]

8. RHAG, RHCE, and RHD: Proteins that form the Rh blood group antigens, which are important for blood transfusion compatibility.[22][23][24]

9. BPGM: An enzyme that synthesizes 2,3-bisphosphoglycerate (2,3-BPG), a molecule that regulates hemoglobin's affinity for oxygen and enhances oxygen delivery to tissues.[25][26][27]

10. ABCB6 and ABCG2: ATP-binding cassette transporters that play roles in heme biosynthesis and iron homeostasis, respectively.[28][29][30]

In summary, this system of interacting proteins is primarily involved in erythropoiesis, a critical process for oxygen transport and homeostasis. The proteins contribute to various aspects of RBC development, function, and regulation, including gene expression, signaling pathways, heme biosynthesis, hemoglobin production, membrane transport, structural integrity, and blood group antigen formation.

========================================================================================================================================================================================================
[1] Li, Yanming, Liu, Shuge, Sun, Hongying, Yang, Yadong, Qi, Heyuan, Ding, Nan, Zheng, Jiawen, Dong, Xunong, Qu, Hongzhu, Zhang, Zhaojun, Fang, Xiangdong. ""MiR-218 Inhibits Erythroid Differentiation and Alters Iron Metabolism by Targeting ALAS2 in K562 Cells."" International journal of molecular sciences, 2015, pp. 28156-68.
[2] Hu, Shu-Ting, Li, Xin-Yu, Chen, Han, Xu, Lyu-Hong, Fang, Jian-Pei. ""[Knockdown of ALAS2 Affects Erythroid Differentiation by Down-regulating Mitophagy Receptor BNIP3L]."" Zhongguo shi yan xue ye xue za zhi, 2020, pp. 1710-1717.
[3] Zhang, Yingchi, Zhang, Jingliao, An, Wenbin, Wan, Yang, Ma, Shihui, Yin, Jie, Li, Xichuan, Gao, Jie, Yuan, Weiping, Guo, Ye, Engel, James Douglas, Shi, Lihong, Cheng, Tao, Zhu, Xiaofan. ""Intron 1 GATA site enhances ALAS2 expression indispensably during erythroid differentiation."" Nucleic acids research, 2017, pp. 657-671.
[4] Cubranić, Aleksandar, Redzovic, Arnela, Dobrila-Dintinjana, Renata, Vukelić, Jelena, Dintinjana, Marijan. ""Mystery Story about Erythropoietin (Epo) and Erythropoietin Receptor (EpoR) are Disguised?"" Hepato-gastroenterology, 2015, pp. 585-9.
[5] Sanchis-Gomar, Fabian, Perez-Quilis, Carme, Lippi, Giuseppe. ""Erythropoietin receptor (EpoR) agonism is used to treat a wide range of disease."" Molecular medicine (Cambridge, Mass.), 2013, pp. 62-4.
[6] Keller, Alexandra, Wingelhofer, Bettina, Peter, Barbara, Bauer, Karin, Berger, Daniela, Gamperl, Susanne, Reifinger, Martin, Cerny-Reiterer, Sabine, Moriggl, Richard, Willmann, Michael, Valent, Peter, Hadzijusufovic, Emir. ""The JAK2/STAT5 signaling pathway as a potential therapeutic target in canine mastocytoma."" Veterinary and comparative oncology, 2018, pp. 55-68.
[7] Peng, Yahui, Li, Jihong, Luo, Dixian, Zhang, Shuai, Li, Sijia, Wang, Dayong, Wang, Xidi, Zhang, Zhujun, Wang, Xue, Sun, Changhui, Gao, Xu, Hui, Yang, He, Rongzhang. ""Muscle atrophy induced by overexpression of ALAS2 is related to muscle mitochondrial dysfunction."" Skeletal muscle, 2021, pp. 9.
[8] Tchaikovskii, Vassili, Desnick, Robert J, Bishop, David F. ""Molecular expression, characterization and mechanism of ALAS2 gain-of-function mutants."" Molecular medicine (Cambridge, Mass.), 2019, pp. 4.
[9] Ono, Koya, Fujiwara, Tohru, Saito, Kei, Nishizawa, Hironari, Takahashi, Noriyuki, Suzuki, Chie, Ochi, Tetsuro, Kato, Hiroki, Ishii, Yusho, Onodera, Koichi, Ichikawa, Satoshi, Fukuhara, Noriko, Onishi, Yasushi, Yokoyama, Hisayuki, Yamada, Rie, Nakamura, Yukio, Igarashi, Kazuhiko, Harigae, Hideo. ""Congenital sideroblastic anemia model due to ALAS2 mutation is susceptible to ferroptosis."" Scientific reports, 2022, pp. 9024.
[10] Malczewska-Lenczowska, Jadwiga, Orysiak, Joanna, Majorczyk, Edyta, Zdanowicz, Ryszard, Szczepańska, Beata, Starczewski, Michal, Kaczmarski, Jacek, Dybek, Tomasz, Pokrywka, Andrzej, Ahmetov, Ildus I, Sitkowski, Dariusz. ""Total Hemoglobin Mass, Aerobic Capacity, and HBB Gene in Polish Road Cyclists."" Journal of strength and conditioning research, 2016, pp. 3512-3519.
[11] Maman, Shelly, Sagi-Assif, Orit, Yuan, Weirong, Ginat, Ravit, Meshel, Tsipi, Zubrilov, Inna, Keisari, Yona, Lu, Weiyue, Lu, Wuyuan, Witz, Isaac P. ""The Beta Subunit of Hemoglobin (HBB2/HBB) Suppresses Neuroblastoma Growth and Metastasis."" Cancer research, 2017, pp. 14-26.
[12] Cai, Liuhong, Bai, Hao, Mahairaki, Vasiliki, Gao, Yongxing, He, Chaoxia, Wen, Yanfei, Jin, You-Chuan, Wang, You, Pan, Rachel L, Qasba, Armaan, Ye, Zhaohui, Cheng, Linzhao. ""A Universal Approach to Correct Various HBB Gene Mutations in Human Stem Cells for Gene Therapy of Beta-Thalassemia and Sickle Cell Disease."" Stem cells translational medicine, 2018, pp. 87-97.
[13] He, Ben-Jin, Liao, Lin, Deng, Zeng-Fu, Tao, Yi-Feng, Xu, Yu-Chan, Lin, Fa-Quan. ""Molecular Genetic Mechanisms of Hereditary Spherocytosis: Current Perspectives."" Acta haematologica, 2018, pp. 60-66.
[14] Jennings, Michael L. ""Cell physiology and molecular mechanism of anion transport by erythrocyte band 3/AE1."" American journal of physiology. Cell physiology, 2021, pp. C1028-C1059.
[15] Cordat, Emmanuelle, Reithmeier, Reinhart A F. ""Structure, function, and trafficking of SLC4 and SLC26 anion transporters."" Current topics in membranes, 2014, pp. 1-67.
[16] Anil More, Tejashree, Kedar, Prabhakar. ""Unravelling the genetic and phenotypic heterogeneity of SPTA1 gene variants in Hereditary Elliptocytosis and Hereditary Pyropoikilocytosis patients using next-generation sequencing."" Gene, 2022, pp. 146796.
[17] Vives-Corrons, Joan-Lluis, Krishnevskaya, Elena, Hernández-Rodriguez, Inés, Payán-Pernia, Salvador, Sevilla, Ángel F Remacha, Badell, Isabel. ""Red cell ektacytometry in two patients with chronic hemolytic anemia and three new α-spectrin variants."" Annals of hematology, 2022, pp. 549-555.
[18] Delaunay, J, Alloisio, N, Morle, L, Baklouti, F, Dalla Venezia, N, Maillet, P, Wilmotte, R. ""Molecular genetics of hereditary elliptocytosis and hereditary spherocytosis."" Annales de genetique, 1996, pp. 209-21.
[19] Nakada, Norihiro, Mikami, Tetuo, Horie, Kayo, Nagashio, Ryo, Sakurai, Yasutaka, Sanoyama, Itaru, Yoshida, Tsutomu, Sada, Miwa, Kobayashi, Kiyonori, Sato, Yuichi, Okayasu, Isao, Murakumo, Yoshiki. ""Expression of CA2 and CA9 carbonic anhydrases in ulcerative colitis and ulcerative colitis-associated colorectal cancer."" Pathology international, 2020, pp. 523-532.
[20] Green, J, Yamaguchi, D T, Kleeman, C R, Muallem, S. ""Cytosolic pH regulation in osteoblasts. Regulation of anion exchange by intracellular pH and Ca2+ ions."" The Journal of general physiology, 1990, pp. 121-45.
[21] Ozsoy, Hatice Zehra. ""Anticonvulsant Effects of Carbonic Anhydrase Inhibitors: The Enigmatic Link Between Carbonic Anhydrases and Electrical Activity of the Brain."" Neurochemical research, 2021, pp. 2783-2799.
[22] Sawadogo, Salam, Nebie, Koumpingnin, Millogo, Tieba, Kafando, Eléonore, Sawadogo, Abdoul-Guyani, Dahourou, Honorine, Traore, Fauceny, Ouattara, Siaka, Ouedraogo, Oumarou, Kienou, Kisito, Dieudonné, Yonli Yentema, Deneys, Véronique. ""Distribution of ABO and RHD blood group antigens in blood donors in Burkina Faso."" International journal of immunogenetics, 2019, pp. 1-6.
[23] Liu, Zhong, Zeng, Rong, Chen, Qing, Li, Min, Shi, Guang-yao, Wei, Peng, Huang, Cheng-yin, Tang, Rong-cai, Sun, Jun, Zhang, Xue-guang. ""Genotyping for Kidd, Kell, Duffy, Scianna, and RHCE blood group antigens polymorphisms in Jiangsu Chinese Han."" Chinese medical journal, 2012, pp. 1076-81.
[24] Enawgaw, Bamlaku, Aynalem, Melak, Melku, Mulugeta. ""Distribution of ABO and Rh-D Blood Group Antigens Among Blood Donors in the Amhara Regional State, Ethiopia."" Journal of blood medicine, 2022, pp. 97-104.
[25] E, Guoji, Sun, Binda, Liu, Bao, Xu, Gang, He, Shu, Wang, Yu, Feng, Lan, Wei, Hannan, Zhang, Jianyang, Chen, Jian, Gao, Yuqi, Zhang, Erlong. ""Enhanced BPGM/2,3-DPG pathway activity suppresses glycolysis in hypoxic astrocytes via FIH-1 and TET2."" Brain research bulletin, 2023, pp. 36-46.
[26] Barichard, F, Joulin, V, Henry, I, Garel, M C, Valentin, C, Rosa, R, Cohen-Solal, M, Junien, C. ""Chromosomal assignment of the human 2,3-bisphosphoglycerate mutase gene (BPGM) to region 7q34----7q22."" Human genetics, 1987, pp. 283-5.
[27] Takubo, T, Tsuda, I, Tatsumi, N, Kasuya, K, Taniguchi, Y, Fujita, T, Uchida, K, Matsuo, Y, Hayashi, T. ""An enzyme-linked immunosorbent assay and reference ranges for bisphosphoglycerate mutase in human erythrocytes."" Journal of clinical laboratory analysis, 1998, pp. 263-7.
[28] Sakurai, Aki, Tamura, Ai, Onishi, Yuko, Ishikawa, Toshihisa. ""Genetic polymorphisms of ATP-binding cassette transporters ABCB1 and ABCG2: therapeutic implications."" Expert opinion on pharmacotherapy, 2005, pp. 2455-73.
[29] Mischkulnig, Mario, Roetzer-Pejrimovsky, Thomas, Lötsch-Gojo, Daniela, Kastner, Nina, Bruckner, Katharina, Prihoda, Romana, Lang, Alexandra, Martinez-Moreno, Mauricio, Furtner, Julia, Berghoff, Anna, Woehrer, Adelheid, Berger, Walter, Widhalm, Georg, Kiesel, Barbara. ""Heme Biosynthesis Factors and 5-ALA Induced Fluorescence: Analysis of mRNA and Protein Expression in Fluorescing and Non-fluorescing Gliomas."" Frontiers in medicine, 2022, pp. 907442.
[30] Wang, Pengcheng, Sachar, Madhav, Lu, Jie, Shehu, Amina I, Zhu, Junjie, Chen, Jing, Liu, Ke, Anderson, Karl E, Xie, Wen, Gonzalez, Frank J, Klaassen, Curtis D, Ma, Xiaochao. ""The essential role of the transporter ABCG2 in the pathophysiology of erythropoietic protoporphyria."" Science advances, 2019, pp. eaaw6127.
"	0.5680492	0.7883565	GO	Tied	NA
Diff. expressed gene set	HYPOXIA	NA	ACKR3 ADM ADORA2B AK4 AKAP12 ALDOA ALDOB ALDOC AMPD3 ANGPTL4 ANKZF1 ANXA2 ATF3 ATP7A B3GALT6 B4GALNT2 BCAN BCL2 BGN BHLHE40 BNIP3L BRS3 BTG1 CA12 CASP6 CAV1 CAVIN1 CAVIN3 CCN1 CCN2 CCN5 CCNG2 CDKN1A CDKN1B CDKN1C CHST2 CHST3 CITED2 COL5A1 CP CSRP2 CXCR4 DCN DDIT3 DDIT4 DPYSL4 DTNA DUSP1 EDN2 EFNA1 EFNA3 EGFR ENO1 ENO2 ENO3 ERO1A ERRFI1 ETS1 EXT1 F3 FAM162A FBP1 FOS FOSL2 FOXO3 GAA GALK1 GAPDH GAPDHS GBE1 GCK GCNT2 GLRX GPC1 GPC3 GPC4 GPI GRHPR GYS1 HAS1 HDLBP HEXA HK1 HK2 HMOX1 HOXB9 HS3ST1 HSPA5 IDS IER3 IGFBP1 IGFBP3 IL6 ILVBL INHA IRS2 ISG20 JMJD6 JUN KDELR3 KDM3A KIF5A KLF6 KLF7 KLHL24 LALBA LARGE1 LDHA LDHC LOX LXN MAFF MAP3K1 MIF MT1E MT2A MXI1 MYH9 NAGK NCAN NDRG1 NDST1 NDST2 NEDD4L NFIL3 NOCT NR3C1 P4HA1 P4HA2 PAM PCK1 PDGFB PDK1 PDK3 PFKFB3 PFKL PFKP PGAM2 PGF PGK1 PGM1 PGM2 PHKG1 PIM1 PKLR PKP1 PLAC8 PLAUR PLIN2 PNRC1 PPARGC1A PPFIA4 PPP1R15A PPP1R3C PRDX5 PRKCA PYGM RBPJ RORA RRAGD S100A4 SAP30 SCARB1 SDC2 SDC3 SDC4 SELENBP1 SERPINE1 SIAH2 SLC25A1 SLC2A1 SLC2A3 SLC2A5 SLC37A4 SLC6A6 SRPX STBD1 STC1 STC2 SULT2B1 TES TGFB3 TGFBI TGM2 TIPARP TKTL1 TMEM45A TNFAIP3 TPBG TPD52 TPI1 TPST2 UGP2 VEGFA VHL VLDLR WSB1 XPNPEP1 ZFP36 ZNF292	200	7.643856189774724	Glycolytic Process 	GO:0006096	GPI;TPI1;PKLR;PGAM2;ENO1;ENO2;ENO3;HK2;GCK;HK1;LDHA;PFKL;PGK1;GAPDHS;ALDOC;ALDOB;GAPDH;PGM1	18	9	1.44e-29	2.62e-26	Glycolysis and Angiogenesis Regulation	"The interacting proteins in this system are primarily involved in glycolysis and angiogenesis regulation. Glycolysis is a crucial metabolic pathway for energy production, while angiogenesis is the formation of new blood vessels from pre-existing ones.

Glycolysis-related proteins:
1. ALDOA, ALDOB, and ALDOC are aldolase enzymes that catalyze the conversion of fructose-1,6-bisphosphate to glyceraldehyde-3-phosphate and dihydroxyacetone phosphate.
2. ENO1, ENO2, and ENO3 are enolase enzymes that catalyze the conversion of 2-phosphoglycerate to phosphoenolpyruvate.
3. GAPDH and GAPDHS are glyceraldehyde-3-phosphate dehydrogenases that catalyze the conversion of glyceraldehyde-3-phosphate to 1,3-bisphosphoglycerate.
4. HK1 and HK2 are hexokinase enzymes that catalyze the conversion of glucose to glucose-6-phosphate.
5. PFKL, PFKP, and PFKFB3 are phosphofructokinase enzymes that catalyze the conversion of fructose-6-phosphate to fructose-1,6-bisphosphate.
6. PGAM2, PGK1, PGM1, PGM2, and PHKG1 are involved in the conversion of 1,3-bisphosphoglycerate to 3-phosphoglycerate.
7. PKLR is a pyruvate kinase that catalyzes the conversion of phosphoenolpyruvate to pyruvate.
8. LDHA and LDHC are lactate dehydrogenase enzymes that catalyze the conversion of pyruvate to lactate.

Angiogenesis-related proteins:
1. VEGFA is a vascular endothelial growth factor that promotes angiogenesis.
2. ANGPTL4 is an angiopoietin-like protein that regulates angiogenesis.
3. FGF2 and PDGFB are growth factors that stimulate angiogenesis.
4. TGFBI and TGFB3 are transforming growth factor-beta proteins that regulate angiogenesis.
5. EDN2 is an endothelin protein that modulates angiogenesis.
6. EFNA1 and EFNA3 are ephrin-A proteins that regulate angiogenesis through Eph receptor signaling.

Other notable proteins:
1. BCL2 is an anti-apoptotic protein that promotes cell survival.
2. CASP6 is a caspase involved in apoptosis.
3. CDKN1A, CDKN1B, and CDKN1C are cyclin-dependent kinase inhibitors that regulate cell cycle progression.
4. EGFR is a receptor tyrosine kinase involved in cell growth and differentiation.
5. HIF1A is a hypoxia-inducible factor that regulates cellular response to low oxygen levels.
6. JUN and FOS are transcription factors that regulate gene expression in response to various stimuli.
7. MT1E and MT2A are metallothioneins that bind and regulate metal ions.
8. SLC2A1, SLC2A3, and SLC2A5 are glucose transporters that facilitate glucose uptake.

In conclusion, the most prominent biological process performed by this system of interacting proteins is the regulation of glycolysis and angiogenesis. These processes are essential for energy production and the formation of new blood vessels, respectively."	42	21	"The interacting proteins in this system are primarily involved in glycolysis and angiogenesis regulation. Glycolysis is a crucial metabolic pathway for energy production, while angiogenesis is the formation of new blood vessels from pre-existing ones.

1. ALDOA, ALDOB, and ALDOC are aldolase enzymes that catalyze the conversion of fructose-1,6-bisphosphate to glyceraldehyde-3-phosphate and dihydroxyacetone phosphate.[1][2][3]

2. ENO1, ENO2, and ENO3 are enolase enzymes that catalyze the conversion of 2-phosphoglycerate to phosphoenolpyruvate.[4][5][6]

3. GAPDH and GAPDHS are glyceraldehyde-3-phosphate dehydrogenases that catalyze the conversion of glyceraldehyde-3-phosphate to 1,3-bisphosphoglycerate.[7][8][9]

4. HK1 and HK2 are hexokinase enzymes that catalyze the conversion of glucose to glucose-6-phosphate.[10][11][12]

5. PFKL, PFKP, and PFKFB3 are phosphofructokinase enzymes that catalyze the conversion of fructose-6-phosphate to fructose-1,6-bisphosphate.[13][14][15]

6. PGAM2, PGK1, PGM1, PGM2, and PHKG1 are involved in the conversion of 1,3-bisphosphoglycerate to 3-phosphoglycerate.[16][17][18]

7. PKLR is a pyruvate kinase that catalyzes the conversion of phosphoenolpyruvate to pyruvate.[19][20][21]

8. LDHA and LDHC are lactate dehydrogenase enzymes that catalyze the conversion of pyruvate to lactate.[22][23][24]

1. VEGFA is a vascular endothelial growth factor that promotes angiogenesis.[25][26][27]

2. ANGPTL4 is an angiopoietin-like protein that regulates angiogenesis.[28][29][30]

3. FGF2 and PDGFB are growth factors that stimulate angiogenesis.[31][32][33]

4. TGFBI and TGFB3 are transforming growth factor-beta proteins that regulate angiogenesis.[34][35][36]

5. EDN2 is an endothelin protein that modulates angiogenesis.[37][38][39]

6. EFNA1 and EFNA3 are ephrin-A proteins that regulate angiogenesis through Eph receptor signaling.[40][41][42]

1. BCL2 is an anti-apoptotic protein that promotes cell survival.[43][44][45]

2. CASP6 is a caspase involved in apoptosis.[46][47][48]

3. CDKN1A, CDKN1B, and CDKN1C are cyclin-dependent kinase inhibitors that regulate cell cycle progression.[49][50][51]

4. EGFR is a receptor tyrosine kinase involved in cell growth and differentiation.[52][53][54]

5. HIF1A is a hypoxia-inducible factor that regulates cellular response to low oxygen levels.[55][56][57]

6. JUN and FOS are transcription factors that regulate gene expression in response to various stimuli.[58][59][60]

7. MT1E and MT2A are metallothioneins that bind and regulate metal ions.[61][62][63]

8. SLC2A1, SLC2A3, and SLC2A5 are glucose transporters that facilitate glucose uptake.[64][65][66]

In conclusion, the most prominent biological process performed by this system of interacting proteins is the regulation of glycolysis and angiogenesis. These processes are essential for energy production and the formation of new blood vessels, respectively.

========================================================================================================================================================================================================
[1] Liu, Guijun, Wang, Ningning, Zhang, Cunzhen, Li, Min, He, Xuxiao, Yin, Chunzhao, Tu, Qiaochu, Shen, Xia, Zhang, Lili, Lv, Jingwen, Wang, Yongqiang, Jiang, Huimin, Chen, Shiting, Li, Nan, Tao, Yongzhen, Yin, Huiyong. ""Fructose-1,6-Bisphosphate Aldolase B Depletion Promotes Hepatocellular Carcinogenesis Through Activating Insulin Receptor Signaling and Lipogenesis."" Hepatology (Baltimore, Md.), 2021, pp. 3037-3055.
[2] Li, Chien-Hsiu, Chan, Ming-Hsien, Chang, Yu-Chan. ""The role of fructose 1,6-bisphosphate-mediated glycolysis/gluconeogenesis genes in cancer prognosis."" Aging, 2022, pp. 3233-3258.
[3] He, Xuxiao, Li, Min, Yu, Hongming, Liu, Guijun, Wang, Ningning, Yin, Chunzhao, Tu, Qiaochu, Narla, Goutham, Tao, Yongzhen, Cheng, Shuqun, Yin, Huiyong. ""Loss of hepatic aldolase B activates Akt and promotes hepatocellular carcinogenesis by destabilizing the Aldob/Akt/PP2A protein complex."" PLoS biology, 2020, pp. e3000803.
[4] Prabhakar, Veena, Löttgert, Tanja, Gigolashvili, Tamara, Bell, Kirsten, Flügge, Ulf-Ingo, Häusler, Rainer E. ""Molecular and functional characterization of the plastid-localized Phosphoenolpyruvate enolase (ENO1) from Arabidopsis thaliana."" FEBS letters, 2009, pp. 983-91.
[5] Huang, Chen Kai, Sun, Ying, Lv, Lei, Ping, Yong. ""ENO1 and Cancer."" Molecular therapy oncolytics, 2022, pp. 288-298.
[6] Ji, Hong, Wang, Jianfa, Guo, Jingru, Li, Yue, Lian, Shuai, Guo, Wenjin, Yang, Huanmin, Kong, Fanzhi, Zhen, Li, Guo, Li, Liu, Yanzhi. ""Progress in the biological function of alpha-enolase."" Animal nutrition (Zhongguo xu mu shou yi xue hui), 2016, pp. 12-17.
[7] Chaudhary, Surbhi, Dhiman, Asmita, Patidar, Anil, Malhotra, Himanshu, Talukdar, Sharmila, Dilawari, Rahul, Chaubey, Gaurav Kumar, Modanwal, Radheshyam, Raje, Chaaya Iyengar, Raje, Manoj. ""Moonlighting glyceraldehyde-3-phosphate dehydrogenase (GAPDH) modulates protein aggregation."" Biochimica et biophysica acta. Molecular basis of disease, 2021, pp. 166202.
[8] El Kadmiri, N, Slassi, I, El Moutawakil, B, Nadifi, S, Tadevosyan, A, Hachem, A, Soukri, A. ""Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease."" Pathologie-biologie, 2014, pp. 333-6.
[9] Nicholls, Craig, Li, He, Liu, Jun-Ping. ""GAPDH: a common enzyme with uncommon functions."" Clinical and experimental pharmacology & physiology, 2012, pp. 674-9.
[10] Varanasi, Siva Karthik, Jaggi, Ujjaldeep, Hay, Nissim, Rouse, Barry T. ""Hexokinase II may be dispensable for CD4 T cell responses against a virus infection."" PloS one, 2018, pp. e0191533.
[11] Pedersen, Peter L. ""Mitochondrial matters of the heart: a plethora of regulatory modes to maintain function for a long lifetime."" Journal of bioenergetics and biomembranes, 2009, pp. 95-8.
[12] Leng, Lige, Yuan, Ziqi, Pan, Ruiyuan, Su, Xiao, Wang, Han, Xue, Jin, Zhuang, Kai, Gao, Ju, Chen, Zhenlei, Lin, Hui, Xie, Wenting, Li, Huifang, Chen, Zhenyi, Ren, Keke, Zhang, Xiao, Wang, Wenting, Jin, Zi-Bing, Wu, Shengxi, Wang, Xinglong, Yuan, Zengqiang, Xu, Huaxi, Chow, Hei-Man, Zhang, Jie. ""Microglial hexokinase 2 deficiency increases ATP generation through lipid metabolism leading to β-amyloid clearance."" Nature metabolism, 2022, pp. 1287-1305.
[13] Umar, Sheikh Mohammad, Kashyap, Akanksha, Kahol, Shruti, Mathur, Sandeep R, Gogia, Ajay, Deo, S V S, Prasad, Chandra Prakash. ""Prognostic and therapeutic relevance of phosphofructokinase platelet-type (PFKP) in breast cancer."" Experimental cell research, 2020, pp. 112282.
[14] Lopez-Fabuel, Irene, Garcia-Macia, Marina, Buondelmonte, Costantina, Burmistrova, Olga, Bonora, Nicolo, Alonso-Batan, Paula, Morant-Ferrando, Brenda, Vicente-Gutierrez, Carlos, Jimenez-Blasco, Daniel, Quintana-Cabrera, Ruben, Fernandez, Emilio, Llop, Jordi, Ramos-Cabrer, Pedro, Sharaireh, Aseel, Guevara-Ferrer, Marta, Fitzpatrick, Lorna, Thompton, Christopher D, McKay, Tristan R, Storch, Stephan, Medina, Diego L, Mole, Sara E, Fedichev, Peter O, Almeida, Angeles, Bolaños, Juan P. ""Aberrant upregulation of the glycolytic enzyme PFKFB3 in CLN7 neuronal ceroid lipofuscinosis."" Nature communications, 2022, pp. 536.
[15] Da, Qingen, Huang, Lei, Huang, Can, Chen, Zee, Jiang, Zhitong, Huang, Fang, Shen, Tao, Sun, Lu, Yan, Zilong, Ye, Xiaoqiang, Yi, Jing, Huang, Yu, Da, JingJing, Ren, Mingming, Liu, Jikui, Wang, Tao, Han, Zhen, Ouyang, Kunfu. ""Glycolytic regulatory enzyme PFKFB3 as a prognostic and tumor microenvironment biomarker in human cancers."" Aging, 2023, pp. 4533-4559.
[16] Nie, Hao, Ju, Haixing, Fan, Jiayi, Shi, Xiaoliu, Cheng, Yaxian, Cang, Xiaohui, Zheng, Zhiguo, Duan, Xiaotao, Yi, Wen. ""O-GlcNAcylation of PGK1 coordinates glycolysis and TCA cycle to promote tumor growth."" Nature communications, 2020, pp. 36.
[17] Qian, Xu, Li, Xinjian, Shi, Zhumei, Xia, Yan, Cai, Qingsong, Xu, Daqian, Tan, Lin, Du, Linyong, Zheng, Yanhua, Zhao, Dan, Zhang, Chuanbao, Lorenzi, Philip L, You, Yongping, Jiang, Bing-Hua, Jiang, Tao, Li, Haitao, Lu, Zhimin. ""PTEN Suppresses Glycolysis by Dephosphorylating and Inhibiting Autophosphorylated PGK1."" Molecular cell, 2019, pp. 516-527.e7.
[18] Zhang, Yajuan, Yu, Guanzhen, Chu, Huiying, Wang, Xiongjun, Xiong, Lingling, Cai, Guoqing, Liu, Ruilong, Gao, Hong, Tao, Bangbao, Li, Wenfeng, Li, Guohui, Liang, Ji, Yang, Weiwei. ""Macrophage-Associated PGK1 Phosphorylation Promotes Aerobic Glycolysis and Tumorigenesis."" Molecular cell, 2018, pp. 201-215.e7.
[19] Li, Dongliang, Zhang, Jing, Jiao, Baoquan, Liu, Yanli, Wang, Youjun, Wang, Zhiwei, Li, Wenjing, Hou, Lanfen, Sun, Yu, Guo, Hongmou, Guo, Xiao. ""[Analysis and prenatal diagnosis of PKLR gene mutations in a family with pyruvate kinase deficiency]."" Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics, 2016, pp. 53-6.
[20] Glenn, D, Gelbart, T, Beutler, E. ""Tight linkage of pyruvate kinase (PKLR) and glucocerebrosidase (GBA) genes."" Human genetics, 1994, pp. 635-8.
[21] Jaouani, M, Manco, L, Kalai, M, Chaouch, L, Douzi, K, Silva, A, Macedo, S, Darragi, I, Boudriga, I, Chaouachi, D, Fitouri, Z, Van Wijk, R, Ribeiro, M L, Abbes, S. ""Molecular basis of pyruvate kinase deficiency among Tunisians: description of new mutations affecting coding and noncoding regions in the PKLR gene."" International journal of laboratory hematology, 2017, pp. 223-231.
[22] Tang, Huanghui, Duan, Chongwen, Bleher, Reiner, Goldberg, Erwin. ""Human lactate dehydrogenase A (LDHA) rescues mouse Ldhc-null sperm function."" Biology of reproduction, 2013, pp. 96.
[23] Edwards, Y H, Povey, S, LeVan, K M, Driscoll, C E, Millan, J L, Goldberg, E. ""Locus determining the human sperm-specific lactate dehydrogenase, LDHC, is syntenic with LDHA."" Developmental genetics, 1987, pp. 219-32.
[24] Odet, Fanny, Duan, Chongwen, Willis, William D, Goulding, Eugenia H, Kung, Aisha, Eddy, Edward M, Goldberg, Erwin. ""Expression of the gene for mouse lactate dehydrogenase C (Ldhc) is required for male fertility."" Biology of reproduction, 2008, pp. 26-34.
[25] Claesson-Welsh, L, Welsh, M. ""VEGFA and tumour angiogenesis."" Journal of internal medicine, 2013, pp. 114-27.
[26] Zou, Gengyi, Zhang, Xiaotong, Wang, Lun, Li, Xiyang, Xie, Tianyu, Zhao, Jin, Yan, Jie, Wang, Longlong, Ye, Haoyu, Jiao, Shunchang, Xiang, Rong, Shi, Yi. ""Herb-sourced emodin inhibits angiogenesis of breast cancer by targeting VEGFA transcription."" Theranostics, 2020, pp. 6839-6853.
[27] Chen, Limin, Xie, Xinsheng, Wang, Tiantian, Xu, Linlin, Zhai, Zhenyu, Wu, Haibin, Deng, Libin, Lu, Quqin, Chen, Zhengjun, Yang, Xiao, Lu, Hua, Chen, Ye-Guang, Luo, Shiwen. ""ARL13B promotes angiogenesis and glioma growth by activating VEGFA-VEGFR2 signaling."" Neuro-oncology, 2023, pp. 871-885.
[28] Kersten, Sander. ""Role and mechanism of the action of angiopoietin-like protein ANGPTL4 in plasma lipid metabolism."" Journal of lipid research, 2021, pp. 100150.
[29] Chen, Yan Q, Pottanat, Thomas G, Siegel, Robert W, Ehsani, Mariam, Qian, Yue-Wei, Roell, William C, Konrad, Robert J. ""Angiopoietin-like protein 4(E40K) and ANGPTL4/8 complex have reduced, temperature-dependent LPL-inhibitory activity compared to ANGPTL4."" Biochemical and biophysical research communications, 2021, pp. 498-503.
[30] Chen, Yan Q, Pottanat, Thomas G, Siegel, Robert W, Ehsani, Mariam, Qian, Yue-Wei, Zhen, Eugene Y, Regmi, Ajit, Roell, William C, Guo, Haihong, Luo, M Jane, Gimeno, Ruth E, Van't Hooft, Ferdinand, Konrad, Robert J. ""Angiopoietin-like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids."" Journal of lipid research, 2020, pp. 1203-1220.
[31] Du, Shangce, Yang, Zhi, Lu, Xiaofeng, Yousuf, Suhail, Zhao, Min, Li, Wenxi, Miao, Ji, Wang, Xingzhou, Yu, Heng, Zhu, Xinya, Chen, Hong, Shi, Linseng, Xu, En, Xia, Xuefeng, Guan, Wenxian. ""Anoikis resistant gastric cancer cells promote angiogenesis and peritoneal metastasis through C/EBPβ-mediated PDGFB autocrine and paracrine signaling."" Oncogene, 2021, pp. 5764-5779.
[32] Eguchi, Ryoji, Wakabayashi, Ichiro. ""HDGF enhances VEGF‑dependent angiogenesis and FGF‑2 is a VEGF‑independent angiogenic factor in non‑small cell lung cancer."" Oncology reports, 2020, pp. 14-28.
[33] Atallah, Isis, Cieza Rivera, Ana M, Rivero Lezcano, Octavio M, Tascón-González, Laura, González-Cortés, Carolina, Diez Tascón, Cristina, Fernández-Villa, Tania, Martín, Vicente. ""Increased serum concentrations of estrogen-induced growth factors Midkine and FGF2 in NF1 patients with plexiform neurofibroma."" American journal of translational research, 2022, pp. 3180-3188.
[34] Lee, Seul Gi, Kim, Jin Soo, Kim, Ha-Jeong, Schlaepfer, David D, Kim, In-San, Nam, Ju-Ock. ""Endothelial angiogenic activity and adipose angiogenesis is controlled by extracellular matrix protein TGFBI."" Scientific reports, 2021, pp. 9644.
[35] Chiavarina, Barbara, Costanza, Brunella, Ronca, Roberto, Blomme, Arnaud, Rezzola, Sara, Chiodelli, Paola, Giguelay, Ambre, Belthier, Guillame, Doumont, Gilles, Van Simaeys, Gaetan, Lacroix, Simon, Yokobori, Takehiko, Erkhem-Ochir, Bilguun, Balaguer, Patrick, Cavailles, Vincent, Fabbrizio, Eric, Di Valentin, Emmanuel, Gofflot, Stephanie, Detry, Olivier, Jerusalem, Guy, Goldman, Serge, Delvenne, Philippe, Bellahcène, Akeila, Pannequin, Julie, Castronovo, Vincent, Turtoi, Andrei. ""Metastatic colorectal cancer cells maintain the TGFβ program and use TGFBI to fuel angiogenesis."" Theranostics, 2021, pp. 1626-1640.
[36] Choi, Seung-Il, Kim, Bong-Yoon, Dadakhujaev, Shorafidinkhuja, Oh, Jun-Young, Kim, Tae-Im, Kim, Joo Young, Kim, Eung Kweon. ""Impaired autophagy and delayed autophagic clearance of transforming growth factor β-induced protein (TGFBI) in granular corneal dystrophy type 2."" Autophagy, 2012, pp. 1782-97.
[37] Klipper, Eyal, Levit, Anat, Mastich, Yonit, Berisha, Bajram, Schams, Dieter, Meidan, Rina. ""Induction of endothelin-2 expression by luteinizing hormone and hypoxia: possible role in bovine corpus luteum formation."" Endocrinology, 2010, pp. 1914-22.
[38] Alrashdi, Saeed F, Deliyanti, Devy, Talia, Dean M, Wilkinson-Berka, Jennifer L. ""Endothelin-2 Injures the Blood-Retinal Barrier and Macroglial Müller Cells: Interactions with Angiotensin II, Aldosterone, and NADPH Oxidase."" The American journal of pathology, 2018, pp. 805-817.
[39] Rattner, Amir, Yu, Huimin, Williams, John, Smallwood, Philip M, Nathans, Jeremy. ""Endothelin-2 signaling in the neural retina promotes the endothelial tip cell state and inhibits angiogenesis."" Proceedings of the National Academy of Sciences of the United States of America, 2013, pp. E3830-9.
[40] Wang, Hui, Wang, Lin, Zhou, Xiaocheng, Luo, Xinyue, Liu, Ke, Jiang, Erhui, Chen, Yang, Shao, Zhe, Shang, Zhengjun. ""OSCC Exosomes Regulate miR-210-3p Targeting EFNA3 to Promote Oral Cancer Angiogenesis through the PI3K/AKT Pathway."" BioMed research international, 2020, pp. 2125656.
[41] Hao, Yongping, Li, Guang. ""Role of EFNA1 in tumorigenesis and prospects for cancer therapy."" Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, pp. 110567.
[42] Zhuang, Yu, Cheng, Mengjia, Li, Meng, Cui, Jinjie, Huang, Jinyang, Zhang, Chenglong, Si, Jiawen, Lin, Kaili, Yu, Hongbo. ""Small extracellular vesicles derived from hypoxic mesenchymal stem cells promote vascularized bone regeneration through the miR-210-3p/EFNA3/PI3K pathway."" Acta biomaterialia, 2022, pp. 413-426.
[43] Orzalli, Megan H, Prochera, Aleksandra, Payne, Laurellee, Smith, Avi, Garlick, Jonathan A, Kagan, Jonathan C. ""Virus-mediated inactivation of anti-apoptotic Bcl-2 family members promotes Gasdermin-E-dependent pyroptosis in barrier epithelial cells."" Immunity, 2021, pp. 1447-1462.e5.
[44] Valentini, Elisabetta, D'Aguanno, Simona, Di Martile, Marta, Montesano, Camilla, Ferraresi, Virginia, Patsilinakos, Alexandros, Sabatino, Manuela, Antonini, Lorenzo, Chiacchiarini, Martina, Valente, Sergio, Mai, Antonello, Colotti, Gianni, Ragno, Rino, Trisciuoglio, Daniela, Del Bufalo, Donatella. ""Targeting the anti-apoptotic Bcl-2 family proteins: machine learning virtual screening and biological evaluation of new small molecules."" Theranostics, 2022, pp. 2427-2444.
[45] Lovato, Andrea, Franz, Leonardo, Carraro, Valentina, Bandolin, Luigia, Contro, Giacomo, Ottaviano, Giancarlo, de Filippis, Cosimo, Blandamura, Stella, Alessandrini, Lara, Marioni, Gino. ""Maspin expression and anti-apoptotic pathway regulation by bcl2 in laryngeal cancer."" Annals of diagnostic pathology, 2020, pp. 151471.
[46] Vigneswara, Vasanthy, Akpan, Nsikan, Berry, Martin, Logan, Ann, Troy, Carol M, Ahmed, Zubair. ""Combined suppression of CASP2 and CASP6 protects retinal ganglion cells from apoptosis and promotes axon regeneration through CNTF-mediated JAK/STAT signalling."" Brain : a journal of neurology, 2014, pp. 1656-75.
[47] Guo, Kai, Zhao, Jiahui, Jin, Qianxu, Yan, Hongshan, Shi, Yunpeng, Zhao, Zongmao. ""CASP6 predicts poor prognosis in glioma and correlates with tumor immune microenvironment."" Frontiers in oncology, 2022, pp. 818283.
[48] Lee, Jong Woo, Kim, Mee Ran, Soung, Young Hwa, Nam, Suk Woo, Kim, Sang Ho, Lee, Jung Young, Yoo, Nam Jin, Lee, Sug Hyung. ""Mutational analysis of the CASP6 gene in colorectal and gastric carcinomas."" APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2006, pp. 646-50.
[49] Bi, Guoshu, Liang, Jiaqi, Zhao, Mengnan, Zhang, Huan, Jin, Xing, Lu, Tao, Zheng, Yuansheng, Bian, Yunyi, Chen, Zhencong, Huang, Yiwei, Besskaya, Valeria, Zhan, Cheng, Wang, Qun, Tan, Lijie. ""miR-6077 promotes cisplatin/pemetrexed resistance in lung adenocarcinoma via CDKN1A/cell cycle arrest and KEAP1/ferroptosis pathways."" Molecular therapy. Nucleic acids, 2022, pp. 366-386.
[50] Lee, Jinkwon, Kim, Kwangho, Ryu, Tae Young, Jung, Cho-Rok, Lee, Moo-Seung, Lim, Jung Hwa, Park, Kunhyang, Kim, Dae-Soo, Son, Mi-Young, Hamamoto, Ryuji, Cho, Hyun-Soo. ""EHMT1 knockdown induces apoptosis and cell cycle arrest in lung cancer cells by increasing CDKN1A expression."" Molecular oncology, 2021, pp. 2989-3002.
[51] Lüdtke, Timo H-W, Farin, Henner F, Rudat, Carsten, Schuster-Gossler, Karin, Petry, Marianne, Barnett, Phil, Christoffels, Vincent M, Kispert, Andreas. ""Tbx2 controls lung growth by direct repression of the cell cycle inhibitor genes Cdkn1a and Cdkn1b."" PLoS genetics, 2013, pp. e1003189.
[52] Talukdar, Sarmistha, Emdad, Luni, Das, Swadesh K, Fisher, Paul B. ""EGFR: An essential receptor tyrosine kinase-regulator of cancer stem cells."" Advances in cancer research, 2020, pp. 161-188.
[53] Akamatsu, Hiroaki, Toi, Yukihiro, Hayashi, Hidetoshi, Fujimoto, Daichi, Tachihara, Motoko, Furuya, Naoki, Otani, Sakiko, Shimizu, Junichi, Katakami, Nobuyuki, Azuma, Koichi, Miura, Naoko, Nishino, Kazumi, Hara, Satoshi, Teraoka, Shunsuke, Morita, Satoshi, Nakagawa, Kazuhiko, Yamamoto, Nobuyuki. ""Efficacy of Osimertinib Plus Bevacizumab vs Osimertinib in Patients With EGFR T790M-Mutated Non-Small Cell Lung Cancer Previously Treated With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor: West Japan Oncology Group 8715L Phase 2 Randomized Clinical Trial."" JAMA oncology, 2021, pp. 386-394.
[54] Reungwetwattana, Thanyanan, Nakagawa, Kazuhiko, Cho, Byoung Chul, Cobo, Manuel, Cho, Eun Kyung, Bertolini, Alessandro, Bohnet, Sabine, Zhou, Caicun, Lee, Ki Hyeong, Nogami, Naoyuki, Okamoto, Isamu, Leighl, Natasha, Hodge, Rachel, McKeown, Astrid, Brown, Andrew P, Rukazenkov, Yuri, Ramalingam, Suresh S, Vansteenkiste, Johan. ""CNS Response to Osimertinib Versus Standard Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer."" Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018, pp. JCO2018783118.
[55] Heck-Swain, Ka Lin, Li, Jiwen, Ruan, Wei, Yuan, Xiaoyi, Wang, Yanyu, Koeppen, Michael, Eltzschig, Holger K. ""Myeloid hypoxia-inducible factor HIF1A provides cardio-protection during ischemia and reperfusion <i>via</i> induction of netrin-1."" Frontiers in cardiovascular medicine, 2022, pp. 970415.
[56] Martinez, Chloe-Anne, Jiramongkol, Yannasittha, Bal, Neha, Alwis, Imala, Nedoboy, Polina E, Farnham, Melissa M J, White, Mark D, Cistulli, Peter A, Cook, Kristina M. ""Intermittent hypoxia enhances the expression of hypoxia inducible factor HIF1A through histone demethylation."" The Journal of biological chemistry, 2022, pp. 102536.
[57] Xu, Zhijian, Zhang, Fengduo, Xu, Hu, Yang, Fan, Zhou, Gezhi, Tong, Minfeng, Li, Yaqing, Yang, Song. ""Melatonin affects hypoxia-inducible factor 1α and ameliorates delayed brain injury following subarachnoid hemorrhage via H19/miR-675/HIF1A/TLR4."" Bioengineered, 2022, pp. 4235-4247.
[58] Liebermann, D A, Gregory, B, Hoffman, B. ""AP-1 (Fos/Jun) transcription factors in hematopoietic differentiation and apoptosis."" International journal of oncology, 1998, pp. 685-700.
[59] Nagesh, Rashmi, Kiran Kumar, K M, Naveen Kumar, M, Patil, Rajeshwari H, Sharma, S Chidananda. ""Regulation of Jun and Fos AP-1 transcription factors by JNK MAPKs signaling cascade in areca nut extract treated KB cells."" Biochemistry and biophysics reports, 2021, pp. 101090.
[60] Jaiswal, A K. ""Jun and Fos regulation of NAD(P)H: quinone oxidoreductase gene expression."" Pharmacogenetics, 1994, pp. 1-10.
[61] Si, Manfei, Lang, Jinghe. ""The roles of metallothioneins in carcinogenesis."" Journal of hematology & oncology, 2018, pp. 107.
[62] Liu, Qichen, Lu, Feng, Chen, Zhong. ""Identification of MT1E as a novel tumor suppressor in hepatocellular carcinoma."" Pathology, research and practice, 2020, pp. 153213.
[63] Lappas, Martha. ""Expression and regulation of metallothioneins in myometrium and fetal membranes."" American journal of reproductive immunology (New York, N.Y. : 1989), 2018, pp. e13040.
[64] Coudert, Edouard, Praud, Christophe, Dupont, Joëlle, Crochet, Sabine, Cailleau-Audouin, Estelle, Bordeau, Thierry, Godet, Estelle, Collin, Anne, Berri, Cécile, Tesseraud, Sophie, Métayer-Coustard, Sonia. ""Expression of glucose transporters SLC2A1, SLC2A8, and SLC2A12 in different chicken muscles during ontogenesis."" Journal of animal science, 2018, pp. 498-509.
[65] Sandoval, C, Askelson, K, Lambo, C A, Dunlap, K A, Satterfield, M C. ""Effect of maternal nutrient restriction on expression of glucose transporters (SLC2A4 and SLC2A1) and insulin signaling in skeletal muscle of SGA and Non-SGA sheep fetuses."" Domestic animal endocrinology, 2021, pp. 106556.
[66] Heaton, Bethany J, Jensen, Rebecca L, Line, James, David, Christopher A W, Brain, Danielle E, Chadwick, Amy E, Liptrott, Neill J. ""Exposure of human immune cells, to the antiretrovirals efavirenz and lopinavir, leads to lower glucose uptake and altered bioenergetic cell profiles through interactions with SLC2A1."" Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, pp. 112999.
"	0.40520227	0.36027944	Tied	LLM	NA
Diff. expressed gene set	IL2 STAT5 SIGNALING	NA	ABCB1 ADAM19 AGER AHCY AHNAK AHR ALCAM AMACR ANXA4 APLP1 ARL4A BATF BATF3 BCL2 BCL2L1 BHLHE40 BMP2 BMPR2 CA2 CAPG CAPN3 CASP3 CCND2 CCND3 CCNE1 CCR4 CD44 CD48 CD79B CD81 CD83 CD86 CDC42SE2 CDC6 CDCP1 CDKN1C CISH CKAP4 COCH COL6A1 CSF1 CSF2 CST7 CTLA4 CTSZ CXCL10 CYFIP1 DCPS DENND5A DHRS3 DRC1 ECM1 EEF1AKMT1 EMP1 ENO3 ENPP1 EOMES ETFBKMT ETV4 F2RL2 FAH FGL2 FLT3LG FURIN GABARAPL1 GADD45B GALM GATA1 GBP4 GLIPR2 GPR65 GPR83 GPX4 GSTO1 GUCY1B1 HIPK2 HK2 HOPX HUWE1 HYCC2 ICOS IFITM3 IFNGR1 IGF1R IGF2R IKZF2 IKZF4 IL10 IL10RA IL13 IL18R1 IL1R2 IL1RL1 IL2RA IL2RB IL3RA IL4R IRF4 IRF6 IRF8 ITGA6 ITGAE ITGAV ITIH5 KLF6 LCLAT1 LIF LRIG1 LRRC8C LTB MAFF MAP3K8 MAP6 MAPKAPK2 MUC1 MXD1 MYC MYO1C MYO1E NCOA3 NCS1 NDRG1 NFIL3 NFKBIZ NOP2 NRP1 NT5E ODC1 P2RX4 P4HA1 PDCD2L PENK PHLDA1 PHTF2 PIM1 PLAGL1 PLEC PLIN2 PLPP1 PLSCR1 PNP POU2F1 PRAF2 PRKCH PRNP PTCH1 PTGER2 PTH1R PTRH2 PUS1 RABGAP1L RGS16 RHOB RHOH RNH1 RORA RRAGD S100A1 SCN9A SELL SELP SERPINB6 SERPINC1 SH3BGRL2 SHE SLC1A5 SLC29A2 SLC2A3 SLC39A8 SMPDL3A SNX14 SNX9 SOCS1 SOCS2 SPP1 SPRED2 SPRY4 ST3GAL4 SWAP70 SYNGR2 SYT11 TGM2 TIAM1 TLR7 TNFRSF18 TNFRSF1B TNFRSF21 TNFRSF4 TNFRSF8 TNFRSF9 TNFSF10 TNFSF11 TRAF1 TTC39B TWSG1 UCK2 UMPS WLS XBP1	199	7.636624620543649	Regulation Of Apoptotic Process 	GO:0042981	GATA1;IGF1R;SOCS2;CCND2;MYC;CASP3;TNFSF10;PIM1;CTLA4;CAPN3;TNFRSF8;PHLDA1;TGM2;IL10;XBP1;GADD45B;ANXA4;RHOB;CXCL10;BMP2;IL2RB;BCL2;ITGA6;CD44;BCL2L1	25	12.562814070351758	3.83e-8	6.48e-5	Cell Signaling and Immune Regulation	"The system of interacting proteins primarily performs cell signaling and immune regulation processes. The proteins involved in these processes include:

1. Cell Signaling: Proteins such as AHR, BCL2, BCL2L1, BMP2, BMPR2, CASP3, CCND2, CCND3, CCNE1, CD44, CD81, CD83, CD86, CDC42SE2, CDC6, CDKN1C, CXCL10, ETV4, F2RL2, FLT3LG, GPR65, GPR83, IGF1R, IGF2R, IL10, IL10RA, IL13, IL18R1, IL1R2, IL1RL1, IL2RA, IL2RB, IL3RA, IL4R, IRF4, IRF6, IRF8, ITGA6, ITGAE, ITGAV, MAP3K8, MAPKAPK2, MYC, NFKBIZ, NRP1, P2RX4, P4HA1, PTCH1, PTGER2, PTH1R, RABGAP1L, RGS16, RHOB, RHOH, RORA, RRAGD, S100A1, SCN9A, SELL, SELP, SLC1A5, SLC29A2, SLC2A3, SLC39A8, SNX14, SNX9, SOCS1, SOCS2, SPP1, SPRED2, SPRY4, ST3GAL4, SWAP70, SYNGR2, SYT11, TGM2, TIAM1, TLR7, TNFRSF18, TNFRSF1B, TNFRSF21, TNFRSF4, TNFRSF8, TNFRSF9, TNFSF10, TNFSF11, TRAF1, and WLS are involved in cell signaling processes. These proteins play roles in various signaling pathways, including growth factor signaling, cytokine signaling, and G-protein-coupled receptor signaling.

2. Immune Regulation: Proteins such as ABCB1, ADAM19, AGER, ALCAM, BATF, BATF3, CD48, CD79B, CDCP1, CISH, COCH, COL6A1, CSF1, CSF2, CTLA4, CTSZ, CXCL10, DCPS, DENND5A, DHRS3, ECM1, EMP1, ENPP1, EOMES, FAH, FGL2, FLT3LG, FURIN, GADD45B, GBP4, GLIPR2, GUCY1B1, HIPK2, HOPX, HUWE1, HYCC2, ICOS, IFITM3, IFNGR1, IKZF2, IKZF4, IL10, IL10RA, IL13, IL18R1, IL1R2, IL1RL1, IL2RA, IL2RB, IL3RA, IL4R, IRF4, IRF6, IRF8, ITGA6, ITGAE, ITGAV, KLF6, LIF, LRIG1, LRRC8C, LTB, MAFF, MAP3K8, MAP6, MUC1, MXD1, MYO1C, MYO1E, NCOA3, NCS1, NDRG1, NFIL3, NOP2, NRP1, NT5E, ODC1, P2RX4, P4HA1, PDCD2L, PENK, PHLDA1, PHTF2, PIM1, PLAGL1, PLEC, PLIN2, PLPP1, PLSCR1, PNP, POU2F1, PRAF2, PRKCH, PRNP, PTCH1, PTGER2, PTH1R, PTRH2, PUS1, RABGAP1L, RGS16, RHOB, RHOH, RNH1, RORA, RRAGD, S100A1, SCN9A, SELL, SELP, SERPINB6, SERPINC1, SH3BGRL2, SHE, SLC1A5, SLC29A2, SLC2A3, SLC39A8, SMPDL3A, SNX14, SNX9, SOCS1, SOCS2, SPP1, SPRED2, SPRY4, ST3GAL4, SWAP70, SYNG"	168	84.42211055276381	"The system of interacting proteins primarily performs cell signaling and immune regulation processes. The proteins involved in these processes include:

1. Cell Signaling: Proteins such as AHR, BCL2, BCL2L1, BMP2, BMPR2, CASP3, CCND2, CCND3, CCNE1, CD44, CD81, CD83, CD86, CDC42SE2, CDC6, CDKN1C, CXCL10, ETV4, F2RL2, FLT3LG, GPR65, GPR83, IGF1R, IGF2R, IL10, IL10RA, IL13, IL18R1, IL1R2, IL1RL1, IL2RA, IL2RB, IL3RA, IL4R, IRF4, IRF6, IRF8, ITGA6, ITGAE, ITGAV, MAP3K8, MAPKAPK2, MYC, NFKBIZ, NRP1, P2RX4, P4HA1, PTCH1, PTGER2, PTH1R, RABGAP1L, RGS16, RHOB, RHOH, RORA, RRAGD, S100A1, SCN9A, SELL, SELP, SLC1A5, SLC29A2, SLC2A3, SLC39A8, SNX14, SNX9, SOCS1, SOCS2, SPP1, SPRED2, SPRY4, ST3GAL4, SWAP70, SYNGR2, SYT11, TGM2, TIAM1, TLR7, TNFRSF18, TNFRSF1B, TNFRSF21, TNFRSF4, TNFRSF8, TNFRSF9, TNFSF10, TNFSF11, TRAF1, and WLS are involved in cell signaling processes. These proteins play roles in various signaling pathways, including growth factor signaling, cytokine signaling, and G-protein-coupled receptor signaling.[1][2][3]

2. Immune Regulation: Proteins such as ABCB1, ADAM19, AGER, ALCAM, BATF, BATF3, CD48, CD79B, CDCP1, CISH, COCH, COL6A1, CSF1, CSF2, CTLA4, CTSZ, CXCL10, DCPS, DENND5A, DHRS3, ECM1, EMP1, ENPP1, EOMES, FAH, FGL2, FLT3LG, FURIN, GADD45B, GBP4, GLIPR2, GUCY1B1, HIPK2, HOPX, HUWE1, HYCC2, ICOS, IFITM3, IFNGR1, IKZF2, IKZF4, IL10, IL10RA, IL13, IL18R1, IL1R2, IL1RL1, IL2RA, IL2RB, IL3RA, IL4R, IRF4, IRF6, IRF8, ITGA6, ITGAE, ITGAV, KLF6, LIF, LRIG1, LRRC8C, LTB, MAFF, MAP3K8, MAP6, MUC1, MXD1, MYO1C, MYO1E, NCOA3, NCS1, NDRG1, NFIL3, NOP2, NRP1, NT5E, ODC1, P2RX4, P4HA1, PDCD2L, PENK, PHLDA1, PHTF2, PIM1, PLAGL1, PLEC, PLIN2, PLPP1, PLSCR1, PNP, POU2F1, PRAF2, PRKCH, PRNP, PTCH1, PTGER2, PTH1R, PTRH2, PUS1, RABGAP1L, RGS16, RHOB, RHOH, RNH1, RORA, RRAGD, S100A1, SCN9A, SELL, SELP, SERPINB6, SERPINC1, SH3BGRL2, SHE, SLC1A5, SLC29A2, SLC2A3, SLC39A8, SMPDL3A, SNX14, SNX9, SOCS1, SOCS2, SPP1, SPRED2, SPRY4, ST3GAL4, SWAP70, SYNG[4][5][6]

========================================================================================================================================================================================================
[1] Yang, Jianming, Pei, Geng, Sun, Xuan, Xiao, Yawen, Miao, Chunhui, Zhou, Lu, Wang, Bangmao, Yang, Liu, Yu, Mingyu, Zhang, Zhi-Song, Keller, Evan T, Yao, Zhi, Wang, Quan. ""RhoB affects colitis through modulating cell signaling and intestinal microbiome."" Microbiome, 2022, pp. 149.
[2] Cherukuri, Anu, Carter, Robert H, Brooks, Stephen, Bornmann, William, Finn, Ronald, Dowd, Cynthia S, Pierce, Susan K. ""B cell signaling is regulated by induced palmitoylation of CD81."" The Journal of biological chemistry, 2004, pp. 31973-82.
[3] Dhar, Debanjan, Antonucci, Laura, Nakagawa, Hayato, Kim, Ju Youn, Glitzner, Elisabeth, Caruso, Stefano, Shalapour, Shabnam, Yang, Ling, Valasek, Mark A, Lee, Sooyeon, Minnich, Kerstin, Seki, Ekihiro, Tuckermann, Jan, Sibilia, Maria, Zucman-Rossi, Jessica, Karin, Michael. ""Liver Cancer Initiation Requires p53 Inhibition by CD44-Enhanced Growth Factor Signaling."" Cancer cell, 2018, pp. 1061-1077.e6.
[4] Kennedy, Alan, Waters, Erin, Rowshanravan, Behzad, Hinze, Claudia, Williams, Cayman, Janman, Daniel, Fox, Thomas A, Booth, Claire, Pesenacker, Anne M, Halliday, Neil, Soskic, Blagoje, Kaur, Satdip, Qureshi, Omar S, Morris, Emma C, Ikemizu, Shinji, Paluch, Christopher, Huo, Jiandong, Davis, Simon J, Boucrot, Emmanuel, Walker, Lucy S K, Sansom, David M. ""Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation."" Nature immunology, 2022, pp. 1365-1378.
[5] Oft, Martin. ""Immune regulation and cytotoxic T cell activation of IL-10 agonists - Preclinical and clinical experience."" Seminars in immunology, 2019, pp. 101325.
[6] Tokunaga, Ryuma, Zhang, Wu, Naseem, Madiha, Puccini, Alberto, Berger, Martin D, Soni, Shivani, McSkane, Michelle, Baba, Hideo, Lenz, Heinz-Josef. ""CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy."" Cancer treatment reviews, 2018, pp. 40-47.
"	0.54110944	0.16082707	LLM	Neither	NA
Diff. expressed gene set	IL6 JAK STAT3 SIGNALING	NA	A2M ACVR1B ACVRL1 BAK1 CBL CCL7 CCR1 CD14 CD36 CD38 CD44 CD9 CNTFR CRLF2 CSF1 CSF2 CSF2RA CSF2RB CSF3R CXCL1 CXCL10 CXCL11 CXCL13 CXCL3 CXCL9 DNTT EBI3 FAS GRB2 HAX1 HMOX1 IFNAR1 IFNGR1 IFNGR2 IL10RB IL12RB1 IL13RA1 IL15RA IL17RA IL17RB IL18R1 IL1B IL1R1 IL1R2 IL2RA IL2RG IL3RA IL4R IL6 IL6ST IL7 IL9R INHBE IRF1 IRF9 ITGA4 ITGB3 JUN LEPR LTB LTBR MAP3K8 MYD88 OSMR PDGFC PF4 PIK3R5 PIM1 PLA2G2A PTPN1 PTPN11 PTPN2 REG1A SOCS1 SOCS3 STAM2 STAT1 STAT2 STAT3 TGFB1 TLR2 TNF TNFRSF12A TNFRSF1A TNFRSF1B TNFRSF21 TYK2	87	6.442943495848728	Cytokine-Mediated Signaling Pathway 	GO:0019221	CNTFR;CXCL9;CSF3R;CSF2;EBI3;CXCL1;CSF2RB;CXCL13;IL2RG;CXCL3;CBL;TNF;CSF2RA;SOCS1;CCL7;LEPR;IL12RB1;IL13RA1;CCR1;IL15RA;IL4R;IL1R1;STAT1;STAT3;PTPN11;TYK2;OSMR;TNFRSF1B;TNFRSF1A;IL17RA;CXCL10;CXCL11;IL6;IL7;IL1B;IL2RA;IL3RA;IL6ST;IL9R;IL18R1;MYD88;PF4;CRLF2	43	49.42528735632184	9.94e-59	1.3e-55	Cytokine Signaling and Regulation	"The primary biological process performed by this system of interacting proteins is cytokine signaling and regulation. The proteins involved in this system play crucial roles in immune response, inflammation, and cellular communication.

1. Cytokine receptors and ligands: The presence of multiple cytokine receptors (e.g., IL2RA, IL4R, IL6ST, IL9R, IL17RA, IL17RB, IL18R1, IL1R1, IL1R2, CSF2RA, CSF2RB, CSF3R, IFNAR1, IFNGR1, IFNGR2, IL10RB, IL12RB1, IL13RA1, IL15RA, IL2RG, IL3RA, OSMR, TNFRSF1A, TNFRSF1B, TNFRSF21) and their respective ligands (e.g., IL1B, IL2, IL4, IL6, IL7, IL9, IL17A, IL17B, IL18, CSF1, CSF2, CSF3, IFNA, IFNG, IL10, IL12, IL13, IL15, OSM, TNF) indicates a strong involvement in cytokine signaling pathways.

2. JAK-STAT signaling: The presence of JAK-STAT signaling components (e.g., STAT1, STAT2, STAT3, TYK2, SOCS1, SOCS3) suggests that this system is involved in the regulation of cytokine-mediated immune responses and cellular processes such as proliferation, differentiation, and apoptosis.

3. TLR and MYD88 signaling: The presence of TLR2 and MYD88 indicates involvement in the Toll-like receptor (TLR) signaling pathway, which plays a crucial role in innate immunity and inflammation.

4. Chemokines and receptors: The presence of chemokines (e.g., CXCL1, CXCL10, CXCL11, CXCL13, CXCL3, CXCL9, CCL7) and their receptors (e.g., CCR1, CD44) suggests a role in chemotaxis and cellular migration during immune responses.

5. Cell adhesion molecules: The presence of integrins (e.g., ITGA4, ITGB3) and other cell adhesion molecules (e.g., CD9, CD36, CD38) indicates a role in cell-cell and cell-matrix interactions, which are essential for immune cell trafficking and tissue repair.

6. Apoptosis and cell survival: The presence of proteins involved in apoptosis (e.g., FAS, BAK1, LTB, LTBR, TNFRSF12A) and cell survival (e.g., HAX1, HMOX1, PIM1) suggests a role in regulating cell death and survival during immune responses and inflammation.

7. Signal transduction and regulation: The presence of various signaling proteins (e.g., GRB2, MAP3K8, PIK3R5, PTPN1, PTPN11, PTPN2, STAM2) and transcription factors (e.g., IRF1, IRF9, JUN) indicates a role in signal transduction and regulation of gene expression in response to cytokine signaling.

In conclusion, this system of interacting proteins is primarily involved in cytokine signaling and regulation, which plays a crucial role in immune response, inflammation, and cellular communication."	71	81.60919540229885	"The primary biological process performed by this system of interacting proteins is cytokine signaling and regulation. The proteins involved in this system play crucial roles in immune response, inflammation, and cellular communication.

1. Cytokine receptors and ligands: The presence of multiple cytokine receptors (e.g., IL2RA, IL4R, IL6ST, IL9R, IL17RA, IL17RB, IL18R1, IL1R1, IL1R2, CSF2RA, CSF2RB, CSF3R, IFNAR1, IFNGR1, IFNGR2, IL10RB, IL12RB1, IL13RA1, IL15RA, IL2RG, IL3RA, OSMR, TNFRSF1A, TNFRSF1B, TNFRSF21) and their respective ligands (e.g., IL1B, IL2, IL4, IL6, IL7, IL9, IL17A, IL17B, IL18, CSF1, CSF2, CSF3, IFNA, IFNG, IL10, IL12, IL13, IL15, OSM, TNF) indicates a strong involvement in cytokine signaling pathways.[1][2][3]

2. JAK-STAT signaling: The presence of JAK-STAT signaling components (e.g., STAT1, STAT2, STAT3, TYK2, SOCS1, SOCS3) suggests that this system is involved in the regulation of cytokine-mediated immune responses and cellular processes such as proliferation, differentiation, and apoptosis.[4][5][6]

3. TLR and MYD88 signaling: The presence of TLR2 and MYD88 indicates involvement in the Toll-like receptor (TLR) signaling pathway, which plays a crucial role in innate immunity and inflammation.[7][8][9]

4. Chemokines and receptors: The presence of chemokines (e.g., CXCL1, CXCL10, CXCL11, CXCL13, CXCL3, CXCL9, CCL7) and their receptors (e.g., CCR1, CD44) suggests a role in chemotaxis and cellular migration during immune responses.[10][11][12]

5. Cell adhesion molecules: The presence of integrins (e.g., ITGA4, ITGB3) and other cell adhesion molecules (e.g., CD9, CD36, CD38) indicates a role in cell-cell and cell-matrix interactions, which are essential for immune cell trafficking and tissue repair.[13][14][15]

6. Apoptosis and cell survival: The presence of proteins involved in apoptosis (e.g., FAS, BAK1, LTB, LTBR, TNFRSF12A) and cell survival (e.g., HAX1, HMOX1, PIM1) suggests a role in regulating cell death and survival during immune responses and inflammation.[16][17][18]

7. Signal transduction and regulation: The presence of various signaling proteins (e.g., GRB2, MAP3K8, PIK3R5, PTPN1, PTPN11, PTPN2, STAM2) and transcription factors (e.g., IRF1, IRF9, JUN) indicates a role in signal transduction and regulation of gene expression in response to cytokine signaling.[19][20][21]

In conclusion, this system of interacting proteins is primarily involved in cytokine signaling and regulation, which plays a crucial role in immune response, inflammation, and cellular communication.

========================================================================================================================================================================================================
[1] Wang, Xiang, Zhao, Xiang-Yu. ""Transcription Factors Associated With IL-15 Cytokine Signaling During NK Cell Development."" Frontiers in immunology, 2021, pp. 610789.
[2] Samarpita, Snigdha, Rasool, Mahaboobkhan. ""Cyanidin attenuates IL-17A cytokine signaling mediated monocyte migration and differentiation into mature osteoclasts in rheumatoid arthritis."" Cytokine, 2021, pp. 155502.
[3] Wajant, H, Grell, M, Scheurich, P. ""TNF receptor associated factors in cytokine signaling."" Cytokine & growth factor reviews, 1999, pp. 15-26.
[4] Zhang, Jiansong, Yuan, Shuangling, Peng, Qi, Ding, Zhen, Hao, Wenqi, Peng, Guiqing, Xiao, Shaobo, Fang, Liurong. ""Porcine Epidemic Diarrhea Virus nsp7 Inhibits Interferon-Induced JAK-STAT Signaling through Sequestering the Interaction between KPNA1 and STAT1."" Journal of virology, 2022, pp. e0040022.
[5] Li, M, Zheng, R, Yuan, F-L. ""MiR-410 affects the proliferation and apoptosis of lung cancer A549 cells through regulation of SOCS3/JAK-STAT signaling pathway."" European review for medical and pharmacological sciences, 2020, pp. 11462.
[6] Shang, Lin, Cao, Jiali, Zhao, Siqi, Zhang, Jingya, He, Yanling. ""TYK2 in Immune Responses and Treatment of Psoriasis."" Journal of inflammation research, 2022, pp. 5373-5385.
[7] Jiang, Song, Li, Xinyan, Hess, Nicholas J, Guan, Yue, Tapping, Richard I. ""TLR10 Is a Negative Regulator of Both MyD88-Dependent and -Independent TLR Signaling."" Journal of immunology (Baltimore, Md. : 1950), 2016, pp. 3834-41.
[8] Liu, Xing-Jun, Liu, Tong, Chen, Gang, Wang, Bing, Yu, Xiao-Lu, Yin, Cui, Ji, Ru-Rong. ""TLR signaling adaptor protein MyD88 in primary sensory neurons contributes to persistent inflammatory and neuropathic pain and neuroinflammation."" Scientific reports, 2016, pp. 28188.
[9] Chen, Feng, Wu, Runliu, Liu, Jiao, Kang, Rui, Li, Jinbao, Tang, Daolin. ""The STING1-MYD88 complex drives ACOD1/IRG1 expression and function in lethal innate immunity."" iScience, 2022, pp. 104561.
[10] Karin, Nathan, Razon, Hila. ""Chemokines beyond chemo-attraction: CXCL10 and its significant role in cancer and autoimmunity."" Cytokine, 2018, pp. 24-28.
[11] Girbl, Tamara, Lenn, Tchern, Perez, Lorena, Rolas, Loïc, Barkaway, Anna, Thiriot, Aude, Del Fresno, Carlos, Lynam, Eleanor, Hub, Elin, Thelen, Marcus, Graham, Gerard, Alon, Ronen, Sancho, David, von Andrian, Ulrich H, Voisin, Mathieu-Benoit, Rot, Antal, Nourshargh, Sussan. ""Distinct Compartmentalization of the Chemokines CXCL1 and CXCL2 and the Atypical Receptor ACKR1 Determine Discrete Stages of Neutrophil Diapedesis."" Immunity, 2018, pp. 1062-1076.e6.
[12] Goncharuk, Marina V, Roy, Debarati, Dubinnyi, Maxim A, Nadezhdin, Kirill D, Srivastava, Ashish, Baidya, Mithu, Dwivedi-Agnihotri, Hemlata, Arseniev, Alexander S, Shukla, Arun K. ""Purification of native CCL7 and its functional interaction with selected chemokine receptors."" Protein expression and purification, 2020, pp. 105617.
[13] Reyes, Raquel, Cardeñes, Beatriz, Machado-Pineda, Yesenia, Cabañas, Carlos. ""Tetraspanin CD9: A Key Regulator of Cell Adhesion in the Immune System."" Frontiers in immunology, 2018, pp. 863.
[14] Ghose, Jayeeta, Viola, Domenico, Terrazas, Cesar, Caserta, Enrico, Troadec, Estelle, Khalife, Jihane, Gunes, Emine Gulsen, Sanchez, James, McDonald, Tinisha, Marcucci, Guido, Kaur, Balveen, Rosenzweig, Michael, Keats, Jonathan, Rosen, Steven, Krishnan, Amrita, Satoskar, Abhay R, Hofmeister, Craig C, Pichiorri, Flavia. ""Daratumumab induces CD38 internalization and impairs myeloma cell adhesion."" Oncoimmunology, 2018, pp. e1486948.
[15] Machado-Pineda, Yesenia, Cardeñes, Beatriz, Reyes, Raquel, López-Martín, Soraya, Toribio, Víctor, Sánchez-Organero, Paula, Suarez, Henar, Grötzinger, Joachim, Lorenzen, Inken, Yáñez-Mó, María, Cabañas, Carlos. ""CD9 Controls Integrin α5β1-Mediated Cell Adhesion by Modulating Its Association With the Metalloproteinase ADAM17."" Frontiers in immunology, 2018, pp. 2474.
[16] Wang, Juan, Cao, Zeyuan, Wang, Panpan, Zhang, Xiao, Tang, Jianxia, He, Yifan, Huang, Zhiqing, Mao, Xueli, Shi, Songtao, Kou, Xiaoxing. ""Apoptotic Extracellular Vesicles Ameliorate Multiple Myeloma by Restoring Fas-Mediated Apoptosis."" ACS nano, 2021, pp. 14360-14372.
[17] Lu, Xiongsong, Xue, Pengfei, Fu, Luyu, Zhang, Jinlong, Jiang, Jiawei, Guo, Xiaofeng, Bao, Guofeng, Xu, Guanhua, Sun, Yuyu, Chen, Jiajia, Cui, Zhiming. ""HAX1 is associated with neuronal apoptosis and astrocyte proliferation after spinal cord injury."" Tissue & cell, 2018, pp. 1-9.
[18] Knight, Julia C, Scharf, Eugene L, Mao-Draayer, Yang. ""Fas activation increases neural progenitor cell survival."" Journal of neuroscience research, 2010, pp. 746-57.
[19] Gui, Rong, Li, Dengqing, Qi, Guannan, Suhad, Ali, Nie, Xinmin. ""Inhibition of Grb2-mediated activation of MAPK signal transduction suppresses NOR<sub>1</sub>/CB1954-induced cytotoxicity in the HepG2 cell line."" Oncology letters, 2012, pp. 566-570.
[20] Tari, A M, Lopez-Berestein, G. ""GRB2: a pivotal protein in signal transduction."" Seminars in oncology, 2001, pp. 142-7.
[21] Smith, Siobhán, Fernando, Thilini, Wu, Pei Wen, Seo, Jane, Ní Gabhann, Joan, Piskareva, Olga, McCarthy, Eoghan, Howard, Donough, O'Connell, Paul, Conway, Richard, Gallagher, Phil, Molloy, Eamonn, Stallings, Raymond L, Kearns, Grainne, Forbess, Lindsy, Ishimori, Mariko, Venuturupalli, Swamy, Wallace, Daniel, Weisman, Michael, Jefferies, Caroline A. ""MicroRNA-302d targets IRF9 to regulate the IFN-induced gene expression in SLE."" Journal of autoimmunity, 2017, pp. 105-111.
"	0.6651654	0.65805835	Tied	Tied	NA
Diff. expressed gene set	INFLAMMATORY RESPONSE	NA	ABCA1 ABI1 ACVR1B ACVR2A ADGRE1 ADM ADORA2B ADRM1 AHR APLNR AQP9 ATP2A2 ATP2B1 ATP2C1 AXL BDKRB1 BEST1 BST2 BTG2 C3AR1 C5AR1 CALCRL CCL17 CCL2 CCL20 CCL22 CCL24 CCL5 CCL7 CCR7 CCRL2 CD14 CD40 CD48 CD55 CD69 CD70 CD82 CDKN1A CHST2 CLEC5A CMKLR1 CSF1 CSF3 CSF3R CX3CL1 CXCL10 CXCL11 CXCL6 CXCL8 CXCL9 CXCR6 CYBB DCBLD2 EBI3 EDN1 EIF2AK2 EMP3 EREG F3 FFAR2 FPR1 FZD5 GABBR1 GCH1 GNA15 GNAI3 GP1BA GPC3 GPR132 GPR183 HAS2 HBEGF HIF1A HPN HRH1 ICAM1 ICAM4 ICOSLG IFITM1 IFNAR1 IFNGR2 IL10 IL10RA IL12B IL15 IL15RA IL18 IL18R1 IL18RAP IL1A IL1B IL1R1 IL2RB IL4R IL6 IL7R INHBA IRAK2 IRF1 IRF7 ITGA5 ITGB3 ITGB8 KCNA3 KCNJ2 KCNMB2 KIF1B KLF6 LAMP3 LCK LCP2 LDLR LIF LPAR1 LTA LY6E LYN MARCO MEFV MEP1A MET MMP14 MSR1 MXD1 MYC NAMPT NDP NFKB1 NFKBIA NLRP3 NMI NMUR1 NOD2 NPFFR2 OLR1 OPRK1 OSM OSMR P2RX4 P2RX7 P2RY2 PCDH7 PDE4B PDPN PIK3R5 PLAUR PROK2 PSEN1 PTAFR PTGER2 PTGER4 PTGIR PTPRE PVR RAF1 RASGRP1 RELA RGS1 RGS16 RHOG RIPK2 RNF144B ROS1 RTP4 SCARF1 SCN1B SELE SELENOS SELL SEMA4D SERPINE1 SGMS2 SLAMF1 SLC11A2 SLC1A2 SLC28A2 SLC31A1 SLC31A2 SLC4A4 SLC7A1 SLC7A2 SPHK1 SRI STAB1 TACR1 TACR3 TAPBP TIMP1 TLR1 TLR2 TLR3 TNFAIP6 TNFRSF1B TNFRSF9 TNFSF10 TNFSF15 TNFSF9 TPBG VIP	200	7.643856189774724	Inflammatory Response 	GO:0006954	PTGER4;CXCL6;CD40;CXCL9;CXCL8;TNFAIP6;PTGER2;C5AR1;FPR1;ADM;MEFV;CX3CL1;RELA;CCL7;IRAK2;CCL5;CCRL2;C3AR1;PROK2;OLR1;NLRP3;CCL2;CCR7;CD14;CCL17;CMKLR1;CCL24;PTGIR;CCL22;CCL20;RIPK2;IL18;CYBB;TACR1;SELE;NFKB1;TLR1;IL1A;CXCL10;CXCL11;IL6;IL1B;TLR3;TLR2	44	22	1.9e-43	3.73e-40	Inflammatory Response and Immune Regulation	"The system of interacting proteins primarily performs the biological process of inflammatory response and immune regulation. The following points support this conclusion:

1. Presence of cytokines and chemokines: The system includes several cytokines (IL10, IL12B, IL15, IL18, IL1A, IL1B, IL6, LIF, OSM) and chemokines (CCL17, CCL2, CCL20, CCL22, CCL24, CCL5, CCL7, CX3CL1, CXCL10, CXCL11, CXCL6, CXCL8, CXCL9) that play crucial roles in immune cell recruitment, activation, and regulation of inflammatory responses.

2. Involvement of pattern recognition receptors: TLR1, TLR2, and TLR3 are part of the Toll-like receptor family, which recognize pathogen-associated molecular patterns and initiate innate immune responses. NOD2 and NLRP3 are intracellular sensors that also contribute to immune activation.

3. Inclusion of cell adhesion molecules: ICAM1, ICAM4, ITGA5, ITGB3, and ITGB8 are involved in cell-cell interactions and leukocyte migration during inflammation.

4. Expression of growth factors and their receptors: CSF1, CSF3, and their receptor CSF3R, as well as EDN1 and HBEGF, are involved in immune cell proliferation, differentiation, and activation.

5. Involvement of transcription factors: IRF1, IRF7, MYC, NFKB1, and RELA are transcription factors that regulate the expression of genes involved in immune responses and inflammation.

6. Presence of cell surface receptors: Several cell surface receptors (CCR7, CD14, CD40, CD48, CD55, CD69, CD70, CD82, CMKLR1, CXCR6, FPR1, GPR132, GPR183, LPAR1, P2RX4, P2RX7, P2RY2, PTAFR, PTGER2, PTGER4, PTGIR, TACR1, TACR3, TNFRSF1B, TNFRSF9) are involved in immune cell activation, signaling, and regulation.

7. Inclusion of enzymes involved in immune regulation: AHR, EIF2AK2, GNA15, GNAI3, IRAK2, LCK, LCP2, LYN, PIK3R5, PTPRE, RASGRP1, RIPK2, and SPHK1 are enzymes that participate in various signaling pathways related to immune responses and inflammation.

8. Expression of membrane transporters: SLC11A2, SLC1A2, SLC28A2, SLC31A1, SLC31A2, SLC4A4, SLC7A1, and SLC7A2 are involved in the transport of ions, nutrients, and other molecules that contribute to immune cell function and inflammatory processes.

In summary, the system of interacting proteins is primarily involved in the inflammatory response and immune regulation, as evidenced by the presence of cytokines, chemokines, pattern recognition receptors, cell adhesion molecules, growth factors, transcription factors, cell surface receptors, and enzymes involved in immune regulation."	89	44.5	"The system of interacting proteins primarily performs the biological process of inflammatory response and immune regulation. The following points support this conclusion:

1. Presence of cytokines and chemokines: The system includes several cytokines (IL10, IL12B, IL15, IL18, IL1A, IL1B, IL6, LIF, OSM) and chemokines (CCL17, CCL2, CCL20, CCL22, CCL24, CCL5, CCL7, CX3CL1, CXCL10, CXCL11, CXCL6, CXCL8, CXCL9) that play crucial roles in immune cell recruitment, activation, and regulation of inflammatory responses.[1][2][3]

2. Involvement of pattern recognition receptors: TLR1, TLR2, and TLR3 are part of the Toll-like receptor family, which recognize pathogen-associated molecular patterns and initiate innate immune responses. NOD2 and NLRP3 are intracellular sensors that also contribute to immune activation.[4][5][6]

3. Inclusion of cell adhesion molecules: ICAM1, ICAM4, ITGA5, ITGB3, and ITGB8 are involved in cell-cell interactions and leukocyte migration during inflammation.[7][8][9]

4. Expression of growth factors and their receptors: CSF1, CSF3, and their receptor CSF3R, as well as EDN1 and HBEGF, are involved in immune cell proliferation, differentiation, and activation.[10][11][12]

5. Involvement of transcription factors: IRF1, IRF7, MYC, NFKB1, and RELA are transcription factors that regulate the expression of genes involved in immune responses and inflammation.[13][14][15]

6. Presence of cell surface receptors: Several cell surface receptors (CCR7, CD14, CD40, CD48, CD55, CD69, CD70, CD82, CMKLR1, CXCR6, FPR1, GPR132, GPR183, LPAR1, P2RX4, P2RX7, P2RY2, PTAFR, PTGER2, PTGER4, PTGIR, TACR1, TACR3, TNFRSF1B, TNFRSF9) are involved in immune cell activation, signaling, and regulation.[16][17][18]

7. Inclusion of enzymes involved in immune regulation: AHR, EIF2AK2, GNA15, GNAI3, IRAK2, LCK, LCP2, LYN, PIK3R5, PTPRE, RASGRP1, RIPK2, and SPHK1 are enzymes that participate in various signaling pathways related to immune responses and inflammation.[19][20][21]

8. Expression of membrane transporters: SLC11A2, SLC1A2, SLC28A2, SLC31A1, SLC31A2, SLC4A4, SLC7A1, and SLC7A2 are involved in the transport of ions, nutrients, and other molecules that contribute to immune cell function and inflammatory processes.[22][23][24]

In summary, the system of interacting proteins is primarily involved in the inflammatory response and immune regulation, as evidenced by the presence of cytokines, chemokines, pattern recognition receptors, cell adhesion molecules, growth factors, transcription factors, cell surface receptors, and enzymes involved in immune regulation.

========================================================================================================================================================================================================
[1] Ouyang, Wenjun, Rutz, Sascha, Crellin, Natasha K, Valdez, Patricia A, Hymowitz, Sarah G. ""Regulation and functions of the IL-10 family of cytokines in inflammation and disease."" Annual review of immunology, 2011, pp. 71-109.
[2] Ouyang, Wenjun, O'Garra, Anne. ""IL-10 Family Cytokines IL-10 and IL-22: from Basic Science to Clinical Translation."" Immunity, 2019, pp. 871-891.
[3] Taniguchi, Koji, Karin, Michael. ""IL-6 and related cytokines as the critical lynchpins between inflammation and cancer."" Seminars in immunology, 2014, pp. 54-74.
[4] Chen, Yujuan, Lin, Junhong, Zhao, Yao, Ma, Xianping, Yi, Huashan. ""Toll-like receptor 3 (TLR3) regulation mechanisms and roles in antiviral innate immune responses."" Journal of Zhejiang University. Science. B, 2021, pp. 609-632.
[5] Mahesh, K C, Ngunjiri, John M, Ghorbani, Amir, Abundo, Michael E C, Wilbanks, Kathryn Q, Lee, Kichoon, Lee, Chang-Won. ""Assessment of TLR3 and MDA5-Mediated Immune Responses Using Knockout Quail Fibroblast Cells."" Avian diseases, 2021, pp. 419-428.
[6] Rice, Tyler A, Brenner, Todd A, Percopo, Caroline M, Ma, Michelle, Keicher, Jesse D, Domachowske, Joseph B, Rosenberg, Helene F. ""Signaling via pattern recognition receptors NOD2 and TLR2 contributes to immunomodulatory control of lethal pneumovirus infection."" Antiviral research, 2016, pp. 131-40.
[7] Qiu, Zhiyuan, Wang, Yan, Zhang, Zhao, Qin, Rong, Peng, Yong, Tang, Weifeng, Xi, Yan, Tian, Guangyu, Zhang, Yeqing. ""Roles of intercellular cell adhesion molecule-1 (ICAM-1) in colorectal cancer: expression, functions, prognosis, tumorigenesis, polymorphisms and therapeutic implications."" Frontiers in oncology, 2022, pp. 1052672.
[8] Kotteas, Elias A, Boulas, Panagiotis, Gkiozos, Ioannis, Tsagkouli, Sofia, Tsoukalas, George, Syrigos, Konstantinos N. ""The intercellular cell adhesion molecule-1 (icam-1) in lung cancer: implications for disease progression and prognosis."" Anticancer research, 2014, pp. 4665-72.
[9] Wang, Ting-Ting, Wang, Xiao-Mei, Zhang, Xiao-Li. ""Circulating Vascular Cell Adhesion Molecule-1 (VCAM-1) and Intercellular Adhesion Molecule-1 (ICAM-1): Relationship with carotid artery elasticity in patients with impaired glucose regulation (IGR)."" Annales d'endocrinologie, 2019, pp. 72-76.
[10] Pampfer, S, Arceci, R J, Pollard, J W. ""Role of colony stimulating factor-1 (CSF-1) and other lympho-hematopoietic growth factors in mouse pre-implantation development."" BioEssays : news and reviews in molecular, cellular and developmental biology, 1991, pp. 535-40.
[11] Roelofs, Luc A J, Oosterwijk, Egbert, Kortmann, Barbara B M, Daamen, Willeke F, Tiemessen, Dorien M, Brouwer, Katrien M, Eggink, Alex J, Crevels, A Jane, Wijnen, Rene M H, van Kuppevelt, Toin H, Geutjes, Paul J, Feitz, Wout F J. ""Bladder Regeneration Using a Smart Acellular Collagen Scaffold with Growth Factors VEGF, FGF2 and HB-EGF."" Tissue engineering. Part A, 2016, pp. 83-92.
[12] Miyauchi, J, Kelleher, C A, Wong, G G, Yang, Y C, Clark, S C, Minkin, S, Minden, M D, McCulloch, E A. ""The effects of combinations of the recombinant growth factors GM-CSF, G-CSF, IL-3, and CSF-1 on leukemic blast cells in suspension culture."" Leukemia, 1988, pp. 382-7.
[13] Feng, Hui, Zhang, Yi-Bing, Gui, Jian-Fang, Lemon, Stanley M, Yamane, Daisuke. ""Interferon regulatory factor 1 (IRF1) and anti-pathogen innate immune responses."" PLoS pathogens, 2021, pp. e1009220.
[14] Cartwright, Tyrell, Perkins, Neil D, L Wilson, Caroline. ""NFKB1: a suppressor of inflammation, ageing and cancer."" The FEBS journal, 2016, pp. 1812-22.
[15] Kortlever, Roderik M, Sodir, Nicole M, Wilson, Catherine H, Burkhart, Deborah L, Pellegrinet, Luca, Brown Swigart, Lamorna, Littlewood, Trevor D, Evan, Gerard I. ""Myc Cooperates with Ras by Programming Inflammation and Immune Suppression."" Cell, 2017, pp. 1301-1315.e14.
[16] Diggs, Laurence P, Ruf, Benjamin, Ma, Chi, Heinrich, Bernd, Cui, Linda, Zhang, Qianfei, McVey, John C, Wabitsch, Simon, Heinrich, Sophia, Rosato, Umberto, Lai, Walter, Subramanyam, Varun, Longerich, Thomas, Loosen, Sven H, Luedde, Tom, Neumann, Ulf Peter, Desar, Sabina, Kleiner, David, Gores, Gregory, Wang, Xin Wei, Greten, Tim F. ""CD40-mediated immune cell activation enhances response to anti-PD-1 in murine intrahepatic cholangiocarcinoma."" Journal of hepatology, 2021, pp. 1145-1154.
[17] Brush, Julie, Mendenhall, Elissa, Guggenheim, Alena, Chan, Tracy, Connelly, Erin, Soumyanath, Amala, Buresh, Randal, Barrett, Richard, Zwickey, Heather. ""The effect of Echinacea purpurea, Astragalus membranaceus and Glycyrrhiza glabra on CD69 expression and immune cell activation in humans."" Phytotherapy research : PTR, 2006, pp. 687-95.
[18] Ciesielska, Anna, Matyjek, Marta, Kwiatkowska, Katarzyna. ""TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling."" Cellular and molecular life sciences : CMLS, 2021, pp. 1233-1261.
[19] Larigot, Lucie, Juricek, Ludmila, Dairou, Julien, Coumoul, Xavier. ""AhR signaling pathways and regulatory functions."" Biochimie open, 2018, pp. 1-9.
[20] Hu, Jieke, Ding, Yuan, Liu, Wen, Liu, Shuzhen. ""When AHR signaling pathways meet viral infections."" Cell communication and signaling : CCS, 2023, pp. 42.
[21] Perepechaeva, Maria L, Klyushova, Lyubov S, Grishanova, Alevtina Y. ""AhR and HIF-1<i>α</i> Signaling Pathways in Benign Meningioma under Hypoxia."" International journal of cell biology, 2023, pp. 6840271.
[22] Abdulhussein, Ahmed A, Wallace, Heather M. ""Polyamines and membrane transporters."" Amino acids, 2014, pp. 655-60.
[23] Sun, Tianshui, Bi, Fangfang, Liu, Zhuonan, Yang, Qing. ""SLC7A2 serves as a potential biomarker and therapeutic target for ovarian cancer."" Aging, 2020, pp. 13281-13296.
[24] Pujol-Giménez, Jonai, Poirier, Marion, Bühlmann, Sven, Schuppisser, Céline, Bhardwaj, Rajesh, Awale, Mahendra, Visini, Ricardo, Javor, Sacha, Hediger, Matthias A, Reymond, Jean-Louis. ""Inhibitors of Human Divalent Metal Transporters DMT1 (SLC11A2) and ZIP8 (SLC39A8) from a GDB-17 Fragment Library."" ChemMedChem, 2021, pp. 3306-3314.
"	0.86390954	0.9999999	GO	GO	NA
Diff. expressed gene set	INTERFERON ALPHA RESPONSE	NA	ADAR B2M BATF2 BST2 C1S CASP1 CASP8 CCRL2 CD47 CD74 CMPK2 CMTR1 CNP CSF1 CXCL10 CXCL11 DDX60 DHX58 EIF2AK2 ELF1 EPSTI1 GBP2 GBP4 GMPR HELZ2 HERC6 HLA-C IFI27 IFI30 IFI35 IFI44 IFI44L IFIH1 IFIT2 IFIT3 IFITM1 IFITM2 IFITM3 IL15 IL4R IL7 IRF1 IRF2 IRF7 IRF9 ISG15 ISG20 LAMP3 LAP3 LGALS3BP LPAR6 LY6E MOV10 MVB12A MX1 NCOA7 NMI NUB1 OAS1 OASL OGFR PARP12 PARP14 PARP9 PLSCR1 PNPT1 PROCR PSMA3 PSMB8 PSMB9 PSME1 PSME2 RIPK2 RNF31 RSAD2 RTP4 SAMD9 SAMD9L SELL SLC25A28 SP110 STAT2 TAP1 TDRD7 TENT5A TMEM140 TRAFD1 TRIM14 TRIM21 TRIM25 TRIM26 TRIM5 TXNIP UBA7 UBE2L6 USP18 WARS1	97	6.599912842187128	Defense Response To Virus 	GO:0051607	IFITM3;RTP4;IFITM1;IFITM2;DDX60;USP18;IFI44L;IFIT3;IFIT2;OASL;IFIH1;TRIM5;DHX58;CASP1;TRIM25;TRIM26;GBP2;TRIM21;RSAD2;STAT2;MX1;EIF2AK2;ISG15;ISG20;BST2;CXCL10;MOV10;PLSCR1;IFI27;OAS1;IRF1;IRF2;IRF7	33	34.02061855670103	4.3500000000000006e-43	3.29e-40	Antiviral Immune Response	"The system of interacting proteins primarily performs the biological process of antiviral immune response. This is supported by the presence of several key proteins involved in the innate immune response against viral infections.

1. Interferon-induced proteins: Many proteins in the system, such as IFI27, IFI35, IFI44, IFI44L, IFIH1, IFIT2, IFIT3, IFITM1, IFITM2, IFITM3, ISG15, and ISG20, are induced by interferons, which are crucial for antiviral defense.

2. Interferon regulatory factors: IRF1, IRF2, IRF7, and IRF9 are transcription factors that regulate the expression of interferon-stimulated genes, further supporting the antiviral immune response.

3. Chemokines: CXCL10 and CXCL11 are chemokines that attract immune cells to the site of infection, promoting the clearance of viruses.

4. Oligoadenylate synthetases: OAS1 and OASL are involved in the activation of RNase L, which degrades viral RNA and inhibits viral replication.

5. Pattern recognition receptors: Proteins such as DDX60 and DHX58 recognize viral nucleic acids and initiate signaling pathways that lead to the production of type I interferons.

6. Tripartite motif-containing proteins: TRIM14, TRIM21, TRIM25, TRIM26, and TRIM5 are involved in the regulation of innate immune signaling and direct antiviral activity.

7. Nucleic acid editing: ADAR is an RNA-editing enzyme that can alter viral RNA sequences, potentially inhibiting viral replication.

8. Proteasome components: PSMB8, PSMB9, PSME1, and PSME2 are involved in the degradation of viral proteins, contributing to the antiviral response.

9. Caspases: CASP1 and CASP8 are involved in the activation of inflammatory cytokines and apoptosis, which can limit viral replication and spread.

In conclusion, the most prominent biological process performed by this system of interacting proteins is the antiviral immune response, as evidenced by the presence of numerous proteins involved in interferon signaling, immune cell recruitment, viral RNA degradation, and viral protein degradation."	34	35.051546391752574	"The system of interacting proteins primarily performs the biological process of antiviral immune response. This is supported by the presence of several key proteins involved in the innate immune response against viral infections.

1. Interferon-induced proteins: Many proteins in the system, such as IFI27, IFI35, IFI44, IFI44L, IFIH1, IFIT2, IFIT3, IFITM1, IFITM2, IFITM3, ISG15, and ISG20, are induced by interferons, which are crucial for antiviral defense.[1][2][3]

2. Interferon regulatory factors: IRF1, IRF2, IRF7, and IRF9 are transcription factors that regulate the expression of interferon-stimulated genes, further supporting the antiviral immune response.[4][5][6]

3. Chemokines: CXCL10 and CXCL11 are chemokines that attract immune cells to the site of infection, promoting the clearance of viruses.[7][8][9]

4. Oligoadenylate synthetases: OAS1 and OASL are involved in the activation of RNase L, which degrades viral RNA and inhibits viral replication.[10][11][12]

5. Pattern recognition receptors: Proteins such as DDX60 and DHX58 recognize viral nucleic acids and initiate signaling pathways that lead to the production of type I interferons.[13][14][15]

6. Tripartite motif-containing proteins: TRIM14, TRIM21, TRIM25, TRIM26, and TRIM5 are involved in the regulation of innate immune signaling and direct antiviral activity.[16][17][18]

7. Nucleic acid editing: ADAR is an RNA-editing enzyme that can alter viral RNA sequences, potentially inhibiting viral replication.[19][20][21]

8. Proteasome components: PSMB8, PSMB9, PSME1, and PSME2 are involved in the degradation of viral proteins, contributing to the antiviral response.[22][23][24]

9. Caspases: CASP1 and CASP8 are involved in the activation of inflammatory cytokines and apoptosis, which can limit viral replication and spread.[25][26][27]

In conclusion, the most prominent biological process performed by this system of interacting proteins is the antiviral immune response, as evidenced by the presence of numerous proteins involved in interferon signaling, immune cell recruitment, viral RNA degradation, and viral protein degradation.

========================================================================================================================================================================================================
[1] Lau, Samantha Lai-Yee, Yuen, Man-Leuk, Kou, Cecy Ying-Chuck, Au, Ka-Wing, Zhou, Junwei, Tsui, Stephen Kwok-Wing. ""Interferons induce the expression of IFITM1 and IFITM3 and suppress the proliferation of rat neonatal cardiomyocytes."" Journal of cellular biochemistry, 2012, pp. 841-7.
[2] Londrigan, Sarah L, Wakim, Linda M, Smith, Jeffrey, Haverkate, Anne J, Brooks, Andrew G, Reading, Patrick C. ""IFITM3 and type I interferons are important for the control of influenza A virus replication in murine macrophages."" Virology, 2020, pp. 17-22.
[3] Yang, Ling, Zhang, Le-Ying, Wang, Chengming, Wang, Bin, Wang, Xue-Min, Zeng, Shen-Ming. ""Differential expression pattern of ISG15 in different tissue explants and cells induced by various interferons."" Microbiology and immunology, 2012, pp. 163-70.
[4] Zhan, Fan-Bin, Liu, Han, Lai, Rui-Fang, Jakovlić, Ivan, Wang, Wei-Min. ""Expression and functional characterization of interferon regulatory factors (irf2, irf7 and irf9) in the blunt snout bream (Megalobrama amblycephala)."" Developmental and comparative immunology, 2017, pp. 239-248.
[5] Irving, Aaron T, Zhang, Qian, Kong, Pui-San, Luko, Katarina, Rozario, Pritisha, Wen, Ming, Zhu, Feng, Zhou, Peng, Ng, Justin H J, Sobota, Radoslaw M, Wang, Lin-Fa. ""Interferon Regulatory Factors IRF1 and IRF7 Directly Regulate Gene Expression in Bats in Response to Viral Infection."" Cell reports, 2020, pp. 108345.
[6] Ahamad, Naseem, Rath, Pramod C. ""Expression of interferon regulatory factors (IRF-1 and IRF-2) during radiation-induced damage and regeneration of bone marrow by transplantation in mouse."" Molecular biology reports, 2019, pp. 551-567.
[7] Karin, Nathan, Razon, Hila. ""Chemokines beyond chemo-attraction: CXCL10 and its significant role in cancer and autoimmunity."" Cytokine, 2018, pp. 24-28.
[8] Tomita, Kyoko, Freeman, Brittany L, Bronk, Steven F, LeBrasseur, Nathan K, White, Thomas A, Hirsova, Petra, Ibrahim, Samar H. ""CXCL10-Mediates Macrophage, but not Other Innate Immune Cells-Associated Inflammation in Murine Nonalcoholic Steatohepatitis."" Scientific reports, 2016, pp. 28786.
[9] Vissers, Marloes, Schreurs, Inge, Jans, Jop, Heldens, Jacco, de Groot, Ronald, de Jonge, Marien I, Ferwerda, Gerben. ""Antibodies enhance CXCL10 production during RSV infection of infant and adult immune cells."" Cytokine, 2015, pp. 458-464.
[10] Schwartz, Samantha L, Park, Esther N, Vachon, Virginia K, Danzy, Shamika, Lowen, Anice C, Conn, Graeme L. ""Human OAS1 activation is highly dependent on both RNA sequence and context of activating RNA motifs."" Nucleic acids research, 2020, pp. 7520-7531.
[11] Rong, Enguang, Wang, Xiaoxue, Chen, Hualan, Yang, Chenghuai, Hu, Jiaxiang, Liu, Wenjie, Wang, Zeng, Chen, Xiaoyun, Zheng, Haixue, Pu, Juan, Sun, Honglei, Smith, Jacqueline, Burt, David W, Liu, Jinhua, Li, Ning, Huang, Yinhua. ""Molecular Mechanisms for the Adaptive Switching Between the OAS/RNase L and OASL/RIG-I Pathways in Birds and Mammals."" Frontiers in immunology, 2018, pp. 1398.
[12] Kulka, Michael, Calvo, Mona S, Ngo, Diana T, Wales, Samantha Q, Goswami, Biswendu B. ""Activation of the 2-5OAS/RNase L pathway in CVB1 or HAV/18f infected FRhK-4 cells does not require induction of OAS1 or OAS2 expression."" Virology, 2009, pp. 169-84.
[13] Fullam, Anthony, Schröder, Martina. ""DExD/H-box RNA helicases as mediators of anti-viral innate immunity and essential host factors for viral replication."" Biochimica et biophysica acta, 2013, pp. 854-65.
[14] Kouwaki, Takahisa, Fukushima, Yoshimi, Daito, Takuji, Sanada, Takahiro, Yamamoto, Naoki, Mifsud, Edin J, Leong, Chean Ring, Tsukiyama-Kohara, Kyoko, Kohara, Michinori, Matsumoto, Misako, Seya, Tsukasa, Oshiumi, Hiroyuki. ""Extracellular Vesicles Including Exosomes Regulate Innate Immune Responses to Hepatitis B Virus Infection."" Frontiers in immunology, 2016, pp. 335.
[15] Xie, Xin, Liu, Pu-Ste, Percipalle, Piergiorgio. ""Analysis of Global Transcriptome Change in Mouse Embryonic Fibroblasts After dsDNA and dsRNA Viral Mimic Stimulation."" Frontiers in immunology, 2019, pp. 836.
[16] Lascano, Josefina, Uchil, Pradeep D, Mothes, Walther, Luban, Jeremy. ""TRIM5 Retroviral Restriction Activity Correlates with the Ability To Induce Innate Immune Signaling."" Journal of virology, 2016, pp. 308-16.
[17] Grütter, Markus G, Luban, Jeremy. ""TRIM5 structure, HIV-1 capsid recognition, and innate immune signaling."" Current opinion in virology, 2012, pp. 142-50.
[18] Fletcher, Adam J, Vaysburd, Marina, Maslen, Sarah, Zeng, Jingwei, Skehel, J Mark, Towers, Greg J, James, Leo C. ""Trivalent RING Assembly on Retroviral Capsids Activates TRIM5 Ubiquitination and Innate Immune Signaling."" Cell host & microbe, 2018, pp. 761-775.e6.
[19] Nishikura, Kazuko. ""Functions and regulation of RNA editing by ADAR deaminases."" Annual review of biochemistry, 2010, pp. 321-49.
[20] Yi, Zongyi, Qu, Liang, Tang, Huixian, Liu, Zhiheng, Liu, Ying, Tian, Feng, Wang, Chunhui, Zhang, Xiaoxue, Feng, Ziqi, Yu, Ying, Yuan, Pengfei, Yi, Zexuan, Zhao, Yanxia, Wei, Wensheng. ""Engineered circular ADAR-recruiting RNAs increase the efficiency and fidelity of RNA editing in vitro and in vivo."" Nature biotechnology, 2022, pp. 946-955.
[21] Reautschnig, Philipp, Wahn, Nicolai, Wettengel, Jacqueline, Schulz, Annika E, Latifi, Ngadhnjim, Vogel, Paul, Kang, Tae-Won, Pfeiffer, Laura S, Zarges, Christine, Naumann, Ulrike, Zender, Lars, Li, Jin Billy, Stafforst, Thorsten. ""CLUSTER guide RNAs enable precise and efficient RNA editing with endogenous ADAR enzymes in vivo."" Nature biotechnology, 2022, pp. 759-768.
[22] Jadeja, Shahnawaz D, Mansuri, Mohmmad Shoab, Singh, Mala, Dwivedi, Mitesh, Laddha, Naresh C, Begum, Rasheedunnisa. ""A case-control study on association of proteasome subunit beta 8 (PSMB8) and transporter associated with antigen processing 1 (TAP1) polymorphisms and their transcript levels in vitiligo from Gujarat."" PloS one, 2017, pp. e0180958.
[23] Fujito, Naoko T, Nonaka, Masaru. ""Highly divergent dimorphic alleles of the proteasome subunit beta type-8 (PSMB8) gene of the bichir Polypterus senegalus: implication for evolution of the PSMB8 gene of jawed vertebrates."" Immunogenetics, 2012, pp. 447-53.
[24] Chen, Danxiang, Jin, Cong, Dong, Xubin, Wen, Jialiang, Xia, Erjie, Wang, Qingxuan, Wang, Ouchen. ""Pan-cancer analysis of the prognostic and immunological role of PSMB8."" Scientific reports, 2021, pp. 20492.
[25] Seale, Kirsten, Burger, Marilize, Posthumus, Michael, Häger, Charlotte K, Stattin, Evalena, Nilsson, Kjell G, Collins, Malcolm, September, Alison V. ""The Apoptosis Pathway and CASP8 Variants Conferring Risk for Acute and Overuse Musculoskeletal Injuries."" Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2020, pp. 680-688.
[26] Newton, Kim, Wickliffe, Katherine E, Maltzman, Allie, Dugger, Debra L, Reja, Rohit, Zhang, Yue, Roose-Girma, Merone, Modrusan, Zora, Sagolla, Meredith S, Webster, Joshua D, Dixit, Vishva M. ""Activity of caspase-8 determines plasticity between cell death pathways."" Nature, 2019, pp. 679-682.
[27] Wang, Yutao, Ning, Xiaohan, Gao, Pengfei, Wu, Shuxian, Sha, Mengyin, Lv, Mengze, Zhou, Xiang, Gao, Juyi, Fang, Run, Meng, Guangxun, Su, Xiaodong, Jiang, Zhengfan. ""Inflammasome Activation Triggers Caspase-1-Mediated Cleavage of cGAS to Regulate Responses to DNA Virus Infection."" Immunity, 2017, pp. 393-404.
"	0.693852	0.5787958	LLM	Tied	NA
Diff. expressed gene set	INTERFERON GAMMA RESPONSE	NA	ADAR APOL6 ARID5B ARL4A AUTS2 B2M BANK1 BATF2 BPGM BST2 BTG1 C1R C1S CASP1 CASP3 CASP4 CASP7 CASP8 CCL2 CCL5 CCL7 CD274 CD38 CD40 CD69 CD74 CD86 CDKN1A CFB CFH CIITA CMKLR1 CMPK2 CMTR1 CSF2RB CXCL10 CXCL11 CXCL9 DDX60 DHX58 EIF2AK2 EIF4E3 EPSTI1 FAS FCGR1A FGL2 FPR1 GBP4 GBP6 GCH1 GPR18 GZMA HELZ2 HERC6 HIF1A HLA-A HLA-B HLA-DMA HLA-DQA1 HLA-DRB1 HLA-G ICAM1 IDO1 IFI27 IFI30 IFI35 IFI44 IFI44L IFIH1 IFIT1 IFIT2 IFIT3 IFITM2 IFITM3 IFNAR2 IL10RA IL15 IL15RA IL18BP IL2RB IL4R IL6 IL7 IRF1 IRF2 IRF4 IRF5 IRF7 IRF8 IRF9 ISG15 ISG20 ISOC1 ITGB7 JAK2 KLRK1 LAP3 LATS2 LCP2 LGALS3BP LY6E LYSMD2 MARCHF1 METTL7B MT2A MTHFD2 MVP MX1 MX2 MYD88 NAMPT NCOA3 NFKB1 NFKBIA NLRC5 NMI NOD1 NUP93 OAS2 OAS3 OASL OGFR P2RY14 PARP12 PARP14 PDE4B PELI1 PFKP PIM1 PLA2G4A PLSCR1 PML PNP PNPT1 PSMA2 PSMA3 PSMB10 PSMB2 PSMB8 PSMB9 PSME1 PSME2 PTGS2 PTPN1 PTPN2 PTPN6 RAPGEF6 RBCK1 RIGI RIPK1 RIPK2 RNF213 RNF31 RSAD2 RTP4 SAMD9L SAMHD1 SECTM1 SELP SERPING1 SLAMF7 SLC25A28 SOCS1 SOCS3 SOD2 SP110 SPPL2A SRI SSPN ST3GAL5 ST8SIA4 STAT1 STAT2 STAT3 STAT4 TAP1 TAPBP TDRD7 TNFAIP2 TNFAIP3 TNFAIP6 TNFSF10 TOR1B TRAFD1 TRIM14 TRIM21 TRIM25 TRIM26 TXNIP UBE2L6 UPP1 USP18 VAMP5 VAMP8 VCAM1 WARS1 XAF1 XCL1 ZBP1 ZNFX1	200	7.643856189774724	Defense Response To Virus 	GO:0051607	IFITM3;RTP4;CD40;IFITM2;NLRC5;IFIT1;DDX60;SAMHD1;USP18;IFI44L;IFIT3;IFIT2;OASL;IFIH1;DHX58;CASP1;TRIM25;TRIM26;TRIM21;IFNAR2;RSAD2;STAT1;MX2;STAT2;MX1;EIF2AK2;ISG15;PML;BST2;ISG20;CXCL10;IL6;PLSCR1;ZNFX1;IFI27;OAS2;IRF1;OAS3;IRF2;IRF7;MYD88;RIGI	42	21	6.72e-45	1.1e-41	Immune Response Regulation	"The system of interacting proteins primarily performs the biological process of immune response regulation. This is supported by the presence of proteins involved in various aspects of the immune response, including cytokine signaling, antigen presentation, and interferon response.

1. Cytokine signaling: Proteins such as IL6, IL15, IL18BP, and IL10RA are involved in cytokine signaling, which modulates immune cell activation and differentiation. For example, IL6 is a pro-inflammatory cytokine, while IL10RA is a receptor for the anti-inflammatory cytokine IL10.

2. Antigen presentation: Proteins such as HLA-A, HLA-B, HLA-DMA, HLA-DQA1, HLA-DRB1, and HLA-G are involved in antigen presentation, a crucial process for the activation of T cells. These proteins are part of the major histocompatibility complex (MHC) class I and II molecules, which present antigens to CD8+ and CD4+ T cells, respectively.

3. Interferon response: Proteins such as IFIH1, IFIT1, IFIT2, IFIT3, IFITM2, IFITM3, IFNAR2, IRF1, IRF2, IRF4, IRF5, IRF7, IRF8, and IRF9 are involved in the interferon response, which is essential for antiviral immunity. Interferons are cytokines that induce the expression of interferon-stimulated genes (ISGs), which have antiviral, immunomodulatory, and cell growth regulatory functions.

4. Inflammation regulation: Proteins such as CASP1, CASP3, CASP4, CASP7, CASP8, NFKB1, NFKBIA, and TNFAIP3 are involved in the regulation of inflammation. For example, CASP1 is a key component of the inflammasome, which is a multiprotein complex that activates pro-inflammatory cytokines. NFKB1 and NFKBIA are components of the NF-kB signaling pathway, which regulates the expression of genes involved in inflammation and immune responses.

5. Cell adhesion and migration: Proteins such as ICAM1, VCAM1, and SELP are involved in cell adhesion and migration, which are essential processes for immune cell trafficking and recruitment to sites of infection or inflammation.

6. Apoptosis regulation: Proteins such as FAS, TRAFD1, and RIPK1 are involved in the regulation of apoptosis, a process of programmed cell death that is crucial for maintaining immune homeostasis and eliminating infected or damaged cells.

In conclusion, the most prominent biological process performed by this system of interacting proteins is immune response regulation, which encompasses various aspects of the immune response, including cytokine signaling, antigen presentation, interferon response, inflammation regulation, cell adhesion and migration, and apoptosis regulation."	38	19	"The system of interacting proteins primarily performs the biological process of immune response regulation. This is supported by the presence of proteins involved in various aspects of the immune response, including cytokine signaling, antigen presentation, and interferon response.

1. Cytokine signaling: Proteins such as IL6, IL15, IL18BP, and IL10RA are involved in cytokine signaling, which modulates immune cell activation and differentiation. For example, IL6 is a pro-inflammatory cytokine, while IL10RA is a receptor for the anti-inflammatory cytokine IL10.[1][2][3]

2. Antigen presentation: Proteins such as HLA-A, HLA-B, HLA-DMA, HLA-DQA1, HLA-DRB1, and HLA-G are involved in antigen presentation, a crucial process for the activation of T cells. These proteins are part of the major histocompatibility complex (MHC) class I and II molecules, which present antigens to CD8+ and CD4+ T cells, respectively.[4][5][6]

3. Interferon response: Proteins such as IFIH1, IFIT1, IFIT2, IFIT3, IFITM2, IFITM3, IFNAR2, IRF1, IRF2, IRF4, IRF5, IRF7, IRF8, and IRF9 are involved in the interferon response, which is essential for antiviral immunity. Interferons are cytokines that induce the expression of interferon-stimulated genes (ISGs), which have antiviral, immunomodulatory, and cell growth regulatory functions.[7][8][9]

4. Inflammation regulation: Proteins such as CASP1, CASP3, CASP4, CASP7, CASP8, NFKB1, NFKBIA, and TNFAIP3 are involved in the regulation of inflammation. For example, CASP1 is a key component of the inflammasome, which is a multiprotein complex that activates pro-inflammatory cytokines. NFKB1 and NFKBIA are components of the NF-kB signaling pathway, which regulates the expression of genes involved in inflammation and immune responses.[10][11][12]

5. Cell adhesion and migration: Proteins such as ICAM1, VCAM1, and SELP are involved in cell adhesion and migration, which are essential processes for immune cell trafficking and recruitment to sites of infection or inflammation.[13][14][15]

6. Apoptosis regulation: Proteins such as FAS, TRAFD1, and RIPK1 are involved in the regulation of apoptosis, a process of programmed cell death that is crucial for maintaining immune homeostasis and eliminating infected or damaged cells.[16][17][18]

In conclusion, the most prominent biological process performed by this system of interacting proteins is immune response regulation, which encompasses various aspects of the immune response, including cytokine signaling, antigen presentation, interferon response, inflammation regulation, cell adhesion and migration, and apoptosis regulation.

========================================================================================================================================================================================================
[1] Wang, Xiang, Zhao, Xiang-Yu. ""Transcription Factors Associated With IL-15 Cytokine Signaling During NK Cell Development."" Frontiers in immunology, 2021, pp. 610789.
[2] Ilangumaran, Subburaj, Ramanathan, Sheela, Ning, Terry, La Rose, Jose, Reinhart, Brandon, Poussier, Philippe, Rottapel, Robert. ""Suppressor of cytokine signaling 1 attenuates IL-15 receptor signaling in CD8+ thymocytes."" Blood, 2003, pp. 4115-22.
[3] Ilangumaran, Subburaj, Ramanathan, Sheela, La Rose, Jose, Poussier, Philippe, Rottapel, Robert. ""Suppressor of cytokine signaling 1 regulates IL-15 receptor signaling in CD8+CD44high memory T lymphocytes."" Journal of immunology (Baltimore, Md. : 1950), 2003, pp. 2435-45.
[4] Bauzá-Martinez, Julia, Heck, Albert J R, Wu, Wei. ""HLA-B and cysteinylated ligands distinguish the antigen presentation landscape of extracellular vesicles."" Communications biology, 2021, pp. 825.
[5] Lorente, Elena, Barriga, Alejandro, García-Arriaza, Juan, Lemonnier, François A, Esteban, Mariano, López, Daniel. ""Complex antigen presentation pathway for an HLA-A*0201-restricted epitope from Chikungunya 6K protein."" PLoS neglected tropical diseases, 2017, pp. e0006036.
[6] Le Bouteiller, P, Solier, C. ""Is antigen presentation the primary function of HLA-G?"" Microbes and infection, 2001, pp. 323-32.
[7] Zhang, Ya, Wang, Yuxin, Liu, Zetian, Zheng, Jiaying, Huang, Youhua, Huang, Xiaohong, Qin, Qiwei. ""Grouper IFIT1 inhibits iridovirus and nodavirus infection by positively regulating interferon response."" Fish & shellfish immunology, 2019, pp. 81-89.
[8] Mears, Harriet V, Emmott, Edward, Chaudhry, Yasmin, Hosmillo, Myra, Goodfellow, Ian G, Sweeney, Trevor R. ""Ifit1 regulates norovirus infection and enhances the interferon response in murine macrophage-like cells."" Wellcome open research, 2019, pp. 82.
[9] Zhao, Xin, Huang, Wenji, Shi, Yanjie, Guo, Jiahong, Xiao, Hehe, Ji, Ning, Feng, Jianhua, Dang, Huifeng, Zou, Jun. ""PLAAT1 inhibits type I interferon response <i>via</i> degradation of IRF3 and IRF7 in Zebrafish."" Frontiers in immunology, 2022, pp. 979919.
[10] Wang, Chenfeng, Ma, Hongdao, Zhang, Bangke, Hua, Tong, Wang, Haibin, Wang, Liang, Han, Lin, Li, Qisheng, Wu, Weiqing, Sun, Yulin, Yang, Haisong, Lu, Xuhua. ""Inhibition of IL1R1 or CASP4 attenuates spinal cord injury through ameliorating NLRP3 inflammasome-induced pyroptosis."" Frontiers in immunology, 2022, pp. 963582.
[11] Wang, Diya, Zhang, Jianbin, Jiang, Wenkai, Cao, Zipeng, Zhao, Fang, Cai, Tongjian, Aschner, Michael, Luo, Wenjing. ""The role of NLRP3-CASP1 in inflammasome-mediated neuroinflammation and autophagy dysfunction in manganese-induced, hippocampal-dependent impairment of learning and memory ability."" Autophagy, 2017, pp. 914-927.
[12] Zou, Chan, Beard, Jordan A, Yang, Guoping, Evans, William E, Bonten, Erik J. ""<i>CASP</i>orter: A Novel Inducible Human CASP1/NALP3/ASC Inflammasome Biosensor."" Journal of inflammation research, 2022, pp. 1183-1194.
[13] Rafat, Marjan, Rotenstein, Lisa S, Hu, Jennifer L, Auguste, Debra T. ""Engineered endothelial cell adhesion via VCAM1 and E-selectin antibody-presenting alginate hydrogels."" Acta biomaterialia, 2012, pp. 2697-703.
[14] Qiu, Zhiyuan, Wang, Yan, Zhang, Zhao, Qin, Rong, Peng, Yong, Tang, Weifeng, Xi, Yan, Tian, Guangyu, Zhang, Yeqing. ""Roles of intercellular cell adhesion molecule-1 (ICAM-1) in colorectal cancer: expression, functions, prognosis, tumorigenesis, polymorphisms and therapeutic implications."" Frontiers in oncology, 2022, pp. 1052672.
[15] Taftaf, Rokana, Liu, Xia, Singh, Salendra, Jia, Yuzhi, Dashzeveg, Nurmaa K, Hoffmann, Andrew D, El-Shennawy, Lamiaa, Ramos, Erika K, Adorno-Cruz, Valery, Schuster, Emma J, Scholten, David, Patel, Dhwani, Zhang, Youbin, Davis, Andrew A, Reduzzi, Carolina, Cao, Yue, D'Amico, Paolo, Shen, Yang, Cristofanilli, Massimo, Muller, William A, Varadan, Vinay, Liu, Huiping. ""ICAM1 initiates CTC cluster formation and trans-endothelial migration in lung metastasis of breast cancer."" Nature communications, 2021, pp. 4867.
[16] Seeberger, H, Knörr, C, Müller-Hermelink, H K, Greiner, A. ""[Impaired CD95-(Fas,APO-1-)apoptosis regulation is a progression factor in early MALT-type lymphoma genesis]."" Medizinische Klinik (Munich, Germany : 1983), 2001, pp. 9-14.
[17] O'Donnell, Joanne A, Lehman, Jesse, Roderick, Justine E, Martinez-Marin, Dalia, Zelic, Matija, Doran, Ciara, Hermance, Nicole, Lyle, Stephen, Pasparakis, Manolis, Fitzgerald, Katherine A, Marshak-Rothstein, Ann, Kelliher, Michelle A. ""Dendritic Cell RIPK1 Maintains Immune Homeostasis by Preventing Inflammation and Autoimmunity."" Journal of immunology (Baltimore, Md. : 1950), 2018, pp. 737-748.
[18] Saint Fleur, Shella, Hoshino, Akemi, Kondo, Kimie, Egawa, Takeshi, Fujii, Hodaka. ""Regulation of Fas-mediated immune homeostasis by an activation-induced protein, Cyclon."" Blood, 2009, pp. 1355-65.
"	0.600703	0.5259061	LLM	Tied	NA
Diff. expressed gene set	KRAS SIGNALING DN	NA	ABCB11 ABCG4 ACTC1 ADRA2C AKR1B10 ALOX12B AMBN ARHGDIG ARPP21 ASB7 ATP4A ATP6V1B1 BARD1 BMPR1B BRDT BTG2 C5 CACNA1F CACNG1 CALCB CALML5 CAMK1D CAPN9 CCDC106 CCNA1 CCR8 CD207 CD40LG CD80 CDH16 CDKAL1 CELSR2 CHRNG CHST2 CKM CLDN16 CLDN8 CLPS CLSTN3 CNTFR COL2A1 COPZ2 COQ8A CPA2 CPB1 CPEB3 CYP11B2 CYP39A1 DCC DLK2 DTNB EDAR EDN1 EDN2 EFHD1 EGF ENTPD7 EPHA5 FGF16 FGF22 FGFR3 FGGY FSHB GAMT GDNF GP1BA GP2 GPR19 GPR3 GPRC5C GRID2 GTF3C5 HNF1A HSD11B2 HTR1B HTR1D IDUA IFI44L IFNG IGFBP2 IL12B IL5 INSL5 IRS4 ITGB1BP2 ITIH3 KCND1 KCNE2 KCNMB1 KCNN1 KCNQ2 KLHDC8A KLK7 KLK8 KMT2D KRT1 KRT13 KRT15 KRT4 KRT5 LFNG LGALS7 LYPD3 MACROH2A2 MAGIX MAST3 MEFV MFSD6 MSH5 MTHFR MX1 MYH7 MYO15A MYOT NGB NOS1 NPHS1 NPY4R NR4A2 NR6A1 NRIP2 NTF3 NUDT11 OXT P2RX6 P2RY4 PAX3 PAX4 PCDHB1 PDCD1 PDE6B PDK2 PKP1 PLAG1 PNMT PRKN PRODH PROP1 PTGFR PTPRJ RGS11 RIBC2 RSAD2 RYR1 RYR2 SCGB1A1 SCN10A SELENOP SERPINA10 SERPINB2 SGK1 SHOX2 SIDT1 SKIL SLC12A3 SLC16A7 SLC25A23 SLC29A3 SLC30A3 SLC38A3 SLC5A5 SLC6A14 SLC6A3 SMPX SNCB SNN SOX10 SPHK2 SPRR3 SPTBN2 SSTR4 STAG3 SYNPO TAS2R4 TCF7L1 TCL1A TENM2 TENT5C TEX15 TFAP2B TFCP2L1 TFF2 TG TGFB2 TGM1 THNSL2 THRB TLX1 TNNI3 TSHB UGT2B17 UPK3B VPREB1 VPS50 WNT16 YBX2 YPEL1 ZBTB16 ZC2HC1C ZNF112	200	7.643856189774724	Muscle Contraction 	GO:0006936	RYR1;GAMT;RYR2;P2RX6;SMPX;CHRNG;MYOT;NOS1;MYH7	9	4.5	4.27e-7	6.95844e-4	Ion Transport Regulation	"The most prominent biological process performed by this system of interacting proteins is the regulation of ion transport. This is supported by the presence of several key proteins involved in ion transport and regulation, such as ATP4A, ATP6V1B1, CACNA1F, CACNG1, KCND1, KCNE2, KCNMB1, KCNN1, KCNQ2, and SLC12A3.

1. ATP4A and ATP6V1B1 are subunits of ATPases involved in proton transport. ATP4A is a subunit of the H+/K+ ATPase responsible for gastric acid secretion, while ATP6V1B1 is a subunit of the vacuolar H+ ATPase involved in acidification of intracellular compartments.

2. CACNA1F and CACNG1 are subunits of voltage-gated calcium channels. CACNA1F is a subunit of the L-type calcium channel, which plays a role in calcium influx in response to membrane depolarization. CACNG1 is a subunit of the T-type calcium channel, which is involved in calcium signaling in various cell types.

3. KCND1, KCNE2, KCNMB1, KCNN1, and KCNQ2 are potassium channel subunits. KCND1 is a subunit of the voltage-gated potassium channel Kv4, which regulates neuronal excitability. KCNE2 is a subunit of the voltage-gated potassium channel Kv7, which is involved in cardiac repolarization. KCNMB1 is a subunit of the large-conductance calcium-activated potassium channel, which is involved in smooth muscle relaxation. KCNN1 is a subunit of the small-conductance calcium-activated potassium channel, which is involved in neuronal excitability and synaptic plasticity. KCNQ2 is a subunit of the voltage-gated potassium channel Kv7, which is involved in neuronal excitability and epilepsy.

4. SLC12A3 is a sodium-chloride cotransporter involved in the regulation of ion balance in the kidney. Mutations in this gene are associated with Gitelman syndrome, a renal salt-wasting disorder.

In conclusion, the most prominent biological process performed by this system of interacting proteins is the regulation of ion transport, which is crucial for maintaining cellular homeostasis and proper functioning of various physiological processes."	10	5	"The most prominent biological process performed by this system of interacting proteins is the regulation of ion transport. This is supported by the presence of several key proteins involved in ion transport and regulation, such as ATP4A, ATP6V1B1, CACNA1F, CACNG1, KCND1, KCNE2, KCNMB1, KCNN1, KCNQ2, and SLC12A3.[1][2][3]

1. ATP4A and ATP6V1B1 are subunits of ATPases involved in proton transport. ATP4A is a subunit of the H+/K+ ATPase responsible for gastric acid secretion, while ATP6V1B1 is a subunit of the vacuolar H+ ATPase involved in acidification of intracellular compartments.[4][5][6]

2. CACNA1F and CACNG1 are subunits of voltage-gated calcium channels. CACNA1F is a subunit of the L-type calcium channel, which plays a role in calcium influx in response to membrane depolarization. CACNG1 is a subunit of the T-type calcium channel, which is involved in calcium signaling in various cell types.[7][8][9]

3. KCND1, KCNE2, KCNMB1, KCNN1, and KCNQ2 are potassium channel subunits. KCND1 is a subunit of the voltage-gated potassium channel Kv4, which regulates neuronal excitability. KCNE2 is a subunit of the voltage-gated potassium channel Kv7, which is involved in cardiac repolarization. KCNMB1 is a subunit of the large-conductance calcium-activated potassium channel, which is involved in smooth muscle relaxation. KCNN1 is a subunit of the small-conductance calcium-activated potassium channel, which is involved in neuronal excitability and synaptic plasticity. KCNQ2 is a subunit of the voltage-gated potassium channel Kv7, which is involved in neuronal excitability and epilepsy.[10][11][12]

4. SLC12A3 is a sodium-chloride cotransporter involved in the regulation of ion balance in the kidney. Mutations in this gene are associated with Gitelman syndrome, a renal salt-wasting disorder.[13][14][15]

In conclusion, the most prominent biological process performed by this system of interacting proteins is the regulation of ion transport, which is crucial for maintaining cellular homeostasis and proper functioning of various physiological processes.

========================================================================================================================================================================================================
[1] Lopez, Juan Pablo, Lücken, Malte D, Brivio, Elena, Karamihalev, Stoyo, Kos, Aron, De Donno, Carlo, Benjamin, Asaf, Yang, Huanqing, Dick, Alec L W, Stoffel, Rainer, Flachskamm, Cornelia, Ressle, Andrea, Roeh, Simone, Huettl, Rosa-Eva, Parl, Andrea, Eggert, Carola, Novak, Bozidar, Yan, Yu, Yeoh, Karin, Holzapfel, Maria, Hauger, Barbara, Harbich, Daniela, Schmid, Bianca, Di Giaimo, Rossella, Turck, Christoph W, Schmidt, Mathias V, Deussing, Jan M, Eder, Matthias, Dine, Julien, Theis, Fabian J, Chen, Alon. ""Ketamine exerts its sustained antidepressant effects via cell-type-specific regulation of Kcnq2."" Neuron, 2022, pp. 2283-2298.e9.
[2] Rahm, Ann-Kathrin, Wieder, Teresa, Gramlich, Dominik, Müller, Mara Elena, Wunsch, Maximilian N, El Tahry, Fadwa A, Heimberger, Tanja, Sandke, Steffi, Weis, Tanja, Most, Patrick, Katus, Hugo A, Thomas, Dierk, Lugenbiel, Patrick. ""Differential regulation of K<sub>Ca</sub> 2.1 (KCNN1) K<sup>+</sup> channel expression by histone deacetylases in atrial fibrillation with concomitant heart failure."" Physiological reports, 2021, pp. e14835.
[3] Mysiewicz, Steven, North, Kelsey C, Moreira, Luiz, Odum, Schyler J, Bukiya, Anna N, Dopico, Alex M. ""Interspecies and regional variability of alcohol action on large cerebral arteries: regulation by KCNMB1 proteins."" American journal of physiology. Regulatory, integrative and comparative physiology, 2023, pp. R480-R496.
[4] Wang, Jing, Barbuskaite, Dagne, Tozzi, Marco, Giannuzzo, Andrea, Sørensen, Christiane E, Novak, Ivana. ""Proton Pump Inhibitors Inhibit Pancreatic Secretion: Role of Gastric and Non-Gastric H+/K+-ATPases."" PloS one, 2015, pp. e0126432.
[5] Paunescu, Teodor G, Jones, Abigail C, Tyszkowski, Robert, Brown, Dennis. ""V-ATPase expression in the mouse olfactory epithelium."" American journal of physiology. Cell physiology, 2008, pp. C923-30.
[6] Pietrement, C, Sun-Wada, G-H, Silva, N Da, McKee, M, Marshansky, V, Brown, D, Futai, M, Breton, S. ""Distinct expression patterns of different subunit isoforms of the V-ATPase in the rat epididymis."" Biology of reproduction, 2006, pp. 185-94.
[7] Mansergh, Fiona, Orton, Noelle C, Vessey, John P, Lalonde, Melanie R, Stell, William K, Tremblay, Francois, Barnes, Steven, Rancourt, Derrick E, Bech-Hansen, N Torben. ""Mutation of the calcium channel gene Cacna1f disrupts calcium signaling, synaptic transmission and cellular organization in mouse retina."" Human molecular genetics, 2005, pp. 3035-46.
[8] Waldner, Derek M, Ito, Kenichi, Chen, Li-Li, Nguyen, Lisa, Chow, Robert L, Lee, Amy, Rancourt, Derrick E, Tremblay, Francois, Stell, William K, Bech-Hansen, N Torben. ""Transgenic Expression of <i>Cacna1f</i> Rescues Vision and Retinal Morphology in a Mouse Model of Congenital Stationary Night Blindness 2A (CSNB2A)."" Translational vision science & technology, 2020, pp. 19.
[9] Waldner, D M, Bech-Hansen, N T, Stell, W K. ""Channeling Vision: Ca<sub>V</sub>1.4-A Critical Link in Retinal Signal Transmission."" BioMed research international, 2018, pp. 7272630.
[10] Hill, Sophie F, Ziobro, Julie M, Jafar-Nejad, Paymaan, Rigo, Frank, Meisler, Miriam H. ""Genetic interaction between Scn8a and potassium channel genes Kcna1 and Kcnq2."" Epilepsia, 2022, pp. e125-e131.
[11] Papanikolaou, Maria, Crump, Shawn M, Abbott, Geoffrey W. ""The focal adhesion protein Testin modulates KCNE2 potassium channel β subunit activity."" Channels (Austin, Tex.), 2021, pp. 229-238.
[12] Zhou, Leng, Köhncke, Clemens, Hu, Zhaoyang, Roepke, Torsten K, Abbott, Geoffrey W. ""The KCNE2 potassium channel β subunit is required for normal lung function and resilience to ischemia and reperfusion injury."" FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2019, pp. 9762-9774.
[13] Li, Nan, Gu, Harvest F. ""Genetic and Biological Effects of <i>SLC12A3</i>, a Sodium-Chloride Cotransporter, in Gitelman Syndrome and Diabetic Kidney Disease."" Frontiers in genetics, 2022, pp. 799224.
[14] Iio, Kenichiro, Mori, Takayasu, Bessho, Saki, Imai, Yosuke, Hatanaka, Masaki, Omori, Hiroki, Kouhara, Haruhiko, Chiga, Motoko, Sohara, Eisei, Uchida, Shinichi, Kaimori, Jun-Ya. ""Gitelman syndrome with a novel frameshift variant in SLC12A3 gene accompanied by chronic kidney disease and type 2 diabetes mellitus."" CEN case reports, 2022, pp. 191-195.
[15] Li, Zongyue, Wu, Huixiao, Wei, Shuoshuo, Liu, Moke, Shi, Yingzhou, Li, Mengzhu, Wang, Ning, Fang, Li, Xiang, Bo, Gao, Ling, Xu, Chao, Zhao, Jiajun. ""R158Q and G212S, novel pathogenic compound heterozygous variants in SLC12A3 of Gitelman syndrome."" Frontiers of medicine, 2022, pp. 932-945.
"	0.28985626	0.14451078	Neither	Neither	NA
Diff. expressed gene set	KRAS SIGNALING UP	NA	ABCB1 ACE ADAM17 ADAM8 ADAMDEC1 ADGRA2 ADGRL4 AKAP12 AKT2 ALDH1A2 ALDH1A3 AMMECR1 ANGPTL4 ANKH ANO1 ANXA10 APOD ARG1 ATG10 AVL9 BIRC3 BMP2 BPGM BTBD3 BTC C3AR1 CA2 CAB39L CBL CBR4 CBX8 CCL20 CCND2 CCSER2 CD37 CDADC1 CFB CFH CFHR2 CIDEA CLEC4A CMKLR1 CPE CROT CSF2 CSF2RA CTSS CXCL10 CXCR4 DCBLD2 DNMBP DOCK2 DUSP6 EMP1 ENG EPB41L3 EPHB2 EREG ERO1A ETS1 ETV1 ETV4 ETV5 EVI5 F13A1 F2RL1 FBXO4 FCER1G FGF9 FLT4 FUCA1 G0S2 GABRA3 GADD45G GALNT3 GFPT2 GLRX GNG11 GPNMB GPRC5B GUCY1A1 GYPC H2BC3 HBEGF HDAC9 HKDC1 HOXD11 HSD11B1 ID2 IGF2 IGFBP3 IKZF1 IL10RA IL1B IL1RL2 IL2RG IL33 IL7R INHBA IRF8 ITGA2 ITGB2 ITGBL1 JUP KCNN4 KIF5C KLF4 LAPTM5 LAT2 LCP1 LIF LY96 MAFB MALL MAP3K1 MAP4K1 MAP7 MMD MMP10 MMP11 MMP9 MPZL2 MTMR10 MYCN NAP1L2 NGF NIN NR0B2 NR1H4 NRP1 PCP4 PCSK1N PDCD1LG2 PECAM1 PEG3 PIGR PLAT PLAU PLAUR PLEK2 PLVAP PPBP PPP1R15A PRDM1 PRELID3B PRKG2 PRRX1 PSMB8 PTBP2 PTCD2 PTGS2 PTPRR RABGAP1L RBM4 RBP4 RELN RETN RGS16 SATB1 SCG3 SCG5 SCN1B SDCCAG8 SEMA3B SERPINA3 SLPI SNAP25 SNAP91 SOX9 SPARCL1 SPON1 SPP1 SPRY2 ST6GAL1 STRN TFPI TLR8 TMEM100 TMEM158 TMEM176A TMEM176B TNFAIP3 TNFRSF1B TNNT2 TOR1AIP2 TPH1 TRAF1 TRIB1 TRIB2 TSPAN1 TSPAN13 TSPAN7 USH1C USP12 VWA5A WDR33 WNT7A YRDC ZNF277 ZNF639	200	7.643856189774724	Positive Regulation Of Protein Modification Process 	GO:0031401	ACE;FLT4;ATG10;IGF2;PLAUR;MMP9;ADAM17;BMP2;RELN;CCND2;GPNMB;FGF9;AKT2;IL1B;PECAM1;SOX9;ENG	17	8.5	1.2e-10	1.33e-7	Inflammation and Extracellular Matrix Remodeling	"The system of interacting proteins primarily involves biological processes related to inflammation and extracellular matrix (ECM) remodeling. Key proteins in these processes include:

1. Inflammation:
- IL1B, IL33, and IL10RA: These proteins are involved in the regulation of inflammatory responses. IL1B and IL33 are pro-inflammatory cytokines, while IL10RA is a receptor for the anti-inflammatory cytokine IL10.
- CXCL10 and CXCR4: These chemokines and their receptor are involved in the recruitment of immune cells to the site of inflammation.
- CCL20: This chemokine is involved in the recruitment of dendritic cells and lymphocytes to the site of inflammation.
- PTGS2: This enzyme is involved in the synthesis of prostaglandins, which are mediators of inflammation.

2. Extracellular Matrix Remodeling:
- MMP9, MMP10, and MMP11: These matrix metalloproteinases are involved in the degradation of ECM components, facilitating tissue remodeling and cell migration.
- TIMP1: This tissue inhibitor of metalloproteinases regulates the activity of MMPs, balancing ECM degradation and synthesis.
- ADAM17 and ADAM8: These proteins are involved in the shedding of cell surface proteins, including growth factors and cytokines, which can modulate cell behavior and ECM remodeling.
- TGFβ1 and BMP2: These growth factors are involved in the regulation of ECM synthesis and cell differentiation.

3. Angiogenesis:
- VEGFA, FLT4, and NRP1: These proteins are involved in the regulation of angiogenesis, the formation of new blood vessels from pre-existing ones. VEGFA is a potent angiogenic factor, while FLT4 and NRP1 are receptors for VEGF family members.

4. Cell Adhesion and Migration:
- ITGA2 and ITGB2: These integrins are involved in cell adhesion to the ECM and cell migration.
- PECAM1 and CD37: These proteins are involved in cell-cell adhesion and communication, particularly in immune cells.

5. Cell Proliferation and Differentiation:
- CCND2, ETS1, and MYCN: These proteins are involved in the regulation of cell proliferation and differentiation, which can influence tissue remodeling and repair.

In summary, the most prominent biological process performed by this system of interacting proteins is inflammation and extracellular matrix remodeling, which involves the regulation of inflammatory responses, ECM degradation and synthesis, angiogenesis, cell adhesion and migration, and cell proliferation and differentiation."	22	11	"The system of interacting proteins primarily involves biological processes related to inflammation and extracellular matrix (ECM) remodeling. Key proteins in these processes include:

- IL1B, IL33, and IL10RA: These proteins are involved in the regulation of inflammatory responses. IL1B and IL33 are pro-inflammatory cytokines, while IL10RA is a receptor for the anti-inflammatory cytokine IL10.[1][2][3]

- CXCL10 and CXCR4: These chemokines and their receptor are involved in the recruitment of immune cells to the site of inflammation.[4][5][6]

- CCL20: This chemokine is involved in the recruitment of dendritic cells and lymphocytes to the site of inflammation.[7][8][9]

- PTGS2: This enzyme is involved in the synthesis of prostaglandins, which are mediators of inflammation.[10][11][12]

- MMP9, MMP10, and MMP11: These matrix metalloproteinases are involved in the degradation of ECM components, facilitating tissue remodeling and cell migration.[13][14][15]

- TIMP1: This tissue inhibitor of metalloproteinases regulates the activity of MMPs, balancing ECM degradation and synthesis.[16][17][18]

- ADAM17 and ADAM8: These proteins are involved in the shedding of cell surface proteins, including growth factors and cytokines, which can modulate cell behavior and ECM remodeling.[19][20][21]

- TGFβ1 and BMP2: These growth factors are involved in the regulation of ECM synthesis and cell differentiation.[22][23][24]

- VEGFA, FLT4, and NRP1: These proteins are involved in the regulation of angiogenesis, the formation of new blood vessels from pre-existing ones. VEGFA is a potent angiogenic factor, while FLT4 and NRP1 are receptors for VEGF family members.[25][26][27]

- ITGA2 and ITGB2: These integrins are involved in cell adhesion to the ECM and cell migration.[28][29][30]

- PECAM1 and CD37: These proteins are involved in cell-cell adhesion and communication, particularly in immune cells.[31][32][33]

- CCND2, ETS1, and MYCN: These proteins are involved in the regulation of cell proliferation and differentiation, which can influence tissue remodeling and repair.[34][35][36]

In summary, the most prominent biological process performed by this system of interacting proteins is inflammation and extracellular matrix remodeling, which involves the regulation of inflammatory responses, ECM degradation and synthesis, angiogenesis, cell adhesion and migration, and cell proliferation and differentiation.

========================================================================================================================================================================================================
[1] Yagami, Akiko, Orihara, Kanami, Morita, Hideaki, Futamura, Kyoko, Hashimoto, Noriko, Matsumoto, Kenji, Saito, Hirohisa, Matsuda, Akio. ""IL-33 mediates inflammatory responses in human lung tissue cells."" Journal of immunology (Baltimore, Md. : 1950), 2010, pp. 5743-50.
[2] Watanabe, Tomohiro, Yamashita, Kouhei, Arai, Yasuyuki, Minaga, Kosuke, Kamata, Ken, Nagai, Tomoyuki, Komeda, Yoriaki, Takenaka, Mamoru, Hagiwara, Satoru, Ida, Hiroshi, Sakurai, Toshiharu, Nishida, Naoshi, Strober, Warren, Kudo, Masatoshi. ""Chronic Fibro-Inflammatory Responses in Autoimmune Pancreatitis Depend on IFN-α and IL-33 Produced by Plasmacytoid Dendritic Cells."" Journal of immunology (Baltimore, Md. : 1950), 2017, pp. 3886-3896.
[3] Sattler, Susanne, Ling, Guang-Sheng, Xu, Damo, Hussaarts, Leonie, Romaine, Andreas, Zhao, Hongzhi, Fossati-Jimack, Liliane, Malik, Talat, Cook, H Terence, Botto, Marina, Lau, Yu-Lung, Smits, Hermelijn H, Liew, Foo Y, Huang, Fang-Ping. ""IL-10-producing regulatory B cells induced by IL-33 (Breg(IL-33)) effectively attenuate mucosal inflammatory responses in the gut."" Journal of autoimmunity, 2014, pp. 107-22.
[4] Zhang, Yan-Fei, Meng, Ling-Bing, Hao, Meng-Lei, Li, Xing-Yu, Zou, Tong. ""CXCR4 and TYROBP mediate the development of atrial fibrillation via inflammation."" Journal of cellular and molecular medicine, 2022, pp. 3557-3567.
[5] Karin, Nathan, Razon, Hila. ""Chemokines beyond chemo-attraction: CXCL10 and its significant role in cancer and autoimmunity."" Cytokine, 2018, pp. 24-28.
[6] Gharib, Khaled, Gadallah, Hend, Elsayed, Ayman. ""Chemokines in Vitiligo Pathogenesis: CXCL10 and 12."" The Journal of clinical and aesthetic dermatology, 2021, pp. 27-32.
[7] Hanna, David N, Smith, Paula Marincola, Novitskiy, Sergey V, Washington, M Kay, Zi, Jinghuan, Weaver, Connie J, Hamaamen, Jalal A, Lewis, Keeli B, Zhu, Jing, Yang, Jing, Liu, Qi, Beauchamp, R Daniel, Means, Anna L. ""SMAD4 Suppresses Colitis-associated Carcinoma Through Inhibition of CCL20/CCR6-mediated Inflammation."" Gastroenterology, 2022, pp. 1334-1350.e14.
[8] Shi, Zhenrui, Garcia-Melchor, Emma, Wu, Xuesong, Getschman, Anthony E, Nguyen, Mimi, Rowland, Douglas J, Wilson, Machelle, Sunzini, Flavia, Akbar, Moeed, Huynh, Mindy, Law, Timothy, Raychaudhuri, Smriti K, Raychaudhuri, Siba P, Volkman, Brian F, Millar, Neal L, Hwang, Sam T. ""Targeting the CCR6/CCL20 Axis in Entheseal and Cutaneous Inflammation."" Arthritis & rheumatology (Hoboken, N.J.), 2021, pp. 2271-2281.
[9] Park, Shin-Young, Kang, Min-Jeong, Jin, Nuri, Lee, So Young, Lee, Yun Young, Jo, Sungsin, Eom, Jeong Yun, Han, Heejae, Chung, Sook In, Jang, Kiseok, Kim, Tae-Hwan, Park, Jungwon, Han, Joong-Soo. ""House dust mite-induced Akt-ERK1/2-C/EBP beta pathway triggers CCL20-mediated inflammation and epithelial-mesenchymal transition for airway remodeling."" FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2022, pp. e22452.
[10] Siemieniuch, M J, Jursza, E, Kowalewski, M P, Majewska, M, Skarzynski, D J. ""Prostaglandin endoperoxide synthase 2 (PTGS2) and prostaglandins F2α and E2 synthases (PGFS and PGES) expression and prostaglandin F2α and E2 secretion following oestrogen and/or progesterone stimulation of the feline endometrium."" Reproduction in domestic animals = Zuchthygiene, 2013, pp. 72-8.
[11] Taniguchi, Ken, Matsuoka, Aki, Kizuka, Fumie, Lee, Lifa, Tamura, Isao, Maekawa, Ryo, Asada, Hiromi, Taketani, Toshiaki, Tamura, Hiroshi, Sugino, Norihiro. ""Prostaglandin F2α (PGF2α) stimulates PTGS2 expression and PGF2α synthesis through NFKB activation via reactive oxygen species in the corpus luteum of pseudopregnant rats."" Reproduction (Cambridge, England), 2010, pp. 885-92.
[12] Zhao, Lijia, Yang, Luda, Zhang, Jing, Xiao, Yaoyao, Wu, Meina, Ma, Tiantian, Wang, Xiaoyu, Zhang, Linlin, Jiang, Haizhen, Chao, Hsu-Wen, Wang, Aihua, Jin, Yaping, Chen, Huatao. ""<i>Bmal1</i> promotes prostaglandin E<sub>2</sub> synthesis by upregulating <i>Ptgs2</i> transcription in response to increasing estradiol levels in <i>day 4</i> pregnant mice."" American journal of physiology. Endocrinology and metabolism, 2021, pp. E747-E759.
[13] Yen, Ching-Yu, Chen, Chung-Ho, Chang, Chao-Hsiang, Tseng, Hung-Fu, Liu, Shyun-Yeu, Chuang, Li-Yeh, Wen, Cheng-Hao, Chang, Hsueh-Wei. ""Matrix metalloproteinases (MMP) 1 and MMP10 but not MMP12 are potential oral cancer markers."" Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals, 2009, pp. 244-9.
[14] Khabbazi, Samira, Hassanshahi, Mohammadhossein, Hassanshahi, Alireza, Peymanfar, Yaser, Su, Yu-Wen, Xian, Cory J. ""Opioids and matrix metalloproteinases: the influence of morphine on MMP-9 production and cancer progression."" Naunyn-Schmiedeberg's archives of pharmacology, 2019, pp. 123-133.
[15] Lund, Ida K, Nielsen, Boye S, Almholt, Kasper, Rønø, Birgitte, Hald, Andreas, Illemann, Martin, Green, Kirsty A, Christensen, Ib J, Rømer, John, Lund, Leif R. ""Concomitant lack of MMP9 and uPA disturbs physiological tissue remodeling."" Developmental biology, 2011, pp. 56-67.
[16] Rai, Nitin, Khanna, Puneet, Kashyap, Seema, Kashyap, Lokesh, Anand, Rahul Kumar, Kumar, Shailendra. ""Comparison of Serum Nucleosomes and Tissue Inhibitor of Metalloproteinase1 (TIMP1) in Predicting Mortality in Adult Critically Ill Patients in Sepsis: Prospective Observational Study."" Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine, 2022, pp. 804-810.
[17] Hu, Xiaoxuan, Hu, Fuxing, Xu, Yongbo, Tang, Jinyuan, Chu, Haibo, Zhong, Yuxu. ""Disequilibrium in MMPs and the tissue inhibitor of metalloproteinases in different segments of the varicose great saphenous vein wall."" International angiology : a journal of the International Union of Angiology, 2019, pp. 185-193.
[18] Tency, Inge, Verstraelen, Hans, Kroes, Ivo, Holtappels, Gabriële, Verhasselt, Bruno, Vaneechoutte, Mario, Verhelst, Rita, Temmerman, Marleen. ""Imbalances between matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in maternal serum during preterm labor."" PloS one, 2012, pp. e49042.
[19] Sriraman, Venkataraman, Eichenlaub-Ritter, Ursula, Bartsch, Jörg W, Rittger, Andrea, Mulders, Sabine M, Richards, Joanne S. ""Regulated expression of ADAM8 (a disintegrin and metalloprotease domain 8) in the mouse ovary: evidence for a regulatory role of luteinizing hormone, progesterone receptor, and epidermal growth factor-like growth factors."" Biology of reproduction, 2008, pp. 1038-48.
[20] Conrad, Catharina, Benzel, Julia, Dorzweiler, Kristina, Cook, Lena, Schlomann, Uwe, Zarbock, Alexander, Slater, Emily P, Nimsky, Christopher, Bartsch, Jörg W. ""ADAM8 in invasive cancers: links to tumor progression, metastasis, and chemoresistance."" Clinical science (London, England : 1979), 2019, pp. 83-99.
[21] Yang, Guang, Cui, Mengying, Jiang, Weibo, Sheng, Jiyao, Yang, Yongsheng, Zhang, Xuewen. ""Molecular switch in human diseases-disintegrin and metalloproteinases, ADAM17."" Aging, 2021, pp. 16859-16872.
[22] Szláma, György, Kondás, Katalin, Trexler, Mária, Patthy, László. ""WFIKKN1 and WFIKKN2 bind growth factors TGFβ1, BMP2 and BMP4 but do not inhibit their signalling activity."" The FEBS journal, 2010, pp. 5040-50.
[23] Li, Quanxi, Kannan, Athilakshmi, Das, Amrita, Demayo, Franco J, Hornsby, Peter J, Young, Steven L, Taylor, Robert N, Bagchi, Milan K, Bagchi, Indrani C. ""WNT4 acts downstream of BMP2 and functions via β-catenin signaling pathway to regulate human endometrial stromal cell differentiation."" Endocrinology, 2013, pp. 446-57.
[24] Li, Yucheng, Lü, Xin, Sun, Xiang, Bai, Shizhu, Li, Shibao, Shi, Junnan. ""Odontoblast-like cell differentiation and dentin formation induced with TGF-β1."" Archives of oral biology, 2011, pp. 1221-9.
[25] Claesson-Welsh, L, Welsh, M. ""VEGFA and tumour angiogenesis."" Journal of internal medicine, 2013, pp. 114-27.
[26] Zou, Gengyi, Zhang, Xiaotong, Wang, Lun, Li, Xiyang, Xie, Tianyu, Zhao, Jin, Yan, Jie, Wang, Longlong, Ye, Haoyu, Jiao, Shunchang, Xiang, Rong, Shi, Yi. ""Herb-sourced emodin inhibits angiogenesis of breast cancer by targeting VEGFA transcription."" Theranostics, 2020, pp. 6839-6853.
[27] Saiz, Maria Laura, DeDiego, Marta L, López-García, Darío, Corte-Iglesias, Viviana, Baragaño Raneros, Aroa, Astola, Ivan, Asensi, Victor, López-Larrea, Carlos, Suarez-Alvarez, Beatriz. ""Epigenetic targeting of the ACE2 and NRP1 viral receptors limits SARS-CoV-2 infectivity."" Clinical epigenetics, 2021, pp. 187.
[28] Chuang, Yu-Chang, Wu, Hsin-Yi, Lin, Yu-Ling, Tzou, Shey-Cherng, Chuang, Cheng-Hsun, Jian, Ting-Yan, Chen, Pin-Rong, Chang, Yuan-Ching, Lin, Chi-Hsin, Huang, Tse-Hung, Wang, Chao-Ching, Chan, Yi-Lin, Liao, Kuang-Wen. ""Blockade of ITGA2 Induces Apoptosis and Inhibits Cell Migration in Gastric Cancer."" Biological procedures online, 2018, pp. 10.
[29] Ding, Wen, Fan, Xiao-Lu, Xu, Xuan, Huang, Jin-Zhou, Xu, Song-Hui, Geng, Qian, Li, Rong, Chen, De, Yan, Guang-Rong. ""Epigenetic silencing of ITGA2 by MiR-373 promotes cell migration in breast cancer."" PloS one, 2015, pp. e0135128.
[30] Ferraro, Angelo, Boni, Themis, Pintzas, Alexander. ""EZH2 regulates cofilin activity and colon cancer cell migration by targeting ITGA2 gene."" PloS one, 2014, pp. e115276.
[31] Gu, Angel, Shively, John E. ""Angiopoietins-1 and -2 play opposing roles in endothelial sprouting of embryoid bodies in 3D culture and their receptor Tie-2 associates with the cell-cell adhesion molecule PECAM1."" Experimental cell research, 2011, pp. 2171-82.
[32] Albelda, S M, Muller, W A, Buck, C A, Newman, P J. ""Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule."" The Journal of cell biology, 1991, pp. 1059-68.
[33] Elangbam, C S, Qualls, C W, Dahlgren, R R. ""Cell adhesion molecules--update."" Veterinary pathology, 1997, pp. 61-73.
[34] Jiang, Pan, Mao, Lianghao, Lei, Xuan, Luo, Chunshan, Zhang, Yiming, Zhong, Xinyu, Yin, Zhenyu, Xu, Xiaofeng, Li, Dapeng, Zheng, Qiping. ""miR-1297 inhibits osteosarcoma cell proliferation and growth by targeting CCND2."" American journal of cancer research, 2022, pp. 3464-3478.
[35] Zhang, Fan, Zhu, Yanjie, Fan, Guoxin, Hu, Shuo. ""<i>MicroRNA-2682-3p</i> inhibits osteosarcoma cell proliferation by targeting <i>CCND2, MMP8</i> and <i>Myd88</i>."" Oncology letters, 2018, pp. 3359-3364.
[36] Kim, Chan Johng, Lee, Choong-Gu, Jung, Ju-Yang, Ghosh, Ambarnil, Hasan, Syed Nurul, Hwang, Sung-Min, Kang, Hyeji, Lee, Changhon, Kim, Gi-Cheon, Rudra, Dipayan, Suh, Chang-Hee, Im, Sin-Hyeog. ""The Transcription Factor Ets1 Suppresses T Follicular Helper Type 2 Cell Differentiation to Halt the Onset of Systemic Lupus Erythematosus."" Immunity, 2018, pp. 1034-1048.e8.
"	0.30142334	0.20476264	Neither	Neither	NA
Diff. expressed gene set	MITOTIC SPINDLE	NA	ABI1 ABL1 ABR ACTN4 AKAP13 ALMS1 ALS2 ANLN APC ARAP3 ARF6 ARFGEF1 ARFIP2 ARHGAP10 ARHGAP27 ARHGAP29 ARHGAP4 ARHGAP5 ARHGDIA ARHGEF11 ARHGEF12 ARHGEF2 ARHGEF3 ARHGEF7 ARL8A ATG4B AURKA BCAR1 BCL2L11 BCR BIN1 BIRC5 BRCA2 BUB1 CAPZB CCDC88A CCNB2 CD2AP CDC27 CDC42 CDC42BPA CDC42EP1 CDC42EP2 CDC42EP4 CDK1 CDK5RAP2 CENPE CENPF CENPJ CEP131 CEP192 CEP250 CEP57 CEP72 CKAP5 CLASP1 CLIP1 CLIP2 CNTRL CNTROB CSNK1D CTTN CYTH2 DLG1 DLGAP5 DOCK2 DOCK4 DST DYNC1H1 DYNLL2 ECT2 EPB41 EPB41L2 ESPL1 EZR FARP1 FBXO5 FGD4 FGD6 FLNA FLNB FSCN1 GEMIN4 GSN HDAC6 HOOK3 INCENP ITSN1 KATNA1 KATNB1 KIF11 KIF15 KIF1B KIF20B KIF22 KIF23 KIF2C KIF3B KIF3C KIF4A KIF5B KIFAP3 KLC1 KNTC1 KPTN LATS1 LLGL1 LMNB1 LRPPRC MAP1S MAP3K11 MAPRE1 MARCKS MARK4 MID1 MID1IP1 MYH10 MYH9 MYO1E MYO9B NCK1 NCK2 NDC80 NEDD9 NEK2 NET1 NF1 NIN NOTCH2 NUMA1 NUSAP1 OPHN1 PAFAH1B1 PALLD PCGF5 PCM1 PCNT PDLIM5 PIF1 PKD2 PLEKHG2 PLK1 PPP4R2 PRC1 PREX1 PXN RAB3GAP1 RABGAP1 RACGAP1 RALBP1 RANBP9 RAPGEF5 RAPGEF6 RASA1 RASA2 RASAL2 RFC1 RHOF RHOT2 RICTOR ROCK1 SAC3D1 SASS6 SEPTIN9 SHROOM1 SHROOM2 SMC1A SMC3 SMC4 SORBS2 SOS1 SPTAN1 SPTBN1 SSH2 STAU1 STK38L SUN2 SYNPO TAOK2 TBCD TIAM1 TLK1 TOP2A TPX2 TRIO TSC1 TTK TUBA4A TUBD1 TUBGCP2 TUBGCP3 TUBGCP5 TUBGCP6 UXT VCL WASF1 WASF2 WASL YWHAE	199	7.636624620543649	Mitotic Spindle Organization 	GO:0007052	SUN2;DYNC1H1;MAP1S;PLK1;KIF23;TTK;KIF11;SMC3;SMC1A;CKAP5;NDC80;AURKA;CENPE;TPX2;KIF3B;INCENP;PRC1;KIF4A;BIRC5;FLNA;CEP192;PCNT;DLGAP5;CLASP1	24	12.060301507537687	1.13e-28	1.66e-25	Regulation of Cytoskeleton Dynamics and Cell Division	"The interacting proteins in this system are primarily involved in the regulation of cytoskeleton dynamics and cell division. Key proteins and their roles are as follows:

1. Actin-binding proteins: ACTN4, CAPZB, FSCN1, and GSN regulate actin filament organization and dynamics, contributing to cell shape, motility, and adhesion.

2. Rho GTPase regulators: ARHGAP10, ARHGAP27, ARHGAP29, ARHGAP4, ARHGAP5, ARHGDIA, ARHGEF11, ARHGEF12, ARHGEF2, ARHGEF3, ARHGEF7, DOCK2, DOCK4, FARP1, FGD4, FGD6, NET1, RACGAP1, RASA1, RASA2, RASAL2, and SOS1 modulate the activity of Rho GTPases (e.g., CDC42, RHOA, and RAC1), which control actin cytoskeleton organization, cell adhesion, and migration.

3. Microtubule-associated proteins: CLASP1, CLIP1, CLIP2, KATNA1, KATNB1, MAP1S, MAPRE1, MARK4, and MID1IP1 regulate microtubule dynamics, stability, and organization, which are essential for cell shape, intracellular transport, and cell division.

4. Kinesins and dyneins: KIF11, KIF15, KIF1B, KIF20B, KIF22, KIF23, KIF2C, KIF3B, KIF3C, KIF4A, KIF5B, KIFAP3, KLC1, DYNC1H1, and DYNLL2 are motor proteins that move along microtubules, playing roles in intracellular transport, spindle formation, and chromosome segregation during cell division.

5. Centrosome and spindle-associated proteins: CENPE, CENPF, CENPJ, CEP131, CEP192, CEP250, CEP57, CEP72, NDC80, NIN, NUMA1, NUSAP1, PCM1, PCNT, and TUBGCP2-6 are involved in centrosome organization, spindle assembly, and chromosome segregation during mitosis.

6. Cell cycle regulators: AURKA, BUB1, CCNB2, CDK1, CKAP5, ESPL1, FBXO5, NEK2, PLK1, PRC1, TTK, and TOP2A control cell cycle progression, particularly during mitosis, by regulating events such as chromosome condensation, spindle assembly, and cytokinesis.

7. Adaptor proteins: ABI1, BCAR1, CD2AP, NCK1, NCK2, and PXN link signaling pathways to the actin cytoskeleton and regulate cell adhesion, migration, and invasion.

In summary, the most prominent biological process performed by this system of interacting proteins is the regulation of cytoskeleton dynamics and cell division. These proteins contribute to various aspects of cell shape, motility, adhesion, and cell cycle progression, with a particular emphasis on the organization and dynamics of actin filaments and microtubules."	85	42.71356783919598	"The interacting proteins in this system are primarily involved in the regulation of cytoskeleton dynamics and cell division. Key proteins and their roles are as follows:

1. Actin-binding proteins: ACTN4, CAPZB, FSCN1, and GSN regulate actin filament organization and dynamics, contributing to cell shape, motility, and adhesion.[1][2][3]

2. Rho GTPase regulators: ARHGAP10, ARHGAP27, ARHGAP29, ARHGAP4, ARHGAP5, ARHGDIA, ARHGEF11, ARHGEF12, ARHGEF2, ARHGEF3, ARHGEF7, DOCK2, DOCK4, FARP1, FGD4, FGD6, NET1, RACGAP1, RASA1, RASA2, RASAL2, and SOS1 modulate the activity of Rho GTPases (e.g., CDC42, RHOA, and RAC1), which control actin cytoskeleton organization, cell adhesion, and migration.[4][5][6]

3. Microtubule-associated proteins: CLASP1, CLIP1, CLIP2, KATNA1, KATNB1, MAP1S, MAPRE1, MARK4, and MID1IP1 regulate microtubule dynamics, stability, and organization, which are essential for cell shape, intracellular transport, and cell division.[7][8][9]

4. Kinesins and dyneins: KIF11, KIF15, KIF1B, KIF20B, KIF22, KIF23, KIF2C, KIF3B, KIF3C, KIF4A, KIF5B, KIFAP3, KLC1, DYNC1H1, and DYNLL2 are motor proteins that move along microtubules, playing roles in intracellular transport, spindle formation, and chromosome segregation during cell division.[10][11][12]

5. Centrosome and spindle-associated proteins: CENPE, CENPF, CENPJ, CEP131, CEP192, CEP250, CEP57, CEP72, NDC80, NIN, NUMA1, NUSAP1, PCM1, PCNT, and TUBGCP2-6 are involved in centrosome organization, spindle assembly, and chromosome segregation during mitosis.[13][14][15]

6. Cell cycle regulators: AURKA, BUB1, CCNB2, CDK1, CKAP5, ESPL1, FBXO5, NEK2, PLK1, PRC1, TTK, and TOP2A control cell cycle progression, particularly during mitosis, by regulating events such as chromosome condensation, spindle assembly, and cytokinesis.[16][17][18]

7. Adaptor proteins: ABI1, BCAR1, CD2AP, NCK1, NCK2, and PXN link signaling pathways to the actin cytoskeleton and regulate cell adhesion, migration, and invasion.[19][20][21]

In summary, the most prominent biological process performed by this system of interacting proteins is the regulation of cytoskeleton dynamics and cell division. These proteins contribute to various aspects of cell shape, motility, adhesion, and cell cycle progression, with a particular emphasis on the organization and dynamics of actin filaments and microtubules.

========================================================================================================================================================================================================
[1] Li, Zhongxun, Shi, Jiao, Zhang, Nannan, Zheng, Xiwang, Jin, Yukun, Wen, Shuxin, Hu, Wanglai, Wu, Yongyan, Gao, Wei. ""FSCN1 acts as a promising therapeutic target in the blockade of tumor cell motility: a review of its function, mechanism, and clinical significance."" Journal of Cancer, 2022, pp. 2528-2539.
[2] Taniuchi, Keisuke, Furihata, Mutsuo, Naganuma, Seiji, Saibara, Toshiji. ""WAVE2 is associated with poor prognosis in pancreatic cancers and promotes cell motility and invasiveness via binding to ACTN4."" Cancer medicine, 2018, pp. 5733-5751.
[3] Gao, Yufei, Li, Guanghu, Sun, Liankun, He, Yichun, Li, Xiaoyan, Sun, Zhi, Wang, Jihan, Jiang, Yang, Shi, Jingwei. ""ACTN4 and the pathways associated with cell motility and adhesion contribute to the process of lung cancer metastasis to the brain."" BMC cancer, 2015, pp. 277.
[4] Häbig, Karina, Gellhaar, Sandra, Heim, Birgit, Djuric, Verena, Giesert, Florian, Wurst, Wolfgang, Walter, Carolin, Hentrich, Thomas, Riess, Olaf, Bonin, Michael. ""LRRK2 guides the actin cytoskeleton at growth cones together with ARHGEF7 and Tropomyosin 4."" Biochimica et biophysica acta, 2013, pp. 2352-67.
[5] Kuroda, S, Fukata, M, Nakagawa, M, Kaibuchi, K. ""Cdc42, Rac1, and their effector IQGAP1 as molecular switches for cadherin-mediated cell-cell adhesion."" Biochemical and biophysical research communications, 1999, pp. 1-6.
[6] Li, Jieli, Liu, Yang, Jin, Yixin, Wang, Rui, Wang, Jian, Lu, Sarah, VanBuren, Vincent, Dostal, David E, Zhang, Shenyuan L, Peng, Xu. ""Essential role of Cdc42 in cardiomyocyte proliferation and cell-cell adhesion during heart development."" Developmental biology, 2017, pp. 271-283.
[7] Leano, Jonathan B, Slep, Kevin C. ""Structures of TOG1 and TOG2 from the human microtubule dynamics regulator CLASP1."" PloS one, 2019, pp. e0219823.
[8] Manning, Amity L, Bakhoum, Samuel F, Maffini, Stefano, Correia-Melo, Clara, Maiato, Helder, Compton, Duane A. ""CLASP1, astrin and Kif2b form a molecular switch that regulates kinetochore-microtubule dynamics to promote mitotic progression and fidelity."" The EMBO journal, 2010, pp. 3531-43.
[9] Maiato, Helder, Fairley, Elizabeth A L, Rieder, Conly L, Swedlow, Jason R, Sunkel, Claudio E, Earnshaw, William C. ""Human CLASP1 is an outer kinetochore component that regulates spindle microtubule dynamics."" Cell, 2003, pp. 891-904.
[10] Huang, Chiu-Jung, Huang, Chih-Cheng, Chang, Chih-Chun. ""Association of the testis-specific TRIM/RBCC protein RNF33/TRIM60 with the cytoplasmic motor proteins KIF3A and KIF3B."" Molecular and cellular biochemistry, 2012, pp. 121-31.
[11] Baptista, Filipa I, Pinto, Maria J, Elvas, Filipe, Almeida, Ramiro D, Ambrósio, António F. ""Diabetes alters KIF1A and KIF5B motor proteins in the hippocampus."" PloS one, 2013, pp. e65515.
[12] Chana, M S, Tripet, B P, Mant, C T, Hodges, R. ""Stability and specificity of heterodimer formation for the coiled-coil neck regions of the motor proteins Kif3A and Kif3B: the role of unstructured oppositely charged regions."" The journal of peptide research : official journal of the American Peptide Society, 2005, pp. 209-20.
[13] Gomez-Ferreria, Maria Ana, Rath, Uttama, Buster, Daniel W, Chanda, Sumit K, Caldwell, Jeremy S, Rines, Daniel R, Sharp, David J. ""Human Cep192 is required for mitotic centrosome and spindle assembly."" Current biology : CB, 2007, pp. 1960-6.
[14] Mills, Christine A, Suzuki, Aussie, Arceci, Anthony, Mo, Jin Yao, Duncan, Alex, Salmon, Edward D, Emanuele, Michael J. ""Nucleolar and spindle-associated protein 1 (NUSAP1) interacts with a SUMO E3 ligase complex during chromosome segregation."" The Journal of biological chemistry, 2017, pp. 17178-17189.
[15] Holdgaard, Søs Grønbæk, Cianfanelli, Valentina, Pupo, Emanuela, Lambrughi, Matteo, Lubas, Michal, Nielsen, Julie C, Eibes, Susana, Maiani, Emiliano, Harder, Lea M, Wesch, Nicole, Foged, Mads Møller, Maeda, Kenji, Nazio, Francesca, de la Ballina, Laura R, Dötsch, Volker, Brech, Andreas, Frankel, Lisa B, Jäättelä, Marja, Locatelli, Franco, Barisic, Marin, Andersen, Jens S, Bekker-Jensen, Simon, Lund, Anders H, Rogov, Vladimir V, Papaleo, Elena, Lanzetti, Letizia, De Zio, Daniela, Cecconi, Francesco. ""Selective autophagy maintains centrosome integrity and accurate mitosis by turnover of centriolar satellites."" Nature communications, 2019, pp. 4176.
[16] Xie, Bowen, Wang, Shuangyan, Jiang, Nian, Li, Jian Jian. ""Cyclin B1/CDK1-regulated mitochondrial bioenergetics in cell cycle progression and tumor resistance."" Cancer letters, 2019, pp. 56-66.
[17] Galarreta, Antonio, Valledor, Pablo, Ubieto-Capella, Patricia, Lafarga, Vanesa, Zarzuela, Eduardo, Muñoz, Javier, Malumbres, Marcos, Lecona, Emilio, Fernandez-Capetillo, Oscar. ""USP7 limits CDK1 activity throughout the cell cycle."" The EMBO journal, 2021, pp. e99692.
[18] Gheghiani, Lilia, Wang, Lei, Zhang, Youwei, Moore, Xavier T R, Zhang, Jinglei, Smith, Steven C, Tian, Yijun, Wang, Liang, Turner, Kristi, Jackson-Cook, Colleen K, Mukhopadhyay, Nitai D, Fu, Zheng. ""PLK1 Induces Chromosomal Instability and Overrides Cell-Cycle Checkpoints to Drive Tumorigenesis."" Cancer research, 2021, pp. 1293-1307.
[19] Ngoenkam, Jatuporn, Paensuwan, Pussadee, Preechanukul, Kanlaya, Khamsri, Boonruang, Yiemwattana, Ichaya, Beck-García, Esmeralda, Minguet, Susana, Schamel, Wolfgang W A, Pongcharoen, Sutatip. ""Non-overlapping functions of Nck1 and Nck2 adaptor proteins in T cell activation."" Cell communication and signaling : CCS, 2014, pp. 21.
[20] Anselmi, Francesca, Orlandini, Maurizio, Rocchigiani, Marina, De Clemente, Caterina, Salameh, Ahmad, Lentucci, Claudia, Oliviero, Salvatore, Galvagni, Federico. ""c-ABL modulates MAP kinases activation downstream of VEGFR-2 signaling by direct phosphorylation of the adaptor proteins GRB2 and NCK1."" Angiogenesis, 2012, pp. 187-97.
[21] Kotula, Leszek. ""Abi1, a critical molecule coordinating actin cytoskeleton reorganization with PI-3 kinase and growth signaling."" FEBS letters, 2012, pp. 2790-4.
"	0.3920295	0.83592606	GO	GO	NA
Diff. expressed gene set	MTORC1 SIGNALING	NA	ABCF2 ACACA ACLY ACSL3 ACTR2 ACTR3 ADD3 ADIPOR2 AK4 ALDOA ARPC5L ASNS ATP2A2 ATP5MC1 ATP6V1D AURKA BCAT1 BHLHE40 BTG2 BUB1 CACYBP CALR CANX CCNF CCNG1 CCT6A CD9 CDC25A CDKN1A CFP COPS5 CORO1A CTH CTSC CXCR4 CYB5B CYP51A1 DAPP1 DDIT3 DDIT4 DDX39A DHCR24 DHCR7 DHFR EBP EDEM1 EEF1E1 EGLN3 EIF2S2 ELOVL5 ELOVL6 ENO1 EPRS1 ERO1A ETF1 FADS1 FADS2 FDXR FGL2 FKBP2 G6PD GAPDH GBE1 GCLC GGA2 GLA GLRX GMPS GOT1 GPI GSK3B GSR GTF2H1 HK2 HMBS HMGCR HMGCS1 HPRT1 HSP90B1 HSPA4 HSPA5 HSPA9 HSPD1 HSPE1 IDH1 IDI1 IFI30 IFRD1 IGFBP5 IMMT INSIG1 ITGB2 LDHA LDLR LGMN LTA4H M6PR MAP2K3 MCM2 MCM4 ME1 MLLT11 MTHFD2 MTHFD2L NAMPT NFIL3 NFKBIB NFYC NIBAN1 NMT1 NUFIP1 NUP205 NUPR1 P4HA1 PDAP1 PDK1 PFKL PGK1 PGM1 PHGDH PIK3R3 PITPNB PLK1 PLOD2 PNO1 PNP POLR3G PPA1 PPIA PPP1R15A PRDX1 PSAT1 PSMA3 PSMA4 PSMB5 PSMC2 PSMC4 PSMC6 PSMD12 PSMD13 PSMD14 PSME3 PSMG1 PSPH QDPR RAB1A RDH11 RIT1 RPA1 RPN1 RRM2 RRP9 SC5D SCD SDF2L1 SEC11A SERP1 SERPINH1 SHMT2 SKAP2 SLA SLC1A4 SLC1A5 SLC2A1 SLC2A3 SLC37A4 SLC6A6 SLC7A11 SLC7A5 SLC9A3R1 SORD SQLE SQSTM1 SRD5A1 SSR1 STARD4 STC1 STIP1 SYTL2 TBK1 TCEA1 TES TFRC TM7SF2 TMEM97 TOMM40 TPI1 TRIB3 TUBA4A TUBG1 TXNRD1 UBE2D3 UCHL5 UFM1 UNG USO1 VLDLR WARS1 XBP1 YKT6	200	7.643856189774724	Cholesterol Biosynthetic Process 	GO:0006695	ACLY;G6PD;HMGCS1;INSIG1;CYP51A1;SC5D;DHCR24;HMGCR;DHCR7;TM7SF2	10	5	2.29e-14	3.64e-11	Cholesterol Biosynthesis and Cellular Energy Metabolism	"The interacting proteins in this system are primarily involved in cholesterol biosynthesis, cellular energy metabolism, and protein folding. The most prominent biological process performed by the system is cholesterol biosynthesis and cellular energy metabolism.

1. Cholesterol biosynthesis: Several proteins in the system are key enzymes in the cholesterol biosynthesis pathway, including HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase), HMGCS1 (3-hydroxy-3-methylglutaryl-CoA synthase 1), DHCR24 (24-dehydrocholesterol reductase), DHCR7 (7-dehydrocholesterol reductase), and SQLE (squalene epoxidase). These proteins catalyze critical steps in the conversion of acetyl-CoA to cholesterol, a vital component of cell membranes and precursor for steroid hormones and bile acids.

2. Cellular energy metabolism: Many proteins in the system are involved in glycolysis, the citric acid cycle, and oxidative phosphorylation, which are essential for generating cellular energy in the form of ATP. Key proteins include GAPDH (glyceraldehyde 3-phosphate dehydrogenase), ENO1 (enolase 1), LDHA (lactate dehydrogenase A), IDH1 (isocitrate dehydrogenase 1), and ATP5MC1 (ATP synthase membrane subunit c locus 1). These proteins facilitate the breakdown of glucose and other substrates to produce ATP, which is crucial for various cellular processes.

3. Protein folding: Several proteins in the system are involved in protein folding, including HSP90B1 (heat shock protein 90 beta family member 1), HSPA4 (heat shock protein family A member 4), HSPA5 (heat shock protein family A member 5), and HSPA9 (heat shock protein family A member 9). These proteins function as molecular chaperones, assisting in the folding and assembly of newly synthesized proteins and preventing protein aggregation.

In conclusion, the interacting proteins in this system play critical roles in cholesterol biosynthesis and cellular energy metabolism, which are essential for maintaining cellular homeostasis and supporting various biological processes."	14	7.000000000000001	"The interacting proteins in this system are primarily involved in cholesterol biosynthesis, cellular energy metabolism, and protein folding. The most prominent biological process performed by the system is cholesterol biosynthesis and cellular energy metabolism.

1. Cholesterol biosynthesis: Several proteins in the system are key enzymes in the cholesterol biosynthesis pathway, including HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase), HMGCS1 (3-hydroxy-3-methylglutaryl-CoA synthase 1), DHCR24 (24-dehydrocholesterol reductase), DHCR7 (7-dehydrocholesterol reductase), and SQLE (squalene epoxidase). These proteins catalyze critical steps in the conversion of acetyl-CoA to cholesterol, a vital component of cell membranes and precursor for steroid hormones and bile acids.[1][2][3]

2. Cellular energy metabolism: Many proteins in the system are involved in glycolysis, the citric acid cycle, and oxidative phosphorylation, which are essential for generating cellular energy in the form of ATP. Key proteins include GAPDH (glyceraldehyde 3-phosphate dehydrogenase), ENO1 (enolase 1), LDHA (lactate dehydrogenase A), IDH1 (isocitrate dehydrogenase 1), and ATP5MC1 (ATP synthase membrane subunit c locus 1). These proteins facilitate the breakdown of glucose and other substrates to produce ATP, which is crucial for various cellular processes.[4][5][6]

3. Protein folding: Several proteins in the system are involved in protein folding, including HSP90B1 (heat shock protein 90 beta family member 1), HSPA4 (heat shock protein family A member 4), HSPA5 (heat shock protein family A member 5), and HSPA9 (heat shock protein family A member 9). These proteins function as molecular chaperones, assisting in the folding and assembly of newly synthesized proteins and preventing protein aggregation.[7][8][9]

In conclusion, the interacting proteins in this system play critical roles in cholesterol biosynthesis and cellular energy metabolism, which are essential for maintaining cellular homeostasis and supporting various biological processes.

========================================================================================================================================================================================================
[1] Lu, Xiao-Yi, Shi, Xiong-Jie, Hu, Ao, Wang, Ju-Qiong, Ding, Yi, Jiang, Wei, Sun, Ming, Zhao, Xiaolu, Luo, Jie, Qi, Wei, Song, Bao-Liang. ""Feeding induces cholesterol biosynthesis via the mTORC1-USP20-HMGCR axis."" Nature, 2020, pp. 479-484.
[2] Shen, Yajie, Zhou, Jingqi, Nie, Kui, Cheng, Shuhua, Chen, Zhengming, Wang, Wenhan, Wei, Weiqing, Jiang, Daiji, Peng, Zijing, Ren, Yizhuo, Zhang, Yirong, Fan, Qiuju, Richards, Kristy L, Qi, Yitao, Cheng, Jinke, Tam, Wayne, Ma, Jiao. ""Oncogenic role of the SOX9-DHCR24-cholesterol biosynthesis axis in IGH-BCL2+ diffuse large B-cell lymphomas."" Blood, 2022, pp. 73-86.
[3] Kalogirou, C, Linxweiler, J, Schmucker, P, Snaebjornsson, M T, Schmitz, W, Wach, S, Krebs, M, Hartmann, E, Puhr, M, Müller, A, Spahn, M, Seitz, A K, Frank, T, Marouf, H, Büchel, G, Eckstein, M, Kübler, H, Eilers, M, Saar, M, Junker, K, Röhrig, F, Kneitz, B, Rosenfeldt, M T, Schulze, A. ""MiR-205-driven downregulation of cholesterol biosynthesis through SQLE-inhibition identifies therapeutic vulnerability in aggressive prostate cancer."" Nature communications, 2021, pp. 5066.
[4] Ooi, Aik T, Gomperts, Brigitte N. ""Molecular Pathways: Targeting Cellular Energy Metabolism in Cancer via Inhibition of SLC2A1 and LDHA."" Clinical cancer research : an official journal of the American Association for Cancer Research, 2015, pp. 2440-4.
[5] Yang, Jia-Shu, Hsu, Jia-Wei, Park, Seung-Yeol, Li, Jian, Oldham, William M, Beznoussenko, Galina V, Mironov, Alexander A, Loscalzo, Joseph, Hsu, Victor W. ""GAPDH inhibits intracellular pathways during starvation for cellular energy homeostasis."" Nature, 2018, pp. 263-267.
[6] Zhong, Xing-Yu, Yuan, Xiu-Ming, Xu, Ying-Ying, Yin, Miao, Yan, Wei-Wei, Zou, Shao-Wu, Wei, Li-Ming, Lu, Hao-Jie, Wang, Yi-Ping, Lei, Qun-Ying. ""CARM1 Methylates GAPDH to Regulate Glucose Metabolism and Is Suppressed in Liver Cancer."" Cell reports, 2018, pp. 3207-3223.
[7] Wang, Jie, Lee, Jessica, Liem, David, Ping, Peipei. ""HSPA5 Gene encoding Hsp70 chaperone BiP in the endoplasmic reticulum."" Gene, 2017, pp. 14-23.
[8] Wang, Bin, Zhang, Jing, Liu, Xin, Chai, Qingqing, Lu, Xiaoran, Yao, Xiaoyu, Yang, Zhichang, Sun, Liangliang, Johnson, Silas F, Schwartz, Richard C, Zheng, Yong-Hui. ""Protein disulfide isomerases (PDIs) negatively regulate ebolavirus structural glycoprotein expression in the endoplasmic reticulum (ER) via the autophagy-lysosomal pathway."" Autophagy, 2022, pp. 2350-2367.
[9] Abbonante, Vittorio, Malara, Alessandro, Chrisam, Martina, Metti, Samuele, Soprano, Paolo, Semplicini, Claudio, Bello, Luca, Bozzi, Valeria, Battiston, Monica, Pecci, Alessandro, Pegoraro, Elena, De Marco, Luigi, Braghetta, Paola, Bonaldo, Paolo, Balduini, Alessandra. ""Lack of COL6/collagen VI causes megakaryocyte dysfunction by impairing autophagy and inducing apoptosis."" Autophagy, 2023, pp. 984-999.
"	0.35064682	0.22160032	Neither	Tied	NA
Diff. expressed gene set	MYC TARGETS V1	NA	ABCE1 ACP1 AIMP2 AP3S1 APEX1 BUB3 C1QBP CAD CANX CBX3 CCNA2 CCT2 CCT3 CCT4 CCT5 CCT7 CDC20 CDC45 CDK2 CDK4 CLNS1A CNBP COPS5 COX5A CSTF2 CTPS1 CUL1 CYC1 DDX18 DDX21 DEK DHX15 DUT EEF1B2 EIF1AX EIF2S1 EIF2S2 EIF3B EIF3D EIF3J EIF4A1 EIF4E EIF4G2 EIF4H EPRS1 ERH ETF1 EXOSC7 FAM120A FBL G3BP1 GLO1 GNL3 GOT2 GSPT1 H2AZ1 HDAC2 HDDC2 HDGF HNRNPA1 HNRNPA2B1 HNRNPA3 HNRNPC HNRNPD HNRNPR HNRNPU HPRT1 HSP90AB1 HSPD1 HSPE1 IARS1 IFRD1 ILF2 IMPDH2 KARS1 KPNA2 KPNB1 LDHA LSM2 LSM7 MAD2L1 MCM2 MCM4 MCM5 MCM6 MCM7 MRPL23 MRPL9 MRPS18B MYC NAP1L1 NCBP1 NCBP2 NDUFAB1 NHP2 NME1 NOLC1 NOP16 NOP56 NPM1 ODC1 ORC2 PA2G4 PABPC1 PABPC4 PCBP1 PCNA PGK1 PHB1 PHB2 POLD2 POLE3 PPIA PPM1G PRDX3 PRDX4 PRPF31 PRPS2 PSMA1 PSMA2 PSMA4 PSMA6 PSMA7 PSMB2 PSMB3 PSMC4 PSMC6 PSMD1 PSMD14 PSMD3 PSMD7 PSMD8 PTGES3 PWP1 RACK1 RAD23B RAN RANBP1 RFC4 RNPS1 RPL14 RPL18 RPL22 RPL34 RPL6 RPLP0 RPS10 RPS2 RPS3 RPS5 RPS6 RRM1 RRP9 RSL1D1 RUVBL2 SERBP1 SET SF3A1 SF3B3 SLC25A3 SMARCC1 SNRPA SNRPA1 SNRPB2 SNRPD1 SNRPD2 SNRPD3 SNRPG SRM SRPK1 SRSF1 SRSF2 SRSF3 SRSF7 SSB SSBP1 STARD7 SYNCRIP TARDBP TCP1 TFDP1 TOMM70 TRA2B TRIM28 TUFM TXNL4A TYMS U2AF1 UBA2 UBE2E1 UBE2L3 USP1 VBP1 VDAC1 VDAC3 XPO1 XPOT XRCC6 YWHAE YWHAQ	200	7.643856189774724	mRNA Splicing, Via Spliceosome 	GO:0000398	SF3B3;SRSF1;HNRNPU;HNRNPR;U2AF1;SYNCRIP;SNRPD2;SNRPD1;TRA2B;DHX15;SNRPB2;SNRPD3;TXNL4A;HNRNPA1;SF3A1;HNRNPA3;NCBP1;NCBP2;SRPK1;LSM2;LSM7;CLNS1A;HNRNPA2B1;SNRPG;SRSF2;SRSF3;RNPS1;PRPF31;SNRPA1;HNRNPC;PABPC1;SRSF7;SNRPA	33	16.5	6.0099999999999994e-30	7.370000000000001e-27	Protein Synthesis and Cell Cycle Regulation	"The system of interacting proteins primarily performs the biological processes of protein synthesis and cell cycle regulation. 

Protein Synthesis:
1. Translation initiation factors: EIF1AX, EIF2S1, EIF2S2, EIF3B, EIF3D, EIF3J, EIF4A1, EIF4E, EIF4G2, EIF4H, and EPRS1 are involved in the initiation of protein synthesis.
2. Ribosomal proteins: RPL14, RPL18, RPL22, RPL34, RPL6, RPLP0, RPS10, RPS2, RPS3, RPS5, and RPS6 are components of the ribosome, which is essential for protein synthesis.
3. Aminoacyl-tRNA synthetases: IARS1 and KARS1 are responsible for charging tRNAs with their respective amino acids, a crucial step in protein synthesis.
4. Elongation factors: EEF1B2 and GSPT1 are involved in the elongation phase of protein synthesis, ensuring the correct addition of amino acids to the growing polypeptide chain.

Cell Cycle Regulation:
1. Cyclins and cyclin-dependent kinases: CCNA2, CDK2, and CDK4 are key regulators of cell cycle progression, controlling the transition between different phases of the cell cycle.
2. Cell division cycle proteins: CDC20, CDC45, and MCM2-7 are involved in DNA replication and cell division, ensuring accurate duplication and segregation of genetic material.
3. Spindle assembly checkpoint proteins: BUB3 and MAD2L1 monitor the proper attachment of chromosomes to the mitotic spindle, preventing premature anaphase onset.
4. DNA replication and repair proteins: APEX1, PCNA, POLD2, POLE3, and XRCC6 are involved in DNA replication, repair, and maintenance, ensuring the fidelity of genetic information.

Other notable processes include RNA processing (HNRNPA1, HNRNPA2B1, HNRNPA3, HNRNPC, HNRNPD, HNRNPR, HNRNPU, and SNRPA), protein folding (CCT2, CCT3, CCT4, CCT5, CCT7, HSP90AB1, HSPD1, and HSPE1), and protein degradation (CUL1, PSMA1, PSMA2, PSMA4, PSMA6, PSMA7, PSMB2, PSMB3, PSMC4, PSMC6, PSMD1, PSMD14, PSMD3, PSMD7, and PSMD8)."	70	35	"The system of interacting proteins primarily performs the biological processes of protein synthesis and cell cycle regulation. 

1. Translation initiation factors: EIF1AX, EIF2S1, EIF2S2, EIF3B, EIF3D, EIF3J, EIF4A1, EIF4E, EIF4G2, EIF4H, and EPRS1 are involved in the initiation of protein synthesis.[1][2][3]

2. Ribosomal proteins: RPL14, RPL18, RPL22, RPL34, RPL6, RPLP0, RPS10, RPS2, RPS3, RPS5, and RPS6 are components of the ribosome, which is essential for protein synthesis.[4][5][6]

3. Aminoacyl-tRNA synthetases: IARS1 and KARS1 are responsible for charging tRNAs with their respective amino acids, a crucial step in protein synthesis.[7][8][9]

4. Elongation factors: EEF1B2 and GSPT1 are involved in the elongation phase of protein synthesis, ensuring the correct addition of amino acids to the growing polypeptide chain.[10][11][12]

1. Cyclins and cyclin-dependent kinases: CCNA2, CDK2, and CDK4 are key regulators of cell cycle progression, controlling the transition between different phases of the cell cycle.[13][14][15]

2. Cell division cycle proteins: CDC20, CDC45, and MCM2-7 are involved in DNA replication and cell division, ensuring accurate duplication and segregation of genetic material.[16][17][18]

3. Spindle assembly checkpoint proteins: BUB3 and MAD2L1 monitor the proper attachment of chromosomes to the mitotic spindle, preventing premature anaphase onset.[19][20][21]

4. DNA replication and repair proteins: APEX1, PCNA, POLD2, POLE3, and XRCC6 are involved in DNA replication, repair, and maintenance, ensuring the fidelity of genetic information.[22][23][24]

Other notable processes include RNA processing (HNRNPA1, HNRNPA2B1, HNRNPA3, HNRNPC, HNRNPD, HNRNPR, HNRNPU, and SNRPA), protein folding (CCT2, CCT3, CCT4, CCT5, CCT7, HSP90AB1, HSPD1, and HSPE1), and protein degradation (CUL1, PSMA1, PSMA2, PSMA4, PSMA6, PSMA7, PSMB2, PSMB3, PSMC4, PSMC6, PSMD1, PSMD14, PSMD3, PSMD7, and PSMD8).[25][26][27]

========================================================================================================================================================================================================
[1] Liang, Hong, Ding, Xuehua, Zhou, Chun, Zhang, Yihua, Xu, Minhui, Zhang, Chengqu, Xu, Lunshan. ""Knockdown of eukaryotic translation initiation factors 3B (EIF3B) inhibits proliferation and promotes apoptosis in glioblastoma cells."" Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2012, pp. 1057-62.
[2] Gindina, Sofya, Botsford, Benjamin, Cowansage, Kiriana, LeDoux, Joseph, Klann, Eric, Hoeffer, Charles, Ostroff, Linnaea. ""Upregulation of eIF4E, but not other translation initiation factors, in dendritic spines during memory formation."" The Journal of comparative neurology, 2021, pp. 3112-3126.
[3] Doepker, Rosalyn C, Hsu, Wei-Li, Saffran, Holly A, Smiley, James R. ""Herpes simplex virus virion host shutoff protein is stimulated by translation initiation factors eIF4B and eIF4H."" Journal of virology, 2004, pp. 4684-99.
[4] Zhang, Yong, O'Leary, Monique N, Peri, Suraj, Wang, Minshi, Zha, Jikun, Melov, Simon, Kappes, Dietmar J, Feng, Qing, Rhodes, Jennifer, Amieux, Paul S, Morris, David R, Kennedy, Brian K, Wiest, David L. ""Ribosomal Proteins Rpl22 and Rpl22l1 Control Morphogenesis by Regulating Pre-mRNA Splicing."" Cell reports, 2017, pp. 545-556.
[5] Artero-Castro, Ana, Castellvi, Josep, García, Angel, Hernández, Javier, Ramón y Cajal, Santiago, Lleonart, Matilde E. ""Expression of the ribosomal proteins Rplp0, Rplp1, and Rplp2 in gynecologic tumors."" Human pathology, 2011, pp. 194-203.
[6] Blitvich, B J, Rayms-Keller, A, Blair, C D, Beaty, B J. ""Molecular cloning and complete cDNA sequences of the ribosomal proteins rpl34 and rpl44 from Aedes triseriatus mosquitoes."" DNA sequence : the journal of DNA sequencing and mapping, 2000, pp. 451-5.
[7] Chung, Scisung, Kang, Mi-Sun, Alimbetov, Dauren S, Mun, Gil-Im, Yunn, Na-Oh, Kim, Yunjin, Kim, Byung-Gyu, Wie, Minwoo, Lee, Eun A, Ra, Jae Sun, Oh, Jung-Min, Lee, Donghyun, Lee, Keondo, Kim, Jihan, Han, Seung Hyun, Kim, Kyong-Tai, Chung, Wan Kyun, Nam, Ki Hyun, Park, Jaehyun, Lee, ByungHoon, Kim, Sunghoon, Zhao, Weixing, Ryu, Sung Ho, Lee, Yun-Sil, Myung, Kyungjae, Cho, Yunje. ""Regulation of BRCA1 stability through the tandem UBX domains of isoleucyl-tRNA synthetase 1."" Nature communications, 2022, pp. 6732.
[8] Zou, Ting-Ting, Sun, Hua-Qin, Zhu, Yu, He, Tian-Tian, Ling, Wen-Wu, Zhu, Hong-Mei, Lin, Zi-Yuan, Liu, Yan-Yan, Liu, Shan-Ling, Wang, He, Zhang, Xue-Mei. ""Compound heterozygous variations in IARS1 cause recurrent liver failure and growth retardation in a Chinese patient: a case report."" BMC pediatrics, 2022, pp. 329.
[9] Wang, Jin-Tao, Zhou, Jing-Bo, Mao, Xue-Ling, Zhou, Li, Chen, Meirong, Zhang, Wenhua, Wang, En-Duo, Zhou, Xiao-Long. ""Commonality and diversity in tRNA substrate recognition in t6A biogenesis by eukaryotic KEOPSs."" Nucleic acids research, 2022, pp. 2223-2239.
[10] Hassan, Md Khurshidul, Kumar, Dinesh, Naik, Monali, Dixit, Manjusha. ""The expression profile and prognostic significance of eukaryotic translation elongation factors in different cancers."" PloS one, 2018, pp. e0191377.
[11] Cristiano, Luigi. ""The pseudogenes of eukaryotic translation elongation factors (EEFs): Role in cancer and other human diseases."" Genes & diseases, 2022, pp. 941-958.
[12] Biterge-Sut, Burcu. ""Alterations in Eukaryotic Elongation Factor complex proteins (EEF1s) in cancer and their implications in epigenetic regulation."" Life sciences, 2019, pp. 116977.
[13] Goel, Shom, DeCristo, Molly J, McAllister, Sandra S, Zhao, Jean J. ""CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest."" Trends in cell biology, 2018, pp. 911-925.
[14] Freeman-Cook, Kevin, Hoffman, Robert L, Miller, Nichol, Almaden, Jonathan, Chionis, John, Zhang, Qin, Eisele, Koleen, Liu, Chaoting, Zhang, Cathy, Huser, Nanni, Nguyen, Lisa, Costa-Jones, Cinthia, Niessen, Sherry, Carelli, Jordan, Lapek, John, Weinrich, Scott L, Wei, Ping, McMillan, Elizabeth, Wilson, Elizabeth, Wang, Tim S, McTigue, Michele, Ferre, Rose Ann, He, You-Ai, Ninkovic, Sacha, Behenna, Douglas, Tran, Khanh T, Sutton, Scott, Nagata, Asako, Ornelas, Martha A, Kephart, Susan E, Zehnder, Luke R, Murray, Brion, Xu, Meirong, Solowiej, James E, Visswanathan, Ravi, Boras, Britton, Looper, David, Lee, Nathan, Bienkowska, Jadwiga R, Zhu, Zhou, Kan, Zhengyan, Ding, Ying, Mu, Xinmeng Jasmine, Oderup, Cecilia, Salek-Ardakani, Shahram, White, Michael A, VanArsdale, Todd, Dann, Stephen G. ""Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor."" Cancer cell, 2021, pp. 1404-1421.e11.
[15] Lamb, Rebecca, Lehn, Sophie, Rogerson, Lynsey, Clarke, Robert B, Landberg, Göran. ""Cell cycle regulators cyclin D1 and CDK4/6 have estrogen receptor-dependent divergent functions in breast cancer migration and stem cell-like activity."" Cell cycle (Georgetown, Tex.), 2013, pp. 2384-94.
[16] Petojevic, Tatjana, Pesavento, James J, Costa, Alessandro, Liang, Jingdan, Wang, Zhijun, Berger, James M, Botchan, Michael R. ""Cdc45 (cell division cycle protein 45) guards the gate of the Eukaryote Replisome helicase stabilizing leading strand engagement."" Proceedings of the National Academy of Sciences of the United States of America, 2015, pp. E249-58.
[17] Lu, Hui-Ping, Du, Xiu-Fang, Li, Jian-Di, Huang, Su-Ning, He, Rong-Quan, Wu, Hua-Yu, Li, Ming-Fen, Wu, Wei-Zi, Chen, Ji-Tian, Mo, Wei-Jia, Chen, Gang. ""Expression of Cell Division Cycle Protein 45 in Tissue Microarrays and the CDC45 Gene by Bioinformatics Analysis in Human Hepatocellular Carcinoma and Patient Outcomes."" Medical science monitor : international medical journal of experimental and clinical research, 2021, pp. e928800.
[18] Perl, Abbey L, O'Connor, Caitlin M, Fa, Pengyan, Mayca Pozo, Franklin, Zhang, Junran, Zhang, Youwei, Narla, Goutham. ""Protein phosphatase 2A controls ongoing DNA replication by binding to and regulating cell division cycle 45 (CDC45)."" The Journal of biological chemistry, 2019, pp. 17043-17059.
[19] Prinz, Florian, Puetter, Vera, Holton, Simon J, Andres, Dorothee, Stegmann, Christian M, Kwiatkowski, Dennis, Prechtl, Stefan, Petersen, Kirstin, Beckmann, Georg, Kreft, Bertolt, Mumberg, Dominik, Fernández-Montalván, Amaury. ""Functional and Structural Characterization of Bub3·BubR1 Interactions Required for Spindle Assembly Checkpoint Signaling in Human Cells."" The Journal of biological chemistry, 2016, pp. 11252-67.
[20] de Voer, Richarda M, Geurts van Kessel, Ad, Weren, Robbert D A, Ligtenberg, Marjolijn J L, Smeets, Dominique, Fu, Lei, Vreede, Lilian, Kamping, Eveline J, Verwiel, Eugène T P, Hahn, Marc-Manuel, Ariaans, Maayke, Spruijt, Liesbeth, van Essen, Ton, Houge, Gunnar, Schackert, Hans K, Sheng, Jian Q, Venselaar, Hanka, van Ravenswaaij-Arts, Conny M A, van Krieken, J Han J M, Hoogerbrugge, Nicoline, Kuiper, Roland P. ""Germline mutations in the spindle assembly checkpoint genes BUB1 and BUB3 are risk factors for colorectal cancer."" Gastroenterology, 2013, pp. 544-7.
[21] Martinez-Exposito, M J, Kaplan, K B, Copeland, J, Sorger, P K. ""Retention of the BUB3 checkpoint protein on lagging chromosomes."" Proceedings of the National Academy of Sciences of the United States of America, 1999, pp. 8493-8.
[22] Boehm, E M, Gildenberg, M S, Washington, M T. ""The Many Roles of PCNA in Eukaryotic DNA Replication."" The Enzymes, 2016, pp. 231-54.
[23] Strzalka, Wojciech, Ziemienowicz, Alicja. ""Proliferating cell nuclear antigen (PCNA): a key factor in DNA replication and cell cycle regulation."" Annals of botany, 2011, pp. 1127-40.
[24] Dimberg, Jan, Skarstedt, Marita, Slind Olsen, Renate, Andersson, Roland E, Matussek, Andreas. ""Gene polymorphism in DNA repair genes XRCC1 and XRCC6 and association with colorectal cancer in Swedish patients."" APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2016, pp. 736-40.
[25] Alarcón, Claudio R, Goodarzi, Hani, Lee, Hyeseung, Liu, Xuhang, Tavazoie, Saeed, Tavazoie, Sohail F. ""HNRNPA2B1 Is a Mediator of m(6)A-Dependent Nuclear RNA Processing Events."" Cell, 2015, pp. 1299-308.
[26] Rossoll, Wilfried, Kröning, Ann-Kathrin, Ohndorf, Uta-Maria, Steegborn, Clemens, Jablonka, Sibylle, Sendtner, Michael. ""Specific interaction of Smn, the spinal muscular atrophy determining gene product, with hnRNP-R and gry-rbp/hnRNP-Q: a role for Smn in RNA processing in motor axons?"" Human molecular genetics, 2002, pp. 93-105.
[27] Okumura, Toshiyuki, Ikeda, Kazuhiro, Ujihira, Takafumi, Okamoto, Koji, Horie-Inoue, Kuniko, Takeda, Satoru, Inoue, Satoshi. ""Proteasome 26S subunit PSMD1 regulates breast cancer cell growth through p53 protein degradation."" Journal of biochemistry, 2018, pp. 19-29.
"	0.31623477	0.2557971	Neither	Tied	NA
Diff. expressed gene set	MYC TARGETS V2	NA	AIMP2 BYSL CBX3 CDK4 DCTPP1 DDX18 DUSP2 EXOSC5 FARSA GNL3 GRWD1 HK2 HSPD1 HSPE1 IMP4 IPO4 LAS1L MAP3K6 MCM4 MCM5 MPHOSPH10 MRTO4 MYBBP1A MYC NDUFAF4 NIP7 NOC4L NOLC1 NOP16 NOP2 NOP56 NPM1 PA2G4 PES1 PHB1 PLK1 PLK4 PPAN PPRC1 PRMT3 PUS1 RABEPK RCL1 RRP12 RRP9 SLC19A1 SLC29A2 SORD SRM SUPV3L1 TBRG4 TCOF1 TFB2M TMEM97 UNG UTP20 WDR43 WDR74	58	5.857980995127572	Ribosome Biogenesis 	GO:0042254	NOP56;NPM1;NOP16;NIP7;WDR74;NOLC1;NOC4L;WDR43;BYSL;RRP9;RCL1;EXOSC5;PES1;GRWD1;MRTO4;MPHOSPH10;UTP20;RRP12	18	31.03448275862069	1.2699999999999999e-24	6.98e-22	Ribosome Biogenesis and Cell Cycle Regulation	"The primary biological process performed by this system of interacting proteins is ribosome biogenesis and cell cycle regulation. Ribosome biogenesis is essential for protein synthesis, while cell cycle regulation ensures proper cell division and growth.

1. Ribosome Biogenesis: Several proteins in this system are involved in ribosome biogenesis, including AIMP2, BYSL, DDX18, EXOSC5, FARSA, GNL3, GRWD1, IMP4, LAS1L, NIP7, NOC4L, NOLC1, NOP16, NOP2, NOP56, NPM1, PA2G4, PES1, PHB1, RABEPK, RCL1, RRP12, RRP9, SUPV3L1, TBRG4, TCOF1, UTP20, WDR43, and WDR74. These proteins contribute to various stages of ribosome biogenesis, such as rRNA processing, ribosomal subunit assembly, and nuclear export of ribosomal subunits.

2. Cell Cycle Regulation: Proteins CDK4, PLK1, and PLK4 are key regulators of the cell cycle. CDK4 is a cyclin-dependent kinase that promotes cell cycle progression by phosphorylating target proteins. PLK1 and PLK4 are members of the polo-like kinase family, which play crucial roles in cell cycle progression, centrosome maturation, and mitotic spindle formation.

3. DNA Replication and Repair: MCM4 and MCM5 are part of the minichromosome maintenance complex, which is essential for DNA replication initiation and elongation. UNG is involved in base excision repair, a process that removes damaged bases from DNA. DCTPP1 is a dCTP pyrophosphatase that hydrolyzes dCTP, preventing the incorporation of damaged nucleotides into DNA.

4. Protein Synthesis and Modification: Proteins such as DUSP2, FARSA, HSPE1, HSPD1, and PRMT3 are involved in protein synthesis and modification. DUSP2 is a dual-specificity phosphatase that dephosphorylates MAP kinases, regulating their activity. FARSA is an aminoacyl-tRNA synthetase that charges tRNA with the amino acid phenylalanine. HSPE1 and HSPD1 are chaperonins that assist in protein folding. PRMT3 is a protein arginine methyltransferase that methylates arginine residues on target proteins.

5. Energy Metabolism: HK2 and NDUFAF4 are involved in energy metabolism. HK2 is a hexokinase that catalyzes the first step of glycolysis, while NDUFAF4 is a subunit of the mitochondrial respiratory chain complex I, which is involved in oxidative phosphorylation.

6. Nucleocytoplasmic Transport: IPO4 is an importin that mediates the nuclear import of proteins containing a nuclear localization signal. MAP3K6 is a kinase that phosphorylates target proteins, regulating their subcellular localization and activity.

7. Transcription Regulation: MYC is a transcription factor that regulates the expression of genes involved in cell growth, proliferation, and metabolism. TFB2M is a subunit of the transcription factor B2 complex, which is involved in mitochondrial transcription initiation."	46	79.3103448275862	"The primary biological process performed by this system of interacting proteins is ribosome biogenesis and cell cycle regulation. Ribosome biogenesis is essential for protein synthesis, while cell cycle regulation ensures proper cell division and growth.

1. Ribosome Biogenesis: Several proteins in this system are involved in ribosome biogenesis, including AIMP2, BYSL, DDX18, EXOSC5, FARSA, GNL3, GRWD1, IMP4, LAS1L, NIP7, NOC4L, NOLC1, NOP16, NOP2, NOP56, NPM1, PA2G4, PES1, PHB1, RABEPK, RCL1, RRP12, RRP9, SUPV3L1, TBRG4, TCOF1, UTP20, WDR43, and WDR74. These proteins contribute to various stages of ribosome biogenesis, such as rRNA processing, ribosomal subunit assembly, and nuclear export of ribosomal subunits.[1][2][3]

2. Cell Cycle Regulation: Proteins CDK4, PLK1, and PLK4 are key regulators of the cell cycle. CDK4 is a cyclin-dependent kinase that promotes cell cycle progression by phosphorylating target proteins. PLK1 and PLK4 are members of the polo-like kinase family, which play crucial roles in cell cycle progression, centrosome maturation, and mitotic spindle formation.[4][5][6]

3. DNA Replication and Repair: MCM4 and MCM5 are part of the minichromosome maintenance complex, which is essential for DNA replication initiation and elongation. UNG is involved in base excision repair, a process that removes damaged bases from DNA. DCTPP1 is a dCTP pyrophosphatase that hydrolyzes dCTP, preventing the incorporation of damaged nucleotides into DNA.[7][8][9]

4. Protein Synthesis and Modification: Proteins such as DUSP2, FARSA, HSPE1, HSPD1, and PRMT3 are involved in protein synthesis and modification. DUSP2 is a dual-specificity phosphatase that dephosphorylates MAP kinases, regulating their activity. FARSA is an aminoacyl-tRNA synthetase that charges tRNA with the amino acid phenylalanine. HSPE1 and HSPD1 are chaperonins that assist in protein folding. PRMT3 is a protein arginine methyltransferase that methylates arginine residues on target proteins.[10][11][12]

5. Energy Metabolism: HK2 and NDUFAF4 are involved in energy metabolism. HK2 is a hexokinase that catalyzes the first step of glycolysis, while NDUFAF4 is a subunit of the mitochondrial respiratory chain complex I, which is involved in oxidative phosphorylation.[13][14][15]

6. Nucleocytoplasmic Transport: IPO4 is an importin that mediates the nuclear import of proteins containing a nuclear localization signal. MAP3K6 is a kinase that phosphorylates target proteins, regulating their subcellular localization and activity.[16][17][18]

7. Transcription Regulation: MYC is a transcription factor that regulates the expression of genes involved in cell growth, proliferation, and metabolism. TFB2M is a subunit of the transcription factor B2 complex, which is involved in mitochondrial transcription initiation.[19][20][21]

========================================================================================================================================================================================================
[1] Zhu, Xueping, Zhang, Wei, Guo, Jie, Zhang, Xuejie, Li, Liping, Wang, Ting, Yan, Jinghua, Zhang, Fuping, Hou, Baidong, Gao, Ning, Gao, George F, Zhou, Xuyu. ""Noc4L-Mediated Ribosome Biogenesis Controls Activation of Regulatory and Conventional T Cells."" Cell reports, 2019, pp. 1205-1220.e4.
[2] Liao, Han, Gaur, Anushri, McConie, Hunter, Shekar, Amirtha, Wang, Karen, Chang, Jeffrey T, Breton, Ghislain, Denicourt, Catherine. ""Human NOP2/NSUN1 regulates ribosome biogenesis through non-catalytic complex formation with box C/D snoRNPs."" Nucleic acids research, 2022, pp. 10695-10716.
[3] Sondalle, S B, Baserga, S J, Yelick, P C. ""The Contributions of the Ribosome Biogenesis Protein Utp5/WDR43 to Craniofacial Development."" Journal of dental research, 2016, pp. 1214-20.
[4] Goel, Shom, DeCristo, Molly J, McAllister, Sandra S, Zhao, Jean J. ""CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest."" Trends in cell biology, 2018, pp. 911-925.
[5] Gheghiani, Lilia, Wang, Lei, Zhang, Youwei, Moore, Xavier T R, Zhang, Jinglei, Smith, Steven C, Tian, Yijun, Wang, Liang, Turner, Kristi, Jackson-Cook, Colleen K, Mukhopadhyay, Nitai D, Fu, Zheng. ""PLK1 Induces Chromosomal Instability and Overrides Cell-Cycle Checkpoints to Drive Tumorigenesis."" Cancer research, 2021, pp. 1293-1307.
[6] AbuHammad, Shatha, Cullinane, Carleen, Martin, Claire, Bacolas, Zoe, Ward, Teresa, Chen, Huiqin, Slater, Alison, Ardley, Kerry, Kirby, Laura, Chan, Keefe T, Brajanovski, Natalie, Smith, Lorey K, Rao, Aparna D, Lelliott, Emily J, Kleinschmidt, Margarete, Vergara, Ismael A, Papenfuss, Anthony T, Lau, Peter, Ghosh, Prerana, Haupt, Sue, Haupt, Ygal, Sanij, Elaine, Poortinga, Gretchen, Pearson, Richard B, Falk, Hendrik, Curtis, David J, Stupple, Paul, Devlin, Mark, Street, Ian, Davies, Michael A, McArthur, Grant A, Sheppard, Karen E. ""Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma."" Proceedings of the National Academy of Sciences of the United States of America, 2019, pp. 17990-18000.
[7] Ishimi, Yukio, Komamura-Kohno, Yuki, Karasawa-Shimizu, Kumiko, Yamada, Kouichi. ""Levels of MCM4 phosphorylation and DNA synthesis in DNA replication block checkpoint control."" Journal of structural biology, 2004, pp. 234-41.
[8] Shultz, Randall W, Lee, Tae-Jin, Allen, George C, Thompson, William F, Hanley-Bowdoin, Linda. ""Dynamic localization of the DNA replication proteins MCM5 and MCM7 in plants."" Plant physiology, 2009, pp. 658-69.
[9] Vetro, Annalisa, Savasta, Salvatore, Russo Raucci, Annalisa, Cerqua, Cristina, Sartori, Geppo, Limongelli, Ivan, Forlino, Antonella, Maruelli, Silvia, Perucca, Paola, Vergani, Debora, Mazzini, Giuliano, Mattevi, Andrea, Stivala, Lucia Anna, Salviati, Leonardo, Zuffardi, Orsetta. ""MCM5: a new actor in the link between DNA replication and Meier-Gorlin syndrome."" European journal of human genetics : EJHG, 2017, pp. 646-650.
[10] Zhu, Rui-Mei, Lin, Wei, Zhang, Wei, Ren, Jun-Ting, Su, Yi, He, Jian-Rong, Lin, Ying, Su, Feng-Xi, Xie, Xiao-Ming, Tang, Lu-Ying, Ren, Ze-Fang. ""Modification effects of genetic polymorphisms in FTO, IL-6, and HSPD1 on the associations of diabetes with breast cancer risk and survival."" PloS one, 2017, pp. e0178850.
[11] Swiercz, Rafal, Person, Maria D, Bedford, Mark T. ""Ribosomal protein S2 is a substrate for mammalian PRMT3 (protein arginine methyltransferase 3)."" The Biochemical journal, 2005, pp. 85-91.
[12] Wu, Xiaoxiao, Guo, Jianying, Chen, Yuling, Liu, Xiaohui, Yang, Guangzhong, Wu, Yin, Tian, Ying, Liu, Nian, Yang, Lin, Wei, Songren, Deng, Haiteng, Chen, Wenming. ""The 60-kDa heat shock protein regulates energy rearrangement and protein synthesis to promote proliferation of multiple myeloma cells."" British journal of haematology, 2020, pp. 741-752.
[13] Jin, Fangfang, Wang, Yanbo, Zhu, Yanan, Li, Shan, Liu, Ying, Chen, Cheng, Wang, Xiaohua, Zen, Ke, Li, Limin. ""The miR-125a/HK2 axis regulates cancer cell energy metabolism reprogramming in hepatocellular carcinoma."" Scientific reports, 2017, pp. 3089.
[14] Li, Kan, Gao, Li, Zhou, Sen, Ma, Yan-Rong, Xiao, Xiao, Jiang, Qian, Kang, Zhi-Hong, Liu, Ming-Long, Liu, Tian-Xi. ""Erythropoietin promotes energy metabolism to improve LPS-induced injury in HK-2 cells via SIRT1/PGC1-α pathway."" Molecular and cellular biochemistry, 2023, pp. 651-663.
[15] Tan, Valerie P, Miyamoto, Shigeki. ""HK2/hexokinase-II integrates glycolysis and autophagy to confer cellular protection."" Autophagy, 2015, pp. 963-4.
[16] Xu, Xia, Zhang, Xinchao, Xing, Huaixin, Liu, Zhifang, Jia, Jihui, Jin, Chunyuan, Zhang, Yingjie. ""Importin-4 functions as a driving force in human primary gastric cancer."" Journal of cellular biochemistry, 2019, pp. 12638-12646.
[17] Zhou, Yang, Liu, Fei, Xu, Qinyang, Yang, Bikang, Li, Xiao, Jiang, Shuheng, Hu, Lipeng, Zhang, Xueli, Zhu, Lili, Li, Qing, Zhu, Xiaolu, Shao, Hongfang, Dai, Miao, Shen, Yifei, Ni, Bo, Wang, Shuai, Zhang, Zhigang, Teng, Yincheng. ""Inhibiting Importin 4-mediated nuclear import of CEBPD enhances chemosensitivity by repression of PRKDC-driven DNA damage repair in cervical cancer."" Oncogene, 2020, pp. 5633-5648.
[18] Xu, Pengpeng, Lin, Wenbo, Liu, Fenglin, Tartakoff, Alan, Tao, Tao. ""Competitive regulation of IPO4 transcription by ELK1 and GABP."" Gene, 2017, pp. 30-38.
[19] Wang, Ruoning, Dillon, Christopher P, Shi, Lewis Zhichang, Milasta, Sandra, Carter, Robert, Finkelstein, David, McCormick, Laura L, Fitzgerald, Patrick, Chi, Hongbo, Munger, Joshua, Green, Douglas R. ""The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation."" Immunity, 2011, pp. 871-82.
[20] Carroll, Patrick A, Freie, Brian W, Mathsyaraja, Haritha, Eisenman, Robert N. ""The MYC transcription factor network: balancing metabolism, proliferation and oncogenesis."" Frontiers of medicine, 2018, pp. 412-425.
[21] Patange, Simona, Ball, David A, Wan, Yihan, Karpova, Tatiana S, Girvan, Michelle, Levens, David, Larson, Daniel R. ""MYC amplifies gene expression through global changes in transcription factor dynamics."" Cell reports, 2022, pp. 110292.
"	0.30611128	0.2519719	Neither	Tied	NA
Diff. expressed gene set	MYOGENESIS	NA	ABLIM1 ACHE ACSL1 ACTA1 ACTC1 ACTN2 ACTN3 ADAM12 ADCY9 AEBP1 AGL AGRN AK1 AKT2 ANKRD2 APLNR APOD APP ATP2A1 ATP6AP1 BAG1 BDKRB2 BHLHE40 BIN1 CACNA1H CACNG1 CAMK2B CASQ1 CASQ2 CAV3 CD36 CDH13 CDKN1A CFD CHRNA1 CHRNB1 CHRNG CKB CKM CKMT2 CLU CNN3 COL15A1 COL1A1 COL3A1 COL4A2 COL6A2 COL6A3 COX6A2 COX7A1 CRAT CRYAB CSRP3 CTF1 DAPK2 DENND2B DES DMD DMPK DTNA EFS EIF4A2 ENO3 EPHB3 ERBB3 FABP3 FDPS FGF2 FHL1 FKBP1B FLII FOXO4 FST FXYD1 GAA GABARAPL2 GADD45B GJA5 GNAO1 GPX3 GSN HBEGF HDAC5 HRC HSPB2 HSPB8 IFRD1 IGF1 IGFBP3 IGFBP7 ITGA7 ITGB1 ITGB4 ITGB5 KCNH1 KCNH2 KIFC3 KLF5 LAMA2 LARGE1 LDB3 LPIN1 LSP1 MAPK12 MAPRE3 MB MEF2A MEF2C MEF2D MRAS MYBPC3 MYBPH MYF6 MYH1 MYH11 MYH2 MYH3 MYH4 MYH7 MYH8 MYH9 MYL1 MYL11 MYL2 MYL3 MYL4 MYL6B MYL7 MYLK MYO1C MYOG MYOM1 MYOM2 MYOZ1 NAV2 NCAM1 NOS1 NOTCH1 NQO1 OCEL1 PC PDE4DIP PDLIM7 PFKM PGAM2 PICK1 PKIA PLXNB2 PPFIA4 PPP1R3C PRNP PSEN2 PTGIS PTP4A3 PVALB PYGM RB1 REEP1 RIT1 RYR1 SCD SCHIP1 SGCA SGCD SGCG SH2B1 SH3BGR SIRT2 SLC6A8 SLN SMTN SOD3 SORBS1 SORBS3 SPARC SPDEF SPEG SPHK1 SPTAN1 SSPN STC2 SVIL SYNGR2 TAGLN TCAP TEAD4 TGFB1 TNNC1 TNNC2 TNNI1 TNNI2 TNNT1 TNNT2 TNNT3 TPD52L1 TPM2 TPM3 TSC2 VIPR1 WWTR1	200	7.643856189774724	Muscle Contraction 	GO:0006936	RYR1;MYL6B;MYOM2;CACNA1H;MYLK;CKMT2;SGCA;CHRNG;BDKRB2;MYH11;ANKRD2;NOS1;CHRNB1;DTNA;TPM3;MYL11;TPM2;PGAM2;GNAO1;MYH1;MYH2;SMTN;MYH3;DES;SLC6A8;MYL1;TNNT2;FXYD1;CASQ2;MYH8;HRC;SSPN;MYH4;CRYAB;MYH7	35	17.5	2.04e-46	3.71e-43	Muscle Contraction and Development	"The primary biological process performed by this system of interacting proteins is muscle contraction and development. The proteins involved in this process can be grouped into several categories, including structural proteins, regulatory proteins, signaling proteins, and metabolic proteins.

1. Structural proteins: These proteins provide the necessary framework for muscle contraction. Key proteins include actin (ACTA1, ACTC1), myosin (MYH1, MYH11, MYH2, MYH3, MYH4, MYH7, MYH8, MYH9), and titin (TCAP). Additionally, proteins such as desmin (DES), dystrophin (DMD), and laminin (LAMA2) contribute to the structural integrity of muscle fibers.

2. Regulatory proteins: These proteins modulate muscle contraction by controlling the availability of calcium ions. Key proteins include troponin (TNNC1, TNNC2, TNNI1, TNNI2, TNNT1, TNNT2, TNNT3), tropomyosin (TPM2, TPM3), and calmodulin (CAMK2B). Calcium release and uptake are regulated by proteins such as ryanodine receptor 1 (RYR1), sarco/endoplasmic reticulum Ca2+-ATPase (ATP2A1), and calsequestrin (CASQ1, CASQ2).

3. Signaling proteins: These proteins are involved in the transmission of signals that regulate muscle growth, differentiation, and adaptation. Key proteins include insulin-like growth factor 1 (IGF1), fibroblast growth factor 2 (FGF2), and transforming growth factor-beta 1 (TGFB1). Additionally, proteins such as AKT2, MEF2A, MEF2C, and MEF2D are involved in the regulation of gene expression and cellular signaling pathways.

4. Metabolic proteins: These proteins are involved in the generation and utilization of energy required for muscle contraction. Key proteins include creatine kinase (CKM, CKMT2), glycogen phosphorylase (PYGM), and phosphofructokinase (PFKM). Additionally, proteins such as lactate dehydrogenase (LDH), enolase (ENO3), and citrate synthase (CS) are involved in energy metabolism.

In summary, this system of interacting proteins plays a crucial role in muscle contraction and development by providing structural support, regulating calcium availability, transmitting signals for growth and adaptation, and generating energy for contraction."	40	20	"The primary biological process performed by this system of interacting proteins is muscle contraction and development. The proteins involved in this process can be grouped into several categories, including structural proteins, regulatory proteins, signaling proteins, and metabolic proteins.

1. Structural proteins: These proteins provide the necessary framework for muscle contraction. Key proteins include actin (ACTA1, ACTC1), myosin (MYH1, MYH11, MYH2, MYH3, MYH4, MYH7, MYH8, MYH9), and titin (TCAP). Additionally, proteins such as desmin (DES), dystrophin (DMD), and laminin (LAMA2) contribute to the structural integrity of muscle fibers.[1][2][3]

2. Regulatory proteins: These proteins modulate muscle contraction by controlling the availability of calcium ions. Key proteins include troponin (TNNC1, TNNC2, TNNI1, TNNI2, TNNT1, TNNT2, TNNT3), tropomyosin (TPM2, TPM3), and calmodulin (CAMK2B). Calcium release and uptake are regulated by proteins such as ryanodine receptor 1 (RYR1), sarco/endoplasmic reticulum Ca2+-ATPase (ATP2A1), and calsequestrin (CASQ1, CASQ2).[4][5][6]

3. Signaling proteins: These proteins are involved in the transmission of signals that regulate muscle growth, differentiation, and adaptation. Key proteins include insulin-like growth factor 1 (IGF1), fibroblast growth factor 2 (FGF2), and transforming growth factor-beta 1 (TGFB1). Additionally, proteins such as AKT2, MEF2A, MEF2C, and MEF2D are involved in the regulation of gene expression and cellular signaling pathways.[7][8][9]

4. Metabolic proteins: These proteins are involved in the generation and utilization of energy required for muscle contraction. Key proteins include creatine kinase (CKM, CKMT2), glycogen phosphorylase (PYGM), and phosphofructokinase (PFKM). Additionally, proteins such as lactate dehydrogenase (LDH), enolase (ENO3), and citrate synthase (CS) are involved in energy metabolism.[10][11][12]

In summary, this system of interacting proteins plays a crucial role in muscle contraction and development by providing structural support, regulating calcium availability, transmitting signals for growth and adaptation, and generating energy for contraction.

========================================================================================================================================================================================================
[1] Negishi, Keita, Aizawa, Kenichi, Shindo, Takayuki, Suzuki, Toru, Sakurai, Takayuki, Saito, Yuichiro, Miyakawa, Takuya, Tanokura, Masaru, Kataoka, Yosky, Maeda, Mitsuyo, Tomida, Shota, Morita, Hiroyuki, Takeda, Norifumi, Komuro, Issei, Kario, Kazuomi, Nagai, Ryozo, Imai, Yasushi. ""An Myh11 single lysine deletion causes aortic dissection by reducing aortic structural integrity and contractility."" Scientific reports, 2022, pp. 8844.
[2] Kelly, Melissa A, Caleshu, Colleen, Morales, Ana, Buchan, Jillian, Wolf, Zena, Harrison, Steven M, Cook, Stuart, Dillon, Mitchell W, Garcia, John, Haverfield, Eden, Jongbloed, Jan D H, Macaya, Daniela, Manrai, Arjun, Orland, Kate, Richard, Gabriele, Spoonamore, Katherine, Thomas, Matthew, Thomson, Kate, Vincent, Lisa M, Walsh, Roddy, Watkins, Hugh, Whiffin, Nicola, Ingles, Jodie, van Tintelen, J Peter, Semsarian, Christopher, Ware, James S, Hershberger, Ray, Funke, Birgit. ""Adaptation and validation of the ACMG/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen's Inherited Cardiomyopathy Expert Panel."" Genetics in medicine : official journal of the American College of Medical Genetics, 2018, pp. 351-359.
[3] Spaulding, Hannah R, Selsby, Joshua T. ""Is Exercise the Right Medicine for Dystrophic Muscle?"" Medicine and science in sports and exercise, 2018, pp. 1723-1732.
[4] Zhao, Bin, Baloch, Zulqarnain, Ma, Yunhan, Wan, Zheng, Huo, Yani, Li, Fujun, Zhao, Yilin. ""Identification of Potential Key Genes and Pathways in Early-Onset Colorectal Cancer Through Bioinformatics Analysis."" Cancer control : journal of the Moffitt Cancer Center, 2019, pp. 1073274819831260.
[5] Marty, Isabelle, Beaufils, Mathilde, Fauré, Julien, Rendu, John. ""Gene therapies for RyR1-related myopathies."" Current opinion in pharmacology, 2023, pp. 102330.
[6] Betzenhauser, Matthew J, Marks, Andrew R. ""Ryanodine receptor channelopathies."" Pflugers Archiv : European journal of physiology, 2010, pp. 467-80.
[7] Ascenzi, Francesca, Barberi, Laura, Dobrowolny, Gabriella, Villa Nova Bacurau, Aline, Nicoletti, Carmine, Rizzuto, Emanuele, Rosenthal, Nadia, Scicchitano, Bianca Maria, Musarò, Antonio. ""Effects of IGF-1 isoforms on muscle growth and sarcopenia."" Aging cell, 2019, pp. e12954.
[8] Ghanim, Husam, Dhindsa, Sandeep, Batra, Manav, Green, Kelly, Abuaysheh, Sanaa, Kuhadiya, Nitesh D, Makdissi, Antoine, Chaudhuri, Ajay, Dandona, Paresh. ""Effect of Testosterone on FGF2, MRF4, and Myostatin in Hypogonadotropic Hypogonadism: Relevance to Muscle Growth."" The Journal of clinical endocrinology and metabolism, 2019, pp. 2094-2102.
[9] Schiaffino, Stefano, Dyar, Kenneth A, Ciciliot, Stefano, Blaauw, Bert, Sandri, Marco. ""Mechanisms regulating skeletal muscle growth and atrophy."" The FEBS journal, 2013, pp. 4294-314.
[10] Glancy, Brian, Kane, Daniel A, Kavazis, Andreas N, Goodwin, Matthew L, Willis, Wayne T, Gladden, L Bruce. ""Mitochondrial lactate metabolism: history and implications for exercise and disease."" The Journal of physiology, 2021, pp. 863-888.
[11] Heden, Timothy D, Chow, Lisa S, Hughey, Curtis C, Mashek, Douglas G. ""Regulation and role of glycophagy in skeletal muscle energy metabolism."" Autophagy, 2022, pp. 1078-1089.
[12] Kim, Seung-Suk, Koo, Jung-Hoon, Kwon, In-Su, Oh, Yoo-Sung, Lee, Sun-Jang, Kim, Eung Joon, Kim, Won-Kyu, Lee, Jin, Cho, Joon-Yong. ""Exercise training and selenium or a combined treatment ameliorates aberrant expression of glucose and lactate metabolic proteins in skeletal muscle in a rodent model of diabetes."" Nutrition research and practice, 2011, pp. 205-13.
"	0.7830999	0.6905811	LLM	LLM	NA
Diff. expressed gene set	NOTCH SIGNALING	NA	APH1A ARRB1 CCND1 CUL1 DLL1 DTX1 DTX2 DTX4 FBXW11 FZD1 FZD5 FZD7 HES1 HEYL JAG1 KAT2A LFNG MAML2 NOTCH1 NOTCH2 NOTCH3 PPARD PRKCA PSEN2 PSENEN RBX1 SAP30 SKP1 ST3GAL6 TCF7L2 WNT2 WNT5A	32	5	Notch Signaling Pathway 	GO:0007219	NOTCH2;APH1A;HEYL;NOTCH3;JAG1;NOTCH1;DTX1;DTX2;HES1;DTX4;DLL1	11	34.375	5.66e-23	4.08e-20	Notch Signaling Pathway	"The primary biological process performed by this system of interacting proteins is the Notch signaling pathway. This pathway is crucial for cell-cell communication, cell fate determination, and tissue development.

1. Notch Receptors and Ligands: NOTCH1, NOTCH2, and NOTCH3 are transmembrane receptors that interact with membrane-bound ligands, such as JAG1 and DLL1. LFNG is a glycosyltransferase that modifies Notch receptors, affecting their ability to bind ligands.

2. Signal Transduction: Upon ligand binding, the Notch receptor undergoes proteolytic cleavage by PSEN2 and PSENEN, releasing the Notch intracellular domain (NICD). APH1A is a component of the γ-secretase complex, which is involved in this cleavage process.

3. Transcriptional Regulation: The NICD translocates to the nucleus and forms a complex with MAML2, a transcriptional coactivator. This complex activates the transcription of target genes, such as HES1 and HEYL, which are involved in cell differentiation and development.

4. Negative Regulation: DTX1, DTX2, and DTX4 are E3 ubiquitin ligases that target the NICD for degradation, thus negatively regulating Notch signaling. CUL1, RBX1, and SKP1 are components of the SCF E3 ubiquitin ligase complex, which also targets NICD for degradation. FBXW11 is an F-box protein that recognizes NICD and recruits it to the SCF complex.

5. Wnt Signaling Crosstalk: WNT2 and WNT5A are ligands for the Wnt signaling pathway, which interacts with the Notch pathway. FZD1, FZD5, and FZD7 are Wnt receptors that can modulate Notch signaling. TCF7L2 is a transcription factor in the Wnt pathway that can also regulate Notch target genes.

6. Other Interactions: ARRB1, CCND1, KAT2A, PPARD, PRKCA, SAP30, and ST3GAL6 are proteins that interact with the Notch pathway components, potentially modulating the pathway's activity or output. These proteins are involved in processes such as cell cycle regulation, chromatin remodeling, and glycosylation.

In conclusion, the Notch signaling pathway is the most prominent biological process performed by this system of interacting proteins. It plays a critical role in cell-cell communication, cell fate determination, and tissue development, with multiple layers of regulation and crosstalk with other signaling pathways."	32	100	"The primary biological process performed by this system of interacting proteins is the Notch signaling pathway. This pathway is crucial for cell-cell communication, cell fate determination, and tissue development.

1. Notch Receptors and Ligands: NOTCH1, NOTCH2, and NOTCH3 are transmembrane receptors that interact with membrane-bound ligands, such as JAG1 and DLL1. LFNG is a glycosyltransferase that modifies Notch receptors, affecting their ability to bind ligands.[1][2][3]

2. Signal Transduction: Upon ligand binding, the Notch receptor undergoes proteolytic cleavage by PSEN2 and PSENEN, releasing the Notch intracellular domain (NICD). APH1A is a component of the γ-secretase complex, which is involved in this cleavage process.[4][5][6]

3. Transcriptional Regulation: The NICD translocates to the nucleus and forms a complex with MAML2, a transcriptional coactivator. This complex activates the transcription of target genes, such as HES1 and HEYL, which are involved in cell differentiation and development.[7][8][9]

4. Negative Regulation: DTX1, DTX2, and DTX4 are E3 ubiquitin ligases that target the NICD for degradation, thus negatively regulating Notch signaling. CUL1, RBX1, and SKP1 are components of the SCF E3 ubiquitin ligase complex, which also targets NICD for degradation. FBXW11 is an F-box protein that recognizes NICD and recruits it to the SCF complex.[10][11][12]

5. Wnt Signaling Crosstalk: WNT2 and WNT5A are ligands for the Wnt signaling pathway, which interacts with the Notch pathway. FZD1, FZD5, and FZD7 are Wnt receptors that can modulate Notch signaling. TCF7L2 is a transcription factor in the Wnt pathway that can also regulate Notch target genes.[13][14][15]

6. Other Interactions: ARRB1, CCND1, KAT2A, PPARD, PRKCA, SAP30, and ST3GAL6 are proteins that interact with the Notch pathway components, potentially modulating the pathway's activity or output. These proteins are involved in processes such as cell cycle regulation, chromatin remodeling, and glycosylation.[16][17][18]

In conclusion, the Notch signaling pathway is the most prominent biological process performed by this system of interacting proteins. It plays a critical role in cell-cell communication, cell fate determination, and tissue development, with multiple layers of regulation and crosstalk with other signaling pathways.

========================================================================================================================================================================================================
[1] Shimizu, K, Chiba, S, Kumano, K, Hosoya, N, Takahashi, T, Kanda, Y, Hamada, Y, Yazaki, Y, Hirai, H. ""Mouse jagged1 physically interacts with notch2 and other notch receptors. Assessment by quantitative methods."" The Journal of biological chemistry, 1999, pp. 32961-9.
[2] Kakuda, Shinako, LoPilato, Rachel K, Ito, Atsuko, Haltiwanger, Robert S. ""Canonical Notch ligands and Fringes have distinct effects on NOTCH1 and NOTCH2."" The Journal of biological chemistry, 2020, pp. 14710-14722.
[3] Norum, Hilde M, Broch, Kaspar, Michelsen, Annika E, Lunde, Ida G, Lekva, Tove, Abraityte, Aurelija, Dahl, Christen P, Fiane, Arnt E, Andreassen, Arne K, Christensen, Geir, Aakhus, Svend, Aukrust, Pål, Gullestad, Lars, Ueland, Thor. ""The Notch Ligands DLL1 and Periostin Are Associated with Symptom Severity and Diastolic Function in Dilated Cardiomyopathy."" Journal of cardiovascular translational research, 2017, pp. 401-410.
[4] Saunders, A M. ""Gene identification in Alzheimer's disease."" Pharmacogenomics, 2001, pp. 239-49.
[5] Rogaev, E I, Sherrington, R, Wu, C, Levesque, G, Liang, Y, Rogaeva, E A, Ikeda, M, Holman, K, Lin, C, Lukiw, W J, de Jong, P J, Fraser, P E, Rommens, J M, St George-Hyslop, P. ""Analysis of the 5' sequence, genomic structure, and alternative splicing of the presenilin-1 gene (PSEN1) associated with early onset Alzheimer disease."" Genomics, 1997, pp. 415-24.
[6] Jia, Weixue, Zhang, Yuanyuan, Wang, Xue, Luo, Lingling, Sun, Heng, Jiang, Yiqun, Wang, Jianbo, Mao, Qiuxia, Guo, Youming, Kong, Lingzhuo, Mo, Ran, Li, Chengrang. ""KRT5 mutation regulate melanin metabolism through notch signalling pathway between keratinocytes and melanocytes."" Experimental dermatology, 2023, pp. 752-765.
[7] Young, Fraser I, Keruzore, Marc, Nan, Xinsheng, Gennet, Nicole, Bellefroid, Eric J, Li, Meng. ""The doublesex-related Dmrta2 safeguards neural progenitor maintenance involving transcriptional regulation of Hes1."" Proceedings of the National Academy of Sciences of the United States of America, 2017, pp. E5599-E5607.
[8] Heron, Elizabeth A, Finkenstädt, Bärbel, Rand, David A. ""Bayesian inference for dynamic transcriptional regulation; the Hes1 system as a case study."" Bioinformatics (Oxford, England), 2007, pp. 2596-603.
[9] Yuan, Ping, Ding, Lu, Chen, Huili, Wang, Yi, Li, Chunhong, Zhao, Shu, Yang, Xiaoyu, Ma, Yizhao, Zhu, Jie, Qi, Xinrui, Zhang, Yanyan, Xia, Xiaohuan, Zheng, Jialin C. ""Neural Stem Cell-Derived Exosomes Regulate Neural Stem Cell Differentiation Through miR-9-Hes1 Axis."" Frontiers in cell and developmental biology, 2021, pp. 601600.
[10] Xie, Chuan-Ming, Wei, Wenyi, Sun, Yi. ""Role of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases in skin cancer."" Journal of genetics and genomics = Yi chuan xue bao, 2013, pp. 97-106.
[11] Zhou, Weihua, Wei, Wenyi, Sun, Yi. ""Genetically engineered mouse models for functional studies of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases."" Cell research, 2013, pp. 599-619.
[12] Gorelik, Maryna, Manczyk, Noah, Pavlenco, Alevtina, Kurinov, Igor, Sidhu, Sachdev S, Sicheri, Frank. ""A Structure-Based Strategy for Engineering Selective Ubiquitin Variant Inhibitors of Skp1-Cul1-F-Box Ubiquitin Ligases."" Structure (London, England : 1993), 2018, pp. 1226-1236.e3.
[13] Jin, Tianru, Liu, Ling. ""The Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus."" Molecular endocrinology (Baltimore, Md.), 2008, pp. 2383-92.
[14] Wang, Liang, Wang, Jiayi, Yin, Xiaolin, Guan, Xin, Li, Ying, Xin, Chenqi, Liu, Jing. ""GIPC2 interacts with Fzd7 to promote prostate cancer metastasis by activating WNT signaling."" Oncogene, 2022, pp. 2609-2623.
[15] Li, Junyi, Zhou, Li, Ouyang, Xinping, He, Pingping. ""Transcription Factor-7-Like-2 (TCF7L2) in Atherosclerosis: A Potential Biomarker and Therapeutic Target."" Frontiers in cardiovascular medicine, 2021, pp. 701279.
[16] Wang, Qiong, He, Guopei, Hou, Mengmeng, Chen, Liutao, Chen, Shangwu, Xu, Anlong, Fu, Yonggui. ""Cell Cycle Regulation by Alternative Polyadenylation of CCND1."" Scientific reports, 2018, pp. 6824.
[17] Moldogazieva, Nurbubu T, Zavadskiy, Sergey P, Sologova, Susanna S, Mokhosoev, Innokenty M, Terentiev, Alexander A. ""Predictive biomarkers for systemic therapy of hepatocellular carcinoma."" Expert review of molecular diagnostics, 2021, pp. 1147-1164.
[18] Sarkar, Debina, Leung, Euphemia Y, Baguley, Bruce C, Finlay, Graeme J, Askarian-Amiri, Marjan E. ""Epigenetic regulation in human melanoma: past and future."" Epigenetics, 2015, pp. 103-21.
"	0.9670621	0.9670621	Tied	Tied	NA
Diff. expressed gene set	OXIDATIVE PHOSPHORYLATION	NA	ABCB7 ACAA1 ACAA2 ACADM ACADSB ACADVL ACAT1 ACO2 AFG3L2 AIFM1 ALAS1 ALDH6A1 ATP1B1 ATP5F1A ATP5F1B ATP5F1C ATP5F1D ATP5F1E ATP5MC1 ATP5MC2 ATP5MC3 ATP5ME ATP5MF ATP5MG ATP5PB ATP5PD ATP5PF ATP5PO ATP6AP1 ATP6V0B ATP6V0C ATP6V0E1 ATP6V1C1 ATP6V1D ATP6V1E1 ATP6V1F ATP6V1G1 ATP6V1H BAX BCKDHA BDH2 CASP7 COX10 COX11 COX15 COX17 COX4I1 COX5A COX5B COX6A1 COX6B1 COX6C COX7A2 COX7A2L COX7B COX7C COX8A CPT1A CS CYB5A CYB5R3 CYC1 CYCS DECR1 DLAT DLD DLST ECH1 ECHS1 ECI1 ETFA ETFB ETFDH FDX1 FH FXN GLUD1 GOT2 GPI GPX4 GRPEL1 HADHA HADHB HCCS HSD17B10 HSPA9 HTRA2 IDH1 IDH2 IDH3A IDH3B IDH3G IMMT ISCA1 ISCU LDHA LDHB LRPPRC MAOB MDH1 MDH2 MFN2 MGST3 MPC1 MRPL11 MRPL15 MRPL34 MRPL35 MRPS11 MRPS12 MRPS15 MRPS22 MRPS30 MTRF1 MTRR MTX2 NDUFA1 NDUFA2 NDUFA3 NDUFA4 NDUFA5 NDUFA6 NDUFA7 NDUFA8 NDUFA9 NDUFAB1 NDUFB1 NDUFB2 NDUFB3 NDUFB4 NDUFB5 NDUFB6 NDUFB7 NDUFB8 NDUFC1 NDUFC2 NDUFS1 NDUFS2 NDUFS3 NDUFS4 NDUFS6 NDUFS7 NDUFS8 NDUFV1 NDUFV2 NNT NQO2 OAT OGDH OPA1 OXA1L PDHA1 PDHB PDHX PDK4 PDP1 PHB2 PHYH PMPCA POLR2F POR PRDX3 RETSAT RHOT1 RHOT2 SDHA SDHB SDHC SDHD SLC25A11 SLC25A12 SLC25A20 SLC25A3 SLC25A4 SLC25A5 SLC25A6 SUCLA2 SUCLG1 SUPV3L1 SURF1 TCIRG1 TIMM10 TIMM13 TIMM17A TIMM50 TIMM8B TIMM9 TOMM22 TOMM70 UQCR10 UQCR11 UQCRB UQCRC1 UQCRC2 UQCRFS1 UQCRH UQCRQ VDAC1 VDAC2 VDAC3	200	7.643856189774724	Cellular Respiration 	GO:0045333	COX7B;COX4I1;ETFA;ETFB;COX6A1;COX7C;UQCRFS1;COX8A;NDUFC2;NDUFC1;SDHC;SDHA;SDHB;COX6B1;OXA1L;NDUFS8;NDUFS7;NDUFS6;NDUFS4;NDUFS3;UQCRC1;NDUFS2;NDUFS1;UQCRC2;NDUFB8;NDUFB7;NDUFB6;UQCRB;COX15;NDUFB5;NDUFB4;NDUFB3;ETFDH;NDUFB2;NDUFB1;COX7A2;UQCR11;UQCR10;COX5B;COX5A;UQCRH;CYC1;NDUFV2;NDUFV1;NDUFA9;NDUFA8;NDUFA7;SURF1;NDUFA6;NDUFA5;MDH2;NDUFA4;NDUFA3;NDUFA2;NDUFA1;COX6C;UQCRQ;NDUFAB1;CYCS	59	29.5	3.219999999999999e-101	2.22e-98	Oxidative Phosphorylation and TCA Cycle	"The primary biological process performed by this system of interacting proteins is oxidative phosphorylation and the tricarboxylic acid (TCA) cycle. The proteins are involved in energy production, specifically in the generation of ATP through the electron transport chain (ETC) and the TCA cycle.

Reasoning and Supporting Information:

1. Presence of ETC Complexes: The proteins NDUFA1-NDUFS8, NDUFV1-NDUFV2, SDHA-SDHD, UQCR10-UQCRQ, COX4I1-COX8A are subunits of the ETC complexes I, II, III, and IV, respectively. These complexes are responsible for transferring electrons through the ETC, ultimately leading to ATP production.

2. ATP Synthesis: The proteins ATP5F1A-ATP5PO are subunits of ATP synthase (Complex V), which synthesizes ATP from ADP and inorganic phosphate using the proton gradient generated by the ETC.

3. TCA Cycle Enzymes: The proteins CS, ACO2, IDH1-IDH3G, OGDH, DLAT, DLD, SDHA, FH, and MDH1-MDH2 are enzymes involved in the TCA cycle, which generates reducing equivalents (NADH and FADH2) that feed into the ETC for ATP production.

4. Mitochondrial Transporters: The proteins SLC25A11, SLC25A12, SLC25A20, SLC25A3, SLC25A4, SLC25A5, and SLC25A6 are mitochondrial transporters that facilitate the exchange of metabolites, including those involved in the TCA cycle and oxidative phosphorylation, between the mitochondrial matrix and the cytosol.

5. Fatty Acid Oxidation: The proteins ACADM, ACADSB, ACADVL, ACAA1, ACAA2, and CPT1A are involved in fatty acid oxidation, which generates acetyl-CoA that feeds into the TCA cycle for energy production.

6. Mitochondrial Protein Import and Assembly: The proteins TIMM10, TIMM13, TIMM17A, TIMM50, TIMM8B, TIMM9, TOMM22, and TOMM70 are involved in the import and assembly of mitochondrial proteins, including those involved in oxidative phosphorylation and the TCA cycle.

7. Mitochondrial Dynamics: The proteins MFN2, OPA1, and RHOT1-RHOT2 are involved in mitochondrial dynamics, including fusion and fission, which are essential for maintaining mitochondrial function and energy production.

8. Reactive Oxygen Species (ROS) Detoxification: The proteins GPX4, PRDX3, and SOD2 are involved in the detoxification of ROS, which are generated as byproducts of oxidative phosphorylation and can cause cellular damage if not properly managed.

9. Apoptosis Regulation: The proteins BAX, AIFM1, and HTRA2 are involved in the regulation of apoptosis, which is influenced by the cellular energy status and mitochondrial function."	52	26	"The primary biological process performed by this system of interacting proteins is oxidative phosphorylation and the tricarboxylic acid (TCA) cycle. The proteins are involved in energy production, specifically in the generation of ATP through the electron transport chain (ETC) and the TCA cycle.

1. Presence of ETC Complexes: The proteins NDUFA1-NDUFS8, NDUFV1-NDUFV2, SDHA-SDHD, UQCR10-UQCRQ, COX4I1-COX8A are subunits of the ETC complexes I, II, III, and IV, respectively. These complexes are responsible for transferring electrons through the ETC, ultimately leading to ATP production.

2. ATP Synthesis: The proteins ATP5F1A-ATP5PO are subunits of ATP synthase (Complex V), which synthesizes ATP from ADP and inorganic phosphate using the proton gradient generated by the ETC.[1][2][3]

3. TCA Cycle Enzymes: The proteins CS, ACO2, IDH1-IDH3G, OGDH, DLAT, DLD, SDHA, FH, and MDH1-MDH2 are enzymes involved in the TCA cycle, which generates reducing equivalents (NADH and FADH2) that feed into the ETC for ATP production.[4][5][6]

4. Mitochondrial Transporters: The proteins SLC25A11, SLC25A12, SLC25A20, SLC25A3, SLC25A4, SLC25A5, and SLC25A6 are mitochondrial transporters that facilitate the exchange of metabolites, including those involved in the TCA cycle and oxidative phosphorylation, between the mitochondrial matrix and the cytosol.[7][8][9]

5. Fatty Acid Oxidation: The proteins ACADM, ACADSB, ACADVL, ACAA1, ACAA2, and CPT1A are involved in fatty acid oxidation, which generates acetyl-CoA that feeds into the TCA cycle for energy production.[10][11][12]

6. Mitochondrial Protein Import and Assembly: The proteins TIMM10, TIMM13, TIMM17A, TIMM50, TIMM8B, TIMM9, TOMM22, and TOMM70 are involved in the import and assembly of mitochondrial proteins, including those involved in oxidative phosphorylation and the TCA cycle.[13][14][15]

7. Mitochondrial Dynamics: The proteins MFN2, OPA1, and RHOT1-RHOT2 are involved in mitochondrial dynamics, including fusion and fission, which are essential for maintaining mitochondrial function and energy production.[16][17][18]

8. Reactive Oxygen Species (ROS) Detoxification: The proteins GPX4, PRDX3, and SOD2 are involved in the detoxification of ROS, which are generated as byproducts of oxidative phosphorylation and can cause cellular damage if not properly managed.[19][20][21]

9. Apoptosis Regulation: The proteins BAX, AIFM1, and HTRA2 are involved in the regulation of apoptosis, which is influenced by the cellular energy status and mitochondrial function.[22][23][24]

========================================================================================================================================================================================================
[1] Ganapathi, Mythily, Friocourt, Gaelle, Gueguen, Naig, Friederich, Marisa W, Le Gac, Gerald, Okur, Volkan, Loaëc, Nadège, Ludwig, Thomas, Ka, Chandran, Tanji, Kurenai, Marcorelles, Pascale, Theodorou, Evangelos, Lignelli-Dipple, Angela, Voisset, Cécile, Walker, Melissa A, Briere, Lauren C, Bourhis, Amélie, Blondel, Marc, LeDuc, Charles, Hagen, Jacob, Cooper, Cathleen, Muraresku, Colleen, Ferec, Claude, Garenne, Armelle, Lelez-Soquet, Servane, Rogers, Cassandra A, Shen, Yufeng, Strode, Dana K, Bizargity, Peyman, Iglesias, Alejandro, Goldstein, Amy, High, Frances A, Network, Undiagnosed Diseases, Sweetser, David A, Ganetzky, Rebecca, Van Hove, Johan L K, Procaccio, Vincent, Le Marechal, Cedric, Chung, Wendy K. ""A homozygous splice variant in ATP5PO, disrupts mitochondrial complex V function and causes Leigh syndrome in two unrelated families."" Journal of inherited metabolic disease, 2022, pp. 996-1012.
[2] Lines, Matthew A, Cuillerier, Alexanne, Chakraborty, Pranesh, Naas, Turaya, Duque Lasio, M Laura, Michaud, Jean, Pileggi, Chantal, Harper, Mary-Ellen, Burelle, Yan, Toler, Tomi L, Sondheimer, Neal, Crawford, Heather P, Millan, Francisca, Geraghty, Michael T. ""A recurrent de novo ATP5F1A substitution associated with neonatal complex V deficiency."" European journal of human genetics : EJHG, 2021, pp. 1719-1724.
[3] Chouhan, Surbhi, Sawant, Mithila, Weimholt, Cody, Luo, Jingqin, Sprung, Robert W, Terrado, Mailyn, Mueller, David M, Earp, H Shelton, Mahajan, Nupam P. ""TNK2/ACK1-mediated phosphorylation of ATP5F1A (ATP synthase F1 subunit alpha) selectively augments survival of prostate cancer while engendering mitochondrial vulnerability."" Autophagy, 2023, pp. 1000-1025.
[4] Molinié, Thibaut, Cougouilles, Elodie, David, Claudine, Cahoreau, Edern, Portais, Jean-Charles, Mourier, Arnaud. ""MDH2 produced OAA is a metabolic switch rewiring the fuelling of respiratory chain and TCA cycle."" Biochimica et biophysica acta. Bioenergetics, 2022, pp. 148532.
[5] Guo, Xue, Park, Jung Eun, Gallart-Palau, Xavier, Sze, Siu Kwan. ""Oxidative Damage to the TCA Cycle Enzyme MDH1 Dysregulates Bioenergetic Enzymatic Activity in the Aged Murine Brain."" Journal of proteome research, 2020, pp. 1706-1717.
[6] Molenaar, Remco J, Maciejewski, Jaroslaw P, Wilmink, Johanna W, van Noorden, Cornelis J F. ""Wild-type and mutated IDH1/2 enzymes and therapy responses."" Oncogene, 2018, pp. 1949-1960.
[7] Rueda, Carlos B, Llorente-Folch, Irene, Traba, Javier, Amigo, Ignacio, Gonzalez-Sanchez, Paloma, Contreras, Laura, Juaristi, Inés, Martinez-Valero, Paula, Pardo, Beatriz, Del Arco, Araceli, Satrustegui, Jorgina. ""Glutamate excitotoxicity and Ca2+-regulation of respiration: Role of the Ca2+ activated mitochondrial transporters (CaMCs)."" Biochimica et biophysica acta, 2016, pp. 1158-1166.
[8] Incampo, Giovanna, Giangregorio, Nicola, Gambacorta, Nicola, Nicolotti, Orazio, Pacifico, Concetta, Palmieri, Luigi, Tonazzi, Annamaria. ""Praseodymium trivalent ion is an effective inhibitor of mitochondrial basic amino acids and carnitine/acylcarnitine carriers."" Biochimica et biophysica acta. Bioenergetics, 2022, pp. 148557.
[9] Alkan, H Furkan, Bogner-Strauss, Juliane G. ""Maintaining cytosolic aspartate levels is a major function of the TCA cycle in proliferating cells."" Molecular & cellular oncology, 2019, pp. e1536843.
[10] Li, Rongqing, Li, Xueqin, Zhao, Jie, Meng, Fandong, Yao, Chen, Bao, Ensi, Sun, Na, Chen, Xin, Cheng, Wanpeng, Hua, Hui, Li, Xiangyang, Wang, Bo, Wang, Hui, Pan, Xiucheng, You, Hongjuan, Yang, Jing, Ikezoe, Takayuki. ""Mitochondrial STAT3 exacerbates LPS-induced sepsis by driving CPT1a-mediated fatty acid oxidation."" Theranostics, 2022, pp. 976-998.
[11] Tan, Zheqiong, Xiao, Lanbo, Tang, Min, Bai, Fang, Li, Jiangjiang, Li, Liling, Shi, Feng, Li, Namei, Li, Yueshuo, Du, Qianqian, Lu, Jingchen, Weng, Xinxian, Yi, Wei, Zhang, Hanwen, Fan, Jia, Zhou, Jian, Gao, Qiang, Onuchic, José N, Bode, Ann M, Luo, Xiangjian, Cao, Ya. ""Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy."" Theranostics, 2018, pp. 2329-2347.
[12] Park, Hee-Seon, Song, Ji-Won, Park, Jin-Ho, Lim, Byung-Kwan, Moon, Og-Sung, Son, Hwa-Young, Lee, Jae-Hyuk, Gao, Bin, Won, Young-Suk, Kwon, Hyo-Jung. ""TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation."" Autophagy, 2021, pp. 2549-2564.
[13] Curado, Silvia, Ober, Elke A, Walsh, Susan, Cortes-Hernandez, Paulina, Verkade, Heather, Koehler, Carla M, Stainier, Didier Y R. ""The mitochondrial import gene tomm22 is specifically required for hepatocyte survival and provides a liver regeneration model."" Disease models & mechanisms, 2010, pp. 486-95.
[14] Urushima, Yuto, Haraguchi, Misa, Yano, Masato. ""Depletion of TMEM65 leads to oxidative stress, apoptosis, induction of mitochondrial unfolded protein response, and upregulation of mitochondrial protein import receptor TOMM22."" Biochemistry and biophysics reports, 2020, pp. 100870.
[15] Dutta, Debdeep, Briere, Lauren C, Kanca, Oguz, Marcogliese, Paul C, Walker, Melissa A, High, Frances A, Vanderver, Adeline, Krier, Joel, Carmichael, Nikkola, Callahan, Christine, Taft, Ryan J, Simons, Cas, Helman, Guy, Network, Undiagnosed Diseases, Wangler, Michael F, Yamamoto, Shinya, Sweetser, David A, Bellen, Hugo J. ""De novo mutations in TOMM70, a receptor of the mitochondrial import translocase, cause neurological impairment."" Human molecular genetics, 2020, pp. 1568-1579.
[16] Noone, John, O'Gorman, Donal J, Kenny, Helena C. ""OPA1 regulation of mitochondrial dynamics in skeletal and cardiac muscle."" Trends in endocrinology and metabolism: TEM, 2022, pp. 710-721.
[17] Hu, Lang, Ding, Mingge, Tang, Daishi, Gao, Erhe, Li, Congye, Wang, Kaiyan, Qi, Bingchao, Qiu, Jihuan, Zhao, Huishou, Chang, Pan, Fu, Feng, Li, Yan. ""Targeting mitochondrial dynamics by regulating Mfn2 for therapeutic intervention in diabetic cardiomyopathy."" Theranostics, 2019, pp. 3687-3706.
[18] Zaman, Mashiat, Shutt, Timothy E. ""The Role of Impaired Mitochondrial Dynamics in MFN2-Mediated Pathology."" Frontiers in cell and developmental biology, 2022, pp. 858286.
[19] Ray, Ankita, Bhati, Tanu, Pradhan, Dibyabhaba, Arora, Renu, Parvez, Suhel, Rastogi, Sangita. ""Aberrant gene expression of superoxide dismutases in Chlamydia trachomatis-infected recurrent spontaneous aborters."" Scientific reports, 2022, pp. 14688.
[20] Hagenbuchner, Judith, Ausserlechner, Michael J. ""Mitochondria and FOXO3: breath or die."" Frontiers in physiology, 2013, pp. 147.
[21] Melov, S. ""Mitochondrial oxidative stress. Physiologic consequences and potential for a role in aging."" Annals of the New York Academy of Sciences, 2000, pp. 219-25.
[22] Dumay, A, Laulier, C, Bertrand, P, Saintigny, Y, Lebrun, F, Vayssière, J-L, Lopez, B S. ""Bax and Bid, two proapoptotic Bcl-2 family members, inhibit homologous recombination, independently of apoptosis regulation."" Oncogene, 2006, pp. 3196-205.
[23] Mao, Jia-Ding, Wu, Pei, Xia, Xiang-Hou, Hu, Ji-Qun, Huang, Wen-Bin, Xu, Guo-Qiang. ""Correlation between expression of gastrin, somatostatin and cell apoptosis regulation gene bcl-2/bax in large intestine carcinoma."" World journal of gastroenterology, 2005, pp. 721-5.
[24] Putcha, G V, Deshmukh, M, Johnson, E M. ""BAX translocation is a critical event in neuronal apoptosis: regulation by neuroprotectants, BCL-2, and caspases."" The Journal of neuroscience : the official journal of the Society for Neuroscience, 1999, pp. 7476-85.
"	0.801169	0.72211516	LLM	LLM	NA
Diff. expressed gene set	P53 PATHWAY	NA	ABAT ABCC5 ABHD4 ACVR1B ADA AEN AK1 ALOX15B ANKRA2 APAF1 APP ATF3 BAIAP2 BAK1 BAX BLCAP BMP2 BTG1 BTG2 CASP1 CCND2 CCND3 CCNG1 CCNK CCP110 CD81 CD82 CDH13 CDK5R1 CDKN1A CDKN2A CDKN2AIP CDKN2B CEBPA CGRRF1 CLCA2 COQ8A CSRNP2 CTSD CTSF CYFIP2 DCXR DDB2 DDIT3 DDIT4 DEF6 DGKA DNTTIP2 DRAM1 EI24 ELP1 EPHA2 EPHX1 EPS8L2 ERCC5 F2R FAM162A FAS FBXW7 FDXR FGF13 FOS FOXO3 FUCA1 GADD45A GLS2 GM2A GPX2 H1-2 H2AC25 H2AJ HBEGF HDAC3 HEXIM1 HINT1 HMOX1 HRAS HSPA4L IER3 IER5 IFI30 IL1A INHBB IP6K2 IRAG2 IRAK1 ISCU ITGB4 JAG2 JUN KIF13B KLF4 KLK8 KRT17 LDHB LIF MAPKAPK3 MDM2 MKNK2 MXD1 MXD4 NDRG1 NHLH2 NINJ1 NOL8 NOTCH1 NUDT15 NUPR1 OSGIN1 PCNA PDGFA PERP PHLDA3 PIDD1 PITPNC1 PLK2 PLK3 PLXNB2 PMM1 POLH POM121 PPM1D PPP1R15A PRKAB1 PRMT2 PROCR PTPN14 PTPRE PVT1 RAB40C RACK1 RAD51C RAD9A RALGDS RAP2B RB1 RCHY1 RETSAT RGS16 RHBDF2 RNF19B RPL18 RPL36 RPS12 RPS27L RRAD RRP8 RXRA S100A10 S100A4 SAT1 SDC1 SEC61A1 SERPINB5 SERTAD3 SESN1 SFN SLC19A2 SLC35D1 SLC3A2 SLC7A11 SOCS1 SP1 SPHK1 ST14 STEAP3 STOM TAP1 TAX1BP3 TCHH TCN2 TGFA TGFB1 TM4SF1 TM7SF3 TNFSF9 TNNI1 TOB1 TP53 TP63 TPD52L1 TPRKB TRAF4 TRAFD1 TRIAP1 TRIB3 TSC22D1 TSPYL2 TXNIP UPP1 VAMP8 VDR VWA5A WRAP73 WWP1 XPC ZBTB16 ZFP36L1 ZMAT3 ZNF365	200	7.643856189774724	Negative Regulation Of Cellular Process 	GO:0048523	RB1;APP;CEBPA;BTG2;CDKN1A;BTG1;NOTCH1;EI24;PPM1D;ACVR1B;TOB1;CDKN2AIP;RRP8;SERTAD3;RACK1;HRAS;IP6K2;TSPYL2;CDKN2B;TGFB1;CDKN2A;F2R;OSGIN1;CGRRF1;ALOX15B;PTPN14;VAMP8;IL1A;BMP2;PLXNB2;CDH13;TXNIP;NUPR1;TP53	34	17	6.53e-18	1.22e-14	Cell Cycle Regulation and Apoptosis	"The interacting proteins in this system are primarily involved in the regulation of the cell cycle and apoptosis. Key proteins include TP53, CDKN1A, CDKN2A, CDKN2B, CCND2, CCND3, CCNG1, CCNK, MDM2, and FAS.

1. TP53 (p53) is a tumor suppressor protein that plays a central role in cell cycle regulation and apoptosis. It is activated in response to DNA damage and other cellular stresses, leading to cell cycle arrest or apoptosis. TP53 interacts with CDKN1A, CDKN2A, and CDKN2B, which are cyclin-dependent kinase inhibitors that regulate cell cycle progression.

2. CDKN1A (p21) is a direct target of TP53 and inhibits the activity of cyclin-CDK complexes, leading to cell cycle arrest. CDKN2A (p16) and CDKN2B (p15) are also cyclin-dependent kinase inhibitors that regulate the G1 phase of the cell cycle by inhibiting CDK4 and CDK6.

3. CCND2 and CCND3 are cyclins that regulate the G1 phase of the cell cycle by forming complexes with CDK4 and CDK6. CCNG1 and CCNK are cyclins that regulate the G2 phase of the cell cycle by forming complexes with CDK2.

4. MDM2 is an E3 ubiquitin ligase that negatively regulates TP53 by promoting its degradation. The interaction between TP53 and MDM2 forms a negative feedback loop that maintains TP53 levels in check.

5. FAS is a cell surface receptor that, upon binding to its ligand, FASL, triggers apoptosis through the activation of caspases, including CASP1. APAF1, BAK1, and BAX are also involved in the intrinsic apoptotic pathway, which is regulated by TP53.

6. Several proteins in this system are involved in DNA repair, including ERCC5, RAD51C, and XPC. These proteins contribute to the maintenance of genomic stability and prevent the accumulation of DNA damage that could lead to cell cycle arrest or apoptosis.

7. The system also includes proteins involved in cellular stress response, such as ATF3, DDIT3, and GADD45A. These proteins are induced by various stress signals and can modulate cell cycle progression and apoptosis.

In conclusion, the most prominent biological process performed by this system of interacting proteins is the regulation of the cell cycle and apoptosis, which is crucial for maintaining cellular homeostasis and preventing the development of diseases such as cancer."	22	11	"The interacting proteins in this system are primarily involved in the regulation of the cell cycle and apoptosis. Key proteins include TP53, CDKN1A, CDKN2A, CDKN2B, CCND2, CCND3, CCNG1, CCNK, MDM2, and FAS.[1][2][3]

1. TP53 (p53) is a tumor suppressor protein that plays a central role in cell cycle regulation and apoptosis. It is activated in response to DNA damage and other cellular stresses, leading to cell cycle arrest or apoptosis. TP53 interacts with CDKN1A, CDKN2A, and CDKN2B, which are cyclin-dependent kinase inhibitors that regulate cell cycle progression.[4][5][6]

2. CDKN1A (p21) is a direct target of TP53 and inhibits the activity of cyclin-CDK complexes, leading to cell cycle arrest. CDKN2A (p16) and CDKN2B (p15) are also cyclin-dependent kinase inhibitors that regulate the G1 phase of the cell cycle by inhibiting CDK4 and CDK6.[7][8][9]

3. CCND2 and CCND3 are cyclins that regulate the G1 phase of the cell cycle by forming complexes with CDK4 and CDK6. CCNG1 and CCNK are cyclins that regulate the G2 phase of the cell cycle by forming complexes with CDK2.[10][11][12]

4. MDM2 is an E3 ubiquitin ligase that negatively regulates TP53 by promoting its degradation. The interaction between TP53 and MDM2 forms a negative feedback loop that maintains TP53 levels in check.[13][14][15]

5. FAS is a cell surface receptor that, upon binding to its ligand, FASL, triggers apoptosis through the activation of caspases, including CASP1. APAF1, BAK1, and BAX are also involved in the intrinsic apoptotic pathway, which is regulated by TP53.[16][17][18]

6. Several proteins in this system are involved in DNA repair, including ERCC5, RAD51C, and XPC. These proteins contribute to the maintenance of genomic stability and prevent the accumulation of DNA damage that could lead to cell cycle arrest or apoptosis.[19][20][21]

7. The system also includes proteins involved in cellular stress response, such as ATF3, DDIT3, and GADD45A. These proteins are induced by various stress signals and can modulate cell cycle progression and apoptosis.[22][23][24]

In conclusion, the most prominent biological process performed by this system of interacting proteins is the regulation of the cell cycle and apoptosis, which is crucial for maintaining cellular homeostasis and preventing the development of diseases such as cancer.

========================================================================================================================================================================================================
[1] Bi, Guoshu, Liang, Jiaqi, Zhao, Mengnan, Zhang, Huan, Jin, Xing, Lu, Tao, Zheng, Yuansheng, Bian, Yunyi, Chen, Zhencong, Huang, Yiwei, Besskaya, Valeria, Zhan, Cheng, Wang, Qun, Tan, Lijie. ""miR-6077 promotes cisplatin/pemetrexed resistance in lung adenocarcinoma via CDKN1A/cell cycle arrest and KEAP1/ferroptosis pathways."" Molecular therapy. Nucleic acids, 2022, pp. 366-386.
[2] Lee, Jinkwon, Kim, Kwangho, Ryu, Tae Young, Jung, Cho-Rok, Lee, Moo-Seung, Lim, Jung Hwa, Park, Kunhyang, Kim, Dae-Soo, Son, Mi-Young, Hamamoto, Ryuji, Cho, Hyun-Soo. ""EHMT1 knockdown induces apoptosis and cell cycle arrest in lung cancer cells by increasing CDKN1A expression."" Molecular oncology, 2021, pp. 2989-3002.
[3] Wang, Juan, Cao, Zeyuan, Wang, Panpan, Zhang, Xiao, Tang, Jianxia, He, Yifan, Huang, Zhiqing, Mao, Xueli, Shi, Songtao, Kou, Xiaoxing. ""Apoptotic Extracellular Vesicles Ameliorate Multiple Myeloma by Restoring Fas-Mediated Apoptosis."" ACS nano, 2021, pp. 14360-14372.
[4] Jiao, Yang, Feng, Yunpeng, Wang, Xiuli. ""Regulation of Tumor Suppressor Gene CDKN2A and Encoded p16-INK4a Protein by Covalent Modifications."" Biochemistry. Biokhimiia, 2018, pp. 1289-1298.
[5] Li, Shuchun, Sun, Jing, Ma, Junjun, Zhou, Cixiang, Yang, Xiao, Zhang, Sen, Huang, Ling, Jia, Hongtao, Shao, Yanfei, Zhang, Enkui, Zheng, Minhua, Zhao, Qian, Zang, Lu. ""LncRNA LENGA acts as a tumor suppressor in gastric cancer through BRD7/TP53 signaling."" Cellular and molecular life sciences : CMLS, 2022, pp. 5.
[6] Meireles Da Costa, Nathalia, Palumbo, Antonio, De Martino, Marco, Fusco, Alfredo, Ribeiro Pinto, Luis Felipe, Nasciutti, Luiz Eurico. ""Interplay between HMGA and TP53 in cell cycle control along tumor progression."" Cellular and molecular life sciences : CMLS, 2021, pp. 817-831.
[7] Goel, Shom, DeCristo, Molly J, McAllister, Sandra S, Zhao, Jean J. ""CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest."" Trends in cell biology, 2018, pp. 911-925.
[8] Kumarasamy, Vishnu, Vail, Paris, Nambiar, Ram, Witkiewicz, Agnieszka K, Knudsen, Erik S. ""Functional Determinants of Cell Cycle Plasticity and Sensitivity to CDK4/6 Inhibition."" Cancer research, 2021, pp. 1347-1360.
[9] Jaumot, M, Estanyol, J M, Serratosa, J, Agell, N, Bachs, O. ""Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes."" Hepatology (Baltimore, Md.), 1999, pp. 385-95.
[10] Goel, Shom, DeCristo, Molly J, McAllister, Sandra S, Zhao, Jean J. ""CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest."" Trends in cell biology, 2018, pp. 911-925.
[11] Freeman-Cook, Kevin, Hoffman, Robert L, Miller, Nichol, Almaden, Jonathan, Chionis, John, Zhang, Qin, Eisele, Koleen, Liu, Chaoting, Zhang, Cathy, Huser, Nanni, Nguyen, Lisa, Costa-Jones, Cinthia, Niessen, Sherry, Carelli, Jordan, Lapek, John, Weinrich, Scott L, Wei, Ping, McMillan, Elizabeth, Wilson, Elizabeth, Wang, Tim S, McTigue, Michele, Ferre, Rose Ann, He, You-Ai, Ninkovic, Sacha, Behenna, Douglas, Tran, Khanh T, Sutton, Scott, Nagata, Asako, Ornelas, Martha A, Kephart, Susan E, Zehnder, Luke R, Murray, Brion, Xu, Meirong, Solowiej, James E, Visswanathan, Ravi, Boras, Britton, Looper, David, Lee, Nathan, Bienkowska, Jadwiga R, Zhu, Zhou, Kan, Zhengyan, Ding, Ying, Mu, Xinmeng Jasmine, Oderup, Cecilia, Salek-Ardakani, Shahram, White, Michael A, VanArsdale, Todd, Dann, Stephen G. ""Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor."" Cancer cell, 2021, pp. 1404-1421.e11.
[12] Kohoutek, J, Dvorák, P, Hampl, A. ""Temporal distribution of CDK4, CDK6, D-type cyclins, and p27 in developing mouse oocytes."" Biology of reproduction, 2004, pp. 139-45.
[13] Kim, Jun Yeob, Lee, Rusia, Xiao, Gu, Forbes, Dominique, Bargonetti, Jill. ""MDM2-C Functions as an E3 Ubiquitin Ligase."" Cancer management and research, 2020, pp. 7715-7724.
[14] Han, Xin, Wei, Wenyi, Sun, Yi. ""PROTAC Degraders with Ligands Recruiting MDM2 E3 Ubiquitin Ligase: An Updated Perspective."" Acta materia medica, 2022, pp. 244-259.
[15] Hines, John, Lartigue, Schan, Dong, Hanqing, Qian, Yimin, Crews, Craig M. ""MDM2-Recruiting PROTAC Offers Superior, Synergistic Antiproliferative Activity via Simultaneous Degradation of BRD4 and Stabilization of p53."" Cancer research, 2019, pp. 251-262.
[16] Peña-Blanco, Aida, García-Sáez, Ana J. ""Bax, Bak and beyond - mitochondrial performance in apoptosis."" The FEBS journal, 2018, pp. 416-431.
[17] Jenner, Andreas, Peña-Blanco, Aida, Salvador-Gallego, Raquel, Ugarte-Uribe, Begoña, Zollo, Cristiana, Ganief, Tariq, Bierlmeier, Jan, Mund, Markus, Lee, Jason E, Ries, Jonas, Schwarzer, Dirk, Macek, Boris, Garcia-Saez, Ana J. ""DRP1 interacts directly with BAX to induce its activation and apoptosis."" The EMBO journal, 2022, pp. e108587.
[18] Condo, I, Testi, R. ""Intracellular mediators of programmed cell death initiated at the cell surface receptor Fas."" Transplant international : official journal of the European Society for Organ Transplantation, 2000, pp. S3-6.
[19] Wu, Cheng-Nan, Chang, Wen-Shin, Shih, Liang-Chun, Wang, Yun-Chi, Lee, Hsu-Tung, Yu, Chien-Chih, Wang, Zhi-Hong, Mong, Mei-Chin, Hsia, Te-Chun, Tsai, Chia-Wen, Bau, DA-Tian. ""Interaction of DNA Repair Gene XPC With Smoking and Betel Quid Chewing Behaviors of Oral Cancer."" Cancer genomics & proteomics, 2021, pp. 441-449.
[20] Duan, Zhipeng, He, Caiyun, Gong, Yantao, Li, Ping, Xu, Qian, Sun, Li-ping, Wang, Zhenning, Xing, Chengzhong, Yuan, Yuan. ""Promoter polymorphisms in DNA repair gene ERCC5 and susceptibility to gastric cancer in Chinese."" Gene, 2012, pp. 274-9.
[21] Soltys, Daniela T, Rocha, Clarissa R R, Lerner, Letícia K, de Souza, Tiago A, Munford, Veridiana, Cabral, Fernanda, Nardo, Tiziana, Stefanini, Miria, Sarasin, Alain, Cabral-Neto, Januário B, Menck, Carlos F M. ""Novel XPG (ERCC5) mutations affect DNA repair and cell survival after ultraviolet but not oxidative stress."" Human mutation, 2013, pp. 481-9.
[22] Wang, Xue-Ming, Liu, Xiu-Mei, Wang, Yuting, Chen, Zhen-Yu. ""Activating transcription factor 3 (ATF3) regulates cell growth, apoptosis, invasion and collagen synthesis in keloid fibroblast through transforming growth factor beta (TGF-beta)/SMAD signaling pathway."" Bioengineered, 2021, pp. 117-126.
[23] Di Marcantonio, Daniela, Martinez, Esteban, Kanefsky, Joice S, Huhn, Jacklyn M, Gabbasov, Rashid, Gupta, Anushk, Krais, John J, Peri, Suraj, Tan, YinFei, Skorski, Tomasz, Dorrance, Adrienne, Garzon, Ramiro, Goldman, Aaron R, Tang, Hsin-Yao, Johnson, Neil, Sykes, Stephen M. ""ATF3 coordinates serine and nucleotide metabolism to drive cell cycle progression in acute myeloid leukemia."" Molecular cell, 2021, pp. 2752-2764.e6.
[24] Han, Na, Yuan, Fang, Xian, Peng, Liu, Nan, Liu, Jianmin, Zhang, Haiyan, Zhang, Huayong, Yao, Kai, Yuan, Gangjun. ""GADD45a Mediated Cell Cycle Inhibition Is Regulated By P53 In Bladder Cancer."" OncoTargets and therapy, 2019, pp. 7591-7599.
"	0.5626327	0.25482336	LLM	LLM	NA
Diff. expressed gene set	PANCREAS BETA CELLS	NA	ABCC8 AKT3 CHGA DCX DPP4 ELP4 FOXA2 FOXO1 G6PC2 GCG GCK HNF1A IAPP INS INSM1 ISL1 LMO2 MAFB NEUROD1 NEUROG3 NKX2-2 NKX6-1 PAK3 PAX4 PAX6 PCSK1 PCSK2 PDX1 PKLR SCGN SEC11A SLC2A2 SPCS1 SRP14 SRP9 SRPRB SST STXBP1 SYT13 VDR	40	5.321928094887363	Regulation Of Insulin Secretion 	GO:0050796	CHGA;NEUROD1;G6PC2;PDX1;GCG;ISL1;GCK;FOXO1;FOXA2	9	22.5	8.93e-14	4.86e-11	Pancreatic Islet Cell Development and Function	"The primary biological process performed by this system of interacting proteins is the development and function of pancreatic islet cells, which are crucial for glucose homeostasis and insulin secretion.

1. Key transcription factors involved in pancreatic islet cell development:
   - PDX1, NEUROD1, NEUROG3, NKX2-2, NKX6-1, ISL1, MAFB, FOXA2, and PAX4 are essential for the differentiation and maturation of pancreatic islet cells, including alpha, beta, and delta cells.
   - Reasoning: These transcription factors regulate the expression of genes necessary for the development and function of islet cells, such as insulin (INS), glucagon (GCG), and somatostatin (SST).

2. Hormones and hormone processing enzymes involved in glucose homeostasis:
   - INS, IAPP, GCG, and SST are hormones secreted by pancreatic islet cells that regulate glucose homeostasis.
   - PCSK1 and PCSK2 are prohormone convertases that process proinsulin and proglucagon into their active forms.
   - Reasoning: These proteins are essential for maintaining glucose homeostasis by regulating the secretion and processing of hormones involved in glucose metabolism.

3. Proteins involved in glucose sensing and insulin secretion:
   - GCK, PKLR, and SLC2A2 are involved in glucose sensing and regulation of insulin secretion in pancreatic beta cells.
   - ABCC8 and VDR play roles in modulating insulin secretion in response to changes in glucose levels.
   - Reasoning: These proteins are crucial for the proper functioning of pancreatic islet cells, as they help regulate insulin secretion in response to glucose levels.

4. Proteins involved in cellular signaling and survival of pancreatic islet cells:
   - AKT3, FOXO1, and PAK3 are involved in cellular signaling pathways that regulate the survival, proliferation, and function of pancreatic islet cells.
   - Reasoning: These proteins are essential for maintaining the integrity and function of pancreatic islet cells, as they help regulate cellular processes such as cell survival and proliferation.

5. Proteins involved in the secretory pathway and vesicle trafficking:
   - ELP4, STXBP1, SYT13, SCGN, SEC11A, SPCS1, SRP14, SRP9, and SRPRB are involved in the secretory pathway and vesicle trafficking, which are essential for the proper secretion of hormones from pancreatic islet cells.
   - Reasoning: These proteins are crucial for the proper functioning of pancreatic islet cells, as they help regulate the secretion of hormones involved in glucose homeostasis.

6. Other proteins with roles in pancreatic islet cell function:
   - CHGA, DCX, DPP4, HNF1A, LMO2, and PAX6 have roles in pancreatic islet cell function, including hormone secretion, cell migration, and gene regulation.
   - Reasoning: These proteins contribute to the overall function and maintenance of pancreatic islet cells, ensuring proper glucose homeostasis and hormone secretion."	38	95	"The primary biological process performed by this system of interacting proteins is the development and function of pancreatic islet cells, which are crucial for glucose homeostasis and insulin secretion.

1. Key transcription factors involved in pancreatic islet cell development:

   - PDX1, NEUROD1, NEUROG3, NKX2-2, NKX6-1, ISL1, MAFB, FOXA2, and PAX4 are essential for the differentiation and maturation of pancreatic islet cells, including alpha, beta, and delta cells.[1][2][3]

   - Reasoning: These transcription factors regulate the expression of genes necessary for the development and function of islet cells, such as insulin (INS), glucagon (GCG), and somatostatin (SST).[4][5][6]

2. Hormones and hormone processing enzymes involved in glucose homeostasis:

   - INS, IAPP, GCG, and SST are hormones secreted by pancreatic islet cells that regulate glucose homeostasis.[7][8][9]

   - PCSK1 and PCSK2 are prohormone convertases that process proinsulin and proglucagon into their active forms.[10][11][12]

   - Reasoning: These proteins are essential for maintaining glucose homeostasis by regulating the secretion and processing of hormones involved in glucose metabolism.

3. Proteins involved in glucose sensing and insulin secretion:

   - GCK, PKLR, and SLC2A2 are involved in glucose sensing and regulation of insulin secretion in pancreatic beta cells.[13][14][15]

   - ABCC8 and VDR play roles in modulating insulin secretion in response to changes in glucose levels.[16][17][18]

   - Reasoning: These proteins are crucial for the proper functioning of pancreatic islet cells, as they help regulate insulin secretion in response to glucose levels.

4. Proteins involved in cellular signaling and survival of pancreatic islet cells:

   - AKT3, FOXO1, and PAK3 are involved in cellular signaling pathways that regulate the survival, proliferation, and function of pancreatic islet cells.[19][20][21]

   - Reasoning: These proteins are essential for maintaining the integrity and function of pancreatic islet cells, as they help regulate cellular processes such as cell survival and proliferation.

5. Proteins involved in the secretory pathway and vesicle trafficking:

   - ELP4, STXBP1, SYT13, SCGN, SEC11A, SPCS1, SRP14, SRP9, and SRPRB are involved in the secretory pathway and vesicle trafficking, which are essential for the proper secretion of hormones from pancreatic islet cells.[22][23][24]

   - Reasoning: These proteins are crucial for the proper functioning of pancreatic islet cells, as they help regulate the secretion of hormones involved in glucose homeostasis.

6. Other proteins with roles in pancreatic islet cell function:

   - CHGA, DCX, DPP4, HNF1A, LMO2, and PAX6 have roles in pancreatic islet cell function, including hormone secretion, cell migration, and gene regulation.[25][26][27]

   - Reasoning: These proteins contribute to the overall function and maintenance of pancreatic islet cells, ensuring proper glucose homeostasis and hormone secretion.

========================================================================================================================================================================================================
[1] Li, Jianfang, Wu, Xinwei, Ke, Jie, Lee, Minjung, Lan, Qingping, Li, Jia, Yu, Jianxiu, Huang, Yun, Sun, De-Qiang, Xie, Ruiyu. ""TET1 dioxygenase is required for FOXA2-associated chromatin remodeling in pancreatic beta-cell differentiation."" Nature communications, 2022, pp. 3907.
[2] Xu, Lifa, Xu, Congjing, Zhou, Shuping, Liu, Xueke, Wang, Jian, Liu, Xinkuang, Qian, Suping, Xin, Yingru, Gao, Yi, Zhu, Yongqiang, Tang, Xiaolong. ""PAX4 promotes PDX1-induced differentiation of mesenchymal stem cells into insulin-secreting cells."" American journal of translational research, 2017, pp. 874-886.
[3] Bastidas-Ponce, Aimée, Roscioni, Sara S, Burtscher, Ingo, Bader, Erik, Sterr, Michael, Bakhti, Mostafa, Lickert, Heiko. ""Foxa2 and Pdx1 cooperatively regulate postnatal maturation of pancreatic β-cells."" Molecular metabolism, 2017, pp. 524-534.
[4] Chiou, Joshua, Zeng, Chun, Cheng, Zhang, Han, Jee Yun, Schlichting, Michael, Miller, Michael, Mendez, Robert, Huang, Serina, Wang, Jinzhao, Sui, Yinghui, Deogaygay, Allison, Okino, Mei-Lin, Qiu, Yunjiang, Sun, Ying, Kudtarkar, Parul, Fang, Rongxin, Preissl, Sebastian, Sander, Maike, Gorkin, David U, Gaulton, Kyle J. ""Single-cell chromatin accessibility identifies pancreatic islet cell type- and state-specific regulatory programs of diabetes risk."" Nature genetics, 2021, pp. 455-466.
[5] Ackermann, Amanda M, Wang, Zhiping, Schug, Jonathan, Naji, Ali, Kaestner, Klaus H. ""Integration of ATAC-seq and RNA-seq identifies human alpha cell and beta cell signature genes."" Molecular metabolism, 2016, pp. 233-244.
[6] Skelin, Masa, Rupnik, Marjan, Cencic, Avrelija. ""Pancreatic beta cell lines and their applications in diabetes mellitus research."" ALTEX, 2010, pp. 105-13.
[7] Narita, R, Toshimori, H, Nakazato, M, Kuribayashi, T, Toshimori, T, Kawabata, K, Takahashi, K, Masukura, S. ""Islet amyloid polypeptide (IAPP) and pancreatic islet amyloid deposition in diabetic and non-diabetic patients."" Diabetes research and clinical practice, 1992, pp. 3-14.
[8] Karlsson, E. ""IAPP as a regulator of glucose homeostasis and pancreatic hormone secretion (review)."" International journal of molecular medicine, 1999, pp. 577-84.
[9] Le Fur, Sophie, Fradin, Delphine, Boileau, Pascal, Bougnères, Pierre. ""Association of Kir6.2 and INS VNTR variants with glucose homeostasis in young obese."" Physiological genomics, 2005, pp. 398-401.
[10] Morash, Michael G, MacDonald, Angela B, Croll, Roger P, Anini, Younes. ""Molecular cloning, ontogeny and tissue distribution of zebrafish (Danio rerio) prohormone convertases: pcsk1 and pcsk2."" General and comparative endocrinology, 2009, pp. 179-87.
[11] Zheng, Xiaoya, Ren, Wei, Zhang, Suhua, Liu, Jingjing, Li, Sufang, Li, Jinchao, Yang, Ping, He, Jun, Su, Shaochu, Li, Ping. ""Association of type 2 diabetes susceptibility genes (TCF7L2, SLC30A8, PCSK1 and PCSK2) and proinsulin conversion in a Chinese population."" Molecular biology reports, 2012, pp. 17-23.
[12] Heni, Martin, Haupt, Axel, Schäfer, Silke A, Ketterer, Caroline, Thamer, Claus, Machicao, Fausto, Stefan, Norbert, Staiger, Harald, Häring, Hans-Ulrich, Fritsche, Andreas. ""Association of obesity risk SNPs in PCSK1 with insulin sensitivity and proinsulin conversion."" BMC medical genetics, 2010, pp. 86.
[13] Sansbury, F H, Flanagan, S E, Houghton, J A L, Shuixian Shen, F L, Al-Senani, A M S, Habeb, A M, Abdullah, M, Kariminejad, A, Ellard, S, Hattersley, A T. ""SLC2A2 mutations can cause neonatal diabetes, suggesting GLUT2 may have a role in human insulin secretion."" Diabetologia, 2012, pp. 2381-5.
[14] Hu, Cheng, Zhang, Rong, Wang, Congrong, Yu, Weihui, Lu, Jingyi, Ma, Xiaojing, Wang, Jie, Jiang, Feng, Tang, Shanshan, Bao, Yuqian, Xiang, Kunsan, Jia, Weiping. ""Effects of GCK, GCKR, G6PC2 and MTNR1B variants on glucose metabolism and insulin secretion."" PloS one, 2010, pp. e11761.
[15] McCulloch, Laura J, van de Bunt, Martijn, Braun, Matthias, Frayn, Keith N, Clark, Anne, Gloyn, Anna L. ""GLUT2 (SLC2A2) is not the principal glucose transporter in human pancreatic beta cells: implications for understanding genetic association signals at this locus."" Molecular genetics and metabolism, 2011, pp. 648-53.
[16] Shaat, Nael, Katsarou, Anastasia, Shahida, Bushra, Prasad, Rashmi B, Kristensen, Karl, Planck, Tereza. ""Association between the rs1544410 polymorphism in the vitamin D receptor (VDR) gene and insulin secretion after gestational diabetes mellitus."" PloS one, 2020, pp. e0232297.
[17] Andrikopoulos, Sofianos, Fam, Barbara C, Holdsworth, Anita, Visinoni, Sherley, Ruan, Zheng, Stathopoulos, Maria, Thorburn, Anne W, Joannides, Christos N, Cancilla, Michael, Balmer, Lois, Proietto, Joseph, Morahan, Grant. ""Identification of ABCC8 as a contributory gene to impaired early-phase insulin secretion in NZO mice."" The Journal of endocrinology, 2016, pp. 61-73.
[18] Sentinelli, F, Bertoccini, L, Barchetta, I, Capoccia, D, Incani, M, Pani, M G, Loche, S, Angelico, F, Arca, M, Morini, S, Manconi, E, Lenzi, A, Cossu, E, Leonetti, F, Baroni, M G, Cavallo, M G. ""The vitamin D receptor (VDR) gene rs11568820 variant is associated with type 2 diabetes and impaired insulin secretion in Italian adult subjects, and associates with increased cardio-metabolic risk in children."" Nutrition, metabolism, and cardiovascular diseases : NMCD, 2016, pp. 407-13.
[19] Wang, Ling, Huang, Delun, Jiang, Zongliang, Luo, Yan, Norris, Carol, Zhang, Ming, Tian, Xiuchun, Tang, Young. ""Akt3 is responsible for the survival and proliferation of embryonic stem cells."" Biology open, 2017, pp. 850-861.
[20] Wu, Zhaojia, Niu, Tong, Xiao, Wei. ""Uev1A promotes breast cancer cell survival and chemoresistance through the AKT-FOXO1-BIM pathway."" Cancer cell international, 2019, pp. 331.
[21] Guo, Sichao, Mangal, Ruchi, Dandu, Chaitu, Geng, Xiaokun, Ding, Yuchuan. ""Role of Forkhead Box Protein O1 (FoxO1) in Stroke: A Literature Review."" Aging and disease, 2022, pp. 521-533.
[22] Swanson, D A, Steel, J M, Valle, D. ""Identification and characterization of the human ortholog of rat STXBP1, a protein implicated in vesicle trafficking and neurotransmitter release."" Genomics, 1998, pp. 373-6.
[23] Liu, Peng, Wei, Jinhong, Mao, Feiyu, Xin, Zechang, Duan, Heng, Du, Yan, Wang, Xiaodong, Li, Zhennan, Qian, Jianjun, Yao, Jie. ""Establishment of a Prognostic Model for Hepatocellular Carcinoma Based on Endoplasmic Reticulum Stress-Related Gene Analysis."" Frontiers in oncology, 2021, pp. 641487.
[24] Malm, Magdalena, Kuo, Chih-Chung, Barzadd, Mona Moradi, Mebrahtu, Aman, Wistbacka, Num, Razavi, Ronia, Volk, Anna-Luisa, Lundqvist, Magnus, Kotol, David, Tegel, Hanna, Hober, Sophia, Edfors, Fredrik, Gräslund, Torbjörn, Chotteau, Veronique, Field, Ray, Varley, Paul G, Roth, Robert G, Lewis, Nathan E, Hatton, Diane, Rockberg, Johan. ""Harnessing secretory pathway differences between HEK293 and CHO to rescue production of difficult to express proteins."" Metabolic engineering, 2022, pp. 171-187.
[25] Ristic, Smiljana, Bates, Peter C. ""Vildagliptin: a novel DPP-4 inhibitor with pancreatic islet enhancement activity for treatment of patients with type 2 diabetes."" Drugs of today (Barcelona, Spain : 1998), 2006, pp. 519-31.
[26] Beimesche, S, Neubauer, A, Herzig, S, Grzeskowiak, R, Diedrich, T, Cierny, I, Scholz, D, Alejel, T, Knepel, W. ""Tissue-specific transcriptional activity of a pancreatic islet cell-specific enhancer sequence/Pax6-binding site determined in normal adult tissues in vivo using transgenic mice."" Molecular endocrinology (Baltimore, Md.), 1999, pp. 718-28.
[27] Alsalim, Wathik, Göransson, Olga, Carr, Richard D, Bizzotto, Roberto, Tura, Andrea, Pacini, Giovanni, Mari, Andrea, Ahrén, Bo. ""Effect of single-dose DPP-4 inhibitor sitagliptin on β-cell function and incretin hormone secretion after meal ingestion in healthy volunteers and drug-naïve, well-controlled type 2 diabetes subjects."" Diabetes, obesity & metabolism, 2018, pp. 1080-1085.
"	0.61273444	0.40776896	LLM	LLM	NA
Diff. expressed gene set	PEROXISOME	NA	ABCB1 ABCB4 ABCB9 ABCC5 ABCC8 ABCD1 ABCD2 ABCD3 ACAA1 ACOT8 ACOX1 ACSL1 ACSL4 ACSL5 ALB ALDH1A1 ALDH9A1 ATXN1 BCL10 CACNA1B CADM1 CAT CDK7 CEL CLN6 CLN8 CNBP CRABP1 CRABP2 CRAT CTBP1 CTPS1 DHCR24 DHRS3 DIO1 DLG4 ECH1 ECI2 EHHADH ELOVL5 EPHX2 ERCC1 ERCC3 ESR2 FABP6 FADS1 FDPS FIS1 GNPAT GSTK1 HAO2 HMGCL HRAS HSD11B2 HSD17B11 HSD17B4 HSD3B7 IDE IDH1 IDH2 IDI1 ISOC1 ITGB1BP1 LONP2 MLYCD MSH2 MVP NR1I2 NUDT19 PABPC1 PEX11A PEX11B PEX13 PEX14 PEX2 PEX5 PEX6 PRDX1 PRDX5 RDH11 RETSAT RXRG SCGB1A1 SCP2 SEMA3C SERPINA6 SIAH1 SLC23A2 SLC25A17 SLC25A19 SLC25A4 SLC27A2 SLC35B2 SMARCC1 SOD1 SOD2 STS SULT2B1 TOP2A TSPO TTR UGT2B17 VPS4B YWHAH	104	6.700439718141092	Fatty Acid Catabolic Process 	GO:0009062	ABCD2;ACOT8;ABCD3;ECI2;HSD17B4;PEX2;PEX13;SLC25A17;SCP2;ACOX1;EHHADH;NUDT19;ACAA1;SLC27A2;HAO2	15	14.423076923076922	1.1100000000000001e-21	1.11e-18	Lipid Metabolism and Detoxification	"The primary biological process performed by this system of interacting proteins is lipid metabolism and detoxification. The proteins involved in this process are responsible for the synthesis, transport, and breakdown of lipids, as well as the detoxification of harmful substances.

1. Lipid metabolism: Several proteins in this system are involved in lipid metabolism, including ACAA1, ACOT8, ACOX1, ACSL1, ACSL4, ACSL5, EHHADH, ELOVL5, FADS1, FDPS, HMGCL, HSD17B11, HSD17B4, HSD3B7, IDI1, LONP2, MLYCD, and SCP2. These proteins play roles in fatty acid oxidation, elongation, desaturation, and synthesis of cholesterol and other lipids. The presence of these proteins indicates that this system is involved in maintaining lipid homeostasis within the cell.

2. Detoxification: Several proteins in this system are involved in detoxification processes, including ALDH1A1, ALDH9A1, CAT, EPHX2, GSTK1, HAO2, PRDX1, PRDX5, SOD1, SOD2, and UGT2B17. These proteins are responsible for the breakdown and elimination of harmful substances, such as reactive oxygen species, xenobiotics, and drugs. The presence of these proteins suggests that this system plays a role in protecting the cell from damage caused by toxic substances.

3. Transport: A number of proteins in this system are involved in the transport of lipids and other molecules, including ABCB1, ABCB4, ABCB9, ABCC5, ABCC8, ABCD1, ABCD2, ABCD3, ALB, FABP6, SLC23A2, SLC25A17, SLC25A19, SLC25A4, SLC27A2, SLC35B2, TSPO, and TTR. These proteins facilitate the movement of lipids and other molecules across cellular membranes, ensuring proper distribution and utilization of these molecules within the cell.

4. DNA repair and maintenance: Some proteins in this system are involved in DNA repair and maintenance, including ERCC1, ERCC3, MSH2, and TOP2A. These proteins play a role in maintaining the integrity of the cell's genetic material, ensuring proper cellular function and preventing the accumulation of mutations that could lead to disease.

5. Protein-protein interactions: Several proteins in this system are involved in protein-protein interactions, including BCL10, CDK7, CNBP, CRABP1, CRABP2, CTBP1, CTPS1, DHCR24, DHRS3, DIO1, DLG4, ECH1, ECI2, ESR2, FIS1, GNPAT, HRAS, IDE, IDH1, IDH2, ISOC1, ITGB1BP1, MVP, NR1I2, NUDT19, PABPC1, PEX11A, PEX11B, PEX13, PEX14, PEX2, PEX5, PEX6, RDH11, RETSAT, RXRG, SCGB1A1, SEMA3C, SERPINA6, SIAH1, SMARCC1, STS, SULT2B1, VPS4B, and YWHAH. These proteins are involved in various cellular processes, such as signal transduction, gene regulation, and protein degradation, and their interactions help to coordinate and regulate these processes within the cell."	96	92.3076923076923	"The primary biological process performed by this system of interacting proteins is lipid metabolism and detoxification. The proteins involved in this process are responsible for the synthesis, transport, and breakdown of lipids, as well as the detoxification of harmful substances.

1. Lipid metabolism: Several proteins in this system are involved in lipid metabolism, including ACAA1, ACOT8, ACOX1, ACSL1, ACSL4, ACSL5, EHHADH, ELOVL5, FADS1, FDPS, HMGCL, HSD17B11, HSD17B4, HSD3B7, IDI1, LONP2, MLYCD, and SCP2. These proteins play roles in fatty acid oxidation, elongation, desaturation, and synthesis of cholesterol and other lipids. The presence of these proteins indicates that this system is involved in maintaining lipid homeostasis within the cell.[1][2][3]

2. Detoxification: Several proteins in this system are involved in detoxification processes, including ALDH1A1, ALDH9A1, CAT, EPHX2, GSTK1, HAO2, PRDX1, PRDX5, SOD1, SOD2, and UGT2B17. These proteins are responsible for the breakdown and elimination of harmful substances, such as reactive oxygen species, xenobiotics, and drugs. The presence of these proteins suggests that this system plays a role in protecting the cell from damage caused by toxic substances.[4][5][6]

3. Transport: A number of proteins in this system are involved in the transport of lipids and other molecules, including ABCB1, ABCB4, ABCB9, ABCC5, ABCC8, ABCD1, ABCD2, ABCD3, ALB, FABP6, SLC23A2, SLC25A17, SLC25A19, SLC25A4, SLC27A2, SLC35B2, TSPO, and TTR. These proteins facilitate the movement of lipids and other molecules across cellular membranes, ensuring proper distribution and utilization of these molecules within the cell.[7][8][9]

4. DNA repair and maintenance: Some proteins in this system are involved in DNA repair and maintenance, including ERCC1, ERCC3, MSH2, and TOP2A. These proteins play a role in maintaining the integrity of the cell's genetic material, ensuring proper cellular function and preventing the accumulation of mutations that could lead to disease.[10][11][12]

5. Protein-protein interactions: Several proteins in this system are involved in protein-protein interactions, including BCL10, CDK7, CNBP, CRABP1, CRABP2, CTBP1, CTPS1, DHCR24, DHRS3, DIO1, DLG4, ECH1, ECI2, ESR2, FIS1, GNPAT, HRAS, IDE, IDH1, IDH2, ISOC1, ITGB1BP1, MVP, NR1I2, NUDT19, PABPC1, PEX11A, PEX11B, PEX13, PEX14, PEX2, PEX5, PEX6, RDH11, RETSAT, RXRG, SCGB1A1, SEMA3C, SERPINA6, SIAH1, SMARCC1, STS, SULT2B1, VPS4B, and YWHAH. These proteins are involved in various cellular processes, such as signal transduction, gene regulation, and protein degradation, and their interactions help to coordinate and regulate these processes within the cell.[13][14][15]

========================================================================================================================================================================================================
[1] Zhou, Xin, Zhao, Rui, Lv, Mengfei, Xu, Xiangyu, Liu, Wenhao, Li, Xiaohua, Gao, Yunyi, Zhao, Zhiyuan, Zhang, Zhaolong, Li, Yuxuan, Xu, Rui, Wan, Qi, Cui, Yu. ""ACSL4 promotes microglia-mediated neuroinflammation by regulating lipid metabolism and VGLL4 expression."" Brain, behavior, and immunity, 2023, pp. 331-343.
[2] Galano, Melanie, Ezzat, Shereen, Papadopoulos, Vassilios. ""SCP2 variant is associated with alterations in lipid metabolism, brainstem neurodegeneration, and testicular defects."" Human genomics, 2022, pp. 32.
[3] Li, Chuanhai, Jiang, Lidan, Jin, Yuan, Zhang, Donghui, Chen, Jing, Qi, Yuan, Fan, Rongrong, Luo, Jiao, Xu, Lin, Ma, Wanli, Zhao, Kunming, Yu, Dianke. ""Lipid metabolism disorders effects of 6:2 chlorinated polyfluorinated ether sulfonate through Hsa-miRNA-532-3p/Acyl-CoA oxidase 1(ACOX1) pathway."" Ecotoxicology and environmental safety, 2021, pp. 113011.
[4] Zhou, Junmei, Sun, Chunbao, Yang, Lu, Wang, Jinhui, Jn-Simon, Natacha, Zhou, Chen, Bryant, Andrew, Cao, Qi, Li, Chenglong, Petersen, Bryon, Pi, Liya. ""Liver regeneration and ethanol detoxification: A new link in YAP regulation of ALDH1A1 during alcohol-related hepatocyte damage."" FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2022, pp. e22224.
[5] Wang, Xiaoqian, Li, Man, Peng, Lirong, Tang, Nanhong. ""SOD2 promotes the expression of ABCC2 through lncRNA CLCA3p and improves the detoxification capability of liver cells."" Toxicology letters, 2020, pp. 9-18.
[6] Zhao, Qian, Zhou, Lujian, Liu, Jianchao, Cao, Zhenzhen, Du, Xiaoxia, Huang, Fudeng, Pan, Gang, Cheng, Fangmin. ""Involvement of CAT in the detoxification of HT-induced ROS burst in rice anther and its relation to pollen fertility."" Plant cell reports, 2018, pp. 741-757.
[7] Odland, Sondre Ulstein, Ravna, Aina Westrheim, Smaglyukova, Natalia, Dietrichs, Erik Sveberg, Sager, Georg. ""Inhibition of ABCC5-mediated cGMP transport by progesterone, testosterone and their analogues."" The Journal of steroid biochemistry and molecular biology, 2021, pp. 105951.
[8] Kawaguchi, Kosuke, Imanaka, Tsuneo. ""Substrate Specificity and the Direction of Transport in the ABC Transporters ABCD1-3 and ABCD4."" Chemical & pharmaceutical bulletin, 2022, pp. 533-539.
[9] Jiang, Bo, Yan, Li-Jun, Wu, Qian. ""<i>ABCB1</i> (C1236T) Polymorphism Affects P-Glycoprotein-Mediated Transport of Methotrexate, Doxorubicin, Actinomycin D, and Etoposide."" DNA and cell biology, 2019, pp. 485-490.
[10] Kim, Dong Eun, Dollé, Martijn E T, Vermeij, Wilbert P, Gyenis, Akos, Vogel, Katharina, Hoeijmakers, Jan H J, Wiley, Christopher D, Davalos, Albert R, Hasty, Paul, Desprez, Pierre-Yves, Campisi, Judith. ""Deficiency in the DNA repair protein ERCC1 triggers a link between senescence and apoptosis in human fibroblasts and mouse skin."" Aging cell, 2020, pp. e13072.
[11] Jiang, Chunming, Shen, Fang, Du, Jianmin, Wang, Xiaohua, Su, Jin, Liu, Zhanli, Huang, Xianmei. ""DNA repair gene ERCC1 polymorphisms and glioma susceptibility among Chinese population: a meta-analysis."" International journal of clinical and experimental medicine, 2015, pp. 10248-55.
[12] Feki-Tounsi, Molka, Khlifi, Rim, Louati, Ibtihel, Fourati, Mohamed, Mhiri, Mohamed-Nabil, Hamza-Chaffai, Amel, Rebai, Ahmed. ""Polymorphisms in XRCC1, ERCC2, and ERCC3 DNA repair genes, CYP1A1 xenobiotic metabolism gene, and tobacco are associated with bladder cancer susceptibility in Tunisian population."" Environmental science and pollution research international, 2017, pp. 22476-22484.
[13] Cheng, Jing, Maurer, Lisa M, Kang, Heejae, Lucas, Peter C, McAllister-Lucas, Linda M. ""Critical protein-protein interactions within the CARMA1-BCL10-MALT1 complex: Take-home points for the cell biologist."" Cellular immunology, 2020, pp. 104158.
[14] Chen, Danna, He, Fei, Lu, Ting, Huang, Jin, Li, Meiyi, Cai, Decheng, Huang, Cheng, Chen, Dong, Xiong, Fu. ""VPS4B deficiency causes early embryonic lethality and induces signal transduction disorders of cell endocytosis."" Genesis (New York, N.Y. : 2000), 2021, pp. e23415.
[15] Herrero, Ana, Reis-Cardoso, Mariana, Jiménez-Gómez, Iñaki, Doherty, Carolanne, Agudo-Ibañez, Lorena, Pinto, Adán, Calvo, Fernando, Kolch, Walter, Crespo, Piero, Matallanas, David. ""Characterisation of HRas local signal transduction networks using engineered site-specific exchange factors."" Small GTPases, 2020, pp. 371-383.
"	0.3823085	0.29890555	Neither	LLM	NA
Diff. expressed gene set	PI3K AKT MTOR SIGNALING	NA	ACACA ACTR2 ACTR3 ADCY2 AKT1 AKT1S1 AP2M1 ARF1 ARHGDIA ARPC3 ATF1 CAB39 CAB39L CALR CAMK4 CDK1 CDK2 CDK4 CDKN1A CDKN1B CFL1 CLTC CSNK2B CXCR4 DAPP1 DDIT3 DUSP3 E2F1 ECSIT EGFR EIF4E FASLG FGF17 FGF22 FGF6 GNA14 GNGT1 GRB2 GRK2 GSK3B HRAS HSP90B1 IL2RG IL4 IRAK4 ITPR2 LCK MAP2K3 MAP2K6 MAP3K7 MAPK1 MAPK10 MAPK8 MAPK9 MAPKAP1 MKNK1 MKNK2 MYD88 NCK1 NFKBIB NGF NOD1 PAK4 PDK1 PFN1 PIK3R3 PIKFYVE PIN1 PITX2 PLA2G12A PLCB1 PLCG1 PPP1CA PPP2R1B PRKAA2 PRKAG1 PRKAR2A PRKCB PTEN PTPN11 RAC1 RAF1 RALB RIPK1 RIT1 RPS6KA1 RPS6KA3 RPTOR SFN SLA SLC2A1 SMAD2 SQSTM1 STAT2 TBK1 THEM4 TIAM1 TNFRSF1A TRAF2 TRIB3 TSC2 UBE2D3 UBE2N VAV3 YWHAB	105	6.714245517666122	Protein Phosphorylation 	GO:0006468	GSK3B;PRKAA2;CAB39;PRKAG1;EGFR;MAPK9;RPS6KA3;MAPK8;TBK1;GRK2;MKNK1;MKNK2;RPS6KA1;AKT1;MAPK1;RIPK1;MAP3K7;PAK4;PDK1;SMAD2;PRKCB;MAPK10;CDK4;LCK;CAMK4;CSNK2B;CDK2;CDK1	28	26.666666666666668	2.7e-21	4.1e-18	PI3K-AKT-mTOR Signaling	"The most prominent biological process performed by this system of interacting proteins is the PI3K-AKT-mTOR signaling pathway. This pathway is crucial for regulating cell growth, survival, and metabolism.

1. Activation of receptor tyrosine kinases (RTKs) such as EGFR and CXCR4 initiates the pathway. This leads to the recruitment of adaptor proteins like GRB2, which in turn activates PI3K (composed of PIK3R3 and other subunits).

2. PI3K phosphorylates PIP2 to generate PIP3, a process negatively regulated by PTEN. PIP3 recruits AKT1 and PDK1 to the plasma membrane, where PDK1 phosphorylates and activates AKT1.

3. AKT1 activation leads to the phosphorylation of several downstream targets, including TSC2, PRAS40, and GSK3B. Phosphorylation of TSC2 inhibits its function, leading to the activation of RHEB and mTORC1 (composed of RPTOR and other subunits).

4. mTORC1 activation promotes protein synthesis and cell growth through the phosphorylation of targets such as EIF4E, RPS6KA1, and RPS6KA3. mTORC1 also regulates autophagy through the phosphorylation of ULK1 and ATG13.

5. AKT1 also activates mTORC2 (composed of RICTOR and other subunits) by phosphorylating SIN1. mTORC2, in turn, phosphorylates and activates AKT1, creating a positive feedback loop.

6. The PI3K-AKT-mTOR pathway is regulated by various feedback mechanisms. For example, mTORC1 activation leads to the phosphorylation of IRS1, which inhibits PI3K activation. Additionally, AKT1 activation can lead to the phosphorylation of FOXO transcription factors, which regulate the expression of genes involved in cell cycle progression and apoptosis.

7. Several proteins in this system are involved in the regulation of cell cycle progression, such as CDK1, CDK2, CDK4, CDKN1A, and CDKN1B. These proteins interact with E2F1, a transcription factor that controls the expression of genes required for cell cycle progression.

8. The PI3K-AKT-mTOR pathway also intersects with other signaling pathways, such as the MAPK/ERK pathway (involving MAPK1, MAPK8, MAPK9, and MAPK10) and the JNK pathway (involving MAP2K3 and MAP2K6). These pathways regulate various cellular processes, including cell proliferation, differentiation, and apoptosis.

9. The system of interacting proteins also includes several proteins involved in the regulation of apoptosis, such as FASLG, TNFRSF1A, and TRAF2. These proteins play a role in the extrinsic apoptotic pathway, which is regulated by the PI3K-AKT-mTOR pathway.

In conclusion, the PI3K-AKT-mTOR signaling pathway is the most prominent biological process performed by this system of interacting proteins. This pathway plays a crucial role in regulating cell growth, survival, and metabolism and intersects with other signaling pathways to control various cellular processes."	28	26.666666666666668	"The most prominent biological process performed by this system of interacting proteins is the PI3K-AKT-mTOR signaling pathway. This pathway is crucial for regulating cell growth, survival, and metabolism.[1][2][3]

1. Activation of receptor tyrosine kinases (RTKs) such as EGFR and CXCR4 initiates the pathway. This leads to the recruitment of adaptor proteins like GRB2, which in turn activates PI3K (composed of PIK3R3 and other subunits).[4][5][6]

2. PI3K phosphorylates PIP2 to generate PIP3, a process negatively regulated by PTEN. PIP3 recruits AKT1 and PDK1 to the plasma membrane, where PDK1 phosphorylates and activates AKT1.[7][8][9]

3. AKT1 activation leads to the phosphorylation of several downstream targets, including TSC2, PRAS40, and GSK3B. Phosphorylation of TSC2 inhibits its function, leading to the activation of RHEB and mTORC1 (composed of RPTOR and other subunits).[10][11][12]

4. mTORC1 activation promotes protein synthesis and cell growth through the phosphorylation of targets such as EIF4E, RPS6KA1, and RPS6KA3. mTORC1 also regulates autophagy through the phosphorylation of ULK1 and ATG13.[13][14][15]

5. AKT1 also activates mTORC2 (composed of RICTOR and other subunits) by phosphorylating SIN1. mTORC2, in turn, phosphorylates and activates AKT1, creating a positive feedback loop.[16][17][18]

6. The PI3K-AKT-mTOR pathway is regulated by various feedback mechanisms. For example, mTORC1 activation leads to the phosphorylation of IRS1, which inhibits PI3K activation. Additionally, AKT1 activation can lead to the phosphorylation of FOXO transcription factors, which regulate the expression of genes involved in cell cycle progression and apoptosis.[19][20][21]

7. Several proteins in this system are involved in the regulation of cell cycle progression, such as CDK1, CDK2, CDK4, CDKN1A, and CDKN1B. These proteins interact with E2F1, a transcription factor that controls the expression of genes required for cell cycle progression.[22][23][24]

8. The PI3K-AKT-mTOR pathway also intersects with other signaling pathways, such as the MAPK/ERK pathway (involving MAPK1, MAPK8, MAPK9, and MAPK10) and the JNK pathway (involving MAP2K3 and MAP2K6). These pathways regulate various cellular processes, including cell proliferation, differentiation, and apoptosis.[25][26][27]

9. The system of interacting proteins also includes several proteins involved in the regulation of apoptosis, such as FASLG, TNFRSF1A, and TRAF2. These proteins play a role in the extrinsic apoptotic pathway, which is regulated by the PI3K-AKT-mTOR pathway.[28][29][30]

In conclusion, the PI3K-AKT-mTOR signaling pathway is the most prominent biological process performed by this system of interacting proteins. This pathway plays a crucial role in regulating cell growth, survival, and metabolism and intersects with other signaling pathways to control various cellular processes.[31][32][33]

========================================================================================================================================================================================================
[1] Peng, Yan, Wang, Yuanyuan, Zhou, Cheng, Mei, Wuxuan, Zeng, Changchun. ""PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?"" Frontiers in oncology, 2022, pp. 819128.
[2] Heras-Sandoval, David, Pérez-Rojas, Jazmin M, Hernández-Damián, Jacqueline, Pedraza-Chaverri, José. ""The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration."" Cellular signalling, 2014, pp. 2694-701.
[3] Du, Liyan, Li, Xiaomei, Zhen, Linhong, Chen, Weiling, Mu, Lingguang, Zhang, Yang, Song, Ailin. ""Everolimus inhibits breast cancer cell growth through PI3K/AKT/mTOR signaling pathway."" Molecular medicine reports, 2018, pp. 7163-7169.
[4] Yang, Lu, Bhattacharya, Arup, Li, Yun, Sexton, Sandra, Ling, Xiang, Li, Fengzhi, Zhang, Yuesheng. ""Depleting receptor tyrosine kinases EGFR and HER2 overcomes resistance to EGFR inhibitors in colorectal cancer."" Journal of experimental & clinical cancer research : CR, 2022, pp. 184.
[5] Kamath, Shantaram, Buolamwini, John K. ""Targeting EGFR and HER-2 receptor tyrosine kinases for cancer drug discovery and development."" Medicinal research reviews, 2006, pp. 569-94.
[6] Hsu, Jennifer L, Hung, Mien-Chie. ""The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer."" Cancer metastasis reviews, 2016, pp. 575-588.
[7] Fruman, David A, Chiu, Honyin, Hopkins, Benjamin D, Bagrodia, Shubha, Cantley, Lewis C, Abraham, Robert T. ""The PI3K Pathway in Human Disease."" Cell, 2017, pp. 605-635.
[8] Carnero, Amancio, Blanco-Aparicio, Carmen, Renner, Oliver, Link, Wolfgang, Leal, Juan F M. ""The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications."" Current cancer drug targets, 2008, pp. 187-98.
[9] Dibble, Christian C, Cantley, Lewis C. ""Regulation of mTORC1 by PI3K signaling."" Trends in cell biology, 2015, pp. 545-55.
[10] Cho, Joseph H, Robinson, James P, Arave, Rowan A, Burnett, William J, Kircher, David A, Chen, Guo, Davies, Michael A, Grossmann, Allie H, VanBrocklin, Matthew W, McMahon, Martin, Holmen, Sheri L. ""AKT1 Activation Promotes Development of Melanoma Metastases."" Cell reports, 2015, pp. 898-905.
[11] Wu, Hua, Lu, Xing-Xing, Wang, Jing-Ru, Yang, Tian-Yu, Li, Xiu-Ming, He, Xiao-Shun, Li, Yi, Ye, Wen-Long, Wu, Yong, Gan, Wen-Juan, Guo, Peng-Da, Li, Jian-Ming. ""TRAF6 inhibits colorectal cancer metastasis through regulating selective autophagic CTNNB1/β-catenin degradation and is targeted for GSK3B/GSK3β-mediated phosphorylation and degradation."" Autophagy, 2019, pp. 1506-1522.
[12] Dai, Xiaoming, Jiang, Cong, Jiang, Qiwei, Fang, Lan, Yu, Haihong, Guo, Jinhe, Yan, Peiqiang, Chi, Fangtao, Zhang, Tao, Inuzuka, Hiroyuki, Asara, John M, Wang, Ping, Guo, Jianping, Wei, Wenyi. ""AMPK-dependent phosphorylation of the GATOR2 component WDR24 suppresses glucose-mediated mTORC1 activation."" Nature metabolism, 2023, pp. 265-276.
[13] Tavernarakis, Nektarios. ""Protein synthesis and aging: eIF4E and the soma vs. germline distinction."" Cell cycle (Georgetown, Tex.), 2007, pp. 1168-71.
[14] Shen, Peng, Reineke, Lucas C, Knutsen, Erik, Chen, Meng, Pichler, Martin, Ling, Hui, Calin, George A. ""Metformin blocks MYC protein synthesis in colorectal cancer via mTOR-4EBP-eIF4E and MNK1-eIF4G-eIF4E signaling."" Molecular oncology, 2018, pp. 1856-1870.
[15] Lee, Dong-Eun, Yoo, Ju Eun, Kim, Jiyea, Kim, Seungki, Kim, Sunshin, Lee, Ho, Cheong, Heesun. ""NEDD4L downregulates autophagy and cell growth by modulating ULK1 and a glutamine transporter."" Cell death & disease, 2020, pp. 38.
[16] Xu, Zhong, Xu, Meng, Liu, Pin, Zhang, Shu, Shang, Runze, Qiao, Yu, Che, Li, Ribback, Silvia, Cigliano, Antonio, Evert, Katja, Pascale, Rosa M, Dombrowski, Frank, Evert, Matthias, Chen, Xi, Calvisi, Diego F, Chen, Xin. ""The mTORC2-Akt1 Cascade Is Crucial for c-Myc to Promote Hepatocarcinogenesis in Mice and Humans."" Hepatology (Baltimore, Md.), 2019, pp. 1600-1613.
[17] Szwed, Angelia, Kim, Eugene, Jacinto, Estela. ""Regulation and metabolic functions of mTORC1 and mTORC2."" Physiological reviews, 2021, pp. 1371-1426.
[18] Ballesteros-Álvarez, Josué, Andersen, Julie K. ""mTORC2: The other mTOR in autophagy regulation."" Aging cell, 2021, pp. e13431.
[19] Hou, Yongying, Wang, Ke, Wan, Weijun, Cheng, Yue, Pu, Xia, Ye, Xiufeng. ""Resveratrol provides neuroprotection by regulating the JAK2/STAT3/PI3K/AKT/mTOR pathway after stroke in rats."" Genes & diseases, 2018, pp. 245-255.
[20] Peng, Yan, Wang, Yuanyuan, Zhou, Cheng, Mei, Wuxuan, Zeng, Changchun. ""PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?"" Frontiers in oncology, 2022, pp. 819128.
[21] Battaglioni, Stefania, Benjamin, Don, Wälchli, Matthias, Maier, Timm, Hall, Michael N. ""mTOR substrate phosphorylation in growth control."" Cell, 2022, pp. 1814-1836.
[22] Xie, Bowen, Wang, Shuangyan, Jiang, Nian, Li, Jian Jian. ""Cyclin B1/CDK1-regulated mitochondrial bioenergetics in cell cycle progression and tumor resistance."" Cancer letters, 2019, pp. 56-66.
[23] Zhang, Quanli, Shi, Run, Bai, Yongkang, Meng, Lijuan, Hu, Jingwen, Zhu, Hongyu, Liu, Tongyan, De, Xiaomeng, Wang, Siwei, Wang, Jie, Xu, Lin, Zhou, Guoren, Yin, Rong. ""Meiotic nuclear divisions 1 (MND1) fuels cell cycle progression by activating a KLF6/E2F1 positive feedback loop in lung adenocarcinoma."" Cancer communications (London, England), 2021, pp. 492-510.
[24] AbuHammad, Shatha, Cullinane, Carleen, Martin, Claire, Bacolas, Zoe, Ward, Teresa, Chen, Huiqin, Slater, Alison, Ardley, Kerry, Kirby, Laura, Chan, Keefe T, Brajanovski, Natalie, Smith, Lorey K, Rao, Aparna D, Lelliott, Emily J, Kleinschmidt, Margarete, Vergara, Ismael A, Papenfuss, Anthony T, Lau, Peter, Ghosh, Prerana, Haupt, Sue, Haupt, Ygal, Sanij, Elaine, Poortinga, Gretchen, Pearson, Richard B, Falk, Hendrik, Curtis, David J, Stupple, Paul, Devlin, Mark, Street, Ian, Davies, Michael A, McArthur, Grant A, Sheppard, Karen E. ""Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma."" Proceedings of the National Academy of Sciences of the United States of America, 2019, pp. 17990-18000.
[25] Hirota, Yuko, Yamashita, Shun-ichi, Kurihara, Yusuke, Jin, Xiulian, Aihara, Masamune, Saigusa, Tetsu, Kang, Dongchon, Kanki, Tomotake. ""Mitophagy is primarily due to alternative autophagy and requires the MAPK1 and MAPK14 signaling pathways."" Autophagy, 2015, pp. 332-43.
[26] Du, Mei-Rong, Zhou, Wen-Hui, Dong, Lin, Zhu, Xiao-Yong, He, Yin-Yan, Yang, Jin-Ying, Li, Da-Jin. ""Cyclosporin A promotes growth and invasiveness in vitro of human first-trimester trophoblast cells via MAPK3/MAPK1-mediated AP1 and Ca2+/calcineurin/NFAT signaling pathways."" Biology of reproduction, 2008, pp. 1102-10.
[27] Motta, Marialetizia, Pannone, Luca, Pantaleoni, Francesca, Bocchinfuso, Gianfranco, Radio, Francesca Clementina, Cecchetti, Serena, Ciolfi, Andrea, Di Rocco, Martina, Elting, Mariet W, Brilstra, Eva H, Boni, Stefania, Mazzanti, Laura, Tamburrino, Federica, Walsh, Larry, Payne, Katelyn, Fernández-Jaén, Alberto, Ganapathi, Mythily, Chung, Wendy K, Grange, Dorothy K, Dave-Wala, Ashita, Reshmi, Shalini C, Bartholomew, Dennis W, Mouhlas, Danielle, Carpentieri, Giovanna, Bruselles, Alessandro, Pizzi, Simone, Bellacchio, Emanuele, Piceci-Sparascio, Francesca, Lißewski, Christina, Brinkmann, Julia, Waclaw, Ronald R, Waisfisz, Quinten, van Gassen, Koen, Wentzensen, Ingrid M, Morrow, Michelle M, Álvarez, Sara, Martínez-García, Mónica, De Luca, Alessandro, Memo, Luigi, Zampino, Giuseppe, Rossi, Cesare, Seri, Marco, Gelb, Bruce D, Zenker, Martin, Dallapiccola, Bruno, Stella, Lorenzo, Prada, Carlos E, Martinelli, Simone, Flex, Elisabetta, Tartaglia, Marco. ""Enhanced MAPK1 Function Causes a Neurodevelopmental Disorder within the RASopathy Clinical Spectrum."" American journal of human genetics, 2020, pp. 499-513.
[28] Ji, Wangsheng, Xin, Yang, Zhang, Lianfei, Liu, Xinqi. ""ALG2 Influences T cell apoptosis by regulating FASLG intracellular transportation."" The Biochemical journal, 2020, pp. 3105-3121.
[29] Ye, Yang, Ye, Fen, Li, Xue, Yang, Qi, Zhou, Jianwei, Xu, Wenrong, Aschner, Michael, Lu, Rongzhu, Miao, Shuhan. ""3,3'-diindolylmethane exerts antiproliferation and apoptosis induction by TRAF2-p38 axis in gastric cancer."" Anti-cancer drugs, 2021, pp. 189-202.
[30] Shang, Chao, Guo, Yan, Hong, Yang, Liu, Yun-hui, Xue, Yi-xue. ""MiR-21 up-regulation mediates glioblastoma cancer stem cells apoptosis and proliferation by targeting FASLG."" Molecular biology reports, 2015, pp. 721-7.
[31] Alzahrani, Ali S. ""PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside."" Seminars in cancer biology, 2019, pp. 125-132.
[32] Xu, Fei, Na, Lixin, Li, Yanfei, Chen, Linjun. ""Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours."" Cell & bioscience, 2020, pp. 54.
[33] Fattahi, Sadegh, Amjadi-Moheb, Fatemeh, Tabaripour, Reza, Ashrafi, Gholam Hossein, Akhavan-Niaki, Haleh. ""PI3K/AKT/mTOR signaling in gastric cancer: Epigenetics and beyond."" Life sciences, 2020, pp. 118513.
"	0.9768652	0.33769584	LLM	LLM	NA
Diff. expressed gene set	PROTEIN SECRETION	NA	ABCA1 ADAM10 ANP32E AP1G1 AP2B1 AP2M1 AP2S1 AP3B1 AP3S1 ARCN1 ARF1 ARFGAP3 ARFGEF1 ARFGEF2 ARFIP1 ATP1A1 ATP6V1B1 ATP6V1H ATP7A BET1 BNIP3 CAV2 CD63 CLCN3 CLN5 CLTA CLTC COG2 COPB1 COPB2 COPE CTSC DNM1L DOP1A DST EGFR ERGIC3 GALC GBF1 GLA GNAS GOLGA4 GOSR2 ICA1 IGF2R KIF1B KRT18 LAMP2 LMAN1 M6PR MAPK1 MON2 NAPA NAPG OCRL PAM PPT1 RAB14 RAB22A RAB2A RAB5A RAB9A RER1 RPS6KA3 SCAMP1 SCAMP3 SCRN1 SEC22B SEC24D SEC31A SGMS1 SH3GL2 SNAP23 SNX2 SOD1 SSPN STAM STX12 STX16 STX7 TMED10 TMED2 TMX1 TOM1L1 TPD52 TSG101 TSPAN8 USO1 VAMP3 VAMP4 VAMP7 VPS45 VPS4B YIPF6 YKT6 ZW10	96	6.584962500721156	Golgi Vesicle Transport 	GO:0048193	NAPA;COPB2;TMED10;COPB1;GOSR2;SNAP23;USO1;NAPG;LMAN1;GOLGA4;SNX2;TMED2;YKT6;SEC31A;RAB2A;GBF1;COG2;SCAMP1;SCAMP3;ARCN1;VAMP7;RER1;ZW10;SEC24D;ERGIC3;SEC22B;COPE;BET1	28	29.166666666666668	6.659999999999998e-34	5.5299999999999996e-31	Intracellular Vesicle Trafficking	"The primary biological process performed by this system of interacting proteins is intracellular vesicle trafficking. This process is crucial for the proper functioning of cells, as it facilitates the transport of proteins, lipids, and other molecules between different cellular compartments.

1. Endocytic and exocytic pathways: Many proteins in this system, such as AP2B1, AP2M1, AP2S1, CLTA, CLTC, DNM1L, EGFR, and VAMP3, are involved in endocytosis and exocytosis. These processes are responsible for the internalization of extracellular material and the release of intracellular material, respectively. Endocytosis and exocytosis are essential for maintaining cellular homeostasis and responding to environmental changes.

2. Protein sorting and trafficking: Proteins like ARF1, ARFGAP3, ARFGEF1, ARFGEF2, COPB1, COPB2, COPE, SEC22B, SEC24D, and SEC31A are involved in the COPI and COPII vesicle-mediated transport systems. These systems are responsible for the sorting and trafficking of proteins between the endoplasmic reticulum (ER) and the Golgi apparatus, as well as within the Golgi apparatus itself.

3. Lysosomal and endosomal pathways: Several proteins in this system, such as ATP6V1B1, ATP6V1H, CLN5, CTSC, IGF2R, LAMP2, M6PR, and PPT1, are involved in the lysosomal and endosomal pathways. These pathways are responsible for the degradation and recycling of cellular components, as well as the regulation of signaling pathways.

4. Membrane remodeling and fusion: Proteins like ABCA1, ADAM10, CAV2, CD63, DOP1A, RAB14, RAB22A, RAB2A, RAB5A, RAB9A, STX12, STX16, STX7, VAMP4, VAMP7, and YKT6 are involved in membrane remodeling and fusion events. These events are essential for the proper functioning of the vesicle trafficking system, as they allow for the formation, movement, and fusion of vesicles with their target membranes.

5. Regulation of vesicle trafficking: Proteins such as ANP32E, AP1G1, AP3B1, AP3S1, ARCN1, GNAS, GOLGA4, GOSR2, MAPK1, MON2, NAPA, NAPG, OCRL, RER1, RPS6KA3, SCAMP1, SCAMP3, SH3GL2, SNAP23, SNX2, SOD1, SSPN, STAM, TMED10, TMED2, TMX1, TOM1L1, TPD52, TSG101, TSPAN8, USO1, VPS45, VPS4B, YIPF6, and ZW10 are involved in the regulation of vesicle trafficking. These proteins ensure that the trafficking process is tightly controlled and coordinated, allowing for the efficient transport of cargo between cellular compartments."	77	80.20833333333334	"The primary biological process performed by this system of interacting proteins is intracellular vesicle trafficking. This process is crucial for the proper functioning of cells, as it facilitates the transport of proteins, lipids, and other molecules between different cellular compartments.

1. Endocytic and exocytic pathways: Many proteins in this system, such as AP2B1, AP2M1, AP2S1, CLTA, CLTC, DNM1L, EGFR, and VAMP3, are involved in endocytosis and exocytosis. These processes are responsible for the internalization of extracellular material and the release of intracellular material, respectively. Endocytosis and exocytosis are essential for maintaining cellular homeostasis and responding to environmental changes.[1][2][3]

2. Protein sorting and trafficking: Proteins like ARF1, ARFGAP3, ARFGEF1, ARFGEF2, COPB1, COPB2, COPE, SEC22B, SEC24D, and SEC31A are involved in the COPI and COPII vesicle-mediated transport systems. These systems are responsible for the sorting and trafficking of proteins between the endoplasmic reticulum (ER) and the Golgi apparatus, as well as within the Golgi apparatus itself.[4][5][6]

3. Lysosomal and endosomal pathways: Several proteins in this system, such as ATP6V1B1, ATP6V1H, CLN5, CTSC, IGF2R, LAMP2, M6PR, and PPT1, are involved in the lysosomal and endosomal pathways. These pathways are responsible for the degradation and recycling of cellular components, as well as the regulation of signaling pathways.[7][8][9]

4. Membrane remodeling and fusion: Proteins like ABCA1, ADAM10, CAV2, CD63, DOP1A, RAB14, RAB22A, RAB2A, RAB5A, RAB9A, STX12, STX16, STX7, VAMP4, VAMP7, and YKT6 are involved in membrane remodeling and fusion events. These events are essential for the proper functioning of the vesicle trafficking system, as they allow for the formation, movement, and fusion of vesicles with their target membranes.[10][11][12]

5. Regulation of vesicle trafficking: Proteins such as ANP32E, AP1G1, AP3B1, AP3S1, ARCN1, GNAS, GOLGA4, GOSR2, MAPK1, MON2, NAPA, NAPG, OCRL, RER1, RPS6KA3, SCAMP1, SCAMP3, SH3GL2, SNAP23, SNX2, SOD1, SSPN, STAM, TMED10, TMED2, TMX1, TOM1L1, TPD52, TSG101, TSPAN8, USO1, VPS45, VPS4B, YIPF6, and ZW10 are involved in the regulation of vesicle trafficking. These proteins ensure that the trafficking process is tightly controlled and coordinated, allowing for the efficient transport of cargo between cellular compartments.[13][14][15]

========================================================================================================================================================================================================
[1] Ganapathy, Ashwinkumar Subramenium, Saha, Kushal, Suchanec, Eric, Singh, Vikash, Verma, Aayush, Yochum, Gregory, Koltun, Walter, Nighot, Meghali, Ma, Thomas, Nighot, Prashant. ""AP2M1 mediates autophagy-induced CLDN2 (claudin 2) degradation through endocytosis and interaction with LC3 and reduces intestinal epithelial tight junction permeability."" Autophagy, 2022, pp. 2086-2103.
[2] Sapmaz, Aysegul, Erson-Bensan, Ayse Elif. ""EGFR endocytosis: more than meets the eye."" Oncotarget, 2023, pp. 297-301.
[3] Pulido, Inés Rojo, Jahn, Reinhard, Gerke, Volker. ""VAMP3 is associated with endothelial weibel-palade bodies and participates in their Ca(2+)-dependent exocytosis."" Biochimica et biophysica acta, 2011, pp. 1038-44.
[4] Khater, Mostafa, Bryant, Christian N, Wu, Guangyu. ""Gβγ translocation to the Golgi apparatus activates ARF1 to spatiotemporally regulate G protein-coupled receptor signaling to MAPK."" The Journal of biological chemistry, 2021, pp. 100805.
[5] Nakai, Waka, Kondo, Yumika, Saitoh, Akina, Naito, Tomoki, Nakayama, Kazuhisa, Shin, Hye-Won. ""ARF1 and ARF4 regulate recycling endosomal morphology and retrograde transport from endosomes to the Golgi apparatus."" Molecular biology of the cell, 2013, pp. 2570-81.
[6] Jin, Eugene Jennifer, Kiral, Ferdi Ridvan, Hiesinger, Peter Robin. ""The where, what, and when of membrane protein degradation in neurons."" Developmental neurobiology, 2018, pp. 283-297.
[7] Dai, Pei, Ruan, Pinglang, Mao, Yu, Tang, Zhongxiang, Qiu, Xiangjie, Bajinka, Ousman, Tan, Yurong. ""Gimap5 promoted RSV degradation through interaction with M6PR."" Journal of medical virology, 2023, pp. e28390.
[8] Kato, Yuji, Arakawa, Satoko, Terasawa, Kazue, Inokuchi, Jin-Ichi, Iwata, Takanori, Shimizu, Shigeomi, Watabe, Tetsuro, Hara-Yokoyama, Miki. ""The ceramide analogue N-(1-hydroxy-3-morpholino-1-phenylpropan-2-yl)decanamide induces large lipid droplet accumulation and highlights the effect of LAMP-2 deficiency on lipid droplet degradation."" Bioorganic & medicinal chemistry letters, 2020, pp. 126891.
[9] Bain, H D C, Davidson, Y S, Robinson, A C, Ryan, S, Rollinson, S, Richardson, A, Jones, M, Snowden, J S, Pickering-Brown, S, Mann, D M A. ""The role of lysosomes and autophagosomes in frontotemporal lobar degeneration."" Neuropathology and applied neurobiology, 2019, pp. 244-261.
[10] Zhong, Li, Liao, Dan, Li, Jingjing, Liu, Wenqiang, Wang, Jingxuan, Zeng, Cuiling, Wang, Xin, Cao, Zhiliang, Zhang, Ruhua, Li, Miao, Jiang, Kuntai, Zeng, Yi-Xin, Sui, Jianhua, Kang, Tiebang. ""Rab22a-NeoF1 fusion protein promotes osteosarcoma lung metastasis through its secretion into exosomes."" Signal transduction and targeted therapy, 2021, pp. 59.
[11] Tian, Xiaoyu, Zheng, Pengli, Zhou, Chenqian, Wang, Xurui, Ma, Hua, Ma, Wei, Zhou, Xiaokai, Teng, Junlin, Chen, Jianguo. ""DIPK2A promotes STX17- and VAMP7-mediated autophagosome-lysosome fusion by binding to VAMP7B."" Autophagy, 2020, pp. 797-810.
[12] Jocher, Georg, Grass, Vincent, Tschirner, Sarah K, Riepler, Lydia, Breimann, Stephan, Kaya, Tuğberk, Oelsner, Madlen, Hamad, M Sabri, Hofmann, Laura I, Blobel, Carl P, Schmidt-Weber, Carsten B, Gokce, Ozgun, Jakwerth, Constanze A, Trimpert, Jakob, Kimpel, Janine, Pichlmair, Andreas, Lichtenthaler, Stefan F. ""ADAM10 and ADAM17 promote SARS-CoV-2 cell entry and spike protein-mediated lung cell fusion."" EMBO reports, 2022, pp. e54305.
[13] Fan, Yizeng, Hou, Tao, Gao, Yang, Dan, Weichao, Liu, Tianjie, Liu, Bo, Chen, Yule, Xie, Hongjun, Yang, Zhao, Chen, Jiaqi, Zeng, Jin, Li, Lei. ""Acetylation-dependent regulation of TPD52 isoform 1 modulates chaperone-mediated autophagy in prostate cancer."" Autophagy, 2021, pp. 4386-4400.
[14] Banks, C J, Andersen, J L. ""Mechanisms of SOD1 regulation by post-translational modifications."" Redox biology, 2019, pp. 101270.
[15] Han, Shan-Shan, Feng, Zhi-Qiang, Liu, Rui, Ye, Jun, Cheng, Wei-Wei, Bao, Jun-Bo. ""Bioinformatics Analysis and RNA-Sequencing of SCAMP3 Expression and Correlated Gene Regulation in Hepatocellular Carcinoma."" OncoTargets and therapy, 2020, pp. 1047-1057.
"	0.5190965	0.47916925	Tied	Neither	NA
Diff. expressed gene set	REACTIVE OXYGEN SPECIES PATHWAY	NA	ABCC1 ATOX1 CAT CDKN2D EGLN2 ERCC2 FES FTL G6PD GCLC GCLM GLRX GLRX2 GPX3 GPX4 GSR HHEX HMOX2 IPCEF1 JUNB LAMTOR5 LSP1 MBP MGST1 MPO MSRA NDUFA6 NDUFB4 NDUFS2 NQO1 OXSR1 PDLIM1 PFKP PRDX1 PRDX2 PRDX4 PRDX6 PRNP PTPA SBNO2 SCAF4 SELENOS SOD1 SOD2 SRXN1 STK25 TXN TXNRD1 TXNRD2	49	5.614709844115208	Hydrogen Peroxide Catabolic Process 	GO:0042744	PRDX2;PRDX4;GPX3;PRDX1;CAT;MPO	6	12.244897959183673	5.94e-12	3.52e-9	Redox Homeostasis and Cellular Respiration	"The primary biological process performed by this system of interacting proteins is the maintenance of redox homeostasis and cellular respiration. The proteins involved in this process are responsible for regulating the balance of reactive oxygen species (ROS) and antioxidants, as well as facilitating energy production through oxidative phosphorylation.

1. Antioxidant defense and ROS regulation: Several proteins in this system are involved in the detoxification of ROS and the maintenance of cellular redox balance. Key proteins include CAT (catalase), GPX3, GPX4 (glutathione peroxidases), GSR (glutathione reductase), PRDX1, PRDX2, PRDX4, PRDX6 (peroxiredoxins), SOD1, SOD2 (superoxide dismutases), TXN (thioredoxin), and TXNRD1, TXNRD2 (thioredoxin reductases). These proteins work together to neutralize ROS and prevent oxidative damage to cellular components.

2. Glutathione synthesis and regulation: The proteins GCLC, GCLM (glutamate-cysteine ligase subunits), and GLRX, GLRX2 (glutaredoxins) are involved in the synthesis and regulation of glutathione, a critical antioxidant molecule. G6PD (glucose-6-phosphate dehydrogenase) also plays a role in maintaining glutathione levels by providing NADPH, a necessary cofactor for GSR.

3. Cellular respiration and energy production: Several proteins in this system are involved in the process of oxidative phosphorylation, which generates ATP for cellular energy. Key proteins include NDUFA6, NDUFB4, NDUFS2 (NADH dehydrogenase subunits), and PFKP (phosphofructokinase). These proteins are essential for the proper functioning of the electron transport chain and the generation of ATP.

4. Metal ion homeostasis: Proteins such as ABCC1 (multidrug resistance-associated protein), ATOX1 (copper chaperone), and FTL (ferritin light chain) are involved in the regulation of metal ion homeostasis, which is crucial for maintaining redox balance and preventing metal-induced oxidative stress.

5. Regulation of redox-sensitive signaling pathways: Several proteins in this system, such as JUNB (transcription factor), HHEX (homeobox protein), and ERCC2 (DNA repair protein), are involved in the regulation of redox-sensitive signaling pathways. These proteins modulate cellular responses to oxidative stress and contribute to the maintenance of redox homeostasis.

In summary, the most prominent biological process performed by this system of interacting proteins is the maintenance of redox homeostasis and cellular respiration. The proteins involved in this process work together to regulate ROS levels, synthesize and regulate antioxidants, facilitate energy production, maintain metal ion homeostasis, and modulate redox-sensitive signaling pathways."	28	57.14285714285714	"The primary biological process performed by this system of interacting proteins is the maintenance of redox homeostasis and cellular respiration. The proteins involved in this process are responsible for regulating the balance of reactive oxygen species (ROS) and antioxidants, as well as facilitating energy production through oxidative phosphorylation.

1. Antioxidant defense and ROS regulation: Several proteins in this system are involved in the detoxification of ROS and the maintenance of cellular redox balance. Key proteins include CAT (catalase), GPX3, GPX4 (glutathione peroxidases), GSR (glutathione reductase), PRDX1, PRDX2, PRDX4, PRDX6 (peroxiredoxins), SOD1, SOD2 (superoxide dismutases), TXN (thioredoxin), and TXNRD1, TXNRD2 (thioredoxin reductases). These proteins work together to neutralize ROS and prevent oxidative damage to cellular components.[1][2][3]

2. Glutathione synthesis and regulation: The proteins GCLC, GCLM (glutamate-cysteine ligase subunits), and GLRX, GLRX2 (glutaredoxins) are involved in the synthesis and regulation of glutathione, a critical antioxidant molecule. G6PD (glucose-6-phosphate dehydrogenase) also plays a role in maintaining glutathione levels by providing NADPH, a necessary cofactor for GSR.[4][5][6]

3. Cellular respiration and energy production: Several proteins in this system are involved in the process of oxidative phosphorylation, which generates ATP for cellular energy. Key proteins include NDUFA6, NDUFB4, NDUFS2 (NADH dehydrogenase subunits), and PFKP (phosphofructokinase). These proteins are essential for the proper functioning of the electron transport chain and the generation of ATP.[7][8][9]

4. Metal ion homeostasis: Proteins such as ABCC1 (multidrug resistance-associated protein), ATOX1 (copper chaperone), and FTL (ferritin light chain) are involved in the regulation of metal ion homeostasis, which is crucial for maintaining redox balance and preventing metal-induced oxidative stress.[10][11][12]

5. Regulation of redox-sensitive signaling pathways: Several proteins in this system, such as JUNB (transcription factor), HHEX (homeobox protein), and ERCC2 (DNA repair protein), are involved in the regulation of redox-sensitive signaling pathways. These proteins modulate cellular responses to oxidative stress and contribute to the maintenance of redox homeostasis.[13][14][15]

In summary, the most prominent biological process performed by this system of interacting proteins is the maintenance of redox homeostasis and cellular respiration. The proteins involved in this process work together to regulate ROS levels, synthesize and regulate antioxidants, facilitate energy production, maintain metal ion homeostasis, and modulate redox-sensitive signaling pathways.

========================================================================================================================================================================================================
[1] Kubo, Eri, Chhunchha, Bhavana, Singh, Prerna, Sasaki, Hiroshi, Singh, Dhirendra P. ""Sulforaphane reactivates cellular antioxidant defense by inducing Nrf2/ARE/Prdx6 activity during aging and oxidative stress."" Scientific reports, 2017, pp. 14130.
[2] Chhunchha, B, Fatma, N, Bhargavan, B, Kubo, E, Kumar, A, Singh, D P. ""Specificity protein, Sp1-mediated increased expression of Prdx6 as a curcumin-induced antioxidant defense in lens epithelial cells against oxidative stress."" Cell death & disease, 2011, pp. e234.
[3] Salminen, Lauren E, Schofield, Peter R, Pierce, Kerrie D, Bruce, Steven E, Griffin, Michael G, Tate, David F, Cabeen, Ryan P, Laidlaw, David H, Conturo, Thomas E, Bolzenius, Jacob D, Paul, Robert H. ""Vulnerability of white matter tracts and cognition to the SOD2 polymorphism: A preliminary study of antioxidant defense genes in brain aging."" Behavioural brain research, 2017, pp. 111-119.
[4] McConnachie, Lisa A, Botta, Dianne, White, Collin C, Weldy, Chad S, Wilkerson, Hui-Wen, Yu, Jianbo, Dills, Russell, Yu, Xiaozhong, Griffith, William C, Faustman, Elaine M, Farin, Federico M, Gill, Sean E, Parks, William C, Hu, Xiaoge, Gao, Xiaohu, Eaton, David L, Kavanagh, Terrance J. ""The glutathione synthesis gene Gclm modulates amphiphilic polymer-coated CdSe/ZnS quantum dot-induced lung inflammation in mice."" PloS one, 2013, pp. e64165.
[5] Weldy, Chad S, White, Collin C, Wilkerson, Hui-Wen, Larson, Timothy V, Stewart, James A, Gill, Sean E, Parks, William C, Kavanagh, Terrance J. ""Heterozygosity in the glutathione synthesis gene Gclm increases sensitivity to diesel exhaust particulate induced lung inflammation in mice."" Inhalation toxicology, 2011, pp. 724-35.
[6] Chow, Eileen S, Long, Dani M, Giebultowicz, Jadwiga M. ""Circadian rhythm in mRNA expression of the glutathione synthesis gene <i>Gclc</i> is controlled by peripheral glial clocks in <i>Drosophila melanogaster</i>."" Physiological entomology, 2016, pp. 369-377.
[7] Sharma, Sudha, Bhattarai, Susmita, Ara, Hosne, Sun, Grace, St Clair, Daret K, Bhuiyan, Md Shenuarin, Kevil, Christopher, Watts, Megan N, Dominic, Paari, Shimizu, Takahiko, McCarthy, Kevin J, Sun, Hong, Panchatcharam, Manikandan, Miriyala, Sumitra. ""SOD2 deficiency in cardiomyocytes defines defective mitochondrial bioenergetics as a cause of lethal dilated cardiomyopathy."" Redox biology, 2020, pp. 101740.
[8] Parikh, Hemang, Nilsson, Emma, Ling, Charlotte, Poulsen, Pernille, Almgren, Peter, Nittby, Henrietta, Eriksson, Karl-Fredrik, Vaag, Allan, Groop, Leif C. ""Molecular correlates for maximal oxygen uptake and type 1 fibers."" American journal of physiology. Endocrinology and metabolism, 2008, pp. E1152-9.
[9] Lavín, José L, Oguiza, José A, Ramírez, Lucía, Pisabarro, Antonio G. ""Comparative genomics of the oxidative phosphorylation system in fungi."" Fungal genetics and biology : FG & B, 2008, pp. 1248-56.
[10] Granitzer, Sebastian, Ellinger, Isabella, Khan, Rumsha, Gelles, Katharina, Widhalm, Raimund, Hengstschläger, Markus, Zeisler, Harald, Desoye, Gernot, Tupova, Lenka, Ceckova, Martina, Salzer, Hans, Gundacker, Claudia. ""In vitro function and in situ localization of Multidrug Resistance-associated Protein (MRP)1 (ABCC1) suggest a protective role against methyl mercury-induced oxidative stress in the human placenta."" Archives of toxicology, 2020, pp. 3799-3817.
[11] Adachi, Tatsuhiko, Nakagawa, Hiroshi, Chung, Ivy, Hagiya, Yuichiro, Hoshijima, Kazuyuki, Noguchi, Noriko, Kuo, Macus Tien, Ishikawa, Toshihisa. ""Nrf2-dependent and -independent induction of ABC transporters ABCC1, ABCC2, and ABCG2 in HepG2 cells under oxidative stress."" Journal of experimental therapeutics & oncology, 2007, pp. 335-48.
[12] Laberge, Rémi-Martin, Karwatsky, Joel, Lincoln, Maximilian C, Leimanis, Mara L, Georges, Elias. ""Modulation of GSH levels in ABCC1 expressing tumor cells triggers apoptosis through oxidative stress."" Biochemical pharmacology, 2007, pp. 1727-37.
[13] Lerner, Leticia K, Moreno, Natália C, Rocha, Clarissa R R, Munford, Veridiana, Santos, Valquíria, Soltys, Daniela T, Garcia, Camila C M, Sarasin, Alain, Menck, Carlos F M. ""XPD/ERCC2 mutations interfere in cellular responses to oxidative stress."" Mutagenesis, 2019, pp. 341-354.
[14] Son, Young-Ok, Heo, Jung-Sun, Kim, Tae-Geum, Jeon, Young-Mi, Kim, Jong-Ghee, Lee, Jeong-Chae. ""Over-expression of JunB inhibits mitochondrial stress and cytotoxicity in human lymphoma cells exposed to chronic oxidative stress."" BMB reports, 2010, pp. 57-61.
[15] Cai, Jiale, Liang, Jiayin, Zhang, Yutong, Shen, Lin, Lin, Huiting, Hu, Tao, Zhan, Sikai, Xie, Meixia, Liang, Shengwang, Xian, Minghua, Wang, Shumei. ""Cyclo-(Phe-Tyr) as a novel cyclic dipeptide compound alleviates ischemic/reperfusion brain injury via JUNB/JNK/NF-κB and SOX5/PI3K/AKT pathways."" Pharmacological research, 2022, pp. 106230.
"	0.64667714	0.56650364	LLM	LLM	NA
Diff. expressed gene set	SPERMATOGENESIS	NA	ACE ACRBP ACRV1 ACTL7B ADAD1 ADAM2 ADCYAP1 AGFG1 AKAP4 ALOX15 ARL4A ART3 AURKA BRAF BUB1 CAMK4 CCNA1 CCNB2 CCT6B CDK1 CDKN3 CFTR CHFR CHRM4 CLGN CLPB CLVS1 CNIH2 COIL CRISP2 CSNK2A2 CST8 DBF4 DCC DDX25 DDX4 DMC1 DMRT1 DNAJB8 DPEP3 ELOVL3 EZH2 GAD1 GAPDHS GFI1 GMCL1 GPR182 GRM8 GSG1 GSTM3 H1-6 HBZ HOXB1 HSPA1L HSPA2 HSPA4L HTR5A IDE IFT88 IL12RB2 IL13RA2 IP6K1 JAM3 KIF2C LDHC LPIN1 MAP7 MAST2 MEP1B MLF1 MLLT10 MTNR1A MTOR NAA11 NCAPH NEFH NEK2 NF2 NOS1 NPHP1 NPY5R OAZ3 ODF1 PACRG PAPOLB PARP2 PCSK1N PCSK4 PDHA2 PEBP1 PGK2 PGS1 PHF7 PHKG2 PIAS2 POMC PRKAR2A PRM2 PSMG1 RAD17 RFC4 RPL39L SCG3 SCG5 SEPTIN4 SHE SIRT1 SLC12A2 SLC2A5 SNAP91 SPATA6 STAM2 STRBP SYCP1 TALDO1 TCP11 TEKT2 THEG TKTL1 TLE4 TNNI3 TNP1 TNP2 TOPBP1 TSN TSSK2 TTK TUBA3C TULP2 VDAC3 YBX2 ZC2HC1C ZC3H14 ZNRF4 ZPBP	135	7.076815597050831	Regulation Of Chromosome Segregation 	GO:0051983	CSNK2A2;KIF2C;BUB1;NCAPH	4	2.9629629629629632	3.58e-5	0.035637324	Spermatogenesis Regulation	"The interacting proteins in this system predominantly contribute to the regulation of spermatogenesis, a process by which male germ cells develop into mature spermatozoa. The proteins involved in this process are essential for male fertility and reproduction.

1. Germ cell development: Several proteins, such as DMC1, DMRT1, DDX4, and SYCP1, play crucial roles in germ cell development and meiosis. DMC1 is involved in homologous recombination, while DMRT1 is essential for sex determination and differentiation. DDX4 is required for germ cell development, and SYCP1 is a component of the synaptonemal complex, which is necessary for proper chromosome pairing during meiosis.

2. Sperm structure and function: Proteins such as AKAP4, ODF1, and TNP1/2 are essential for sperm structure and function. AKAP4 is a major component of the fibrous sheath in the sperm flagellum, while ODF1 is involved in the organization of the outer dense fibers. TNP1 and TNP2 are transition proteins that facilitate chromatin remodeling during spermiogenesis.

3. Sperm motility: Proteins such as GAPDHS, CAMK4, and ACRV1 are involved in sperm motility. GAPDHS is a glycolytic enzyme specific to the sperm tail, providing energy for sperm motility. CAMK4 is a calcium/calmodulin-dependent protein kinase that regulates flagellar movement. ACRV1 is a component of the acrosome, which is essential for sperm-egg interaction.

4. Spermatogenesis regulation: Several proteins, such as ELOVL3, EZH2, and GFI1, are involved in the regulation of spermatogenesis. ELOVL3 is an elongase involved in the synthesis of very long-chain fatty acids, which are essential for spermatogenesis. EZH2 is a histone methyltransferase that regulates gene expression during spermatogenesis. GFI1 is a transcriptional repressor that controls germ cell differentiation.

5. DNA repair and cell cycle control: Proteins such as RAD17, CDK1, and CCNB2 are involved in DNA repair and cell cycle control during spermatogenesis. RAD17 is essential for DNA damage checkpoint activation, while CDK1 and CCNB2 are involved in cell cycle progression.

In conclusion, the interacting proteins in this system are primarily involved in the regulation of spermatogenesis, including germ cell development, sperm structure and function, sperm motility, and DNA repair and cell cycle control. These proteins are essential for male fertility and reproduction."	17	12.592592592592592	"The interacting proteins in this system predominantly contribute to the regulation of spermatogenesis, a process by which male germ cells develop into mature spermatozoa. The proteins involved in this process are essential for male fertility and reproduction.

1. Germ cell development: Several proteins, such as DMC1, DMRT1, DDX4, and SYCP1, play crucial roles in germ cell development and meiosis. DMC1 is involved in homologous recombination, while DMRT1 is essential for sex determination and differentiation. DDX4 is required for germ cell development, and SYCP1 is a component of the synaptonemal complex, which is necessary for proper chromosome pairing during meiosis.[1][2][3]

2. Sperm structure and function: Proteins such as AKAP4, ODF1, and TNP1/2 are essential for sperm structure and function. AKAP4 is a major component of the fibrous sheath in the sperm flagellum, while ODF1 is involved in the organization of the outer dense fibers. TNP1 and TNP2 are transition proteins that facilitate chromatin remodeling during spermiogenesis.[4][5][6]

3. Sperm motility: Proteins such as GAPDHS, CAMK4, and ACRV1 are involved in sperm motility. GAPDHS is a glycolytic enzyme specific to the sperm tail, providing energy for sperm motility. CAMK4 is a calcium/calmodulin-dependent protein kinase that regulates flagellar movement. ACRV1 is a component of the acrosome, which is essential for sperm-egg interaction.[7][8][9]

4. Spermatogenesis regulation: Several proteins, such as ELOVL3, EZH2, and GFI1, are involved in the regulation of spermatogenesis. ELOVL3 is an elongase involved in the synthesis of very long-chain fatty acids, which are essential for spermatogenesis. EZH2 is a histone methyltransferase that regulates gene expression during spermatogenesis. GFI1 is a transcriptional repressor that controls germ cell differentiation.[10][11][12]

5. DNA repair and cell cycle control: Proteins such as RAD17, CDK1, and CCNB2 are involved in DNA repair and cell cycle control during spermatogenesis. RAD17 is essential for DNA damage checkpoint activation, while CDK1 and CCNB2 are involved in cell cycle progression.[13][14][15]

In conclusion, the interacting proteins in this system are primarily involved in the regulation of spermatogenesis, including germ cell development, sperm structure and function, sperm motility, and DNA repair and cell cycle control. These proteins are essential for male fertility and reproduction.

========================================================================================================================================================================================================
[1] Hickford, Danielle E, Frankenberg, Stephen, Pask, Andrew J, Shaw, Geoff, Renfree, Marilyn B. ""DDX4 (VASA) is conserved in germ cell development in marsupials and monotremes."" Biology of reproduction, 2011, pp. 733-43.
[2] Laird, Melanie K, Hore, Timothy A. ""Primordial germ cell expression of SSEA1 and DDX4 (VASA) in female Trichosurus vulpecula (Marsupialia) reveals conserved and unique molecular patterns during marsupial germ cell development."" Reproduction, fertility, and development, 2021, pp. 189-197.
[3] Hong, Seung Kon, Kim, Kook-Han, Song, Eun Joo, Kim, Eunice EunKyeong. ""Structural Basis for the Interaction between the IUS-SPRY Domain of RanBPM and DDX-4 in Germ Cell Development."" Journal of molecular biology, 2016, pp. 4330-4344.
[4] Burmester, S, Hoyer-Fender, S. ""Transcription and translation of the outer dense fiber gene (Odf1) during spermiogenesis in the rat. A study by in situ analyses and polysome fractionation."" Molecular reproduction and development, 1996, pp. 10-20.
[5] Zhao, Ming, Shirley, Cynthia R, Mounsey, Suzanne, Meistrich, Marvin L. ""Nucleoprotein transitions during spermiogenesis in mice with transition nuclear protein Tnp1 and Tnp2 mutations."" Biology of reproduction, 2004, pp. 1016-25.
[6] Dias, G M, López, M L, Ferreira, A T S, Chapeaurouge, D A, Rodrigues, A, Perales, J, Retamal, C A. ""Thiol-disulfide proteins of stallion epididymal spermatozoa."" Animal reproduction science, 2014, pp. 29-39.
[7] Liu, Qishuai, Wang, Li, Yan, Guizhen, Zhang, Weifa, Huan, Zhigang, Li, Jianyuan. ""MiR-125a-5p Alleviates Dysfunction and Inflammation of Pentylenetetrazol- induced Epilepsy Through Targeting Calmodulin-dependent Protein Kinase IV (CAMK4)."" Current neurovascular research, 2019, pp. 365-372.
[8] Khattri, A, Reddy, V P, Pandey, R K, Sudhakar, D V S, Gupta, N J, Chakravarty, B N, Deenadayal, M, Singh, L, Thangaraj, K. ""Novel mutations in calcium/calmodulin-dependent protein kinase IV (CAMK4) gene in infertile men."" International journal of andrology, 2012, pp. 810-818.
[9] Margaryan, Hasmik, Dorosh, Andriy, Capkova, Jana, Manaskova-Postlerova, Pavla, Philimonenko, Anatoly, Hozak, Pavel, Peknicova, Jana. ""Characterization and possible function of glyceraldehyde-3-phosphate dehydrogenase-spermatogenic protein GAPDHS in mammalian sperm."" Reproductive biology and endocrinology : RB&E, 2015, pp. 15.
[10] Sun, Shanshan, Yu, Feng, Xu, Danying, Zheng, Haiyan, Li, Min. ""EZH2, a prominent orchestrator of genetic and epigenetic regulation of solid tumor microenvironment and immunotherapy."" Biochimica et biophysica acta. Reviews on cancer, 2022, pp. 188700.
[11] Yang, Yiying, Liu, Ke, Liu, Meidong, Zhang, Huali, Guo, Muyao. ""EZH2: Its regulation and roles in immune disturbance of SLE."" Frontiers in pharmacology, 2022, pp. 1002741.
[12] Rezaei, Shiva, Hosseinpourfeizi, Mohammad Ali, Moaddab, Yaghoub, Safaralizadeh, Reza. ""Contribution of DNA methylation and EZH2 in SRBC down-regulation in gastric cancer."" Molecular biology reports, 2020, pp. 5721-5727.
[13] Qin, Lili, Fan, Ming, Candas, Demet, Jiang, Guochun, Papadopoulos, Stelios, Tian, Lin, Woloschak, Gayle, Grdina, David J, Li, Jian Jian. ""CDK1 Enhances Mitochondrial Bioenergetics for Radiation-Induced DNA Repair."" Cell reports, 2015, pp. 2056-63.
[14] Shanmugam, Ilanchezhian, Abbas, Mohammad, Ayoub, Farhan, Mirabal, Susan, Bsaili, Manal, Caulder, Erin K, Weinstock, David M, Tomkinson, Alan E, Hromas, Robert, Shaheen, Monte. ""Ubiquitin-specific peptidase 20 regulates Rad17 stability, checkpoint kinase 1 phosphorylation and DNA repair by homologous recombination."" The Journal of biological chemistry, 2014, pp. 22739-22748.
[15] Thorenoor, Nithyananda, Faltejskova-Vychytilova, Petra, Hombach, Sonja, Mlcochova, Jitka, Kretz, Markus, Svoboda, Marek, Slaby, Ondrej. ""Long non-coding RNA ZFAS1 interacts with CDK1 and is involved in p53-dependent cell cycle control and apoptosis in colorectal cancer."" Oncotarget, 2016, pp. 622-37.
"	0.8055906	0.4002213	LLM	LLM	NA
Diff. expressed gene set	TGF BETA SIGNALING	NA	ACVR1 APC ARID4B BCAR3 BMP2 BMPR1A BMPR2 CDH1 CDK9 CDKN1C CTNNB1 ENG FKBP1A FNTA FURIN HDAC1 HIPK2 ID1 ID2 ID3 IFNGR2 JUNB KLF10 LEFTY2 LTBP2 MAP3K7 NCOR2 NOG PMEPA1 PPM1A PPP1CA PPP1R15A RAB31 RHOA SERPINE1 SKI SKIL SLC20A1 SMAD1 SMAD3 SMAD6 SMAD7 SMURF1 SMURF2 SPTBN1 TGFB1 TGFBR1 TGIF1 THBS1 TJP1 TRIM33 UBE2D3 WWTR1 XIAP	54	5.754887502163468	Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway 	GO:0007178	ACVR1;TGFB1;BMPR2;SMAD3;SMURF2;SMURF1;FURIN;LTBP2;SMAD6;TGFBR1;HIPK2;SMAD7;SKI;FKBP1A;BMP2;FNTA;ID1;MAP3K7;LEFTY2;BMPR1A;ENG	21	38.88888888888889	9.43e-33	1.1e-29	TGF-β Signaling Pathway	"The primary biological process performed by this system of interacting proteins is the TGF-β signaling pathway. This pathway is crucial for regulating cell growth, differentiation, and apoptosis. The proteins involved in this process include TGFB1, TGFBR1, SMAD1, SMAD3, SMAD6, SMAD7, and others.

Reasoning and Supporting Information:

1. TGF-β ligands and receptors: TGFB1 is a TGF-β ligand that binds to TGFBR1, a type I receptor, and BMPR2, a type II receptor. This binding activates the receptors and initiates the signaling cascade.

2. SMAD proteins: SMAD1, SMAD3, SMAD6, and SMAD7 are intracellular proteins that transduce signals from TGF-β receptors to the nucleus. SMAD1 and SMAD3 are receptor-regulated SMADs (R-SMADs), while SMAD6 and SMAD7 are inhibitory SMADs (I-SMADs) that negatively regulate the pathway.

3. Activation of R-SMADs: Upon activation of TGF-β receptors, R-SMADs (SMAD1 and SMAD3) are phosphorylated and form complexes with SMAD4, a common mediator SMAD (co-SMAD).

4. Regulation of target genes: The SMAD complexes translocate to the nucleus and regulate the transcription of target genes, such as ID1, ID2, ID3, SERPINE1, and JUNB, which are involved in cell growth, differentiation, and apoptosis.

5. Negative regulation of TGF-β signaling: I-SMADs (SMAD6 and SMAD7) inhibit the pathway by competing with R-SMADs for receptor binding or by targeting the receptors for degradation. SMURF1 and SMURF2 are E3 ubiquitin ligases that mediate the degradation of TGF-β receptors and SMAD proteins, further regulating the pathway.

6. Crosstalk with other pathways: The TGF-β signaling pathway interacts with other cellular pathways, such as the Wnt/β-catenin pathway (involving CTNNB1 and APC), the Hippo pathway (involving WWTR1), and the MAPK pathway (involving MAP3K7).

7. Extracellular regulation: Proteins such as BMP2, BMPR1A, ENG, LEFTY2, LTBP2, NOG, and THBS1 are involved in the extracellular regulation of TGF-β signaling, either by modulating ligand availability or by interacting with receptors.

8. Cellular context: The TGF-β signaling pathway is regulated by various cellular proteins, such as CDH1, CDK9, CDKN1C, FKBP1A, FNTA, FURIN, HDAC1, HIPK2, IFNGR2, KLF10, NCOR2, PMEPA1, PPM1A, PPP1CA, PPP1R15A, RAB31, RHOA, SLC20A1, SPTBN1, TGIF1, TJP1, TRIM33, UBE2D3, and XIAP, which modulate the pathway's activity in response to different cellular contexts and stimuli."	49	90.74074074074076	"The primary biological process performed by this system of interacting proteins is the TGF-β signaling pathway. This pathway is crucial for regulating cell growth, differentiation, and apoptosis. The proteins involved in this process include TGFB1, TGFBR1, SMAD1, SMAD3, SMAD6, SMAD7, and others.[1][2][3]

1. TGF-β ligands and receptors: TGFB1 is a TGF-β ligand that binds to TGFBR1, a type I receptor, and BMPR2, a type II receptor. This binding activates the receptors and initiates the signaling cascade.[4][5][6]

2. SMAD proteins: SMAD1, SMAD3, SMAD6, and SMAD7 are intracellular proteins that transduce signals from TGF-β receptors to the nucleus. SMAD1 and SMAD3 are receptor-regulated SMADs (R-SMADs), while SMAD6 and SMAD7 are inhibitory SMADs (I-SMADs) that negatively regulate the pathway.[7][8][9]

3. Activation of R-SMADs: Upon activation of TGF-β receptors, R-SMADs (SMAD1 and SMAD3) are phosphorylated and form complexes with SMAD4, a common mediator SMAD (co-SMAD).[10][11][12]

4. Regulation of target genes: The SMAD complexes translocate to the nucleus and regulate the transcription of target genes, such as ID1, ID2, ID3, SERPINE1, and JUNB, which are involved in cell growth, differentiation, and apoptosis.[13][14][15]

5. Negative regulation of TGF-β signaling: I-SMADs (SMAD6 and SMAD7) inhibit the pathway by competing with R-SMADs for receptor binding or by targeting the receptors for degradation. SMURF1 and SMURF2 are E3 ubiquitin ligases that mediate the degradation of TGF-β receptors and SMAD proteins, further regulating the pathway.[16][17][18]

6. Crosstalk with other pathways: The TGF-β signaling pathway interacts with other cellular pathways, such as the Wnt/β-catenin pathway (involving CTNNB1 and APC), the Hippo pathway (involving WWTR1), and the MAPK pathway (involving MAP3K7).[19][20][21]

7. Extracellular regulation: Proteins such as BMP2, BMPR1A, ENG, LEFTY2, LTBP2, NOG, and THBS1 are involved in the extracellular regulation of TGF-β signaling, either by modulating ligand availability or by interacting with receptors.[22][23][24]

8. Cellular context: The TGF-β signaling pathway is regulated by various cellular proteins, such as CDH1, CDK9, CDKN1C, FKBP1A, FNTA, FURIN, HDAC1, HIPK2, IFNGR2, KLF10, NCOR2, PMEPA1, PPM1A, PPP1CA, PPP1R15A, RAB31, RHOA, SLC20A1, SPTBN1, TGIF1, TJP1, TRIM33, UBE2D3, and XIAP, which modulate the pathway's activity in response to different cellular contexts and stimuli.[25][26][27]

========================================================================================================================================================================================================
[1] Zhu, Lihua, Liu, Ying, Tang, Haijuan, Wang, Peng. ""FOXP3 activated-LINC01232 accelerates the stemness of non-small cell lung carcinoma by activating TGF-β signaling pathway and recruiting IGF2BP2 to stabilize TGFBR1."" Experimental cell research, 2022, pp. 113024.
[2] Li, Xiaojing, Zeng, Xianpeng. ""Shikonin suppresses progression and epithelial-mesenchymal transition in hepatocellular carcinoma (HCC) cells by modulating miR-106b/SMAD7/TGF-β signaling pathway."" Cell biology international, 2020, pp. 467-476.
[3] Fu, Youwei, Tang, Yin, Wang, Junjie, Guo, Zonghui. ""MicroRNA-181c Suppresses the Biological Progression of Osteosarcoma via Targeting SMAD7 and Regulating Transforming Growth Factor-β (TGF-β) Signaling Pathway."" Medical science monitor : international medical journal of experimental and clinical research, 2019, pp. 4801-4810.
[4] Chu, Kit-Yee, Malik, Anjali, Thamilselvan, Vijayalakshmi, Martinez-Hackert, Erik. ""Type II BMP and activin receptors BMPR2 and ACVR2A share a conserved mode of growth factor recognition."" The Journal of biological chemistry, 2022, pp. 102076.
[5] Peres, Karina Colombera, Teodoro, Larissa, Amaral, Laís Helena Pereira, Teixeira, Elisângela Souza, Barreto, Icléia Siqueira, de Freitas, Leandro Luiz Lopes, Maximo, Valdemar, Assumpção, Lígia V Montalli, Bufalo, Natassia Elena, Ward, Laura Sterian. ""Clinical utility of <i>TGFB1</i> and its receptors (<i>TGFBR1</i> and <i>TGFBR2</i>) in thyroid nodules: evaluation based on single nucleotide polymorphisms and mRNA analysis."" Archives of endocrinology and metabolism, 2021, pp. 172-184.
[6] Vander Ark, Alexandra, Cao, Jingchen, Li, Xiaohong. ""TGF-β receptors: In and beyond TGF-β signaling."" Cellular signalling, 2018, pp. 112-120.
[7] Chen, Yuk-Kwan, Huang, Anderson Hsien-Cheng, Cheng, Pei-Hsun, Yang, Shang-Hsun, Lin, Li-Min. ""Overexpression of Smad proteins, especially Smad7, in oral epithelial dysplasias."" Clinical oral investigations, 2013, pp. 921-32.
[8] Nakayama, T, Berg, L K, Christian, J L. ""Dissection of inhibitory Smad proteins: both N- and C-terminal domains are necessary for full activities of Xenopus Smad6 and Smad7."" Mechanisms of development, 2001, pp. 251-62.
[9] Monteiro, Rui M, de Sousa Lopes, Susana M Chuva, Korchynskyi, Olexander, ten Dijke, Peter, Mummery, Christine L. ""Spatio-temporal activation of Smad1 and Smad5 in vivo: monitoring transcriptional activity of Smad proteins."" Journal of cell science, 2004, pp. 4653-63.
[10] Zhao, Ming, Mishra, Lopa, Deng, Chu-Xia. ""The role of TGF-β/SMAD4 signaling in cancer."" International journal of biological sciences, 2018, pp. 111-123.
[11] McCarthy, Aoife J, Chetty, Runjan. ""<i>Smad4</i>/<i>DPC4</i>."" Journal of clinical pathology, 2018, pp. 661-664.
[12] Hanna, David N, Smith, Paula Marincola, Novitskiy, Sergey V, Washington, M Kay, Zi, Jinghuan, Weaver, Connie J, Hamaamen, Jalal A, Lewis, Keeli B, Zhu, Jing, Yang, Jing, Liu, Qi, Beauchamp, R Daniel, Means, Anna L. ""SMAD4 Suppresses Colitis-associated Carcinoma Through Inhibition of CCL20/CCR6-mediated Inflammation."" Gastroenterology, 2022, pp. 1334-1350.e14.
[13] Hu, Xiao-Meng, Lin, Ting, Huang, Xiao-Yu, Gan, Rui-Huan, Zhao, Yong, Feng, Yan, Ding, Lin-Can, Su, Bo-Hua, Zheng, Da-Li, Lu, You-Guang. ""ID1 contributes to cell growth invasion and migration in salivary adenoid cystic carcinoma."" Molecular medicine reports, 2017, pp. 8907-8915.
[14] Hao, Liang, Liao, Qi, Tang, Qiang, Deng, Huan, Chen, Lu. ""Id-1 promotes osteosarcoma cell growth and inhibits cell apoptosis via PI3K/AKT signaling pathway."" Biochemical and biophysical research communications, 2016, pp. 643-649.
[15] Qi, Jie, Su, Yongyue, Sun, Rongju, Zhang, Fang, Luo, Xiaofeng, Yang, Zongcheng, Luo, Xiangdong. ""CASK inhibits ECV304 cell growth and interacts with Id1."" Biochemical and biophysical research communications, 2005, pp. 517-21.
[16] Bai, Yangjinming, Ying, Ying. ""The Post-translational Modifications of Smurf2 in TGF-β Signaling."" Frontiers in molecular biosciences, 2020, pp. 128.
[17] Kit Leng Lui, Sarah, Iyengar, Prasanna Vasudevan, Jaynes, Patrick, Isa, Zul Fazreen Bin Adam, Pang, Brendan, Tan, Tuan Zea, Eichhorn, Pieter Johan Adam. ""USP26 regulates TGF-β signaling by deubiquitinating and stabilizing SMAD7."" EMBO reports, 2017, pp. 797-808.
[18] Yu, Yi, Gu, Shuchen, Li, Wenjian, Sun, Chuang, Chen, Fenfang, Xiao, Mu, Wang, Lei, Xu, Dewei, Li, Ye, Ding, Chen, Xia, Zongping, Li, Yi, Ye, Sheng, Xu, Pinglong, Zhao, Bin, Qin, Jun, Chen, Ye-Guang, Lin, Xia, Feng, Xin-Hua. ""Smad7 enables STAT3 activation and promotes pluripotency independent of TGF-β signaling."" Proceedings of the National Academy of Sciences of the United States of America, 2017, pp. 10113-10118.
[19] Li, Changgong, Li, Aimin, Xing, Yiming, Li, Min, Chan, Belinda, Ouyang, Ruoyun, Taketo, Makoto Mark, Kucherlapati, Raju, Borok, Zea, Minoo, Parviz. ""Apc deficiency alters pulmonary epithelial cell fate and inhibits Nkx2.1 via triggering TGF-beta signaling."" Developmental biology, 2013, pp. 13-24.
[20] Zhao, Chen-Chen, Jiao, Yang, Zhang, Yi-Yin, Ning, Jie, Zhang, Yi-Ruo, Xu, Jing, Wei, Wei, Kang-Sheng, Gu. ""Lnc SMAD5-AS1 as ceRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt/β-catenin pathway by sponging miR-135b-5p to elevate expression of APC."" Cell death & disease, 2019, pp. 252.
[21] Wu, Xiao-Ting, Wang, Yu-Han, Cai, Xiao-Yue, Dong, Yun, Cui, Qing, Zhou, Ya-Ning, Yang, Xi-Wen, Lu, Wen-Feng, Zhang, Ming. ""RNF115 promotes lung adenocarcinoma through Wnt/β-catenin pathway activation by mediating APC ubiquitination."" Cancer & metabolism, 2021, pp. 7.
[22] Sun, Jian, Ge, Xiaoli, Wang, Yang, Niu, Lei, Tang, Lujia, Pan, Shuming. ""USF2 knockdown downregulates THBS1 to inhibit the TGF-β signaling pathway and reduce pyroptosis in sepsis-induced acute kidney injury."" Pharmacological research, 2022, pp. 105962.
[23] Davies, J. ""Intracellular and extracellular regulation of ureteric bud morphogenesis."" Journal of anatomy, 2001, pp. 257-64.
[24] Gumienny, Tina L, MacNeil, Lesley T, Wang, Huang, de Bono, Mario, Wrana, Jeffrey L, Padgett, Richard W. ""Glypican LON-2 is a conserved negative regulator of BMP-like signaling in Caenorhabditis elegans."" Current biology : CB, 2007, pp. 159-64.
[25] Guca, Ewelina, Suñol, David, Ruiz, Lidia, Konkol, Agnieszka, Cordero, Jorge, Torner, Carles, Aragon, Eric, Martin-Malpartida, Pau, Riera, Antoni, Macias, Maria J. ""TGIF1 homeodomain interacts with Smad MH1 domain and represses TGF-β signaling."" Nucleic acids research, 2018, pp. 9220-9235.
[26] Angelova, A, Tenev, T, Varadinova, T. ""Expression of cellular proteins Bcl-X(L), XIAP and Bax involved in apoptosis in cells infected with herpes simplex virus 1 and effect of pavine alkaloid (-)-thalimonine on virus-induced suppression of apoptosis."" Acta virologica, 2004, pp. 193-6.
[27] Lin, Yueh-Te, Wu, Kou-Juey. ""Epigenetic regulation of epithelial-mesenchymal transition: focusing on hypoxia and TGF-β signaling."" Journal of biomedical science, 2020, pp. 39.
"	0.9685107	0.616875	LLM	LLM	NA
Diff. expressed gene set	TNFA SIGNALING VIA NFKB	NA	ABCA1 ACKR3 AREG ATF3 ATP2B1 B4GALT1 B4GALT5 BCL2A1 BCL3 BCL6 BHLHE40 BIRC2 BIRC3 BMP2 BTG1 BTG2 BTG3 CCL2 CCL20 CCL4 CCL5 CCN1 CCND1 CCNL1 CCRL2 CD44 CD69 CD80 CD83 CDKN1A CEBPB CEBPD CFLAR CLCF1 CSF1 CSF2 CXCL1 CXCL10 CXCL11 CXCL2 CXCL3 CXCL6 DENND5A DNAJB4 DRAM1 DUSP1 DUSP2 DUSP4 DUSP5 EDN1 EFNA1 EGR1 EGR2 EGR3 EHD1 EIF1 ETS2 F2RL1 F3 FJX1 FOS FOSB FOSL1 FOSL2 FUT4 G0S2 GADD45A GADD45B GCH1 GEM GFPT2 GPR183 HBEGF HES1 ICAM1 ICOSLG ID2 IER2 IER3 IER5 IFIH1 IFIT2 IFNGR2 IL12B IL15RA IL18 IL1A IL1B IL23A IL6 IL6ST IL7R INHBA IRF1 IRS2 JAG1 JUN JUNB KDM6B KLF10 KLF2 KLF4 KLF6 KLF9 KYNU LAMB3 LDLR LIF LITAF MAFF MAP2K3 MAP3K8 MARCKS MCL1 MSC MXD1 MYC NAMPT NFAT5 NFE2L2 NFIL3 NFKB1 NFKB2 NFKBIA NFKBIE NINJ1 NR4A1 NR4A2 NR4A3 OLR1 PANX1 PDE4B PDLIM5 PER1 PFKFB3 PHLDA1 PHLDA2 PLAU PLAUR PLEK PLK2 PLPP3 PMEPA1 PNRC1 PPP1R15A PTGER4 PTGS2 PTPRE PTX3 RCAN1 REL RELA RELB RHOB RIGI RIPK2 RNF19B SAT1 SDC4 SERPINB2 SERPINB8 SERPINE1 SGK1 SIK1 SLC16A6 SLC2A3 SLC2A6 SMAD3 SNN SOCS3 SOD2 SPHK1 SPSB1 SQSTM1 STAT5A TANK TAP1 TGIF1 TIPARP TLR2 TNC TNF TNFAIP2 TNFAIP3 TNFAIP6 TNFAIP8 TNFRSF9 TNFSF9 TNIP1 TNIP2 TRAF1 TRIB1 TRIP10 TSC22D1 TUBB2A VEGFA YRDC ZBTB10 ZC3H12A ZFP36	200	7.643856189774724	Positive Regulation Of Transcription By RNA Polymerase II 	GO:0045944	LITAF;TNF;ETS2;MYC;ZC3H12A;NAMPT;IER5;JUNB;IER2;KLF10;KDM6B;EDN1;RIPK2;IL18;FOS;IRF1;SQSTM1;ATF3;TLR2;NFAT5;CEBPB;RELA;RELB;HES1;STAT5A;EGR1;EGR2;JUN;JAG1;SMAD3;LIF;INHBA;KLF4;NFKB1;KLF2;FOSL2;VEGFA;NFKB2;NR4A2;NFKBIA;PER1;CXCL10;NR4A1;BMP2;IL6;KLF6;NR4A3;TNIP1;TNIP2;MAFF;BCL3;REL;F2RL1;RIGI;NFE2L2	55	27.500000000000004	2.1200000000000003e-27	4.49e-24	Inflammatory Response and Cell Cycle Regulation	"The system of interacting proteins primarily involves the inflammatory response and cell cycle regulation. Key proteins involved in these processes include:

1. Inflammatory Response:
- CCL2, CCL4, CCL5, CXCL1, CXCL2, CXCL3, CXCL6, CXCL10, and CXCL11 are chemokines that recruit immune cells to the site of inflammation.
- IL1A, IL1B, IL6, IL12B, IL18, IL23A, and TNF are cytokines that mediate inflammatory response and regulate immune cell functions.
- ICAM1, VCAM1, and CD44 are cell adhesion molecules that facilitate leukocyte migration and extravasation.
- PTGS2 (COX2) is involved in the synthesis of prostaglandins, which contribute to inflammation and pain.
- NFKB1, NFKB2, REL, RELA, and RELB are components of the NF-κB transcription factor complex, which regulates the expression of inflammatory genes.

2. Cell Cycle Regulation:
- CCND1, CDKN1A, and MYC are involved in cell cycle progression and regulation.
- EGR1, EGR2, and EGR3 are early growth response genes that regulate cell growth and differentiation.
- FOS, FOSB, FOSL1, FOSL2, JUN, and JUNB are components of the AP-1 transcription factor complex, which regulates cell proliferation, differentiation, and apoptosis.
- BCL2A1, BCL3, BCL6, BIRC2, BIRC3, and MCL1 are involved in the regulation of apoptosis.
- GADD45A and GADD45B are involved in DNA repair and cell cycle arrest in response to DNA damage.

These proteins interact to regulate the inflammatory response and cell cycle progression, ensuring proper immune response and maintaining cellular homeostasis. The presence of both pro-inflammatory and anti-inflammatory proteins, as well as cell cycle activators and inhibitors, highlights the complexity and fine-tuning of these processes."	44	22	"The system of interacting proteins primarily involves the inflammatory response and cell cycle regulation. Key proteins involved in these processes include:

- CCL2, CCL4, CCL5, CXCL1, CXCL2, CXCL3, CXCL6, CXCL10, and CXCL11 are chemokines that recruit immune cells to the site of inflammation.[1][2][3]

- IL1A, IL1B, IL6, IL12B, IL18, IL23A, and TNF are cytokines that mediate inflammatory response and regulate immune cell functions.[4][5][6]

- ICAM1, VCAM1, and CD44 are cell adhesion molecules that facilitate leukocyte migration and extravasation.[7][8][9]

- PTGS2 (COX2) is involved in the synthesis of prostaglandins, which contribute to inflammation and pain.[10][11][12]

- NFKB1, NFKB2, REL, RELA, and RELB are components of the NF-κB transcription factor complex, which regulates the expression of inflammatory genes.[13][14][15]

- CCND1, CDKN1A, and MYC are involved in cell cycle progression and regulation.[16][17][18]

- EGR1, EGR2, and EGR3 are early growth response genes that regulate cell growth and differentiation.[19][20][21]

- FOS, FOSB, FOSL1, FOSL2, JUN, and JUNB are components of the AP-1 transcription factor complex, which regulates cell proliferation, differentiation, and apoptosis.[22][23][24]

- BCL2A1, BCL3, BCL6, BIRC2, BIRC3, and MCL1 are involved in the regulation of apoptosis.[25][26][27]

- GADD45A and GADD45B are involved in DNA repair and cell cycle arrest in response to DNA damage.[28][29][30]

These proteins interact to regulate the inflammatory response and cell cycle progression, ensuring proper immune response and maintaining cellular homeostasis. The presence of both pro-inflammatory and anti-inflammatory proteins, as well as cell cycle activators and inhibitors, highlights the complexity and fine-tuning of these processes.

========================================================================================================================================================================================================
[1] Karin, Nathan, Razon, Hila. ""Chemokines beyond chemo-attraction: CXCL10 and its significant role in cancer and autoimmunity."" Cytokine, 2018, pp. 24-28.
[2] Girbl, Tamara, Lenn, Tchern, Perez, Lorena, Rolas, Loïc, Barkaway, Anna, Thiriot, Aude, Del Fresno, Carlos, Lynam, Eleanor, Hub, Elin, Thelen, Marcus, Graham, Gerard, Alon, Ronen, Sancho, David, von Andrian, Ulrich H, Voisin, Mathieu-Benoit, Rot, Antal, Nourshargh, Sussan. ""Distinct Compartmentalization of the Chemokines CXCL1 and CXCL2 and the Atypical Receptor ACKR1 Determine Discrete Stages of Neutrophil Diapedesis."" Immunity, 2018, pp. 1062-1076.e6.
[3] De Filippo, Katia, Dudeck, Anne, Hasenberg, Mike, Nye, Emma, van Rooijen, Nico, Hartmann, Karin, Gunzer, Matthias, Roers, Axel, Hogg, Nancy. ""Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation."" Blood, 2013, pp. 4930-7.
[4] Zegeye, Mulugeta M, Lindkvist, Madelene, Fälker, Knut, Kumawat, Ashok K, Paramel, Geena, Grenegård, Magnus, Sirsjö, Allan, Ljungberg, Liza U. ""Activation of the JAK/STAT3 and PI3K/AKT pathways are crucial for IL-6 trans-signaling-mediated pro-inflammatory response in human vascular endothelial cells."" Cell communication and signaling : CCS, 2018, pp. 55.
[5] Ko, Hyunmin, Il Kim, Young, Ahn, Hyung Joon. ""Activin Suppresses the Inflammatory Response of TNF-α -stimulated Human Umbilical Vein Endothelial Cells."" Die Pharmazie, 2022, pp. 152-156.
[6] Valin, Alvaro, Del Rey, Manuel J, Municio, Cristina, Usategui, Alicia, Romero, Marina, Fernández-Felipe, Jesús, Cañete, Juan D, Blanco, Francisco J, Ruano, Yolanda, Criado, Gabriel, Pablos, José L. ""IL6/sIL6R regulates TNFα-inflammatory response in synovial fibroblasts through modulation of transcriptional and post-transcriptional mechanisms."" BMC molecular and cell biology, 2020, pp. 74.
[7] Wolf, Kayla J, Shukla, Poojan, Springer, Kelsey, Lee, Stacey, Coombes, Jason D, Choy, Caleb J, Kenny, Samuel J, Xu, Ke, Kumar, Sanjay. ""A mode of cell adhesion and migration facilitated by CD44-dependent microtentacles."" Proceedings of the National Academy of Sciences of the United States of America, 2020, pp. 11432-11443.
[8] Rafat, Marjan, Rotenstein, Lisa S, Hu, Jennifer L, Auguste, Debra T. ""Engineered endothelial cell adhesion via VCAM1 and E-selectin antibody-presenting alginate hydrogels."" Acta biomaterialia, 2012, pp. 2697-703.
[9] Yoo, Nina, Lee, Ha-Reum, Son, Jang-Mi, Kang, Ho-Bum, Lee, Hee Gu, Yoon, Suk Ran, Yoon, Sun Young, Kim, Jae Wha. ""Genkwadaphnin promotes leukocyte migration by increasing CD44 expression via PKD1/NF-κB signaling pathway."" Immunology letters, 2016, pp. 69-76.
[10] Siemieniuch, M J, Jursza, E, Kowalewski, M P, Majewska, M, Skarzynski, D J. ""Prostaglandin endoperoxide synthase 2 (PTGS2) and prostaglandins F2α and E2 synthases (PGFS and PGES) expression and prostaglandin F2α and E2 secretion following oestrogen and/or progesterone stimulation of the feline endometrium."" Reproduction in domestic animals = Zuchthygiene, 2013, pp. 72-8.
[11] Liu, Hao, Rose, Marie E, Miller, Tricia M, Li, Wenjin, Shinde, Sunita N, Pickrell, Alicia M, Poloyac, Samuel M, Graham, Steven H, Hickey, Robert W. ""COX2-derived primary and cyclopentenone prostaglandins are increased after asphyxial cardiac arrest."" Brain research, 2013, pp. 71-7.
[12] Cipollone, F. ""COX-2 and prostaglandins in atherosclerosis."" Lupus, 2005, pp. 756-9.
[13] Visekruna, Alexander, Volkov, Anton, Steinhoff, Ulrich. ""A key role for NF-κB transcription factor c-Rel in T-lymphocyte-differentiation and effector functions."" Clinical & developmental immunology, 2012, pp. 239368.
[14] Mindt, Barbara C, Krisna, Sai Sakktee, Duerr, Claudia U, Mancini, Mathieu, Richer, Lara, Vidal, Silvia M, Gerondakis, Steven, Langlais, David, Fritz, Jörg H. ""The NF-κB Transcription Factor c-Rel Modulates Group 2 Innate Lymphoid Cell Effector Functions and Drives Allergic Airway Inflammation."" Frontiers in immunology, 2021, pp. 664218.
[15] Luu, Maik, Romero, Rossana, Bazant, Jasmin, Abass, Elfadil, Hartmann, Sabrina, Leister, Hanna, Fischer, Florence, Mahdavi, Rouzbeh, Plaza-Sirvent, Carlos, Schmitz, Ingo, Steinhoff, Ulrich, Visekruna, Alexander. ""The NF-κB transcription factor c-Rel controls host defense against Citrobacter rodentium."" European journal of immunology, 2020, pp. 292-294.
[16] Bretones, Gabriel, Delgado, M Dolores, León, Javier. ""Myc and cell cycle control."" Biochimica et biophysica acta, 2015, pp. 506-16.
[17] Zhu, Qingqing, Zhang, Chongguo, Qu, Tianyu, Lu, Xiyi, He, Xuezhi, Li, Wei, Yin, Dandan, Han, Liang, Guo, Renhua, Zhang, Erbao. ""MNX1-AS1 Promotes Phase Separation of IGF2BP1 to Drive c-Myc-Mediated Cell-Cycle Progression and Proliferation in Lung Cancer."" Cancer research, 2022, pp. 4340-4358.
[18] Wang, Xuehui, Chen, Minghui, Fang, Lin. ""hsa_circ_0068631 promotes breast cancer progression through c-Myc by binding to EIF4A3."" Molecular therapy. Nucleic acids, 2021, pp. 122-134.
[19] Yang, Liuqing, Li, Lina, Chang, Pan, Wei, Ming, Chen, Jianting, Zhu, Chaofan, Jia, Jing. ""miR-25 Regulates Gastric Cancer Cell Growth and Apoptosis by Targeting EGR2."" Frontiers in genetics, 2021, pp. 690196.
[20] Guo, Hao, Zhang, Linlei. ""EGR1/2 Inhibits Papillary Thyroid Carcinoma Cell Growth by Suppressing the Expression of PTEN and BAX."" Biochemical genetics, 2021, pp. 1544-1557.
[21] Adamson, Eileen D, Mercola, Dan. ""Egr1 transcription factor: multiple roles in prostate tumor cell growth and survival."" Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2002, pp. 93-102.
[22] Ren, Wen, Yang, Lan, Deng, Tian, Wu, Caijuan, Li, Yuanjing, Wu, Jingwen, Huang, Zhu, Du, Faliang, Guo, Lvhua. ""Calcitonin gene‑related peptide regulates FOSL2 expression and cell proliferation of BMSCs via mmu_circRNA_003795."" Molecular medicine reports, 2019, pp. 3732-3742.
[23] Han, Yu, Zhao, Xingyu, Sun, Yifu, Sui, Yutong, Liu, Jianguo. ""Effects of FOSL1 silencing on osteosarcoma cell proliferation, invasion and migration through the ERK/AP-1 signaling pathway."" Journal of cellular physiology, 2019, pp. 3598-3612.
[24] He, Jiangtu, Mai, Jieying, Li, Yan, Chen, Linyi, Xu, Hui, Zhu, Xiaofei, Pan, Qiuhui. ""miR-597 inhibits breast cancer cell proliferation, migration and invasion through FOSL2."" Oncology reports, 2017, pp. 2672-2678.
[25] Luo, Qingyu, Wu, Xiaowei, Zhao, Pengfei, Nan, Yabing, Chang, Wan, Zhu, Xiaolin, Su, Dan, Liu, Zhihua. ""OTUD1 Activates Caspase-Independent and Caspase-Dependent Apoptosis by Promoting AIF Nuclear Translocation and MCL1 Degradation."" Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2021, pp. 2002874.
[26] Hu, Yiming, Zhang, Haohao, Xie, Ningxia, Liu, Dandan, Jiang, Yuhang, Liu, Zhi, Ye, Deji, Liu, Sanhong, Chen, Xi, Li, Cuifeng, Wang, Qi, Huang, Xingxu, Liu, Yongzhong, Shi, Yufang, Zhang, Xiaoren. ""Bcl-3 promotes TNF-induced hepatocyte apoptosis by regulating the deubiquitination of RIP1."" Cell death and differentiation, 2022, pp. 1176-1186.
[27] Zhu, Hua-Long, Dai, Li-Min, Xiong, Yong-Wei, Shi, Xue-Ting, Liu, Wei-Bo, Fu, Yi-Ting, Zhou, Guo-Xiang, Zhang, Shuang, Gao, Lan, Zhang, Cheng, Zhao, Ling-Li, Xu, Xiao-Feng, Huang, Yi-Chao, Xu, De-Xiang, Wang, Hua. ""Gestational exposure to environmental cadmium induces placental apoptosis and fetal growth restriction via Parkin-modulated MCL-1 degradation."" Journal of hazardous materials, 2022, pp. 127268.
[28] Jung, H J, Kim, E H, Mun, J-Y, Park, S, Smith, M L, Han, S S, Seo, Y R. ""Base excision DNA repair defect in Gadd45a-deficient cells."" Oncogene, 2007, pp. 7517-25.
[29] Hollander, M C, Kovalsky, O, Salvador, J M, Kim, K E, Patterson, A D, Haines, D C, Fornace, A J. ""Dimethylbenzanthracene carcinogenesis in Gadd45a-null mice is associated with decreased DNA repair and increased mutation frequency."" Cancer research, 2001, pp. 2487-91.
[30] Kim, Yeo Jin, Kim, Hyoung-June, Kim, Hye Lim, Kim, Hyo Jeong, Kim, Hyun Soo, Lee, Tae Ryong, Shin, Dong Wook, Seo, Young Rok. ""A Protective Mechanism of Visible Red Light in Normal Human Dermal Fibroblasts: Enhancement of GADD45A-Mediated DNA Repair Activity."" The Journal of investigative dermatology, 2017, pp. 466-474.
"	0.2687403	0.21155284	Neither	LLM	NA
Diff. expressed gene set	UNFOLDED PROTEIN RESPONSE	NA	ALDH18A1 ARFGAP1 ASNS ATF3 ATF4 ATF6 ATP6V0D1 BAG3 BANF1 CALR CCL2 CEBPB CEBPG CHAC1 CKS1B CNOT2 CNOT4 CNOT6 CXXC1 DCP1A DCP2 DCTN1 DDIT4 DDX10 DKC1 DNAJA4 DNAJB9 DNAJC3 EDC4 EDEM1 EEF2 EIF2AK3 EIF2S1 EIF4A1 EIF4A2 EIF4A3 EIF4E EIF4EBP1 EIF4G1 ERN1 ERO1A EXOC2 EXOSC1 EXOSC10 EXOSC2 EXOSC4 EXOSC5 EXOSC9 FKBP14 FUS GEMIN4 GOSR2 H2AX HERPUD1 HSP90B1 HSPA5 HSPA9 HYOU1 IARS1 IFIT1 IGFBP1 IMP3 KDELR3 KHSRP KIF5B LSM1 LSM4 MTHFD2 MTREX NABP1 NFYA NFYB NHP2 NOLC1 NOP14 NOP56 NPM1 PAIP1 PARN PDIA5 PDIA6 POP4 PREB PSAT1 RPS14 RRP9 SDAD1 SEC11A SEC31A SERP1 SHC1 SKIC3 SLC1A4 SLC30A5 SLC7A5 SPCS1 SPCS3 SRPRA SRPRB SSR1 STC2 TARS1 TATDN2 TSPYL2 TUBB2A VEGFA WFS1 WIPI1 XBP1 XPOT YIF1A YWHAZ ZBTB17	113	6.820178962415188	Response To Endoplasmic Reticulum Stress 	GO:0034976	ERO1A;XBP1;CEBPB;HSPA5;WFS1;EIF2AK3;PDIA6;EIF2S1;HSP90B1;HERPUD1;ERN1;DNAJB9;HYOU1;CHAC1;ATF6;ATF3;ATF4	17	15.04424778761062	8.25e-20	9.07e-17	Integrated Stress Response (ISR)	"The system of interacting proteins primarily performs the Integrated Stress Response (ISR), a cellular process that helps cells adapt to various stress conditions. The ISR is initiated by the activation of eukaryotic initiation factor 2 alpha (eIF2α) kinases, such as EIF2AK3, which phosphorylate EIF2S1, leading to a reduction in global protein synthesis and the selective translation of stress-responsive genes.

Key components of the ISR include:

1. Unfolded Protein Response (UPR): The proteins ATF6, IRE1 (ERN1), and PERK (EIF2AK3) are sensors of endoplasmic reticulum (ER) stress. Upon activation, they induce the expression of chaperones (e.g., HSPA5, CALR, PDIA5, PDIA6) and other proteins (e.g., EDEM1, HERPUD1, DNAJB9) to restore ER homeostasis.

2. Amino Acid Starvation Response: ASNS and ATF4 are involved in the regulation of amino acid biosynthesis. Under amino acid deprivation, ATF4 activates the transcription of genes involved in amino acid synthesis (e.g., PSAT1, SLC1A4, SLC7A5) and transport.

3. Oxidative Stress Response: ERO1A and HYOU1 are involved in the response to oxidative stress. ERO1A generates disulfide bonds in the ER, while HYOU1 is a molecular chaperone that assists in protein folding under oxidative stress conditions.

4. Translational Control: EIF4A1, EIF4A2, EIF4A3, EIF4E, EIF4EBP1, and EIF4G1 are components of the eukaryotic translation initiation complex, which regulates protein synthesis. The phosphorylation of EIF2S1 by EIF2AK3 leads to a decrease in global protein synthesis, allowing cells to conserve resources and prioritize the translation of stress-responsive genes.

5. Transcriptional Regulation: ATF3, CEBPB, CEBPG, and XBP1 are transcription factors that regulate the expression of stress-responsive genes. For example, XBP1 is a key regulator of the UPR, activating the transcription of genes involved in protein folding, ER-associated degradation (ERAD), and lipid biosynthesis.

6. mRNA Decay: DCP1A, DCP2, EDC4, and CNOT2 are involved in mRNA decay, a process that helps maintain cellular homeostasis by degrading aberrant or unnecessary transcripts.

7. Protein Degradation: BAG3, DNAJA4, and DNAJC3 are involved in protein quality control, assisting in the degradation of misfolded or damaged proteins through the ubiquitin-proteasome system or autophagy.

In summary, the ISR is a coordinated response to various cellular stress conditions, involving the regulation of protein synthesis, folding, degradation, and transcriptional control to maintain cellular homeostasis and promote cell survival."	35	30.973451327433622	"The system of interacting proteins primarily performs the Integrated Stress Response (ISR), a cellular process that helps cells adapt to various stress conditions. The ISR is initiated by the activation of eukaryotic initiation factor 2 alpha (eIF2α) kinases, such as EIF2AK3, which phosphorylate EIF2S1, leading to a reduction in global protein synthesis and the selective translation of stress-responsive genes.[1][2][3]

Key components of the ISR include:

1. Unfolded Protein Response (UPR): The proteins ATF6, IRE1 (ERN1), and PERK (EIF2AK3) are sensors of endoplasmic reticulum (ER) stress. Upon activation, they induce the expression of chaperones (e.g., HSPA5, CALR, PDIA5, PDIA6) and other proteins (e.g., EDEM1, HERPUD1, DNAJB9) to restore ER homeostasis.[4][5][6]

2. Amino Acid Starvation Response: ASNS and ATF4 are involved in the regulation of amino acid biosynthesis. Under amino acid deprivation, ATF4 activates the transcription of genes involved in amino acid synthesis (e.g., PSAT1, SLC1A4, SLC7A5) and transport.[7][8][9]

3. Oxidative Stress Response: ERO1A and HYOU1 are involved in the response to oxidative stress. ERO1A generates disulfide bonds in the ER, while HYOU1 is a molecular chaperone that assists in protein folding under oxidative stress conditions.[10][11][12]

4. Translational Control: EIF4A1, EIF4A2, EIF4A3, EIF4E, EIF4EBP1, and EIF4G1 are components of the eukaryotic translation initiation complex, which regulates protein synthesis. The phosphorylation of EIF2S1 by EIF2AK3 leads to a decrease in global protein synthesis, allowing cells to conserve resources and prioritize the translation of stress-responsive genes.[13][14][15]

5. Transcriptional Regulation: ATF3, CEBPB, CEBPG, and XBP1 are transcription factors that regulate the expression of stress-responsive genes. For example, XBP1 is a key regulator of the UPR, activating the transcription of genes involved in protein folding, ER-associated degradation (ERAD), and lipid biosynthesis.[16][17][18]

6. mRNA Decay: DCP1A, DCP2, EDC4, and CNOT2 are involved in mRNA decay, a process that helps maintain cellular homeostasis by degrading aberrant or unnecessary transcripts.[19][20][21]

7. Protein Degradation: BAG3, DNAJA4, and DNAJC3 are involved in protein quality control, assisting in the degradation of misfolded or damaged proteins through the ubiquitin-proteasome system or autophagy.[22][23][24]

In summary, the ISR is a coordinated response to various cellular stress conditions, involving the regulation of protein synthesis, folding, degradation, and transcriptional control to maintain cellular homeostasis and promote cell survival.

========================================================================================================================================================================================================
[1] Sowers, Carrie R, Wang, Rong, Bourne, Rebecca A, McGrath, Barbara C, Hu, Jingjie, Bevilacqua, Sarah C, Paton, James C, Paton, Adrienne W, Collardeau-Frachon, Sophie, Nicolino, Marc, Cavener, Douglas R. ""The protein kinase PERK/EIF2AK3 regulates proinsulin processing not via protein synthesis but by controlling endoplasmic reticulum chaperones."" The Journal of biological chemistry, 2018, pp. 5134-5149.
[2] Zhang, Rui, Qin, Xiaodong, Yang, Yang, Zhu, Xueliang, Zhao, Shuaiyang, Zhang, Zhixiong, Su, Qianlong, Zhao, Zhixun, Yin, Xiangping, Meng, Xuelian, Zhang, Zhidong, Li, Yanmin. ""STING1 is essential for an RNA-virus triggered autophagy."" Autophagy, 2022, pp. 816-828.
[3] Ho, Cally J, Samarasekera, Gayathri, Rothe, Katharina, Xu, Jing, Yang, Kevin C, Leung, Emily, Chan, Michelle, Jiang, Xiaoyan, Gorski, Sharon M. ""Puncta intended: connecting the dots between autophagy and cell stress networks."" Autophagy, 2021, pp. 1028-1033.
[4] Mohamed, Eslam, Sierra, Rosa A, Trillo-Tinoco, Jimena, Cao, Yu, Innamarato, Patrick, Payne, Kyle K, de Mingo Pulido, Alvaro, Mandula, Jessica, Zhang, Shuzhong, Thevenot, Paul, Biswas, Subir, Abdalla, Sarah K, Costich, Tara Lee, Hänggi, Kay, Anadon, Carmen M, Flores, Elsa R, Haura, Eric B, Mehrotra, Shikhar, Pilon-Thomas, Shari, Ruffell, Brian, Munn, David H, Cubillos-Ruiz, Juan R, Conejo-Garcia, Jose R, Rodriguez, Paulo C. ""The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling."" Immunity, 2020, pp. 668-682.e7.
[5] Fan, Ping, Jordan, V Craig. ""PERK, Beyond an Unfolded Protein Response Sensor in Estrogen-Induced Apoptosis in Endocrine-Resistant Breast Cancer."" Molecular cancer research : MCR, 2022, pp. 193-201.
[6] Rozpedek, W, Pytel, D, Mucha, B, Leszczynska, H, Diehl, J A, Majsterek, I. ""The Role of the PERK/eIF2α/ATF4/CHOP Signaling Pathway in Tumor Progression During Endoplasmic Reticulum Stress."" Current molecular medicine, 2016, pp. 533-44.
[7] Zhou, Xingquan, Xiong, Hui, Lu, Yi, Geng, Meijuan, Lu, Yumei, Zhang, Lirong, Zhu, Xu. ""PKD2 deficiency suppresses amino acid biosynthesis in ADPKD by impairing the PERK-TBL2-eIF2ɑ-ATF4 pathway."" Biochemical and biophysical research communications, 2021, pp. 73-79.
[8] Gao, Ruize, Kalathur, Ravi K R, Coto-Llerena, Mairene, Ercan, Caner, Buechel, David, Shuang, Song, Piscuoglio, Salvatore, Dill, Michael T, Camargo, Fernando D, Christofori, Gerhard, Tang, Fengyuan. ""YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis."" EMBO molecular medicine, 2021, pp. e14351.
[9] Hao, Liuyi, Zhong, Wei, Dong, Haibo, Guo, Wei, Sun, Xinguo, Zhang, Wenliang, Yue, Ruichao, Li, Tianjiao, Griffiths, Alexandra, Ahmadi, Ali Reza, Sun, Zhaoli, Song, Zhenyuan, Zhou, Zhanxiang. ""ATF4 activation promotes hepatic mitochondrial dysfunction by repressing NRF1-TFAM signalling in alcoholic steatohepatitis."" Gut, 2021, pp. 1933-1945.
[10] Wang, Zhe, Tan, Chen, Duan, Caihan, Wu, Junhao, Zhou, Dan, Hou, Lingzhi, Qian, Wei, Han, Chaoqun, Hou, Xiaohua. ""FUT2-dependent fucosylation of HYOU1 protects intestinal stem cells against inflammatory injury by regulating unfolded protein response."" Redox biology, 2023, pp. 102618.
[11] Guo, Qiang, Liu, Xiao-Li, Liu, Hua-Song, Luo, Xiang-Yu, Yuan, Ye, Ji, Yan-Mei, Liu, Tao, Guo, Jia-Long, Zhang, Jun. ""The Risk Model Based on the Three Oxidative Stress-Related Genes Evaluates the Prognosis of LAC Patients."" Oxidative medicine and cellular longevity, 2022, pp. 4022896.
[12] Shergalis, Andrea G, Hu, Shuai, Bankhead, Armand, Neamati, Nouri. ""Role of the ERO1-PDI interaction in oxidative protein folding and disease."" Pharmacology & therapeutics, 2020, pp. 107525.
[13] Connor, John H, Lyles, Douglas S. ""Vesicular stomatitis virus infection alters the eIF4F translation initiation complex and causes dephosphorylation of the eIF4E binding protein 4E-BP1."" Journal of virology, 2002, pp. 10177-87.
[14] Zhang, Ying, Li, Yan, Yang, Da-Qing. ""Phosphorylation of eIF-4E positively regulates formation of the eIF-4F translation initiation complex following DNA damage."" Biochemical and biophysical research communications, 2008, pp. 54-9.
[15] Sowers, Carrie R, Wang, Rong, Bourne, Rebecca A, McGrath, Barbara C, Hu, Jingjie, Bevilacqua, Sarah C, Paton, James C, Paton, Adrienne W, Collardeau-Frachon, Sophie, Nicolino, Marc, Cavener, Douglas R. ""The protein kinase PERK/EIF2AK3 regulates proinsulin processing not via protein synthesis but by controlling endoplasmic reticulum chaperones."" The Journal of biological chemistry, 2018, pp. 5134-5149.
[16] Lõhelaid, Helike, Anttila, Jenni E, Liew, Hock-Kean, Tseng, Kuan-Yin, Teppo, Jaakko, Stratoulias, Vassilis, Airavaara, Mikko. ""UPR Responsive Genes <i>Manf</i> and <i>Xbp1</i> in Stroke."" Frontiers in cellular neuroscience, 2022, pp. 900725.
[17] Spaan, Claudia N, Smit, Wouter L, van Lidth de Jeude, Jooske F, Meijer, Bartolomeus J, Muncan, Vanesa, van den Brink, Gijs R, Heijmans, Jarom. ""Expression of UPR effector proteins ATF6 and XBP1 reduce colorectal cancer cell proliferation and stemness by activating PERK signaling."" Cell death & disease, 2019, pp. 490.
[18] Wang, Jie-Mei, Li, Hainan, Xu, Liping, Kim, Hyunbae, Qiu, Yining, Zhang, Kezhong. ""Boosting UPR transcriptional activator XBP1 accelerates acute wound healing."" PNAS nexus, 2023, pp. pgad050.
[19] Yoon, Je-Hyun, Choi, Eui-Ju, Parker, Roy. ""Dcp2 phosphorylation by Ste20 modulates stress granule assembly and mRNA decay in Saccharomyces cerevisiae."" The Journal of cell biology, 2010, pp. 813-27.
[20] Zeidan, Quira, He, Feng, Zhang, Fan, Zhang, Hongen, Jacobson, Allan, Hinnebusch, Alan G. ""Conserved mRNA-granule component Scd6 targets Dhh1 to repress translation initiation and activates Dcp2-mediated mRNA decay in vivo."" PLoS genetics, 2018, pp. e1007806.
[21] Hallacli, Erinc, Kayatekin, Can, Nazeen, Sumaiya, Wang, Xiou H, Sheinkopf, Zoe, Sathyakumar, Shubhangi, Sarkar, Souvarish, Jiang, Xin, Dong, Xianjun, Di Maio, Roberto, Wang, Wen, Keeney, Matthew T, Felsky, Daniel, Sandoe, Jackson, Vahdatshoar, Aazam, Udeshi, Namrata D, Mani, D R, Carr, Steven A, Lindquist, Susan, De Jager, Philip L, Bartel, David P, Myers, Chad L, Greenamyre, J Timothy, Feany, Mel B, Sunyaev, Shamil R, Chung, Chee Yeun, Khurana, Vikram. ""The Parkinson's disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability."" Cell, 2022, pp. 2035-2056.e33.
[22] Rapino, F, Abhari, B A, Jung, M, Fulda, S. ""NIK is required for NF-κB-mediated induction of BAG3 upon inhibition of constitutive protein degradation pathways."" Cell death & disease, 2015, pp. e1692.
[23] Rapino, F, Jung, M, Fulda, S. ""BAG3 induction is required to mitigate proteotoxicity via selective autophagy following inhibition of constitutive protein degradation pathways."" Oncogene, 2014, pp. 1713-24.
[24] Ying, Zhong-Ming, Lv, Qian-Kun, Yao, Xiao-Yu, Dong, An-Qi, Yang, Ya-Ping, Cao, Yu-Lan, Wang, Fen, Gong, Ai-Ping, Liu, Chun-Feng. ""BAG3 promotes autophagy and suppresses NLRP3 inflammasome activation in Parkinson's disease."" Annals of translational medicine, 2022, pp. 1218.
"	0.61427575	0.73086727	GO	GO	NA
Diff. expressed gene set	UV RESPONSE DN	NA	ABCC1 ACVR2A ADD3 ADGRL2 ADORA2B AGGF1 AKT3 AMPH ANXA2 ANXA4 APBB2 ARHGEF9 ATP2B1 ATP2B4 ATP2C1 ATRN ATRX ATXN1 BCKDHB BDNF BHLHE40 BMPR1A CACNA1A CAP2 CAV1 CCN1 CDC42BPA CDK13 CDKN1B CDON CELF2 CITED2 COL11A1 COL1A1 COL1A2 COL3A1 COL5A2 DAB2 DBP DDAH1 DLC1 DLG1 DMAC2L DUSP1 DYRK1A EFEMP1 ERBB2 F3 FBLN5 FHL2 FYN FZD2 GCNT1 GJA1 GRK5 HAS2 ICA1 ID1 IGF1R IGFBP5 INPP4B INSIG1 IRS1 ITGB3 KALRN KCNMA1 KIT LAMC1 LDLR LPAR1 LTBP1 MAGI2 MAP1B MAP2K5 MAPK14 MET MGLL MGMT MIOS MMP16 MRPS31 MT1E MTA1 MYC NEK7 NFIB NFKB1 NIPBL NOTCH2 NR1D2 NR3C1 NRP1 PDGFRB PDLIM5 PEX14 PHF3 PIAS3 PIK3CD PIK3R3 PLCB4 PLPP3 PMP22 PPARG PRDM2 PRKAR2B PRKCA PRKCE PTEN PTGFR PTPN21 PTPRM RASA2 RBPMS RGS4 RND3 RUNX1 RXRA SCAF8 SCHIP1 SCN8A SDC2 SERPINE1 SFMBT1 SIPA1L1 SLC22A18 SLC7A1 SMAD3 SMAD7 SNAI2 SPOP SRI SYNE1 SYNJ2 TENT4A TFPI TGFBR2 TGFBR3 TJP1 TOGARAM1 VAV2 VLDLR WDR37 YTHDC1 ZMIZ1	144	7.169925001442312	Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway 	GO:0007178	TGFBR3;COL3A1;SMAD3;COL1A2;ZMIZ1;MAGI2;ID1;PPARG;ACVR2A;SMAD7;BMPR1A;TGFBR2	12	8.333333333333332	1.7e-10	3.02e-7	Extracellular Matrix Remodeling	"The most prominent biological process performed by this system of interacting proteins is extracellular matrix (ECM) remodeling. This process is crucial for various cellular functions, including cell adhesion, migration, and differentiation.

Reasoning and Supporting Information:

1. ECM components: Several proteins in the list, such as COL1A1, COL1A2, COL3A1, COL5A2, and COL11A1, are collagen family members, which are major structural components of the ECM. Additionally, proteins like LAMC1 and FBLN5 are also involved in ECM structure and organization.

2. ECM regulators: Proteins like MMP16, TIMP1, and ADAMTS1 are involved in ECM degradation and remodeling. MMP16 is a matrix metalloproteinase that degrades ECM components, while TIMP1 is an inhibitor of metalloproteinases, and ADAMTS1 is a disintegrin and metalloproteinase with thrombospondin motifs.

3. Cell adhesion and migration: Integrins, such as ITGB3, are transmembrane receptors that mediate cell adhesion to the ECM and regulate cell migration. Additionally, proteins like VAV2, RASA2, and RND3 are involved in the regulation of cell adhesion and migration through their roles in cytoskeletal organization and signaling pathways.

4. Growth factors and receptors: Several proteins in the list, such as TGFBR2, TGFBR3, PDGFRB, and IGF1R, are growth factor receptors that regulate cell proliferation, differentiation, and migration. These receptors are activated by growth factors like TGF-β, PDGF, and IGF, which are involved in ECM remodeling.

5. Signaling pathways: Proteins like SMAD3, SMAD7, MAPK14, and AKT3 are involved in signaling pathways that regulate ECM remodeling. For example, SMAD3 and SMAD7 are intracellular mediators of TGF-β signaling, which is a key pathway in ECM regulation.

6. Transcription factors: Several transcription factors in the list, such as SNAI2, RUNX1, and MYC, regulate the expression of genes involved in ECM remodeling. For example, SNAI2 is a transcriptional repressor of E-cadherin, which is involved in cell adhesion and migration.

In conclusion, the system of interacting proteins is primarily involved in the process of extracellular matrix remodeling, which is crucial for various cellular functions, including cell adhesion, migration, and differentiation."	23	15.97222222222222	"The most prominent biological process performed by this system of interacting proteins is extracellular matrix (ECM) remodeling. This process is crucial for various cellular functions, including cell adhesion, migration, and differentiation.

1. ECM components: Several proteins in the list, such as COL1A1, COL1A2, COL3A1, COL5A2, and COL11A1, are collagen family members, which are major structural components of the ECM. Additionally, proteins like LAMC1 and FBLN5 are also involved in ECM structure and organization.[1][2][3]

2. ECM regulators: Proteins like MMP16, TIMP1, and ADAMTS1 are involved in ECM degradation and remodeling. MMP16 is a matrix metalloproteinase that degrades ECM components, while TIMP1 is an inhibitor of metalloproteinases, and ADAMTS1 is a disintegrin and metalloproteinase with thrombospondin motifs.[4][5][6]

3. Cell adhesion and migration: Integrins, such as ITGB3, are transmembrane receptors that mediate cell adhesion to the ECM and regulate cell migration. Additionally, proteins like VAV2, RASA2, and RND3 are involved in the regulation of cell adhesion and migration through their roles in cytoskeletal organization and signaling pathways.[7][8][9]

4. Growth factors and receptors: Several proteins in the list, such as TGFBR2, TGFBR3, PDGFRB, and IGF1R, are growth factor receptors that regulate cell proliferation, differentiation, and migration. These receptors are activated by growth factors like TGF-β, PDGF, and IGF, which are involved in ECM remodeling.[10][11][12]

5. Signaling pathways: Proteins like SMAD3, SMAD7, MAPK14, and AKT3 are involved in signaling pathways that regulate ECM remodeling. For example, SMAD3 and SMAD7 are intracellular mediators of TGF-β signaling, which is a key pathway in ECM regulation.[13][14][15]

6. Transcription factors: Several transcription factors in the list, such as SNAI2, RUNX1, and MYC, regulate the expression of genes involved in ECM remodeling. For example, SNAI2 is a transcriptional repressor of E-cadherin, which is involved in cell adhesion and migration.[16][17][18]

In conclusion, the system of interacting proteins is primarily involved in the process of extracellular matrix remodeling, which is crucial for various cellular functions, including cell adhesion, migration, and differentiation.

========================================================================================================================================================================================================
[1] Kuivaniemi, Helena, Tromp, Gerard. ""Type III collagen (COL3A1): Gene and protein structure, tissue distribution, and associated diseases."" Gene, 2019, pp. 151-171.
[2] Hald, J D, Folkestad, L, Harsløf, T, Lund, A M, Duno, M, Jensen, J B, Neghabat, S, Brixen, K, Langdahl, B. ""Skeletal phenotypes in adult patients with osteogenesis imperfecta-correlations with COL1A1/COL1A2 genotype and collagen structure."" Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2016, pp. 3331-3341.
[3] Blank, Martha, McGregor, Narelle E, Rowley, Lynn, Kung, Louise H W, Crimeen-Irwin, Blessing, Poulton, Ingrid J, Walker, Emma C, Gooi, Jonathan H, Lamandé, Shireen R, Sims, Natalie A, Bateman, John F. ""The effect of carbamazepine on bone structure and strength in control and osteogenesis imperfecta (Col1a2 <sup>+/p.G610C</sup> ) mice."" Journal of cellular and molecular medicine, 2022, pp. 4021-4031.
[4] Lou, Lili, Tian, Mengyuan, Chang, Jingxia, Li, Fangfang, Zhang, Guojun. ""MiRNA-192-5p attenuates airway remodeling and autophagy in asthma by targeting MMP-16 and ATG7."" Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, pp. 109692.
[5] Vianello, Annamaria, Caponi, Laura, Galetta, Fabio, Franzoni, Ferdinando, Taddei, Marco, Rossi, Marco, Pietrini, Pietro, Santoro, Gino. ""β2-Microglobulin and TIMP1 Are Linked Together in Cardiorenal Remodeling and Failure."" Cardiorenal medicine, 2015, pp. 1-11.
[6] Brown, Hannah M, Dunning, Kylie R, Robker, Rebecca L, Boerboom, Derek, Pritchard, Melanie, Lane, Michelle, Russell, Darryl L. ""ADAMTS1 cleavage of versican mediates essential structural remodeling of the ovarian follicle and cumulus-oocyte matrix during ovulation in mice."" Biology of reproduction, 2010, pp. 549-57.
[7] Havel, L S, Kline, E R, Salgueiro, A M, Marcus, A I. ""Vimentin regulates lung cancer cell adhesion through a VAV2-Rac1 pathway to control focal adhesion kinase activity."" Oncogene, 2015, pp. 1979-90.
[8] Liu, Baohui, Dong, Huimin, Lin, Xi, Yang, Xiangsheng, Yue, Xiaojing, Yang, Jian, Li, Yuntao, Wu, Liquan, Zhu, Xiaonan, Zhang, Shenqi, Tian, Daofeng, Wang, Junmin, Cai, Qiang, Mao, Shanping, Chen, Qianxue, Chang, Jiang. ""RND3 promotes Snail 1 protein degradation and inhibits glioblastoma cell migration and invasion."" Oncotarget, 2016, pp. 82411-82423.
[9] Zhou, Yizhuo, Li, Shanshan, Huang, Qiongping, Xie, Lele, Zhu, Xueliang. ""Nanog suppresses cell migration by downregulating thymosin β4 and Rnd3."" Journal of molecular cell biology, 2013, pp. 239-49.
[10] Jiang, Kai, Yang, Zhihong, Cheng, Long, Wang, Shibin, Ning, Kang, Zhou, Lei, Lin, Jing, Zhong, Hui, Wang, Lisheng, Li, Yang, Huang, Junjian, Zhang, Hao, Ye, Qinong. ""Mediator of ERBB2-driven cell motility (MEMO) promotes extranuclear estrogen receptor signaling involving the growth factor receptors IGF1R and ERBB2."" The Journal of biological chemistry, 2013, pp. 24590-9.
[11] Yuan, Jialing, Yi, Ke, Yang, Lingyun. ""TGFBR2 Regulates Hedgehog Pathway and Cervical Cancer Cell Proliferation and Migration by Mediating SMAD4."" Journal of proteome research, 2020, pp. 3377-3385.
[12] Noel, Pierre. ""Eosinophilic myeloid disorders."" Seminars in hematology, 2012, pp. 120-7.
[13] Zhao, Yuanyuan, Ma, Jing, Fan, Yanling, Wang, Zhiyong, Tian, Ran, Ji, Wei, Zhang, Fei, Niu, Ruifang. ""TGF-β transactivates EGFR and facilitates breast cancer migration and invasion through canonical Smad3 and ERK/Sp1 signaling pathways."" Molecular oncology, 2018, pp. 305-321.
[14] Liu, Zhongliang, Xu, Baogui, Ding, Yaping, Ding, Xianjun, Yang, Zuisu. ""Guizhi Fuling pill attenuates liver fibrosis <i>in vitro</i> and <i>in vivo</i> via inhibiting TGF-β1/Smad2/3 and activating IFN-γ/Smad7 signaling pathways."" Bioengineered, 2022, pp. 9357-9368.
[15] Yadav, Hariom, Quijano, Celia, Kamaraju, Anil K, Gavrilova, Oksana, Malek, Rana, Chen, Weiping, Zerfas, Patricia, Zhigang, Duan, Wright, Elizabeth C, Stuelten, Christina, Sun, Peter, Lonning, Scott, Skarulis, Monica, Sumner, Anne E, Finkel, Toren, Rane, Sushil G. ""Protection from obesity and diabetes by blockade of TGF-β/Smad3 signaling."" Cell metabolism, 2011, pp. 67-79.
[16] Lie-A-Ling, Michael, Marinopoulou, Elli, Li, Yaoyong, Patel, Rahima, Stefanska, Monika, Bonifer, Constanze, Miller, Crispin, Kouskoff, Valerie, Lacaud, Georges. ""RUNX1 positively regulates a cell adhesion and migration program in murine hemogenic endothelium prior to blood emergence."" Blood, 2014, pp. e11-20.
[17] Akeson, R, Bernards, R. ""N-myc down regulates neural cell adhesion molecule expression in rat neuroblastoma."" Molecular and cellular biology, 1990, pp. 2012-6.
[18] Wu, Ning, Rollin, Jérome, Masse, Ingrid, Lamartine, Jérôme, Gidrol, Xavier. ""p63 regulates human keratinocyte proliferation via MYC-regulated gene network and differentiation commitment through cell adhesion-related gene network."" The Journal of biological chemistry, 2012, pp. 5627-38.
"	0.36609077	0.30475155	Neither	Neither	NA
Diff. expressed gene set	UV RESPONSE UP	NA	ABCB1 ACAA1 AGO2 ALAS1 ALDOA AMD1 AP2S1 APOM AQP3 ARRB2 ASNS ATF3 ATP6V1C1 ATP6V1F BAK1 BCL2L11 BID BMP2 BSG BTG1 BTG2 BTG3 C4BPB CA2 CASP3 CCK CCND3 CCNE1 CDC34 CDC5L CDK2 CDKN1C CDKN2B CDO1 CEBPG CHKA CHRNA5 CLCN2 CLTB CNP COL2A1 CREG1 CTSV CXCL2 CYB5B CYB5R1 CYP1A1 DDX21 DGAT1 DLG4 DNAJA1 DNAJB1 E2F5 EIF2S3 EIF5 ENO2 EPCAM EPHX1 FEN1 FGF18 FKBP4 FMO1 FOS FOSB FURIN GAL GCH1 GGH GLS GPX3 GRINA GRPEL1 H2AX HLA-F HMOX1 HNRNPU HSPA13 HSPA2 HTR7 HYAL2 ICAM1 IGFBP2 IL6 IL6ST IRF1 JUNB KCNH2 KLHDC3 LHX2 LYN MAOA MAPK8IP2 MARK2 MGAT1 MMP14 MRPL23 MSX1 NAT1 NFKBIA NKX2-5 NPTX2 NPTXR NR4A1 NTRK3 NUP58 NXF1 OLFM1 ONECUT1 PARP2 PDAP1 PDLIM3 PLCL1 POLE3 POLG2 POLR2H PPAT PPIF PPP1R2 PPT1 PRKACA PRKCD PRPF3 PSMC3 PTPRD RAB27A RASGRP1 RET RFC4 RHOB RPN1 RRAD RXRB SELENOW SHOX2 SIGMAR1 SLC25A4 SLC6A12 SLC6A8 SOD2 SPR SQSTM1 STARD3 STIP1 STK25 SULT1A1 TACR3 TAP1 TARS1 TCHH TFRC TGFBRAP1 TMBIM6 TST TUBA4A TYRO3 UROD WIZ YKT6	158	7.303780748177103	Response To Hydrogen Peroxide 	GO:0042542	IL6;STK25;PRKCD;PPIF;HMOX1;RHOB	6	3.79746835443038	1.59e-6	0.001362186	Cell Cycle Regulation and Apoptosis	"The most prominent biological process performed by this system of interacting proteins is cell cycle regulation and apoptosis. This is supported by the presence of several key proteins involved in these processes.

1. Cell cycle regulation: Several proteins in the list are involved in cell cycle regulation, including CCND3, CCNE1, CDK2, CDKN1C, and CDKN2B. These proteins play crucial roles in controlling cell cycle progression, with CCND3 and CCNE1 being cyclins that regulate CDK2 activity, and CDKN1C and CDKN2B acting as cyclin-dependent kinase inhibitors.

2. Apoptosis: Proteins such as BAK1, BCL2L11, BID, and CASP3 are involved in the regulation of apoptosis. BAK1 and BCL2L11 are pro-apoptotic proteins, while BID is a BH3-only protein that can activate BAK1 and BCL2L11. CASP3 is a key executioner caspase that cleaves various cellular substrates, leading to apoptosis.

3. DNA repair and replication: Proteins such as FEN1, POLG2, and RFC4 are involved in DNA repair and replication processes. FEN1 is a structure-specific nuclease that plays a role in DNA replication and repair, while POLG2 is a subunit of DNA polymerase gamma, which is involved in mitochondrial DNA replication. RFC4 is a subunit of the replication factor C complex, which is essential for DNA replication and repair.

4. Transcription and translation regulation: Proteins such as E2F5, EIF2S3, EIF5, and POLR2H are involved in the regulation of transcription and translation. E2F5 is a transcription factor that regulates the expression of genes involved in cell cycle progression, while EIF2S3 and EIF5 are translation initiation factors. POLR2H is a subunit of RNA polymerase II, which is responsible for synthesizing mRNA.

5. Oxidative stress response: Proteins such as GPX3, SOD2, and HMOX1 are involved in the cellular response to oxidative stress. GPX3 and SOD2 are antioxidant enzymes that protect cells from oxidative damage, while HMOX1 is an enzyme that degrades heme, producing biliverdin, which has antioxidant properties.

6. Signal transduction: Proteins such as MAPK8IP2, PRKACA, PRKCD, and RASGRP1 are involved in signal transduction pathways. MAPK8IP2 is a scaffold protein that regulates the JNK signaling pathway, while PRKACA and PRKCD are protein kinases that play roles in various signaling pathways. RASGRP1 is a guanine nucleotide exchange factor that activates the Ras signaling pathway.

In conclusion, this system of interacting proteins is primarily involved in cell cycle regulation and apoptosis, with additional roles in DNA repair and replication, transcription and translation regulation, oxidative stress response, and signal transduction."	23	14.556962025316457	"The most prominent biological process performed by this system of interacting proteins is cell cycle regulation and apoptosis. This is supported by the presence of several key proteins involved in these processes.

1. Cell cycle regulation: Several proteins in the list are involved in cell cycle regulation, including CCND3, CCNE1, CDK2, CDKN1C, and CDKN2B. These proteins play crucial roles in controlling cell cycle progression, with CCND3 and CCNE1 being cyclins that regulate CDK2 activity, and CDKN1C and CDKN2B acting as cyclin-dependent kinase inhibitors.[1][2][3]

2. Apoptosis: Proteins such as BAK1, BCL2L11, BID, and CASP3 are involved in the regulation of apoptosis. BAK1 and BCL2L11 are pro-apoptotic proteins, while BID is a BH3-only protein that can activate BAK1 and BCL2L11. CASP3 is a key executioner caspase that cleaves various cellular substrates, leading to apoptosis.[4][5][6]

3. DNA repair and replication: Proteins such as FEN1, POLG2, and RFC4 are involved in DNA repair and replication processes. FEN1 is a structure-specific nuclease that plays a role in DNA replication and repair, while POLG2 is a subunit of DNA polymerase gamma, which is involved in mitochondrial DNA replication. RFC4 is a subunit of the replication factor C complex, which is essential for DNA replication and repair.[7][8][9]

4. Transcription and translation regulation: Proteins such as E2F5, EIF2S3, EIF5, and POLR2H are involved in the regulation of transcription and translation. E2F5 is a transcription factor that regulates the expression of genes involved in cell cycle progression, while EIF2S3 and EIF5 are translation initiation factors. POLR2H is a subunit of RNA polymerase II, which is responsible for synthesizing mRNA.[10][11][12]

5. Oxidative stress response: Proteins such as GPX3, SOD2, and HMOX1 are involved in the cellular response to oxidative stress. GPX3 and SOD2 are antioxidant enzymes that protect cells from oxidative damage, while HMOX1 is an enzyme that degrades heme, producing biliverdin, which has antioxidant properties.[13][14][15]

6. Signal transduction: Proteins such as MAPK8IP2, PRKACA, PRKCD, and RASGRP1 are involved in signal transduction pathways. MAPK8IP2 is a scaffold protein that regulates the JNK signaling pathway, while PRKACA and PRKCD are protein kinases that play roles in various signaling pathways. RASGRP1 is a guanine nucleotide exchange factor that activates the Ras signaling pathway.[16][17][18]

In conclusion, this system of interacting proteins is primarily involved in cell cycle regulation and apoptosis, with additional roles in DNA repair and replication, transcription and translation regulation, oxidative stress response, and signal transduction.

========================================================================================================================================================================================================
[1] Tsytlonok, Maksym, Sanabria, Hugo, Wang, Yuefeng, Felekyan, Suren, Hemmen, Katherina, Phillips, Aaron H, Yun, Mi-Kyung, Waddell, M Brett, Park, Cheon-Gil, Vaithiyalingam, Sivaraja, Iconaru, Luigi, White, Stephen W, Tompa, Peter, Seidel, Claus A M, Kriwacki, Richard. ""Dynamic anticipation by Cdk2/Cyclin A-bound p27 mediates signal integration in cell cycle regulation."" Nature communications, 2019, pp. 1676.
[2] Gu, Y, Rosenblatt, J, Morgan, D O. ""Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15."" The EMBO journal, 1992, pp. 3995-4005.
[3] Yang, Xuefeng, Zu, Xuyu, Tang, Jing, Xiong, Wei, Zhang, Yuan, Liu, Feng, Jiang, Yuyang. ""Zbtb7 suppresses the expression of CDK2 and E2F4 in liver cancer cells: implications for the role of Zbtb7 in cell cycle regulation."" Molecular medicine reports, 2012, pp. 1475-80.
[4] Wang, Xiaoyan, Zhang, Zhitao, Wang, Mei. ""MiR-29a regulates cardiomyocyte apoptosis by targeting Bak1 in diabetic cardiomyopathy."" Journal of biochemistry, 2022, pp. 663-671.
[5] Wu, Guihao, Li, Xin, Zhan, Yongtong, Fan, Xuhong, Xu, Lingjun, Chen, Tongsheng, Wang, Xiaoping. ""BID- and BAX-mediated mitochondrial pathway dominates A-1331852-induced apoptosis in senescent A549 cells."" Biochemical and biophysical research communications, 2022, pp. 160-167.
[6] Manara, Anna, Imanifard, Zahra, Fracasso, Linda, Bellin, Diana, Crimi, Massimo. ""Plants expressing murine pro-apoptotic protein Bid do not have enhanced PCD."" BMC research notes, 2020, pp. 450.
[7] Wörtz, Julia, Smith, Victoria, Fallmann, Jörg, König, Sabine, Thuraisingam, Tharani, Walther, Paul, Urlaub, Henning, Stadler, Peter F, Allers, Thorsten, Hille, Frank, Marchfelder, Anita. ""Cas1 and Fen1 Display Equivalent Functions During Archaeal DNA Repair."" Frontiers in microbiology, 2022, pp. 822304.
[8] Lu, Xiao, Liu, Rui, Wang, Meina, Kumar, Alagamuthu Karthick, Pan, Feiyan, He, Lingfeng, Hu, Zhigang, Guo, Zhigang. ""MicroRNA-140 impedes DNA repair by targeting FEN1 and enhances chemotherapeutic response in breast cancer."" Oncogene, 2020, pp. 234-247.
[9] Kim, H S, Brill, S J. ""Rfc4 interacts with Rpa1 and is required for both DNA replication and DNA damage checkpoints in Saccharomyces cerevisiae."" Molecular and cellular biology, 2001, pp. 3725-37.
[10] Li, Lina, Liu, Jie, Huang, Wei. ""E2F5 promotes proliferation and invasion of gastric cancer through directly upregulating UBE2T transcription."" Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2022, pp. 937-945.
[11] Teissier, S, Pang, C L, Thierry, F. ""The E2F5 repressor is an activator of E6/E7 transcription and of the S-phase entry in HPV18-associated cells."" Oncogene, 2010, pp. 5061-70.
[12] Sun, Ji, Li, Hong, Huo, Qi, Cui, Meiling, Ge, Chao, Zhao, Fangyu, Tian, Hua, Chen, Taoyang, Yao, Ming, Li, Jinjun. ""The transcription factor FOXN3 inhibits cell proliferation by downregulating E2F5 expression in hepatocellular carcinoma cells."" Oncotarget, 2016, pp. 43534-43545.
[13] Dikalova, Anna E, Itani, Hana A, Nazarewicz, Rafal R, McMaster, William G, Flynn, Charles R, Uzhachenko, Roman, Fessel, Joshua P, Gamboa, Jorge L, Harrison, David G, Dikalov, Sergey I. ""Sirt3 Impairment and SOD2 Hyperacetylation in Vascular Oxidative Stress and Hypertension."" Circulation research, 2017, pp. 564-574.
[14] Li, Lin, Wang, Hui, Zhao, Shuping, Zhao, Yuan, Chen, Yongping, Zhang, Jiuyan, Wang, Chuqiao, Sun, Ning, Fan, Honggang. ""Paeoniflorin ameliorates lipopolysaccharide-induced acute liver injury by inhibiting oxidative stress and inflammation via SIRT1/FOXO1a/SOD2 signaling in rats."" Phytotherapy research : PTR, 2022, pp. 2558-2571.
[15] Ding, Guanxiong, Liu, Fang, Shen, Baixin, Feng, Chenchen, Xu, Jianfeng, Ding, Qiang. ""The association between polymorphisms in prooxidant or antioxidant enzymes (myeloperoxidase, SOD2, and CAT) and genes and prostate cancer risk in the Chinese population of Han nationality."" Clinical genitourinary cancer, 2012, pp. 251-5.
[16] Mor, Adam, Philips, Mark R. ""Compartmentalized Ras/MAPK signaling."" Annual review of immunology, 2006, pp. 771-800.
[17] Šmidák, Roman, Mayer, Rupert Laurenz, Bileck, Andrea, Gerner, Christopher, Mechtcheriakova, Diana, Stork, Oliver, Lubec, Gert, Li, Lin. ""Quantitative proteomics reveals protein kinases and phosphatases in the individual phases of contextual fear conditioning in the C57BL/6J mouse."" Behavioural brain research, 2016, pp. 208-17.
[18] Søberg, Kristoffer, Jahnsen, Tore, Rognes, Torbjørn, Skålhegg, Bjørn S, Laerdahl, Jon K. ""Evolutionary paths of the cAMP-dependent protein kinase (PKA) catalytic subunits."" PloS one, 2013, pp. e60935.
"	0.35319117	0.47665223	GO	Neither	NA
Diff. expressed gene set	WNT BETA CATENIN SIGNALING	NA	ADAM17 AXIN1 AXIN2 CCND2 CSNK1E CTNNB1 CUL1 DKK1 DKK4 DLL1 DVL2 FRAT1 FZD1 FZD8 GNAI1 HDAC11 HDAC2 HDAC5 HEY1 HEY2 JAG1 JAG2 KAT2A LEF1 MAML1 MYC NCOR2 NCSTN NKD1 NOTCH1 NOTCH4 NUMB PPARD PSEN2 PTCH1 RBPJ SKP2 TCF7 TP53 WNT1 WNT5B WNT6	42	5.392317422778761	Notch Signaling Pathway 	GO:0007219	JAG2;ADAM17;NOTCH1;JAG1;HEY1;MAML1;NOTCH4;HEY2;RBPJ;DLL1	10	23.809523809523807	4.24e-19	2.95e-16	Wnt/Notch Signaling Pathway Regulation	"The primary biological process performed by this system of interacting proteins is the regulation of the Wnt and Notch signaling pathways. These pathways play crucial roles in cell proliferation, differentiation, and development.

1. Wnt signaling pathway: The proteins FZD1, FZD8, WNT1, WNT5B, and WNT6 are involved in the activation of the Wnt signaling pathway. DVL2, AXIN1, AXIN2, and CTNNB1 are essential components of the Wnt pathway, regulating the stability and activity of β-catenin (CTNNB1). The proteins CSNK1E, GNAI1, and FRAT1 also contribute to the regulation of this pathway. Additionally, DKK1 and DKK4 act as Wnt antagonists, inhibiting the pathway.

2. Notch signaling pathway: The proteins NOTCH1, NOTCH4, DLL1, JAG1, and JAG2 are involved in the activation of the Notch signaling pathway. MAML1, RBPJ, and NCSTN are essential components of the Notch pathway, regulating the transcription of target genes. NUMB acts as a negative regulator of Notch signaling.

3. Transcription factors and co-factors: LEF1, TCF7, and MYC are transcription factors that regulate target gene expression in response to Wnt and Notch signaling. MAML1, NCOR2, and KAT2A are co-factors that modulate the activity of these transcription factors.

4. Cell cycle regulation: CCND2 and TP53 are involved in cell cycle regulation, with CCND2 promoting cell cycle progression and TP53 acting as a tumor suppressor. SKP2 and CUL1 are components of the SCF ubiquitin ligase complex, which targets proteins for degradation, including cell cycle regulators.

5. Histone deacetylases (HDACs): HDAC2, HDAC5, and HDAC11 are involved in the regulation of gene expression through histone deacetylation, which can modulate the activity of Wnt and Notch signaling pathways.

6. Other interacting proteins: ADAM17, PPARD, and PTCH1 have roles in the regulation of the Wnt and Notch signaling pathways, as well as other cellular processes. NKD1 acts as a negative regulator of the Wnt signaling pathway.

In summary, this system of interacting proteins is primarily involved in the regulation of the Wnt and Notch signaling pathways, which are essential for cell proliferation, differentiation, and development. The proteins in this system modulate the activity of these pathways through various mechanisms, including direct activation or inhibition, transcriptional regulation, cell cycle control, and epigenetic modifications."	39	92.85714285714286	"The primary biological process performed by this system of interacting proteins is the regulation of the Wnt and Notch signaling pathways. These pathways play crucial roles in cell proliferation, differentiation, and development.

1. Wnt signaling pathway: The proteins FZD1, FZD8, WNT1, WNT5B, and WNT6 are involved in the activation of the Wnt signaling pathway. DVL2, AXIN1, AXIN2, and CTNNB1 are essential components of the Wnt pathway, regulating the stability and activity of β-catenin (CTNNB1). The proteins CSNK1E, GNAI1, and FRAT1 also contribute to the regulation of this pathway. Additionally, DKK1 and DKK4 act as Wnt antagonists, inhibiting the pathway.[1][2][3]

2. Notch signaling pathway: The proteins NOTCH1, NOTCH4, DLL1, JAG1, and JAG2 are involved in the activation of the Notch signaling pathway. MAML1, RBPJ, and NCSTN are essential components of the Notch pathway, regulating the transcription of target genes. NUMB acts as a negative regulator of Notch signaling.[4][5][6]

3. Transcription factors and co-factors: LEF1, TCF7, and MYC are transcription factors that regulate target gene expression in response to Wnt and Notch signaling. MAML1, NCOR2, and KAT2A are co-factors that modulate the activity of these transcription factors.[7][8][9]

4. Cell cycle regulation: CCND2 and TP53 are involved in cell cycle regulation, with CCND2 promoting cell cycle progression and TP53 acting as a tumor suppressor. SKP2 and CUL1 are components of the SCF ubiquitin ligase complex, which targets proteins for degradation, including cell cycle regulators.[10][11][12]

5. Histone deacetylases (HDACs): HDAC2, HDAC5, and HDAC11 are involved in the regulation of gene expression through histone deacetylation, which can modulate the activity of Wnt and Notch signaling pathways.[13][14][15]

6. Other interacting proteins: ADAM17, PPARD, and PTCH1 have roles in the regulation of the Wnt and Notch signaling pathways, as well as other cellular processes. NKD1 acts as a negative regulator of the Wnt signaling pathway.[16][17][18]

In summary, this system of interacting proteins is primarily involved in the regulation of the Wnt and Notch signaling pathways, which are essential for cell proliferation, differentiation, and development. The proteins in this system modulate the activity of these pathways through various mechanisms, including direct activation or inhibition, transcriptional regulation, cell cycle control, and epigenetic modifications.

========================================================================================================================================================================================================
[1] Chouhan, Surbhi, Singh, Snahlata, Athavale, Dipti, Ramteke, Pranay, Pandey, Vimal, Joseph, Jomon, Mohan, Rajashekar, Shetty, Praveen Kumar, Bhat, Manoj Kumar. ""Glucose induced activation of canonical Wnt signaling pathway in hepatocellular carcinoma is regulated by DKK4."" Scientific reports, 2016, pp. 27558.
[2] Fu, Hengyi, Tan, Xiujun, Ye, Ling, Wang, Chenglin. ""The glycoprotein Wnt6 regulates human dental papilla cells differentiation by canonical Wnt signaling pathway."" Archives of oral biology, 2022, pp. 105469.
[3] Sremac, Maja, Paic, Frane, Grubelic Ravic, Katja, Serman, Ljiljana, Pavicic Dujmovic, Aja, Brcic, Iva, Krznaric, Zeljko, Nikuseva Martic, Tamara. ""Aberrant expression of SFRP1, SFRP3, DVL2 and DVL3 Wnt signaling pathway components in diffuse gastric carcinoma."" Oncology letters, 2021, pp. 822.
[4] Wu, Qiuyu, Chen, Xiangjie, Qiao, Caixia, Cao, Xinhua, Du, Qian, Yuan, Yukang, Zuo, Yibo, Miao, Ying, Zheng, Zhijin, Zhang, Tingting, Zang, Lichao, Yang, Xinyu, Shi, Weifeng, Xie, Zhijun, Xu, Yang, Wu, Depei, Wen, Chengping, Zheng, Hui. ""Methotrexate and Triptolide regulate Notch signaling pathway by targeting the Nedd4-Numb axis."" International immunopharmacology, 2023, pp. 109595.
[5] Lim, JiaWen, Frecot, Desiree Isabella, Stubenrauch, Frank, Iftner, Thomas, Simon, Claudia. ""Cottontail rabbit papillomavirus E6 proteins: Interaction with MAML1 and modulation of the Notch signaling pathway."" Virology, 2022, pp. 52-60.
[6] Shen, Er-Dong, Zeng, Qiang. ""Inhibition of the Numb/Notch signaling pathway increases radiation sensitivity in human nasopharyngeal carcinoma cells."" The Kaohsiung journal of medical sciences, 2019, pp. 474-485.
[7] Wilde, Blake R, Ayer, Donald E. ""Interactions between Myc and MondoA transcription factors in metabolism and tumourigenesis."" British journal of cancer, 2015, pp. 1529-33.
[8] Santiago, Larion, Daniels, Garrett, Wang, Dongwen, Deng, Fang-Ming, Lee, Peng. ""Wnt signaling pathway protein LEF1 in cancer, as a biomarker for prognosis and a target for treatment."" American journal of cancer research, 2017, pp. 1389-1406.
[9] Chachoua, Ilyas, Tzelepis, Ilias, Dai, Hao, Lim, Jia Pei, Lewandowska-Ronnegren, Anna, Casagrande, Felipe Beccaria, Wu, Shuangyang, Vestlund, Johanna, Mallet de Lima, Carolina Diettrich, Bhartiya, Deeksha, Scholz, Barbara A, Martino, Mirco, Mehmood, Rashid, Göndör, Anita. ""Canonical WNT signaling-dependent gating of MYC requires a noncanonical CTCF function at a distal binding site."" Nature communications, 2022, pp. 204.
[10] Schultz-Rogers, Laura E, Thayer, Michelle L, Kambakam, Sekhar, Wierson, Wesley A, Helmer, Jordan A, Wishman, Mark D, Wall, Kristen A, Greig, Jessica L, Forsman, Jaimie L, Puchhalapalli, Kavya, Nair, Siddharth, Weiss, Trevor J, Luiken, Jon M, Blackburn, Patrick R, Ekker, Stephen C, Kool, Marcel, McGrail, Maura. ""Rbbp4 loss disrupts neural progenitor cell cycle regulation independent of Rb and leads to Tp53 acetylation and apoptosis."" Developmental dynamics : an official publication of the American Association of Anatomists, 2022, pp. 1267-1290.
[11] Elahi, Abul H, Morales, Cordelia S, Xu, Xiaoliang L, Eliades, Alexia, Patsalis, Philippos C, Abramson, David H, Jhanwar, Suresh C. ""Targeted pharmacologic inhibition of S-phase kinase-associated protein 2 (SKP2) mediated cell cycle regulation in lung and other RB-Related cancers: A brief review of current status and future prospects."" Advances in biological regulation, 2023, pp. 100964.
[12] Castagnino, Paola, Kothapalli, Devashish, Hawthorne, Elizabeth A, Liu, Shu-Lin, Xu, Tina, Rao, Shilpa, Yung, Yuval, Assoian, Richard K. ""miR-221/222 compensates for Skp2-mediated p27 degradation and is a primary target of cell cycle regulation by prostacyclin and cAMP."" PloS one, 2013, pp. e56140.
[13] Li, Liang, Xie, Wei. ""LncRNA HDAC11-AS1 Suppresses Atherosclerosis by Inhibiting HDAC11-Mediated Adropin Histone Deacetylation."" Journal of cardiovascular translational research, 2022, pp. 1256-1269.
[14] Zhang, Yu, Du, Linhu, Yan, Jinhua, Bai, Qianxiang, Niu, Qiao, Mo, Yiqun, Zhang, Qunwei, Nie, Jisheng. ""Prenatal benzo[a]pyrene exposure impairs hippocampal synaptic plasticity and cognitive function in SD rat offspring during adolescence and adulthood via HDAC2-mediated histone deacetylation."" Ecotoxicology and environmental safety, 2022, pp. 114180.
[15] Hu, Tianjing, Schreiter, Friederike C, Bagchi, Rushita A, Tatman, Philip D, Hannink, Mark, McKinsey, Timothy A. ""HDAC5 catalytic activity suppresses cardiomyocyte oxidative stress and NRF2 target gene expression."" The Journal of biological chemistry, 2019, pp. 8640-8652.
[16] Stancikova, Jitka, Krausova, Michaela, Kolar, Michal, Fafilek, Bohumil, Svec, Jiri, Sedlacek, Radislav, Neroldova, Magdalena, Dobes, Jan, Horazna, Monika, Janeckova, Lucie, Vojtechova, Martina, Oliverius, Martin, Jirsa, Milan, Korinek, Vladimir. ""NKD1 marks intestinal and liver tumors linked to aberrant Wnt signaling."" Cellular signalling, 2015, pp. 245-56.
[17] Angonin, Diane, Van Raay, Terence J. ""Nkd1 functions as a passive antagonist of Wnt signaling."" PloS one, 2013, pp. e74666.
[18] Li, Lijun, Gao, Ruiying, Huangfu, Weizhong, Zhang, Fang, Wang, Ruixia. ""Clinical Significance of NKD Inhibitor of WNT Signaling Pathway 1 (NKD1) in Glioblastoma."" Genetics research, 2023, pp. 1184101.
"	0.63066363	0.6031543	Tied	LLM	NA
Diff. expressed gene set	peroxisome	NA	PEX1 PEX2 PEX3 PEX4 PEX5 PEX6 PEX7 PEX8	8	3	Protein Targeting To Peroxisome 	GO:0006625	PEX7;PEX3;PEX6;PEX5;PEX2;PEX1	6	75	2.52e-18	1.4e-16	Peroxisome Biogenesis	"The primary biological process performed by the interacting proteins PEX1, PEX2, PEX3, PEX4, PEX5, PEX6, PEX7, and PEX8 is peroxisome biogenesis. These proteins are collectively known as peroxins and are essential for the formation, maintenance, and function of peroxisomes.

1. PEX1 and PEX6: These AAA-ATPases form a heterohexameric complex that is crucial for the recycling of PEX5, a peroxisomal matrix protein receptor. PEX1 and PEX6 mutations can lead to peroxisome biogenesis disorders, such as Zellweger syndrome.

2. PEX2, PEX10, and PEX12: These proteins function as E3 ubiquitin ligases and are involved in the ubiquitination of PEX5, which is necessary for its recycling. Mutations in these genes can also result in peroxisome biogenesis disorders.

3. PEX3: This integral peroxisomal membrane protein is involved in the early stages of peroxisome formation. It is responsible for the insertion of other peroxisomal membrane proteins, such as PEX19. PEX3 mutations can lead to a lack of functional peroxisomes.

4. PEX4: This protein is a ubiquitin-conjugating enzyme (E2) that interacts with PEX2, PEX10, and PEX12 to facilitate PEX5 ubiquitination. PEX4 mutations can result in peroxisome biogenesis disorders.

5. PEX5: This cytosolic receptor recognizes and binds to peroxisomal matrix proteins containing a peroxisomal targeting signal 1 (PTS1). PEX5 transports these proteins to the peroxisome and is then recycled by PEX1 and PEX6. Mutations in PEX5 can lead to peroxisome biogenesis disorders.

6. PEX7: This cytosolic receptor recognizes and binds to peroxisomal matrix proteins containing a peroxisomal targeting signal 2 (PTS2). PEX7 transports these proteins to the peroxisome and is then recycled. Mutations in PEX7 can result in peroxisome biogenesis disorders, such as rhizomelic chondrodysplasia punctata.

7. PEX8: This protein is an intraperoxisomal receptor for PEX7 and is involved in the import of PTS2-containing proteins. PEX8 mutations can lead to peroxisome biogenesis disorders.

In summary, the interacting proteins PEX1, PEX2, PEX3, PEX4, PEX5, PEX6, PEX7, and PEX8 play crucial roles in peroxisome biogenesis, including the formation, maintenance, and function of peroxisomes. Mutations in these proteins can result in peroxisome biogenesis disorders, highlighting their importance in cellular processes."	8	100	"The primary biological process performed by the interacting proteins PEX1, PEX2, PEX3, PEX4, PEX5, PEX6, PEX7, and PEX8 is peroxisome biogenesis. These proteins are collectively known as peroxins and are essential for the formation, maintenance, and function of peroxisomes.[1][2][3]

1. PEX1 and PEX6: These AAA-ATPases form a heterohexameric complex that is crucial for the recycling of PEX5, a peroxisomal matrix protein receptor. PEX1 and PEX6 mutations can lead to peroxisome biogenesis disorders, such as Zellweger syndrome.[4][5][6]

2. PEX2, PEX10, and PEX12: These proteins function as E3 ubiquitin ligases and are involved in the ubiquitination of PEX5, which is necessary for its recycling. Mutations in these genes can also result in peroxisome biogenesis disorders.[7][8][9]

3. PEX3: This integral peroxisomal membrane protein is involved in the early stages of peroxisome formation. It is responsible for the insertion of other peroxisomal membrane proteins, such as PEX19. PEX3 mutations can lead to a lack of functional peroxisomes.[10][11][12]

4. PEX4: This protein is a ubiquitin-conjugating enzyme (E2) that interacts with PEX2, PEX10, and PEX12 to facilitate PEX5 ubiquitination. PEX4 mutations can result in peroxisome biogenesis disorders.[13][14][15]

5. PEX5: This cytosolic receptor recognizes and binds to peroxisomal matrix proteins containing a peroxisomal targeting signal 1 (PTS1). PEX5 transports these proteins to the peroxisome and is then recycled by PEX1 and PEX6. Mutations in PEX5 can lead to peroxisome biogenesis disorders.[16][17][18]

6. PEX7: This cytosolic receptor recognizes and binds to peroxisomal matrix proteins containing a peroxisomal targeting signal 2 (PTS2). PEX7 transports these proteins to the peroxisome and is then recycled. Mutations in PEX7 can result in peroxisome biogenesis disorders, such as rhizomelic chondrodysplasia punctata.[19][20][21]

7. PEX8: This protein is an intraperoxisomal receptor for PEX7 and is involved in the import of PTS2-containing proteins. PEX8 mutations can lead to peroxisome biogenesis disorders.[22][23][24]

In summary, the interacting proteins PEX1, PEX2, PEX3, PEX4, PEX5, PEX6, PEX7, and PEX8 play crucial roles in peroxisome biogenesis, including the formation, maintenance, and function of peroxisomes. Mutations in these proteins can result in peroxisome biogenesis disorders, highlighting their importance in cellular processes.[25][26][27]

========================================================================================================================================================================================================
[1] Jansen, Renate L M, van der Klei, Ida J. ""The peroxisome biogenesis factors Pex3 and Pex19: multitasking proteins with disputed functions."" FEBS letters, 2019, pp. 457-474.
[2] Tan, Dongyan, Blok, Neil B, Rapoport, Tom A, Walz, Thomas. ""Structures of the double-ring AAA ATPase Pex1-Pex6 involved in peroxisome biogenesis."" The FEBS journal, 2016, pp. 986-92.
[3] Chang, Jinlan, Mast, Fred D, Fagarasanu, Andrei, Rachubinski, Dorian A, Eitzen, Gary A, Dacks, Joel B, Rachubinski, Richard A. ""Pex3 peroxisome biogenesis proteins function in peroxisome inheritance as class V myosin receptors."" The Journal of cell biology, 2009, pp. 233-46.
[4] Ratbi, Ilham, Falkenberg, Kim D, Sommen, Manou, Al-Sheqaih, Nada, Guaoua, Soukaina, Vandeweyer, Geert, Urquhart, Jill E, Chandler, Kate E, Williams, Simon G, Roberts, Neil A, El Alloussi, Mustapha, Black, Graeme C, Ferdinandusse, Sacha, Ramdi, Hind, Heimler, Audrey, Fryer, Alan, Lynch, Sally-Ann, Cooper, Nicola, Ong, Kai Ren, Smith, Claire E L, Inglehearn, Christopher F, Mighell, Alan J, Elcock, Claire, Poulter, James A, Tischkowitz, Marc, Davies, Sally J, Sefiani, Abdelaziz, Mironov, Aleksandr A, Newman, William G, Waterham, Hans R, Van Camp, Guy. ""Heimler Syndrome Is Caused by Hypomorphic Mutations in the Peroxisome-Biogenesis Genes PEX1 and PEX6."" American journal of human genetics, 2015, pp. 535-45.
[5] Tan, Dongyan, Blok, Neil B, Rapoport, Tom A, Walz, Thomas. ""Structures of the double-ring AAA ATPase Pex1-Pex6 involved in peroxisome biogenesis."" The FEBS journal, 2016, pp. 986-92.
[6] Kiel, J A, Hilbrands, R E, Bovenberg, R A, Veenhuis, M. ""Isolation of Penicillium chrysogenum PEX1 and PEX6 encoding AAA proteins involved in peroxisome biogenesis."" Applied microbiology and biotechnology, 2000, pp. 238-42.
[7] Wang, Wei, Subramani, Suresh. ""Role of PEX5 ubiquitination in maintaining peroxisome dynamics and homeostasis."" Cell cycle (Georgetown, Tex.), 2017, pp. 2037-2045.
[8] Gualdrón-López, Melisa, Chevalier, Nathalie, Van Der Smissen, Patrick, Courtoy, Pierre J, Rigden, Daniel J, Michels, Paul A M. ""Ubiquitination of the glycosomal matrix protein receptor PEX5 in Trypanosoma brucei by PEX4 displays novel features."" Biochimica et biophysica acta, 2013, pp. 3076-3092.
[9] Fan, Jilian, Quan, Sheng, Orth, Travis, Awai, Chie, Chory, Joanne, Hu, Jianping. ""The Arabidopsis PEX12 gene is required for peroxisome biogenesis and is essential for development."" Plant physiology, 2005, pp. 231-9.
[10] Fakieh, Mohammad H, Drake, Peter J M, Lacey, Joanne, Munck, Joanne M, Motley, Alison M, Hettema, Ewald H. ""Intra-ER sorting of the peroxisomal membrane protein Pex3 relies on its luminal domain."" Biology open, 2013, pp. 829-37.
[11] Emmanouilidis, Leonidas, Schütz, Ulrike, Tripsianes, Konstantinos, Madl, Tobias, Radke, Juliane, Rucktäschel, Robert, Wilmanns, Matthias, Schliebs, Wolfgang, Erdmann, Ralf, Sattler, Michael. ""Allosteric modulation of peroxisomal membrane protein recognition by farnesylation of the peroxisomal import receptor PEX19."" Nature communications, 2017, pp. 14635.
[12] Maxit, C, Denzler, I, Marchione, D, Agosta, G, Koster, J, Wanders, R J A, Ferdinandusse, S, Waterham, H R. ""Novel PEX3 Gene Mutations Resulting in a Moderate Zellweger Spectrum Disorder."" JIMD reports, 2017, pp. 71-75.
[13] Fan, Jilian, Quan, Sheng, Orth, Travis, Awai, Chie, Chory, Joanne, Hu, Jianping. ""The Arabidopsis PEX12 gene is required for peroxisome biogenesis and is essential for development."" Plant physiology, 2005, pp. 231-9.
[14] Zhang, Chao, Zhan, Fei-Xia, Tian, Wo-Tu, Xu, Yang-Qi, Zhu, Ze-Yu, Wang, Yan, Song, Xing-Wang, Cao, Li. ""Ataxia with novel compound heterozygous PEX10 mutations and a literature review of PEX10-related peroxisome biogenesis disorders."" Clinical neurology and neurosurgery, 2019, pp. 92-96.
[15] Warren, D S, Wolfe, B D, Gould, S J. ""Phenotype-genotype relationships in PEX10-deficient peroxisome biogenesis disorder patients."" Human mutation, 2000, pp. 509-21.
[16] Apanasets, Oksana, Grou, Cláudia P, Van Veldhoven, Paul P, Brees, Chantal, Wang, Bo, Nordgren, Marcus, Dodt, Gabriele, Azevedo, Jorge E, Fransen, Marc. ""PEX5, the shuttling import receptor for peroxisomal matrix proteins, is a redox-sensitive protein."" Traffic (Copenhagen, Denmark), 2014, pp. 94-103.
[17] Pedrosa, Ana G, Francisco, Tânia, Bicho, Diana, Dias, Ana F, Barros-Barbosa, Aurora, Hagmann, Vera, Dodt, Gabriele, Rodrigues, Tony A, Azevedo, Jorge E. ""Peroxisomal monoubiquitinated PEX5 interacts with the AAA ATPases PEX1 and PEX6 and is unfolded during its dislocation into the cytosol."" The Journal of biological chemistry, 2018, pp. 11553-11563.
[18] Demers, Nicholas D, Riccio, Victoria, Jo, Doo Sin, Bhandari, Sushil, Law, Kelsey B, Liao, Weifang, Kim, Choy, McQuibban, G Angus, Choe, Seong-Kyu, Cho, Dong-Hyung, Kim, Peter K. ""PEX13 prevents pexophagy by regulating ubiquitinated PEX5 and peroxisomal ROS."" Autophagy, 2023, pp. 1781-1802.
[19] Okumoto, Kanji, Miyata, Non, Fujiki, Yukio. ""Identification of Peroxisomal Protein Complexes with PTS Receptors, Pex5 and Pex7, in Mammalian Cells."" Sub-cellular biochemistry, 2018, pp. 287-298.
[20] Emmanouilidis, Leonidas, Gopalswamy, Mohanraj, Passon, Daniel M, Wilmanns, Matthias, Sattler, Michael. ""Structural biology of the import pathways of peroxisomal matrix proteins."" Biochimica et biophysica acta, 2016, pp. 804-13.
[21] Wang, Xiaofeng, Wang, Pingping, Zhang, Zhuangzhuang, Farré, Jean-Claude, Li, Xuezhi, Wang, Ruonan, Xia, Zhijie, Subramani, Suresh, Ma, Changle. ""The autophagic degradation of cytosolic pools of peroxisomal proteins by a new selective pathway."" Autophagy, 2020, pp. 154-166.
[22] Masih, Suzena, Moirangthem, Amita, Phadke, Shubha R. ""Twins with PEX7 related intellectual disability and cataract: Highlighting phenotypes of peroxisome biogenesis disorder 9B."" American journal of medical genetics. Part A, 2021, pp. 1504-1508.
[23] Kunze, Markus, Malkani, Naila, Maurer-Stroh, Sebastian, Wiesinger, Christoph, Schmid, Johannes A, Berger, Johannes. ""Mechanistic insights into PTS2-mediated peroxisomal protein import: the co-receptor PEX5L drastically increases the interaction strength between the cargo protein and the receptor PEX7."" The Journal of biological chemistry, 2015, pp. 4928-4940.
[24] Kechasov, Dmitry, de Grahl, Imke, Endries, Pierre, Reumann, Sigrun. ""Evolutionary Maintenance of the PTS2 Protein Import Pathway in the Stramenopile Alga <i>Nannochloropsis</i>."" Frontiers in cell and developmental biology, 2020, pp. 593922.
[25] Jansen, Renate L M, van der Klei, Ida J. ""The peroxisome biogenesis factors Pex3 and Pex19: multitasking proteins with disputed functions."" FEBS letters, 2019, pp. 457-474.
[26] Tan, Dongyan, Blok, Neil B, Rapoport, Tom A, Walz, Thomas. ""Structures of the double-ring AAA ATPase Pex1-Pex6 involved in peroxisome biogenesis."" The FEBS journal, 2016, pp. 986-92.
[27] Chang, Jinlan, Mast, Fred D, Fagarasanu, Andrei, Rachubinski, Dorian A, Eitzen, Gary A, Dacks, Joel B, Rachubinski, Richard A. ""Pex3 peroxisome biogenesis proteins function in peroxisome inheritance as class V myosin receptors."" The Journal of cell biology, 2009, pp. 233-46.
"	0.8213074	0.68589514	LLM	LLM	NA
NeST	EMT	NEST:108	APC CBL CDH1 CDH2 CTNNA1 CTNNB1 EGF EGFR ERBB2 FYN HDAC1 HDAC2 SOX2 TCF7L2	14	3.807354922057604	ERBB2-EGFR Signaling Pathway 	GO:0038134	EGF;ERBB2;EGFR	3	21.428571428571427	2.73e-9	7.75e-7	Wnt Signaling and Cell Adhesion Regulation	"1. Wnt signaling pathway involvement:
- CTNNB1 (beta-catenin) is a key component of the Wnt signaling pathway.
- TCF7L2 (TCF4) is a transcription factor that interacts with CTNNB1 to regulate gene expression.
- APC is a negative regulator of Wnt signaling, promoting CTNNB1 degradation.
- These interactions suggest the system is involved in the regulation of Wnt signaling, which plays a role in cell proliferation, differentiation, and migration.

2. Cell adhesion and cytoskeleton regulation:
- CDH1 (E-cadherin) and CDH2 (N-cadherin) are cell adhesion molecules involved in cell-cell adhesion.
- CTNNA1 (alpha-catenin) links the cadherin-catenin complex to the actin cytoskeleton.
- The interaction between CDH1, CDH2, CTNNA1, and CTNNB1 suggests the system plays a role in regulating cell adhesion and cytoskeleton organization.

3. Receptor tyrosine kinase signaling:
- EGF, EGFR, and ERBB2 are involved in the epidermal growth factor receptor (EGFR) signaling pathway.
- FYN is a Src family kinase that can be activated by receptor tyrosine kinases, such as EGFR.
- CBL is an E3 ubiquitin ligase that can regulate receptor tyrosine kinase signaling by promoting receptor degradation.
- These interactions indicate the system's involvement in regulating receptor tyrosine kinase signaling, which can influence cell proliferation, survival, and migration.

4. Transcriptional regulation and epigenetic modification:
- HDAC1 and HDAC2 are histone deacetylases that regulate gene expression through epigenetic modification.
- SOX2 is a transcription factor involved in maintaining pluripotency and self-renewal in stem cells.
- The presence of HDAC1, HDAC2, and SOX2 suggests the system is involved in transcriptional regulation and epigenetic modification, which can impact cell fate determination and differentiation.

In conclusion, this system of interacting proteins is primarily involved in the regulation of Wnt signaling and cell adhesion, with additional roles in receptor tyrosine kinase signaling and transcriptional regulation."	14	100	"- CTNNB1 (beta-catenin) is a key component of the Wnt signaling pathway.[1][2][3]

- TCF7L2 (TCF4) is a transcription factor that interacts with CTNNB1 to regulate gene expression.[4][5][6]

- APC is a negative regulator of Wnt signaling, promoting CTNNB1 degradation.[7][8][9]

- These interactions suggest the system is involved in the regulation of Wnt signaling, which plays a role in cell proliferation, differentiation, and migration.

2. Cell adhesion and cytoskeleton regulation:

- CDH1 (E-cadherin) and CDH2 (N-cadherin) are cell adhesion molecules involved in cell-cell adhesion.[10][11][12]

- CTNNA1 (alpha-catenin) links the cadherin-catenin complex to the actin cytoskeleton.[13][14][15]

- The interaction between CDH1, CDH2, CTNNA1, and CTNNB1 suggests the system plays a role in regulating cell adhesion and cytoskeleton organization.[16][17][18]

- EGF, EGFR, and ERBB2 are involved in the epidermal growth factor receptor (EGFR) signaling pathway.[19][20][21]

- FYN is a Src family kinase that can be activated by receptor tyrosine kinases, such as EGFR.[22][23][24]

- CBL is an E3 ubiquitin ligase that can regulate receptor tyrosine kinase signaling by promoting receptor degradation.[25][26][27]

- These interactions indicate the system's involvement in regulating receptor tyrosine kinase signaling, which can influence cell proliferation, survival, and migration.

4. Transcriptional regulation and epigenetic modification:

- HDAC1 and HDAC2 are histone deacetylases that regulate gene expression through epigenetic modification.[28][29][30]

- SOX2 is a transcription factor involved in maintaining pluripotency and self-renewal in stem cells.[31][32][33]

- The presence of HDAC1, HDAC2, and SOX2 suggests the system is involved in transcriptional regulation and epigenetic modification, which can impact cell fate determination and differentiation.[34][35][36]

In conclusion, this system of interacting proteins is primarily involved in the regulation of Wnt signaling and cell adhesion, with additional roles in receptor tyrosine kinase signaling and transcriptional regulation.

========================================================================================================================================================================================================
[1] Huang, Qian, Wang, Chao-Cai, Liu, Yun-Guang, Zhao, Chang-Ming, Zhang, Tian-Ping, Liu, Yan, Wang, Hua. ""Clinical relevance of genetic polymorphisms in WNT signaling pathway (<i>SFRP1</i>, <i>WNT3A</i>, <i>CTNNB1, WIF-1</i>, <i>DKK-1</i>, <i>LRP5</i>, <i>LRP6</i>) on pulmonary tuberculosis in a Chinese population."" Frontiers in immunology, 2022, pp. 1011700.
[2] Sunaga, N, Kohno, T, Kolligs, F T, Fearon, E R, Saito, R, Yokota, J. ""Constitutive activation of the Wnt signaling pathway by CTNNB1 (beta-catenin) mutations in a subset of human lung adenocarcinoma."" Genes, chromosomes & cancer, 2001, pp. 316-21.
[3] Huo, Junyu, Wu, Liqun, Zang, Yunjin. ""Development and validation of a CTNNB1-associated metabolic prognostic model for hepatocellular carcinoma."" Journal of cellular and molecular medicine, 2021, pp. 1151-1165.
[4] Li, Junyi, Zhou, Li, Ouyang, Xinping, He, Pingping. ""Transcription Factor-7-Like-2 (TCF7L2) in Atherosclerosis: A Potential Biomarker and Therapeutic Target."" Frontiers in cardiovascular medicine, 2021, pp. 701279.
[5] Musavi, Z, Azarpira, N, Sangtarash, M H, Kordi, M, Kazemi, K, Geramizadeh, B, Malek-Hosseini, S A. ""Polymorphism of Transcription Factor-7-Like 2 (TCF7L2) Gene and New-Onset Diabetes after Liver Transplantation."" International journal of organ transplantation medicine, 2015, pp. 14-22.
[6] Tanabe, Shihori, Kawabata, Takeshi, Aoyagi, Kazuhiko, Yokozaki, Hiroshi, Sasaki, Hiroki. ""Gene expression and pathway analysis of <i>CTNNB1</i> in cancer and stem cells."" World journal of stem cells, 2016, pp. 384-395.
[7] Sehgal, Priyanka, Lanauze, Claudia, Wang, Xin, Hayer, Katharina E, Torres-Diz, Manuel, Leu, N Adrian, Sela, Yogev, Stanger, Ben Z, Lengner, Christopher J, Thomas-Tikhonenko, Andrei. ""MYC Hyperactivates Wnt Signaling in <i>APC</i>/<i>CTNNB1</i>-Mutated Colorectal Cancer Cells through miR-92a-Dependent Repression of <i>DKK3</i>."" Molecular cancer research : MCR, 2021, pp. 2003-2014.
[8] Hankey, William, Frankel, Wendy L, Groden, Joanna. ""Functions of the APC tumor suppressor protein dependent and independent of canonical WNT signaling: implications for therapeutic targeting."" Cancer metastasis reviews, 2018, pp. 159-172.
[9] Baril, Martin, Es-Saad, Salwa, Chatel-Chaix, Laurent, Fink, Karin, Pham, Tram, Raymond, Valérie-Ann, Audette, Karine, Guenier, Anne-Sophie, Duchaine, Jean, Servant, Marc, Bilodeau, Marc, Cohen, Eric, Grandvaux, Nathalie, Lamarre, Daniel. ""Genome-wide RNAi screen reveals a new role of a WNT/CTNNB1 signaling pathway as negative regulator of virus-induced innate immune responses."" PLoS pathogens, 2013, pp. e1003416.
[10] Silies, Marion, Klämbt, Christian. ""APC/C(Fzr/Cdh1)-dependent regulation of cell adhesion controls glial migration in the Drosophila PNS."" Nature neuroscience, 2010, pp. 1357-64.
[11] Shenoy, Santosh. ""CDH1 (E-Cadherin) Mutation and Gastric Cancer: Genetics, Molecular Mechanisms and Guidelines for Management."" Cancer management and research, 2019, pp. 10477-10486.
[12] Ye, Chun-Cui, Wang, Jun. ""E-cadherin (CDH1) gene -160C/A polymorphism and the risk of colorectal cancer: A meta-analysis involving 17,291 subjects."" The journal of gene medicine, 2021, pp. e3370.
[13] Lobo, Silvana, Benusiglio, Patrick R, Coulet, Florence, Boussemart, Lise, Golmard, Lisa, Spier, Isabel, Hüneburg, Robert, Aretz, Stefan, Colas, Chrystelle, Oliveira, Carla. ""Cancer predisposition and germline CTNNA1 variants."" European journal of medical genetics, 2021, pp. 104316.
[14] Huang, Jinhua, Wang, Huihui, Xu, Yuting, Li, Chunhua, Lv, Xinyue, Han, Xintong, Chen, Xiaochun, Chen, Yu, Yu, Zhiying. ""The Role of CTNNA1 in Malignancies: An Updated Review."" Journal of Cancer, 2023, pp. 219-230.
[15] Chi, Qiang, Xu, Hui, Song, Dianbin, Wang, Zhiyong, Wang, Zemin, Ma, Guang. ""α-E-Catenin (CTNNA1) Inhibits Cell Proliferation, Invasion and EMT of Bladder Cancer."" Cancer management and research, 2020, pp. 12747-12758.
[16] Silies, Marion, Klämbt, Christian. ""APC/C(Fzr/Cdh1)-dependent regulation of cell adhesion controls glial migration in the Drosophila PNS."" Nature neuroscience, 2010, pp. 1357-64.
[17] Yang, Hui-Li, Lai, Zhen-Zhen, Shi, Jia-Wei, Zhou, Wen-Jie, Mei, Jie, Ye, Jiang-Feng, Zhang, Tao, Wang, Jian, Zhao, Jian-Yuan, Li, Da-Jin, Li, Ming-Qing. ""A defective lysophosphatidic acid-autophagy axis increases miscarriage risk by restricting decidual macrophage residence."" Autophagy, 2022, pp. 2459-2480.
[18] Naoe, Hideaki, Araki, Kimi, Nagano, Osamu, Kobayashi, Yusuke, Ishizawa, Jo, Chiyoda, Tatsuyuki, Shimizu, Takatsune, Yamamura, Ken-ichi, Sasaki, Yutaka, Saya, Hideyuki, Kuninaka, Shinji. ""The anaphase-promoting complex/cyclosome activator Cdh1 modulates Rho GTPase by targeting p190 RhoGAP for degradation."" Molecular and cellular biology, 2010, pp. 3994-4005.
[19] Levantini, Elena, Maroni, Giorgia, Del Re, Marzia, Tenen, Daniel G. ""EGFR signaling pathway as therapeutic target in human cancers."" Seminars in cancer biology, 2022, pp. 253-275.
[20] Sousa de Almeida, Mauro, Roshanfekr, Arya, Balog, Sandor, Petri-Fink, Alke, Rothen-Rutishauser, Barbara. ""Cellular Uptake of Silica Particles Influences EGFR Signaling Pathway and is Affected in Response to EGF."" International journal of nanomedicine, 2023, pp. 1047-1061.
[21] Wei, Po-Li, Lin, Jang-Chun, Hung, Chin-Sheng, Makondi, Precious Takondwa, Batzorig, Uyanga, Chang, Tung-Cheng, Huang, Chien-Yu, Chang, Yu-Jia. ""Human α-defensin 6 (HD6) suppresses CRC proliferation and metastasis through abolished EGF/EGFR signaling pathway."" International journal of medical sciences, 2022, pp. 34-46.
[22] Chen, Zhongwen, Oh, Dongmyung, Dubey, Alok Kumar, Yao, Mingxi, Yang, Beverly, Groves, Jay T, Sheetz, Michael. ""EGFR family and Src family kinase interactions: mechanics matters?"" Current opinion in cell biology, 2018, pp. 97-102.
[23] Du, Guifang, Wang, Jing, Zhang, Ting, Ding, Qiang, Jia, Xiaodong, Zhao, Xueke, Dong, Jinke, Yang, Xinrui, Lu, Shanshan, Zhang, Cuihong, Liu, Ze, Zeng, Zhen, Safadi, Rifaat, Qi, Ruizhao, Zhao, Xin, Hong, Zhixian, Lu, Yinying. ""Targeting Src family kinase member Fyn by Saracatinib attenuated liver fibrosis in vitro and in vivo."" Cell death & disease, 2020, pp. 118.
[24] Gururajan, Murali, Cavassani, Karen A, Sievert, Margarit, Duan, Peng, Lichterman, Jake, Huang, Jen-Ming, Smith, Bethany, You, Sungyong, Nandana, Srinivas, Chu, Gina Chia-Yi, Mink, Sheldon, Josson, Sajni, Liu, Chunyan, Morello, Matteo, Jones, Lawrence W M, Kim, Jayoung, Freeman, Michael R, Bhowmick, Neil, Zhau, Haiyen E, Chung, Leland W K, Posadas, Edwin M. ""SRC family kinase FYN promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancer."" Oncotarget, 2015, pp. 44072-83.
[25] Tang, Rong, Langdon, Wallace Y, Zhang, Jian. ""Regulation of immune responses by E3 ubiquitin ligase Cbl-b."" Cellular immunology, 2019, pp. 103878.
[26] Chen, Hongxia, Bai, Yunpeng, Kobayashi, Michihiro, Xiao, Shiyu, Cai, Wenjie, Barajas, Sergio, Chen, Sisi, Miao, Jinmin, Meke, Frederick Nguele, Vemula, Sasidhar, Ropa, James P, Croop, James M, Boswell, H Scott, Wan, Jun, Jia, Yuzhi, Liu, Huiping, Li, Loretta S, Altman, Jessica K, Eklund, Elizabeth A, Ji, Peng, Tong, Wei, Band, Hamid, Huang, Danny T, Platanias, Leonidas C, Zhang, Zhong-Yin, Liu, Yan. ""PRL2 phosphatase enhances oncogenic FLT3 signaling via dephosphorylation of the E3 ubiquitin ligase CBL at tyrosine 371."" Blood, 2023, pp. 244-259.
[27] Liu, Qingjun, Zhou, Hong, Langdon, Wallace Y, Zhang, Jian. ""E3 ubiquitin ligase Cbl-b in innate and adaptive immunity."" Cell cycle (Georgetown, Tex.), 2014, pp. 1875-84.
[28] Moreno-Yruela, Carlos, Zhang, Di, Wei, Wei, Bæk, Michael, Liu, Wenchao, Gao, Jinjun, Danková, Daniela, Nielsen, Alexander L, Bolding, Julie E, Yang, Lu, Jameson, Samuel T, Wong, Jiemin, Olsen, Christian A, Zhao, Yingming. ""Class I histone deacetylases (HDAC1-3) are histone lysine delactylases."" Science advances, 2022, pp. eabi6696.
[29] Kiweler, Nicole, Brill, Boris, Wirth, Matthias, Breuksch, Ines, Laguna, Teresa, Dietrich, Cornelia, Strand, Susanne, Schneider, Günter, Groner, Bernd, Butter, Falk, Heinzel, Thorsten, Brenner, Walburgis, Krämer, Oliver H. ""The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cells."" Archives of toxicology, 2018, pp. 2227-2243.
[30] Demyanenko, S V, Dzreyan, V A, Neginskaya, M A, Uzdensky, A B. ""Expression of Histone Deacetylases HDAC1 and HDAC2 and Their Role in Apoptosis in the Penumbra Induced by Photothrombotic Stroke."" Molecular neurobiology, 2020, pp. 226-238.
[31] Zhang, Shuchen, Cui, Wei. ""Sox2, a key factor in the regulation of pluripotency and neural differentiation."" World journal of stem cells, 2014, pp. 305-11.
[32] Swain, Niharika, Thakur, Mansee, Pathak, Jigna, Swain, Biswaranjan. ""SOX2, OCT4 and NANOG: The core embryonic stem cell pluripotency regulators in oral carcinogenesis."" Journal of oral and maxillofacial pathology : JOMFP, 2020, pp. 368-373.
[33] An, Zhaojun, Liu, Peng, Zheng, Jiashun, Si, Chaozeng, Li, Tianda, Chen, Yang, Ma, Tianhua, Zhang, Michael Q, Zhou, Qi, Ding, Sheng. ""Sox2 and Klf4 as the Functional Core in Pluripotency Induction without Exogenous Oct4."" Cell reports, 2019, pp. 1986-2000.e8.
[34] Rodda, David J, Chew, Joon-Lin, Lim, Leng-Hiong, Loh, Yuin-Han, Wang, Bei, Ng, Huck-Hui, Robson, Paul. ""Transcriptional regulation of nanog by OCT4 and SOX2."" The Journal of biological chemistry, 2005, pp. 24731-7.
[35] Taylor, Tiegh, Sikorska, Natalia, Shchuka, Virlana M, Chahar, Sanjay, Ji, Chenfan, Macpherson, Neil N, Moorthy, Sakthi D, de Kort, Marit A C, Mullany, Shanelle, Khader, Nawrah, Gillespie, Zoe E, Langroudi, Lida, Tobias, Ian C, Lenstra, Tineke L, Mitchell, Jennifer A, Sexton, Tom. ""Transcriptional regulation and chromatin architecture maintenance are decoupled functions at the <i>Sox2</i> locus."" Genes & development, 2022, pp. 699-717.
[36] Vilas, Jéssica M, Ferreirós, Alba, Carneiro, Carmen, Morey, Lluis, Da Silva-Álvarez, Sabela, Fernandes, Tânia, Abad, María, Di Croce, Luciano, García-Caballero, Tomás, Serrano, Manuel, Rivas, Carmen, Vidal, Anxo, Collado, Manuel. ""Transcriptional regulation of Sox2 by the retinoblastoma family of pocket proteins."" Oncotarget, 2015, pp. 2992-3002.
"	0.36138797	0.37219244	Neither	LLM	NA
NeST	Regulation of E2F transcription via DREAM complex	NEST:119	E2F1 E2F2 E2F3 E2F4 E2F5 MDM2 RB1 RBL1 RBL2 TFDP1 TP53	11	3.4594316186372973	Regulation Of Transcription Involved In G1/S Transition Of Mitotic Cell Cycle 	GO:0000083	RB1;TFDP1;E2F1;E2F2	4	36.36363636363637	1.91e-10	5.16e-8	Cell Cycle Regulation	"The primary biological process performed by this system of interacting proteins is the regulation of the cell cycle, specifically the G1/S phase transition. The key proteins involved in this process are E2F transcription factors (E2F1-5), retinoblastoma proteins (RB1, RBL1, RBL2), and tumor protein p53 (TP53).

E2F transcription factors (E2F1-5) are essential for the regulation of cell cycle progression. E2F1-3 are activators, promoting cell cycle progression, while E2F4-5 are repressors, inhibiting cell cycle progression. These proteins bind to the promoters of target genes, regulating their expression and controlling cell cycle progression.

Retinoblastoma proteins (RB1, RBL1, RBL2) are tumor suppressors that regulate the activity of E2F transcription factors. In their hypophosphorylated state, they bind to and inhibit E2F1-3, preventing cell cycle progression. Upon phosphorylation by cyclin-dependent kinases (CDKs), they release E2F1-3, allowing cell cycle progression.

Tumor protein p53 (TP53) is a crucial tumor suppressor that regulates cell cycle arrest, DNA repair, and apoptosis in response to cellular stress. TP53 activates the transcription of p21, a CDK inhibitor, which in turn inhibits CDK activity and prevents RB1 phosphorylation, leading to cell cycle arrest.

MDM2 is an E3 ubiquitin ligase that negatively regulates TP53 by promoting its degradation. This interaction is crucial for maintaining appropriate TP53 levels and preventing excessive cell cycle arrest or apoptosis.

TFDP1 (DP1) is a transcription factor that forms heterodimers with E2F transcription factors, enhancing their DNA-binding activity and promoting cell cycle progression.

In summary, this system of interacting proteins plays a critical role in regulating the cell cycle, particularly the G1/S phase transition, through the interplay between E2F transcription factors, retinoblastoma proteins, and TP53. The balance between these proteins ensures proper cell cycle progression and prevents uncontrolled cell proliferation."	8	72.72727272727273	"The primary biological process performed by this system of interacting proteins is the regulation of the cell cycle, specifically the G1/S phase transition. The key proteins involved in this process are E2F transcription factors (E2F1-5), retinoblastoma proteins (RB1, RBL1, RBL2), and tumor protein p53 (TP53).[1][2][3]

E2F transcription factors (E2F1-5) are essential for the regulation of cell cycle progression. E2F1-3 are activators, promoting cell cycle progression, while E2F4-5 are repressors, inhibiting cell cycle progression. These proteins bind to the promoters of target genes, regulating their expression and controlling cell cycle progression.[4][5][6]

Retinoblastoma proteins (RB1, RBL1, RBL2) are tumor suppressors that regulate the activity of E2F transcription factors. In their hypophosphorylated state, they bind to and inhibit E2F1-3, preventing cell cycle progression. Upon phosphorylation by cyclin-dependent kinases (CDKs), they release E2F1-3, allowing cell cycle progression.[7][8][9]

Tumor protein p53 (TP53) is a crucial tumor suppressor that regulates cell cycle arrest, DNA repair, and apoptosis in response to cellular stress. TP53 activates the transcription of p21, a CDK inhibitor, which in turn inhibits CDK activity and prevents RB1 phosphorylation, leading to cell cycle arrest.[10][11][12]

MDM2 is an E3 ubiquitin ligase that negatively regulates TP53 by promoting its degradation. This interaction is crucial for maintaining appropriate TP53 levels and preventing excessive cell cycle arrest or apoptosis.[13][14][15]

TFDP1 (DP1) is a transcription factor that forms heterodimers with E2F transcription factors, enhancing their DNA-binding activity and promoting cell cycle progression.[16][17][18]

In summary, this system of interacting proteins plays a critical role in regulating the cell cycle, particularly the G1/S phase transition, through the interplay between E2F transcription factors, retinoblastoma proteins, and TP53. The balance between these proteins ensures proper cell cycle progression and prevents uncontrolled cell proliferation.[19][20][21]

========================================================================================================================================================================================================
[1] Schultz-Rogers, Laura E, Thayer, Michelle L, Kambakam, Sekhar, Wierson, Wesley A, Helmer, Jordan A, Wishman, Mark D, Wall, Kristen A, Greig, Jessica L, Forsman, Jaimie L, Puchhalapalli, Kavya, Nair, Siddharth, Weiss, Trevor J, Luiken, Jon M, Blackburn, Patrick R, Ekker, Stephen C, Kool, Marcel, McGrail, Maura. ""Rbbp4 loss disrupts neural progenitor cell cycle regulation independent of Rb and leads to Tp53 acetylation and apoptosis."" Developmental dynamics : an official publication of the American Association of Anatomists, 2022, pp. 1267-1290.
[2] Yang, Guodong, Lu, Xiaozhao, Wang, Li, Bian, Yongqian, Fu, Haiyan, Wei, Mengying, Pu, Jun, Jin, Liang, Yao, Libo, Lu, Zifan. ""E2F1 and RNA binding protein QKI comprise a negative feedback in the cell cycle regulation."" Cell cycle (Georgetown, Tex.), 2011, pp. 2703-13.
[3] Hong, Seong Hwi, Eun, Jung Woo, Choi, Sung Kyung, Shen, Qingyu, Choi, Wahn Soo, Han, Jeung-Whan, Nam, Suk Woo, You, Jueng Soo. ""Epigenetic reader BRD4 inhibition as a therapeutic strategy to suppress E2F2-cell cycle regulation circuit in liver cancer."" Oncotarget, 2016, pp. 32628-40.
[4] Liu, Xiaowei, Cai, Yuanxia, Cheng, Cheng, Gu, Yaoyao, Hu, Xiaoxiao, Chen, Kai, Wu, Yeming, Wu, Zhixiang. ""PCLAF promotes neuroblastoma G1/S cell cycle progression via the E2F1/PTTG1 axis."" Cell death & disease, 2022, pp. 178.
[5] Liu, Ying, Liu, Donghai, Wan, Wuqing. ""MYCN-induced E2F5 promotes neuroblastoma cell proliferation through regulating cell cycle progression."" Biochemical and biophysical research communications, 2019, pp. 35-40.
[6] Wang, Yuting, Liu, Liping, Song, Yifan, Yu, Xiaojie, Deng, Hongkui. ""Unveiling E2F4, TEAD1 and AP-1 as regulatory transcription factors of the replicative senescence program by multi-omics analysis."" Protein & cell, 2022, pp. 742-759.
[7] Liu, Xiaowei, Cai, Yuanxia, Cheng, Cheng, Gu, Yaoyao, Hu, Xiaoxiao, Chen, Kai, Wu, Yeming, Wu, Zhixiang. ""PCLAF promotes neuroblastoma G1/S cell cycle progression via the E2F1/PTTG1 axis."" Cell death & disease, 2022, pp. 178.
[8] Hatzistergos, Konstantinos E, Williams, Adam R, Dykxhoorn, Derek, Bellio, Michael A, Yu, Wendou, Hare, Joshua M. ""Tumor Suppressors RB1 and CDKN2a Cooperatively Regulate Cell-Cycle Progression and Differentiation During Cardiomyocyte Development and Repair."" Circulation research, 2019, pp. 1184-1197.
[9] Hamid, Anis A, Gray, Kathryn P, Shaw, Grace, MacConaill, Laura E, Evan, Carolyn, Bernard, Brandon, Loda, Massimo, Corcoran, Niall M, Van Allen, Eliezer M, Choudhury, Atish D, Sweeney, Christopher J. ""Compound Genomic Alterations of TP53, PTEN, and RB1 Tumor Suppressors in Localized and Metastatic Prostate Cancer."" European urology, 2019, pp. 89-97.
[10] Zhao, Wenpeng, Zhang, Liang, Zhang, Yaya, Jiang, Zhengye, Lu, Hanwen, Xie, Yuanyuan, Han, Wanhong, Zhao, Wentao, He, Jiawei, Shi, Zhongjie, Yang, Huiying, Chen, Junjie, Chen, Sifang, Li, Zhangyu, Mao, Jianyao, Zhou, Liwei, Gao, Xin, Li, Wenhua, Tan, Guowei, Zhang, Bingchang, Wang, Zhanxiang. ""The CDK inhibitor AT7519 inhibits human glioblastoma cell growth by inducing apoptosis, pyroptosis and cell cycle arrest."" Cell death & disease, 2023, pp. 11.
[11] Pennycook, Betheney R, Barr, Alexis R. ""Palbociclib-mediated cell cycle arrest can occur in the absence of the CDK inhibitors p21 and p27."" Open biology, 2021, pp. 210125.
[12] Aasland, Dorthe, Götzinger, Laura, Hauck, Laura, Berte, Nancy, Meyer, Jessica, Effenberger, Melanie, Schneider, Simon, Reuber, Emelie E, Roos, Wynand P, Tomicic, Maja T, Kaina, Bernd, Christmann, Markus. ""Temozolomide Induces Senescence and Repression of DNA Repair Pathways in Glioblastoma Cells via Activation of ATR-CHK1, p21, and NF-κB."" Cancer research, 2019, pp. 99-113.
[13] Zhou, Jiajia, Kryczek, Ilona, Li, Shasha, Li, Xiong, Aguilar, Angelo, Wei, Shuang, Grove, Sara, Vatan, Linda, Yu, Jiali, Yan, Yijian, Liao, Peng, Lin, Heng, Li, Jing, Li, Gaopeng, Du, Wan, Wang, Weichao, Lang, Xueting, Wang, Weimin, Wang, Shaomeng, Zou, Weiping. ""The ubiquitin ligase MDM2 sustains STAT5 stability to control T cell-mediated antitumor immunity."" Nature immunology, 2021, pp. 460-470.
[14] Kim, Jun Yeob, Lee, Rusia, Xiao, Gu, Forbes, Dominique, Bargonetti, Jill. ""MDM2-C Functions as an E3 Ubiquitin Ligase."" Cancer management and research, 2020, pp. 7715-7724.
[15] Han, Xin, Wei, Wenyi, Sun, Yi. ""PROTAC Degraders with Ligands Recruiting MDM2 E3 Ubiquitin Ligase: An Updated Perspective."" Acta materia medica, 2022, pp. 244-259.
[16] Mäkelä, Juho-Antti, Toppari, Jorma. ""Retinoblastoma-E2F Transcription Factor Interplay Is Essential for Testicular Development and Male Fertility."" Frontiers in endocrinology, 2022, pp. 903684.
[17] Kassab, Amal, Gupta, Ishita, Moustafa, Ala-Eddin Al. ""Role of E2F transcription factor in oral cancer: Recent insight and advancements."" Seminars in cancer biology, 2023, pp. 28-41.
[18] Li, Luwen, Wang, Shiguan, Zhang, Yihang, Pan, Jihong. ""The E2F transcription factor 2: What do we know?"" Bioscience trends, 2021, pp. 83-92.
[19] Meireles Da Costa, Nathalia, Palumbo, Antonio, De Martino, Marco, Fusco, Alfredo, Ribeiro Pinto, Luis Felipe, Nasciutti, Luiz Eurico. ""Interplay between HMGA and TP53 in cell cycle control along tumor progression."" Cellular and molecular life sciences : CMLS, 2021, pp. 817-831.
[20] Fischer, Martin, Müller, Gerd A. ""Cell cycle transcription control: DREAM/MuvB and RB-E2F complexes."" Critical reviews in biochemistry and molecular biology, 2017, pp. 638-662.
[21] Johnson, D G, Schneider-Broussard, R. ""Role of E2F in cell cycle control and cancer."" Frontiers in bioscience : a journal and virtual library, 1998, pp. d447-8.
"	0.40929407	0.42937723	Tied	GO	NA
NeST	PML body	NEST:123	CREBBP DAXX EP300 HDAC1 NPM1 PARP1 PML RB1 TERT	9	3.169925001442312	Cellular Response To Light Stimulus 	GO:0071482	CREBBP;NPM1;PARP1;EP300	4	44.44444444444444	1.26e-8	4.16e-6	Chromatin Remodeling and Transcription Regulation	"The system of interacting proteins CREBBP, DAXX, EP300, HDAC1, NPM1, PARP1, PML, RB1, and TERT primarily perform chromatin remodeling and transcription regulation. 

1. CREBBP and EP300: Both CREBBP (CREB-binding protein) and EP300 (E1A binding protein p300) are histone acetyltransferases (HATs) that play a crucial role in transcription regulation. They acetylate histones, leading to a more relaxed chromatin structure and promoting gene transcription. Additionally, they act as transcriptional coactivators by interacting with various transcription factors.

2. HDAC1: Histone deacetylase 1 (HDAC1) is involved in chromatin remodeling by removing acetyl groups from histones, leading to a more condensed chromatin structure and transcriptional repression. It counteracts the actions of CREBBP and EP300, providing a balance in transcription regulation.

3. DAXX: Death domain-associated protein 6 (DAXX) is a multifunctional protein involved in transcription regulation and chromatin remodeling. It acts as a transcriptional repressor by interacting with various transcription factors and histone deacetylases, including HDAC1.

4. NPM1: Nucleophosmin (NPM1) is a nucleolar protein involved in ribosome biogenesis, chromatin remodeling, and transcription regulation. It interacts with histones and other chromatin-associated proteins, such as HDAC1, to modulate chromatin structure and gene expression.

5. PARP1: Poly(ADP-ribose) polymerase 1 (PARP1) is involved in DNA repair, chromatin remodeling, and transcription regulation. It modifies target proteins by adding ADP-ribose moieties, which can affect their function and interactions. PARP1 has been shown to interact with CREBBP and EP300, modulating their HAT activity and transcriptional regulation.

6. PML: Promyelocytic leukemia protein (PML) is involved in the formation of PML nuclear bodies, which are implicated in various cellular processes, including transcription regulation and chromatin remodeling. PML interacts with DAXX and other chromatin-associated proteins to modulate gene expression.

7. RB1: Retinoblastoma protein (RB1) is a tumor suppressor protein that plays a critical role in cell cycle regulation and transcription regulation. It interacts with various transcription factors and chromatin remodeling proteins, such as HDAC1, to repress gene transcription.

8. TERT: Telomerase reverse transcriptase (TERT) is the catalytic subunit of telomerase, which is involved in maintaining telomere length and cellular immortality. TERT has also been implicated in transcription regulation by interacting with various transcription factors and chromatin remodeling proteins.

In conclusion, the primary biological process performed by this system of interacting proteins is chromatin remodeling and transcription regulation. The proteins work together to modulate chromatin structure and gene expression, ensuring proper cellular function and homeostasis."	9	100	"The system of interacting proteins CREBBP, DAXX, EP300, HDAC1, NPM1, PARP1, PML, RB1, and TERT primarily perform chromatin remodeling and transcription regulation. [1][2][3]

1. CREBBP and EP300: Both CREBBP (CREB-binding protein) and EP300 (E1A binding protein p300) are histone acetyltransferases (HATs) that play a crucial role in transcription regulation. They acetylate histones, leading to a more relaxed chromatin structure and promoting gene transcription. Additionally, they act as transcriptional coactivators by interacting with various transcription factors.[4][5][6]

2. HDAC1: Histone deacetylase 1 (HDAC1) is involved in chromatin remodeling by removing acetyl groups from histones, leading to a more condensed chromatin structure and transcriptional repression. It counteracts the actions of CREBBP and EP300, providing a balance in transcription regulation.[7][8][9]

3. DAXX: Death domain-associated protein 6 (DAXX) is a multifunctional protein involved in transcription regulation and chromatin remodeling. It acts as a transcriptional repressor by interacting with various transcription factors and histone deacetylases, including HDAC1.[10][11][12]

4. NPM1: Nucleophosmin (NPM1) is a nucleolar protein involved in ribosome biogenesis, chromatin remodeling, and transcription regulation. It interacts with histones and other chromatin-associated proteins, such as HDAC1, to modulate chromatin structure and gene expression.[13][14][15]

5. PARP1: Poly(ADP-ribose) polymerase 1 (PARP1) is involved in DNA repair, chromatin remodeling, and transcription regulation. It modifies target proteins by adding ADP-ribose moieties, which can affect their function and interactions. PARP1 has been shown to interact with CREBBP and EP300, modulating their HAT activity and transcriptional regulation.[16][17][18]

6. PML: Promyelocytic leukemia protein (PML) is involved in the formation of PML nuclear bodies, which are implicated in various cellular processes, including transcription regulation and chromatin remodeling. PML interacts with DAXX and other chromatin-associated proteins to modulate gene expression.[19][20][21]

7. RB1: Retinoblastoma protein (RB1) is a tumor suppressor protein that plays a critical role in cell cycle regulation and transcription regulation. It interacts with various transcription factors and chromatin remodeling proteins, such as HDAC1, to repress gene transcription.[22][23][24]

8. TERT: Telomerase reverse transcriptase (TERT) is the catalytic subunit of telomerase, which is involved in maintaining telomere length and cellular immortality. TERT has also been implicated in transcription regulation by interacting with various transcription factors and chromatin remodeling proteins.[25][26][27]

In conclusion, the primary biological process performed by this system of interacting proteins is chromatin remodeling and transcription regulation. The proteins work together to modulate chromatin structure and gene expression, ensuring proper cellular function and homeostasis.

========================================================================================================================================================================================================
[1] Sinha, Saptarshi, Molla, Sefinew, Kundu, Chanakya Nath. ""PARP1-modulated chromatin remodeling is a new target for cancer treatment."" Medical oncology (Northwood, London, England), 2021, pp. 118.
[2] Jiang, Bo-Hua, Chen, Wei-Yi, Li, Hsin-Yang, Chien, Yueh, Chang, Wei-Chao, Hsieh, Pei-Chen, Wu, Ping, Chen, Chieh-Yu, Song, Hui-Yung, Chien, Chian-Shiu, Sung, Yen-Jen, Chiou, Shih-Hwa. ""CHD1L Regulated PARP1-Driven Pluripotency and Chromatin Remodeling During the Early-Stage Cell Reprogramming."" Stem cells (Dayton, Ohio), 2015, pp. 2961-72.
[3] Al-Yhya, Nouf, Khan, Muhammad Farooq, Almeer, Rafa Sharaf, Alshehri, Mana M, Aldughaim, Mohammed S, Wadaan, Mohammad Ahmed. ""Pharmacological inhibition of HDAC1/3-interacting proteins induced morphological changes, and hindered the cell proliferation and migration of hepatocellular carcinoma cells."" Environmental science and pollution research international, 2021, pp. 49000-49013.
[4] Liu, Shan, Zhou, Jie, Ye, Xiangling, Chen, Danni, Chen, Weimin, Lin, Yaobin, Chen, Zhizhong, Chen, Biyun, Shang, Jin. ""A novel lncRNA SNHG29 regulates EP300- related histone acetylation modification and inhibits FLT3-ITD AML development."" Leukemia, 2023, pp. 1421-1434.
[5] Wang, Yingshuang, Feng, Feifei, Zheng, Pingping, Wang, Lijuan, Wang, Yanjun, Lv, Yaogai, Shen, Li, Li, Kexin, Feng, Tianyu, Chen, Yang, Liu, Zhigang, Yao, Yan. ""Dysregulated lncRNA and mRNA may promote the progression of ischemic stroke via immune and inflammatory pathways: results from RNA sequencing and bioinformatics analysis."" Genes & genomics, 2022, pp. 97-108.
[6] Nibbeling, Esther A R, Duarri, Anna, Verschuuren-Bemelmans, Corien C, Fokkens, Michiel R, Karjalainen, Juha M, Smeets, Cleo J L M, de Boer-Bergsma, Jelkje J, van der Vries, Gerben, Dooijes, Dennis, Bampi, Giovana B, van Diemen, Cleo, Brunt, Ewout, Ippel, Elly, Kremer, Berry, Vlak, Monique, Adir, Noam, Wijmenga, Cisca, van de Warrenburg, Bart P C, Franke, Lude, Sinke, Richard J, Verbeek, Dineke S. ""Exome sequencing and network analysis identifies shared mechanisms underlying spinocerebellar ataxia."" Brain : a journal of neurology, 2017, pp. 2860-2878.
[7] Zhou, Yonggang, Santoro, Raffaella, Grummt, Ingrid. ""The chromatin remodeling complex NoRC targets HDAC1 to the ribosomal gene promoter and represses RNA polymerase I transcription."" The EMBO journal, 2002, pp. 4632-40.
[8] Choi, Yong Seok, Jeong, Sunjoo. ""PI3-kinase and PDK-1 regulate HDAC1-mediated transcriptional repression of transcription factor NF-kappaB."" Molecules and cells, 2005, pp. 241-6.
[9] Binda, O, Nassif, C, Branton, P E. ""SIRT1 negatively regulates HDAC1-dependent transcriptional repression by the RBP1 family of proteins."" Oncogene, 2008, pp. 3384-92.
[10] Zhou, Yonggang, Santoro, Raffaella, Grummt, Ingrid. ""The chromatin remodeling complex NoRC targets HDAC1 to the ribosomal gene promoter and represses RNA polymerase I transcription."" The EMBO journal, 2002, pp. 4632-40.
[11] Xue, Yutong, Gibbons, Richard, Yan, Zhijiang, Yang, Dafeng, McDowell, Tarra L, Sechi, Salvatore, Qin, Jun, Zhou, Sharleen, Higgs, Doug, Wang, Weidong. ""The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies."" Proceedings of the National Academy of Sciences of the United States of America, 2003, pp. 10635-40.
[12] Moreno-Yruela, Carlos, Zhang, Di, Wei, Wei, Bæk, Michael, Liu, Wenchao, Gao, Jinjun, Danková, Daniela, Nielsen, Alexander L, Bolding, Julie E, Yang, Lu, Jameson, Samuel T, Wong, Jiemin, Olsen, Christian A, Zhao, Yingming. ""Class I histone deacetylases (HDAC1-3) are histone lysine delactylases."" Science advances, 2022, pp. eabi6696.
[13] Lindström, Mikael S. ""NPM1/B23: A Multifunctional Chaperone in Ribosome Biogenesis and Chromatin Remodeling."" Biochemistry research international, 2011, pp. 195209.
[14] Zhou, Yonggang, Santoro, Raffaella, Grummt, Ingrid. ""The chromatin remodeling complex NoRC targets HDAC1 to the ribosomal gene promoter and represses RNA polymerase I transcription."" The EMBO journal, 2002, pp. 4632-40.
[15] Okuwaki, Mitsuru, Sumi, Ayako, Hisaoka, Miharu, Saotome-Nakamura, Ai, Akashi, Satoko, Nishimura, Yoshifumi, Nagata, Kyosuke. ""Function of homo- and hetero-oligomers of human nucleoplasmin/nucleophosmin family proteins NPM1, NPM2 and NPM3 during sperm chromatin remodeling."" Nucleic acids research, 2012, pp. 4861-78.
[16] Ray Chaudhuri, Arnab, Nussenzweig, André. ""The multifaceted roles of PARP1 in DNA repair and chromatin remodelling."" Nature reviews. Molecular cell biology, 2017, pp. 610-621.
[17] Zada, David, Sela, Yaniv, Matosevich, Noa, Monsonego, Adir, Lerer-Goldshtein, Tali, Nir, Yuval, Appelbaum, Lior. ""Parp1 promotes sleep, which enhances DNA repair in neurons."" Molecular cell, 2021, pp. 4979-4993.e7.
[18] Mao, Zhiyong, Hine, Christopher, Tian, Xiao, Van Meter, Michael, Au, Matthew, Vaidya, Amita, Seluanov, Andrei, Gorbunova, Vera. ""SIRT6 promotes DNA repair under stress by activating PARP1."" Science (New York, N.Y.), 2011, pp. 1443-6.
[19] Ishov, A M, Sotnikov, A G, Negorev, D, Vladimirova, O V, Neff, N, Kamitani, T, Yeh, E T, Strauss, J F, Maul, G G. ""PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1."" The Journal of cell biology, 1999, pp. 221-34.
[20] Hornofova, Terezie, Pokorna, Barbora, Hubackova, Sona Stemberkova, Uvizl, Alena, Kosla, Jan, Bartek, Jiri, Hodny, Zdenek, Vasicova, Pavla. ""Phospho-SIM and exon8b of PML protein regulate formation of doxorubicin-induced rDNA-PML compartment."" DNA repair, 2022, pp. 103319.
[21] Segalla, Simona, Rinaldi, Laura, Kilstrup-Nielsen, Charlotte, Badaracco, Gianfranco, Minucci, Saverio, Pelicci, Pier Giuseppe, Landsberger, Nicoletta. ""Retinoic acid receptor alpha fusion to PML affects its transcriptional and chromatin-remodeling properties."" Molecular and cellular biology, 2003, pp. 8795-808.
[22] Wilting, Roel H, Yanover, Eva, Heideman, Marinus R, Jacobs, Heinz, Horner, James, van der Torre, Jaco, DePinho, Ronald A, Dannenberg, Jan-Hermen. ""Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesis."" The EMBO journal, 2010, pp. 2586-97.
[23] Lee, Hsueh-Yun, Tang, Di-Wei, Liu, Chi-Yuan, Cho, Er-Chieh. ""A novel HDAC1/2 inhibitor suppresses colorectal cancer through apoptosis induction and cell cycle regulation."" Chemico-biological interactions, 2022, pp. 109778.
[24] Dyson, Nicholas J. ""RB1: a prototype tumor suppressor and an enigma."" Genes & development, 2016, pp. 1492-502.
[25] Yuan, Xiaotian, Larsson, Catharina, Xu, Dawei. ""Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players."" Oncogene, 2019, pp. 6172-6183.
[26] McKelvey, Brittany A, Umbricht, Christopher B, Zeiger, Martha A. ""Telomerase Reverse Transcriptase (TERT) Regulation in Thyroid Cancer: A Review."" Frontiers in endocrinology, 2020, pp. 485.
[27] Guo, Yuchen, Chen, Yi, Zhang, Lianghui, Ma, Ling, Jiang, Keyu, Yao, Gang, Zhu, Lingjun. ""TERT Promoter Mutations and Telomerase in Melanoma."" Journal of oncology, 2022, pp. 6300329.
"	0.24734227	0.2742912	Neither	LLM	NA
NeST	Extended mismatch repair complex	NEST:125	ERCC1 ERCC4 MLH1 MLH3 MSH2 MSH3 MSH6 PMS1 PMS2 SLX4	10	3.321928094887362	Mismatch Repair 	GO:0006298	MSH6;MSH2;MSH3;PMS2;MLH1;MLH3;PMS1	7	70	2.27e-19	1.57e-17	DNA Repair and Mismatch Repair	"The system of interacting proteins ERCC1, ERCC4, MLH1, MLH3, MSH2, MSH3, MSH6, PMS1, PMS2, and SLX4 primarily perform DNA repair and mismatch repair processes. 

1. ERCC1 and ERCC4: These proteins form a heterodimeric endonuclease complex involved in nucleotide excision repair (NER). NER is a critical process that removes bulky DNA lesions caused by UV radiation and chemical mutagens. ERCC1 is responsible for DNA damage recognition, while ERCC4 provides the catalytic activity for DNA incision.

2. MLH1, MLH3, PMS1, and PMS2: These proteins are part of the MutL family and play essential roles in mismatch repair (MMR). MMR is a process that corrects base-pair mismatches and insertion/deletion loops that arise during DNA replication. MLH1 forms heterodimers with PMS2 (MutLα), MLH3 (MutLγ), and PMS1 (MutLβ), which are involved in different aspects of MMR. MutLα is the primary complex responsible for MMR, while MutLγ and MutLβ have specialized roles in meiotic recombination and mutation avoidance, respectively.

3. MSH2, MSH3, and MSH6: These proteins belong to the MutS family and are crucial for mismatch recognition in MMR. MSH2 forms heterodimers with MSH6 (MutSα) and MSH3 (MutSβ). MutSα recognizes base-pair mismatches and small insertion/deletion loops, while MutSβ recognizes larger insertion/deletion loops. Both complexes initiate the MMR process by binding to the mismatch and recruiting MutL proteins.

4. SLX4: This protein acts as a scaffold for multiple DNA repair nucleases, including ERCC4. SLX4 is involved in the repair of DNA interstrand crosslinks, which are highly toxic lesions that covalently link both DNA strands. By interacting with ERCC4 and other nucleases, SLX4 coordinates the incisions required for crosslink repair.

In summary, the primary biological process performed by this system of interacting proteins is DNA repair and mismatch repair. These proteins work together to maintain genomic integrity by recognizing and repairing various types of DNA damage and replication errors."	10	100	"The system of interacting proteins ERCC1, ERCC4, MLH1, MLH3, MSH2, MSH3, MSH6, PMS1, PMS2, and SLX4 primarily perform DNA repair and mismatch repair processes. [1][2][3]

1. ERCC1 and ERCC4: These proteins form a heterodimeric endonuclease complex involved in nucleotide excision repair (NER). NER is a critical process that removes bulky DNA lesions caused by UV radiation and chemical mutagens. ERCC1 is responsible for DNA damage recognition, while ERCC4 provides the catalytic activity for DNA incision.[4][5][6]

2. MLH1, MLH3, PMS1, and PMS2: These proteins are part of the MutL family and play essential roles in mismatch repair (MMR). MMR is a process that corrects base-pair mismatches and insertion/deletion loops that arise during DNA replication. MLH1 forms heterodimers with PMS2 (MutLα), MLH3 (MutLγ), and PMS1 (MutLβ), which are involved in different aspects of MMR. MutLα is the primary complex responsible for MMR, while MutLγ and MutLβ have specialized roles in meiotic recombination and mutation avoidance, respectively.[7][8][9]

3. MSH2, MSH3, and MSH6: These proteins belong to the MutS family and are crucial for mismatch recognition in MMR. MSH2 forms heterodimers with MSH6 (MutSα) and MSH3 (MutSβ). MutSα recognizes base-pair mismatches and small insertion/deletion loops, while MutSβ recognizes larger insertion/deletion loops. Both complexes initiate the MMR process by binding to the mismatch and recruiting MutL proteins.[10][11][12]

4. SLX4: This protein acts as a scaffold for multiple DNA repair nucleases, including ERCC4. SLX4 is involved in the repair of DNA interstrand crosslinks, which are highly toxic lesions that covalently link both DNA strands. By interacting with ERCC4 and other nucleases, SLX4 coordinates the incisions required for crosslink repair.[13][14][15]

In summary, the primary biological process performed by this system of interacting proteins is DNA repair and mismatch repair. These proteins work together to maintain genomic integrity by recognizing and repairing various types of DNA damage and replication errors.

========================================================================================================================================================================================================
[1] Young, Sarah J, West, Stephen C. ""Coordinated roles of SLX4 and MutSβ in DNA repair and the maintenance of genome stability."" Critical reviews in biochemistry and molecular biology, 2021, pp. 157-177.
[2] Jiang, Chunming, Shen, Fang, Du, Jianmin, Wang, Xiaohua, Su, Jin, Liu, Zhanli, Huang, Xianmei. ""DNA repair gene ERCC1 polymorphisms and glioma susceptibility among Chinese population: a meta-analysis."" International journal of clinical and experimental medicine, 2015, pp. 10248-55.
[3] Nargund, Amrita M, Xu, Chang, Mandoli, Amit, Okabe, Atsushi, Chen, Gao Bin, Huang, Kie Kyon, Sheng, Taotao, Yao, Xiaosai, Teo, Jia Ming Nickolas, Sundar, Raghav, Kok, Yee Jiun, See, Yi Xiang, Xing, Manjie, Li, Zhimei, Yong, Chern Han, Anand, Aparna, A I, Zul Fazreen, Poon, Lai Fong, Ng, Michelle Shu Wen, Koh, Javier Yu Peng, Ooi, Wen Fong, Tay, Su Ting, Ong, Xuewen, Tan, Angie Lay Keng, Grabsch, Heike I, Fullwood, Melissa J, Teh, Tean Bin, Bi, Xuezhi, Kaneda, Atsushi, Li, Shang, Tan, Patrick. ""Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer."" Cancer research, 2022, pp. 2538-2551.
[4] Joyce, Eric F, Tanneti, S Nikhila, McKim, Kim S. ""Drosophila hold'em is required for a subset of meiotic crossovers and interacts with the dna repair endonuclease complex subunits MEI-9 and ERCC1."" Genetics, 2009, pp. 335-40.
[5] Xie, Qiong-Hui, He, Xing-Xing, Chang, Ying, Sun, Shu-zhen, Jiang, Xiang, Li, Pei-Yuan, Lin, Ju-Sheng. ""MiR-192 inhibits nucleotide excision repair by targeting ERCC3 and ERCC4 in HepG2.2.15 cells."" Biochemical and biophysical research communications, 2011, pp. 440-5.
[6] Anjali, Kumari, Kumar, Tarun, Kumar, Puneet, Narayan, Gopeshwar, Singh, Sunita. ""Association of nonsynonymous SNPs of nucleotide excision repair genes ERCC4 rs1800067 (G/A) and ERCC5 rs17655 (G/C) as predisposing risk factors for gallbladder cancer."" Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2022, pp. 1533-1540.
[7] Rogacheva, Maria V, Manhart, Carol M, Chen, Cheng, Guarne, Alba, Surtees, Jennifer, Alani, Eric. ""Mlh1-Mlh3, a meiotic crossover and DNA mismatch repair factor, is a Msh2-Msh3-stimulated endonuclease."" The Journal of biological chemistry, 2014, pp. 5664-73.
[8] Rahman, Md Maminur, Mohiuddin, Mohiuddin, Shamima Keka, Islam, Yamada, Kousei, Tsuda, Masataka, Sasanuma, Hiroyuki, Andreani, Jessica, Guerois, Raphael, Borde, Valerie, Charbonnier, Jean-Baptiste, Takeda, Shunichi. ""Genetic evidence for the involvement of mismatch repair proteins, PMS2 and MLH3, in a late step of homologous recombination."" The Journal of biological chemistry, 2020, pp. 17460-17475.
[9] Goellner, Eva M, Smith, Catherine E, Campbell, Christopher S, Hombauer, Hans, Desai, Arshad, Putnam, Christopher D, Kolodner, Richard D. ""PCNA and Msh2-Msh6 activate an Mlh1-Pms1 endonuclease pathway required for Exo1-independent mismatch repair."" Molecular cell, 2014, pp. 291-304.
[10] Mukherjee, Shayantani, Law, Sean M, Feig, Michael. ""Deciphering the mismatch recognition cycle in MutS and MSH2-MSH6 using normal-mode analysis."" Biophysical journal, 2009, pp. 1707-20.
[11] Lee, Susan D, Surtees, Jennifer A, Alani, Eric. ""Saccharomyces cerevisiae MSH2-MSH3 and MSH2-MSH6 complexes display distinct requirements for DNA binding domain I in mismatch recognition."" Journal of molecular biology, 2007, pp. 53-66.
[12] Bouvet, Delphine, Bodo, Sahra, Munier, Annie, Guillerm, Erell, Bertrand, Romane, Colas, Chrystelle, Duval, Alex, Coulet, Florence, Muleris, Martine. ""Methylation Tolerance-Based Functional Assay to Assess Variants of Unknown Significance in the MLH1 and MSH2 Genes and Identify Patients With Lynch Syndrome."" Gastroenterology, 2019, pp. 421-431.
[13] Young, Sarah J, West, Stephen C. ""Coordinated roles of SLX4 and MutSβ in DNA repair and the maintenance of genome stability."" Critical reviews in biochemistry and molecular biology, 2021, pp. 157-177.
[14] Payliss, Brandon J, Tse, Ying Wah E, Reichheld, Sean E, Lemak, Alexander, Yun, Hwa Young, Houliston, Scott, Patel, Ayushi, Arrowsmith, Cheryl H, Sharpe, Simon, Wyatt, Haley D M. ""Phosphorylation of the DNA repair scaffold SLX4 drives folding of the SAP domain and activation of the MUS81-EME1 endonuclease."" Cell reports, 2022, pp. 111537.
[15] Aprosoff, Camila M, Dyakov, Boris J A, Cheung, Vivian H W, Wong, Cassandra J, Palandra, Mikaela, Gingras, Anne-Claude, Wyatt, Haley D M. ""Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification."" Journal of proteome research, 2023, pp. 1660-1681.
"	0.76138616	0.7637749	Tied	Tied	NA
NeST	Regulation of beta catenin transcriptional activity	NEST:126	CHEK2 CREBBP CTNNB1 EP300 HDAC2 HDAC3 KAT6A KMT2A TCF3 TP53	10	3.321928094887362	Positive Regulation Of Nucleic Acid-Templated Transcription 	GO:1903508	CREBBP;HDAC2;KMT2A;CHEK2;KAT6A;CTNNB1;EP300;TCF3;TP53	9	90	9.22e-14	3.53e-11	Regulation of Gene Expression and DNA Damage Response	"Proteins: CHEK2, CREBBP, CTNNB1, EP300, HDAC2, HDAC3, KAT6A, KMT2A, TCF3, TP53.

1. DNA Damage Response and Cell Cycle Regulation:
- CHEK2 and TP53 are key players in DNA damage response and cell cycle regulation.
- CHEK2 is a serine/threonine kinase that phosphorylates TP53, enhancing its stability and transcriptional activity.
- TP53 is a tumor suppressor that regulates cell cycle progression and apoptosis in response to DNA damage.

2. Chromatin Remodeling and Histone Modification:
- CREBBP, EP300, KAT6A, and KMT2A are involved in chromatin remodeling and histone modification.
- CREBBP and EP300 are histone acetyltransferases that promote gene transcription by relaxing chromatin structure.
- KAT6A is a histone acetyltransferase that acetylates histone H3, facilitating transcriptional activation.
- KMT2A is a histone methyltransferase that methylates histone H3, promoting gene expression.

3. Histone Deacetylation and Transcriptional Repression:
- HDAC2 and HDAC3 are histone deacetylases that remove acetyl groups from histones, leading to chromatin condensation and transcriptional repression.

4. Wnt Signaling and Cell Adhesion:
- CTNNB1 is a key component of the Wnt signaling pathway and is involved in cell adhesion.
- CTNNB1 forms a complex with TCF3, regulating the transcription of Wnt target genes.

5. Transcriptional Regulation:
- TCF3 is a transcription factor that interacts with CTNNB1 and other co-factors to regulate gene expression.

In conclusion, the most prominent biological process performed by this system of interacting proteins is the regulation of gene expression and DNA damage response. These proteins play crucial roles in maintaining genomic stability, controlling cell cycle progression, and modulating transcription through chromatin remodeling and histone modifications."	10	100	"Proteins: CHEK2, CREBBP, CTNNB1, EP300, HDAC2, HDAC3, KAT6A, KMT2A, TCF3, TP53.

1. DNA Damage Response and Cell Cycle Regulation:

- CHEK2 and TP53 are key players in DNA damage response and cell cycle regulation.[1][2][3]

- CHEK2 is a serine/threonine kinase that phosphorylates TP53, enhancing its stability and transcriptional activity.[4][5][6]

- TP53 is a tumor suppressor that regulates cell cycle progression and apoptosis in response to DNA damage.[7][8][9]

2. Chromatin Remodeling and Histone Modification:

- CREBBP, EP300, KAT6A, and KMT2A are involved in chromatin remodeling and histone modification.[10][11][12]

- CREBBP and EP300 are histone acetyltransferases that promote gene transcription by relaxing chromatin structure.[13][14][15]

- KAT6A is a histone acetyltransferase that acetylates histone H3, facilitating transcriptional activation.[16][17][18]

- KMT2A is a histone methyltransferase that methylates histone H3, promoting gene expression.[19][20][21]

3. Histone Deacetylation and Transcriptional Repression:

- HDAC2 and HDAC3 are histone deacetylases that remove acetyl groups from histones, leading to chromatin condensation and transcriptional repression.[22][23][24]

4. Wnt Signaling and Cell Adhesion:

- CTNNB1 is a key component of the Wnt signaling pathway and is involved in cell adhesion.[25][26][27]

- CTNNB1 forms a complex with TCF3, regulating the transcription of Wnt target genes.[28][29][30]

- TCF3 is a transcription factor that interacts with CTNNB1 and other co-factors to regulate gene expression.[31][32][33]

In conclusion, the most prominent biological process performed by this system of interacting proteins is the regulation of gene expression and DNA damage response. These proteins play crucial roles in maintaining genomic stability, controlling cell cycle progression, and modulating transcription through chromatin remodeling and histone modifications.

========================================================================================================================================================================================================
[1] Lindemann, A, Takahashi, H, Patel, A A, Osman, A A, Myers, J N. ""Targeting the DNA Damage Response in OSCC with TP53 Mutations."" Journal of dental research, 2018, pp. 635-644.
[2] de Souza, Samara Silva, da Costa, Jaqueline Custódio, da Silva, Grazyelle Sebrenski, de Almeida-Val, Vera Maria Fonseca. ""Malathion alters the transcription of target genes of the tumour suppressor tp53 and cancerous processes in Colossoma macropomum: Mechanisms of DNA damage response, oxidative stress and apoptosis."" Chemico-biological interactions, 2023, pp. 110405.
[3] Stubbins, Ryan J, Korotev, Sophia, Godley, Lucy A. ""Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies."" Current hematologic malignancy reports, 2022, pp. 94-104.
[4] He, Min, Slee, Elizabeth A, Sun, Mengmeng, Hu, Chunxiu, Chang, Wen-Te, Xu, Guowang, Lu, Xin, Wang, Mei. ""Defect in Ser312 phosphorylation of Tp53 dysregulates lipid metabolism for fatty accumulation and fatty liver susceptibility: Revealed by lipidomics."" Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2022, pp. 123491.
[5] Legartová, Soňa, Fagherazzi, Paolo, Goswami, Pratik, Brazda, Vaclav, Lochmanová, Gabriela, Koutná, Irena, Bártová, Eva. ""Irradiation potentiates p53 phosphorylation and p53 binding to the promoter and coding region of the TP53 gene."" Biochimie, 2023, pp. 154-168.
[6] Andersson, Natalie, Saba, Karim H, Magnusson, Linda, Nilsson, Jenny, Karlsson, Jenny, Nord, Karolin H, Gisselsson, David. ""Inactivation of RB1, CDKN2A, and TP53 have distinct effects on genomic stability at side-by-side comparison in karyotypically normal cells."" Genes, chromosomes & cancer, 2023, pp. 93-100.
[7] Basset-Séguin, N, Molès, J P, Mils, V, Dereure, O, Guilhou, J J. ""TP53 tumor suppressor gene and skin carcinogenesis."" The Journal of investigative dermatology, 1994, pp. 102S-106S.
[8] Basset-Séguin, N, Molès, J P, Mils, V, Dereure, O, Guilhou, J J. ""TP53 tumor-suppressor gene and human carcinogenesis."" Experimental dermatology, 1993, pp. 99-105.
[9] Meireles Da Costa, Nathalia, Palumbo, Antonio, De Martino, Marco, Fusco, Alfredo, Ribeiro Pinto, Luis Felipe, Nasciutti, Luiz Eurico. ""Interplay between HMGA and TP53 in cell cycle control along tumor progression."" Cellular and molecular life sciences : CMLS, 2021, pp. 817-831.
[10] Sharma, Neeti, Jadhav, Shweta P, Bapat, Sharmila A. ""CREBBP re-arrangements affect protein function and lead to aberrant neuronal differentiation."" Differentiation; research in biological diversity, 2010, pp. 218-31.
[11] Huang, Yao-Hui, Cai, Kun, Xu, Peng-Peng, Wang, Li, Huang, Chuan-Xin, Fang, Ying, Cheng, Shu, Sun, Xiao-Jian, Liu, Feng, Huang, Jin-Yan, Ji, Meng-Meng, Zhao, Wei-Li. ""CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis."" Signal transduction and targeted therapy, 2021, pp. 10.
[12] Krivtsov, Andrei V, Evans, Kathryn, Gadrey, Jayant Y, Eschle, Benjamin K, Hatton, Charlie, Uckelmann, Hannah J, Ross, Kenneth N, Perner, Florian, Olsen, Sarah N, Pritchard, Tara, McDermott, Lisa, Jones, Connor D, Jing, Duohui, Braytee, Ali, Chacon, Diego, Earley, Eric, McKeever, Brian M, Claremon, David, Gifford, Andrew J, Lee, Heather J, Teicher, Beverly A, Pimanda, John E, Beck, Dominik, Perry, Jennifer A, Smith, Malcolm A, McGeehan, Gerard M, Lock, Richard B, Armstrong, Scott A. ""A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia."" Cancer cell, 2019, pp. 660-673.e11.
[13] Durbin, Adam D, Wang, Tingjian, Wimalasena, Virangika K, Zimmerman, Mark W, Li, Deyao, Dharia, Neekesh V, Mariani, Luca, Shendy, Noha A M, Nance, Stephanie, Patel, Anand G, Shao, Ying, Mundada, Maya, Maxham, Lily, Park, Paul M C, Sigua, Logan H, Morita, Ken, Conway, Amy Saur, Robichaud, Amanda L, Perez-Atayde, Antonio R, Bikowitz, Melissa J, Quinn, Taylor R, Wiest, Olaf, Easton, John, Schönbrunn, Ernst, Bulyk, Martha L, Abraham, Brian J, Stegmaier, Kimberly, Look, A Thomas, Qi, Jun. ""EP300 Selectively Controls the Enhancer Landscape of MYCN-Amplified Neuroblastoma."" Cancer discovery, 2022, pp. 730-751.
[14] Gordon, Max J, Smith, Mitchell R, Nastoupil, Loretta J. ""Follicular lymphoma: The long and winding road leading to your cure?"" Blood reviews, 2023, pp. 100992.
[15] Marschalek, Rolf. ""MLL leukemia and future treatment strategies."" Archiv der Pharmazie, 2015, pp. 221-8.
[16] Partynska, Aleksandra, Piotrowska, Aleksandra, Pawelczyk, Konrad, Rzechonek, Adam, Ratajczak-Wielgomas, Katarzyna, Podhorska-Okolow, Marzenna, Dziegiel, Piotr. ""The Expression of Histone Acetyltransferase KAT6A in Non-small Cell Lung Cancer."" Anticancer research, 2022, pp. 5731-5741.
[17] Lv, Deguan, Jia, Feng, Hou, Yanli, Sang, Youzhou, Alvarez, Angel A, Zhang, Weiwei, Gao, Wei-Qiang, Hu, Bo, Cheng, Shi-Yuan, Ge, Jianwei, Li, Yanxin, Feng, Haizhong. ""Histone Acetyltransferase KAT6A Upregulates PI3K/AKT Signaling through TRIM24 Binding."" Cancer research, 2017, pp. 6190-6201.
[18] Zhao, Wei, Mo, Huanye, Liu, Runkun, Chen, Tianxiang, Yang, Nan, Liu, Zhikui. ""Matrix stiffness-induced upregulation of histone acetyltransferase KAT6A promotes hepatocellular carcinoma progression through regulating SOX2 expression."" British journal of cancer, 2022, pp. 202-210.
[19] Sharma, Sriganesh B, Melvin, William J, Audu, Christopher O, Bame, Monica, Rhoads, Nicole, Wu, Weisheng, Kanthi, Yogendra, Knight, Jason S, Adili, Reheman, Holinstat, Michael A, Wakefield, Thomas W, Henke, Peter K, Moore, Bethany B, Gallagher, Katherine A, Obi, Andrea T. ""The histone methyltransferase MLL1/KMT2A in monocytes drives coronavirus-associated coagulopathy and inflammation."" Blood, 2023, pp. 725-742.
[20] Jakovcevski, Mira, Ruan, Hongyu, Shen, Erica Y, Dincer, Aslihan, Javidfar, Behnam, Ma, Qi, Peter, Cyril J, Cheung, Iris, Mitchell, Amanda C, Jiang, Yan, Lin, Cong L, Pothula, Venu, Stewart, A Francis, Ernst, Patricia, Yao, Wei-Dong, Akbarian, Schahram. ""Neuronal Kmt2a/Mll1 histone methyltransferase is essential for prefrontal synaptic plasticity and working memory."" The Journal of neuroscience : the official journal of the Society for Neuroscience, 2015, pp. 5097-108.
[21] Fang, Yang, Zhang, Dan, Hu, Tingting, Zhao, Hongyan, Zhao, Xuan, Lou, Zhefeng, He, Yongshan, Qin, Wenzheng, Xia, Jianfu, Zhang, Xiaohua, Ye, Le-Chi. ""KMT2A histone methyltransferase contributes to colorectal cancer development by promoting cathepsin Z transcriptional activation."" Cancer medicine, 2019, pp. 3544-3552.
[22] Seo, Jinwon, Min, Soo Kee, Park, Hye-Rim, Kim, Dong Hoon, Kwon, Mi Jung, Kim, Lee Su, Ju, Young-Su. ""Expression of Histone Deacetylases HDAC1, HDAC2, HDAC3, and HDAC6 in Invasive Ductal Carcinomas of the Breast."" Journal of breast cancer, 2014, pp. 323-31.
[23] Demyanenko, S V, Dzreyan, V A, Neginskaya, M A, Uzdensky, A B. ""Expression of Histone Deacetylases HDAC1 and HDAC2 and Their Role in Apoptosis in the Penumbra Induced by Photothrombotic Stroke."" Molecular neurobiology, 2020, pp. 226-238.
[24] Müller, Berit Maria, Jana, Lisa, Kasajima, Atsuko, Lehmann, Annika, Prinzler, Judith, Budczies, Jan, Winzer, Klaus-Jürgen, Dietel, Manfred, Weichert, Wilko, Denkert, Carsten. ""Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer--overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression."" BMC cancer, 2013, pp. 215.
[25] Sehgal, Priyanka, Lanauze, Claudia, Wang, Xin, Hayer, Katharina E, Torres-Diz, Manuel, Leu, N Adrian, Sela, Yogev, Stanger, Ben Z, Lengner, Christopher J, Thomas-Tikhonenko, Andrei. ""MYC Hyperactivates Wnt Signaling in <i>APC</i>/<i>CTNNB1</i>-Mutated Colorectal Cancer Cells through miR-92a-Dependent Repression of <i>DKK3</i>."" Molecular cancer research : MCR, 2021, pp. 2003-2014.
[26] Huang, Qian, Wang, Chao-Cai, Liu, Yun-Guang, Zhao, Chang-Ming, Zhang, Tian-Ping, Liu, Yan, Wang, Hua. ""Clinical relevance of genetic polymorphisms in WNT signaling pathway (<i>SFRP1</i>, <i>WNT3A</i>, <i>CTNNB1, WIF-1</i>, <i>DKK-1</i>, <i>LRP5</i>, <i>LRP6</i>) on pulmonary tuberculosis in a Chinese population."" Frontiers in immunology, 2022, pp. 1011700.
[27] Huo, Junyu, Wu, Liqun, Zang, Yunjin. ""Development and validation of a CTNNB1-associated metabolic prognostic model for hepatocellular carcinoma."" Journal of cellular and molecular medicine, 2021, pp. 1151-1165.
[28] Huo, Junyu, Wu, Liqun, Zang, Yunjin. ""Development and validation of a CTNNB1-associated metabolic prognostic model for hepatocellular carcinoma."" Journal of cellular and molecular medicine, 2021, pp. 1151-1165.
[29] Liang, Binyong, Wang, Haichuan, Qiao, Yu, Wang, Xue, Qian, Manning, Song, Xinhua, Zhou, Yi, Zhang, Yi, Shang, Runze, Che, Li, Chen, Yifa, Huang, Zhiyong, Wu, Hong, Monga, Satdarshan P, Zeng, Yong, Calvisi, Diego F, Chen, Xiaoping, Chen, Xin. ""Differential requirement of Hippo cascade during CTNNB1 or AXIN1 mutation-driven hepatocarcinogenesis."" Hepatology (Baltimore, Md.), 2023, pp. 1929-1942.
[30] Ye, Gengtai, Yang, Qingbin, Lei, Xuetao, Zhu, Xianjun, Li, Fengping, He, Jiayong, Chen, Hao, Ling, Ruoyu, Zhang, Haisheng, Lin, Tian, Liang, Zhiping, Liang, Yanrui, Huang, Haipeng, Guo, Weihong, Deng, Haijun, Liu, Hao, Hu, Yanfeng, Yu, Jiang, Li, Guoxin. ""Nuclear MYH9-induced CTNNB1 transcription, targeted by staurosporin, promotes gastric cancer cell anoikis resistance and metastasis."" Theranostics, 2020, pp. 7545-7560.
[31] Dong, Lihua, Huang, Jingjing, Zu, Peng, Liu, Jing, Gao, Xue, Du, Jianwei, Li, Yufu. ""Transcription factor 3 (TCF3) combined with histone deacetylase 3 (HDAC3) down-regulates microRNA-101 to promote Burkitt lymphoma cell proliferation and inhibit apoptosis."" Bioengineered, 2021, pp. 7995-8005.
[32] Masuda, Junko, Kawamoto, Hiroshi, Strober, Warren, Takayama, Eiji, Mizutani, Akifumi, Murakami, Hiroshi, Ikawa, Tomokatsu, Kitani, Atsushi, Maeno, Narumi, Shigehiro, Tsukasa, Satoh, Ayano, Seno, Akimasa, Arun, Vaidyanath, Kasai, Tomonari, Fuss, Ivan J, Katsura, Yoshimoto, Seno, Masaharu. ""Transient Tcf3 Gene Repression by TALE-Transcription Factor Targeting."" Applied biochemistry and biotechnology, 2016, pp. 1559-1573.
[33] Slyper, Michal, Shahar, Amit, Bar-Ziv, Anat, Granit, Roy Z, Hamburger, Tamar, Maly, Bella, Peretz, Tamar, Ben-Porath, Ittai. ""Control of breast cancer growth and initiation by the stem cell-associated transcription factor TCF3."" Cancer research, 2012, pp. 5613-24.
"	0.358258	0.28554475	Neither	Neither	NA
NeST	Histone methyltransferase subcomplex	NEST:133	EP300 KDM6A KMT2A KMT2B KMT2D MEN1	6	2.584962500721156	Histone H3-K4 Methylation 	GO:0051568	KMT2D;KMT2A;KMT2B;KDM6A;MEN1	5	83.33333333333334	1.48e-14	2.53e-12	Histone Modification and Chromatin Remodeling	"Proteins: EP300, KDM6A, KMT2A, KMT2B, KMT2D, MEN1

1. Histone acetylation: EP300 is a histone acetyltransferase (HAT) that catalyzes the transfer of acetyl groups to lysine residues on histone tails, leading to chromatin relaxation and transcriptional activation. This process is crucial for the regulation of gene expression.

2. Histone demethylation: KDM6A is a histone demethylase that specifically removes methyl groups from histone H3 lysine 27 (H3K27), a mark associated with transcriptional repression. This demethylation event contributes to the activation of gene expression.

3. Histone methylation: KMT2A, KMT2B, and KMT2D are histone methyltransferases that catalyze the addition of methyl groups to histone H3 lysine 4 (H3K4), a mark associated with transcriptional activation. These enzymes play a critical role in the regulation of gene expression and chromatin structure.

4. Chromatin remodeling: The interaction between EP300, KDM6A, KMT2A, KMT2B, and KMT2D suggests a coordinated regulation of histone modifications, leading to chromatin remodeling and the modulation of gene expression.

5. Tumor suppressor function: MEN1 is a tumor suppressor protein that interacts with histone modifying enzymes, including KMT2A and KMT2D. This interaction may contribute to the regulation of gene expression and the prevention of tumorigenesis.

In conclusion, the most prominent biological process performed by this system of interacting proteins is histone modification and chromatin remodeling, which is essential for the regulation of gene expression and the maintenance of genomic stability."	6	100	"Proteins: EP300, KDM6A, KMT2A, KMT2B, KMT2D, MEN1

1. Histone acetylation: EP300 is a histone acetyltransferase (HAT) that catalyzes the transfer of acetyl groups to lysine residues on histone tails, leading to chromatin relaxation and transcriptional activation. This process is crucial for the regulation of gene expression.[1][2][3]

2. Histone demethylation: KDM6A is a histone demethylase that specifically removes methyl groups from histone H3 lysine 27 (H3K27), a mark associated with transcriptional repression. This demethylation event contributes to the activation of gene expression.[4][5][6]

3. Histone methylation: KMT2A, KMT2B, and KMT2D are histone methyltransferases that catalyze the addition of methyl groups to histone H3 lysine 4 (H3K4), a mark associated with transcriptional activation. These enzymes play a critical role in the regulation of gene expression and chromatin structure.[7][8][9]

4. Chromatin remodeling: The interaction between EP300, KDM6A, KMT2A, KMT2B, and KMT2D suggests a coordinated regulation of histone modifications, leading to chromatin remodeling and the modulation of gene expression.[10][11][12]

5. Tumor suppressor function: MEN1 is a tumor suppressor protein that interacts with histone modifying enzymes, including KMT2A and KMT2D. This interaction may contribute to the regulation of gene expression and the prevention of tumorigenesis.[13][14][15]

In conclusion, the most prominent biological process performed by this system of interacting proteins is histone modification and chromatin remodeling, which is essential for the regulation of gene expression and the maintenance of genomic stability.

========================================================================================================================================================================================================
[1] Liu, Shan, Zhou, Jie, Ye, Xiangling, Chen, Danni, Chen, Weimin, Lin, Yaobin, Chen, Zhizhong, Chen, Biyun, Shang, Jin. ""A novel lncRNA SNHG29 regulates EP300- related histone acetylation modification and inhibits FLT3-ITD AML development."" Leukemia, 2023, pp. 1421-1434.
[2] Wang, Wan-Ping, Tzeng, Tsai-Yu, Wang, Jing-Ya, Lee, Don-Ching, Lin, Yu-Hsiang, Wu, Pei-Chun, Chen, Yen-Po, Chiu, Ing-Ming, Chi, Ya-Hui. ""The EP300, KDM5A, KDM6A and KDM6B chromatin regulators cooperate with KLF4 in the transcriptional activation of POU5F1."" PloS one, 2012, pp. e52556.
[3] He, Dong-Mei, Wu, Hong, Wu, Xiu-Li, Ding, Li, Xu, Ling, Li, Yang-Qiu. ""The gene expression patterns of BMPR2, EP300, TGFβ2, and TNFAIP3 in B-Lymphoma cells."" Cancer biology & medicine, 2014, pp. 202-7.
[4] Chang, Soojeong, Yim, Sujin, Park, Hyunsung. ""The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism."" Experimental & molecular medicine, 2019, pp. 1-17.
[5] Gažová, Iveta, Lengeling, Andreas, Summers, Kim M. ""Lysine demethylases KDM6A and UTY: The X and Y of histone demethylation."" Molecular genetics and metabolism, 2019, pp. 31-44.
[6] Biagini, Tommaso, Petrizzelli, Francesco, Bianco, Salvatore Daniele, Liorni, Niccolò, Napoli, Alessandro, Castellana, Stefano, Luigi Vescovi, Angelo, Carella, Massimo, Caputo, Viviana, Mazza, Tommaso. ""KDM6A missense variants hamper H3 histone demethylation in lung squamous cell carcinoma."" Computational and structural biotechnology journal, 2022, pp. 3151-3160.
[7] Ortega-Molina, Ana, Boss, Isaac W, Canela, Andres, Pan, Heng, Jiang, Yanwen, Zhao, Chunying, Jiang, Man, Hu, Deqing, Agirre, Xabier, Niesvizky, Itamar, Lee, Ji-Eun, Chen, Hua-Tang, Ennishi, Daisuke, Scott, David W, Mottok, Anja, Hother, Christoffer, Liu, Shichong, Cao, Xing-Jun, Tam, Wayne, Shaknovich, Rita, Garcia, Benjamin A, Gascoyne, Randy D, Ge, Kai, Shilatifard, Ali, Elemento, Olivier, Nussenzweig, Andre, Melnick, Ari M, Wendel, Hans-Guido. ""The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development."" Nature medicine, 2015, pp. 1199-208.
[8] Alam, Hunain, Tang, Ming, Maitituoheti, Mayinuer, Dhar, Shilpa S, Kumar, Manish, Han, Chae Young, Ambati, Chandrashekar R, Amin, Samir B, Gu, Bingnan, Chen, Tsai-Yu, Lin, Yu-Hsi, Chen, Jichao, Muller, Florian L, Putluri, Nagireddy, Flores, Elsa R, DeMayo, Francesco J, Baseler, Laura, Rai, Kunal, Lee, Min Gyu. ""KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung Cancer."" Cancer cell, 2020, pp. 599-617.e7.
[9] Chang, Soojeong, Yim, Sujin, Park, Hyunsung. ""The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism."" Experimental & molecular medicine, 2019, pp. 1-17.
[10] Grandits, Alexander M, Wieser, Rotraud. ""Gene expression changes contribute to stemness and therapy resistance of relapsed acute myeloid leukemia: roles of SOCS2, CALCRL, MTSS1, and KDM6A."" Experimental hematology, 2021, pp. 1-11.
[11] He, Dong-Mei, Wu, Hong, Wu, Xiu-Li, Ding, Li, Xu, Ling, Li, Yang-Qiu. ""The gene expression patterns of BMPR2, EP300, TGFβ2, and TNFAIP3 in B-Lymphoma cells."" Cancer biology & medicine, 2014, pp. 202-7.
[12] Barrows, Douglas, Feng, Lijuan, Carroll, Thomas S, Allis, C David. ""Loss of UTX/KDM6A and the activation of FGFR3 converge to regulate differentiation gene-expression programs in bladder cancer."" Proceedings of the National Academy of Sciences of the United States of America, 2020, pp. 25732-25741.
[13] Ozyerli-Goknar, Ezgi, Nizamuddin, Sheikh, Timmers, H T Marc. ""A Box of Chemistry to Inhibit the MEN1 Tumor Suppressor Gene Promoting Leukemia."" ChemMedChem, 2021, pp. 1391-1402.
[14] Sun, Peng, Wu, Tong, Sun, Xiaoliang, Cui, Zilian, Zhang, Haiyang, Xia, Qinghua, Zhang, Dong. ""KMT2D inhibits the growth and metastasis of bladder Cancer cells by maintaining the tumor suppressor genes."" Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, pp. 108924.
[15] Massey, Sheersh, Khan, Mohammad Aasif, Rab, Safia Obaidur, Mustafa, Saad, Khan, Asifa, Malik, Zoya, Shaik, Rahimunnisa, Verma, Mohit Kumar, Deo, Svs, Husain, Syed Akhtar. ""Evaluating the role of MEN1 gene expression and its clinical significance in breast cancer patients."" PloS one, 2023, pp. e0288482.
"	0.5418793	0.5188646	Tied	GO	NA
NeST	RPA complex associated proteins	NEST:134	ATM ATR BLM BRCA1 XPA XPC	6	2.584962500721156	DNA Metabolic Process 	GO:0006259	BLM;XPA;ATM;XPC;BRCA1;ATR	6	100	8.46e-12	8.65e-10	DNA Damage Response and Repair	"Proteins: ATM, ATR, BLM, BRCA1, XPA, XPC

1. ATM and ATR: Key sensors and transducers of DNA damage
- ATM and ATR are phosphatidylinositol 3-kinase-related kinases (PIKKs) that sense DNA damage and initiate the DNA damage response (DDR) by phosphorylating downstream targets.
- ATM primarily responds to DNA double-strand breaks (DSBs), while ATR is activated by single-stranded DNA (ssDNA) and stalled replication forks.
- Both ATM and ATR phosphorylate and activate checkpoint kinases CHK1 and CHK2, leading to cell cycle arrest and allowing time for DNA repair.

2. BLM: Helicase involved in DNA repair and replication
- BLM is a RecQ helicase that unwinds DNA during replication, repair, and recombination.
- BLM plays a role in homologous recombination (HR) repair of DSBs, preventing the formation of harmful DNA structures and promoting accurate repair.
- BLM also resolves replication stress by promoting restart of stalled replication forks and preventing the formation of aberrant DNA structures.

3. BRCA1: Tumor suppressor and mediator of DNA repair
- BRCA1 is a multifunctional protein involved in DNA repair, cell cycle checkpoint control, and maintenance of genomic stability.
- BRCA1 plays a crucial role in HR repair of DSBs by interacting with multiple proteins, including RAD51, to promote accurate repair.
- BRCA1 also participates in non-homologous end joining (NHEJ) repair of DSBs, ensuring proper repair pathway choice.

4. XPA and XPC: Nucleotide excision repair (NER) factors
- XPA and XPC are essential components of the NER pathway, which removes a wide range of DNA lesions, including UV-induced photoproducts and bulky adducts.
- XPC recognizes and binds to DNA lesions, initiating the NER process by recruiting other NER factors.
- XPA plays a central role in damage verification and assembly of the NER pre-incision complex, ensuring accurate repair.

In conclusion, the primary biological process performed by this system of interacting proteins is the DNA damage response and repair. The proteins ATM, ATR, BLM, BRCA1, XPA, and XPC work together to sense, signal, and repair various types of DNA damage, ensuring the maintenance of genomic stability and preventing the accumulation of mutations that could lead to diseases such as cancer."	6	100	"Proteins: ATM, ATR, BLM, BRCA1, XPA, XPC

1. ATM and ATR: Key sensors and transducers of DNA damage[1][2][3]

- ATM and ATR are phosphatidylinositol 3-kinase-related kinases (PIKKs) that sense DNA damage and initiate the DNA damage response (DDR) by phosphorylating downstream targets.[4][5][6]

- ATM primarily responds to DNA double-strand breaks (DSBs), while ATR is activated by single-stranded DNA (ssDNA) and stalled replication forks.[7][8][9]

- Both ATM and ATR phosphorylate and activate checkpoint kinases CHK1 and CHK2, leading to cell cycle arrest and allowing time for DNA repair.[10][11][12]

2. BLM: Helicase involved in DNA repair and replication[13][14][15]

- BLM is a RecQ helicase that unwinds DNA during replication, repair, and recombination.[16][17][18]

- BLM plays a role in homologous recombination (HR) repair of DSBs, preventing the formation of harmful DNA structures and promoting accurate repair.[19][20][21]

- BLM also resolves replication stress by promoting restart of stalled replication forks and preventing the formation of aberrant DNA structures.

3. BRCA1: Tumor suppressor and mediator of DNA repair[22][23][24]

- BRCA1 is a multifunctional protein involved in DNA repair, cell cycle checkpoint control, and maintenance of genomic stability.[25][26][27]

- BRCA1 plays a crucial role in HR repair of DSBs by interacting with multiple proteins, including RAD51, to promote accurate repair.[28][29][30]

- BRCA1 also participates in non-homologous end joining (NHEJ) repair of DSBs, ensuring proper repair pathway choice.[31][32][33]

4. XPA and XPC: Nucleotide excision repair (NER) factors[34][35][36]

- XPA and XPC are essential components of the NER pathway, which removes a wide range of DNA lesions, including UV-induced photoproducts and bulky adducts.[37][38][39]

- XPC recognizes and binds to DNA lesions, initiating the NER process by recruiting other NER factors.[40][41][42]

- XPA plays a central role in damage verification and assembly of the NER pre-incision complex, ensuring accurate repair.[43][44][45]

In conclusion, the primary biological process performed by this system of interacting proteins is the DNA damage response and repair. The proteins ATM, ATR, BLM, BRCA1, XPA, and XPC work together to sense, signal, and repair various types of DNA damage, ensuring the maintenance of genomic stability and preventing the accumulation of mutations that could lead to diseases such as cancer.[46][47][48]

========================================================================================================================================================================================================
[1] Smith, Joanne, Tho, Lye Mun, Xu, Naihan, Gillespie, David A. ""The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer."" Advances in cancer research, 2010, pp. 73-112.
[2] Blackford, Andrew N, Jackson, Stephen P. ""ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response."" Molecular cell, 2017, pp. 801-817.
[3] Baretic, Domagoj, Maia de Oliveira, Taiana, Niess, Martina, Wan, Paul, Pollard, Hannah, Johnson, Christopher M, Truman, Caroline, McCall, Eileen, Fisher, David, Williams, Roger, Phillips, Christopher. ""Structural insights into the critical DNA damage sensors DNA-PKcs, ATM and ATR."" Progress in biophysics and molecular biology, 2019, pp. 4-16.
[4] Blackford, Andrew N, Jackson, Stephen P. ""ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response."" Molecular cell, 2017, pp. 801-817.
[5] Zhang, Jingjing, Wu, Qiong, Zhu, Lucheng, Xie, Shujun, Tu, Linglan, Yang, Yuhong, Wu, Kan, Zhao, Yanyan, Wang, Yuqing, Xu, Yasi, Chen, Xueqin, Ma, Shenglin, Zhang, Shirong. ""SERPINE2/PN-1 regulates the DNA damage response and radioresistance by activating ATM in lung cancer."" Cancer letters, 2022, pp. 268-283.
[6] Lopez-Pelaez, Marta, Young, Lucy, Vazquez-Chantada, Mercedes, Nelson, Nadine, Durant, Steve, Wilkinson, Robert W, Poon, Edmund, Gaspar, Miguel, Valge-Archer, Viia, Smith, Paul, Dovedi, Simon J. ""Targeting DNA damage response components induces enhanced STING-dependent type-I IFN response in ATM deficient cancer cells and drives dendritic cell activation."" Oncoimmunology, 2022, pp. 2117321.
[7] Williams, Rhys M, Zhang, Xiaodong. ""Roles of ATM and ATR in DNA double strand breaks and replication stress."" Progress in biophysics and molecular biology, 2021, pp. 109-119.
[8] Williams, Rhys M, Zhang, Xiaodong. ""Roles of ATM and ATR in DNA double strand breaks and replication stress."" Progress in biophysics and molecular biology, 2021, pp. 27-38.
[9] Shiotani, Bunsyo, Zou, Lee. ""Single-stranded DNA orchestrates an ATM-to-ATR switch at DNA breaks."" Molecular cell, 2009, pp. 547-58.
[10] Smith, Joanne, Tho, Lye Mun, Xu, Naihan, Gillespie, David A. ""The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer."" Advances in cancer research, 2010, pp. 73-112.
[11] Blackford, Andrew N, Jackson, Stephen P. ""ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response."" Molecular cell, 2017, pp. 801-817.
[12] Qiu, Zhaojun, Oleinick, Nancy L, Zhang, Junran. ""ATR/CHK1 inhibitors and cancer therapy."" Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2018, pp. 450-464.
[13] Dhar, Srijita, Brosh, Robert M. ""BLM's balancing act and the involvement of FANCJ in DNA repair."" Cell cycle (Georgetown, Tex.), 2018, pp. 2207-2220.
[14] Bendtsen, Kristian Moss, Jensen, Martin Borch, May, Alfred, Rasmussen, Lene Juel, Trusina, Ala, Bohr, Vilhelm A, Jensen, Mogens H. ""Dynamics of the DNA repair proteins WRN and BLM in the nucleoplasm and nucleoli."" European biophysics journal : EBJ, 2014, pp. 509-16.
[15] Frank, Bernd, Hoffmeister, Michael, Klopp, Norman, Illig, Thomas, Chang-Claude, Jenny, Brenner, Hermann. ""Colorectal cancer and polymorphisms in DNA repair genes WRN, RMI1 and BLM."" Carcinogenesis, 2010, pp. 442-5.
[16] Manthei, Kelly A, Keck, James L. ""The BLM dissolvasome in DNA replication and repair."" Cellular and molecular life sciences : CMLS, 2013, pp. 4067-84.
[17] de Renty, Christelle, Pond, Kelvin W, Yagle, Mary K, Ellis, Nathan A. ""BLM Sumoylation Is Required for Replication Stability and Normal Fork Velocity During DNA Replication."" Frontiers in molecular biosciences, 2022, pp. 875102.
[18] Wang, W, Seki, M, Narita, Y, Sonoda, E, Takeda, S, Yamada, K, Masuko, T, Katada, T, Enomoto, T. ""Possible association of BLM in decreasing DNA double strand breaks during DNA replication."" The EMBO journal, 2000, pp. 3428-35.
[19] Chu, W K, Hanada, K, Kanaar, R, Hickson, I D. ""BLM has early and late functions in homologous recombination repair in mouse embryonic stem cells."" Oncogene, 2010, pp. 4705-14.
[20] Tripathi, Vivek, Nagarjuna, Tirunelvely, Sengupta, Sagar. ""BLM helicase-dependent and -independent roles of 53BP1 during replication stress-mediated homologous recombination."" The Journal of cell biology, 2007, pp. 9-14.
[21] Dhar, Srijita, Brosh, Robert M. ""BLM's balancing act and the involvement of FANCJ in DNA repair."" Cell cycle (Georgetown, Tex.), 2018, pp. 2207-2220.
[22] Li, Qianyan, Engebrecht, JoAnne. ""BRCA1 and BRCA2 Tumor Suppressor Function in Meiosis."" Frontiers in cell and developmental biology, 2021, pp. 668309.
[23] Minami, Akari, Nakanishi, Atsuko, Ogura, Yasunori, Kitagishi, Yasuko, Matsuda, Satoru. ""Connection between Tumor Suppressor BRCA1 and PTEN in Damaged DNA Repair."" Frontiers in oncology, 2014, pp. 318.
[24] Yoshida, Kiyotsugu, Miki, Yoshio. ""Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage."" Cancer science, 2004, pp. 866-71.
[25] Yoshida, Kiyotsugu, Miki, Yoshio. ""Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage."" Cancer science, 2004, pp. 866-71.
[26] Tarsounas, Madalena, Sung, Patrick. ""The antitumorigenic roles of BRCA1-BARD1 in DNA repair and replication."" Nature reviews. Molecular cell biology, 2020, pp. 284-299.
[27] Jhanwar-Uniyal, Meena. ""BRCA1 in cancer, cell cycle and genomic stability."" Frontiers in bioscience : a journal and virtual library, 2003, pp. s1107-17.
[28] Zhang, Shuai, Cao, Mengru, Yan, Shi, Liu, Yuechao, Fan, Weina, Cui, Yimeng, Tian, Fanglin, Gu, Ruixue, Cui, Yaowen, Zhan, Yuning, Sun, Yuanyuan, Xing, Ying, Cai, Li, Song, Yang. ""TRIM44 promotes BRCA1 functions in HR repair to induce Cisplatin Chemoresistance in Lung Adenocarcinoma by Deubiquitinating FLNA."" International journal of biological sciences, 2022, pp. 2962-2979.
[29] Lai, Tsung-Huei, Ewald, Brett, Zecevic, Alma, Liu, Chaomei, Sulda, Melanie, Papaioannou, Dimitrios, Garzon, Ramiro, Blachly, James S, Plunkett, William, Sampath, Deepa. ""HDAC Inhibition Induces MicroRNA-182, which Targets RAD51 and Impairs HR Repair to Sensitize Cells to Sapacitabine in Acute Myelogenous Leukemia."" Clinical cancer research : an official journal of the American Association for Cancer Research, 2016, pp. 3537-49.
[30] Takemoto, Kazumasa, Tani, Naoki, Takada-Horisawa, Yuki, Fujimura, Sayoko, Tanno, Nobuhiro, Yamane, Mariko, Okamura, Kaho, Sugimoto, Michihiko, Araki, Kimi, Ishiguro, Kei-Ichiro. ""Meiosis-Specific C19orf57/4930432K21Rik/BRME1 Modulates Localization of RAD51 and DMC1 to DSBs in Mouse Meiotic Recombination."" Cell reports, 2020, pp. 107686.
[31] Takaoka, Miho, Miki, Yoshio. ""BRCA1 gene: function and deficiency."" International journal of clinical oncology, 2018, pp. 36-44.
[32] Bau, Da-Tian, Mau, Yi-Chien, Shen, Chen-Yang. ""The role of BRCA1 in non-homologous end-joining."" Cancer letters, 2006, pp. 1-8.
[33] Badie, Sophie, Carlos, Ana Rita, Folio, Cecilia, Okamoto, Keiji, Bouwman, Peter, Jonkers, Jos, Tarsounas, Madalena. ""BRCA1 and CtIP promote alternative non-homologous end-joining at uncapped telomeres."" The EMBO journal, 2015, pp. 410-24.
[34] Zebian, Abir, Shaito, Abdullah, Mazurier, Frédéric, Rezvani, Hamid Reza, Zibara, Kazem. ""XPC beyond nucleotide excision repair and skin cancers."" Mutation research. Reviews in mutation research, 2019, pp. 108286.
[35] Lindsey-Boltz, Laura A, Yang, Yanyan, Kose, Cansu, Deger, Nazli, Eynullazada, Khagani, Kawara, Hiroaki, Sancar, Aziz. ""Nucleotide excision repair in Human cell lines lacking both XPC and CSB proteins."" Nucleic acids research, 2023, pp. 6238-6245.
[36] Musich, Phillip R, Li, Zhengke, Zou, Yue. ""Xeroderma Pigmentosa Group A (XPA), Nucleotide Excision Repair and Regulation by ATR in Response to Ultraviolet Irradiation."" Advances in experimental medicine and biology, 2017, pp. 41-54.
[37] Fadda, Elisa. ""Role of the XPA protein in the NER pathway: A perspective on the function of structural disorder in macromolecular assembly."" Computational and structural biotechnology journal, 2016, pp. 78-85.
[38] Fadda, Elisa. ""Conformational determinants for the recruitment of ERCC1 by XPA in the nucleotide excision repair (NER) Pathway: structure and dynamics of the XPA binding motif."" Biophysical journal, 2013, pp. 2503-11.
[39] Moraes, Maria Carolina S, de Andrade, Annabel Quinet, Carvalho, Helotonio, Guecheva, Temenouga, Agnoletto, Mateus H, Henriques, João A P, Sarasin, Alain, Stary, Anne, Saffi, Jenifer, Menck, Carlos F M. ""Both XPA and DNA polymerase eta are necessary for the repair of doxorubicin-induced DNA lesions."" Cancer letters, 2012, pp. 108-18.
[40] Robu, Mihaela, Shah, Rashmi G, Purohit, Nupur K, Zhou, Pengbo, Naegeli, Hanspeter, Shah, Girish M. ""Poly(ADP-ribose) polymerase 1 escorts XPC to UV-induced DNA lesions during nucleotide excision repair."" Proceedings of the National Academy of Sciences of the United States of America, 2017, pp. E6847-E6856.
[41] Feher, Katie M, Kolbanovskiy, Alexander, Durandin, Alexander, Shim, Yoonjung, Min, Jung-Hyun, Lee, Yuan Cho, Shafirovich, Vladimir, Mu, Hong, Broyde, Suse, Geacintov, Nicholas E. ""The DNA damage-sensing NER repair factor XPC-RAD23B does not recognize bulky DNA lesions with a missing nucleotide opposite the lesion."" DNA repair, 2020, pp. 102985.
[42] Zebian, Abir, Shaito, Abdullah, Mazurier, Frédéric, Rezvani, Hamid Reza, Zibara, Kazem. ""XPC beyond nucleotide excision repair and skin cancers."" Mutation research. Reviews in mutation research, 2019, pp. 108286.
[43] Lee, Joon-Hwa, Park, Chin-Ju, Arunkumar, Alphonse I, Chazin, Walter J, Choi, Byong-Seok. ""NMR study on the interaction between RPA and DNA decamer containing cis-syn cyclobutane pyrimidine dimer in the presence of XPA: implication for damage verification and strand-specific dual incision in nucleotide excision repair."" Nucleic acids research, 2003, pp. 4747-54.
[44] Mu, Hong, Geacintov, Nicholas E, Broyde, Suse, Yeo, Jung-Eun, Schärer, Orlando D. ""Molecular basis for damage recognition and verification by XPC-RAD23B and TFIIH in nucleotide excision repair."" DNA repair, 2018, pp. 33-42.
[45] Fadda, Elisa. ""Role of the XPA protein in the NER pathway: A perspective on the function of structural disorder in macromolecular assembly."" Computational and structural biotechnology journal, 2016, pp. 78-85.
[46] Blackford, Andrew N, Jackson, Stephen P. ""ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response."" Molecular cell, 2017, pp. 801-817.
[47] Wu, Chenming, Chang, Yiming, Chen, Junliang, Su, Yang, Li, Lei, Chen, Yuping, Li, Yunhui, Wu, Jinhuan, Huang, Jinzhou, Zhao, Fei, Wang, Wenrui, Yin, Hui, Wang, Shunli, Jin, Mingpeng, Lou, Zhenkun, Zhu, Wei-Guo, Luo, Kuntian, Zhang, Jie, Yuan, Jian. ""USP37 regulates DNA damage response through stabilizing and deubiquitinating BLM."" Nucleic acids research, 2021, pp. 11224-11240.
[48] Foo, Tzeh Keong, Xia, Bing. ""BRCA1-Dependent and Independent Recruitment of PALB2-BRCA2-RAD51 in the DNA Damage Response and Cancer."" Cancer research, 2022, pp. 3191-3197.
"	0.41036648	0.22505553	LLM	LLM	NA
NeST	PIK3/AKT signaling	NEST:138	AKT1 AKT2 AKT3 FOXO3 HSP90AA1 PDPK1 PIK3CB PIK3CD PRKCZ PRKDC PTEN	11	3.4594316186372973	Protein Modification Process 	GO:0036211	PDPK1;PRKDC;AKT2;AKT3;PTEN;AKT1;PIK3CD;PRKCZ	8	72.72727272727273	3.68e-10	1.05e-7	PI3K-AKT Signaling	"The primary biological process performed by this system of interacting proteins is the phosphatidylinositol 3-kinase (PI3K)-AKT signaling pathway. This pathway plays a crucial role in regulating cell survival, growth, proliferation, and metabolism.

1. AKT isoforms and activation: AKT1, AKT2, and AKT3 are three isoforms of AKT, a serine/threonine kinase. Their activation is initiated by PI3K, which phosphorylates phosphatidylinositol-4,5-bisphosphate (PIP2) to generate phosphatidylinositol-3,4,5-trisphosphate (PIP3). PDPK1, a 3-phosphoinositide-dependent protein kinase, then phosphorylates and activates AKT.

2. PTEN regulation: PTEN, a phosphatase, negatively regulates the PI3K-AKT pathway by dephosphorylating PIP3 back to PIP2. This action prevents AKT activation and maintains pathway homeostasis.

3. PI3K isoforms: PIK3CB and PIK3CD are catalytic subunits of class IA and IB PI3Ks, respectively. They are responsible for the production of PIP3, which is essential for AKT activation.

4. FOXO3 regulation: FOXO3, a forkhead box transcription factor, is a downstream target of AKT. AKT phosphorylates FOXO3, leading to its nuclear exclusion and inhibition of target gene transcription. This process promotes cell survival and inhibits apoptosis.

5. PRKCZ and PRKDC involvement: PRKCZ, a protein kinase C isoform, and PRKDC, a DNA-dependent protein kinase, are known to interact with AKT. PRKCZ can activate AKT, while PRKDC is involved in DNA repair and cell survival, potentially linking the PI3K-AKT pathway to DNA damage response.

6. HSP90AA1 interaction: HSP90AA1, a heat shock protein, is known to interact with AKT and maintain its stability. This interaction is crucial for proper AKT function and regulation of the PI3K-AKT pathway.

In conclusion, the PI3K-AKT signaling pathway is the most prominent biological process performed by this system of interacting proteins. It is essential for regulating cell survival, growth, proliferation, and metabolism, and involves the interplay of various protein isoforms and regulatory mechanisms."	11	100	"The primary biological process performed by this system of interacting proteins is the phosphatidylinositol 3-kinase (PI3K)-AKT signaling pathway. This pathway plays a crucial role in regulating cell survival, growth, proliferation, and metabolism.[1][2][3]

1. AKT isoforms and activation: AKT1, AKT2, and AKT3 are three isoforms of AKT, a serine/threonine kinase. Their activation is initiated by PI3K, which phosphorylates phosphatidylinositol-4,5-bisphosphate (PIP2) to generate phosphatidylinositol-3,4,5-trisphosphate (PIP3). PDPK1, a 3-phosphoinositide-dependent protein kinase, then phosphorylates and activates AKT.[4][5][6]

2. PTEN regulation: PTEN, a phosphatase, negatively regulates the PI3K-AKT pathway by dephosphorylating PIP3 back to PIP2. This action prevents AKT activation and maintains pathway homeostasis.[7][8][9]

3. PI3K isoforms: PIK3CB and PIK3CD are catalytic subunits of class IA and IB PI3Ks, respectively. They are responsible for the production of PIP3, which is essential for AKT activation.[10][11][12]

4. FOXO3 regulation: FOXO3, a forkhead box transcription factor, is a downstream target of AKT. AKT phosphorylates FOXO3, leading to its nuclear exclusion and inhibition of target gene transcription. This process promotes cell survival and inhibits apoptosis.[13][14][15]

5. PRKCZ and PRKDC involvement: PRKCZ, a protein kinase C isoform, and PRKDC, a DNA-dependent protein kinase, are known to interact with AKT. PRKCZ can activate AKT, while PRKDC is involved in DNA repair and cell survival, potentially linking the PI3K-AKT pathway to DNA damage response.[16][17][18]

6. HSP90AA1 interaction: HSP90AA1, a heat shock protein, is known to interact with AKT and maintain its stability. This interaction is crucial for proper AKT function and regulation of the PI3K-AKT pathway.[19][20][21]

In conclusion, the PI3K-AKT signaling pathway is the most prominent biological process performed by this system of interacting proteins. It is essential for regulating cell survival, growth, proliferation, and metabolism, and involves the interplay of various protein isoforms and regulatory mechanisms.

========================================================================================================================================================================================================
[1] Xie, Youbang, Shi, Xuefeng, Sheng, Kuo, Han, Guoxiong, Li, Wenqian, Zhao, Qiangqiang, Jiang, Baili, Feng, Jianming, Li, Jianping, Gu, Yuhai. ""PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia (Review)."" Molecular medicine reports, 2019, pp. 783-791.
[2] Jafari, Mahjoobeh, Ghadami, Elham, Dadkhah, Tahereh, Akhavan-Niaki, Haleh. ""PI3k/AKT signaling pathway: Erythropoiesis and beyond."" Journal of cellular physiology, 2019, pp. 2373-2385.
[3] Wang, Jincheng, Hu, Kaili, Cai, Xuanyan, Yang, Bo, He, Qiaojun, Wang, Jiajia, Weng, Qinjie. ""Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis."" Acta pharmaceutica Sinica. B, 2022, pp. 18-32.
[4] Hsu, Han-Shui, Liu, Chen-Chi, Lin, Jiun-Han, Hsu, Tien-Wei, Hsu, Jyuan-Wei, Su, Kelly, Hung, Shih-Chieh. ""Involvement of ER stress, PI3K/AKT activation, and lung fibroblast proliferation in bleomycin-induced pulmonary fibrosis."" Scientific reports, 2017, pp. 14272.
[5] Mahajan, Kiran, Mahajan, Nupam P. ""PI3K-independent AKT activation in cancers: a treasure trove for novel therapeutics."" Journal of cellular physiology, 2012, pp. 3178-84.
[6] Fruman, David A, Chiu, Honyin, Hopkins, Benjamin D, Bagrodia, Shubha, Cantley, Lewis C, Abraham, Robert T. ""The PI3K Pathway in Human Disease."" Cell, 2017, pp. 605-635.
[7] Sun, Chen, Zhao, Jing, Jin, Yecheng, Hou, Congzhe, Zong, Wen, Lu, Tingting, Li, Huashun, Gao, Jiangang. ""PTEN regulation of the proliferation and differentiation of auditory progenitors through the PTEN/PI3K/Akt-signaling pathway in mice."" Neuroreport, 2014, pp. 177-83.
[8] Huang, Xingjun, Liu, Guihua, Guo, Jiao, Su, Zhengquan. ""The PI3K/AKT pathway in obesity and type 2 diabetes."" International journal of biological sciences, 2018, pp. 1483-1496.
[9] Hu, Mingli, Zhu, Shixuan, Xiong, Shengwei, Xue, Xingxing, Zhou, Xiaodong. ""MicroRNAs and the PTEN/PI3K/Akt pathway in gastric cancer (Review)."" Oncology reports, 2019, pp. 1439-1454.
[10] Baer, Romain, Cintas, Célia, Therville, Nicole, Guillermet-Guibert, Julie. ""Implication of PI3K/Akt pathway in pancreatic cancer: When PI3K isoforms matter?"" Advances in biological regulation, 2015, pp. 19-35.
[11] Chen, Mo, Choi, Suyong, Wen, Tianmu, Chen, Changliang, Thapa, Narendra, Lee, Jeong Hyo, Cryns, Vincent L, Anderson, Richard A. ""A p53-phosphoinositide signalosome regulates nuclear AKT activation."" Nature cell biology, 2022, pp. 1099-1113.
[12] Lin, Kevin H, Rutter, Justine C, Xie, Abigail, Killarney, Shane T, Vaganay, Camille, Benaksas, Chaima, Ling, Frank, Sodaro, Gaetano, Meslin, Paul-Arthur, Bassil, Christopher F, Fenouille, Nina, Hoj, Jacob, Washart, Rachel, Ang, Hazel X, Cerda-Smith, Christian, Chaintreuil, Paul, Jacquel, Arnaud, Auberger, Patrick, Forget, Antoine, Itzykson, Raphael, Lu, Min, Lin, Jiaxing, Pierobon, Mariaelena, Sheng, Zhecheng, Li, Xinghai, Chilkoti, Ashutosh, Owzar, Kouros, Rizzieri, David A, Pardee, Timothy S, Benajiba, Lina, Petricoin, Emanuel, Puissant, Alexandre, Wood, Kris C. ""P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemia."" Nature cancer, 2022, pp. 837-851.
[13] Brunet, A, Bonni, A, Zigmond, M J, Lin, M Z, Juo, P, Hu, L S, Anderson, M J, Arden, K C, Blenis, J, Greenberg, M E. ""Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor."" Cell, 1999, pp. 857-68.
[14] Gao, Haoji, Wang, Weige, Li, Qinyu. ""GANT61 suppresses cell survival, invasion and epithelial-mesenchymal transition through inactivating AKT/mTOR and JAK/STAT3 pathways in anaplastic thyroid carcinoma."" Cancer biology & therapy, 2022, pp. 369-377.
[15] Zhang, Xin, Hu, Can, Kong, Chun-Yan, Song, Peng, Wu, Hai-Ming, Xu, Si-Chi, Yuan, Yu-Pei, Deng, Wei, Ma, Zhen-Guo, Tang, Qi-Zhu. ""FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT."" Cell death and differentiation, 2020, pp. 540-555.
[16] Sun, Shangfeng, Cheng, Shuguang, Zhu, Yunxiao, Zhang, Peng, Liu, Ning, Xu, Tong, Sun, Chao, Lv, Yanfeng. ""Identification of PRKDC (Protein Kinase, DNA-Activated, Catalytic Polypeptide) as an essential gene for colorectal cancer (CRCs) cells."" Gene, 2016, pp. 90-96.
[17] Saini, Divyalakshmi, Sudheer, K R, Kumar, P R Vivek, Soren, D C, Jain, Vinay, Koya, P K M, Jaikrishan, G, Das, Birajalaxmi. ""Evaluation of the influence of chronic low-dose radiation on DNA repair gene polymorphisms [<i>XRCC1</i>, <i>XRCC3, PRKDC (XRCC7), LIG1</i>, <i>NEIL1</i>] in individuals from normal and high level natural radiation areas of Kerala Coast."" International journal of radiation biology, 2020, pp. 734-739.
[18] Casey, Jillian P, Nobbs, Michael, McGettigan, Paul, Lynch, Sallyann, Ennis, Sean. ""Recessive mutations in MCM4/PRKDC cause a novel syndrome involving a primary immunodeficiency and a disorder of DNA repair."" Journal of medical genetics, 2012, pp. 242-5.
[19] Yang, Yinxi, Wu, Yifeng, Hou, Lihong, Ge, Xin, Song, Guoquan, Jin, Hongdou. ""Heat shock protein 20 suppresses breast carcinogenesis by inhibiting the MAPK and AKT signaling pathways."" Oncology letters, 2022, pp. 462.
[20] Wu, Wei, Hu, Zhenzhen, Xiong, Linkai, Zou, Juntao. ""Heat shock protein 47 promotes cell migration and invasion through AKT signal in non-small cell lung cancer."" Anti-cancer drugs, 2022, pp. 268-277.
[21] Jeffery, Jessie, Neyt, Christine, Moore, Wade, Paterson, Scott, Bower, Neil I, Chenevix-Trench, Georgia, Verkade, Heather, Hogan, Benjamin M, Khanna, Kum Kum. ""Cep55 regulates embryonic growth and development by promoting Akt stability in zebrafish."" FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2015, pp. 1999-2009.
"	0.96565133	0.20156243	LLM	LLM	NA
NeST	EGFR/PI3K signaling	NEST:153	ABL1 CBL CRKL CTNNB1 EGF EGFR ERBB2 MET PIK3R1 PIK3R2 SOCS1	11	3.4594316186372973	ERBB2-EGFR Signaling Pathway 	GO:0038134	EGF;ERBB2;EGFR	3	27.27272727272727	1.24e-9	4.97e-7	Receptor Tyrosine Kinase Signaling	"The most prominent biological process performed by this system of interacting proteins is receptor tyrosine kinase (RTK) signaling. This process is crucial for cellular communication, growth, and differentiation.

1. Key RTKs: EGFR, ERBB2, and MET are receptor tyrosine kinases that play essential roles in cell signaling. EGFR and ERBB2 are members of the ErbB family, while MET is a receptor for hepatocyte growth factor (HGF). Activation of these receptors leads to downstream signaling cascades.

2. Ligand binding: EGF is a ligand for EGFR, promoting receptor dimerization and autophosphorylation, initiating downstream signaling.

3. Adaptor proteins: CRKL is an adaptor protein that interacts with phosphorylated tyrosine residues on activated RTKs, facilitating the recruitment of other signaling proteins.

4. Negative regulation: SOCS1 and CBL are negative regulators of RTK signaling. SOCS1 inhibits the JAK/STAT pathway, while CBL promotes receptor ubiquitination and degradation.

5. PI3K/AKT pathway: PIK3R1 and PIK3R2 are regulatory subunits of phosphoinositide 3-kinase (PI3K), which is activated by RTKs. This activation leads to the production of phosphatidylinositol (3,4,5)-trisphosphate (PIP3), which in turn activates AKT, a serine/threonine kinase involved in cell survival, growth, and metabolism.

6. Wnt/β-catenin pathway: CTNNB1, also known as β-catenin, is a key component of the Wnt signaling pathway. While not directly involved in RTK signaling, it is worth noting that cross-talk between RTK and Wnt pathways can occur, influencing cellular processes such as proliferation and migration.

7. ABL1 involvement: ABL1 is a non-receptor tyrosine kinase that can be activated by RTKs, including EGFR and MET. ABL1 is involved in various cellular processes, including cytoskeletal remodeling, cell adhesion, and DNA repair.

In conclusion, the prominent biological process performed by this system of interacting proteins is receptor tyrosine kinase signaling, which is essential for cellular communication, growth, and differentiation. The proteins in this system play various roles in the activation, regulation, and downstream signaling of RTKs."	11	100	"The most prominent biological process performed by this system of interacting proteins is receptor tyrosine kinase (RTK) signaling. This process is crucial for cellular communication, growth, and differentiation.

1. Key RTKs: EGFR, ERBB2, and MET are receptor tyrosine kinases that play essential roles in cell signaling. EGFR and ERBB2 are members of the ErbB family, while MET is a receptor for hepatocyte growth factor (HGF). Activation of these receptors leads to downstream signaling cascades.[1][2][3]

2. Ligand binding: EGF is a ligand for EGFR, promoting receptor dimerization and autophosphorylation, initiating downstream signaling.[4][5][6]

3. Adaptor proteins: CRKL is an adaptor protein that interacts with phosphorylated tyrosine residues on activated RTKs, facilitating the recruitment of other signaling proteins.[7][8][9]

4. Negative regulation: SOCS1 and CBL are negative regulators of RTK signaling. SOCS1 inhibits the JAK/STAT pathway, while CBL promotes receptor ubiquitination and degradation.[10][11][12]

5. PI3K/AKT pathway: PIK3R1 and PIK3R2 are regulatory subunits of phosphoinositide 3-kinase (PI3K), which is activated by RTKs. This activation leads to the production of phosphatidylinositol (3,4,5)-trisphosphate (PIP3), which in turn activates AKT, a serine/threonine kinase involved in cell survival, growth, and metabolism.[13][14][15]

6. Wnt/β-catenin pathway: CTNNB1, also known as β-catenin, is a key component of the Wnt signaling pathway. While not directly involved in RTK signaling, it is worth noting that cross-talk between RTK and Wnt pathways can occur, influencing cellular processes such as proliferation and migration.[16][17][18]

7. ABL1 involvement: ABL1 is a non-receptor tyrosine kinase that can be activated by RTKs, including EGFR and MET. ABL1 is involved in various cellular processes, including cytoskeletal remodeling, cell adhesion, and DNA repair.[19][20][21]

In conclusion, the prominent biological process performed by this system of interacting proteins is receptor tyrosine kinase signaling, which is essential for cellular communication, growth, and differentiation. The proteins in this system play various roles in the activation, regulation, and downstream signaling of RTKs.

========================================================================================================================================================================================================
[1] Patnaik, Sunil Kumar, Chandrasekar, M J N, Nagarjuna, Palathoti, Ramamurthi, Deepthi, Swaroop, Akey Krishna. ""Targeting of ErbB1, ErbB2, and their Dual Targeting Using Small Molecules and Natural Peptides: Blocking EGFR Cell Signaling Pathways in Cancer: A Mini-Review."" Mini reviews in medicinal chemistry, 2022, pp. 2831-2846.
[2] Yang, Lu, Bhattacharya, Arup, Li, Yun, Sexton, Sandra, Ling, Xiang, Li, Fengzhi, Zhang, Yuesheng. ""Depleting receptor tyrosine kinases EGFR and HER2 overcomes resistance to EGFR inhibitors in colorectal cancer."" Journal of experimental & clinical cancer research : CR, 2022, pp. 184.
[3] Hsu, Jennifer L, Hung, Mien-Chie. ""The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer."" Cancer metastasis reviews, 2016, pp. 575-588.
[4] Sugiyama, Michael G, Brown, Aidan I, Vega-Lugo, Jesus, Borges, Jazlyn P, Scott, Andrew M, Jaqaman, Khuloud, Fairn, Gregory D, Antonescu, Costin N. ""Confinement of unliganded EGFR by tetraspanin nanodomains gates EGFR ligand binding and signaling."" Nature communications, 2023, pp. 2681.
[5] Shao, Qiang, Zhu, Weiliang. ""Ligand binding effects on the activation of the EGFR extracellular domain."" Physical chemistry chemical physics : PCCP, 2019, pp. 8141-8151.
[6] Sabbah, Dima A, Hajjo, Rima, Sweidan, Kamal. ""Review on Epidermal Growth Factor Receptor (EGFR) Structure, Signaling Pathways, Interactions, and Recent Updates of EGFR Inhibitors."" Current topics in medicinal chemistry, 2020, pp. 815-834.
[7] Birge, Raymond B, Kalodimos, Charalampos, Inagaki, Fuyuhiko, Tanaka, Shinya. ""Crk and CrkL adaptor proteins: networks for physiological and pathological signaling."" Cell communication and signaling : CCS, 2009, pp. 13.
[8] Shi, C S, Tuscano, J, Kehrl, J H. ""Adaptor proteins CRK and CRKL associate with the serine/threonine protein kinase GCKR promoting GCKR and SAPK activation."" Blood, 2000, pp. 776-82.
[9] Sattler, M, Salgia, R, Okuda, K, Uemura, N, Durstin, M A, Pisick, E, Xu, G, Li, J L, Prasad, K V, Griffin, J D. ""The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway."" Oncogene, 1996, pp. 839-46.
[10] Tang, Rong, Langdon, Wallace Y, Zhang, Jian. ""Negative regulation of receptor tyrosine kinases by ubiquitination: Key roles of the Cbl family of E3 ubiquitin ligases."" Frontiers in endocrinology, 2022, pp. 971162.
[11] Huang, Fang, Gu, Hua. ""Negative regulation of lymphocyte development and function by the Cbl family of proteins."" Immunological reviews, 2008, pp. 229-38.
[12] Ahmed, Chulbul M I, Larkin, Joseph, Johnson, Howard M. ""SOCS1 Mimetics and Antagonists: A Complementary Approach to Positive and Negative Regulation of Immune Function."" Frontiers in immunology, 2015, pp. 183.
[13] Zhou, Jian, Xu, Ningbo, Liu, Boyang, Wang, Chenyang, He, Zhenyan, Lenahan, Cameron, Tang, Wenhui, Zeng, Huijun, Guo, Hongbo. ""lncRNA XLOC013218 promotes cell proliferation and TMZ resistance by targeting the PIK3R2-mediated PI3K/AKT pathway in glioma."" Cancer science, 2022, pp. 2681-2692.
[14] Gao, Jie, Zhou, Xiao-Li, Kong, Rui-Na, Ji, Lian-Mei, He, Ling-Ling, Zhao, Dong-Bao. ""microRNA-126 targeting PIK3R2 promotes rheumatoid arthritis synovial fibro-blasts proliferation and resistance to apoptosis by regulating PI3K/AKT pathway."" Experimental and molecular pathology, 2016, pp. 192-8.
[15] Song, Lei, Li, Dan, Gu, Yue, Wen, Zhong-Mei, Jie, Jing, Zhao, Dan, Peng, Li-Ping. ""MicroRNA-126 Targeting PIK3R2 Inhibits NSCLC A549 Cell Proliferation, Migration, and Invasion by Regulation of PTEN/PI3K/AKT Pathway."" Clinical lung cancer, 2016, pp. e65-e75.
[16] Sehgal, Priyanka, Lanauze, Claudia, Wang, Xin, Hayer, Katharina E, Torres-Diz, Manuel, Leu, N Adrian, Sela, Yogev, Stanger, Ben Z, Lengner, Christopher J, Thomas-Tikhonenko, Andrei. ""MYC Hyperactivates Wnt Signaling in <i>APC</i>/<i>CTNNB1</i>-Mutated Colorectal Cancer Cells through miR-92a-Dependent Repression of <i>DKK3</i>."" Molecular cancer research : MCR, 2021, pp. 2003-2014.
[17] Huang, Qian, Wang, Chao-Cai, Liu, Yun-Guang, Zhao, Chang-Ming, Zhang, Tian-Ping, Liu, Yan, Wang, Hua. ""Clinical relevance of genetic polymorphisms in WNT signaling pathway (<i>SFRP1</i>, <i>WNT3A</i>, <i>CTNNB1, WIF-1</i>, <i>DKK-1</i>, <i>LRP5</i>, <i>LRP6</i>) on pulmonary tuberculosis in a Chinese population."" Frontiers in immunology, 2022, pp. 1011700.
[18] Wu, Hua, Lu, Xing-Xing, Wang, Jing-Ru, Yang, Tian-Yu, Li, Xiu-Ming, He, Xiao-Shun, Li, Yi, Ye, Wen-Long, Wu, Yong, Gan, Wen-Juan, Guo, Peng-Da, Li, Jian-Ming. ""TRAF6 inhibits colorectal cancer metastasis through regulating selective autophagic CTNNB1/β-catenin degradation and is targeted for GSK3B/GSK3β-mediated phosphorylation and degradation."" Autophagy, 2019, pp. 1506-1522.
[19] Talukdar, Sarmistha, Emdad, Luni, Das, Swadesh K, Fisher, Paul B. ""EGFR: An essential receptor tyrosine kinase-regulator of cancer stem cells."" Advances in cancer research, 2020, pp. 161-188.
[20] Kozuki, Toshiyuki. ""Skin problems and EGFR-tyrosine kinase inhibitor."" Japanese journal of clinical oncology, 2016, pp. 291-8.
[21] Nilsson, Monique B, Yang, Yan, Heeke, Simon, Patel, Sonia A, Poteete, Alissa, Udagawa, Hibiki, Elamin, Yasir Y, Moran, Cesar A, Kashima, Yukie, Arumugam, Thiruvengadam, Yu, Xiaoxing, Ren, Xiaoyang, Diao, Lixia, Shen, Li, Wang, Qi, Zhang, Minying, Robichaux, Jacqulyne P, Shi, Chunhua, Pfeil, Allyson N, Tran, Hai, Gibbons, Don L, Bock, Jason, Wang, Jing, Minna, John D, Kobayashi, Susumu S, Le, Xiuning, Heymach, John V. ""CD70 is a therapeutic target upregulated in EMT-associated EGFR tyrosine kinase inhibitor resistance."" Cancer cell, 2023, pp. 340-355.e6.
"	0.6078402	0.79863095	GO	GO	NA
NeST	Phosphatase 2A catalytic subunit	NEST:170	PPP2CA PPP2CB PPP2R1A PPP2R1B PPP2R2A	5	2.321928094887362	Protein Dephosphorylation 	GO:0006470	PPP2CA;PPP2CB;PPP2R1B;PPP2R1A;PPP2R2A	5	100	8.44e-12	5.66e-10	Protein Phosphatase 2A (PP2A) Regulation	"Proteins: PPP2CA, PPP2CB, PPP2R1A, PPP2R1B, PPP2R2A

1. Heterotrimeric complex formation:
- PPP2CA and PPP2CB are catalytic subunits of PP2A, a serine/threonine phosphatase.
- PPP2R1A and PPP2R1B are regulatory subunits, providing substrate specificity and localization.
- PPP2R2A is a regulatory B subunit, further modulating substrate specificity.
- The heterotrimeric complex consists of one catalytic (PPP2CA or PPP2CB), one scaffold (PPP2R1A or PPP2R1B), and one regulatory (PPP2R2A) subunit.

2. Regulation of cellular processes:
- PP2A dephosphorylates target proteins, reversing the effects of kinases.
- PP2A regulates cell cycle progression, apoptosis, and signal transduction pathways.
- The specific combination of subunits determines the target proteins and cellular processes regulated.

3. Substrate specificity and localization:
- PPP2R1A and PPP2R1B bind to the catalytic subunits, forming a core dimer.
- PPP2R2A interacts with the core dimer, providing additional substrate specificity.
- Different combinations of subunits target PP2A to specific subcellular locations and substrates.

4. Implications in human diseases:
- Dysregulation of PP2A has been implicated in cancer, neurodegenerative diseases, and diabetes.
- Mutations in PPP2R1A and PPP2R1B have been associated with various cancers.
- Understanding the interactions between these proteins may provide therapeutic targets for these diseases."	5	100	"Proteins: PPP2CA, PPP2CB, PPP2R1A, PPP2R1B, PPP2R2A

- PPP2CA and PPP2CB are catalytic subunits of PP2A, a serine/threonine phosphatase.[1][2][3]

- PPP2R1A and PPP2R1B are regulatory subunits, providing substrate specificity and localization.[4][5][6]

- PPP2R2A is a regulatory B subunit, further modulating substrate specificity.[7][8][9]

- The heterotrimeric complex consists of one catalytic (PPP2CA or PPP2CB), one scaffold (PPP2R1A or PPP2R1B), and one regulatory (PPP2R2A) subunit.[10][11][12]

- PP2A dephosphorylates target proteins, reversing the effects of kinases.[13][14][15]

- PP2A regulates cell cycle progression, apoptosis, and signal transduction pathways.[16][17][18]

- The specific combination of subunits determines the target proteins and cellular processes regulated.

- PPP2R1A and PPP2R1B bind to the catalytic subunits, forming a core dimer.[19][20][21]

- PPP2R2A interacts with the core dimer, providing additional substrate specificity.[22][23][24]

- Different combinations of subunits target PP2A to specific subcellular locations and substrates.

- Dysregulation of PP2A has been implicated in cancer, neurodegenerative diseases, and diabetes.

- Mutations in PPP2R1A and PPP2R1B have been associated with various cancers.[25][26][27]

- Understanding the interactions between these proteins may provide therapeutic targets for these diseases.

========================================================================================================================================================================================================
[1] Gu, Pengyu, Qi, Xin, Zhou, Yue, Wang, Yun, Gao, Xiang. ""Generation of Ppp2Ca and Ppp2Cb conditional null alleles in mouse."" Genesis (New York, N.Y. : 2000), 2012, pp. 429-36.
[2] Yang, Cheng-Lei, Qiu, Xue, Lin, Jin-Yan, Chen, Xiao-Yu, Zhang, Yu-Mei, Hu, Xiao-Yin, Zhong, Jian-Hong, Tang, Shen, Li, Xi-Yi, Xiang, Bang-De, Zhang, Zhi-Ming. ""Potential Role and Clinical Value of PPP2CA in Hepatocellular Carcinoma."" Journal of clinical and translational hepatology, 2021, pp. 661-671.
[3] Eydmann, M E, Knowles, M A. ""Mutation analysis of 8p genes POLB and PPP2CB in bladder cancer."" Cancer genetics and cytogenetics, 1997, pp. 167-71.
[4] De, Pradip, Carlson, Jennifer H, Leyland-Jones, Brian, Dey, Nandini. ""Role of ""oncogenic nexus"" of CIP2A in breast oncogenesis: how does it work?"" American journal of cancer research, 2015, pp. 2872-91.
[5] Jeong, Ae Lee, Han, Sora, Lee, Sunyi, Su Park, Jeong, Lu, Yiling, Yu, Shuangxing, Li, Jane, Chun, Kyung-Hee, Mills, Gordon B, Yang, Young. ""Patient derived mutation W257G of PPP2R1A enhances cancer cell migration through SRC-JNK-c-Jun pathway."" Scientific reports, 2016, pp. 27391.
[6] Nagendra, Deepak C, Burke, James, Maxwell, G Larry, Risinger, John I. ""PPP2R1A mutations are common in the serous type of endometrial cancer."" Molecular carcinogenesis, 2012, pp. 826-31.
[7] Fowle, Holly, Zhao, Ziran, Graña, Xavier. ""PP2A holoenzymes, substrate specificity driving cellular functions and deregulation in cancer."" Advances in cancer research, 2019, pp. 55-93.
[8] Panicker, Nikita, Coutman, Melody, Lawlor-O'Neill, Charley, Kahl, Richard G S, Roselli, Séverine, Verrills, Nicole M. ""<i>Ppp2r2a</i> Knockout Mice Reveal That Protein Phosphatase 2A Regulatory Subunit, PP2A-B55α, Is an Essential Regulator of Neuronal and Epidermal Embryonic Development."" Frontiers in cell and developmental biology, 2020, pp. 358.
[9] Hu, P, Yu, L, Zhang, M, Zheng, L, Zhao, Y, Fu, Q, Zhao, S. ""Molecular cloning and mapping of the brain-abundant B1gamma subunit of protein phosphatase 2A, PPP2R2C, to human chromosome 4p16."" Genomics, 2000, pp. 83-6.
[10] D'Arcy, Brandon M, Swingle, Mark R, Papke, Cinta M, Abney, Kevin A, Bouska, Erin S, Prakash, Aishwarya, Honkanen, Richard E. ""The Antitumor Drug LB-100 Is a Catalytic Inhibitor of Protein Phosphatase 2A (PPP2CA) and 5 (PPP5C) Coordinating with the Active-Site Catalytic Metals in PPP5C."" Molecular cancer therapeutics, 2019, pp. 556-566.
[11] Reynhout, Sara, Jansen, Sandra, Haesen, Dorien, van Belle, Siska, de Munnik, Sonja A, Bongers, Ernie M H F, Schieving, Jolanda H, Marcelis, Carlo, Amiel, Jeanne, Rio, Marlène, Mclaughlin, Heather, Ladda, Roger, Sell, Susan, Kriek, Marjolein, Peeters-Scholte, Cacha M P C D, Terhal, Paulien A, van Gassen, Koen L, Verbeek, Nienke, Henry, Sonja, Scott Schwoerer, Jessica, Malik, Saleem, Revencu, Nicole, Ferreira, Carlos R, Macnamara, Ellen, Braakman, Hilde M H, Brimble, Elise, Ruzhnikov, Maura R Z, Wagner, Matias, Harrer, Philip, Wieczorek, Dagmar, Kuechler, Alma, Tziperman, Barak, Barel, Ortal, de Vries, Bert B A, Gordon, Christopher T, Janssens, Veerle, Vissers, Lisenka E L M. ""De Novo Mutations Affecting the Catalytic Cα Subunit of PP2A, PPP2CA, Cause Syndromic Intellectual Disability Resembling Other PP2A-Related Neurodevelopmental Disorders."" American journal of human genetics, 2019, pp. 139-156.
[12] Morita, Ken, He, Shuning, Nowak, Radosław P, Wang, Jinhua, Zimmerman, Mark W, Fu, Cong, Durbin, Adam D, Martel, Megan W, Prutsch, Nicole, Gray, Nathanael S, Fischer, Eric S, Look, A Thomas. ""Allosteric Activators of Protein Phosphatase 2A Display Broad Antitumor Activity Mediated by Dephosphorylation of MYBL2."" Cell, 2020, pp. 702-715.e20.
[13] Juang, Yuang-Taung, Wang, Ying, Jiang, Guisen, Peng, Hai-Bin, Ergin, Sukran, Finnell, Michelle, Magilavy, Abigail, Kyttaris, Vasileios C, Tsokos, George C. ""PP2A dephosphorylates Elf-1 and determines the expression of CD3zeta and FcRgamma in human systemic lupus erythematosus T cells."" Journal of immunology (Baltimore, Md. : 1950), 2008, pp. 3658-64.
[14] Corcoran, Niall M, Martin, Daniel, Hutter-Paier, Birgit, Windisch, Manfred, Nguyen, Thanh, Nheu, Lina, Sundstrom, Lars E, Costello, Anthony J, Hovens, Christopher M. ""Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease model."" Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2010, pp. 1025-33.
[15] Jeong, Ae Lee, Yang, Young. ""PP2A function toward mitotic kinases and substrates during the cell cycle."" BMB reports, 2013, pp. 289-94.
[16] Wlodarchak, Nathan, Xing, Yongna. ""PP2A as a master regulator of the cell cycle."" Critical reviews in biochemistry and molecular biology, 2016, pp. 162-84.
[17] Jeong, Ae Lee, Yang, Young. ""PP2A function toward mitotic kinases and substrates during the cell cycle."" BMB reports, 2013, pp. 289-94.
[18] Kurimchak, Alison, Graña, Xavier. ""PP2A holoenzymes negatively and positively regulate cell cycle progression by dephosphorylating pocket proteins and multiple CDK substrates."" Gene, 2012, pp. 1-7.
[19] Morita, Ken, He, Shuning, Nowak, Radosław P, Wang, Jinhua, Zimmerman, Mark W, Fu, Cong, Durbin, Adam D, Martel, Megan W, Prutsch, Nicole, Gray, Nathanael S, Fischer, Eric S, Look, A Thomas. ""Allosteric Activators of Protein Phosphatase 2A Display Broad Antitumor Activity Mediated by Dephosphorylation of MYBL2."" Cell, 2020, pp. 702-715.e20.
[20] Jeong, Ae Lee, Han, Sora, Lee, Sunyi, Su Park, Jeong, Lu, Yiling, Yu, Shuangxing, Li, Jane, Chun, Kyung-Hee, Mills, Gordon B, Yang, Young. ""Patient derived mutation W257G of PPP2R1A enhances cancer cell migration through SRC-JNK-c-Jun pathway."" Scientific reports, 2016, pp. 27391.
[21] Salter, E Alan, Wierzbicki, Andrzej, Honkanen, Richard E, Swingle, Mark R. ""Quantum-based modeling implies that bidentate Arg<sup>89</sup>-substrate binding enhances serine/threonine protein phosphatase-2A(PPP2R5D/PPP2R1A/PPP2CA)-mediated dephosphorylation."" Frontiers in cell and developmental biology, 2023, pp. 1141804.
[22] Beca, Francisco, Pereira, Miguel, Cameselle-Teijeiro, Jorge F, Martins, Diana, Schmitt, Fernando. ""Altered PPP2R2A and Cyclin D1 expression defines a subgroup of aggressive luminal-like breast cancer."" BMC cancer, 2015, pp. 285.
[23] Zhang, Mingjuan, Wang, Su, Yi, Aiwen, Qiao, Yongsheng. ""microRNA-665 is down-regulated in gastric cancer and inhibits proliferation, invasion, and EMT by targeting PPP2R2A."" Cell biochemistry and function, 2020, pp. 409-418.
[24] Fowle, Holly, Zhao, Ziran, Graña, Xavier. ""PP2A holoenzymes, substrate specificity driving cellular functions and deregulation in cancer."" Advances in cancer research, 2019, pp. 55-93.
[25] Wang, Feng, Zou, Yang, Liu, Fa-Ying, Yu, Xiao-Hong, Huang, Huang, Zhang, Nan, Qi, Ying-Ying, Liu, Rong-Fang, Liu, Xiao-Yan, Chen, Jia, Huang, Ou-Ping, He, Ming. ""Infrequent mutations of the PPP2R1A and PPP2R1B genes in patients with ovarian cancer."" Molecular medicine reports, 2013, pp. 1826-30.
[26] Shih, Ie-Ming, Panuganti, Pradeep K, Kuo, Kuan-Tin, Mao, Tsui-Lien, Kuhn, Elisabetta, Jones, Sian, Velculescu, Victor E, Kurman, Robert J, Wang, Tian-Li. ""Somatic mutations of PPP2R1A in ovarian and uterine carcinomas."" The American journal of pathology, 2011, pp. 1442-7.
[27] Zou, Yang, Zhou, Jiang-Yan, Guo, Jiu-Bai, Wang, Li-Qun, Luo, Yong, Zhang, Zi-Yu, Liu, Fa-Ying, Tan, Jun, Wang, Feng, Huang, Ou-Ping. ""The presence of KRAS, PPP2R1A and ARID1A mutations in 101 Chinese samples with ovarian endometriosis."" Mutation research, 2018, pp. 1-5.
"	0.76139176	0.52320486	LLM	LLM	NA
NeST	RNA metabolism	NEST:19	BCLAF1 BRD4 CASP8 CDC73 CREBBP DDX3X EWSR1 FUBP1 FUS GATA3 PRCC PRKDC PRPF40B RBM10 SF1 SF3B1 SPEN SRSF2 TNF U2AF1 UPF1 ZRSR2	22	4.459431618637297	RNA Splicing, Via Transesterification Reactions With Bulged Adenosine As Nucleophile 	GO:0000377	ZRSR2;SRSF2;PRPF40B;U2AF1;SF3B1;RBM10	6	27.27272727272727	3.24e-8	1.38e-5	Apoptosis and Splicing Regulation	"Proteins: BCLAF1, BRD4, CASP8, CDC73, CREBBP, DDX3X, EWSR1, FUBP1, FUS, GATA3, PRCC, PRKDC, PRPF40B, RBM10, SF1, SF3B1, SPEN, SRSF2, TNF, U2AF1, UPF1, ZRSR2.

Analysis:

1. Apoptosis regulation: CASP8 and TNF are key proteins involved in apoptosis. CASP8 is a caspase protein that initiates the extrinsic apoptotic pathway, while TNF is a cytokine that can induce apoptosis through TNF receptor signaling. BCLAF1 is a pro-apoptotic protein that interacts with CASP8 and TNF, enhancing their apoptotic functions.

2. Splicing regulation: Several proteins in this system are involved in pre-mRNA splicing, including SF1, SF3B1, U2AF1, SRSF2, ZRSR2, PRPF40B, and RBM10. These proteins are components of the spliceosome or regulate spliceosome assembly and function. Abnormalities in splicing regulation can lead to various diseases, including cancer.

3. Transcriptional regulation: CREBBP, BRD4, and GATA3 are transcriptional regulators. CREBBP is a histone acetyltransferase that modulates chromatin structure and transcription. BRD4 is a bromodomain-containing protein that binds to acetylated histones and regulates gene expression. GATA3 is a transcription factor that plays a role in T-cell development and differentiation.

4. RNA processing and stability: DDX3X, EWSR1, FUBP1, FUS, and UPF1 are RNA-binding proteins involved in various aspects of RNA metabolism, including transcription, splicing, mRNA export, and mRNA stability. Dysregulation of these proteins can contribute to the development of diseases such as cancer and neurodegenerative disorders.

5. DNA repair and cell cycle regulation: PRKDC, CDC73, and PRCC are involved in DNA repair and cell cycle regulation. PRKDC is a DNA-dependent protein kinase involved in DNA double-strand break repair. CDC73 is a component of the PAF1 complex, which is involved in transcriptional regulation and chromatin remodeling. PRCC is a component of the RCC1 complex, which is involved in cell cycle progression.

In conclusion, the most prominent biological process performed by this system of interacting proteins is the regulation of apoptosis and splicing. These processes are critical for maintaining cellular homeostasis and preventing the development of diseases such as cancer."	22	100	"Proteins: BCLAF1, BRD4, CASP8, CDC73, CREBBP, DDX3X, EWSR1, FUBP1, FUS, GATA3, PRCC, PRKDC, PRPF40B, RBM10, SF1, SF3B1, SPEN, SRSF2, TNF, U2AF1, UPF1, ZRSR2.

1. Apoptosis regulation: CASP8 and TNF are key proteins involved in apoptosis. CASP8 is a caspase protein that initiates the extrinsic apoptotic pathway, while TNF is a cytokine that can induce apoptosis through TNF receptor signaling. BCLAF1 is a pro-apoptotic protein that interacts with CASP8 and TNF, enhancing their apoptotic functions.[1][2][3]

2. Splicing regulation: Several proteins in this system are involved in pre-mRNA splicing, including SF1, SF3B1, U2AF1, SRSF2, ZRSR2, PRPF40B, and RBM10. These proteins are components of the spliceosome or regulate spliceosome assembly and function. Abnormalities in splicing regulation can lead to various diseases, including cancer.[4][5][6]

3. Transcriptional regulation: CREBBP, BRD4, and GATA3 are transcriptional regulators. CREBBP is a histone acetyltransferase that modulates chromatin structure and transcription. BRD4 is a bromodomain-containing protein that binds to acetylated histones and regulates gene expression. GATA3 is a transcription factor that plays a role in T-cell development and differentiation.[7][8][9]

4. RNA processing and stability: DDX3X, EWSR1, FUBP1, FUS, and UPF1 are RNA-binding proteins involved in various aspects of RNA metabolism, including transcription, splicing, mRNA export, and mRNA stability. Dysregulation of these proteins can contribute to the development of diseases such as cancer and neurodegenerative disorders.[10][11][12]

5. DNA repair and cell cycle regulation: PRKDC, CDC73, and PRCC are involved in DNA repair and cell cycle regulation. PRKDC is a DNA-dependent protein kinase involved in DNA double-strand break repair. CDC73 is a component of the PAF1 complex, which is involved in transcriptional regulation and chromatin remodeling. PRCC is a component of the RCC1 complex, which is involved in cell cycle progression.[13][14][15]

In conclusion, the most prominent biological process performed by this system of interacting proteins is the regulation of apoptosis and splicing. These processes are critical for maintaining cellular homeostasis and preventing the development of diseases such as cancer.

========================================================================================================================================================================================================
[1] Wang, Yan, Shnyra, Alexander, Africa, Charlene, Warholic, Christopher, McArthur, Carole. ""Activation of the extrinsic apoptotic pathway by TNF-alpha in human salivary gland (HSG) cells in vitro, suggests a role for the TNF receptor (TNF-R) and intercellular adhesion molecule-1 (ICAM-1) in Sjögren's syndrome-associated autoimmune sialadenitis."" Archives of oral biology, 2009, pp. 986-96.
[2] Leahomschi, S, Molinsky, J, Klanova, M, Andera, L, Peterka, M, Gasova, Z, Klener, P, Trneny, M, Necas, E, Simonova, T, Zivny, J, Klener, P. ""Multi-level disruption of the extrinsic apoptotic pathway mediates resistance of leukemia cells to TNF-related apoptosis-inducing ligand (TRAIL)."" Neoplasma, 2013, pp. 223-31.
[3] Karki, Rajendra, Sharma, Bhesh Raj, Tuladhar, Shraddha, Williams, Evan Peter, Zalduondo, Lillian, Samir, Parimal, Zheng, Min, Sundaram, Balamurugan, Banoth, Balaji, Malireddi, R K Subbarao, Schreiner, Patrick, Neale, Geoffrey, Vogel, Peter, Webby, Richard, Jonsson, Colleen Beth, Kanneganti, Thirumala-Devi. ""Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes."" Cell, 2021, pp. 149-168.e17.
[4] Butt, Haroon, Bazin, Jeremie, Alshareef, Sahar, Eid, Ayman, Benhamed, Moussa, Reddy, Anireddy S N, Crespi, Martin, Mahfouz, Magdy M. ""Overlapping roles of spliceosomal components SF3B1 and PHF5A in rice splicing regulation."" Communications biology, 2021, pp. 529.
[5] Rodor, Julie, FitzPatrick, David R, Eyras, Eduardo, Cáceres, Javier F. ""The RNA-binding landscape of RBM10 and its role in alternative splicing regulation in models of mouse early development."" RNA biology, 2017, pp. 45-57.
[6] Wang, Yongbo, Gogol-Döring, Andreas, Hu, Hao, Fröhler, Sebastian, Ma, Yunxia, Jens, Marvin, Maaskola, Jonas, Murakawa, Yasuhiro, Quedenau, Claudia, Landthaler, Markus, Kalscheuer, Vera, Wieczorek, Dagmar, Wang, Yang, Hu, Yuhui, Chen, Wei. ""Integrative analysis revealed the molecular mechanism underlying RBM10-mediated splicing regulation."" EMBO molecular medicine, 2013, pp. 1431-42.
[7] Donati, Benedetta, Lorenzini, Eugenia, Ciarrocchi, Alessia. ""BRD4 and Cancer: going beyond transcriptional regulation."" Molecular cancer, 2018, pp. 164.
[8] Sdelci, Sara, Rendeiro, André F, Rathert, Philipp, You, Wanhui, Lin, Jung-Ming G, Ringler, Anna, Hofstätter, Gerald, Moll, Herwig P, Gürtl, Bettina, Farlik, Matthias, Schick, Sandra, Klepsch, Freya, Oldach, Matthew, Buphamalai, Pisanu, Schischlik, Fiorella, Májek, Peter, Parapatics, Katja, Schmidl, Christian, Schuster, Michael, Penz, Thomas, Buckley, Dennis L, Hudecz, Otto, Imre, Richard, Wang, Shuang-Yan, Maric, Hans Michael, Kralovics, Robert, Bennett, Keiryn L, Müller, Andre C, Mechtler, Karl, Menche, Jörg, Bradner, James E, Winter, Georg E, Klavins, Kristaps, Casanova, Emilio, Bock, Christoph, Zuber, Johannes, Kubicek, Stefan. ""MTHFD1 interaction with BRD4 links folate metabolism to transcriptional regulation."" Nature genetics, 2019, pp. 990-998.
[9] Wu, Shwu-Yuan, Chiang, Cheng-Ming. ""The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation."" The Journal of biological chemistry, 2007, pp. 13141-5.
[10] Lennox, Ashley L, Hoye, Mariah L, Jiang, Ruiji, Johnson-Kerner, Bethany L, Suit, Lindsey A, Venkataramanan, Srivats, Sheehan, Charles J, Alsina, Fernando C, Fregeau, Brieana, Aldinger, Kimberly A, Moey, Ching, Lobach, Iryna, Afenjar, Alexandra, Babovic-Vuksanovic, Dusica, Bézieau, Stéphane, Blackburn, Patrick R, Bunt, Jens, Burglen, Lydie, Campeau, Philippe M, Charles, Perrine, Chung, Brian H Y, Cogné, Benjamin, Curry, Cynthia, D'Agostino, Maria Daniela, Di Donato, Nataliya, Faivre, Laurence, Héron, Delphine, Innes, A Micheil, Isidor, Bertrand, Keren, Boris, Kimball, Amy, Klee, Eric W, Kuentz, Paul, Küry, Sébastien, Martin-Coignard, Dominique, Mirzaa, Ghayda, Mignot, Cyril, Miyake, Noriko, Matsumoto, Naomichi, Fujita, Atsushi, Nava, Caroline, Nizon, Mathilde, Rodriguez, Diana, Blok, Lot Snijders, Thauvin-Robinet, Christel, Thevenon, Julien, Vincent, Marie, Ziegler, Alban, Dobyns, William, Richards, Linda J, Barkovich, A James, Floor, Stephen N, Silver, Debra L, Sherr, Elliott H. ""Pathogenic DDX3X Mutations Impair RNA Metabolism and Neurogenesis during Fetal Cortical Development."" Neuron, 2020, pp. 404-420.e8.
[11] Shen, Hui, Yanas, Amber, Owens, Michael C, Zhang, Celia, Fritsch, Clark, Fare, Charlotte M, Copley, Katie E, Shorter, James, Goldman, Yale E, Liu, Kathy Fange. ""Sexually dimorphic RNA helicases DDX3X and DDX3Y differentially regulate RNA metabolism through phase separation."" Molecular cell, 2022, pp. 2588-2603.e9.
[12] Ajamian, Lara, Abrahamyan, Levon, Milev, Miroslav, Ivanov, Pavel V, Kulozik, Andreas E, Gehring, Niels H, Mouland, Andrew J. ""Unexpected roles for UPF1 in HIV-1 RNA metabolism and translation."" RNA (New York, N.Y.), 2008, pp. 914-27.
[13] Saini, Divyalakshmi, Sudheer, K R, Kumar, P R Vivek, Soren, D C, Jain, Vinay, Koya, P K M, Jaikrishan, G, Das, Birajalaxmi. ""Evaluation of the influence of chronic low-dose radiation on DNA repair gene polymorphisms [<i>XRCC1</i>, <i>XRCC3, PRKDC (XRCC7), LIG1</i>, <i>NEIL1</i>] in individuals from normal and high level natural radiation areas of Kerala Coast."" International journal of radiation biology, 2020, pp. 734-739.
[14] Casey, Jillian P, Nobbs, Michael, McGettigan, Paul, Lynch, Sallyann, Ennis, Sean. ""Recessive mutations in MCM4/PRKDC cause a novel syndrome involving a primary immunodeficiency and a disorder of DNA repair."" Journal of medical genetics, 2012, pp. 242-5.
[15] Anderson, C W, Dunn, J J, Freimuth, P I, Galloway, A M, Allalunis-Turner, M J. ""Frameshift mutation in PRKDC, the gene for DNA-PKcs, in the DNA repair-defective, human, glioma-derived cell line M059J."" Radiation research, 2001, pp. 2-9.
"	0.45342645	0.44643027	Tied	GO	NA
NeST	MutS homologs	NEST:231	MLH1 MSH2 MSH3 MSH6 PMS2	5	2.321928094887362	Mismatch Repair 	GO:0006298	MSH6;MSH2;MSH3;PMS2;MLH1	5	100	1.99e-15	8.57e-14	Mismatch Repair	"The system of interacting proteins MLH1, MSH2, MSH3, MSH6, and PMS2 primarily performs the biological process of mismatch repair (MMR). MMR is crucial for maintaining genomic stability by correcting base mismatches and insertion/deletion loops that arise during DNA replication.

1. MSH2-MSH6 and MSH2-MSH3 heterodimers: MSH2 forms heterodimers with MSH6 (MutSα) and MSH3 (MutSβ). MutSα recognizes base mismatches and small insertion/deletion loops, while MutSβ recognizes larger insertion/deletion loops. Both heterodimers initiate the MMR process by binding to the mismatch site.

2. MLH1-PMS2 heterodimer (MutLα): MLH1 forms a heterodimer with PMS2, known as MutLα. MutLα is recruited to the mismatch site by MutSα or MutSβ and acts as a molecular matchmaker, coordinating the activities of other proteins involved in MMR.

3. Strand discrimination and excision: The MMR system distinguishes the newly synthesized strand from the template strand using pre-existing nicks or gaps. MLH1-PMS2, along with other proteins, facilitates the excision of the incorrect base from the newly synthesized strand.

4. DNA resynthesis and ligation: After the excision of the incorrect base, DNA polymerase fills the gap by synthesizing the correct nucleotide, and DNA ligase seals the nick, completing the MMR process.

5. Role in preventing cancer: Defects in MMR proteins, including MLH1, MSH2, MSH6, and PMS2, are associated with an increased risk of developing certain types of cancer, such as Lynch syndrome-associated colorectal cancer. Thus, the MMR system plays a crucial role in preventing cancer by maintaining genomic stability.

In conclusion, the primary biological process performed by the interacting proteins MLH1, MSH2, MSH3, MSH6, and PMS2 is mismatch repair, which is essential for maintaining genomic stability and preventing cancer."	5	100	"The system of interacting proteins MLH1, MSH2, MSH3, MSH6, and PMS2 primarily performs the biological process of mismatch repair (MMR). MMR is crucial for maintaining genomic stability by correcting base mismatches and insertion/deletion loops that arise during DNA replication.[1][2][3]

1. MSH2-MSH6 and MSH2-MSH3 heterodimers: MSH2 forms heterodimers with MSH6 (MutSα) and MSH3 (MutSβ). MutSα recognizes base mismatches and small insertion/deletion loops, while MutSβ recognizes larger insertion/deletion loops. Both heterodimers initiate the MMR process by binding to the mismatch site.[4][5][6]

2. MLH1-PMS2 heterodimer (MutLα): MLH1 forms a heterodimer with PMS2, known as MutLα. MutLα is recruited to the mismatch site by MutSα or MutSβ and acts as a molecular matchmaker, coordinating the activities of other proteins involved in MMR.[7][8][9]

3. Strand discrimination and excision: The MMR system distinguishes the newly synthesized strand from the template strand using pre-existing nicks or gaps. MLH1-PMS2, along with other proteins, facilitates the excision of the incorrect base from the newly synthesized strand.[10][11][12]

4. DNA resynthesis and ligation: After the excision of the incorrect base, DNA polymerase fills the gap by synthesizing the correct nucleotide, and DNA ligase seals the nick, completing the MMR process.

5. Role in preventing cancer: Defects in MMR proteins, including MLH1, MSH2, MSH6, and PMS2, are associated with an increased risk of developing certain types of cancer, such as Lynch syndrome-associated colorectal cancer. Thus, the MMR system plays a crucial role in preventing cancer by maintaining genomic stability.[13][14][15]

In conclusion, the primary biological process performed by the interacting proteins MLH1, MSH2, MSH3, MSH6, and PMS2 is mismatch repair, which is essential for maintaining genomic stability and preventing cancer.[16][17][18]

========================================================================================================================================================================================================
[1] DuPrie, Matthew L, Palacio, Tatiana, Calil, Felipe A, Kolodner, Richard D, Putnam, Christopher D. ""Mlh1 interacts with both Msh2 and Msh6 for recruitment during mismatch repair."" DNA repair, 2022, pp. 103405.
[2] Nargund, Amrita M, Xu, Chang, Mandoli, Amit, Okabe, Atsushi, Chen, Gao Bin, Huang, Kie Kyon, Sheng, Taotao, Yao, Xiaosai, Teo, Jia Ming Nickolas, Sundar, Raghav, Kok, Yee Jiun, See, Yi Xiang, Xing, Manjie, Li, Zhimei, Yong, Chern Han, Anand, Aparna, A I, Zul Fazreen, Poon, Lai Fong, Ng, Michelle Shu Wen, Koh, Javier Yu Peng, Ooi, Wen Fong, Tay, Su Ting, Ong, Xuewen, Tan, Angie Lay Keng, Grabsch, Heike I, Fullwood, Melissa J, Teh, Tean Bin, Bi, Xuezhi, Kaneda, Atsushi, Li, Shang, Tan, Patrick. ""Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer."" Cancer research, 2022, pp. 2538-2551.
[3] Javeed, Saira, Chughtai, Anila, Zafar, Ghazi, Khalid, Fatima, Batool, Ayma, Chughtai, Akhtar S. ""An Evaluation of the Immunohistochemical Expression of Mismatch Repair Proteins (MSH2, MSH6, MLH1, and PMS2) in Prostate Adenocarcinoma."" Cureus, 2022, pp. e27448.
[4] Drotschmann, Karin, Hall, Mark C, Shcherbakova, Polina V, Wang, Hong, Erie, Dorothy A, Brownewell, Floyd R, Kool, Eric T, Kunkel, Thomas A. ""DNA binding properties of the yeast Msh2-Msh6 and Mlh1-Pms1 heterodimers."" Biological chemistry, 2002, pp. 969-75.
[5] Wang, H, Lawrence, C W, Li, G M, Hays, J B. ""Specific binding of human MSH2.MSH6 mismatch-repair protein heterodimers to DNA incorporating thymine- or uracil-containing UV light photoproducts opposite mismatched bases."" The Journal of biological chemistry, 1999, pp. 16894-900.
[6] Mukherjee, Shayantani, Law, Sean M, Feig, Michael. ""Deciphering the mismatch recognition cycle in MutS and MSH2-MSH6 using normal-mode analysis."" Biophysical journal, 2009, pp. 1707-20.
[7] Kadyrova, Lyudmila Y, Gujar, Vaibhavi, Burdett, Vickers, Modrich, Paul L, Kadyrov, Farid A. ""Human MutLγ, the MLH1-MLH3 heterodimer, is an endonuclease that promotes DNA expansion."" Proceedings of the National Academy of Sciences of the United States of America, 2020, pp. 3535-3542.
[8] DuPrie, Matthew L, Palacio, Tatiana, Calil, Felipe A, Kolodner, Richard D, Putnam, Christopher D. ""Mlh1 interacts with both Msh2 and Msh6 for recruitment during mismatch repair."" DNA repair, 2022, pp. 103405.
[9] Takahashi, Masanobu, Shimodaira, Hideki, Andreutti-Zaugg, Corinne, Iggo, Richard, Kolodner, Richard D, Ishioka, Chikashi. ""Functional analysis of human MLH1 variants using yeast and in vitro mismatch repair assays."" Cancer research, 2007, pp. 4595-604.
[10] De' Angelis, Gian Luigi, Bottarelli, Lorena, Azzoni, Cinzia, De' Angelis, Nicola, Leandro, Gioacchino, Di Mario, Francesco, Gaiani, Federica, Negri, Francesca. ""Microsatellite instability in colorectal cancer."" Acta bio-medica : Atenei Parmensis, 2018, pp. 97-101.
[11] Gelsomino, Fabio, Barbolini, Monica, Spallanzani, Andrea, Pugliese, Giuseppe, Cascinu, Stefano. ""The evolving role of microsatellite instability in colorectal cancer: A review."" Cancer treatment reviews, 2016, pp. 19-26.
[12] Marti, Thomas M, Kunz, Christophe, Fleck, Oliver. ""DNA mismatch repair and mutation avoidance pathways."" Journal of cellular physiology, 2002, pp. 28-41.
[13] Han, Quanli, Liu, Si, Cui, Zhi, Wang, Qi, Ma, Tonghui, Jiang, Liwen, Li, Xiaomo, Dai, Guanghai. ""Case Report and Literature Review: Diagnosis, Tailored Genetic Counseling and Cancer Prevention for a Locally Advanced dMMR/MSI-H/TMB-H Lung Cancer Patient With Concurrent Lynch Syndrome Mediated by a Rare <i>PMS2</i> Splicing Variant (c.1144+1G>A)."" Frontiers in genetics, 2021, pp. 799807.
[14] Johnson, R E, Kovvali, G K, Prakash, L, Prakash, S. ""Requirement of the yeast MSH3 and MSH6 genes for MSH2-dependent genomic stability."" The Journal of biological chemistry, 1996, pp. 7285-8.
[15] Peled, Jonathan U, Sellers, Rani S, Iglesias-Ussel, Maria D, Shin, Dong-Mi, Montagna, Cristina, Zhao, Chunfang, Li, Ziqiang, Edelmann, Winfried, Morse, Herbert C, Scharff, Matthew D. ""Msh6 protects mature B cells from lymphoma by preserving genomic stability."" The American journal of pathology, 2010, pp. 2597-608.
[16] DuPrie, Matthew L, Palacio, Tatiana, Calil, Felipe A, Kolodner, Richard D, Putnam, Christopher D. ""Mlh1 interacts with both Msh2 and Msh6 for recruitment during mismatch repair."" DNA repair, 2022, pp. 103405.
[17] Nargund, Amrita M, Xu, Chang, Mandoli, Amit, Okabe, Atsushi, Chen, Gao Bin, Huang, Kie Kyon, Sheng, Taotao, Yao, Xiaosai, Teo, Jia Ming Nickolas, Sundar, Raghav, Kok, Yee Jiun, See, Yi Xiang, Xing, Manjie, Li, Zhimei, Yong, Chern Han, Anand, Aparna, A I, Zul Fazreen, Poon, Lai Fong, Ng, Michelle Shu Wen, Koh, Javier Yu Peng, Ooi, Wen Fong, Tay, Su Ting, Ong, Xuewen, Tan, Angie Lay Keng, Grabsch, Heike I, Fullwood, Melissa J, Teh, Tean Bin, Bi, Xuezhi, Kaneda, Atsushi, Li, Shang, Tan, Patrick. ""Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer."" Cancer research, 2022, pp. 2538-2551.
[18] Javeed, Saira, Chughtai, Anila, Zafar, Ghazi, Khalid, Fatima, Batool, Ayma, Chughtai, Akhtar S. ""An Evaluation of the Immunohistochemical Expression of Mismatch Repair Proteins (MSH2, MSH6, MLH1, and PMS2) in Prostate Adenocarcinoma."" Cureus, 2022, pp. e27448.
"	0.68202823	0.68202823	Tied	Tied	NA
NeST	Beta-catenin destruction complex	NEST:239	APC AXIN1 CTNNB1 GSK3B HLA-A	5	2.321928094887362	Proteasomal Protein Catabolic Process 	GO:0010498	GSK3B;APC;AXIN1;CTNNB1	4	80	7.06e-8	2.27e-5	Wnt Signaling Pathway Regulation	"Proteins: APC, AXIN1, CTNNB1, GSK3B, HLA-A

1. APC and AXIN1: Both APC (adenomatous polyposis coli) and AXIN1 (axis inhibition protein 1) are key components of the destruction complex, which plays a crucial role in regulating the Wnt signaling pathway. The destruction complex targets CTNNB1 (beta-catenin) for degradation, preventing its accumulation in the cytoplasm and subsequent translocation to the nucleus.

2. CTNNB1: CTNNB1 (beta-catenin) is a central player in the Wnt signaling pathway. In the absence of Wnt ligands, CTNNB1 is phosphorylated by GSK3B (glycogen synthase kinase 3 beta) and targeted for degradation by the proteasome. When Wnt ligands are present, the destruction complex is inhibited, allowing CTNNB1 to accumulate in the cytoplasm and translocate to the nucleus, where it activates target gene transcription.

3. GSK3B: GSK3B (glycogen synthase kinase 3 beta) is a serine/threonine kinase that phosphorylates CTNNB1, marking it for degradation by the proteasome. GSK3B is an essential component of the destruction complex, and its activity is regulated by Wnt signaling.

4. HLA-A: HLA-A (human leukocyte antigen A) is a major histocompatibility complex (MHC) class I molecule involved in antigen presentation to CD8+ T cells. Although not directly involved in the Wnt signaling pathway, HLA-A may have an indirect effect on the pathway through its role in immune surveillance and response to cellular stress.

In conclusion, the most prominent biological process performed by this system of interacting proteins is the regulation of the Wnt signaling pathway, which is crucial for various cellular processes such as cell proliferation, differentiation, and migration. The proteins APC, AXIN1, CTNNB1, and GSK3B are directly involved in this process, while HLA-A may have an indirect effect through its role in immune surveillance."	5	100	"Proteins: APC, AXIN1, CTNNB1, GSK3B, HLA-A

1. APC and AXIN1: Both APC (adenomatous polyposis coli) and AXIN1 (axis inhibition protein 1) are key components of the destruction complex, which plays a crucial role in regulating the Wnt signaling pathway. The destruction complex targets CTNNB1 (beta-catenin) for degradation, preventing its accumulation in the cytoplasm and subsequent translocation to the nucleus.[1][2][3]

2. CTNNB1: CTNNB1 (beta-catenin) is a central player in the Wnt signaling pathway. In the absence of Wnt ligands, CTNNB1 is phosphorylated by GSK3B (glycogen synthase kinase 3 beta) and targeted for degradation by the proteasome. When Wnt ligands are present, the destruction complex is inhibited, allowing CTNNB1 to accumulate in the cytoplasm and translocate to the nucleus, where it activates target gene transcription.[4][5][6]

3. GSK3B: GSK3B (glycogen synthase kinase 3 beta) is a serine/threonine kinase that phosphorylates CTNNB1, marking it for degradation by the proteasome. GSK3B is an essential component of the destruction complex, and its activity is regulated by Wnt signaling.[7][8][9]

4. HLA-A: HLA-A (human leukocyte antigen A) is a major histocompatibility complex (MHC) class I molecule involved in antigen presentation to CD8+ T cells. Although not directly involved in the Wnt signaling pathway, HLA-A may have an indirect effect on the pathway through its role in immune surveillance and response to cellular stress.[10][11][12]

In conclusion, the most prominent biological process performed by this system of interacting proteins is the regulation of the Wnt signaling pathway, which is crucial for various cellular processes such as cell proliferation, differentiation, and migration. The proteins APC, AXIN1, CTNNB1, and GSK3B are directly involved in this process, while HLA-A may have an indirect effect through its role in immune surveillance.[13][14][15]

========================================================================================================================================================================================================
[1] Ranes, Michael, Zaleska, Mariola, Sakalas, Saira, Knight, Ruth, Guettler, Sebastian. ""Reconstitution of the destruction complex defines roles of AXIN polymers and APC in β-catenin capture, phosphorylation, and ubiquitylation."" Molecular cell, 2021, pp. 3246-3261.e11.
[2] Han, Wonhee, Koo, Youngmu, Chaieb, Leila, Keum, Byeong-Rak, Han, Jin-Kwan. ""UCHL5 controls β-catenin destruction complex function through Axin1 regulation."" Scientific reports, 2022, pp. 3687.
[3] de Man, Saskia Madelon Ada, van Amerongen, Renée. ""Zooming in on the WNT/CTNNB1 Destruction Complex: Functional Mechanistic Details with Implications for Therapeutic Targeting."" Handbook of experimental pharmacology, 2021, pp. 137-173.
[4] Sehgal, Priyanka, Lanauze, Claudia, Wang, Xin, Hayer, Katharina E, Torres-Diz, Manuel, Leu, N Adrian, Sela, Yogev, Stanger, Ben Z, Lengner, Christopher J, Thomas-Tikhonenko, Andrei. ""MYC Hyperactivates Wnt Signaling in <i>APC</i>/<i>CTNNB1</i>-Mutated Colorectal Cancer Cells through miR-92a-Dependent Repression of <i>DKK3</i>."" Molecular cancer research : MCR, 2021, pp. 2003-2014.
[5] Huang, Qian, Wang, Chao-Cai, Liu, Yun-Guang, Zhao, Chang-Ming, Zhang, Tian-Ping, Liu, Yan, Wang, Hua. ""Clinical relevance of genetic polymorphisms in WNT signaling pathway (<i>SFRP1</i>, <i>WNT3A</i>, <i>CTNNB1, WIF-1</i>, <i>DKK-1</i>, <i>LRP5</i>, <i>LRP6</i>) on pulmonary tuberculosis in a Chinese population."" Frontiers in immunology, 2022, pp. 1011700.
[6] Wu, Hua, Lu, Xing-Xing, Wang, Jing-Ru, Yang, Tian-Yu, Li, Xiu-Ming, He, Xiao-Shun, Li, Yi, Ye, Wen-Long, Wu, Yong, Gan, Wen-Juan, Guo, Peng-Da, Li, Jian-Ming. ""TRAF6 inhibits colorectal cancer metastasis through regulating selective autophagic CTNNB1/β-catenin degradation and is targeted for GSK3B/GSK3β-mediated phosphorylation and degradation."" Autophagy, 2019, pp. 1506-1522.
[7] Sehgal, Priyanka, Lanauze, Claudia, Wang, Xin, Hayer, Katharina E, Torres-Diz, Manuel, Leu, N Adrian, Sela, Yogev, Stanger, Ben Z, Lengner, Christopher J, Thomas-Tikhonenko, Andrei. ""MYC Hyperactivates Wnt Signaling in <i>APC</i>/<i>CTNNB1</i>-Mutated Colorectal Cancer Cells through miR-92a-Dependent Repression of <i>DKK3</i>."" Molecular cancer research : MCR, 2021, pp. 2003-2014.
[8] Huang, Qian, Wang, Chao-Cai, Liu, Yun-Guang, Zhao, Chang-Ming, Zhang, Tian-Ping, Liu, Yan, Wang, Hua. ""Clinical relevance of genetic polymorphisms in WNT signaling pathway (<i>SFRP1</i>, <i>WNT3A</i>, <i>CTNNB1, WIF-1</i>, <i>DKK-1</i>, <i>LRP5</i>, <i>LRP6</i>) on pulmonary tuberculosis in a Chinese population."" Frontiers in immunology, 2022, pp. 1011700.
[9] Ng, Charlotte K Y, Dazert, Eva, Boldanova, Tuyana, Coto-Llerena, Mairene, Nuciforo, Sandro, Ercan, Caner, Suslov, Aleksei, Meier, Marie-Anne, Bock, Thomas, Schmidt, Alexander, Ketterer, Sylvia, Wang, Xueya, Wieland, Stefan, Matter, Matthias S, Colombi, Marco, Piscuoglio, Salvatore, Terracciano, Luigi M, Hall, Michael N, Heim, Markus H. ""Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages."" Nature communications, 2022, pp. 2436.
[10] Lorente, Elena, Barriga, Alejandro, García-Arriaza, Juan, Lemonnier, François A, Esteban, Mariano, López, Daniel. ""Complex antigen presentation pathway for an HLA-A*0201-restricted epitope from Chikungunya 6K protein."" PLoS neglected tropical diseases, 2017, pp. e0006036.
[11] Hong, Cheol-Hwa, Sohn, Hyun-Jung, Lee, Hyun-Joo, Cho, Hyun-Il, Kim, Tai-Gyu. ""Antigen Presentation by Individually Transferred HLA Class I Genes in HLA-A, HLA-B, HLA-C Null Human Cell Line Generated Using the Multiplex CRISPR-Cas9 System."" Journal of immunotherapy (Hagerstown, Md. : 1997), 2017, pp. 201-210.
[12] Zhan, T, Rindtorff, N, Boutros, M. ""Wnt signaling in cancer."" Oncogene, 2017, pp. 1461-1473.
[13] Goto, Toshiyasu, Matsuzawa, Junhei, Iemura, Shun-Ichiro, Natsume, Tohru, Shibuya, Hiroshi. ""WDR26 is a new partner of Axin1 in the canonical Wnt signaling pathway."" FEBS letters, 2016, pp. 1291-303.
[14] Li, Fei-Feng, Zhao, Zhi-Xun, Yan, Peng, Wang, Song, Liu, Zheng, Zhang, Qiong, Zhang, Xiao-Ning, Sun, Chang-Hao, Wang, Xi-Shan, Wang, Gui-Yu, Liu, Shu-Lin. ""Different effection of p.1125Val>Ala and rs11954856 in APC on Wnt signaling pathway."" Oncotarget, 2017, pp. 70854-70864.
[15] Yang, Wenhua, Cui, Guozhong, Ding, Mingjian, Yang, Meng, Dai, Dianlu. ""MicroRNA-124-3p.1 promotes cell proliferation through Axin1-dependent Wnt signaling pathway and predicts a poor prognosis of triple-negative breast cancer."" Journal of clinical laboratory analysis, 2020, pp. e23266.
"	0.4009534	0.3689537	Tied	LLM	NA
NeST	MAPK signaling	NEST:256	ERBB2 ERBB4 FGFR2 FGFR4 HRAS KRAS	6	2.584962500721156	Positive Regulation Of Phosphorylation 	GO:0042327	ERBB4;ERBB2;KRAS;FGFR4;HRAS;FGFR2	6	100	2.22e-12	5.07e-10	Receptor Tyrosine Kinase Signaling	"The most prominent biological process performed by this system of interacting proteins is receptor tyrosine kinase (RTK) signaling. This process is critical for cellular communication, growth, and differentiation.

1. ERBB2 and ERBB4: Both proteins belong to the epidermal growth factor receptor (EGFR) family, which are receptor tyrosine kinases. They play a crucial role in cell proliferation and differentiation by binding to specific ligands, leading to the activation of downstream signaling pathways such as the MAPK and PI3K/AKT pathways.

2. FGFR2 and FGFR4: These proteins are members of the fibroblast growth factor receptor (FGFR) family, which are also receptor tyrosine kinases. They are involved in various cellular processes, including cell growth, differentiation, and migration. FGFR2 and FGFR4 bind to fibroblast growth factors (FGFs) and activate downstream signaling pathways, such as the RAS/MAPK and PI3K/AKT pathways.

3. HRAS and KRAS: Both proteins are members of the RAS family of small GTPases, which function as molecular switches in various signaling pathways. They are activated by RTKs, such as ERBB2, ERBB4, FGFR2, and FGFR4, and play a critical role in the regulation of cell growth, differentiation, and survival. HRAS and KRAS are involved in the activation of the MAPK and PI3K/AKT pathways.

In summary, the prominent biological process performed by this system of interacting proteins is receptor tyrosine kinase signaling, which is essential for cellular communication, growth, and differentiation. The proteins ERBB2, ERBB4, FGFR2, and FGFR4 function as RTKs, while HRAS and KRAS are downstream effectors in the signaling pathways. These proteins work together to regulate various cellular processes, including cell proliferation, differentiation, and migration."	6	100	"The most prominent biological process performed by this system of interacting proteins is receptor tyrosine kinase (RTK) signaling. This process is critical for cellular communication, growth, and differentiation.

1. ERBB2 and ERBB4: Both proteins belong to the epidermal growth factor receptor (EGFR) family, which are receptor tyrosine kinases. They play a crucial role in cell proliferation and differentiation by binding to specific ligands, leading to the activation of downstream signaling pathways such as the MAPK and PI3K/AKT pathways.[1][2][3]

2. FGFR2 and FGFR4: These proteins are members of the fibroblast growth factor receptor (FGFR) family, which are also receptor tyrosine kinases. They are involved in various cellular processes, including cell growth, differentiation, and migration. FGFR2 and FGFR4 bind to fibroblast growth factors (FGFs) and activate downstream signaling pathways, such as the RAS/MAPK and PI3K/AKT pathways.[4][5][6]

3. HRAS and KRAS: Both proteins are members of the RAS family of small GTPases, which function as molecular switches in various signaling pathways. They are activated by RTKs, such as ERBB2, ERBB4, FGFR2, and FGFR4, and play a critical role in the regulation of cell growth, differentiation, and survival. HRAS and KRAS are involved in the activation of the MAPK and PI3K/AKT pathways.[7][8][9]

In summary, the prominent biological process performed by this system of interacting proteins is receptor tyrosine kinase signaling, which is essential for cellular communication, growth, and differentiation. The proteins ERBB2, ERBB4, FGFR2, and FGFR4 function as RTKs, while HRAS and KRAS are downstream effectors in the signaling pathways. These proteins work together to regulate various cellular processes, including cell proliferation, differentiation, and migration.[10][11][12]

========================================================================================================================================================================================================
[1] Wei, Dang, Rui, Bian, Qingquan, Fan, Chen, Cai, Ping, Hu Yun, Xiaoling, Song, Hao, Weng, Jun, Gu. ""KIF11 promotes cell proliferation via ERBB2/PI3K/AKT signaling pathway in gallbladder cancer."" International journal of biological sciences, 2021, pp. 514-526.
[2] Ma, Xuejiao, Chen, Jingruo, Huang, Bohan, Fu, Shiqi, Qu, Shuai, Yu, Rong, Zhao, Yuhua. ""ErbB2-upregulated HK1 and HK2 promote breast cancer cell proliferation, migration and invasion."" Medical oncology (Northwood, London, England), 2023, pp. 154.
[3] Kedashiro, Shin, Kameyama, Takeshi, Mizutani, Kiyohito, Takai, Yoshimi. ""Stimulatory role of nectin-4 and p95-ErbB2 in multilayered T47D cell proliferation."" Genes to cells : devoted to molecular & cellular mechanisms, 2022, pp. 451-464.
[4] Fang, Xianlong, Yang, Dongmei, Luo, Hongping, Wu, Shuai, Dong, Wenjie, Xiao, Jing, Yuan, Sujing, Ni, Aimin, Zhang, Kang-Jian, Liu, Xin-Yuan, Chu, Liang. ""SNORD126 promotes HCC and CRC cell growth by activating the PI3K-AKT pathway through FGFR2."" Journal of molecular cell biology, 2017, pp. 243-255.
[5] Shi, Yuanyuan, Liu, Xuejiao, Fredimoses, Mangaladoss, Song, Mengqiu, Chen, Hanyong, Liu, Kangdong, Lee, Mee-Hyun, Dong, Zigang. ""FGFR2 regulation by picrasidine Q inhibits the cell growth and induces apoptosis in esophageal squamous cell carcinoma."" Journal of cellular biochemistry, 2018, pp. 2231-2239.
[6] Park, Jihyun, Kim, Sun Young, Kim, Ha-Jung, Kim, Kyoung-Mee, Choi, Eun Young, Kang, Myung-Soo. ""A reciprocal regulatory circuit between CD44 and FGFR2 via c-myc controls gastric cancer cell growth."" Oncotarget, 2016, pp. 28670-83.
[7] Yin, Guowei, Huang, Jing, Petela, Johnny, Jiang, Hongmei, Zhang, Yuetong, Gong, Siqi, Wu, Jiaxin, Liu, Bei, Shi, Jianyou, Gao, Yijun. ""Targeting small GTPases: emerging grasps on previously untamable targets, pioneered by KRAS."" Signal transduction and targeted therapy, 2023, pp. 212.
[8] Cai, Qixu, Hosokawa, Tomohisa, Zeng, Menglong, Hayashi, Yasunori, Zhang, Mingjie. ""Shank3 Binds to and Stabilizes the Active Form of Rap1 and HRas GTPases via Its NTD-ANK Tandem with Distinct Mechanisms."" Structure (London, England : 1993), 2020, pp. 290-300.e4.
[9] Yuan, Ling, Li, Jiaxin, Yang, Yi, Chen, Yan, Bu, Yang, Ye, Mengyi, Mao, Xiongjie, Ma, Tingting, Yu, Lei, Nan, Yi. ""LINC00514 promotes gastric cancer cell growth and EMT progression via miR-204-3p/KRAS."" Aging, 2021, pp. 12007-12015.
[10] Talwelkar, Sarang S, Nagaraj, Ashwini S, Devlin, Jennifer R, Hemmes, Annabrita, Potdar, Swapnil, Kiss, Elina A, Saharinen, Pipsa, Salmenkivi, Kaisa, Mäyränpää, Mikko I, Wennerberg, Krister, Verschuren, Emmy W. ""Receptor Tyrosine Kinase Signaling Networks Define Sensitivity to ERBB Inhibition and Stratify <i>Kras</i>-Mutant Lung Cancers."" Molecular cancer therapeutics, 2019, pp. 1863-1874.
[11] Tapinos, Nikos, Ohnishi, Makoto, Rambukkana, Anura. ""ErbB2 receptor tyrosine kinase signaling mediates early demyelination induced by leprosy bacilli."" Nature medicine, 2006, pp. 961-6.
[12] Mukherji, Mridul, Brill, Laurence M, Ficarro, Scott B, Hampton, Garret M, Schultz, Peter G. ""A phosphoproteomic analysis of the ErbB2 receptor tyrosine kinase signaling pathways."" Biochemistry, 2006, pp. 15529-40.
"	0.6257839	0.399123	LLM	LLM	NA
NeST	MutL alpha/beta complex	NEST:277	BRCA1 BRIP1 MLH1 PMS1 PMS2	5	2.321928094887362	Mismatch Repair 	GO:0006298	PMS2;MLH1;PMS1	3	60	1.72e-8	1.6e-6	DNA Repair and Maintenance	"The system of interacting proteins, consisting of BRCA1, BRIP1, MLH1, PMS1, and PMS2, primarily performs the biological process of DNA repair and maintenance. This process is crucial for maintaining genomic stability and preventing the accumulation of mutations that could lead to diseases such as cancer.

1. BRCA1: BRCA1 is a tumor suppressor protein that plays a critical role in maintaining genomic stability. It is involved in the repair of double-strand DNA breaks through homologous recombination, a high-fidelity repair mechanism. BRCA1 also participates in cell cycle checkpoint control, ensuring that damaged DNA is not replicated before repair. Loss of BRCA1 function is associated with an increased risk of breast and ovarian cancer.

2. BRIP1: BRIP1, also known as BACH1 or FANCJ, is a DNA helicase that interacts with BRCA1. It is involved in the repair of DNA interstrand crosslinks, which can cause replication fork stalling and lead to genomic instability. Mutations in BRIP1 have been linked to Fanconi anemia, a rare genetic disorder characterized by bone marrow failure and an increased risk of cancer.

3. MLH1: MLH1 is a key component of the DNA mismatch repair (MMR) system, which corrects base-pair mismatches and small insertion/deletion loops that arise during DNA replication. Loss of MLH1 function results in microsatellite instability and an increased risk of colorectal and endometrial cancer.

4. PMS1: PMS1 is another component of the MMR system and forms a heterodimer with MLH1. The MLH1-PMS1 complex recognizes and binds to DNA mismatches, initiating the repair process. Mutations in PMS1 have been associated with hereditary nonpolyposis colorectal cancer (HNPCC), also known as Lynch syndrome.

5. PMS2: PMS2 is a third component of the MMR system and forms a heterodimer with MLH1, similar to PMS1. The MLH1-PMS2 complex is responsible for the repair of DNA mismatches and the prevention of mutation accumulation. Mutations in PMS2 are also associated with Lynch syndrome.

In conclusion, the interacting proteins BRCA1, BRIP1, MLH1, PMS1, and PMS2 are primarily involved in the biological process of DNA repair and maintenance. These proteins function together to maintain genomic stability and prevent the accumulation of mutations that could lead to diseases such as cancer."	5	100	"The system of interacting proteins, consisting of BRCA1, BRIP1, MLH1, PMS1, and PMS2, primarily performs the biological process of DNA repair and maintenance. This process is crucial for maintaining genomic stability and preventing the accumulation of mutations that could lead to diseases such as cancer.[1][2][3]

1. BRCA1: BRCA1 is a tumor suppressor protein that plays a critical role in maintaining genomic stability. It is involved in the repair of double-strand DNA breaks through homologous recombination, a high-fidelity repair mechanism. BRCA1 also participates in cell cycle checkpoint control, ensuring that damaged DNA is not replicated before repair. Loss of BRCA1 function is associated with an increased risk of breast and ovarian cancer.[4][5][6]

2. BRIP1: BRIP1, also known as BACH1 or FANCJ, is a DNA helicase that interacts with BRCA1. It is involved in the repair of DNA interstrand crosslinks, which can cause replication fork stalling and lead to genomic instability. Mutations in BRIP1 have been linked to Fanconi anemia, a rare genetic disorder characterized by bone marrow failure and an increased risk of cancer.[7][8][9]

3. MLH1: MLH1 is a key component of the DNA mismatch repair (MMR) system, which corrects base-pair mismatches and small insertion/deletion loops that arise during DNA replication. Loss of MLH1 function results in microsatellite instability and an increased risk of colorectal and endometrial cancer.[10][11][12]

4. PMS1: PMS1 is another component of the MMR system and forms a heterodimer with MLH1. The MLH1-PMS1 complex recognizes and binds to DNA mismatches, initiating the repair process. Mutations in PMS1 have been associated with hereditary nonpolyposis colorectal cancer (HNPCC), also known as Lynch syndrome.[13][14][15]

5. PMS2: PMS2 is a third component of the MMR system and forms a heterodimer with MLH1, similar to PMS1. The MLH1-PMS2 complex is responsible for the repair of DNA mismatches and the prevention of mutation accumulation. Mutations in PMS2 are also associated with Lynch syndrome.[16][17][18]

In conclusion, the interacting proteins BRCA1, BRIP1, MLH1, PMS1, and PMS2 are primarily involved in the biological process of DNA repair and maintenance. These proteins function together to maintain genomic stability and prevent the accumulation of mutations that could lead to diseases such as cancer.[19][20][21]

========================================================================================================================================================================================================
[1] Yoshida, Kiyotsugu, Miki, Yoshio. ""Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage."" Cancer science, 2004, pp. 866-71.
[2] Tarsounas, Madalena, Sung, Patrick. ""The antitumorigenic roles of BRCA1-BARD1 in DNA repair and replication."" Nature reviews. Molecular cell biology, 2020, pp. 284-299.
[3] Savage, Kienan I, Harkin, D Paul. ""BRCA1, a 'complex' protein involved in the maintenance of genomic stability."" The FEBS journal, 2015, pp. 630-46.
[4] Li, Qianyan, Engebrecht, JoAnne. ""BRCA1 and BRCA2 Tumor Suppressor Function in Meiosis."" Frontiers in cell and developmental biology, 2021, pp. 668309.
[5] Minami, Akari, Nakanishi, Atsuko, Ogura, Yasunori, Kitagishi, Yasuko, Matsuda, Satoru. ""Connection between Tumor Suppressor BRCA1 and PTEN in Damaged DNA Repair."" Frontiers in oncology, 2014, pp. 318.
[6] Jhanwar-Uniyal, Meena. ""BRCA1 in cancer, cell cycle and genomic stability."" Frontiers in bioscience : a journal and virtual library, 2003, pp. s1107-17.
[7] Yoshida, Kiyotsugu, Miki, Yoshio. ""Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage."" Cancer science, 2004, pp. 866-71.
[8] Tarsounas, Madalena, Sung, Patrick. ""The antitumorigenic roles of BRCA1-BARD1 in DNA repair and replication."" Nature reviews. Molecular cell biology, 2020, pp. 284-299.
[9] Savage, Kienan I, Matchett, Kyle B, Barros, Eliana M, Cooper, Kevin M, Irwin, Gareth W, Gorski, Julia J, Orr, Katy S, Vohhodina, Jekaterina, Kavanagh, Joy N, Madden, Angelina F, Powell, Alexander, Manti, Lorenzo, McDade, Simon S, Park, Ben Ho, Prise, Kevin M, McIntosh, Stuart A, Salto-Tellez, Manuel, Richard, Derek J, Elliott, Christopher T, Harkin, D Paul. ""BRCA1 deficiency exacerbates estrogen-induced DNA damage and genomic instability."" Cancer research, 2014, pp. 2773-2784.
[10] Zhang, Mu, Zhao, Jiawei, Glazer, Peter M, Bai, Wenlong, Bepler, Gerold, Zhang, Xiaohong Mary. ""Acetylation of MLH1 by CBP increases cellular DNA mismatch repair activity."" Journal of biochemistry, 2023, pp. 183-191.
[11] Rogacheva, Maria V, Manhart, Carol M, Chen, Cheng, Guarne, Alba, Surtees, Jennifer, Alani, Eric. ""Mlh1-Mlh3, a meiotic crossover and DNA mismatch repair factor, is a Msh2-Msh3-stimulated endonuclease."" The Journal of biological chemistry, 2014, pp. 5664-73.
[12] Stark, Andreas M, Doukas, Alexander, Hugo, Heinz-Herrmann, Hedderich, Jürgen, Hattermann, Kirsten, Maximilian Mehdorn, H, Held-Feindt, Janka. ""Expression of DNA mismatch repair proteins MLH1, MSH2, and MSH6 in recurrent glioblastoma."" Neurological research, 2015, pp. 95-105.
[13] Korabiowska, M, Dengler, H, Kellner, S, Stachura, J, Schauer, A. ""Decreased expression of MLH1, MSH2, PMS1 and PMS2 in pigmented lesions indicates accumulation of failed DNA repair along with malignant transformation and tumour progression."" Oncology reports, 1997, pp. 653-5.
[14] Kahn, Ryan M, Gordhandas, Sushmita, Maddy, Brandon Paul, Baltich Nelson, Becky, Askin, Gulce, Christos, Paul J, Caputo, Thomas A, Chapman-Davis, Eloise, Holcomb, Kevin, Frey, Melissa K. ""Universal endometrial cancer tumor typing: How much has immunohistochemistry, microsatellite instability, and MLH1 methylation improved the diagnosis of Lynch syndrome across the population?"" Cancer, 2019, pp. 3172-3183.
[15] Yokoyama, Takanori, Takehara, Kazuhiro, Sugimoto, Nao, Kaneko, Keika, Fujimoto, Etsuko, Okazawa-Sakai, Mika, Okame, Shinichi, Shiroyama, Yuko, Yokoyama, Takashi, Teramoto, Norihiro, Ohsumi, Shozo, Saito, Shinya, Imai, Kazuho, Sugano, Kokichi. ""Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review."" BMC cancer, 2018, pp. 576.
[16] Reitsam, Nic Gabriel, Märkl, Bruno, Dintner, Sebastian, Waidhauser, Johanna, Vlasenko, Dmytro, Grosser, Bianca. ""Concurrent loss of MLH1, PMS2 and MSH6 immunoexpression in digestive system cancers indicating a widespread dysregulation in DNA repair processes."" Frontiers in oncology, 2022, pp. 1019798.
[17] Schafmayer, Clemens, Buch, Stephan, Egberts, Jan Hendrik, Franke, Andre, Brosch, Mario, El Sharawy, Abdou, Conring, Mareike, Koschnick, Maralde, Schwiedernoch, Sven, Katalinic, Alexander, Kremer, Bernd, Fölsch, Ulrich R, Krawczak, Michael, Fändrich, Fred, Schreiber, Stefan, Tepel, Jürgen, Hampe, Jochen. ""Genetic investigation of DNA-repair pathway genes PMS2, MLH1, MSH2, MSH6, MUTYH, OGG1 and MTH1 in sporadic colon cancer."" International journal of cancer, 2007, pp. 555-8.
[18] Kurpiel, Brett, Thomas, Martha S, Mubeen, Mansoor, Ring, Kari L, Modesitt, Susan C, Moskaluk, Christopher A, Mills, Anne M. ""MLH1/PMS2-deficient Endometrial Carcinomas in a Universally Screened Population: MLH1 Hypermethylation and Germline Mutation Status."" International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists, 2022, pp. 1-11.
[19] Yoshida, Kiyotsugu, Miki, Yoshio. ""Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage."" Cancer science, 2004, pp. 866-71.
[20] Tarsounas, Madalena, Sung, Patrick. ""The antitumorigenic roles of BRCA1-BARD1 in DNA repair and replication."" Nature reviews. Molecular cell biology, 2020, pp. 284-299.
[21] Savage, Kienan I, Harkin, D Paul. ""BRCA1, a 'complex' protein involved in the maintenance of genomic stability."" The FEBS journal, 2015, pp. 630-46.
"	0.45544624	0.62469625	GO	GO	NA
NeST	ECM-cytoskeleton assembly	NEST:51	ACTA2 FANCC FGF10 PALLD PDGFRB TNF	6	2.584962500721156	Positive Regulation Of ERK1 And ERK2 Cascade 	GO:0070374	PDGFRB;TNF;FGF10	3	50	1.38e-5	0.00455016	Actin Cytoskeleton Regulation and Cellular Signaling	"Analysis:

1. ACTA2: ACTA2 encodes for alpha-actin 2, a major component of the actin cytoskeleton. It plays a crucial role in cell motility, structure, and integrity. The presence of ACTA2 in this system suggests a role in maintaining cellular architecture and facilitating movement.

2. FANCC: FANCC is a component of the Fanconi anemia (FA) core complex, which is involved in DNA repair and the response to DNA damage. Its interaction with other proteins in this system may contribute to maintaining genomic stability and preventing mutations.

3. FGF10: FGF10 is a member of the fibroblast growth factor (FGF) family, which is involved in various biological processes, including cell growth, differentiation, and migration. FGF10 specifically plays a role in tissue development and repair, suggesting a possible involvement in cellular signaling and tissue regeneration in this system.

4. PALLD: PALLD encodes for palladin, an actin-binding protein that plays a role in actin cytoskeleton organization and cell adhesion. Its interaction with ACTA2 in this system may contribute to the regulation of the actin cytoskeleton and cellular structure.

5. PDGFRB: PDGFRB is a receptor tyrosine kinase that binds platelet-derived growth factor (PDGF) and is involved in various cellular processes, including cell proliferation, differentiation, and migration. Its presence in this system suggests a role in cellular signaling and response to growth factors.

6. TNF: TNF encodes for tumor necrosis factor, a pro-inflammatory cytokine involved in immune response, inflammation, and apoptosis. Its interaction with other proteins in this system may contribute to the regulation of cellular stress responses and inflammation.

In conclusion, the most prominent biological process performed by this system of interacting proteins is the regulation of the actin cytoskeleton and cellular signaling. This is supported by the presence of ACTA2, PALLD, and PDGFRB, which are involved in maintaining cellular structure and facilitating movement, as well as FGF10 and TNF, which contribute to cellular signaling and response to growth factors and inflammation."	6	100	"1. ACTA2: ACTA2 encodes for alpha-actin 2, a major component of the actin cytoskeleton. It plays a crucial role in cell motility, structure, and integrity. The presence of ACTA2 in this system suggests a role in maintaining cellular architecture and facilitating movement.[1][2][3]

2. FANCC: FANCC is a component of the Fanconi anemia (FA) core complex, which is involved in DNA repair and the response to DNA damage. Its interaction with other proteins in this system may contribute to maintaining genomic stability and preventing mutations.[4][5][6]

3. FGF10: FGF10 is a member of the fibroblast growth factor (FGF) family, which is involved in various biological processes, including cell growth, differentiation, and migration. FGF10 specifically plays a role in tissue development and repair, suggesting a possible involvement in cellular signaling and tissue regeneration in this system.[7][8][9]

4. PALLD: PALLD encodes for palladin, an actin-binding protein that plays a role in actin cytoskeleton organization and cell adhesion. Its interaction with ACTA2 in this system may contribute to the regulation of the actin cytoskeleton and cellular structure.[10][11][12]

5. PDGFRB: PDGFRB is a receptor tyrosine kinase that binds platelet-derived growth factor (PDGF) and is involved in various cellular processes, including cell proliferation, differentiation, and migration. Its presence in this system suggests a role in cellular signaling and response to growth factors.[13][14][15]

6. TNF: TNF encodes for tumor necrosis factor, a pro-inflammatory cytokine involved in immune response, inflammation, and apoptosis. Its interaction with other proteins in this system may contribute to the regulation of cellular stress responses and inflammation.[16][17][18]

In conclusion, the most prominent biological process performed by this system of interacting proteins is the regulation of the actin cytoskeleton and cellular signaling. This is supported by the presence of ACTA2, PALLD, and PDGFRB, which are involved in maintaining cellular structure and facilitating movement, as well as FGF10 and TNF, which contribute to cellular signaling and response to growth factors and inflammation.[19][20][21]

========================================================================================================================================================================================================
[1] Jeon, Myeongjin, You, Daeun, Bae, Soo Youn, Kim, Seok Won, Nam, Seok Jin, Kim, Hyeon Ho, Kim, Sangmin, Lee, Jeong Eon. ""Dimerization of EGFR and HER2 induces breast cancer cell motility through STAT1-dependent ACTA2 induction."" Oncotarget, 2017, pp. 50570-50581.
[2] Disabella, Eliana, Grasso, Maurizia, Gambarin, Fabiana Isabella, Narula, Nupoor, Dore, Roberto, Favalli, Valentina, Serio, Alessandra, Antoniazzi, Elena, Mosconi, Mario, Pasotti, Michele, Odero, Attilio, Arbustini, Eloisa. ""Risk of dissection in thoracic aneurysms associated with mutations of smooth muscle alpha-actin 2 (ACTA2)."" Heart (British Cardiac Society), 2011, pp. 321-6.
[3] Rockey, Don C, Weymouth, Nate, Shi, Zengdun. ""Smooth muscle α actin (Acta2) and myofibroblast function during hepatic wound healing."" PloS one, 2013, pp. e77166.
[4] Pan, Zhi-Wen, Wang, Xiao-Jia, Chen, Tianhui, Ding, Xiao-Wen, Jiang, Xiyi, Gao, Yun, Mo, Wen-Ju, Huang, Yuan, Lou, Cai-Jin, Cao, Wen-Ming. ""Deleterious Mutations in DNA Repair Gene <i>FANCC</i> Exist in <i>BRCA1/2</i>-Negative Chinese Familial Breast and/or Ovarian Cancer Patients."" Frontiers in oncology, 2019, pp. 169.
[5] Kitao, Hiroyuki, Yamamoto, Kazuhiko, Matsushita, Nobuko, Ohzeki, Mioko, Ishiai, Masamichi, Takata, Minoru. ""Functional interplay between BRCA2/FancD1 and FancC in DNA repair."" The Journal of biological chemistry, 2006, pp. 21312-21320.
[6] Niedzwiedz, Wojciech, Mosedale, Georgina, Johnson, Mark, Ong, Chong Yi, Pace, Paul, Patel, Ketan J. ""The Fanconi anaemia gene FANCC promotes homologous recombination and error-prone DNA repair."" Molecular cell, 2004, pp. 607-20.
[7] Matsubara, Yusuke, Aoki, Michiru, Endo, Tonami, Sato, Kan. ""Characterization of the expression profiles of adipogenesis-related factors, ZNF423, KLFs and FGF10, during preadipocyte differentiation and abdominal adipose tissue development in chickens."" Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology, 2013, pp. 189-95.
[8] Ohta, Hiroya, Itoh, Nobuyuki. ""Roles of FGFs as Adipokines in Adipose Tissue Development, Remodeling, and Metabolism."" Frontiers in endocrinology, 2014, pp. 18.
[9] Clayton, Natasha S, Grose, Richard P. ""Emerging Roles of Fibroblast Growth Factor 10 in Cancer."" Frontiers in genetics, 2018, pp. 499.
[10] Niedenberger, Bryan A, Chappell, Vesna A, Otey, Carol A, Geyer, Christopher B. ""Actin dynamics regulate subcellular localization of the F-actin-binding protein PALLD in mouse Sertoli cells."" Reproduction (Cambridge, England), 2014, pp. 333-41.
[11] Yadav, Rahul, Vattepu, Ravi, Beck, Moriah R. ""Phosphoinositide Binding Inhibits Actin Crosslinking and Polymerization by Palladin."" Journal of molecular biology, 2016, pp. 4031-4047.
[12] Chen, Daomei, Li, Bin, Jiang, Liang, Li, Yizhou, Yang, Yepeng, Luo, Zhifang, Wang, Jiaqiang. ""Pristine Cu-MOF Induces Mitotic Catastrophe and Alterations of Gene Expression and Cytoskeleton in Ovarian Cancer Cells."" ACS applied bio materials, 2020, pp. 4081-4094.
[13] Dunn, I F, Heese, O, Black, P M. ""Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs."" Journal of neuro-oncology, 2000, pp. 121-37.
[14] Reigstad, Laila J, Varhaug, Jan E, Lillehaug, Johan R. ""Structural and functional specificities of PDGF-C and PDGF-D, the novel members of the platelet-derived growth factors family."" The FEBS journal, 2005, pp. 5723-41.
[15] Pinkas, H, Fisch, B, Rozansky, G, Felz, C, Kessler-Icekson, G, Krissi, H, Nitke, S, Ao, A, Abir, R. ""Platelet-derived growth factors (PDGF-A and -B) and their receptors in human fetal and adult ovaries."" Molecular human reproduction, 2008, pp. 199-206.
[16] Ferguson, Thomas A, Griffith, Thomas S. ""The role of Fas ligand and TNF-related apoptosis-inducing ligand (TRAIL) in the ocular immune response."" Chemical immunology and allergy, 2007, pp. 140-154.
[17] Kong, Linghe, Qian, Kun, Wu, Siwei, Li, Bingxi, Guo, Zheng, Yin, Xiaoxue, Huang, Yu, Ye, Jianmin, Tu, Xiao, Fu, Shengli. ""Functional characterization of TNF-α in pufferfish (Takifugu obscurus) in immune response and apoptosis against Aeromonas hydrophila."" Journal of fish diseases, 2021, pp. 1343-1353.
[18] Pontes, Gerlândia N, Cardoso, Elaine C, Carneiro-Sampaio, Magda M S, Markus, Regina P. ""Pineal melatonin and the innate immune response: the TNF-alpha increase after cesarean section suppresses nocturnal melatonin production."" Journal of pineal research, 2007, pp. 365-71.
[19] Vasilopoulos, Y, Gkretsi, V, Armaka, M, Aidinis, V, Kollias, G. ""Actin cytoskeleton dynamics linked to synovial fibroblast activation as a novel pathogenic principle in TNF-driven arthritis."" Annals of the rheumatic diseases, 2007, pp. iii23-8.
[20] Koukouritaki, S B, Vardaki, E A, Papakonstanti, E A, Lianos, E, Stournaras, C, Emmanouel, D S. ""TNF-alpha induces actin cytoskeleton reorganization in glomerular epithelial cells involving tyrosine phosphorylation of paxillin and focal adhesion kinase."" Molecular medicine (Cambridge, Mass.), 1999, pp. 382-92.
[21] Mattson, M P, Barger, S W, Furukawa, K, Bruce, A J, Wyss-Coray, T, Mark, R J, Mucke, L. ""Cellular signaling roles of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer's disease."" Brain research. Brain research reviews, 1997, pp. 47-61.
"	0.6487546	0.22992301	LLM	LLM	NA
NeST	Cyclin D associated events in G1	NEST:58	CCND1 CCND2 CCND3 CCNE1 CCNE2 CDK4 CDK5 CDK6 CDKN1A CDKN1B CDKN1C CDKN2A CDKN2B CDKN2C CKS1B E2F1 E2F2 E2F3 E2F4 E2F5 HLA-A MDM2 RB1 RBL1 RBL2 TFDP1 TP53	27	4.754887502163468	G1/S Transition Of Mitotic Cell Cycle 	GO:0000082	CDKN1A;CDKN1B;CCND3;TFDP1;CDK6;CCND2;CCNE2;CDK5;CCND1;CCNE1;CDK4;E2F1;E2F2;E2F3	14	51.85185185185185	3.8800000000000003e-29	1.7500000000000002e-26	Cell Cycle Regulation	"The primary biological process performed by this system of interacting proteins is the regulation of the cell cycle. The cell cycle is a series of events that lead to cell growth, DNA replication, and cell division. The proteins involved in this system play crucial roles in controlling the progression of the cell cycle and ensuring the fidelity of DNA replication.

1. Cyclins and cyclin-dependent kinases (CDKs): CCND1, CCND2, CCND3, CCNE1, CCNE2, CDK4, CDK5, CDK6 are cyclins and CDKs that form complexes to regulate cell cycle progression. Cyclins (CCND1-3, CCNE1-2) bind to and activate CDKs (CDK4, CDK5, CDK6), which in turn phosphorylate target proteins to control cell cycle progression.

2. CDK inhibitors: CDKN1A, CDKN1B, CDKN1C, CDKN2A, CDKN2B, CDKN2C are CDK inhibitors that negatively regulate the cell cycle by binding to and inhibiting the activity of cyclin-CDK complexes. This prevents the phosphorylation of target proteins and halts cell cycle progression.

3. Retinoblastoma (Rb) family proteins: RB1, RBL1, RBL2 are tumor suppressor proteins that regulate cell cycle progression by binding to and inhibiting the activity of E2F transcription factors. In their hypophosphorylated state, Rb proteins sequester E2Fs, preventing the transcription of genes required for cell cycle progression.

4. E2F transcription factors: E2F1, E2F2, E2F3, E2F4, E2F5 are transcription factors that regulate the expression of genes required for cell cycle progression, particularly the G1/S transition. When Rb proteins are phosphorylated by cyclin-CDK complexes, E2Fs are released and activate the transcription of target genes.

5. TP53 and MDM2: TP53 is a tumor suppressor protein that plays a critical role in cell cycle regulation by inducing cell cycle arrest or apoptosis in response to DNA damage. MDM2 is an E3 ubiquitin ligase that negatively regulates TP53 by targeting it for proteasomal degradation.

6. CKS1B: CKS1B is a regulatory subunit of the cyclin-dependent kinase CDC28, which is involved in cell cycle progression. CKS1B is required for the proper function of CDC28 and its associated cyclins.

7. HLA-A: HLA-A is a major histocompatibility complex (MHC) class I molecule involved in the presentation of antigenic peptides to CD8+ T cells. Although not directly involved in cell cycle regulation, its interaction with other proteins in this system may have implications for immune surveillance and cancer development.

8. TFDP1: TFDP1 is a transcription factor that forms a complex with E2F proteins, enhancing their DNA-binding activity and promoting the transcription of genes required for cell cycle progression.

In summary, this system of interacting proteins plays a crucial role in the regulation of the cell cycle, ensuring proper cell growth, DNA replication, and cell division. Dysregulation of these proteins can lead to uncontrolled cell proliferation and the development of cancer."	27	100	"The primary biological process performed by this system of interacting proteins is the regulation of the cell cycle. The cell cycle is a series of events that lead to cell growth, DNA replication, and cell division. The proteins involved in this system play crucial roles in controlling the progression of the cell cycle and ensuring the fidelity of DNA replication.

1. Cyclins and cyclin-dependent kinases (CDKs): CCND1, CCND2, CCND3, CCNE1, CCNE2, CDK4, CDK5, CDK6 are cyclins and CDKs that form complexes to regulate cell cycle progression. Cyclins (CCND1-3, CCNE1-2) bind to and activate CDKs (CDK4, CDK5, CDK6), which in turn phosphorylate target proteins to control cell cycle progression.[1][2][3]

2. CDK inhibitors: CDKN1A, CDKN1B, CDKN1C, CDKN2A, CDKN2B, CDKN2C are CDK inhibitors that negatively regulate the cell cycle by binding to and inhibiting the activity of cyclin-CDK complexes. This prevents the phosphorylation of target proteins and halts cell cycle progression.[4][5][6]

3. Retinoblastoma (Rb) family proteins: RB1, RBL1, RBL2 are tumor suppressor proteins that regulate cell cycle progression by binding to and inhibiting the activity of E2F transcription factors. In their hypophosphorylated state, Rb proteins sequester E2Fs, preventing the transcription of genes required for cell cycle progression.[7][8][9]

4. E2F transcription factors: E2F1, E2F2, E2F3, E2F4, E2F5 are transcription factors that regulate the expression of genes required for cell cycle progression, particularly the G1/S transition. When Rb proteins are phosphorylated by cyclin-CDK complexes, E2Fs are released and activate the transcription of target genes.[10][11][12]

5. TP53 and MDM2: TP53 is a tumor suppressor protein that plays a critical role in cell cycle regulation by inducing cell cycle arrest or apoptosis in response to DNA damage. MDM2 is an E3 ubiquitin ligase that negatively regulates TP53 by targeting it for proteasomal degradation.[13][14][15]

6. CKS1B: CKS1B is a regulatory subunit of the cyclin-dependent kinase CDC28, which is involved in cell cycle progression. CKS1B is required for the proper function of CDC28 and its associated cyclins.[16][17][18]

7. HLA-A: HLA-A is a major histocompatibility complex (MHC) class I molecule involved in the presentation of antigenic peptides to CD8+ T cells. Although not directly involved in cell cycle regulation, its interaction with other proteins in this system may have implications for immune surveillance and cancer development.[19][20][21]

8. TFDP1: TFDP1 is a transcription factor that forms a complex with E2F proteins, enhancing their DNA-binding activity and promoting the transcription of genes required for cell cycle progression.[22][23][24]

In summary, this system of interacting proteins plays a crucial role in the regulation of the cell cycle, ensuring proper cell growth, DNA replication, and cell division. Dysregulation of these proteins can lead to uncontrolled cell proliferation and the development of cancer.

========================================================================================================================================================================================================
[1] Kozar, Katarzyna, Sicinski, Piotr. ""Cell cycle progression without cyclin D-CDK4 and cyclin D-CDK6 complexes."" Cell cycle (Georgetown, Tex.), 2005, pp. 388-91.
[2] Gong, Xueqian, Litchfield, Lacey M, Webster, Yue, Chio, Li-Chun, Wong, Swee Seong, Stewart, Trent R, Dowless, Michele, Dempsey, Jack, Zeng, Yi, Torres, Raquel, Boehnke, Karsten, Mur, Cecilia, Marugán, Carlos, Baquero, Carmen, Yu, Chunping, Bray, Steven M, Wulur, Isabella H, Bi, Chen, Chu, Shaoyou, Qian, Hui-Rong, Iversen, Philip W, Merzoug, Farhana F, Ye, Xiang S, Reinhard, Christoph, De Dios, Alfonso, Du, Jian, Caldwell, Charles W, Lallena, María José, Beckmann, Richard P, Buchanan, Sean G. ""Genomic Aberrations that Activate D-type Cyclins Are Associated with Enhanced Sensitivity to the CDK4 and CDK6 Inhibitor Abemaciclib."" Cancer cell, 2017, pp. 761-776.e6.
[3] Kohoutek, J, Dvorák, P, Hampl, A. ""Temporal distribution of CDK4, CDK6, D-type cyclins, and p27 in developing mouse oocytes."" Biology of reproduction, 2004, pp. 139-45.
[4] Bi, Guoshu, Liang, Jiaqi, Zhao, Mengnan, Zhang, Huan, Jin, Xing, Lu, Tao, Zheng, Yuansheng, Bian, Yunyi, Chen, Zhencong, Huang, Yiwei, Besskaya, Valeria, Zhan, Cheng, Wang, Qun, Tan, Lijie. ""miR-6077 promotes cisplatin/pemetrexed resistance in lung adenocarcinoma via CDKN1A/cell cycle arrest and KEAP1/ferroptosis pathways."" Molecular therapy. Nucleic acids, 2022, pp. 366-386.
[5] Lee, Jinkwon, Kim, Kwangho, Ryu, Tae Young, Jung, Cho-Rok, Lee, Moo-Seung, Lim, Jung Hwa, Park, Kunhyang, Kim, Dae-Soo, Son, Mi-Young, Hamamoto, Ryuji, Cho, Hyun-Soo. ""EHMT1 knockdown induces apoptosis and cell cycle arrest in lung cancer cells by increasing CDKN1A expression."" Molecular oncology, 2021, pp. 2989-3002.
[6] Jeong, Eun-Hui, Lee, Tae-Gul, Ko, Yun Jung, Kim, Seo Yun, Kim, Hye-Ryoun, Kim, Hyunggee, Kim, Cheol Hyeon. ""Anti-tumor effect of CDK inhibitors on CDKN2A-defective squamous cell lung cancer cells."" Cellular oncology (Dordrecht), 2018, pp. 663-675.
[7] Yao, Yang, Liu, Chao, Wang, Bojun, Guan, Xin, Fang, Lin, Zhan, Fei, Sun, Haoxiu, Li, Hengzhen, Lou, Changjie, Yan, Feihu, Lu, Xiaolin, Cui, Luying, Liao, Yuanyu, Han, Shuling, Yao, Yuanfei, Zhang, Yanqiao. ""HOXB9 blocks cell cycle progression to inhibit pancreatic cancer cell proliferation through the DNMT1/RBL2/c-Myc axis."" Cancer letters, 2022, pp. 215595.
[8] Lam, E W, La Thangue, N B. ""DP and E2F proteins: coordinating transcription with cell cycle progression."" Current opinion in cell biology, 1994, pp. 859-66.
[9] Guarner, Ana, Morris, Robert, Korenjak, Michael, Boukhali, Myriam, Zappia, Maria Paula, Van Rechem, Capucine, Whetstine, Johnathan R, Ramaswamy, Sridhar, Zou, Lee, Frolov, Maxim V, Haas, Wilhelm, Dyson, Nicholas J. ""E2F/DP Prevents Cell-Cycle Progression in Endocycling Fat Body Cells by Suppressing dATM Expression."" Developmental cell, 2017, pp. 689-703.e5.
[10] Engeland, Kurt. ""Cell cycle regulation: p53-p21-RB signaling."" Cell death and differentiation, 2022, pp. 946-960.
[11] Giacinti, C, Giordano, A. ""RB and cell cycle progression."" Oncogene, 2006, pp. 5220-7.
[12] Zatulovskiy, Evgeny, Zhang, Shuyuan, Berenson, Daniel F, Topacio, Benjamin R, Skotheim, Jan M. ""Cell growth dilutes the cell cycle inhibitor Rb to trigger cell division."" Science (New York, N.Y.), 2020, pp. 466-471.
[13] Kussie, P H, Gorina, S, Marechal, V, Elenbaas, B, Moreau, J, Levine, A J, Pavletich, N P. ""Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain."" Science (New York, N.Y.), 1996, pp. 948-53.
[14] Basset-Séguin, N, Molès, J P, Mils, V, Dereure, O, Guilhou, J J. ""TP53 tumor suppressor gene and skin carcinogenesis."" The Journal of investigative dermatology, 1994, pp. 102S-106S.
[15] Li, Hongyan, Zhang, Hong, Huang, Guomin, Bing, Zhitong, Xu, Duling, Liu, Jiadi, Luo, Hongtao, An, Xiaoli. ""Loss of RPS27a expression regulates the cell cycle, apoptosis, and proliferation via the RPL11-MDM2-p53 pathway in lung adenocarcinoma cells."" Journal of experimental & clinical cancer research : CR, 2022, pp. 33.
[16] Senn, Heather, Shapiro, Rebecca S, Cowen, Leah E. ""Cdc28 provides a molecular link between Hsp90, morphogenesis, and cell cycle progression in Candida albicans."" Molecular biology of the cell, 2012, pp. 268-83.
[17] Zimmermann, Christine, Chymkowitch, Pierre, Eldholm, Vegard, Putnam, Christopher D, Lindvall, Jessica M, Omerzu, Manja, Bjørås, Magnar, Kolodner, Richard D, Enserink, Jorrit M. ""A chemical-genetic screen to unravel the genetic network of CDC28/CDK1 links ubiquitin and Rad6-Bre1 to cell cycle progression."" Proceedings of the National Academy of Sciences of the United States of America, 2011, pp. 18748-53.
[18] Martín-Ezquerra, Gemma, Salgado, Rocío, Toll, Agustí, Baró, Teresa, Mojal, Sergi, Yébenes, Mireia, Garcia-Muret, Ma Pilar, Solé, Francesc, Quitllet, Francesc Alameda, Espinet, Blanca, Pujol, Ramon M. ""CDC28 protein kinase regulatory subunit 1B (CKS1B) expression and genetic status analysis in oral squamous cell carcinoma."" Histology and histopathology, 2011, pp. 71-7.
[19] Lorente, Elena, Barriga, Alejandro, García-Arriaza, Juan, Lemonnier, François A, Esteban, Mariano, López, Daniel. ""Complex antigen presentation pathway for an HLA-A*0201-restricted epitope from Chikungunya 6K protein."" PLoS neglected tropical diseases, 2017, pp. e0006036.
[20] Hong, Cheol-Hwa, Sohn, Hyun-Jung, Lee, Hyun-Joo, Cho, Hyun-Il, Kim, Tai-Gyu. ""Antigen Presentation by Individually Transferred HLA Class I Genes in HLA-A, HLA-B, HLA-C Null Human Cell Line Generated Using the Multiplex CRISPR-Cas9 System."" Journal of immunotherapy (Hagerstown, Md. : 1997), 2017, pp. 201-210.
[21] Rooney, Michael S, Shukla, Sachet A, Wu, Catherine J, Getz, Gad, Hacohen, Nir. ""Molecular and genetic properties of tumors associated with local immune cytolytic activity."" Cell, 2015, pp. 48-61.
[22] Mäkelä, Juho-Antti, Toppari, Jorma. ""Retinoblastoma-E2F Transcription Factor Interplay Is Essential for Testicular Development and Male Fertility."" Frontiers in endocrinology, 2022, pp. 903684.
[23] Kassab, Amal, Gupta, Ishita, Moustafa, Ala-Eddin Al. ""Role of E2F transcription factor in oral cancer: Recent insight and advancements."" Seminars in cancer biology, 2023, pp. 28-41.
[24] Li, Luwen, Wang, Shiguan, Zhang, Yihang, Pan, Jihong. ""The E2F transcription factor 2: What do we know?"" Bioscience trends, 2021, pp. 83-92.
"	0.55678684	0.6280365	GO	GO	NA
NeST	Chromosome centrometric region	NEST:59	AURKA AURKB BUB1B CHEK1 MKI67 RAD51 TOP2A	7	2.807354922057604	Regulation Of Cell Cycle Process 	GO:0010564	CHEK1;MKI67;AURKB;AURKA	4	57.14285714285714	5.87e-8	9.75e-6	Mitotic Regulation and DNA Repair	"Proteins: AURKA, AURKB, BUB1B, CHEK1, MKI67, RAD51, TOP2A.

1. AURKA and AURKB: Both proteins belong to the Aurora kinase family, which plays a crucial role in mitotic regulation. AURKA is involved in centrosome maturation and spindle assembly, while AURKB is essential for chromosome alignment and cytokinesis. Their interaction ensures proper cell division and prevents chromosomal instability.

2. BUB1B: This protein is a component of the mitotic spindle assembly checkpoint (SAC), which ensures accurate chromosome segregation during mitosis. BUB1B interacts with AURKB to regulate the SAC and prevent aneuploidy, a condition where cells have an abnormal number of chromosomes.

3. CHEK1: CHEK1 is a serine/threonine kinase involved in the DNA damage response pathway. It is activated in response to DNA damage and phosphorylates several substrates, including RAD51, to initiate DNA repair. Its interaction with other proteins in this system highlights the importance of maintaining genomic integrity during cell division.

4. MKI67: This protein is a cellular marker for proliferation, as it is expressed during all active phases of the cell cycle (G1, S, G2, and M). Its interaction with other proteins in this system suggests a role in coordinating cell division and ensuring proper cell cycle progression.

5. RAD51: RAD51 is a key protein in the homologous recombination pathway, which is essential for the repair of DNA double-strand breaks. Its interaction with CHEK1 and other proteins in this system highlights the importance of DNA repair in maintaining genomic stability during cell division.

6. TOP2A: This protein is a type II topoisomerase that plays a critical role in DNA replication, transcription, and chromosome segregation. It is involved in the resolution of topological stress during these processes, ensuring proper DNA replication and segregation. Its interaction with other proteins in this system underscores the importance of maintaining genomic integrity during cell division.

In conclusion, the most prominent biological process performed by this system of interacting proteins is mitotic regulation and DNA repair. The proteins work together to ensure proper cell division, maintain genomic stability, and prevent chromosomal abnormalities."	7	100	"Proteins: AURKA, AURKB, BUB1B, CHEK1, MKI67, RAD51, TOP2A.

1. AURKA and AURKB: Both proteins belong to the Aurora kinase family, which plays a crucial role in mitotic regulation. AURKA is involved in centrosome maturation and spindle assembly, while AURKB is essential for chromosome alignment and cytokinesis. Their interaction ensures proper cell division and prevents chromosomal instability.[1][2][3]

2. BUB1B: This protein is a component of the mitotic spindle assembly checkpoint (SAC), which ensures accurate chromosome segregation during mitosis. BUB1B interacts with AURKB to regulate the SAC and prevent aneuploidy, a condition where cells have an abnormal number of chromosomes.[4][5][6]

3. CHEK1: CHEK1 is a serine/threonine kinase involved in the DNA damage response pathway. It is activated in response to DNA damage and phosphorylates several substrates, including RAD51, to initiate DNA repair. Its interaction with other proteins in this system highlights the importance of maintaining genomic integrity during cell division.[7][8][9]

4. MKI67: This protein is a cellular marker for proliferation, as it is expressed during all active phases of the cell cycle (G1, S, G2, and M). Its interaction with other proteins in this system suggests a role in coordinating cell division and ensuring proper cell cycle progression.[10][11][12]

5. RAD51: RAD51 is a key protein in the homologous recombination pathway, which is essential for the repair of DNA double-strand breaks. Its interaction with CHEK1 and other proteins in this system highlights the importance of DNA repair in maintaining genomic stability during cell division.[13][14][15]

6. TOP2A: This protein is a type II topoisomerase that plays a critical role in DNA replication, transcription, and chromosome segregation. It is involved in the resolution of topological stress during these processes, ensuring proper DNA replication and segregation. Its interaction with other proteins in this system underscores the importance of maintaining genomic integrity during cell division.[16][17][18]

In conclusion, the most prominent biological process performed by this system of interacting proteins is mitotic regulation and DNA repair. The proteins work together to ensure proper cell division, maintain genomic stability, and prevent chromosomal abnormalities.

========================================================================================================================================================================================================
[1] Nikonova, Anna S, Astsaturov, Igor, Serebriiskii, Ilya G, Dunbrack, Roland L, Golemis, Erica A. ""Aurora A kinase (AURKA) in normal and pathological cell division."" Cellular and molecular life sciences : CMLS, 2013, pp. 661-87.
[2] Qin, Y, Zhang, S, Deng, S, An, G, Qin, X, Li, F, Xu, Y, Hao, M, Yang, Y, Zhou, W, Chang, H, Qiu, L. ""Epigenetic silencing of miR-137 induces drug resistance and chromosomal instability by targeting AURKA in multiple myeloma."" Leukemia, 2017, pp. 1123-1135.
[3] Endah, Endah, Wulandari, Febri, Putri, Yurananda, Jenie, Riris Istighfari, Meiyanto, Edy. ""Piperine Increases Pentagamavunon-1 Anti-cancer Activity on 4T1 Breast Cancer Through Mitotic Catastrophe Mechanism and Senescence with Sharing Targeting on Mitotic Regulatory Proteins."" Iranian journal of pharmaceutical research : IJPR, 2022, pp. e123820.
[4] Matsuura, Shinya, Matsumoto, Yoshiyuki, Morishima, Ken-ichi, Izumi, Hideki, Matsumoto, Hiroshi, Ito, Emi, Tsutsui, Keisuke, Kobayashi, Junya, Tauchi, Hiroshi, Kajiwara, Yoshinori, Hama, Seiji, Kurisu, Kaoru, Tahara, Hidetoshi, Oshimura, Mitsuo, Komatsu, Kenshi, Ikeuchi, Tatsuro, Kajii, Tadashi. ""Monoallelic BUB1B mutations and defective mitotic-spindle checkpoint in seven families with premature chromatid separation (PCS) syndrome."" American journal of medical genetics. Part A, 2006, pp. 358-67.
[5] Hanks, Sandra, Coleman, Kim, Reid, Sarah, Plaja, Alberto, Firth, Helen, Fitzpatrick, David, Kidd, Alexa, Méhes, Károly, Nash, Richard, Robin, Nathanial, Shannon, Nora, Tolmie, John, Swansbury, John, Irrthum, Alexandre, Douglas, Jenny, Rahman, Nazneen. ""Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B."" Nature genetics, 2004, pp. 1159-61.
[6] Pavone, Piero, Pappalardo, Xena Giada, Mustafa, Naira, Falsaperla, Raffaele, Marino, Simona Domenica, Corsello, Giovanni, Bianca, Sebastiano, Parano, Enrico, Ruggieri, Martino. ""Pathogenic correlation between mosaic variegated aneuploidy 1 (MVA1) and a novel BUB1B variant: a reappraisal of a severe syndrome."" Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2022, pp. 6529-6538.
[7] Foo, Tzeh Keong, Xia, Bing. ""BRCA1-Dependent and Independent Recruitment of PALB2-BRCA2-RAD51 in the DNA Damage Response and Cancer."" Cancer research, 2022, pp. 3191-3197.
[8] McKenzie, Lisa D, LeClair, John W, Miller, Kayla N, Strong, Averey D, Chan, Hilda L, Oates, Edward L, Ligon, Keith L, Brennan, Cameron W, Chheda, Milan G. ""CHD4 regulates the DNA damage response and RAD51 expression in glioblastoma."" Scientific reports, 2019, pp. 4444.
[9] Bai, Xiaobin, Wang, Jia, Huo, Longwei, Xie, Yuchen, Xie, Wanfu, Xu, Gaofeng, Wang, Maode. ""Serine/Threonine Kinase CHEK1-Dependent Transcriptional Regulation of RAD54L Promotes Proliferation and Radio Resistance in Glioblastoma."" Translational oncology, 2018, pp. 140-146.
[10] Loibl, Sibylle, Poortmans, Philip, Morrow, Monica, Denkert, Carsten, Curigliano, Giuseppe. ""Breast cancer."" Lancet (London, England), 2021, pp. 1750-1769.
[11] Uxa, Sigrid, Castillo-Binder, Paola, Kohler, Robin, Stangner, Konstanze, Müller, Gerd A, Engeland, Kurt. ""Ki-67 gene expression."" Cell death and differentiation, 2021, pp. 3357-3370.
[12] Wei, Dang, Rui, Bian, Qingquan, Fan, Chen, Cai, Ping, Hu Yun, Xiaoling, Song, Hao, Weng, Jun, Gu. ""KIF11 promotes cell proliferation via ERBB2/PI3K/AKT signaling pathway in gallbladder cancer."" International journal of biological sciences, 2021, pp. 514-526.
[13] Zhao, Jiao, Tian, Shanshan, Guo, Qiushi, Bao, Kaiwen, Yu, Guohui, Wang, Xiaodan, Shen, Xilin, Zhang, Jieyou, Chen, Jiaxin, Yang, Ying, Liu, Ling, Li, Xiangchun, Hao, Jihui, Yang, Na, Liu, Zhe, Ai, Ding, Yang, Jie, Zhu, Yi, Yao, Zhi, Ma, Shuai, Zhang, Kai, Shi, Lei. ""A PARylation-phosphorylation cascade promotes TOPBP1 loading and RPA-RAD51 exchange in homologous recombination."" Molecular cell, 2022, pp. 2571-2587.e9.
[14] Demeyer, A, Benhelli-Mokrani, H, Chénais, B, Weigel, P, Fleury, F. ""Inhibiting homologous recombination by targeting RAD51 protein."" Biochimica et biophysica acta. Reviews on cancer, 2021, pp. 188597.
[15] Hariharasudhan, Gurusamy, Jeong, Seo-Yeon, Kim, Min-Ji, Jung, Sung Mi, Seo, Gwanwoo, Moon, Ju-Ran, Lee, Sumi, Chang, In-Youb, Kee, Younghoon, You, Ho Jin, Lee, Jung-Hee. ""TOPORS-mediated RAD51 SUMOylation facilitates homologous recombination repair."" Nucleic acids research, 2022, pp. 1501-1516.
[16] Uusküla-Reimand, Liis, Wilson, Michael D. ""Untangling the roles of TOP2A and TOP2B in transcription and cancer."" Science advances, 2022, pp. eadd4920.
[17] Bao, Zhong-Ming, Yao, Dan, Qian, Xu, Zhang, Hua-Guo, Yang, Ming, Guo, Yun-Hu, Qin, Lei. ""Activating transcription factor 2 promotes the progression of hepatocellular carcinoma by inducing the activation of the WHSC1-mediated TOP2A/PI3K/AKT axis."" The Kaohsiung journal of medical sciences, 2022, pp. 662-674.
[18] Pommier, Yves, Nussenzweig, André, Takeda, Shunichi, Austin, Caroline. ""Human topoisomerases and their roles in genome stability and organization."" Nature reviews. Molecular cell biology, 2022, pp. 407-427.
"	0.49449745	0.25601375	LLM	LLM	NA
NeST	Culin-RIng uniqutin ligase complex	NEST:61	CUL3 DDB2 ELOC MDM2 NF2 STK11 TET2 VHL	8	3	Protein Ubiquitination 	GO:0016567	CUL3;MDM2;VHL;ELOC;DDB2	5	62.5	2.5e-7	5.61e-5	Ubiquitin-Proteasome Pathway	"The system of interacting proteins CUL3, DDB2, ELOC, MDM2, NF2, STK11, TET2, and VHL primarily participates in the ubiquitin-proteasome pathway, which is responsible for the degradation of proteins in the cell.

1. CUL3: Cullin-3 is a scaffold protein that forms the core of E3 ubiquitin ligase complexes. It plays a crucial role in the ubiquitination of target proteins, marking them for degradation by the proteasome.

2. DDB2: DNA damage-binding protein 2 is a component of the UV-DDB complex, which is involved in nucleotide excision repair. DDB2 also functions as a substrate receptor for CUL4-DDB1 E3 ubiquitin ligase, targeting proteins for degradation.

3. ELOC: Elongin C is a component of the Elongin BC complex, which acts as an adaptor for Cullin-RING E3 ubiquitin ligases, such as VHL. This interaction promotes the ubiquitination of target proteins.

4. MDM2: Mouse double minute 2 homolog is an E3 ubiquitin ligase that targets the tumor suppressor protein p53 for degradation. MDM2 also interacts with other proteins, regulating their stability and activity.

5. NF2: Neurofibromin 2, also known as Merlin, is a tumor suppressor protein that regulates cell growth and proliferation. NF2 has been reported to interact with CUL3, suggesting a role in the ubiquitin-proteasome pathway.

6. STK11: Serine/threonine kinase 11, also known as LKB1, is a tumor suppressor protein that regulates cell polarity and energy metabolism. STK11 has been shown to interact with CUL3, implicating it in the ubiquitin-proteasome pathway.

7. TET2: Tet methylcytosine dioxygenase 2 is an enzyme involved in DNA demethylation. TET2 has been reported to interact with CUL3, suggesting a role in the ubiquitin-proteasome pathway.

8. VHL: Von Hippel-Lindau tumor suppressor protein is a component of the VCB-CUL2 E3 ubiquitin ligase complex, which targets hypoxia-inducible factor (HIF) for degradation. VHL also interacts with Elongin C, further supporting its involvement in the ubiquitin-proteasome pathway.

In conclusion, the most prominent biological process performed by this system of interacting proteins is the ubiquitin-proteasome pathway, which is essential for maintaining cellular protein homeostasis and regulating various cellular processes. The interactions among these proteins facilitate the ubiquitination and subsequent degradation of target proteins, ensuring proper cellular function."	8	100	"The system of interacting proteins CUL3, DDB2, ELOC, MDM2, NF2, STK11, TET2, and VHL primarily participates in the ubiquitin-proteasome pathway, which is responsible for the degradation of proteins in the cell.[1][2][3]

1. CUL3: Cullin-3 is a scaffold protein that forms the core of E3 ubiquitin ligase complexes. It plays a crucial role in the ubiquitination of target proteins, marking them for degradation by the proteasome.[4][5][6]

2. DDB2: DNA damage-binding protein 2 is a component of the UV-DDB complex, which is involved in nucleotide excision repair. DDB2 also functions as a substrate receptor for CUL4-DDB1 E3 ubiquitin ligase, targeting proteins for degradation.[7][8][9]

3. ELOC: Elongin C is a component of the Elongin BC complex, which acts as an adaptor for Cullin-RING E3 ubiquitin ligases, such as VHL. This interaction promotes the ubiquitination of target proteins.[10][11][12]

4. MDM2: Mouse double minute 2 homolog is an E3 ubiquitin ligase that targets the tumor suppressor protein p53 for degradation. MDM2 also interacts with other proteins, regulating their stability and activity.[13][14][15]

5. NF2: Neurofibromin 2, also known as Merlin, is a tumor suppressor protein that regulates cell growth and proliferation. NF2 has been reported to interact with CUL3, suggesting a role in the ubiquitin-proteasome pathway.[16][17][18]

6. STK11: Serine/threonine kinase 11, also known as LKB1, is a tumor suppressor protein that regulates cell polarity and energy metabolism. STK11 has been shown to interact with CUL3, implicating it in the ubiquitin-proteasome pathway.[19][20][21]

7. TET2: Tet methylcytosine dioxygenase 2 is an enzyme involved in DNA demethylation. TET2 has been reported to interact with CUL3, suggesting a role in the ubiquitin-proteasome pathway.[22][23][24]

8. VHL: Von Hippel-Lindau tumor suppressor protein is a component of the VCB-CUL2 E3 ubiquitin ligase complex, which targets hypoxia-inducible factor (HIF) for degradation. VHL also interacts with Elongin C, further supporting its involvement in the ubiquitin-proteasome pathway.[25][26][27]

In conclusion, the most prominent biological process performed by this system of interacting proteins is the ubiquitin-proteasome pathway, which is essential for maintaining cellular protein homeostasis and regulating various cellular processes. The interactions among these proteins facilitate the ubiquitination and subsequent degradation of target proteins, ensuring proper cellular function.

========================================================================================================================================================================================================
[1] Xu, Qun, Li, Jinyou, Yang, Ji, Xu, Zherong. ""CUL3 and COPS5 Related to the Ubiquitin-Proteasome Pathway Are Potential Genes for Muscle Atrophy in Mice."" Evidence-based complementary and alternative medicine : eCAM, 2022, pp. 1488905.
[2] Chen, Guang, Zhou, Jun, Chen, Jie, Zhu, Jin, Liu, Shuang-Chun, Ding, Xiao-Fei, Zhang, Qiang. ""VHL regulates NEK1 via both HIF-2α pathway and ubiquitin-proteasome pathway in renal cancer cell."" Biochemical and biophysical research communications, 2019, pp. 797-802.
[3] Salinas, Gregory D, Blair, Leslie A C, Needleman, Leigh A, Gonzales, Justina D, Chen, Ying, Li, Min, Singer, Jeffrey D, Marshall, John. ""Actinfilin is a Cul3 substrate adaptor, linking GluR6 kainate receptor subunits to the ubiquitin-proteasome pathway."" The Journal of biological chemistry, 2006, pp. 40164-73.
[4] Li, Xuan, Yang, Kai-Bin, Chen, Wei, Mai, Jia, Wu, Xiao-Qi, Sun, Ting, Wu, Rui-Yan, Jiao, Lin, Li, Dan-Dan, Ji, Jiao, Zhang, Hai-Liang, Yu, Yan, Chen, Yu-Hong, Feng, Gong-Kan, Deng, Rong, Li, Jun-Dong, Zhu, Xiao-Feng. ""CUL3 (cullin 3)-mediated ubiquitination and degradation of BECN1 (beclin 1) inhibit autophagy and promote tumor progression."" Autophagy, 2021, pp. 4323-4340.
[5] Zhai, Fengguang, Li, Jingyun, Ye, Meng, Jin, Xiaofeng. ""The functions and effects of CUL3-E3 ligases mediated non-degradative ubiquitination."" Gene, 2022, pp. 146562.
[6] Saritas, Turgay, Cuevas, Catherina A, Ferdaus, Mohammed Z, Kuppe, Christoph, Kramann, Rafael, Moeller, Marcus J, Floege, Jürgen, Singer, Jeffrey D, McCormick, James A. ""Disruption of CUL3-mediated ubiquitination causes proximal tubule injury and kidney fibrosis."" Scientific reports, 2019, pp. 4596.
[7] Córdoba-Cañero, Dolores, Cognat, Valérie, Ariza, Rafael R, Roldán Arjona, Teresa, Molinier, Jean. ""Dual control of ROS1-mediated active DNA demethylation by DNA damage-binding protein 2 (DDB2)."" The Plant journal : for cell and molecular biology, 2017, pp. 1170-1181.
[8] Hu, Zhibin, Shao, Minhua, Yuan, Jing, Xu, Liang, Wang, Feng, Wang, Yi, Yuan, Wentao, Qian, Ji, Ma, Hongxia, Wang, Ying, Liu, Hongliang, Chen, Weihong, Yang, Lin, Jin, Guangfu, Huo, Xiang, Chen, Feng, Jin, Li, Wei, Qingyi, Huang, Wei, Lu, Daru, Wu, Tangchun, Shen, Hongbing. ""Polymorphisms in DNA damage binding protein 2 (DDB2) and susceptibility of primary lung cancer in the Chinese: a case-control study."" Carcinogenesis, 2006, pp. 1475-80.
[9] Zhang, Ying, Mandemaker, Imke K, Matsumoto, Syota, Foreman, Oded, Holland, Christopher P, Lloyd, Whitney R, Sugasawa, Kaoru, Vermeulen, Wim, Marteijn, Jurgen A, Galardy, Paul J. ""USP44 Stabilizes DDB2 to Facilitate Nucleotide Excision Repair and Prevent Tumors."" Frontiers in cell and developmental biology, 2021, pp. 663411.
[10] Zhang, Qing, Yang, Haifeng. ""The Roles of VHL-Dependent Ubiquitination in Signaling and Cancer."" Frontiers in oncology, 2012, pp. 35.
[11] Aki, Daisuke, Li, Qian, Li, Hui, Liu, Yun-Cai, Lee, Jee Ho. ""Immune regulation by protein ubiquitination: roles of the E3 ligases VHL and Itch."" Protein & cell, 2019, pp. 395-404.
[12] Wang, Kankan, Reichermeier, Kurt M, Liu, Xing. ""Quantitative analyses for effects of neddylation on CRL2<sup>VHL</sup> substrate ubiquitination and degradation."" Protein science : a publication of the Protein Society, 2021, pp. 2338-2345.
[13] Sola, Martina, Rendon-Angel, Azucena, Rojo Martinez, Viviana, Sgrignani, Jacopo, Magrin, Claudia, Piovesana, Ester, Cavalli, Andrea, Paganetti, Paolo, Papin, Stéphanie. ""Tau protein binds to the P53 E3 ubiquitin ligase MDM2."" Scientific reports, 2023, pp. 10208.
[14] Lee, Jihyun, Kim, Jongdoo, Kim, Eun Mi, Kim, Ukjin, Kang, A-Ram, Park, Jong Kuk, Um, Hong-Duck. ""p21<sup>WAF1/CIP1</sup> promotes p53 protein degradation by facilitating p53-Wip1 and p53-Mdm2 interaction."" Biochemical and biophysical research communications, 2021, pp. 23-28.
[15] Kim, Jongdoo, Lee, Jihyun, Kim, Ukjin, Park, Jong-Kuk, Um, Hong-Duck. ""Slug promotes p53 and p21 protein degradation by inducing Mdm2 expression in HCT116 colon cancer cells."" Oncology letters, 2021, pp. 681.
[16] Tranchant, Robin, Quetel, Lisa, Tallet, Anne, Meiller, Clement, Renier, Annie, de Koning, Leanne, de Reynies, Aurelien, Le Pimpec-Barthes, Francoise, Zucman-Rossi, Jessica, Jaurand, Marie-Claude, Jean, Didier. ""Co-occurring Mutations of Tumor Suppressor Genes, <i>LATS2</i> and <i>NF2</i>, in Malignant Pleural Mesothelioma."" Clinical cancer research : an official journal of the American Association for Cancer Research, 2017, pp. 3191-3202.
[17] McClatchey, Andrea I, Giovannini, Marco. ""Membrane organization and tumorigenesis--the NF2 tumor suppressor, Merlin."" Genes & development, 2005, pp. 2265-77.
[18] Primi, Marina C, Rangarajan, Erumbi S, Patil, Dipak N, Izard, Tina. ""Conformational flexibility determines the Nf2/merlin tumor suppressor functions."" Matrix biology plus, 2021, pp. 100074.
[19] Marinaccio, Christian, Suraneni, Praveen, Celik, Hamza, Volk, Andrew, Wen, Qiang Jeremy, Ling, Te, Bulic, Marinka, Lasho, Terra, Koche, Richard P, Famulare, Christopher A, Farnoud, Noushin, Stein, Brady, Schieber, Michael, Gurbuxani, Sandeep, Root, David E, Younger, Scott T, Hoffman, Ronald, Gangat, Naseema, Ntziachristos, Panagiotis, Chandel, Navdeep S, Levine, Ross L, Rampal, Raajit K, Challen, Grant A, Tefferi, Ayalew, Crispino, John D. ""LKB1/<i>STK11</i> Is a Tumor Suppressor in the Progression of Myeloproliferative Neoplasms."" Cancer discovery, 2021, pp. 1398-1410.
[20] Rho, Seung Bae, Byun, Hyun Jung, Kim, Boh-Ram, Lee, Chang Hoon. ""LKB1/STK11 Tumor Suppressor Reduces Angiogenesis by Directly Interacting with VEGFR2 in Tumorigenesis."" Biomolecules & therapeutics, 2023, pp. 456-465.
[21] Dorr, Casey, Janik, Callie, Weg, Madison, Been, Raha A, Bader, Justin, Kang, Ryan, Ng, Brandon, Foran, Lindsey, Landman, Sean R, O'Sullivan, M Gerard, Steinbach, Michael, Sarver, Aaron L, Silverstein, Kevin A T, Largaespada, David A, Starr, Timothy K. ""Transposon Mutagenesis Screen Identifies Potential Lung Cancer Drivers and CUL3 as a Tumor Suppressor."" Molecular cancer research : MCR, 2015, pp. 1238-47.
[22] Okashita, Naoki, Kuroki, Shunsuke, Maeda, Ryo, Tachibana, Makoto. ""TET2 catalyzes active DNA demethylation of the Sry promoter and enhances its expression."" Scientific reports, 2019, pp. 13462.
[23] Qiao, Yan, Zhou, Yanhua, Yang, Honglan, He, Zhixu, Fan, Anran. ""Tet2-mediated DNA demethylation regulates the proliferation and apoptosis of human leukemia K562 cells."" Cellular and molecular biology (Noisy-le-Grand, France), 2023, pp. 23-27.
[24] Xu, Qun, Li, Jinyou, Yang, Ji, Xu, Zherong. ""CUL3 and COPS5 Related to the Ubiquitin-Proteasome Pathway Are Potential Genes for Muscle Atrophy in Mice."" Evidence-based complementary and alternative medicine : eCAM, 2022, pp. 1488905.
[25] Buckley, Dennis L, Van Molle, Inge, Gareiss, Peter C, Tae, Hyun Seop, Michel, Julien, Noblin, Devin J, Jorgensen, William L, Ciulli, Alessio, Crews, Craig M. ""Targeting the von Hippel-Lindau E3 ubiquitin ligase using small molecules to disrupt the VHL/HIF-1α interaction."" Journal of the American Chemical Society, 2012, pp. 4465-8.
[26] Cardote, Teresa A F, Gadd, Morgan S, Ciulli, Alessio. ""Crystal Structure of the Cul2-Rbx1-EloBC-VHL Ubiquitin Ligase Complex."" Structure (London, England : 1993), 2017, pp. 901-911.e3.
[27] Nguyen, Henry C, Yang, Haitao, Fribourgh, Jennifer L, Wolfe, Leslie S, Xiong, Yong. ""Insights into Cullin-RING E3 ubiquitin ligase recruitment: structure of the VHL-EloBC-Cul2 complex."" Structure (London, England : 1993), 2015, pp. 441-449.
"	0.42402902	0.37787658	Tied	Tied	NA
NeST	Actin and actin-associated proteins	NEST:63	CBL MYH11 PIK3CA PPP1CB TPM1	5	2.321928094887362	Cardiac Muscle Contraction 	GO:0060048	PIK3CA;TPM1	2	40	2.63e-5	0.002047553	Actin-Myosin Regulation and Signaling	"1. Actin-Myosin Interaction: MYH11 and TPM1 are both involved in the regulation of actin-myosin interactions. MYH11 is a smooth muscle myosin heavy chain, which is a major component of the contractile apparatus in smooth muscle cells. TPM1 is a tropomyosin protein that binds to actin filaments and regulates actin-myosin interactions in muscle contraction. The interaction between these two proteins suggests a role in the regulation of muscle contraction and cytoskeletal organization.

2. Phosphatase Activity: PPP1CB is a catalytic subunit of protein phosphatase 1 (PP1), which is involved in the regulation of various cellular processes, including muscle contraction, by dephosphorylating target proteins. The interaction between PPP1CB and MYH11 or TPM1 may modulate the phosphorylation state of these proteins, thus affecting their function in actin-myosin regulation.

3. PI3K Signaling: PIK3CA is a catalytic subunit of phosphatidylinositol 3-kinase (PI3K), which is involved in various cellular processes, including cell growth, survival, and migration. The interaction between PIK3CA and CBL, an E3 ubiquitin-protein ligase, suggests a role in the regulation of PI3K signaling. CBL can mediate the ubiquitination and degradation of PI3K, thus modulating its activity and downstream signaling pathways.

4. CBL-Mediated Regulation: CBL can also interact with MYH11, suggesting a potential role in the regulation of actin-myosin interactions through ubiquitination and degradation of MYH11. This interaction may provide a link between PI3K signaling and actin-myosin regulation.

In conclusion, the most prominent biological process performed by this system of interacting proteins is the regulation of actin-myosin interactions and signaling, which is crucial for muscle contraction and cytoskeletal organization. The interactions between these proteins suggest a complex regulatory network involving phosphorylation, ubiquitination, and signaling pathways."	5	100	"1. Actin-Myosin Interaction: MYH11 and TPM1 are both involved in the regulation of actin-myosin interactions. MYH11 is a smooth muscle myosin heavy chain, which is a major component of the contractile apparatus in smooth muscle cells. TPM1 is a tropomyosin protein that binds to actin filaments and regulates actin-myosin interactions in muscle contraction. The interaction between these two proteins suggests a role in the regulation of muscle contraction and cytoskeletal organization.[1][2][3]

2. Phosphatase Activity: PPP1CB is a catalytic subunit of protein phosphatase 1 (PP1), which is involved in the regulation of various cellular processes, including muscle contraction, by dephosphorylating target proteins. The interaction between PPP1CB and MYH11 or TPM1 may modulate the phosphorylation state of these proteins, thus affecting their function in actin-myosin regulation.[4][5][6]

3. PI3K Signaling: PIK3CA is a catalytic subunit of phosphatidylinositol 3-kinase (PI3K), which is involved in various cellular processes, including cell growth, survival, and migration. The interaction between PIK3CA and CBL, an E3 ubiquitin-protein ligase, suggests a role in the regulation of PI3K signaling. CBL can mediate the ubiquitination and degradation of PI3K, thus modulating its activity and downstream signaling pathways.[7][8][9]

4. CBL-Mediated Regulation: CBL can also interact with MYH11, suggesting a potential role in the regulation of actin-myosin interactions through ubiquitination and degradation of MYH11. This interaction may provide a link between PI3K signaling and actin-myosin regulation.[10][11][12]

In conclusion, the most prominent biological process performed by this system of interacting proteins is the regulation of actin-myosin interactions and signaling, which is crucial for muscle contraction and cytoskeletal organization. The interactions between these proteins suggest a complex regulatory network involving phosphorylation, ubiquitination, and signaling pathways.

========================================================================================================================================================================================================
[1] Rysev, Nikita A, Karpicheva, Olga E, Redwood, Charles S, Borovikov, Yurii S. ""The effect of the Asp175Asn and Glu180Gly TPM1 mutations on actin-myosin interaction during the ATPase cycle."" Biochimica et biophysica acta, 2012, pp. 366-73.
[2] Isselbacher, Eric M, Lino Cardenas, Christian Lacks, Lindsay, Mark E. ""Hereditary Influence in Thoracic Aortic Aneurysm and Dissection."" Circulation, 2016, pp. 2516-28.
[3] Keyt, Lucas K, Duran, Jason M, Bui, Quan M, Chen, Chao, Miyamoto, Michael I, Silva Enciso, Jorge, Tardiff, Jil C, Adler, Eric D. ""Thin filament cardiomyopathies: A review of genetics, disease mechanisms, and emerging therapeutics."" Frontiers in cardiovascular medicine, 2022, pp. 972301.
[4] Velusamy, Thirunavukkarasu, Palanisamy, Nallasivam, Kalyana-Sundaram, Shanker, Sahasrabuddhe, Anagh Anant, Maher, Christopher A, Robinson, Daniel R, Bahler, David W, Cornell, Timothy T, Wilson, Thomas E, Lim, Megan S, Chinnaiyan, Arul M, Elenitoba-Johnson, Kojo S J. ""Recurrent reciprocal RNA chimera involving YPEL5 and PPP1CB in chronic lymphocytic leukemia."" Proceedings of the National Academy of Sciences of the United States of America, 2013, pp. 3035-40.
[5] Swain, Jason E, Ding, Jun, Brautigan, David L, Villa-Moruzzi, Emma, Smith, Gary D. ""Proper chromatin condensation and maintenance of histone H3 phosphorylation during mouse oocyte meiosis requires protein phosphatase activity."" Biology of reproduction, 2007, pp. 628-38.
[6] Silva, Joana V, Freitas, Maria J, Fardilha, Margarida. ""Phosphoprotein phosphatase 1 complexes in spermatogenesis."" Current molecular pharmacology, 2014, pp. 136-46.
[7] Agell, Laia, Hernández, Silvia, Salido, Marta, de Muga, Silvia, Juanpere, Nuria, Arumí-Uria, Montserrat, Menendez, Silvia, Lorenzo, Marta, Lorente, José A, Serrano, Sergio, Lloreta, Josep. ""PI3K signaling pathway is activated by PIK3CA mRNA overexpression and copy gain in prostate tumors, but PIK3CA, BRAF, KRAS and AKT1 mutations are infrequent events."" Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2011, pp. 443-52.
[8] Huang, Yen-Sung, Wu, Chang-Chieh, Chang, Che-Chang, Huang, Shiu-Feng, Kuo, Hong-Yi, Shih, Hsiu-Ming. ""Reciprocal regulation of Daxx and PIK3CA promotes colorectal cancer cell growth."" Cellular and molecular life sciences : CMLS, 2022, pp. 367.
[9] Wang, Zhongyu, Shang, Jun, Li, Zhiqin, Li, Huanhuan, Zhang, Chufan, He, Kai, Li, Shikang, Ju, Wen. ""PIK3CA Is Regulated by CUX1, Promotes Cell Growth and Metastasis in Bladder Cancer <i>via</i> Activating Epithelial-Mesenchymal Transition."" Frontiers in oncology, 2020, pp. 536072.
[10] Tang, Rong, Langdon, Wallace Y, Zhang, Jian. ""Negative regulation of receptor tyrosine kinases by ubiquitination: Key roles of the Cbl family of E3 ubiquitin ligases."" Frontiers in endocrinology, 2022, pp. 971162.
[11] Dibble, Christian C, Cantley, Lewis C. ""Regulation of mTORC1 by PI3K signaling."" Trends in cell biology, 2015, pp. 545-55.
[12] Lien, Evan C, Dibble, Christian C, Toker, Alex. ""PI3K signaling in cancer: beyond AKT."" Current opinion in cell biology, 2017, pp. 62-71.
"	0.5246696	0.29323885	LLM	LLM	NA
NeST	Protein nuclear transport	NEST:69	DAXX NUP93 NUP98 RANBP2 TERT XPO1	6	2.584962500721156	Nuclear Transport 	GO:0051169	NUP93;RANBP2;XPO1;NUP98	4	66.66666666666666	1.85e-10	2.49e-8	Telomere Maintenance and Nuclear Transport	"Proteins: DAXX, NUP93, NUP98, RANBP2, TERT, XPO1.

1. Telomere maintenance: TERT is the catalytic subunit of telomerase, an enzyme responsible for maintaining telomere length, which is crucial for genomic stability and cellular lifespan. DAXX is a chaperone protein that interacts with TERT, regulating its nuclear localization and activity.

2. Nuclear pore complex assembly: NUP93 and NUP98 are nucleoporins, essential components of the nuclear pore complex (NPC). They play a critical role in the assembly and structural integrity of the NPC, which is responsible for the selective transport of macromolecules between the nucleus and cytoplasm.

3. Nucleocytoplasmic transport: RANBP2 is a large, multifunctional protein that acts as a binding partner for the small GTPase RAN. It is involved in the regulation of nucleocytoplasmic transport, specifically in the export of proteins and RNA molecules from the nucleus to the cytoplasm. XPO1, also known as CRM1, is a major nuclear export receptor that mediates the export of numerous proteins, including DAXX and TERT, through the NPC.

4. Interactions and regulation: The interactions between these proteins are crucial for the proper functioning of the system. DAXX and TERT interaction regulates telomerase activity, while NUP93 and NUP98 interactions contribute to NPC assembly. RANBP2 and XPO1 interactions facilitate the export of proteins, including DAXX and TERT, from the nucleus.

In conclusion, the most prominent biological process performed by this system of interacting proteins is telomere maintenance and nuclear transport. The proteins are involved in maintaining telomere length, assembling the nuclear pore complex, and regulating nucleocytoplasmic transport. The interactions between these proteins are essential for the proper functioning of the system."	6	100	"Proteins: DAXX, NUP93, NUP98, RANBP2, TERT, XPO1.

1. Telomere maintenance: TERT is the catalytic subunit of telomerase, an enzyme responsible for maintaining telomere length, which is crucial for genomic stability and cellular lifespan. DAXX is a chaperone protein that interacts with TERT, regulating its nuclear localization and activity.[1][2][3]

2. Nuclear pore complex assembly: NUP93 and NUP98 are nucleoporins, essential components of the nuclear pore complex (NPC). They play a critical role in the assembly and structural integrity of the NPC, which is responsible for the selective transport of macromolecules between the nucleus and cytoplasm.[4][5][6]

3. Nucleocytoplasmic transport: RANBP2 is a large, multifunctional protein that acts as a binding partner for the small GTPase RAN. It is involved in the regulation of nucleocytoplasmic transport, specifically in the export of proteins and RNA molecules from the nucleus to the cytoplasm. XPO1, also known as CRM1, is a major nuclear export receptor that mediates the export of numerous proteins, including DAXX and TERT, through the NPC.[7][8][9]

4. Interactions and regulation: The interactions between these proteins are crucial for the proper functioning of the system. DAXX and TERT interaction regulates telomerase activity, while NUP93 and NUP98 interactions contribute to NPC assembly. RANBP2 and XPO1 interactions facilitate the export of proteins, including DAXX and TERT, from the nucleus.[10][11][12]

In conclusion, the most prominent biological process performed by this system of interacting proteins is telomere maintenance and nuclear transport. The proteins are involved in maintaining telomere length, assembling the nuclear pore complex, and regulating nucleocytoplasmic transport. The interactions between these proteins are essential for the proper functioning of the system.

========================================================================================================================================================================================================
[1] Duan, Xiao-Feng, Zhao, Qiang. ""TERT-mediated and ATRX-mediated Telomere Maintenance and Neuroblastoma."" Journal of pediatric hematology/oncology, 2018, pp. 1-6.
[2] Wang, Li-Na, Wang, Li, Cheng, Guanghui, Dai, Mingkai, Yu, Yunhai, Teng, Guoxin, Zhao, Jingjie, Xu, Dawei. ""The association of telomere maintenance and TERT expression with susceptibility to human papillomavirus infection in cervical epithelium."" Cellular and molecular life sciences : CMLS, 2022, pp. 110.
[3] Tang, Mengfan, Li, Yujing, Zhang, Yi, Chen, Yuxi, Huang, Wenjun, Wang, Dan, Zaug, Arthur J, Liu, Dan, Zhao, Yong, Cech, Thomas R, Ma, Wenbin, Songyang, Zhou. ""Disease mutant analysis identifies a new function of DAXX in telomerase regulation and telomere maintenance."" Journal of cell science, 2015, pp. 331-41.
[4] Madheshiya, Pankaj K, Shukla, Ekta, Singh, Jyotsana, Bawaria, Shrankhla, Ansari, Mohammed Yousuf, Chauhan, Radha. ""Insights into the role of Nup62 and Nup93 in assembling cytoplasmic ring and central transport channel of the nuclear pore complex."" Molecular biology of the cell, 2022, pp. ar139.
[5] Sonawane, Parshuram J, S Dewangan, Pravin, Madheshiya, Pankaj Kumar, Chopra, Kriti, Kumar, Mohit, Niranjan, Sangeeta, Ansari, Mohammed Yousuf, Singh, Jyotsana, Bawaria, Shrankhla, Banerjee, Manidipa, Chauhan, Radha. ""Molecular and structural analysis of central transport channel in complex with Nup93 of nuclear pore complex."" Protein science : a publication of the Protein Society, 2020, pp. 2510-2527.
[6] Galy, Vincent, Mattaj, Iain W, Askjaer, Peter. ""Caenorhabditis elegans nucleoporins Nup93 and Nup205 determine the limit of nuclear pore complex size exclusion in vivo."" Molecular biology of the cell, 2003, pp. 5104-15.
[7] Kuersten, S, Ohno, M, Mattaj, I W. ""Nucleocytoplasmic transport: Ran, beta and beyond."" Trends in cell biology, 2001, pp. 497-503.
[8] McGoldrick, Philip, Lau, Agnes, You, Zhipeng, Durcan, Thomas M, Robertson, Janice. ""Loss of C9orf72 perturbs the Ran-GTPase gradient and nucleocytoplasmic transport, generating compositionally diverse Importin β-1 granules."" Cell reports, 2023, pp. 112134.
[9] Porter, Frederick W, Bochkov, Yury A, Albee, Alison J, Wiese, Christiane, Palmenberg, Ann C. ""A picornavirus protein interacts with Ran-GTPase and disrupts nucleocytoplasmic transport."" Proceedings of the National Academy of Sciences of the United States of America, 2006, pp. 12417-22.
[10] Yuan, Xiaotian, Larsson, Catharina, Xu, Dawei. ""Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players."" Oncogene, 2019, pp. 6172-6183.
[11] Günes, Cagatay, Wezel, Felix, Southgate, Jennifer, Bolenz, Christian. ""Implications of TERT promoter mutations and telomerase activity in urothelial carcinogenesis."" Nature reviews. Urology, 2018, pp. 386-393.
[12] Marchese, Paola Valeria, Mollica, Veronica, Tassinari, Elisa, De Biase, Dario, Giunchi, Francesca, Marchetti, Andrea, Rosellini, Matteo, Fiorentino, Michelangelo, Massari, Francesco. ""Implications of TERT promoter mutations and telomerase activity in solid tumors with a focus on genitourinary cancers."" Expert review of molecular diagnostics, 2022, pp. 997-1008.
"	0.5832325	0.92332864	GO	GO	NA
NeST	EGFR-MAPK signaling	NEST:73	ABL1 AKT1 ARAF BRAF CBL CDC25A CDKN1B EGFR HDAC4 HDAC5 HRAS KRAS MAP2K1 MAP2K2 MAPK1 MDM4 MYC RAF1 STAT3 STAT5A TNF TSC1 TSC2	23	4.523561956057013	Regulation Of Cell Population Proliferation 	GO:0042127	HDAC4;STAT5A;MAP2K1;CDKN1B;STAT3;TSC2;TSC1;EGFR;MYC;AKT1;MDM4;KRAS;RAF1;HRAS	14	60.86956521739131	7.71e-15	5.99e-12	MAPK/ERK Signaling Pathway	"The most prominent biological process performed by this system of interacting proteins is the Mitogen-Activated Protein Kinase/Extracellular signal-Regulated Kinase (MAPK/ERK) signaling pathway. This pathway is crucial for regulating cell proliferation, differentiation, and survival.

1. Growth factor receptor activation: EGFR, a receptor tyrosine kinase, is activated upon binding to its ligand, leading to its autophosphorylation. This event initiates the downstream signaling cascade. EGFR is known to be involved in various cancers when mutated or overexpressed.

2. Recruitment of adaptor proteins: The phosphorylated EGFR recruits adaptor proteins, such as GRB2, which in turn binds to SOS, a guanine nucleotide exchange factor. This complex activates the small GTPase HRAS, which is a member of the RAS family (HRAS, KRAS, and NRAS). RAS proteins act as molecular switches, cycling between active (GTP-bound) and inactive (GDP-bound) states.

3. Activation of RAF kinases: Active RAS proteins recruit and activate RAF kinases (ARAF, BRAF, and RAF1) by promoting their dimerization and phosphorylation. RAF kinases are serine/threonine kinases that initiate the MAPK/ERK signaling cascade.

4. MAPK/ERK cascade: Activated RAF kinases phosphorylate and activate MAP2K1 and MAP2K2 (also known as MEK1 and MEK2), which in turn phosphorylate and activate MAPK1 (also known as ERK2). This sequential activation of kinases is the core of the MAPK/ERK signaling pathway.

5. Regulation of transcription factors: Activated MAPK1 translocates to the nucleus and phosphorylates various transcription factors, such as MYC, STAT3, and STAT5A, which regulate the expression of genes involved in cell proliferation, differentiation, and survival.

6. Negative regulation: Several proteins in this system negatively regulate the MAPK/ERK signaling pathway. CDKN1B (also known as p27) inhibits the cell cycle progression, while TSC1 and TSC2 form a complex that inhibits the mTOR pathway, which is involved in cell growth and protein synthesis. ABL1, a non-receptor tyrosine kinase, can also negatively regulate the RAS-RAF-MAPK pathway.

7. Protein degradation: CBL, an E3 ubiquitin ligase, mediates the ubiquitination and degradation of activated EGFR, thus terminating the signaling. MDM4, an MDM2 homolog, negatively regulates p53, a tumor suppressor protein, by promoting its degradation.

8. Epigenetic regulation: HDAC4 and HDAC5, members of the histone deacetylase family, are involved in the epigenetic regulation of gene expression by removing acetyl groups from histones, leading to chromatin condensation and transcriptional repression.

9. Inflammatory response: TNF, a pro-inflammatory cytokine, can activate the MAPK/ERK signaling pathway and is involved in various cellular processes, such as cell proliferation, differentiation, and apoptosis.

In conclusion, the MAPK/ERK signaling pathway is the most prominent biological process performed by this system of interacting proteins, playing a crucial role in cell proliferation, differentiation, and survival. Dysregulation of this pathway is implicated in various diseases, including cancer."	21	91.30434782608695	NA	0.76025486	0.2146343	LLM	LLM	NA
NeST	Mediator complex	NEST:90	CDK8 ESR1 FBXW7 MED1 MED12 RARA	6	2.584962500721156	Cellular Response To Hormone Stimulus 	GO:0032870	MED1;RARA;ESR1	3	50	1.99e-6	3.01733e-4	Transcriptional Regulation	"The primary biological process performed by this system of interacting proteins is transcriptional regulation. This process involves the control of gene expression through the modulation of transcription initiation and elongation.

1. CDK8: Cyclin-dependent kinase 8 (CDK8) is a component of the Mediator complex, which is essential for the regulation of RNA polymerase II-dependent transcription. CDK8 phosphorylates the C-terminal domain of RNA polymerase II, influencing the transition from transcription initiation to elongation.

2. ESR1: Estrogen receptor 1 (ESR1) is a nuclear hormone receptor that binds to estrogen and functions as a transcription factor. Upon ligand binding, ESR1 forms a dimer and interacts with specific DNA sequences, modulating the transcription of target genes involved in cell growth, differentiation, and survival.

3. FBXW7: F-box and WD repeat domain-containing 7 (FBXW7) is an E3 ubiquitin-protein ligase that targets specific proteins for ubiquitin-mediated degradation. FBXW7 plays a role in transcriptional regulation by controlling the stability of transcription factors, such as c-Myc and Notch, thereby influencing cell proliferation and differentiation.

4. MED1: Mediator complex subunit 1 (MED1) is a component of the Mediator complex, which is crucial for the regulation of RNA polymerase II-dependent transcription. MED1 serves as a coactivator for nuclear hormone receptors, such as ESR1 and RARA, and facilitates the recruitment of RNA polymerase II to target gene promoters.

5. MED12: Mediator complex subunit 12 (MED12) is another component of the Mediator complex, playing a role in the regulation of RNA polymerase II-dependent transcription. MED12 interacts with transcription factors, such as ESR1 and RARA, and modulates their activity, thereby influencing gene expression.

6. RARA: Retinoic acid receptor alpha (RARA) is a nuclear hormone receptor that binds to retinoic acid and functions as a transcription factor. Similar to ESR1, RARA forms a dimer upon ligand binding and interacts with specific DNA sequences, regulating the transcription of target genes involved in cell differentiation, growth, and survival.

In summary, the primary biological process performed by this system of interacting proteins is transcriptional regulation, with a focus on the modulation of RNA polymerase II-dependent transcription. The proteins CDK8, ESR1, FBXW7, MED1, MED12, and RARA interact to control gene expression through various mechanisms, including the regulation of transcription initiation and elongation, the stability of transcription factors, and the recruitment of RNA polymerase II to target gene promoters."	6	100	NA	0.32756776	0.25701198	Neither	LLM	NA
